data_2dsm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dsm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 C--O 1.228 -0.077 0 CA-C-O 121.874 0.845 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.32 121.24 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.478 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.779 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 29.0 pt20 -93.78 142.11 27.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 22' ' ' ILE . 22.5 mt -114.68 148.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.54 174.94 9.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.53 -35.72 70.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.91 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -82.43 -11.07 58.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.66 40.7 7.6 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.186 -1.006 . . . . 0.0 113.08 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 19.5 t70 -93.62 -95.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 23.9 tt0 177.42 126.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.779 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 39.8 t -109.21 104.63 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.308 0.575 . . . . 0.0 110.323 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.5 p -92.55 167.25 15.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.596 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 31.6 Cg_endo -65.09 -9.2 20.81 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.52 HG23 HD21 ' B' ' 65' ' ' LEU . 3.4 t -112.76 29.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.68 0.752 . . . . 0.0 109.133 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -129.84 139.69 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.862 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -89.27 128.54 35.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.547 ' CD2' HG21 ' A' ' 42' ' ' ILE . 18.6 p90 -142.4 170.11 16.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.44 135.58 49.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 30.4 mt -96.28 115.33 35.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.813 0.34 . . . . 0.0 110.264 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.47 88.1 6.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.407 0.622 . . . . 0.0 109.561 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.566 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 83.07 -33.42 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.229 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.16 -22.81 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.713 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.89 147.56 23.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 0.0 110.226 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.547 HG21 ' CD2' ' A' ' 35' ' ' TYR . 94.5 mt -94.38 128.85 45.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.909 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 48' ' ' LEU . 3.8 mp -130.03 129.59 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.178 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 45' ' ' ARG . 4.1 tt -67.36 138.7 56.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.413 ' N ' HD21 ' A' ' 44' ' ' LEU . 8.2 mmm-85 -53.55 -22.46 8.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.27 -40.8 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.252 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.58 -4.56 58.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.001 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HA ' HG23 ' A' ' 43' ' ' ILE . 33.8 tp -61.81 -44.2 97.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.54 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.1 -45.3 71.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.912 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -62.46 -48.7 78.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.387 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.5 -36.61 81.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.617 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.694 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 70.6 mt -66.8 -39.53 87.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.261 0.553 . . . . 0.0 110.485 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -70.49 -21.53 62.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.153 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.08 -59.5 2.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.65 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 27.3 tt0 -103.12 -67.46 0.88 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.2 tt 42.33 43.32 2.94 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.456 0.646 . . . . 0.0 109.378 -168.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.65 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -126.32 6.4 7.63 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.949 -1.119 . . . . 0.0 113.839 -166.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 54.6 -153.88 0.29 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.0 tp10 -112.89 101.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.037 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -97.77 110.17 22.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.521 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.71 163.66 13.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.874 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -144.98 -179.14 6.42 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 172.056 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 122.067 0.937 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.67 129.35 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.836 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -140.73 165.49 27.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.23 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.456 HG21 ' HA2' ' B' ' 26' ' ' GLY . 16.8 mt -132.02 156.22 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.435 ' N ' HG23 ' B' ' 22' ' ' ILE . 4.7 p-10 -79.89 -165.85 0.9 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 110.784 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -72.15 -34.74 68.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.557 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.4 -41.02 25.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 118.22 38.12 0.82 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 11.1 t70 -86.2 -93.38 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 32.0 tt0 168.81 121.99 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' B' ' 35' ' ' TYR . 14.4 t -112.53 127.56 69.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.444 0.64 . . . . 0.0 110.505 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.643 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 69.3 p -124.63 169.64 10.47 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.65 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.643 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 44.6 Cg_endo -68.58 18.15 0.15 Allowed 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.452 2.101 . . . . 0.0 113.053 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' B' ' 30' ' ' THR . 35.7 t -108.7 -32.44 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.866 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.45 ' OD2' HG12 ' B' ' 29' ' ' VAL . 6.0 p-10 -104.14 134.87 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.581 0.705 . . . . 0.0 111.086 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.7 135.74 48.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.477 ' CG ' HG11 ' B' ' 29' ' ' VAL . 26.0 p90 -152.1 166.42 31.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.737 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.88 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 75.5 t -135.82 146.97 28.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.9 mt -112.77 118.33 57.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.431 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 1.1 m-20 -98.02 88.9 4.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.566 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 70.47 24.08 77.06 Favored Glycine 0 C--N 1.319 -0.4 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.448 172.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.6 -23.99 8.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.549 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.39 138.33 35.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.821 0.343 . . . . 0.0 110.541 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -89.33 136.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.627 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.421 ' HB ' HD21 ' B' ' 48' ' ' LEU . 3.8 mp -134.97 131.25 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -52.19 140.3 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -67.36 -5.21 13.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 0.0 109.827 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.74 -26.49 54.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.471 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.87 5.07 9.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.737 0.78 . . . . 0.0 109.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.88 ' HG ' ' HB ' ' B' ' 36' ' ' VAL . 2.7 tm? -66.99 -38.19 85.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.013 -170.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -58.95 -39.61 82.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -63.66 -39.64 94.84 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.229 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.08 -38.66 72.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.641 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.42 ' HG ' HD13 ' B' ' 48' ' ' LEU . 18.8 mt -67.12 -25.06 66.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.955 0.407 . . . . 0.0 110.86 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.13 -41.04 74.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.748 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.51 -41.12 9.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.693 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -100.89 -52.71 3.23 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.374 -0.204 . . . . 0.0 111.414 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 tp 76.59 37.37 0.32 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.896 0.748 . . . . 0.0 111.491 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 75.97 -11.39 11.44 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 170.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -101.24 120.84 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.359 0.579 . . . . 0.0 112.036 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 43.7 tt0 -92.28 102.03 14.53 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.58 109.16 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.844 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.462 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 9.7 mmmm -116.29 78.72 1.22 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.122 0.487 . . . . 0.0 111.157 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.11 165.7 19.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.99 60.61 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.242 0.339 . . . . 0.0 110.928 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 63.64 19.37 11.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.845 0.831 . . . . 0.0 110.049 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.52 HD21 HG23 ' A' ' 32' ' ' VAL . 26.5 tp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.743 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.517 -0.301 0 CA-C-O 121.784 0.802 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.24 132.26 67.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.985 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.533 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 13.2 pt20 -142.19 159.39 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.163 -175.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.6 mt -133.14 149.49 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 4.5 p-10 -78.69 -171.16 2.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.16 0.505 . . . . 0.0 110.589 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -72.03 -27.94 63.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.564 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.28 -8.13 57.97 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.13 39.69 15.56 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.143 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 17.4 t70 -95.8 -89.81 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.5 tt0 176.54 142.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 68.8 t -122.22 121.38 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.55 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -117.75 162.86 26.92 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.13 -11.14 7.19 Favored 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 122.899 2.399 . . . . 0.0 114.224 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -96.44 2.29 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.004 0.431 . . . . 0.0 110.793 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -99.75 140.55 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.901 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.28 111.02 18.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -138.77 158.48 44.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.005 0.431 . . . . 0.0 110.818 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.488 ' HB ' HD23 ' A' ' 48' ' ' LEU . 92.3 t -133.89 140.59 46.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 46.4 mt -101.89 121.24 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.611 0.243 . . . . 0.0 110.435 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.09 88.74 3.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.425 0.631 . . . . 0.0 110.029 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.763 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 87.63 -24.52 10.11 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.271 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.26 -28.11 0.5 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.55 130.33 35.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.095 0.474 . . . . 0.0 109.896 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.482 HG12 HG12 ' A' ' 37' ' ' ILE . 76.8 mt -87.41 137.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.547 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.8 mp -138.74 125.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.147 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -52.84 148.68 7.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -62.89 -11.99 22.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.02 -15.33 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.278 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -117.36 -13.54 10.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.488 HD23 ' HB ' ' A' ' 36' ' ' VAL . 22.9 tp -64.74 -38.2 90.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -50.6 -51.57 47.28 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.652 0.595 . . . . 0.0 110.691 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 tpp85 -67.42 -36.23 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.958 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -65.73 -43.9 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.738 0.304 . . . . 0.0 110.432 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 46.7 mt -71.76 -22.51 61.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -78.61 -22.23 47.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.122 0.487 . . . . 0.0 109.738 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 72.7 mm-40 -93.68 -60.12 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 25.0 tt0 -92.15 -67.68 0.84 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.485 -173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 14.2 tp 43.73 37.98 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.047 0.451 . . . . 0.0 110.541 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.664 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -127.74 2.02 6.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.991 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.571 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.9 OUTLIER 61.33 -153.75 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.34 0.591 . . . . 0.0 110.686 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 11.1 tp10 -106.03 102.18 11.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.496 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' B' ' 36' ' ' VAL . 32.6 m-85 -89.54 104.78 17.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.504 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 55.4 mttm -118.49 94.14 4.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 111.241 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -83.43 70.27 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.311 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.937 178.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 121.149 0.5 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.23 135.62 49.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.572 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -136.36 -179.48 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.912 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' B' ' 28' ' ' GLU . 15.2 mt -129.59 141.62 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 2.5 p-10 -88.98 -170.92 3.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.06 0.457 . . . . 0.0 110.517 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.44 -30.12 70.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.412 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.26 -39.88 74.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.118 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.08 2.56 31.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.328 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.7 m-20 -71.83 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 34.5 tt0 172.84 157.82 0.11 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.459 174.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 76.7 t -130.51 105.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.534 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.776 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -104.19 171.26 5.21 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.776 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 25.9 Cg_endo -62.93 -0.57 2.16 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.682 2.254 . . . . 0.0 113.418 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.43 6.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.063 0.459 . . . . 0.0 110.582 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -102.92 138.88 39.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.259 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.7 128.4 33.59 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -156.62 159.59 38.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.394 0.616 . . . . 0.0 111.334 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 48' ' ' LEU . 78.1 t -134.4 137.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.245 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 59.4 mt -103.66 110.28 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -81.93 84.54 6.9 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 109.916 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.763 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 74.32 -16.51 2.88 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.712 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.04 -22.73 0.45 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -83.09 121.15 26.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.73 129.08 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.3 mp -134.32 136.85 52.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.548 ' HB3' ' OE1' ' B' ' 46' ' ' GLU . 39.4 mt -55.73 145.94 22.65 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 170.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -12.45 61.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.548 ' OE1' ' HB3' ' B' ' 44' ' ' LEU . 1.5 pm0 -87.75 -10.84 49.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -123.76 0.56 8.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.828 0.823 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' B' ' 36' ' ' VAL . 18.7 tp -67.96 -51.21 50.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.987 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.35 -53.96 12.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.31 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 0.1 OUTLIER -76.82 -33.73 57.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 -175.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.452 ' CD2' HG12 ' B' ' 43' ' ' ILE . 43.7 t80 -69.22 -40.02 78.2 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.761 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.7 mt -62.82 -38.73 91.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' B' ' 53' ' ' ARG . 1.3 tmm_? -55.32 -33.99 63.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.812 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 64.3 mm-40 -87.35 -38.32 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.162 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' B' ' 57' ' ' GLY . 5.9 tp-100 -99.07 -68.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 112.128 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 63.5 mt 40.75 43.59 1.69 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.117 0.484 . . . . 0.0 109.828 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.525 ' N ' ' HG3' ' B' ' 55' ' ' GLN . . . -105.22 -14.14 23.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.191 -167.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.571 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 7.9 m-85 58.7 -158.43 0.3 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.529 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -112.81 102.0 10.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 162.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -103.29 106.25 16.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.141 -170.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.86 150.07 25.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 0.0 110.886 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -137.35 140.1 41.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.35 -12.62 61.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.164 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 60.6 26.03 15.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.567 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.252 0.548 . . . . 0.0 110.192 178.717 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 121.145 0.497 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.34 84.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.188 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.692 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 21.9 pt20 -105.29 159.49 15.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 27' ' ' ASP . 14.0 mt -124.83 144.64 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . 1.2 p-10 -88.06 -176.95 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.068 0.461 . . . . 0.0 111.135 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.96 -37.18 71.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.174 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -65.57 -43.05 91.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.19 16.95 5.94 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 44' ' ' LEU . 9.2 t0 -106.45 158.61 16.77 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.47 132.19 41.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.229 0.537 . . . . 0.0 110.505 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 55.9 t -107.36 96.22 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.584 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.736 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 48.5 p -97.31 172.82 4.56 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.736 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 19.6 Cg_endo -62.22 -7.33 9.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.286 1.991 . . . . 0.0 112.523 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.14 -0.08 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 109.978 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -106.4 131.33 53.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.668 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -133.6 164.21 27.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.91 144.39 33.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 55.1 mt -106.43 115.72 48.64 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 122.182 0.991 . . . . 0.0 110.805 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB3' HD11 ' A' ' 43' ' ' ILE . 44.1 t0 -109.95 89.3 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.239 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.455 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.72 41.29 15.65 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.606 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.65 -17.28 15.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.965 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.92 137.84 32.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 35.1 mt -94.26 139.56 18.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.803 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.5 mp -139.03 127.73 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 27' ' ' ASP . 92.5 mt -57.03 145.49 30.38 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 169.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -19.54 35.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.466 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.46 -44.04 92.33 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.977 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -110.38 7.9 23.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.357 0.599 . . . . 0.0 110.044 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.71 -35.12 79.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.299 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.14 -33.43 67.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.296 0.569 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 8.4 tpm_? -67.01 -53.34 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.505 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.803 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -63.87 -43.29 96.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.44 -29.03 68.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.845 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -71.38 -26.52 62.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.751 0.31 . . . . 0.0 110.362 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 16.9 mm-40 -85.83 -68.96 0.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.974 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -103.88 -21.78 13.6 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.959 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.2 tp 65.45 44.24 3.16 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.441 0.463 . . . . 0.0 112.166 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.455 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.56 -11.42 68.36 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.742 171.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -95.89 104.37 16.3 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.718 -0.284 . . . . 0.0 110.467 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 61' ' ' LYS . 45.0 tt0 -93.04 102.84 15.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.017 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.485 ' HA ' HG22 ' B' ' 36' ' ' VAL . 94.1 m-85 -79.12 109.05 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.877 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 25.5 mmtp -109.65 105.8 15.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.164 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -75.81 168.65 19.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.499 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 0.0 111.389 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.57 94.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -103.34 157.38 17.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.64 HG12 ' HA ' ' B' ' 28' ' ' GLU . 18.6 mt -130.78 147.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.661 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' B' ' 29' ' ' VAL . 10.0 p-10 -73.72 -166.84 0.4 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.425 0.631 . . . . 0.0 111.062 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.86 -36.11 79.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.61 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -89.97 -34.82 15.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.491 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 110.51 41.35 1.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.802 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.38 -10.34 41.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.016 0.436 . . . . 0.0 109.846 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.64 ' HA ' HG12 ' B' ' 22' ' ' ILE . 30.8 tt0 65.09 97.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.066 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' B' ' 23' ' ' ASP . 40.6 t -95.86 103.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.02 -173.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.707 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 66.4 p -96.44 167.34 12.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.959 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.707 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.0 Cg_endo -64.76 20.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.649 2.899 . . . . 0.0 113.698 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 30' ' ' THR . 20.9 t -101.76 -21.15 5.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.159 0.504 . . . . 0.0 109.818 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -115.45 169.3 9.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.935 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -103.39 146.36 28.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 110.451 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.39 170.82 18.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.122 0.487 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.602 ' HB ' HD11 ' B' ' 48' ' ' LEU . 82.0 t -136.84 140.36 43.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mt -102.73 118.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 40' ' ' GLY . 26.5 t70 -89.48 86.55 6.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.509 ' O ' HG21 ' A' ' 37' ' ' ILE . . . 74.68 -36.27 1.02 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.212 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 38' ' ' ASP . . . -179.79 -25.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -173.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.58 130.95 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.18 124.81 40.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.16 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.26 121.8 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.137 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' B' ' 46' ' ' GLU . 1.7 tt -58.57 138.75 56.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.482 ' N ' HD22 ' B' ' 44' ' ' LEU . 5.5 mmm-85 -56.46 -16.76 6.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.551 ' HG2' HD23 ' B' ' 44' ' ' LEU . 9.0 mm-40 -74.57 -28.49 60.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -173.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -125.82 24.02 7.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.813 0.816 . . . . 0.0 109.447 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' B' ' 36' ' ' VAL . 25.9 tp -68.78 -45.14 72.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.264 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -45.84 67.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.112 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 9.3 tpt180 -68.6 -43.2 76.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.309 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.49 -45.95 77.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.874 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.34 -30.0 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.612 0.244 . . . . 0.0 111.066 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -63.1 -41.9 99.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -93.75 -25.91 17.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.756 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp60 -102.5 -67.74 0.86 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.356 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 40.77 40.31 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.689 0.756 . . . . 0.0 109.693 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.756 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -103.04 -34.01 4.13 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.381 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.9 -165.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.8 tp10 -115.74 102.26 9.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 123.45 45.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.098 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.86 176.81 7.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 0.0 110.347 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -166.33 170.84 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.72 57.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.463 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 58.58 24.17 11.7 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.424 0.63 . . . . 0.0 111.157 -172.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.4 103.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.407 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 152.05 23.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.233 0.539 . . . . 0.0 111.451 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 28' ' ' GLU . 53.4 mt -118.88 149.4 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.89 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.2 p-10 -84.34 -163.01 0.73 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 -177.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -75.95 -25.0 55.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.025 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -69.05 -33.01 72.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.7 33.78 10.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.789 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -103.4 -80.73 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.939 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 179.28 137.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.34 115.88 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 p -104.71 162.5 19.61 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 28.0 Cg_endo -62.95 -1.62 2.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 113.161 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.77 -2.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.575 0.226 . . . . 0.0 111.101 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.21 -170.95 1.74 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 5.1 t0 -126.87 134.9 50.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.59 -171.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' CD2' HG21 ' A' ' 42' ' ' ILE . 35.5 p90 -156.49 161.05 40.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.048 0.452 . . . . 0.0 111.452 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.416 ' HB ' HD12 ' A' ' 48' ' ' LEU . 87.4 t -137.25 144.73 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 19.2 mt -105.6 124.66 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 111.403 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.421 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 16.8 t70 -96.99 87.99 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.19 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 80.6 -22.22 4.88 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.502 173.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.58 -31.57 0.37 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 123.61 28.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.519 HG12 HG12 ' A' ' 37' ' ' ILE . 70.5 mt -82.56 142.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.883 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.5 mp -136.41 132.7 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -60.17 143.57 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HG3' ' CG ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -58.03 -19.68 33.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.75 -33.78 60.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.63 0.15 16.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 28.7 tp -55.99 -56.08 25.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.979 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -68.63 -23.5 64.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.22 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -73.92 -42.73 60.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.421 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 55.5 t80 -64.63 -36.1 83.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.369 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.626 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 77.6 mt -65.74 -33.61 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.291 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -68.63 -28.62 67.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 6.1 mm-40 -80.51 -57.74 3.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.601 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.556 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 6.0 tt0 -102.93 -67.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER 48.19 45.35 19.89 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -169.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.556 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -109.31 -33.76 2.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.285 -167.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.474 ' CD2' ' HA3' ' B' ' 57' ' ' GLY . 1.7 m-85 63.5 -166.71 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.152 0.476 . . . . 0.0 109.748 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.2 tp10 -107.6 101.84 11.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.391 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -106.7 112.04 24.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.985 0.421 . . . . 0.0 110.24 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -101.69 177.55 4.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -162.42 136.44 6.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.555 0.693 . . . . 0.0 110.396 178.508 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.775 ' HB2' ' HD3' ' B' ' 31' ' ' PRO . 8.5 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.086 0.469 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 101.87 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.76 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' B' ' 29' ' ' VAL . 7.8 pt20 -140.31 133.83 30.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.427 HG23 ' N ' ' B' ' 23' ' ' ASP . 5.1 mt -99.36 154.64 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.335 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 5.8 p-10 -93.66 -170.65 2.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.724 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.59 -36.09 77.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.458 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -69.83 -36.34 75.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.077 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.87 33.2 6.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.668 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' B' ' 28' ' ' GLU . 11.5 t70 -98.62 -96.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' B' ' 27' ' ' ASP . 31.6 mm-40 -167.57 137.79 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 109.551 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 92.4 t -123.66 101.05 8.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.692 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.877 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.0 p -103.16 175.75 2.11 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.474 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.877 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 29.8 Cg_endo -62.96 -10.83 21.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.49 2.127 . . . . 0.0 113.512 -177.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.02 13.91 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.024 0.44 . . . . 0.0 110.786 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -112.92 152.49 29.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -97.0 124.4 40.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.0 159.87 41.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' B' ' 48' ' ' LEU . 53.7 t -129.87 143.07 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.5 mt -110.21 115.67 50.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 CA-C-O 121.804 0.811 . . . . 0.0 110.887 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.96 87.46 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.185 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 79.4 -18.77 6.4 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.38 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 -21.83 0.4 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.575 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.64 142.71 27.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -94.79 134.58 31.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.414 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.4 mp -127.9 128.18 68.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.438 HD22 ' N ' ' B' ' 45' ' ' ARG . 1.9 tt -61.8 137.45 58.25 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.438 ' N ' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.08 0.15 3.91 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -172.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.76 -12.74 30.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.368 0.604 . . . . 0.0 110.032 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -114.38 -7.01 12.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.512 0.672 . . . . 0.0 110.055 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.546 HD11 ' HB ' ' B' ' 36' ' ' VAL . 49.9 tp -57.19 -44.27 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.062 -170.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -59.85 -40.65 89.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.968 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -69.5 -43.28 73.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.161 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -62.73 -36.34 82.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 62.9 mt -70.41 -30.76 67.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 0.0 110.68 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -94.16 -49.5 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.723 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -103.03 -53.0 2.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 tp 72.04 47.99 0.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.303 0.641 . . . . 0.0 112.162 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.474 ' HA3' ' CD2' ' A' ' 58' ' ' PHE . . . 82.24 -31.13 2.92 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.938 -0.648 . . . . 0.0 114.24 169.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.95 122.9 25.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.667 -0.313 . . . . 0.0 111.322 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.633 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 8.1 tp10 -92.26 102.35 14.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -95.54 120.1 35.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.86 -167.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -115.44 178.11 4.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.836 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -169.51 149.66 4.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.72 75.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.02 0.438 . . . . 0.0 110.523 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 61.49 28.61 17.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.246 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 0.0 110.166 177.283 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 121.437 0.637 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.47 144.95 30.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.877 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -133.86 139.92 46.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 23' ' ' ASP . 19.3 mt -112.74 152.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -81.24 179.9 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.038 0.447 . . . . 0.0 110.771 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -56.4 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.465 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -70.83 -45.22 64.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.439 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.03 15.77 3.75 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.667 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.83 132.57 44.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.23 124.28 23.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.965 0.412 . . . . 0.0 110.595 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 23' ' ' ASP . 44.8 t -108.58 107.31 22.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.686 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 24.0 p -95.99 167.61 12.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 62.7 Cg_exo -52.74 -16.63 5.98 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.273 2.649 . . . . 0.0 114.32 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.93 2.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.652 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -105.72 150.48 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' HB3' ' HD3' ' A' ' 45' ' ' ARG . 19.2 m-20 -94.82 120.72 35.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 109.863 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.9 p90 -142.59 161.76 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.871 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' B' ' 60' ' ' PHE . 75.7 t -131.94 134.97 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 51.2 mt -95.97 121.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.524 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 28.7 t70 -90.2 86.73 6.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 78.4 -40.43 1.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.115 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.84 -28.48 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -81.66 136.05 35.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.456 HG23 ' CD2' ' A' ' 35' ' ' TYR . 92.7 mt -87.66 134.24 28.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.548 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.418 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -138.76 135.17 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 172.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.25 145.18 55.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HG2' HD23 ' A' ' 48' ' ' LEU . 25.5 mtp-105 -65.61 -5.99 9.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.2 -63.2 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.503 . . . . 0.0 109.946 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.04 -14.89 61.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.586 HD23 ' HG2' ' A' ' 45' ' ' ARG . 18.6 tp -51.74 -42.6 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.336 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -60.21 -44.23 95.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -41.43 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.999 0.428 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 84.5 t80 -65.91 -43.76 87.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.39 -23.24 61.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.537 0.208 . . . . 0.0 111.33 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -70.51 -46.81 62.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 110.393 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.48 -35.91 29.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.205 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.48 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 26.3 tp60 -97.59 -67.54 0.84 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.319 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 44.32 41.14 4.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.583 0.706 . . . . 0.0 109.131 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -108.34 -24.1 6.35 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.309 -0.948 . . . . 0.0 114.528 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CG ' ' HA3' ' B' ' 57' ' ' GLY . 1.0 OUTLIER 57.53 -151.81 0.41 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -175.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.536 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 33.0 mt-10 -113.61 101.39 9.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.983 163.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -93.63 103.53 15.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.785 ' HZ3' HD12 ' B' ' 37' ' ' ILE . 93.5 mttt -117.48 105.34 11.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.75 0.786 . . . . 0.0 111.777 -173.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.13 160.16 30.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.191 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.379 0 O-C-N 123.291 0.369 . . . . 0.0 111.134 177.467 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.513 0.673 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.39 128.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.727 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.547 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 26.1 pt20 -107.27 149.79 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.928 0.394 . . . . 0.0 111.031 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 13.3 mt -112.7 140.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.162 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.56 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 13.1 p-10 -77.06 -170.4 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.112 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.88 -26.66 60.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -80.32 -23.17 40.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.709 0.29 . . . . 0.0 110.772 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 89.26 17.29 55.9 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.948 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.89 -8.61 42.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.28 0.562 . . . . 0.0 109.929 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' B' ' 22' ' ' ILE . 43.1 tt0 76.65 139.57 0.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.861 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 14.5 t -112.68 102.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 110.488 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 59.3 p -84.75 159.53 57.71 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.828 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 48.6 Cg_endo -69.21 7.68 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.651 2.234 . . . . 0.0 112.811 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.95 -6.46 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.285 0.564 . . . . 0.0 109.591 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -117.64 160.14 21.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.969 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.86 143.73 29.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.455 ' HB3' HG12 ' B' ' 29' ' ' VAL . 13.1 p90 -145.69 166.07 26.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.354 0.597 . . . . 0.0 110.672 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 59' ' ' GLU . 53.8 t -136.96 144.54 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.785 HD12 ' HZ3' ' A' ' 61' ' ' LYS . 33.7 mt -109.94 116.81 53.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.377 0.608 . . . . 0.0 110.087 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.47 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 2.0 m-20 -97.44 86.67 3.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.891 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 62.63 45.56 95.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.826 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.3 64.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.845 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 3.3 tp10 -95.51 119.43 34.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.432 HG23 ' HA ' ' B' ' 23' ' ' ASP . 97.0 mt -83.89 120.84 35.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.58 ' HB ' HD11 ' B' ' 48' ' ' LEU . 2.7 mp -126.26 128.6 71.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.425 ' H ' ' HB2' ' B' ' 23' ' ' ASP . 28.5 tp -66.58 139.75 57.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.604 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -60.25 -15.99 29.86 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.75 -45.03 82.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.74 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.48 17.66 6.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 111.493 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.58 HD11 ' HB ' ' B' ' 43' ' ' ILE . 48.9 tp -63.21 -31.49 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.389 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.76 -45.83 59.11 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 111.583 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -68.78 -37.11 79.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.416 . . . . 0.0 110.898 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.406 ' CZ ' ' HG2' ' B' ' 41' ' ' GLU . 15.9 t80 -72.77 -32.66 65.78 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 75.1 mt -65.37 -29.33 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.413 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 -64.74 -44.75 89.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.431 . . . . 0.0 110.205 174.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.12 -54.36 9.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.783 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -103.52 -67.08 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.02 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 24.1 tp 78.72 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.855 0.722 . . . . 0.0 111.241 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 79.87 -45.55 2.97 Favored Glycine 0 C--O 1.235 0.205 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.736 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -69.53 139.1 53.77 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.569 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 3.9 tp10 -114.69 102.21 9.81 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 167.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.515 ' HA ' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -83.86 93.76 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.541 -175.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.468 ' HG2' ' HG3' ' B' ' 59' ' ' GLU . 27.9 mmtm -93.49 83.17 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.326 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' B' ' 64' ' ' GLN . 92.9 m-20 -81.83 60.23 4.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.441 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 64' ' ' GLN . . . 68.78 -27.18 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.9 0.88 . . . . 0.0 113.016 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' B' ' 62' ' ' ASN . 96.8 mt-30 67.67 18.32 9.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.332 0.587 . . . . 0.0 110.409 -175.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 179.68 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 121.154 0.502 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -81.33 83.7 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.999 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.464 ' NE2' HD11 ' A' ' 42' ' ' ILE . 10.9 pt20 -96.35 166.21 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 22' ' ' ILE . 6.5 mt -125.12 157.57 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.64 -169.86 2.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -72.8 -26.42 61.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.567 0.222 . . . . 0.0 111.022 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -72.87 -40.82 65.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.89 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 17.82 4.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.264 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -104.98 129.88 53.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -59.0 120.0 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.278 0.561 . . . . 0.0 111.603 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 44' ' ' LEU . 41.0 t -95.9 113.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 p -103.74 166.57 11.48 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.19 -6.01 2.56 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.782 2.321 . . . . 0.0 113.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -96.07 -4.38 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.368 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -110.13 166.26 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.406 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.88 119.02 38.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.452 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 29' ' ' VAL . 32.2 p90 -135.97 149.76 49.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 0.0 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.61 133.71 68.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.2 mt -97.5 121.4 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -94.75 84.27 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.876 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.32 -47.59 2.96 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.437 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.29 -29.02 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 129.19 34.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.509 0.671 . . . . 0.0 110.765 174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.464 HD11 ' NE2' ' A' ' 21' ' ' GLN . 57.6 mt -90.59 133.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.981 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.3 mp -136.61 132.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 29' ' ' VAL . 84.4 mt -58.65 151.62 20.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.299 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -12.77 22.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.938 0.399 . . . . 0.0 110.882 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.99 -36.24 72.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.422 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.66 5.19 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 110.617 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.86 -48.58 81.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.068 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.96 -37.18 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 6.8 tpt180 -73.62 -39.81 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.698 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -64.08 -47.83 78.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.19 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.801 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 65.7 mt -61.98 -41.24 97.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 50.5 ttt-85 -46.54 -40.21 12.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.143 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -49.81 8.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.037 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 5.6 tp-100 -88.34 -68.2 0.78 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.801 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 48.0 mt 42.89 30.86 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.368 0.267 . . . . 0.0 111.286 -171.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.798 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -127.64 3.27 7.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.692 -166.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 53.87 -149.63 0.41 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.447 0.623 . . . . 0.0 110.313 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.545 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.9 tp10 -112.16 101.95 10.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.65 117.38 31.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.712 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.92 156.82 24.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.411 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -141.06 160.44 40.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.501 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.437 178.658 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 121.551 0.691 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -77.89 101.05 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.544 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.55 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 12.9 pt20 -101.56 158.49 16.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.586 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' B' ' 28' ' ' GLU . 53.2 mt -140.83 152.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.857 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.79 -173.87 2.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.331 0.586 . . . . 0.0 111.148 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -67.11 -29.18 68.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.153 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -79.78 -14.49 58.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.288 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.86 33.49 26.97 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.287 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.1 -87.2 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.843 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' B' ' 22' ' ' ILE . 41.7 tt0 -179.17 137.5 0.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.86 120.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.037 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 77.0 p -108.09 169.09 6.98 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.29 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_exo -60.36 -2.5 1.91 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.858 2.372 . . . . 0.0 113.022 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.37 -11.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.736 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.15 147.08 26.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.707 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.35 112.18 23.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -133.68 157.8 44.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 0.0 111.221 -172.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.84 145.0 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.423 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 67.7 mt -107.18 110.72 32.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.282 0.563 . . . . 0.0 109.881 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.6 92.25 3.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.203 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.06 36.6 31.24 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.521 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.94 -28.64 7.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.187 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.83 150.22 24.7 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 78.6 mt -108.86 141.48 24.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.564 -174.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mp -134.77 123.0 40.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.504 HD22 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -59.85 140.06 56.89 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.573 HH11 HD21 ' B' ' 48' ' ' LEU . 11.3 mmm180 -55.92 -17.97 7.86 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -77.22 -31.43 55.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.523 . . . . 0.0 110.047 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -102.96 -7.01 21.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.525 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.573 HD21 HH11 ' B' ' 45' ' ' ARG . 45.1 tp -64.45 -28.64 69.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.427 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -54.33 45.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.94 -33.31 70.36 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.732 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.72 -40.36 87.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.335 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 75.8 mt -72.06 -32.55 67.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 53' ' ' ARG . 44.1 mtt180 -64.11 -40.53 96.4 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.491 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -79.85 -65.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.802 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -95.1 -41.83 8.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.825 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 23.1 tp 78.41 17.98 1.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.895 0.747 . . . . 0.0 111.56 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.13 -38.36 3.19 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.069 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -65.88 117.2 7.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.724 -0.28 . . . . 0.0 110.956 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.556 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 37.0 tt0 -92.3 102.19 14.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.638 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -85.42 112.03 20.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.556 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 7.1 mmmm -115.22 88.6 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.241 0.544 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -82.55 154.22 25.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.52 69.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 48.8 81.18 0.05 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.252 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.321 -0.668 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.877 -178.3 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.124 0.488 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.67 132.77 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.786 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -123.59 171.18 9.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.567 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.429 HG21 ' HA2' ' A' ' 26' ' ' GLY . 21.8 mt -138.61 155.22 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.619 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 22' ' ' ILE . 5.6 p-10 -82.42 -167.52 1.62 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -69.97 -34.26 73.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.921 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -82.07 -15.46 53.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 85.25 36.98 10.23 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.728 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.6 t70 -87.93 -85.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.7 tt0 176.15 136.55 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.621 0.576 . . . . 0.0 109.676 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.438 HG23 HD23 ' A' ' 44' ' ' LEU . 73.6 t -123.09 112.65 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.484 . . . . 0.0 110.67 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 32' ' ' VAL . 70.7 p -104.81 162.01 21.06 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.45 7.22 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.946 2.431 . . . . 0.0 113.257 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 t -103.89 -12.09 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.145 0.498 . . . . 0.0 109.884 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -92.87 151.31 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.635 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -97.02 115.44 27.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.403 0.62 . . . . 0.0 109.704 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.59 172.89 12.34 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.571 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.452 ' HB ' HD13 ' A' ' 48' ' ' LEU . 64.2 t -137.03 139.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 14.5 mt -95.65 110.11 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.732 0.777 . . . . 0.0 109.455 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' OD2' ' HG3' ' A' ' 55' ' ' GLN . 9.8 t0 -82.66 85.87 6.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.243 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 59' ' ' GLU . . . 76.43 -35.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.091 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.18 -28.29 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.43 147.17 29.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.815 0.34 . . . . 0.0 110.396 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.5 mt -97.78 129.76 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.286 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mp -136.71 123.88 31.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD23 HG23 ' A' ' 29' ' ' VAL . 85.6 mt -56.19 146.38 23.56 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -68.56 -0.02 4.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.221 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -81.26 -19.18 43.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.94 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -129.09 -7.01 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.245 0.545 . . . . 0.0 110.335 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 HD13 ' HB ' ' A' ' 36' ' ' VAL . 28.7 tp -50.2 -35.58 27.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.3 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -52.29 -42.57 63.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.004 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -69.83 -39.61 76.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.196 0.522 . . . . 0.0 110.351 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -38.09 88.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.194 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 62.2 mt -69.95 -25.04 63.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.036 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -69.08 -38.47 79.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.7 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.8 -67.83 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 8.7 pt20 -102.92 -20.89 14.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 40.3 tp 69.5 23.04 6.14 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 168.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.87 0.64 39.25 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.356 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.13 127.88 55.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.608 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 23.9 tt0 -91.95 102.03 14.59 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.72 122.12 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -111.84 -175.68 2.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.871 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.76 161.49 23.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.834 0.349 . . . . 0.0 111.06 177.741 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.5 107.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.006 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.498 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 10.5 pt20 -89.03 132.62 34.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 109.974 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.411 HG21 HD13 ' B' ' 22' ' ' ILE . 21.9 mt -116.44 148.94 18.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.796 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -79.88 -174.58 4.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -71.6 -22.84 61.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.363 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' B' ' 47' ' ' ASN . 13.8 t80 -74.39 -45.25 48.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.44 27.64 2.79 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.059 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -96.0 -124.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -141.05 140.55 34.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.434 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 41.8 t -119.81 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.486 0.66 . . . . 0.0 109.345 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -86.96 167.77 20.59 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.89 -3.6 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.853 2.369 . . . . 0.0 113.496 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.43 8.48 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.226 0.536 . . . . 0.0 110.509 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -106.23 130.87 54.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.02 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.26 120.98 23.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' B' ' 42' ' ' ILE . 34.8 p90 -143.3 164.53 29.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.44 ' HB ' HD11 ' B' ' 48' ' ' LEU . 72.9 t -132.8 145.83 33.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 39' ' ' GLY . 46.9 mt -111.57 127.89 68.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.342 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.415 ' CB ' ' HE2' ' B' ' 51' ' ' TYR . 25.3 t70 -119.29 89.77 3.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.052 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 42.37 9.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.303 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.58 -22.25 11.56 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.934 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -87.56 129.13 35.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.996 0.426 . . . . 0.0 110.151 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.502 HG21 ' CD2' ' B' ' 35' ' ' TYR . 78.3 mt -83.99 141.07 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.0 mp -135.57 125.37 42.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.56 148.03 20.71 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -61.33 -17.36 53.39 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.959 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.52 0.11 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.741 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' B' ' 25' ' ' TYR . 54.0 t30 -124.04 -1.74 8.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 109.167 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.44 HD11 ' HB ' ' B' ' 36' ' ' VAL . 39.6 tp -69.15 -45.41 70.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.07 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.91 -53.08 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.125 0.488 . . . . 0.0 110.596 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.37 -47.48 85.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.956 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.415 ' HE2' ' CB ' ' B' ' 38' ' ' ASP . 92.7 t80 -62.76 -39.95 95.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.481 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.699 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 43.0 mt -67.72 -47.55 69.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.394 -0.191 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -59.39 -19.03 43.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 110.903 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.07 -54.13 4.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.936 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.813 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 6.3 tp60 -91.53 -67.64 0.84 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 19.4 mt 39.57 34.85 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.813 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -120.46 -1.03 12.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.22 -171.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.46 -157.26 0.27 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -115.88 101.88 9.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.687 169.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.92 121.48 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.154 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -136.11 68.07 1.45 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.868 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -71.35 176.68 4.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.043 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -74.55 -5.93 45.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.884 0.373 . . . . 0.0 110.507 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 55.87 43.22 27.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.616 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 87.7 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.712 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.202 0.525 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t 70.82 110.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.175 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.461 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 6.7 pt20 -122.37 158.4 29.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.223 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.43 145.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 1.2 p-10 -77.26 -161.06 0.19 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.037 0.446 . . . . 0.0 110.196 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.5 -23.83 39.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.65 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -104.33 -4.07 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.1 5.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.769 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -114.13 149.06 36.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.07 127.79 34.05 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 110.472 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.492 HG21 HD22 ' A' ' 44' ' ' LEU . 15.7 t -95.69 117.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.766 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 p -115.6 169.04 7.36 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.766 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 47.7 Cg_endo -67.3 20.21 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.987 2.458 . . . . 0.0 114.3 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 30' ' ' THR . 22.4 t -122.19 -26.62 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.118 0.485 . . . . 0.0 110.248 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.69 145.47 29.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.0 110.853 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.546 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 1.8 t70 -87.81 142.87 27.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.01 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' HB3' HG11 ' A' ' 29' ' ' VAL . 26.8 p90 -149.96 164.66 34.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.802 0.334 . . . . 0.0 111.021 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.4 153.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.368 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 73.6 mt -111.16 108.22 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.079 0 CA-C-O 121.819 0.819 . . . . 0.0 111.051 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' HB2' HD11 ' A' ' 43' ' ' ILE . 1.8 m-20 -99.88 90.5 4.45 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.769 -177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 74.58 23.98 73.86 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.03 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.93 -29.98 6.57 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.365 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.1 158.78 15.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.366 0.603 . . . . 0.0 111.095 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.58 138.87 26.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.142 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 38' ' ' ASP . 3.9 mp -131.56 122.8 51.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -59.23 135.07 57.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 14.3 mmt180 -58.08 -14.23 6.32 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.78 -14.49 56.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.476 . . . . 0.0 110.149 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -115.4 -9.91 12.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.403 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 28.2 tp -68.8 -28.77 67.06 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.138 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 53' ' ' ARG . 3.3 tm-20 -54.43 -66.37 0.41 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.61 -28.66 67.11 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.332 -177.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.38 -40.99 94.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.497 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 39.0 mt -65.42 -33.16 75.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HG3' ' HA ' ' A' ' 50' ' ' ARG . 11.1 mtm180 -62.55 -39.31 93.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.065 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 23.5 mm-40 -87.66 -52.79 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.713 0.292 . . . . 0.0 111.317 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -90.24 -51.55 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.138 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.98 44.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.361 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 79.37 -51.72 3.98 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 121.236 -0.507 . . . . 0.0 114.158 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -68.98 122.97 19.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.773 -0.251 . . . . 0.0 110.862 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -92.52 101.78 14.22 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.251 170.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.46 95.23 6.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.917 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HD2' HD13 ' B' ' 37' ' ' ILE . 16.8 mttp -98.41 87.61 3.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.715 0.769 . . . . 0.0 110.632 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -81.42 176.49 9.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.811 177.392 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.513 0.673 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.1 90.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.21 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.659 ' OE1' ' HB ' ' B' ' 29' ' ' VAL . 0.9 OUTLIER -106.69 166.19 10.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.401 HG21 HD11 ' B' ' 22' ' ' ILE . 14.6 mt -128.0 151.74 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -71.56 -173.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -67.41 -32.12 72.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -86.1 -45.69 11.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.75 31.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.233 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.78 125.43 53.68 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.78 128.05 34.37 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 111.393 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.659 ' HB ' ' OE1' ' B' ' 21' ' ' GLN . 19.0 t -114.57 119.6 61.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.005 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 36.2 p -110.34 164.56 14.54 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.744 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 51.9 Cg_exo -53.98 -18.73 13.82 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.388 2.725 . . . . 0.0 114.209 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.91 -0.93 10.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.949 0.404 . . . . 0.0 111.175 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -102.51 147.26 26.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.84 128.72 42.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.411 ' OH ' ' HD3' ' A' ' 61' ' ' LYS . 30.1 p90 -148.48 -178.01 6.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.451 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 98.4 t -140.05 139.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.462 HD13 ' HD2' ' A' ' 61' ' ' LYS . 45.1 mt -105.02 117.85 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 110.073 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.92 92.04 3.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.468 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.539 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 84.74 0.57 89.18 Favored Glycine 0 C--N 1.316 -0.534 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.645 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.4 -20.27 4.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.724 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -99.82 151.06 21.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.012 0.434 . . . . 0.0 110.17 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.76 138.86 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.608 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.664 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.2 mp -140.01 126.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' B' ' 48' ' ' LEU . 20.5 mt -55.81 146.67 20.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 172.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -62.4 -11.15 14.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.63 0.252 . . . . 0.0 111.354 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 31.9 tp10 -74.75 -51.36 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -100.5 3.54 42.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.664 HD23 ' HB ' ' B' ' 43' ' ' ILE . 2.8 tm? -65.75 -33.16 75.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.342 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.34 -49.67 76.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.505 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -67.25 -32.66 73.84 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.306 0.574 . . . . 0.0 110.165 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -66.85 -43.89 82.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 24.5 mt -66.89 -23.75 66.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -69.4 -33.83 73.59 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -84.7 -65.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.533 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' B' ' 57' ' ' GLY . 47.2 tp60 -85.35 -67.2 0.82 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.554 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.733 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 18.6 tp 60.35 -22.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' B' ' 55' ' ' GLN . . . -107.31 35.88 4.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.897 -167.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 50.51 -153.48 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.145 0.473 . . . . 0.0 110.933 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 10.9 tp10 -110.56 102.39 10.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.251 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -91.83 117.73 30.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.75 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -118.63 -173.1 2.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.587 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . 0.514 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 29.9 p-10 -168.72 -175.45 2.43 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.39 15.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.815 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' B' ' 62' ' ' ASN . 67.2 mt-30 57.74 48.79 13.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.34 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.724 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -97.58 101.24 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.871 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 29' ' ' VAL . 4.9 pt20 -123.06 156.71 34.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' ASP . 22.7 mt -125.21 138.3 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.714 0.292 . . . . 0.0 111.491 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -67.36 162.26 23.32 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.435 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -50.2 -35.37 26.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 113.134 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.87 1.08 48.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 39.14 7.95 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -121.4 127.81 51.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.71 125.73 26.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.585 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.643 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 58.0 t -120.33 102.1 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.548 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.762 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 p -78.19 166.58 42.17 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.762 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -59.69 -10.67 12.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.892 2.395 . . . . 0.0 114.472 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.61 7.76 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.659 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -98.65 154.53 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 7.7 m-20 -76.89 111.3 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.656 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.495 ' HB3' HG11 ' A' ' 29' ' ' VAL . 42.9 p90 -147.52 168.17 22.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 111.164 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.9 t -137.75 148.23 25.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 60.1 mt -105.67 118.52 53.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-O 121.306 0.575 . . . . 0.0 110.052 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.506 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 2.1 m-20 -106.39 87.68 2.6 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.615 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.63 80.14 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.102 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.99 -25.82 2.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.012 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -97.39 155.97 16.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.114 0.483 . . . . 0.0 110.78 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.1 mt -96.4 137.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.363 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.488 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 3.7 mp -131.34 120.51 46.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD21 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -57.51 136.66 56.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' N ' HD21 ' A' ' 44' ' ' LEU . 11.9 mmm-85 -55.78 -13.96 2.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.82 -57.39 7.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.293 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.0 7.52 44.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.434 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 46.0 tp -54.68 -28.97 51.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.257 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -42.26 -46.18 4.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.623 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 2.4 mpt_? -73.89 -39.56 63.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.265 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -44.77 83.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.966 0.412 . . . . 0.0 110.665 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.909 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 51.9 mt -68.31 -24.58 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -76.8 -26.76 54.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.916 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -92.41 -70.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.821 0.344 . . . . 0.0 111.731 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.4 -23.21 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.878 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.909 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 42.3 tp 66.14 43.32 2.9 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.316 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.506 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.21 -18.31 41.88 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.811 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 9.3 m-85 -99.46 136.7 39.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.564 -0.374 . . . . 0.0 110.719 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.444 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 34.7 tt0 -93.05 102.02 14.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 167.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.06 92.49 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.934 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE2' ' OE2' ' A' ' 59' ' ' GLU . 14.1 mmtt -97.56 173.83 6.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 111.955 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.6 175.85 9.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.425 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 120.703 0.287 . . . . 0.0 111.021 176.409 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.963 0.887 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.37 94.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.083 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.432 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 9.2 pt20 -92.4 131.34 37.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.211 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 23' ' ' ASP . 36.1 mt -104.83 141.73 19.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.491 ' O ' HG23 ' B' ' 22' ' ' ILE . 0.5 OUTLIER -76.75 173.67 11.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.63 -21.82 60.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.304 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.65 3.61 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.0 27.24 14.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.402 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.92 145.27 43.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.606 0.703 . . . . 0.0 109.813 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.43 119.53 13.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.413 . . . . 0.0 111.172 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.432 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 18.6 t -90.28 88.15 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.441 ' C ' ' H ' ' B' ' 32' ' ' VAL . 51.1 p -68.27 157.92 86.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.853 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.1 13.99 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.86 2.374 . . . . 0.0 112.635 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' B' ' 30' ' ' THR . 33.8 m -121.95 3.1 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.055 176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -114.28 151.98 32.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.988 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.93 136.55 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.46 ' CD2' HG22 ' B' ' 42' ' ' ILE . 21.0 p90 -149.34 166.28 29.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.2 t -136.04 142.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 46.2 mt -104.83 120.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.647 0.261 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.07 91.07 5.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.3 0.572 . . . . 0.0 109.75 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 37' ' ' ILE . . . 81.19 -28.97 2.86 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.154 174.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.48 -27.2 0.15 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.42 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.233 0.54 . . . . 0.0 110.534 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.46 HG22 ' CD2' ' B' ' 35' ' ' TYR . 79.2 mt -82.24 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.468 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.751 ' HB ' HD21 ' B' ' 48' ' ' LEU . 3.7 mp -130.44 123.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.975 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 51.0 mt -55.46 143.91 27.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.693 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 10.7 mmt180 -66.96 0.81 2.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -73.01 -35.23 66.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 0.0 110.803 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -129.05 5.76 5.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.304 0.573 . . . . 0.0 110.265 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.751 HD21 ' HB ' ' B' ' 43' ' ' ILE . 3.0 tm? -51.71 -44.78 63.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.129 -172.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -59.79 -30.29 68.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.851 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 0.6 OUTLIER -76.35 -38.58 55.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.313 . . . . 0.0 110.808 -178.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -66.25 -32.47 73.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 32.9 mt -64.9 -48.24 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.47 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 7.5 ptp180 -69.04 -27.58 65.78 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.448 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -93.98 -34.57 13.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.536 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 54.2 tp60 -103.19 -67.88 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.085 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER 37.32 40.3 0.19 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.827 0.704 . . . . 0.0 110.078 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.536 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -131.21 6.19 5.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.652 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 50.8 -154.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.852 0.326 . . . . 0.0 110.126 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 5.9 tp10 -102.83 101.84 11.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.644 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.83 95.92 10.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 110.345 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -112.89 56.26 0.68 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.439 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.24 74.35 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.14 8.97 3.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.238 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' B' ' 64' ' ' GLN . 7.8 tp60 52.11 40.89 29.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.037 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.1 t -114.87 102.42 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.303 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.2 148.72 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.544 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 23' ' ' ASP . 34.9 mt -123.89 154.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 9.2 p-10 -78.15 -164.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 110.328 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.92 -27.9 43.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.723 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.27 -17.38 34.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.21 5.91 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.163 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 t70 -92.08 -96.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.7 tt0 174.35 118.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.88 95.1 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.259 0.552 . . . . 0.0 110.76 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' VAL . 9.1 p -80.73 161.64 63.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.917 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 46.6 Cg_endo -67.96 13.71 0.18 Allowed 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 122.828 2.352 . . . . 0.0 113.177 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' THR . 27.3 m -115.43 11.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.614 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.74 172.76 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.289 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -103.79 125.22 50.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.862 0.363 . . . . 0.0 110.452 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.01 169.91 16.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.227 0.537 . . . . 0.0 110.877 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' B' ' 60' ' ' PHE . 70.7 t -137.53 139.55 43.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -105.76 120.99 57.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.436 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -108.76 86.98 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.15 42.9 34.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.21 -0.904 . . . . 0.0 113.681 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.04 -17.63 57.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.786 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -109.18 133.48 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.361 0.601 . . . . 0.0 110.923 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -85.77 137.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.585 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 3.0 mp -135.18 128.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.52 143.91 57.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.614 ' HD2' HD22 ' A' ' 48' ' ' LEU . 11.9 mmm-85 -63.55 -11.65 26.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.42 -49.6 73.1 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.113 0.258 . . . . 0.0 111.266 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -129.35 39.15 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.712 . . . . 0.0 110.155 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.614 HD22 ' HD2' ' A' ' 45' ' ' ARG . 11.7 tp -71.63 -35.82 70.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.773 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -55.35 -36.73 66.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.963 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 mtt-85 -78.27 -27.46 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.092 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.26 -33.7 61.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.492 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.729 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 73.5 mt -71.09 -24.54 62.33 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.57 172.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -71.32 -28.2 63.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 51.8 mm-40 -86.04 -54.05 4.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.391 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.515 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 11.0 tt0 -99.23 -67.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.781 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 4.7 tp 49.31 31.32 3.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.35 0.406 . . . . 0.0 110.408 -174.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.515 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -125.3 -6.17 6.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.73 -164.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.02 -154.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.802 0.801 . . . . 0.0 109.312 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.569 ' OE2' HD12 ' B' ' 37' ' ' ILE . 28.0 tt0 -116.44 102.28 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.457 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -83.49 102.68 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 6.0 tptm -97.91 90.29 4.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 -175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -85.16 44.91 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.918 -174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.482 179.472 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.2 p30 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.816 0.341 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 138.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.669 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 14.2 pt20 -132.96 168.55 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 110.821 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.438 HG23 ' N ' ' B' ' 23' ' ' ASP . 34.5 mt -136.28 155.95 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.615 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 6.3 p-10 -79.38 -171.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.189 0.519 . . . . 0.0 110.791 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -70.04 -29.88 67.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.754 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -88.07 -21.52 24.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.1 38.5 4.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.025 -1.083 . . . . 0.0 113.227 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.6 t70 -89.09 -89.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 37.1 tt0 171.97 137.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.669 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 59.5 t -116.83 109.58 28.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.947 0.403 . . . . 0.0 110.707 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -94.17 159.84 33.33 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.56 3.76 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.67 -0.83 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 109.983 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -102.49 142.13 34.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.707 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.501 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 6.7 m-20 -83.85 120.18 25.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.307 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 21.9 p90 -142.58 161.94 36.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.589 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' B' ' 48' ' ' LEU . 84.4 t -124.81 139.48 50.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.569 HD12 ' OE2' ' A' ' 59' ' ' GLU . 53.4 mt -106.47 112.51 39.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 40' ' ' GLY . 1.4 m-20 -85.39 85.02 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.949 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.626 ' HA3' ' HG3' ' B' ' 59' ' ' GLU . . . 74.53 -32.15 1.0 Allowed Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.602 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 38' ' ' ASP . . . 171.52 -21.73 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -81.44 143.04 32.39 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.2 mt -107.75 119.8 57.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.421 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.413 ' N ' HD12 ' B' ' 43' ' ' ILE . 3.0 mp -126.73 121.72 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.115 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 40.6 mt -57.23 146.4 28.49 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.501 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 66.7 mtp180 -69.07 0.26 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -60.1 -51.82 68.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.004 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -126.45 19.71 7.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' B' ' 36' ' ' VAL . 16.8 tp -53.23 -37.4 62.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.23 -43.82 64.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.575 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.71 -36.26 65.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.296 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -67.49 -35.98 80.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.0 -31.31 70.92 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.585 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -69.87 -24.24 63.39 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.709 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -89.09 -55.92 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.44 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.906 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.8 tp 82.72 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 124.141 0.9 . . . . 0.0 111.801 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.405 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 81.46 -49.4 4.02 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.45 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 33.6 m-85 -70.92 124.45 24.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.626 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 26.7 mt-10 -92.08 101.79 14.33 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.751 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.52 ' HA ' HG22 ' A' ' 36' ' ' VAL . 97.1 m-85 -81.4 87.92 6.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.514 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -107.39 80.53 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.631 0.729 . . . . 0.0 110.923 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -71.9 158.26 36.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.05 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.01 95.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.994 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 55.47 58.77 4.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.307 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.621 HD13 ' H ' ' B' ' 65' ' ' LEU . 4.2 mp . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.492 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.554 0.693 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 t -93.92 124.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.694 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.479 ' NE2' HD12 ' A' ' 42' ' ' ILE . 9.8 pt20 -123.19 157.58 32.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 13.0 mt -120.03 152.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.0 p-10 -90.6 -167.91 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.306 0.574 . . . . 0.0 110.904 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -69.93 -24.52 63.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -89.38 -34.26 16.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.496 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA2' ' CG2' ' A' ' 22' ' ' ILE . . . 99.74 27.67 7.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.591 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.71 -10.42 48.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 73.08 120.38 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.338 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 23' ' ' ASP . 47.6 t -113.61 113.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.514 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 p -102.97 167.75 9.79 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.4 -11.49 6.43 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.826 2.35 . . . . 0.0 113.404 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.27 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.464 0.65 . . . . 0.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -107.62 146.08 32.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' OD2' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -89.92 130.52 36.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.431 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.6 p90 -153.76 161.58 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.825 0.345 . . . . 0.0 111.023 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 49.4 t -128.18 150.33 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 40.5 mt -115.78 116.88 53.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.157 0 CA-C-O 121.894 0.855 . . . . 0.0 111.187 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.41 89.32 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.731 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.521 ' HA2' ' CG2' ' B' ' 37' ' ' ILE . . . 69.17 45.11 63.07 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.247 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.5 -21.9 35.9 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.464 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -91.72 133.53 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.241 0.543 . . . . 0.0 110.578 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.479 HD12 ' NE2' ' A' ' 21' ' ' GLN . 60.3 mt -91.74 132.18 36.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.916 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.814 ' HB ' HD21 ' A' ' 48' ' ' LEU . 3.1 mp -130.99 125.99 58.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 29' ' ' VAL . 18.2 tp -63.61 143.54 57.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.511 ' HG3' ' OD2' ' A' ' 34' ' ' ASP . 12.8 mmm180 -62.48 -6.89 3.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 7.2 mm-40 -71.33 -57.79 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.47 0.34 53.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.814 HD21 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -62.76 -27.29 69.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.461 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.37 -48.33 74.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.694 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -61.6 -41.76 97.9 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.429 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.47 -37.96 89.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.292 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 19.5 mt -71.32 -26.7 62.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -71.3 -45.68 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.432 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.12 -32.38 13.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -102.97 -56.16 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.188 -0.32 . . . . 0.0 110.374 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 26.6 tp 77.65 37.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 111.914 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' CD2' ' B' ' 58' ' ' PHE . . . 89.43 -43.54 3.02 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.137 172.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.421 ' HE2' HD22 ' A' ' 56' ' ' LEU . 3.3 m-85 -70.14 117.97 12.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.526 ' O ' HG11 ' B' ' 36' ' ' VAL . 9.6 tp10 -92.04 101.43 13.97 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.436 ' HA ' HG21 ' B' ' 36' ' ' VAL . 63.8 m-85 -89.75 86.29 6.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.06 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -84.71 174.77 9.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -142.34 177.26 8.38 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 174.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.83 103.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.988 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.436 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 10.4 pt20 -104.91 158.13 16.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.786 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.429 HG21 ' N ' ' B' ' 23' ' ' ASP . 18.1 mt -130.08 155.76 41.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 6.7 p-10 -83.88 -165.11 1.04 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.273 0.558 . . . . 0.0 110.955 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.77 -31.68 68.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.373 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -41.13 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.576 0.227 . . . . 0.0 110.891 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.3 35.82 3.03 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.671 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 19.0 t70 -88.58 -89.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 41.1 tt0 176.02 130.66 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 48.3 t -114.35 113.12 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.191 0.519 . . . . 0.0 110.819 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 67.1 p -106.15 169.3 7.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.3 Cg_exo -58.68 -4.54 1.96 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.154 2.569 . . . . 0.0 114.151 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.456 HG21 ' OG1' ' B' ' 30' ' ' THR . 19.2 m -106.52 0.65 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 110.795 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -96.78 136.94 36.62 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.534 ' HB3' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -80.68 108.54 14.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -126.63 155.44 42.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.106 0.479 . . . . 0.0 111.236 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 59' ' ' GLU . 41.8 t -129.85 145.75 35.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.521 ' CG2' ' HA2' ' A' ' 39' ' ' GLY . 36.1 mt -115.23 126.3 72.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.609 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.74 83.35 3.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.18 3.38 Favored Glycine 0 C--O 1.227 -0.327 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.303 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.76 -30.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -81.39 134.24 35.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.098 0.475 . . . . 0.0 110.315 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.92 138.37 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.386 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.8 mp -137.04 130.72 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.416 HD22 HG21 ' B' ' 29' ' ' VAL . 79.8 mt -60.39 150.06 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.534 ' HG3' ' HB3' ' B' ' 34' ' ' ASP . 20.8 mmt180 -61.37 -11.84 11.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.89 0.376 . . . . 0.0 110.964 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.1 -36.52 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.664 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -111.75 8.12 20.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.914 0.388 . . . . 0.0 110.644 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.523 HD11 ' HB ' ' B' ' 36' ' ' VAL . 63.9 tp -60.64 -47.93 84.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.443 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.71 -47.94 80.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.623 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 7.0 mtp180 -64.3 -45.96 85.69 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.111 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.431 ' CG ' HG12 ' B' ' 43' ' ' ILE . 47.1 t80 -59.07 -39.39 81.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.661 0.267 . . . . 0.0 110.925 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 39.0 mt -72.55 -28.72 63.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.611 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 8.4 ptp180 -86.86 -11.5 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.286 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 70.2 mm-40 -92.67 -54.92 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.185 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.415 ' HG2' ' N ' ' B' ' 57' ' ' GLY . 5.0 tt0 -102.02 -65.96 0.95 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -174.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 2.2 tp 55.0 43.94 29.03 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' B' ' 55' ' ' GLN . . . -100.87 -50.37 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.771 -165.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 48.05 -176.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.271 0.628 . . . . 0.0 110.908 -167.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 30.8 tt0 -103.79 102.49 12.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.609 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.61 100.69 13.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.328 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -91.43 162.06 14.73 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.51 138.4 9.72 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.92 -43.75 64.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 68.59 -3.42 1.38 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.578 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -179.244 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 122.051 0.929 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.34 121.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.04 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 171.79 7.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 28' ' ' GLU . 21.0 mt -136.39 139.42 45.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 166.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.69 -166.99 1.74 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -70.78 -19.8 62.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.307 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -74.54 -32.43 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.549 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.97 25.55 26.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.143 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -96.42 -85.4 0.34 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HA ' HG12 ' A' ' 22' ' ' ILE . 17.5 tt0 -176.81 150.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 174.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG22 ' HB3' ' A' ' 23' ' ' ASP . 58.6 t -130.92 117.34 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.702 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 p -116.25 168.45 8.6 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.854 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.702 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 41.2 Cg_endo -67.71 9.84 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.726 2.284 . . . . 0.0 113.766 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.1 6.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.517 . . . . 0.0 109.999 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -109.78 147.07 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.995 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.23 124.12 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -147.3 163.95 34.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.771 ' HB ' HD13 ' A' ' 48' ' ' LEU . 61.6 t -136.52 137.72 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -99.64 121.83 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.86 86.48 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' HG21 ' B' ' 37' ' ' ILE . . . 77.55 -36.26 1.59 Allowed Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.768 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.628 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.67 135.24 34.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.108 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -91.17 133.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.988 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.9 mp -136.87 134.5 48.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 60.7 mt -54.39 151.57 7.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.67 -8.04 24.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.67 -45.47 10.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.245 0.545 . . . . 0.0 109.719 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -85.86 -4.95 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.229 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.771 HD13 ' HB ' ' A' ' 36' ' ' VAL . 56.1 tp -54.97 -50.83 67.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.521 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.557 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 mt-10 -52.81 -48.99 66.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.307 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -59.44 -49.36 78.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.76 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.6 -32.92 74.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 40.4 mt -72.25 -24.36 61.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.566 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 94.0 mtt180 -72.13 -38.98 69.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.6 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -68.82 0.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.872 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 11.8 pt20 -103.79 -53.12 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.677 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 18.3 tp 47.78 43.37 16.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -123.5 -3.82 8.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.139 -1.029 . . . . 0.0 114.633 -165.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.22 -160.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 11.0 mm-40 -105.27 101.75 11.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -110.53 104.53 13.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.167 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 71.1 mmtt -101.8 152.46 20.86 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -155.89 149.91 25.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.43 0 O-C-N 123.084 0.24 . . . . 0.0 111.317 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -121.9 119.52 58.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.587 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 173.92 12.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.103 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.425 HG21 ' N ' ' B' ' 23' ' ' ASP . 30.3 mt -130.42 155.98 42.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.425 ' N ' HG21 ' B' ' 22' ' ' ILE . 7.5 p-10 -81.14 -162.19 0.47 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.257 0.551 . . . . 0.0 111.109 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -76.83 -30.2 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.743 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -80.51 -19.76 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.314 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.422 ' HA2' HG22 ' B' ' 22' ' ' ILE . . . 83.92 41.09 8.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.611 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.37 -82.68 0.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 178.02 140.91 0.09 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.464 HG12 ' HB3' ' B' ' 35' ' ' TYR . 21.9 t -126.4 141.72 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.685 ' HG1' ' HB2' ' B' ' 33' ' ' ASP . 71.5 p -124.53 155.83 68.57 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 -15.19 42.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.778 2.318 . . . . 0.0 112.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.53 9.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.636 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . 0.685 ' HB2' ' HG1' ' B' ' 30' ' ' THR . 0.1 OUTLIER -125.17 150.55 46.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -86.32 130.06 34.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.224 0.535 . . . . 0.0 110.743 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.464 ' HB3' HG12 ' B' ' 29' ' ' VAL . 32.9 p90 -144.0 152.22 40.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' B' ' 48' ' ' LEU . 74.9 t -129.78 139.92 50.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 57.6 mt -101.09 116.84 45.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.623 0.725 . . . . 0.0 109.697 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -112.76 91.0 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.304 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.12 -4.37 86.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.44 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.93 4.33 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.87 143.04 27.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 110.308 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.474 HG12 HG12 ' B' ' 37' ' ' ILE . 81.3 mt -97.26 129.12 47.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.237 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.03 129.46 75.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.72 131.23 50.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.532 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 2.3 tmm_? -70.42 0.97 5.58 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -167.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.28 -7.21 57.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.436 0.636 . . . . 0.0 109.85 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -129.15 20.16 5.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.647 HD13 ' HB ' ' B' ' 36' ' ' VAL . 58.9 tp -71.4 -38.37 71.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.992 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.5 -44.61 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.98 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.68 -46.09 87.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.009 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -68.85 -32.88 72.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.04 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.9 mt -72.92 -28.51 62.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.615 0.245 . . . . 0.0 110.925 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.626 HH21 ' HG2' ' B' ' 54' ' ' GLU . 6.7 ttp180 -64.12 -41.53 97.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.234 0.54 . . . . 0.0 110.012 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.626 ' HG2' HH21 ' B' ' 53' ' ' ARG . 49.5 mt-10 -91.0 -51.02 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.876 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.407 HE21 ' HG2' ' B' ' 59' ' ' GLU . 7.2 tp60 -94.5 -54.46 3.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.435 0.16 . . . . 0.0 111.376 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.8 tp 74.82 33.54 0.77 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 -11.04 60.74 Favored Glycine 0 C--O 1.235 0.18 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.602 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -105.47 110.1 22.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.606 0.241 . . . . 0.0 111.3 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.407 ' HG2' HE21 ' B' ' 55' ' ' GLN . 0.0 OUTLIER -92.07 102.12 14.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.56 110.02 21.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.06 -171.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.93 97.39 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 111.264 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -85.38 162.94 18.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.79 10.68 2.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 111.131 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -82.95 76.93 9.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.772 176.684 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.14 97.3 5.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.452 ' NE2' HD11 ' A' ' 42' ' ' ILE . 10.6 pt20 -108.21 159.37 16.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.474 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 23' ' ' ASP . 26.7 mt -130.53 156.49 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 22' ' ' ILE . 7.7 p-10 -77.83 -167.7 1.05 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -75.37 -31.76 60.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.443 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.21 -19.19 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.523 -174.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.28 50.12 2.67 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.404 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -99.64 -94.89 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -179.49 123.87 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.85 106.84 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.774 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.8 p -93.24 158.28 37.45 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HB2' HD23 ' B' ' 65' ' ' LEU . 27.9 Cg_exo -62.98 1.29 1.19 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.689 2.259 . . . . 0.0 113.18 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -98.8 -4.44 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.349 0.595 . . . . 0.0 109.928 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.47 ' O ' ' HD1' ' A' ' 35' ' ' TYR . 52.0 m-20 -108.64 120.44 42.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.706 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.11 126.24 27.48 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.949 0.404 . . . . 0.0 110.717 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 33' ' ' ASP . 38.9 p90 -146.35 168.0 22.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 0.0 110.902 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' B' ' 60' ' ' PHE . 75.4 t -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.75 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 24.4 mt -106.16 122.06 59.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 56' ' ' LEU . 10.2 t70 -94.06 86.77 5.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.708 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . 78.52 -42.52 2.22 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.021 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.27 -30.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.47 145.6 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.21 0.529 . . . . 0.0 110.472 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.452 HD11 ' NE2' ' A' ' 21' ' ' GLN . 66.3 mt -102.57 136.85 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.006 -172.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.434 ' HB ' HD12 ' A' ' 48' ' ' LEU . 2.6 mp -138.41 129.53 36.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 175.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.07 150.52 24.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.252 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.05 -5.93 25.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.403 178.005 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -55.73 15.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 110.188 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.64 25.25 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.143 0.973 . . . . 0.0 109.138 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 36.1 tp -56.0 -50.18 71.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.164 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.67 -28.51 69.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.571 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.415 ' NH2' ' HD2' ' A' ' 53' ' ' ARG . 1.1 tpm_? -64.24 -49.27 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 110.265 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 33.4 t80 -75.68 -24.57 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.939 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.742 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 50.6 mt -69.69 -26.64 64.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HD2' ' NH2' ' A' ' 50' ' ' ARG . 18.4 ttm180 -86.02 -19.5 30.24 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 1.1 tp10 -79.16 -54.09 6.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.18 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.613 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 30.2 tt0 -103.14 -67.69 0.87 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.559 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.1 tt 33.03 47.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.689 0.757 . . . . 0.0 109.716 -168.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.613 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -118.7 -18.09 4.92 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.733 -170.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 10.6 m-85 53.55 -151.54 0.33 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.628 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 21.1 mt-10 -119.64 102.13 8.4 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.919 166.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -84.36 119.87 25.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.628 ' HZ1' ' HB3' ' A' ' 59' ' ' GLU . 46.0 mmtm -117.57 102.58 9.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 111.599 -177.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -79.37 160.54 26.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.721 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.66 0.267 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t 55.82 76.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.355 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.504 ' OE1' HD13 ' B' ' 42' ' ' ILE . 3.5 pp0? -93.33 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.653 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -126.75 147.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.801 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' B' ' 29' ' ' VAL . 5.3 p-10 -86.18 -164.41 1.04 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.08 0.467 . . . . 0.0 110.761 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -68.28 -28.96 67.64 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.26 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -59.76 -44.24 93.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.675 0.274 . . . . 0.0 111.008 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.22 33.21 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.029 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.3 -84.84 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.715 0.293 . . . . 0.0 110.342 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -169.55 142.2 2.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' B' ' 23' ' ' ASP . 22.0 t -123.65 86.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.676 0.75 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.436 ' C ' ' H ' ' B' ' 32' ' ' VAL . 0.1 OUTLIER -81.29 153.85 71.71 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.093 175.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.06 12.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 123.4 2.734 . . . . 0.0 114.787 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' B' ' 30' ' ' THR . 33.9 m -103.21 -5.55 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.048 0.451 . . . . 0.0 110.282 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.35 155.81 17.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.267 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.618 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 5.3 m-20 -89.81 118.61 29.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.542 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -144.24 160.59 40.72 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.703 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.61 146.87 31.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.601 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mt -103.02 100.02 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.75 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 7.8 m-20 -96.54 90.8 5.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.463 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.597 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 72.49 37.1 58.61 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.516 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.62 -26.27 23.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.595 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.23 142.54 27.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.769 0.319 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.504 HD13 ' OE1' ' B' ' 21' ' ' GLN . 76.7 mt -100.49 128.43 52.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.424 ' N ' HD12 ' B' ' 43' ' ' ILE . 4.3 mp -126.46 126.8 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.302 . . . . 0.0 110.422 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.515 HD23 ' HG2' ' B' ' 46' ' ' GLU . 1.1 tt -69.37 134.69 49.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.618 ' HE ' ' HB3' ' B' ' 34' ' ' ASP . 15.6 mtm180 -69.25 0.53 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . 0.515 ' HG2' HD23 ' B' ' 44' ' ' LEU . 42.6 mm-40 -69.05 -18.05 63.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.893 0.378 . . . . 0.0 110.387 171.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -129.24 3.5 5.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.196 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 61.4 tp -57.74 -33.21 68.22 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.159 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 30.6 mt-10 -57.4 -52.66 64.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.779 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.513 ' HA ' ' HD3' ' B' ' 53' ' ' ARG . 7.4 mpt_? -71.14 -31.56 67.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -65.72 -39.38 91.11 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.337 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -69.38 -29.32 67.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.513 ' HD3' ' HA ' ' B' ' 50' ' ' ARG . 32.4 mtp180 -65.7 -32.71 74.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -94.45 -62.48 1.32 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.77 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -85.5 -42.2 14.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.051 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.6 tp 74.11 13.42 4.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.142 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.75 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 88.28 -29.03 5.82 Favored Glycine 0 CA--C 1.517 0.169 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.487 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -69.85 126.05 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.581 0.229 . . . . 0.0 111.107 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.1 tp10 -92.77 101.88 14.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . 0.51 ' HA ' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.31 86.0 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -84.08 93.64 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 0.0 110.658 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -66.1 126.44 28.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.742 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.58 64.59 8.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 110.541 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -76.52 -56.16 4.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.39 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.572 HD23 ' HB2' ' A' ' 31' ' ' PRO . 24.4 tp . . . . . 0 C--O 1.234 0.277 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.141 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.06 0.457 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 t -84.29 117.56 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.0 159.68 41.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.347 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 23' ' ' ASP . 20.8 mt -134.03 153.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.647 0.261 . . . . 0.0 110.377 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.8 p-10 -80.44 -177.77 6.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 110.78 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.62 -28.14 69.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.848 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -86.61 -17.24 34.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 37.43 6.96 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.746 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 t70 -90.84 -88.39 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.9 tt0 174.69 138.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.8 116.93 28.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.033 0.444 . . . . 0.0 110.338 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.765 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 60.5 p -110.05 172.8 3.31 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.999 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.765 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 42.6 Cg_endo -68.48 2.3 2.97 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.313 2.009 . . . . 0.0 112.197 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.34 14.04 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.548 0.69 . . . . 0.0 109.449 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' HB3' HD11 ' A' ' 44' ' ' LEU . 41.9 m-20 -118.69 146.62 44.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.207 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.01 118.26 30.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HB3' HD13 ' A' ' 44' ' ' LEU . 31.0 p90 -144.02 168.01 21.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.486 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HB ' HD12 ' A' ' 48' ' ' LEU . 72.0 t -131.51 133.68 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 ' O ' ' HA2' ' B' ' 39' ' ' GLY . 61.1 mt -103.52 121.96 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.323 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -93.13 86.2 5.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.339 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.537 ' C ' ' HG3' ' A' ' 59' ' ' GLU . . . 78.31 -31.56 1.85 Allowed Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.35 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.43 -23.0 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.14 130.56 35.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.3 mt -89.76 129.14 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.567 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.6 mp -133.98 122.73 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 35' ' ' TYR . 13.9 tp -64.8 149.76 48.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -23.42 32.47 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -81.54 -22.92 37.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 110.59 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -112.9 4.25 16.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.298 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.667 HD12 ' HB ' ' A' ' 36' ' ' VAL . 29.3 tp -70.68 -60.68 2.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 35.1 mt-10 -61.93 -16.18 49.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -165.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 53' ' ' ARG . 19.2 tpt180 -80.99 -49.91 10.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.225 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' HD2' HG12 ' A' ' 43' ' ' ILE . 16.1 t80 -63.75 -43.27 96.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 14.9 mt -63.82 -41.36 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 40.0 ttm-85 -52.04 -46.53 65.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.845 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.01 -25.26 23.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 29.0 tt0 -99.47 -68.08 0.82 Allowed 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.423 -0.798 . . . . 0.0 112.048 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 65.5 mt 42.27 43.99 3.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.317 0.58 . . . . 0.0 109.71 -169.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -100.8 -14.33 32.04 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.277 -168.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 57.22 -151.59 0.41 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.537 ' HG3' ' C ' ' A' ' 39' ' ' GLY . 2.3 mt-10 -118.22 102.16 8.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 163.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.37 103.55 12.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.078 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -109.04 37.83 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.305 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -55.71 119.38 5.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.775 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 -175.485 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.405 0.622 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.66 131.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.712 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.602 HE21 HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.99 -172.9 4.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.362 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' B' ' 28' ' ' GLU . 41.0 mt -126.7 150.04 32.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.6 OUTLIER -83.11 -170.08 2.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.796 0.332 . . . . 0.0 110.285 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.07 -27.25 62.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.76 0.424 . . . . 0.0 111.021 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . 0.408 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 29.1 t80 -76.61 -30.59 56.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.75 30.08 5.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.188 -1.005 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -111.65 132.33 54.66 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.467 ' HA ' HG12 ' B' ' 22' ' ' ILE . 26.1 tt0 -64.71 124.18 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.334 0.588 . . . . 0.0 110.598 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' B' ' 35' ' ' TYR . 42.9 t -104.47 129.94 56.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.814 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 72.0 p -118.89 175.69 2.03 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.827 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_endo -64.47 5.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.392 2.062 . . . . 0.0 113.207 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' B' ' 30' ' ' THR . 3.6 t -116.1 18.53 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.576 0.703 . . . . 0.0 109.418 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -129.1 125.81 37.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.366 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.38 109.76 2.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.211 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.413 ' HB3' HG13 ' B' ' 29' ' ' VAL . 16.6 p90 -135.88 149.13 48.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.159 0.504 . . . . 0.0 110.197 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.87 142.59 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.21 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.5 mt -102.93 115.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.524 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -94.63 89.06 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.518 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 83.0 -26.65 4.2 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.642 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.32 -26.25 0.35 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.44 129.55 34.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.602 HG21 HE21 ' B' ' 21' ' ' GLN . 64.3 mt -93.1 136.6 24.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.686 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -136.44 133.96 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.419 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -69.05 143.75 54.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.626 ' HD3' HD22 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -57.23 -20.71 28.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -172.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.43 -29.93 62.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.1 0.476 . . . . 0.0 110.708 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -106.92 -12.62 15.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.604 0.716 . . . . 0.0 109.773 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.626 HD22 ' HD3' ' B' ' 45' ' ' ARG . 31.5 tp -60.67 -52.01 66.93 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.959 -175.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.31 -37.31 80.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.323 0.582 . . . . 0.0 110.236 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 23.8 tpt85 -64.58 -53.55 46.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.234 176.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.67 -36.54 76.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.996 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 66.7 mt -63.66 -47.32 81.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.912 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 14.1 ptt85 -63.22 -28.46 70.05 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.242 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.57 -36.84 17.32 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.665 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.2 tp-100 -103.04 -68.19 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 27.1 mt 38.5 40.57 0.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.504 0.502 . . . . 0.0 110.723 -167.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.665 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -107.06 -13.72 20.73 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.306 -167.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 57.75 -154.93 0.34 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.66 102.03 9.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.306 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.55 99.86 11.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -92.43 91.6 7.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.111 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.0 128.56 36.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.828 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.96 -11.02 60.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.365 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 54.51 78.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.814 0.816 . . . . 0.0 110.119 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.634 -174.439 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 89.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.732 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.404 ' NE2' HG22 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -115.94 141.05 48.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.582 -178.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 23' ' ' ASP . 27.8 mt -99.62 161.23 3.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 3.2 p-10 -79.35 -167.12 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -77.38 -31.37 54.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.734 0.302 . . . . 0.0 111.591 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -80.03 -31.96 39.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.66 39.99 1.52 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.635 -1.269 . . . . 0.0 113.067 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.02 -110.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -174.38 124.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.54 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -105.19 165.12 13.74 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.089 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.73 1.65 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.289 2.66 . . . . 0.0 114.304 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.22 17.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -112.99 138.16 50.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.215 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.44 116.07 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -133.56 166.99 21.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.774 ' HB ' HD21 ' A' ' 48' ' ' LEU . 92.3 t -135.63 138.38 48.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.0 mt -106.44 114.05 44.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 52.6 t0 -95.44 87.74 4.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.21 0.529 . . . . 0.0 110.373 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.735 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 81.29 -11.64 42.87 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.264 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -22.4 1.56 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -83.89 130.16 34.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.404 HG22 ' NE2' ' A' ' 21' ' ' GLN . 81.4 mt -89.11 131.04 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.383 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.537 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.5 mp -134.8 136.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -74.1 146.12 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.555 ' N ' HD21 ' A' ' 44' ' ' LEU . 2.0 mmt180 -56.47 -21.52 26.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.51 -40.56 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.943 0.401 . . . . 0.0 110.024 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -89.18 -1.35 58.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 110.447 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.774 HD21 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -64.14 -40.6 96.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.02 -55.56 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.666 -174.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -64.53 -35.23 80.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.596 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -46.75 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' A' ' 48' ' ' LEU . 87.7 mt -66.35 -26.43 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -73.79 -33.72 64.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.687 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.68 -51.04 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 12.8 tt0 -90.47 -68.36 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.492 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 38.74 35.56 0.12 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.792 0.682 . . . . 0.0 110.763 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -136.73 10.44 3.98 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.145 -171.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 1.3 m-85 58.34 -158.65 0.29 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.235 0.54 . . . . 0.0 110.882 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.6 tp10 -100.88 102.02 12.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.03 90.48 4.91 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.916 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 73.5 mmtt -86.64 147.12 26.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.521 -175.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -119.22 141.78 48.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.768 0.318 . . . . 0.0 111.066 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.415 0.626 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.83 127.0 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.266 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -135.92 172.39 13.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.367 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.439 HG23 HD11 ' B' ' 22' ' ' ILE . 11.9 mt -130.68 146.31 34.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 178.67 7.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -63.81 -26.15 68.5 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.734 0.414 . . . . 0.0 111.79 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.65 -2.06 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.67 17.32 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.736 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.36 128.66 39.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -72.57 99.69 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.0 t -86.61 114.64 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.517 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 78.3 p -102.61 172.85 3.94 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.011 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 77.1 Cg_exo -49.56 -22.47 6.52 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.224 2.616 . . . . 0.0 114.331 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.95 6.81 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -101.77 123.39 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -69.19 121.79 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.256 -179.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 26.0 p90 -144.66 161.14 39.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.909 0.385 . . . . 0.0 110.988 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' B' ' 48' ' ' LEU . 54.4 t -135.09 143.73 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.577 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 48.9 mt -109.32 115.93 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 111.223 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.07 90.11 6.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 109.529 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.735 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 81.97 -34.12 2.6 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.282 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.69 -24.7 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -174.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -82.59 134.57 35.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.074 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 69.1 mt -92.52 129.57 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.827 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.01 122.52 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.51 141.37 47.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.518 ' HG3' ' OD2' ' B' ' 34' ' ' ASP . 30.3 mmm-85 -60.81 -12.07 9.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -67.99 -47.06 69.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.71 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -103.17 -3.66 25.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.973 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' B' ' 36' ' ' VAL . 37.4 tp -47.86 -41.92 25.31 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.662 -173.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -53.98 -44.61 70.97 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.808 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -74.67 -41.29 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -65.16 -45.16 86.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.447 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 35.2 mt -69.84 -24.84 63.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.199 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -68.15 -44.25 76.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.558 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -93.81 -30.33 14.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.554 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp-100 -99.34 -67.55 0.84 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.09 37.89 1.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.439 0.638 . . . . 0.0 109.607 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.554 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -116.62 1.04 20.23 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.819 -165.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.68 -150.91 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.773 0.787 . . . . 0.0 109.377 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.04 101.79 9.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.33 96.57 10.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.31 86.16 2.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.512 0.673 . . . . 0.0 111.072 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -67.93 169.49 9.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.839 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.443 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -77.05 13.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 62.47 14.93 7.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.975 0.417 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 93.0 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.154 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.247 0.546 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t -131.71 137.12 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.476 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.518 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -116.53 116.11 27.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.549 0.69 . . . . 0.0 110.387 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.17 142.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -63.08 -170.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.151 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -73.81 -31.64 63.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.455 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -72.17 -36.69 69.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 109.952 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 24.32 7.55 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.003 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 6.7 t70 -80.5 -81.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 40.3 tt0 163.92 123.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.809 0.693 . . . . 0.0 110.299 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 35' ' ' TYR . 9.4 t -113.35 134.89 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -111.47 153.93 43.99 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.201 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.62 1.73 2.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.0 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.14 -3.8 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.503 0.668 . . . . 0.0 109.46 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.38 179.39 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -111.7 128.98 56.24 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' HB3' HG12 ' A' ' 29' ' ' VAL . 36.8 p90 -141.46 167.47 22.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.136 0.493 . . . . 0.0 110.691 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.968 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 96.2 t -136.62 138.29 46.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.8 113.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.214 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 40' ' ' GLY . 11.8 t0 -88.22 88.6 7.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.137 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.514 ' O ' HG23 ' B' ' 37' ' ' ILE . . . 73.95 -27.65 0.95 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.423 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 165.43 -22.05 0.13 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -82.49 145.93 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.107 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 21' ' ' GLN . 83.5 mt -98.51 131.21 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.455 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HB ' HD21 ' A' ' 48' ' ' LEU . 1.7 mp -139.69 130.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 45' ' ' ARG . 5.6 tt -63.13 143.22 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.438 ' N ' HD23 ' A' ' 44' ' ' LEU . 10.5 mmm-85 -51.06 -23.28 2.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.83 -29.96 35.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.067 0.46 . . . . 0.0 110.808 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.81 -12.7 18.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.431 0.634 . . . . 0.0 109.911 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.968 ' HG ' ' HB ' ' A' ' 36' ' ' VAL . 2.8 tm? -61.68 -37.12 82.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.845 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -54.76 -52.4 62.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HE ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 ttm180 -76.34 -20.66 57.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -76.43 -30.7 57.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.021 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 56' ' ' LEU . 64.8 mt -67.72 -32.76 73.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.272 0.558 . . . . 0.0 109.667 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -61.38 -35.13 76.65 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -74.99 -64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.182 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -103.27 -59.22 1.75 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.8 tp 89.45 39.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.101 0.96 . . . . 0.0 112.117 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' B' ' 57' ' ' GLY . . . 72.39 57.67 5.44 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.449 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -155.2 120.22 4.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.123 0.461 . . . . 0.0 112.102 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.53 ' CB ' ' HB ' ' B' ' 37' ' ' ILE . 3.1 mm-40 -101.45 101.7 12.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 160.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.75 109.51 19.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.298 -168.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -121.42 174.63 6.63 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -165.12 169.95 15.56 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.192 178.348 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.27 109.08 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.41 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 13.6 pt20 -93.21 132.78 37.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.164 0.507 . . . . 0.0 111.284 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.455 HD13 HG21 ' B' ' 22' ' ' ILE . 24.2 mt -103.25 151.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 0.5 OUTLIER -85.09 -177.91 6.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.62 -25.0 67.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.807 0.443 . . . . 0.0 111.82 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -89.65 -18.02 27.28 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.51 13.59 27.82 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.633 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.72 129.45 36.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.32 99.59 4.14 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.513 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 46.5 t -81.38 101.16 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.44 0.638 . . . . 0.0 111.189 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 21.9 p -86.06 163.12 44.33 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.471 174.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 50.5 Cg_endo -68.82 20.33 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.933 2.422 . . . . 0.0 113.37 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' B' ' 30' ' ' THR . 7.0 t -116.67 1.01 8.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.109 0.481 . . . . 0.0 109.994 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -121.83 170.15 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -92.66 124.89 37.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.576 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.458 ' HB3' HG12 ' B' ' 29' ' ' VAL . 18.5 p90 -136.73 146.22 45.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.97 0.414 . . . . 0.0 110.64 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.67 138.95 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 36.8 mt -99.86 113.62 35.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-O 121.628 0.727 . . . . 0.0 109.83 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -106.87 90.17 3.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.653 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' B' ' 59' ' ' GLU . . . 81.51 12.01 82.4 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.421 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.38 -30.46 4.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -97.51 150.29 21.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.331 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 72.9 mt -89.76 140.79 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.176 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.439 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.3 mp -134.41 129.9 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.506 HD11 HG22 ' B' ' 29' ' ' VAL . 3.9 tt -72.18 137.8 47.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HG2' HD22 ' B' ' 48' ' ' LEU . 12.3 mtm180 -70.85 0.32 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.92 -15.26 56.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.23 3.21 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.278 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.591 ' HG ' ' HG ' ' B' ' 52' ' ' LEU . 28.1 tp -73.24 -34.89 66.13 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -170.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -51.59 -41.49 61.23 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' B' ' 53' ' ' ARG . 7.6 ttm180 -77.55 -33.31 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -71.01 -38.21 72.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.591 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 58.0 mt -67.34 -29.15 68.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.164 0.506 . . . . 0.0 110.072 172.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' B' ' 50' ' ' ARG . 18.6 ttm180 -65.77 -28.19 68.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -70.01 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.647 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' B' ' 56' ' ' LEU . 2.4 pt20 -104.23 -48.63 3.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' B' ' 55' ' ' GLN . 29.0 tp 82.36 42.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.918 0.761 . . . . 0.0 111.224 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 57' ' ' GLY . . . 95.3 -20.57 48.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.763 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -87.58 107.39 18.57 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -174.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.596 ' CG ' ' HA3' ' B' ' 39' ' ' GLY . 3.0 mm-40 -101.63 102.24 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.147 0.498 . . . . 0.0 110.679 171.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -89.62 123.05 33.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.454 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -127.12 79.89 1.91 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 111.013 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -75.12 162.55 28.42 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' B' ' 65' ' ' LEU . . . -58.36 -36.34 73.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.485 0.183 . . . . 0.0 111.35 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.06 -13.45 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' B' ' 63' ' ' ALA . 53.7 tp . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 121.951 0.881 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.82 102.79 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.51 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt20 -101.39 147.54 26.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.05 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.422 HG23 ' HA2' ' A' ' 26' ' ' GLY . 29.0 mt -123.17 153.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 6.4 p-10 -76.29 -164.89 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -78.78 -29.97 45.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.954 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HD2' HD21 ' A' ' 47' ' ' ASN . 65.5 m-85 -96.1 -7.57 35.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 22' ' ' ILE . . . 84.87 51.18 3.89 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.164 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 18.5 t70 -94.77 -86.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 35.1 tt0 167.89 135.36 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.312 1.045 . . . . 0.0 108.212 170.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.53 104.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 110.68 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.79 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 71.9 p -96.12 174.08 3.71 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.79 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.6 Cg_endo -66.05 4.24 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.15 1.9 . . . . 0.0 112.416 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 30' ' ' THR . 26.4 t -103.39 -18.23 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.133 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -94.43 119.93 33.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.379 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.23 138.58 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.402 ' CD2' HG23 ' A' ' 42' ' ' ILE . 21.3 p90 -155.93 166.24 34.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.206 0.526 . . . . 0.0 111.136 -173.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG12 ' O ' ' B' ' 59' ' ' GLU . 69.4 t -135.07 145.79 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 20.1 mt -103.37 120.11 52.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 121.794 0.807 . . . . 0.0 110.82 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.438 ' HB3' HD13 ' A' ' 43' ' ' ILE . 26.2 t0 -105.93 90.28 3.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.607 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 77.9 20.13 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.09 42.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.77 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.71 139.17 34.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.7 mt -88.86 138.88 18.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.51 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -139.53 127.47 26.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.3 tt -62.88 148.62 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.815 HH11 HD22 ' A' ' 48' ' ' LEU . 8.2 mmm180 -61.89 -7.25 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.89 -55.39 3.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 0.0 110.725 175.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.494 HD21 ' HD2' ' A' ' 25' ' ' TYR . 15.0 p-10 -89.62 3.64 51.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.312 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.815 HD22 HH11 ' A' ' 45' ' ' ARG . 36.8 tp -61.16 -32.62 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.986 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -44.43 -54.32 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.301 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.49 ' NH2' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -68.77 -33.09 73.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.87 -172.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.574 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -76.18 -39.3 55.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.712 -176.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.5 mt -67.73 -22.28 65.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.794 0.807 . . . . 0.0 109.364 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.49 HH11 ' NH2' ' A' ' 50' ' ' ARG . 27.9 ttm180 -76.65 -25.17 53.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.264 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -90.16 -69.48 0.72 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.861 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.12 -16.16 15.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 30.3 tp 71.74 28.34 2.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 171.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 98.54 -8.51 62.09 Favored Glycine 0 C--N 1.321 -0.294 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.748 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.4 ' HE1' ' HA3' ' B' ' 57' ' ' GLY . 12.4 m-85 -117.1 129.76 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.078 0.439 . . . . 0.0 111.995 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.674 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 11.8 mt-10 -96.45 102.14 13.88 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 164.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -81.81 106.67 13.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.674 ' HE2' ' HB3' ' A' ' 59' ' ' GLU . 3.8 mptp? -108.68 80.61 1.35 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 109.766 174.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -83.75 146.47 28.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.227 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 121.375 0.607 . . . . 0.0 110.331 179.452 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 121.599 0.714 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.79 130.99 60.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.479 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.456 ' OE1' HG23 ' B' ' 42' ' ' ILE . 3.0 pp0? -148.14 163.63 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.48 150.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.671 0.272 . . . . 0.0 110.964 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.37 -168.08 1.06 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -70.56 -29.01 65.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.74 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -86.04 -8.63 57.79 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.58 36.88 25.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.242 168.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 -92.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.423 0.611 . . . . 0.0 110.493 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -173.46 137.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -119.19 121.23 66.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.016 0.436 . . . . 0.0 110.14 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 57.3 p -102.42 168.81 8.38 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.84 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 33.4 Cg_endo -64.97 -4.03 8.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.58 2.186 . . . . 0.0 112.627 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.53 -2.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.304 0.573 . . . . 0.0 110.138 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -107.54 136.8 46.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.47 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -69.1 116.23 9.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.289 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.24 139.41 35.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 110.583 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.55 139.16 45.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 36.2 mt -91.18 96.69 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.822 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 95.2 m-20 -79.17 90.63 4.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.022 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.596 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 78.05 -17.66 5.81 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.971 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.39 -19.34 0.92 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 8.3 tp10 -93.02 144.67 25.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.456 HG23 ' OE1' ' B' ' 21' ' ' GLN . 80.2 mt -99.95 129.7 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.156 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.19 128.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.484 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 82.2 mt -54.52 141.35 31.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 23.8 mtm180 -71.65 0.52 8.52 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.584 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.03 -13.04 59.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -128.35 -0.62 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.153 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 36.2 tp -60.37 -40.35 90.5 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.826 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 27.4 tt0 -53.66 -51.64 62.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.559 0.218 . . . . 0.0 111.056 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . 0.568 ' HD2' ' HD3' ' B' ' 53' ' ' ARG . 9.9 mmm180 -61.71 -36.29 80.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.366 -176.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.416 ' HH ' ' HG2' ' B' ' 41' ' ' GLU . 10.0 t80 -65.36 -43.38 90.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.947 0.403 . . . . 0.0 110.08 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 73.4 mt -71.92 -31.26 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.568 ' HD3' ' HD2' ' B' ' 50' ' ' ARG . 19.5 mtp180 -63.95 -33.4 75.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 25.1 mm-40 -92.18 -61.99 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.259 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -98.19 -29.17 13.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.1 tp 80.42 7.32 1.49 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.461 0.704 . . . . 0.0 111.924 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.822 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 91.74 1.55 70.71 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.414 -0.898 . . . . 0.0 115.149 166.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -98.94 134.91 41.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.78 0.79 . . . . 0.0 109.725 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.697 ' HB3' ' HE2' ' B' ' 61' ' ' LYS . 6.7 mt-10 -92.21 101.65 14.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.401 171.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.36 122.36 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.118 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.697 ' HE2' ' HB3' ' B' ' 59' ' ' GLU . 72.2 mmtt -119.17 157.62 27.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' B' ' 62' ' ' ASN . 3.1 m120 -135.59 137.78 42.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.04 0.447 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.11 -49.66 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.899 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.94 2.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.459 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -171.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.521 -0.139 0 CA-C-O 121.782 0.801 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.86 102.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.623 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 167.14 15.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mt -116.74 153.93 18.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.997 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.528 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 4.3 p-10 -83.84 -160.08 0.42 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.562 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -80.07 -23.51 41.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -41.13 35.55 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.6 45.32 1.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.825 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.28 -88.71 0.45 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 176.83 129.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.27 138.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 32' ' ' VAL . 63.7 p -123.82 160.5 51.22 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.26 2.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.185 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.567 HG21 HD22 ' B' ' 65' ' ' LEU . 12.0 t -97.47 -16.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.4 141.72 45.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.794 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.2 138.85 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.698 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CD2' HG23 ' A' ' 42' ' ' ILE . 33.1 p90 -148.69 175.01 11.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.891 175.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 94.5 t -134.5 139.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.51 HG22 ' HA2' ' B' ' 39' ' ' GLY . 18.3 mt -103.42 119.76 52.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -105.11 89.51 3.16 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.369 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 88.87 -40.09 3.09 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.22 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.35 -23.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.654 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.49 164.91 14.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 111.055 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.444 HG23 ' CD2' ' A' ' 35' ' ' TYR . 71.2 mt -116.82 129.29 73.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.809 -171.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.759 ' HB ' HD21 ' A' ' 48' ' ' LEU . 3.0 mp -130.35 123.72 56.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.197 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 3.9 tt -60.37 141.31 56.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.46 ' N ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.7 -16.95 7.28 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -77.59 -33.42 53.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.419 0.628 . . . . 0.0 110.006 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -104.97 -5.76 20.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.957 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.759 HD21 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -66.79 -25.95 66.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.791 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.95 -30.05 68.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 74.3 ttt180 -82.65 -33.82 27.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.562 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.3 t80 -69.26 -36.3 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 29.6 mt -74.91 -34.64 62.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.996 0.426 . . . . 0.0 110.095 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' HB3' ' HA ' ' A' ' 50' ' ' ARG . 4.6 ttp180 -59.86 -55.4 34.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.182 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -93.0 -39.21 11.23 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.622 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 50.5 tp60 -97.49 -68.39 0.8 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.792 -0.568 . . . . 0.0 111.164 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' HG ' ' HE1' ' B' ' 58' ' ' PHE . 0.7 OUTLIER 39.35 34.97 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.658 0.742 . . . . 0.0 110.225 -175.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.622 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -117.24 -19.81 4.98 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.873 -1.156 . . . . 0.0 114.583 -165.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 58.32 -153.96 0.37 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 7.4 tp10 -109.28 101.78 10.75 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.302 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.38 121.26 30.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.2 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -119.96 148.07 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.55 0.691 . . . . 0.0 111.105 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.42 148.05 47.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.035 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.122 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.14 97.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.027 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.496 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 11.0 pt20 -116.11 151.91 34.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.687 -170.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 15.4 mt -119.65 146.45 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.171 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.9 OUTLIER -70.77 -173.71 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 111.16 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.24 -30.57 71.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.585 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.64 -43.84 11.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.21 29.01 0.3 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.781 -1.2 . . . . 0.0 113.486 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -114.77 137.87 51.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.34 132.28 53.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 111.734 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 16.4 t -111.26 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.233 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 31.5 p -87.02 164.47 36.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.5 Cg_endo -65.38 -3.7 8.06 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.77 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 t -101.27 1.28 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.327 0.584 . . . . 0.0 109.656 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -112.35 141.31 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.154 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 8.6 m-20 -78.06 135.73 37.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.24 162.97 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.962 0.41 . . . . 0.0 110.638 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.53 144.38 38.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 37.0 mt -107.05 100.14 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 0.0 109.265 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.767 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 5.9 m-20 -93.56 90.27 6.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.543 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.51 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . 74.75 25.46 69.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.393 176.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.78 -12.38 59.35 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.82 133.22 37.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -95.62 130.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.523 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.9 mp -138.2 126.13 29.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' B' ' 23' ' ' ASP . 5.2 mp -55.25 143.2 28.77 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.532 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 12.3 mtp180 -70.27 -0.38 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.707 0.289 . . . . 0.0 111.598 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.59 -16.15 43.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.781 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -123.74 -4.36 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.884 0.85 . . . . 0.0 109.309 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 2.6 tm? -65.4 -35.4 80.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.963 -175.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 1.9 tm-20 -57.25 -55.96 27.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -60.68 -36.38 78.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.052 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.26 -33.55 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.676 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 68.6 mt -69.53 -29.16 66.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.474 . . . . 0.0 110.299 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' B' ' 53' ' ' ARG . 46.3 mtp85 -72.07 -24.28 61.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.46 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.44 -66.46 0.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.631 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -98.21 -34.31 10.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.641 -174.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.2 tp 77.05 1.97 3.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.491 0.717 . . . . 0.0 111.276 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.767 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 106.92 -32.91 6.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.097 170.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.541 ' HE1' ' HG ' ' A' ' 56' ' ' LEU . 34.2 m-85 -70.93 123.43 22.01 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.671 -0.311 . . . . 0.0 110.819 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.438 ' OE1' ' HE2' ' B' ' 61' ' ' LYS . 40.5 tt0 -95.57 101.99 13.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.287 170.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -82.88 91.78 7.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.438 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 60.5 mmtt -81.75 75.07 8.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -64.51 158.43 24.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.09 -51.53 24.1 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.665 0.603 . . . . 0.0 110.876 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 62.28 15.45 7.61 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.61 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 32' ' ' VAL . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.533 0.683 . . . . 0.0 110.445 -178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.598 0.713 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.2 t -117.91 87.98 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.948 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.416 ' OE1' ' HB ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -120.95 172.59 7.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.21 -176.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 28' ' ' GLU . 45.5 mt -129.8 150.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.9 p-10 -86.36 -170.28 3.02 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.2 -17.73 62.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.407 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.401 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 2.0 t80 -76.73 -41.99 42.94 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.74 34.92 3.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.987 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -102.36 -87.24 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.062 0.431 . . . . 0.0 109.992 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.519 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 -175.45 138.96 0.42 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 HD21 ' A' ' 44' ' ' LEU . 7.9 t -125.86 113.52 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 110.75 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 32' ' ' VAL . 24.9 p -114.84 163.93 18.13 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.022 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.71 7.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.499 2.799 . . . . 0.0 114.637 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' A' ' 30' ' ' THR . 22.0 m -100.18 -5.87 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.59 176.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -119.96 160.31 22.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.26 121.35 37.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.926 -173.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.21 159.66 41.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.055 0.455 . . . . 0.0 110.701 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 48' ' ' LEU . 96.0 t -134.08 142.42 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.753 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 42' ' ' ILE . 18.7 mt -102.73 121.74 54.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.623 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -94.48 89.17 5.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 79.58 -51.08 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.616 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -31.14 0.02 OUTLIER Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -174.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.59 142.2 33.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.229 0.537 . . . . 0.0 110.038 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 37' ' ' ILE . 84.0 mt -98.22 135.78 31.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.306 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 2.2 mp -137.78 132.1 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 29' ' ' VAL . 83.4 mt -58.92 152.6 19.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 172.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 48' ' ' LEU . 44.5 mmm-85 -63.65 -16.3 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.92 0.39 . . . . 0.0 110.577 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.22 -38.63 50.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.45 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.5 4.06 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.335 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 36' ' ' VAL . 40.4 tp -60.58 -41.32 94.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.499 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.16 -55.17 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.122 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.7 51.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.87 -45.0 91.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.481 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 58.0 mt -66.51 -48.77 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -61.97 -29.05 69.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.655 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -51.83 8.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.491 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.569 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 7.2 tt0 -103.49 -67.49 0.88 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 20.2 mt 47.72 43.35 16.67 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -168.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.569 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -113.65 1.94 24.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.672 -166.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' CZ ' ' HE1' ' B' ' 58' ' ' PHE . 8.3 m-85 59.33 -154.84 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.484 0.642 . . . . 0.0 109.69 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.5 tp10 -122.12 102.05 7.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 166.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.602 ' HD2' HD22 ' A' ' 62' ' ' ASN . 9.0 m-85 -99.26 110.95 23.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.247 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 74.1 mmtt -112.5 63.89 0.63 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.127 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.602 HD22 ' HD2' ' A' ' 60' ' ' PHE . 50.8 m-80 -74.11 149.87 40.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.093 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.925 0.869 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.6 124.11 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.096 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . 0.484 ' NE2' HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -130.01 166.55 19.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 0.0 111.438 -176.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.479 HG23 ' N ' ' B' ' 23' ' ' ASP . 23.8 mt -119.96 161.21 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.721 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.479 ' N ' HG23 ' B' ' 22' ' ' ILE . 5.0 p-10 -89.69 -159.87 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -73.02 -37.96 66.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.375 -175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -87.09 3.07 47.66 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.352 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 73.07 20.52 80.0 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.607 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.5 t70 -72.34 -87.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.308 173.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 30.2 tt0 175.33 141.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.36 123.04 67.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 0.0 110.3 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 64.0 p -106.86 160.94 24.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.936 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.06 3.36 0.56 Allowed 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.038 2.492 . . . . 0.0 113.558 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.4 12.86 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.599 0.714 . . . . 0.0 109.433 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -113.15 158.39 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.458 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.35 105.71 17.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -128.64 157.16 42.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.169 0.509 . . . . 0.0 110.512 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.4 ' HB ' HD22 ' B' ' 48' ' ' LEU . 92.2 t -135.24 142.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.883 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 34.3 mt -105.96 124.24 61.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.63 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 30.6 t70 -120.6 90.51 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.769 . . . . 0.0 110.696 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.41 28.42 27.47 Favored Glycine 0 C--N 1.315 -0.609 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.261 172.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 -22.72 38.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.295 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.98 136.41 33.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.484 HG21 ' NE2' ' B' ' 21' ' ' GLN . 74.3 mt -101.25 133.34 44.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.4 124.13 39.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.524 HD22 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -68.1 143.61 55.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.524 ' N ' HD22 ' B' ' 44' ' ' LEU . 38.9 mmm-85 -53.72 -22.02 8.29 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.2 -36.78 75.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -106.4 -19.94 13.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.407 ' CD2' ' HD2' ' B' ' 45' ' ' ARG . 24.4 tp -55.75 -42.41 75.38 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -172.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -33.6 68.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -41.02 25.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 0.0 110.258 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -57.92 -44.2 86.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.692 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.63 -38.84 64.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -57.82 -39.01 76.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -83.45 -43.99 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.555 ' HG2' ' H ' ' B' ' 57' ' ' GLY . 46.3 tt0 -99.5 -67.09 0.87 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.48 29.95 1.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.599 0.36 . . . . 0.0 111.689 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.555 ' H ' ' HG2' ' B' ' 55' ' ' GLN . . . -125.44 15.22 7.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.584 -171.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.503 ' HE1' ' CZ ' ' A' ' 58' ' ' PHE . 2.3 m-30 56.8 -153.36 0.37 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.999 0.428 . . . . 0.0 109.98 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' B' ' 59' ' ' GLU . 3.7 tp10 -117.93 102.16 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.313 0.578 . . . . 0.0 110.5 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -83.64 100.92 11.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.817 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -85.19 -175.46 5.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -165.83 168.12 16.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.43 11.31 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 70.21 -81.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.456 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.333 0.587 . . . . 0.0 110.117 -171.392 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.58 92.27 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.496 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 26.9 pt20 -88.26 167.08 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.243 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG21 ' HA2' ' A' ' 26' ' ' GLY . 28.4 mt -136.19 149.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.03 -179.99 4.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -57.99 -35.9 71.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.818 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -84.64 -12.96 52.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 87.76 40.78 6.6 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.118 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 28' ' ' GLU . 12.4 t70 -90.27 -97.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.409 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 29.6 tt0 179.38 127.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 22.0 t -123.04 107.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.226 0.536 . . . . 0.0 110.534 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 67.6 p -98.0 168.28 10.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.016 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 50.2 Cg_exo -56.52 -10.54 5.18 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.049 2.499 . . . . 0.0 113.721 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.19 10.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -106.19 145.73 31.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.928 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.571 ' OD1' ' HB2' ' B' ' 62' ' ' ASN . 35.9 m-20 -89.39 124.82 34.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -148.21 164.71 33.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.391 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.66 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 64.3 t -133.43 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 90.7 mt -112.94 108.17 24.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-O 121.685 0.755 . . . . 0.0 110.638 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -83.3 79.62 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.943 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.1 5.84 29.11 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.513 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.7 -24.8 1.97 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.545 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 40.0 mt-10 -81.56 134.28 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.2 mt -96.45 122.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.717 ' HB ' HD21 ' A' ' 48' ' ' LEU . 3.9 mp -129.45 127.55 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.188 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -62.36 143.03 57.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -55.58 -20.88 14.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.63 -47.54 80.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.603 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -96.86 0.44 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.193 0.521 . . . . 0.0 110.114 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' ' 43' ' ' ILE . 2.9 tm? -68.6 -36.71 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.394 -172.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.02 -34.28 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.81 -34.16 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 110.272 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.86 -41.76 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.386 174.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -63.52 -34.21 77.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.748 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -64.8 -41.83 95.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.605 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -66.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -103.33 -25.42 13.31 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.876 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 31.3 tp 64.1 43.46 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 173.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 86.14 -16.55 42.58 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.377 -0.916 . . . . 0.0 114.106 172.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.491 ' HE2' HD21 ' A' ' 56' ' ' LEU . 12.6 m-85 -91.7 133.29 35.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.89 102.01 14.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -78.5 107.02 10.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.716 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 17.5 tptt -93.81 177.09 6.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -143.62 151.89 40.7 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.444 0.64 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.86 105.37 18.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -106.59 162.01 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.502 . . . . 0.0 111.678 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.422 HG23 ' N ' ' B' ' 23' ' ' ASP . 35.1 mt -128.54 154.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.474 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.464 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 4.7 p-10 -82.79 -167.29 1.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.488 0.661 . . . . 0.0 111.601 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.1 -35.74 81.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.026 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -83.73 -7.61 59.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.73 65.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.165 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 28.3 t70 -80.53 -84.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 35.1 tt0 174.9 135.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . 0.435 HG22 HD21 ' B' ' 44' ' ' LEU . 40.7 t -121.51 118.34 55.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.211 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.818 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 70.2 p -111.93 172.67 3.36 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.324 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.818 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 46.3 Cg_endo -69.43 19.69 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.824 2.349 . . . . 0.0 113.071 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' B' ' 30' ' ' THR . 10.6 t -121.07 -3.42 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 109.961 177.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -101.76 172.3 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.718 -173.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.513 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 14.8 m-20 -111.39 106.42 15.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.509 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 22.0 p90 -124.84 142.5 51.4 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.987 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.4 138.76 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.194 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' B' ' 41' ' ' GLU . 57.0 mt -100.2 109.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.084 0.468 . . . . 0.0 110.664 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.43 90.1 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.149 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.49 -2.55 46.12 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.457 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.53 -30.47 1.42 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.149 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 31.1 mt-10 -88.13 145.33 25.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' B' ' 35' ' ' TYR . 61.7 mt -95.8 130.29 44.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.072 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.61 122.15 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.268 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 93.7 mt -62.15 144.69 55.07 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' CB ' ' B' ' 48' ' ' LEU . 48.0 mtm180 -69.27 -0.24 5.89 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.238 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.56 -27.23 64.96 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.1 2.54 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.025 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.579 ' CB ' ' HA ' ' B' ' 45' ' ' ARG . 32.5 tp -58.72 -40.75 84.62 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.49 -42.23 74.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.458 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -75.0 -40.02 60.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.587 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.05 -34.1 77.61 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.292 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 20.2 mt -72.19 -29.41 63.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.085 0.469 . . . . 0.0 110.585 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -65.46 -50.44 65.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 110.193 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.42 -48.64 12.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.244 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' GLN . . . . . 0.554 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 4.3 tp-100 -96.02 -67.6 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.515 -174.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 4.9 tp 42.74 40.26 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.743 0.652 . . . . 0.0 109.509 -171.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.554 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -101.41 -24.35 8.91 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.489 -0.862 . . . . 0.0 114.1 -165.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.72 -151.77 0.33 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.7 tp10 -116.44 101.78 8.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -107.33 111.83 24.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.582 -171.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.515 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 73.5 mmtt -124.62 -169.56 2.0 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.728 0.775 . . . . 0.0 110.99 -175.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . 0.571 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 6.4 p30 -169.35 -159.44 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.06 57.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 118.531 0.605 . . . . 0.0 111.417 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 61.19 19.79 10.39 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.074 0.55 . . . . 0.0 111.161 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 -176.26 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.935 0.398 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.23 172.77 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.92 159.65 30.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.16 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 4.8 p30 -150.94 109.17 3.06 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.516 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 4' ' ' ASN . 11.1 Cg_endo -55.57 -33.93 88.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.069 2.513 . . . . 0.0 111.707 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.507 ' HG3' HG22 ' A' ' 8' ' ' ILE . 26.8 ptm -140.81 157.84 44.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 t -78.28 92.86 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.067 0.461 . . . . 0.0 110.195 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 6' ' ' MET . 26.8 pt -93.83 155.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.545 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -88.62 103.56 16.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -90.54 174.06 7.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.784 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.02 -41.94 88.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.024 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 17.8 t-80 65.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.086 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' H ' ' HB3' ' A' ' 12' ' ' HIS . 27.5 m-20 -144.39 132.22 21.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -146.72 140.77 26.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.8 0.334 . . . . 0.0 110.99 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.486 HD21 ' H ' ' A' ' 15' ' ' LEU . 2.6 pt? -129.72 164.31 24.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.913 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.94 141.27 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.983 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 1.6 mp0 -68.83 123.46 21.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 m -62.65 -67.8 0.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 110.442 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -143.47 23.17 1.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.874 0.845 . . . . 0.0 109.271 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.32 121.24 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.478 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.779 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 29.0 pt20 -93.78 142.11 27.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 22' ' ' ILE . 22.5 mt -114.68 148.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.54 174.94 9.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.53 -35.72 70.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.91 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -82.43 -11.07 58.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.66 40.7 7.6 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.186 -1.006 . . . . 0.0 113.08 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 19.5 t70 -93.62 -95.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 23.9 tt0 177.42 126.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.779 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 39.8 t -109.21 104.63 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.308 0.575 . . . . 0.0 110.323 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.5 p -92.55 167.25 15.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.596 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 31.6 Cg_endo -65.09 -9.2 20.81 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.52 HG23 HD21 ' B' ' 65' ' ' LEU . 3.4 t -112.76 29.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.68 0.752 . . . . 0.0 109.133 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -129.84 139.69 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.862 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -89.27 128.54 35.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.547 ' CD2' HG21 ' A' ' 42' ' ' ILE . 18.6 p90 -142.4 170.11 16.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.44 135.58 49.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 30.4 mt -96.28 115.33 35.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.813 0.34 . . . . 0.0 110.264 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.47 88.1 6.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.407 0.622 . . . . 0.0 109.561 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.566 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 83.07 -33.42 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.229 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.16 -22.81 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.713 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.89 147.56 23.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 0.0 110.226 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.547 HG21 ' CD2' ' A' ' 35' ' ' TYR . 94.5 mt -94.38 128.85 45.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.909 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 48' ' ' LEU . 3.8 mp -130.03 129.59 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.178 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 45' ' ' ARG . 4.1 tt -67.36 138.7 56.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.413 ' N ' HD21 ' A' ' 44' ' ' LEU . 8.2 mmm-85 -53.55 -22.46 8.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.27 -40.8 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.252 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.58 -4.56 58.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.001 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HA ' HG23 ' A' ' 43' ' ' ILE . 33.8 tp -61.81 -44.2 97.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.54 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.1 -45.3 71.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.912 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -62.46 -48.7 78.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.387 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.5 -36.61 81.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.617 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.694 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 70.6 mt -66.8 -39.53 87.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.261 0.553 . . . . 0.0 110.485 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -70.49 -21.53 62.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.153 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.08 -59.5 2.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.65 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 27.3 tt0 -103.12 -67.46 0.88 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.2 tt 42.33 43.32 2.94 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.456 0.646 . . . . 0.0 109.378 -168.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.65 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -126.32 6.4 7.63 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.949 -1.119 . . . . 0.0 113.839 -166.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 54.6 -153.88 0.29 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.0 tp10 -112.89 101.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.037 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -97.77 110.17 22.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.521 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.71 163.66 13.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.874 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -144.98 -179.14 6.42 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 65' ' ' LEU . . . -60.49 -32.29 71.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 172.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 71.86 -43.47 0.56 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.508 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 63' ' ' ALA . 1.7 tm? -57.5 -44.19 84.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.02 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 56.88 73.92 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.042 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -65.52 122.2 16.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -75.85 71.14 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.4 m80 40.7 -95.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.423 1.089 . . . . 0.0 112.808 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -150.94 -28.47 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.6 t60 77.16 -49.77 0.54 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.022 0.929 . . . . 0.0 111.722 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 C--O 1.244 0.8 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.979 176.08 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.773 0.321 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.46 179.59 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 75.21 -47.85 0.62 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.912 0.885 . . . . 0.0 112.182 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 62.5 t30 -79.85 116.69 62.9 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 23.2 Cg_exo -63.71 92.91 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.219 2.612 . . . . 0.0 113.322 -174.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 63.8 mtt -111.15 -9.88 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.26 140.55 42.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 pt -127.64 160.47 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.079 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.25 143.06 26.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.674 0.273 . . . . 0.0 110.319 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -142.75 170.0 16.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.989 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -89.62 -178.11 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.035 0.445 . . . . 0.0 111.205 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -89.58 76.92 7.29 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.52 -52.54 65.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.424 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.96 86.22 3.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.089 0.471 . . . . 0.0 110.95 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.8 -38.08 3.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.606 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -71.1 153.97 42.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.52 122.63 16.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -84.42 -80.09 0.2 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.953 0.406 . . . . 0.0 111.592 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -121.06 12.53 11.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.939 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.67 129.35 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.836 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -140.73 165.49 27.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.23 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.456 HG21 ' HA2' ' B' ' 26' ' ' GLY . 16.8 mt -132.02 156.22 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.435 ' N ' HG23 ' B' ' 22' ' ' ILE . 4.7 p-10 -79.89 -165.85 0.9 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 110.784 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -72.15 -34.74 68.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.557 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.4 -41.02 25.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 118.22 38.12 0.82 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 11.1 t70 -86.2 -93.38 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 32.0 tt0 168.81 121.99 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' B' ' 35' ' ' TYR . 14.4 t -112.53 127.56 69.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.444 0.64 . . . . 0.0 110.505 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.643 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 69.3 p -124.63 169.64 10.47 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.65 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.643 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 44.6 Cg_endo -68.58 18.15 0.15 Allowed 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.452 2.101 . . . . 0.0 113.053 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' B' ' 30' ' ' THR . 35.7 t -108.7 -32.44 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.866 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.45 ' OD2' HG12 ' B' ' 29' ' ' VAL . 6.0 p-10 -104.14 134.87 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.581 0.705 . . . . 0.0 111.086 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.7 135.74 48.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.477 ' CG ' HG11 ' B' ' 29' ' ' VAL . 26.0 p90 -152.1 166.42 31.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.737 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.88 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 75.5 t -135.82 146.97 28.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.9 mt -112.77 118.33 57.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.431 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 1.1 m-20 -98.02 88.9 4.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.566 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 70.47 24.08 77.06 Favored Glycine 0 C--N 1.319 -0.4 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.448 172.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.6 -23.99 8.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.549 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.39 138.33 35.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.821 0.343 . . . . 0.0 110.541 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -89.33 136.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.627 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.421 ' HB ' HD21 ' B' ' 48' ' ' LEU . 3.8 mp -134.97 131.25 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -52.19 140.3 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -67.36 -5.21 13.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 0.0 109.827 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.74 -26.49 54.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.471 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.87 5.07 9.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.737 0.78 . . . . 0.0 109.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.88 ' HG ' ' HB ' ' B' ' 36' ' ' VAL . 2.7 tm? -66.99 -38.19 85.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.013 -170.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -58.95 -39.61 82.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -63.66 -39.64 94.84 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.229 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.08 -38.66 72.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.641 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.42 ' HG ' HD13 ' B' ' 48' ' ' LEU . 18.8 mt -67.12 -25.06 66.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.955 0.407 . . . . 0.0 110.86 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.13 -41.04 74.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.748 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.51 -41.12 9.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.693 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -100.89 -52.71 3.23 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.374 -0.204 . . . . 0.0 111.414 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 tp 76.59 37.37 0.32 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.896 0.748 . . . . 0.0 111.491 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 75.97 -11.39 11.44 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 170.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -101.24 120.84 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.359 0.579 . . . . 0.0 112.036 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 43.7 tt0 -92.28 102.03 14.53 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.58 109.16 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.844 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.462 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 9.7 mmmm -116.29 78.72 1.22 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.122 0.487 . . . . 0.0 111.157 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.11 165.7 19.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.99 60.61 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.242 0.339 . . . . 0.0 110.928 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 63.64 19.37 11.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.845 0.831 . . . . 0.0 110.049 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.52 HD21 HG23 ' A' ' 32' ' ' VAL . 26.5 tp -121.91 29.17 7.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.743 -176.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -71.57 74.8 0.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.424 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.74 95.96 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -67.84 137.55 55.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.151 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -62.34 109.22 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -151.4 118.99 6.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -72.38 -38.77 68.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.392 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.558 -0.734 . . . . 0.0 109.595 176.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.505 0.193 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.34 76.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.203 1.001 . . . . 0.0 111.368 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.62 -67.35 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.804 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -157.31 101.12 1.89 Allowed Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.832 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.91 103.86 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.518 2.145 . . . . 0.0 111.436 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.3 ptm -74.66 72.76 1.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.662 0.744 . . . . 0.0 110.864 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.57 -16.25 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.223 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.1 tt -123.5 94.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.582 0.706 . . . . 0.0 111.342 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -114.99 83.49 1.92 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -107.17 150.12 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -72.61 131.93 43.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.309 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -134.68 -14.5 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.86 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' OD2' ' HG2' ' A' ' 14' ' ' LYS . 23.4 t70 -177.88 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.3 pttm -163.66 -178.06 5.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.733 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.548 HD21 ' H ' ' A' ' 15' ' ' LEU . 2.3 pt? -120.06 168.82 10.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.72 -173.42 4.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.115 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 64.79 94.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.8 m -115.57 -52.66 2.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -133.12 67.04 1.54 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.784 0.802 . . . . 0.0 109.658 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.24 132.26 67.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.985 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.533 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 13.2 pt20 -142.19 159.39 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.163 -175.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.6 mt -133.14 149.49 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 4.5 p-10 -78.69 -171.16 2.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.16 0.505 . . . . 0.0 110.589 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -72.03 -27.94 63.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.564 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.28 -8.13 57.97 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.13 39.69 15.56 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.143 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 17.4 t70 -95.8 -89.81 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.5 tt0 176.54 142.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 68.8 t -122.22 121.38 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.55 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -117.75 162.86 26.92 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.13 -11.14 7.19 Favored 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 122.899 2.399 . . . . 0.0 114.224 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -96.44 2.29 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.004 0.431 . . . . 0.0 110.793 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -99.75 140.55 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.901 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.28 111.02 18.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -138.77 158.48 44.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.005 0.431 . . . . 0.0 110.818 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.488 ' HB ' HD23 ' A' ' 48' ' ' LEU . 92.3 t -133.89 140.59 46.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 46.4 mt -101.89 121.24 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.611 0.243 . . . . 0.0 110.435 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.09 88.74 3.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.425 0.631 . . . . 0.0 110.029 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.763 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 87.63 -24.52 10.11 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.271 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.26 -28.11 0.5 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.55 130.33 35.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.095 0.474 . . . . 0.0 109.896 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.482 HG12 HG12 ' A' ' 37' ' ' ILE . 76.8 mt -87.41 137.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.547 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.8 mp -138.74 125.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.147 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.6 mt -52.84 148.68 7.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -62.89 -11.99 22.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.02 -15.33 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.278 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -117.36 -13.54 10.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.488 HD23 ' HB ' ' A' ' 36' ' ' VAL . 22.9 tp -64.74 -38.2 90.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -50.6 -51.57 47.28 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.652 0.595 . . . . 0.0 110.691 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 tpp85 -67.42 -36.23 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.958 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -65.73 -43.9 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.738 0.304 . . . . 0.0 110.432 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 46.7 mt -71.76 -22.51 61.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -78.61 -22.23 47.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.122 0.487 . . . . 0.0 109.738 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 72.7 mm-40 -93.68 -60.12 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 25.0 tt0 -92.15 -67.68 0.84 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.485 -173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 14.2 tp 43.73 37.98 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.047 0.451 . . . . 0.0 110.541 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.664 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -127.74 2.02 6.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.991 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.571 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.9 OUTLIER 61.33 -153.75 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.34 0.591 . . . . 0.0 110.686 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 11.1 tp10 -106.03 102.18 11.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.496 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' B' ' 36' ' ' VAL . 32.6 m-85 -89.54 104.78 17.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.504 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 55.4 mttm -118.49 94.14 4.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 111.241 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HB3' HD12 ' A' ' 65' ' ' LEU . 48.6 m-80 -83.43 70.27 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.311 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.45 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.937 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -151.94 17.57 0.67 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.183 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD12 ' HB3' ' A' ' 62' ' ' ASN . 94.9 mt -69.62 114.82 8.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.537 -175.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.04 89.76 5.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.405 0.621 . . . . 0.0 110.081 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -141.63 42.35 1.73 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.477 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -69.21 121.43 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.537 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.5 m80 72.47 143.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.996 0.81 . . . . 0.0 110.857 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -86.58 -179.9 6.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -67.96 -34.52 76.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.272 176.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' B' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.128 0.49 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.1 3.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.31 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -122.31 171.61 8.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.672 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.5 154.51 37.95 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.83 113.53 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.288 2.659 . . . . 0.0 112.667 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -70.92 171.96 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.204 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.37 118.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.6 0.714 . . . . 0.0 111.464 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.1 tp -124.93 0.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.788 0.804 . . . . 0.0 109.529 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -72.37 168.05 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.021 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -103.64 176.01 5.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.855 0.36 . . . . 0.0 110.63 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -92.75 158.55 15.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.303 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -92.64 169.33 10.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.372 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.19 -47.66 34.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.252 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -154.42 151.16 28.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.641 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.33 -39.2 5.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.24 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 60.8 p 54.34 -162.57 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.787 0.835 . . . . 0.0 111.629 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.68 -14.94 59.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 109.83 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 8.7 m 70.56 -80.55 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.089 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.84 89.24 4.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.0 110.289 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.23 135.62 49.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.572 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -136.36 -179.48 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.912 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' B' ' 28' ' ' GLU . 15.2 mt -129.59 141.62 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 2.5 p-10 -88.98 -170.92 3.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.06 0.457 . . . . 0.0 110.517 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.44 -30.12 70.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.412 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.26 -39.88 74.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.118 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.08 2.56 31.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.328 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.7 m-20 -71.83 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 34.5 tt0 172.84 157.82 0.11 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.459 174.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 76.7 t -130.51 105.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.534 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.776 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -104.19 171.26 5.21 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.776 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 25.9 Cg_endo -62.93 -0.57 2.16 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.682 2.254 . . . . 0.0 113.418 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.43 6.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.063 0.459 . . . . 0.0 110.582 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -102.92 138.88 39.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.259 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.7 128.4 33.59 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -156.62 159.59 38.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.394 0.616 . . . . 0.0 111.334 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 48' ' ' LEU . 78.1 t -134.4 137.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.245 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 59.4 mt -103.66 110.28 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -81.93 84.54 6.9 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 109.916 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.763 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 74.32 -16.51 2.88 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.712 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.04 -22.73 0.45 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -83.09 121.15 26.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.73 129.08 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.3 mp -134.32 136.85 52.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.548 ' HB3' ' OE1' ' B' ' 46' ' ' GLU . 39.4 mt -55.73 145.94 22.65 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 170.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -12.45 61.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.548 ' OE1' ' HB3' ' B' ' 44' ' ' LEU . 1.5 pm0 -87.75 -10.84 49.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -123.76 0.56 8.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.828 0.823 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' B' ' 36' ' ' VAL . 18.7 tp -67.96 -51.21 50.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.987 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.35 -53.96 12.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.31 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 0.1 OUTLIER -76.82 -33.73 57.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 -175.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.452 ' CD2' HG12 ' B' ' 43' ' ' ILE . 43.7 t80 -69.22 -40.02 78.2 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.761 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.7 mt -62.82 -38.73 91.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' B' ' 53' ' ' ARG . 1.3 tmm_? -55.32 -33.99 63.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.812 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 64.3 mm-40 -87.35 -38.32 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.162 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' B' ' 57' ' ' GLY . 5.9 tp-100 -99.07 -68.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 112.128 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 63.5 mt 40.75 43.59 1.69 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.117 0.484 . . . . 0.0 109.828 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.525 ' N ' ' HG3' ' B' ' 55' ' ' GLN . . . -105.22 -14.14 23.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.191 -167.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.571 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 7.9 m-85 58.7 -158.43 0.3 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.529 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -112.81 102.0 10.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 162.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -103.29 106.25 16.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.141 -170.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.86 150.07 25.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 0.0 110.886 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -137.35 140.1 41.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.35 -12.62 61.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.164 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 60.6 26.03 15.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.567 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.14 80.11 2.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.252 0.548 . . . . 0.0 110.192 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' B' ' 68' ' ' HIS . 12.8 pt-20 -73.75 -19.77 60.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.779 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 p80 49.52 20.63 0.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.045 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.49 ' H ' ' HG3' ' B' ' 66' ' ' GLU . 30.7 t-80 -83.56 137.55 33.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.256 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.17 111.16 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.24 49.43 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.478 -171.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.64 171.37 15.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.675 0.274 . . . . 0.0 110.445 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.633 -0.698 . . . . 0.0 110.268 177.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.749 0.309 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.62 0.67 9.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.85 -71.64 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.42 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 61.85 98.87 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 112.145 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.57 101.1 1.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.533 2.155 . . . . 0.0 112.258 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -70.7 119.14 14.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 p -82.13 -20.04 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -124.39 139.77 49.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.337 . . . . 0.0 110.797 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -122.28 147.68 45.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.348 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.39 108.04 19.24 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.47 98.99 10.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.169 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -104.12 138.55 40.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.83 89.0 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.695 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt 177.06 141.26 0.08 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.668 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -97.12 -57.61 2.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.983 0.42 . . . . 0.0 110.101 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -95.8 149.92 20.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -99.78 103.7 15.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.95 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.4 p 49.01 -92.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 113.705 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -127.27 8.94 6.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.145 0.497 . . . . 0.0 110.316 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.34 84.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.188 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.692 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 21.9 pt20 -105.29 159.49 15.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 27' ' ' ASP . 14.0 mt -124.83 144.64 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . 1.2 p-10 -88.06 -176.95 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.068 0.461 . . . . 0.0 111.135 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.96 -37.18 71.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.174 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -65.57 -43.05 91.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.19 16.95 5.94 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 44' ' ' LEU . 9.2 t0 -106.45 158.61 16.77 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.47 132.19 41.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.229 0.537 . . . . 0.0 110.505 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 55.9 t -107.36 96.22 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.584 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.736 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 48.5 p -97.31 172.82 4.56 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.736 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 19.6 Cg_endo -62.22 -7.33 9.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.286 1.991 . . . . 0.0 112.523 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.14 -0.08 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 109.978 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -106.4 131.33 53.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.668 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -133.6 164.21 27.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.91 144.39 33.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 55.1 mt -106.43 115.72 48.64 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 122.182 0.991 . . . . 0.0 110.805 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB3' HD11 ' A' ' 43' ' ' ILE . 44.1 t0 -109.95 89.3 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.239 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.72 41.29 15.65 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.606 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.65 -17.28 15.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.965 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.92 137.84 32.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 35.1 mt -94.26 139.56 18.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.803 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.5 mp -139.03 127.73 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 27' ' ' ASP . 92.5 mt -57.03 145.49 30.38 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 169.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -19.54 35.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.466 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.46 -44.04 92.33 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.977 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -110.38 7.9 23.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.357 0.599 . . . . 0.0 110.044 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.71 -35.12 79.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.299 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.14 -33.43 67.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.296 0.569 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 8.4 tpm_? -67.01 -53.34 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.505 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.803 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -63.87 -43.29 96.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.44 -29.03 68.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.845 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -71.38 -26.52 62.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.751 0.31 . . . . 0.0 110.362 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 16.9 mm-40 -85.83 -68.96 0.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.974 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -103.88 -21.78 13.6 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.959 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.2 tp 65.45 44.24 3.16 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.441 0.463 . . . . 0.0 112.166 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.455 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.56 -11.42 68.36 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.742 171.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -95.89 104.37 16.3 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.718 -0.284 . . . . 0.0 110.467 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 61' ' ' LYS . 45.0 tt0 -93.04 102.84 15.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.017 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.485 ' HA ' HG22 ' B' ' 36' ' ' VAL . 94.1 m-85 -79.12 109.05 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.877 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 25.5 mmtp -109.65 105.8 15.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.164 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 64' ' ' GLN . 2.7 m120 -75.81 168.65 19.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.499 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.503 ' HB1' HD22 ' A' ' 65' ' ' LEU . . . -70.22 32.51 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 0.0 111.389 175.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 62' ' ' ASN . 45.5 mt-30 60.1 16.04 5.64 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 111.078 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD22 ' HB1' ' A' ' 63' ' ' ALA . 2.1 pt? -90.25 93.61 9.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.925 0.869 . . . . 0.0 111.535 -173.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -82.17 -68.11 0.73 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 58.88 25.22 13.37 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.146 162.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -97.45 135.41 39.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.876 0.369 . . . . 0.0 110.035 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -70.11 111.18 5.58 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -75.31 82.41 2.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.597 0.713 . . . . 0.0 111.161 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 176.62 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.721 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.01 -173.454 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.799 0.333 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -139.72 28.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.964 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -80.52 74.17 7.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.004 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -172.13 95.05 0.39 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.61 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.35 112.47 1.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.635 2.223 . . . . 0.0 111.609 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.5 mtt -87.79 -16.33 34.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.751 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.5 -25.69 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.057 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -88.56 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.349 0.595 . . . . 0.0 110.483 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.94 -1.19 57.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.186 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -125.11 15.99 8.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.84 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -80.47 113.54 18.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.831 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -147.63 133.82 19.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.152 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -170.4 -149.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.517 ' HB2' HD11 ' B' ' 15' ' ' LEU . 26.7 mttt 76.39 -68.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 174.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' B' ' 14' ' ' LYS . 5.8 mp -91.05 20.47 4.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.996 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -61.04 -45.11 96.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.399 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -88.76 120.78 30.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -90.3 -82.23 0.28 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.58 30.03 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.57 94.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -103.34 157.38 17.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.64 HG12 ' HA ' ' B' ' 28' ' ' GLU . 18.6 mt -130.78 147.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.661 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' B' ' 29' ' ' VAL . 10.0 p-10 -73.72 -166.84 0.4 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.425 0.631 . . . . 0.0 111.062 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.86 -36.11 79.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.61 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -89.97 -34.82 15.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.491 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 110.51 41.35 1.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.802 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.38 -10.34 41.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.016 0.436 . . . . 0.0 109.846 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.64 ' HA ' HG12 ' B' ' 22' ' ' ILE . 30.8 tt0 65.09 97.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.066 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' B' ' 23' ' ' ASP . 40.6 t -95.86 103.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.02 -173.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.707 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 66.4 p -96.44 167.34 12.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.959 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.707 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.0 Cg_endo -64.76 20.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.649 2.899 . . . . 0.0 113.698 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 30' ' ' THR . 20.9 t -101.76 -21.15 5.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.159 0.504 . . . . 0.0 109.818 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -115.45 169.3 9.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.935 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -103.39 146.36 28.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 110.451 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.39 170.82 18.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.122 0.487 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.602 ' HB ' HD11 ' B' ' 48' ' ' LEU . 82.0 t -136.84 140.36 43.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mt -102.73 118.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 40' ' ' GLY . 26.5 t70 -89.48 86.55 6.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.509 ' O ' HG21 ' A' ' 37' ' ' ILE . . . 74.68 -36.27 1.02 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.212 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 38' ' ' ASP . . . -179.79 -25.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -173.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.58 130.95 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.18 124.81 40.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.16 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.26 121.8 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.137 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' B' ' 46' ' ' GLU . 1.7 tt -58.57 138.75 56.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.482 ' N ' HD22 ' B' ' 44' ' ' LEU . 5.5 mmm-85 -56.46 -16.76 6.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.551 ' HG2' HD23 ' B' ' 44' ' ' LEU . 9.0 mm-40 -74.57 -28.49 60.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -173.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -125.82 24.02 7.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.813 0.816 . . . . 0.0 109.447 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' B' ' 36' ' ' VAL . 25.9 tp -68.78 -45.14 72.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.264 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -45.84 67.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.112 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 9.3 tpt180 -68.6 -43.2 76.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.309 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.49 -45.95 77.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.874 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.34 -30.0 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.612 0.244 . . . . 0.0 111.066 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -63.1 -41.9 99.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -93.75 -25.91 17.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.756 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp60 -102.5 -67.74 0.86 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.356 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 40.77 40.31 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.689 0.756 . . . . 0.0 109.693 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.756 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -103.04 -34.01 4.13 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.381 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.9 -165.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.8 tp10 -115.74 102.26 9.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 123.45 45.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.098 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.86 176.81 7.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 0.0 110.347 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -166.33 170.84 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.72 57.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.463 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 58.58 24.17 11.7 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.26 65.73 8.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.424 0.63 . . . . 0.0 111.157 -172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.75 4.38 42.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.537 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -73.52 157.02 37.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.06 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -75.91 -73.63 0.26 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.4 t60 46.77 43.69 13.31 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.764 0.665 . . . . 0.0 111.721 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -77.58 159.3 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.327 0.584 . . . . 0.0 112.057 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -127.9 144.49 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.884 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.377 -178.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 163.19 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.77 100.88 12.83 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -118.76 122.96 29.4 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.353 0.597 . . . . 0.0 110.959 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -95.75 13.19 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 69.2 mtm -89.21 76.71 7.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.674 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.35 -3.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 168.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.75 123.66 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.6 m120 60.13 77.93 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.704 0.628 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -93.62 139.35 30.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.449 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 68.52 164.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.843 0.714 . . . . 0.0 111.826 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.2 -55.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.787 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -117.12 11.95 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.203 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -113.19 23.6 13.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.052 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tt -136.76 127.45 27.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.759 0.314 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -129.92 -172.56 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.16 139.26 24.47 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 m 76.12 -39.85 0.38 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -80.27 14.51 1.91 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.4 103.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.407 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 152.05 23.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.233 0.539 . . . . 0.0 111.451 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 28' ' ' GLU . 53.4 mt -118.88 149.4 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.89 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.2 p-10 -84.34 -163.01 0.73 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 -177.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -75.95 -25.0 55.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.025 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -69.05 -33.01 72.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.7 33.78 10.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.789 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -103.4 -80.73 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.939 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 179.28 137.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.34 115.88 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 p -104.71 162.5 19.61 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 28.0 Cg_endo -62.95 -1.62 2.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 113.161 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.77 -2.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.575 0.226 . . . . 0.0 111.101 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.21 -170.95 1.74 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 5.1 t0 -126.87 134.9 50.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.59 -171.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' CD2' HG21 ' A' ' 42' ' ' ILE . 35.5 p90 -156.49 161.05 40.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.048 0.452 . . . . 0.0 111.452 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.416 ' HB ' HD12 ' A' ' 48' ' ' LEU . 87.4 t -137.25 144.73 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 19.2 mt -105.6 124.66 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 111.403 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.421 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 16.8 t70 -96.99 87.99 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.19 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 80.6 -22.22 4.88 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.502 173.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.58 -31.57 0.37 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 123.61 28.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.519 HG12 HG12 ' A' ' 37' ' ' ILE . 70.5 mt -82.56 142.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.883 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.5 mp -136.41 132.7 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -60.17 143.57 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HG3' ' CG ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -58.03 -19.68 33.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.75 -33.78 60.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.63 0.15 16.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 28.7 tp -55.99 -56.08 25.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.979 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -68.63 -23.5 64.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.22 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -73.92 -42.73 60.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 55.5 t80 -64.63 -36.1 83.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.369 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.626 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 77.6 mt -65.74 -33.61 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.291 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -68.63 -28.62 67.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 6.1 mm-40 -80.51 -57.74 3.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.601 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.556 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 6.0 tt0 -102.93 -67.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER 48.19 45.35 19.89 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -169.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.556 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -109.31 -33.76 2.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.285 -167.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.474 ' CD2' ' HA3' ' B' ' 57' ' ' GLY . 1.7 m-85 63.5 -166.71 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.152 0.476 . . . . 0.0 109.748 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.2 tp10 -107.6 101.84 11.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.391 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -106.7 112.04 24.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.985 0.421 . . . . 0.0 110.24 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -101.69 177.55 4.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -162.42 136.44 6.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.97 62.85 1.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.555 0.693 . . . . 0.0 110.396 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -86.92 43.19 1.07 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.764 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 tp -81.4 90.53 6.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.662 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -89.0 103.89 16.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.622 0.725 . . . . 0.0 110.39 177.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -78.93 129.78 34.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.67 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -80.93 90.7 5.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.228 0.537 . . . . 0.0 111.766 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -115.5 125.53 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -109.87 149.81 29.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.802 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -121.45 132.43 54.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.54 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.193 177.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.773 0.321 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.16 99.96 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.506 0.67 . . . . 0.0 110.373 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.8 23.64 12.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.218 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -109.03 98.29 29.5 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.289 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.88 146.05 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.743 2.295 . . . . 0.0 112.654 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 47.1 ttm -132.93 95.66 3.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.875 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t 64.22 87.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.648 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 pt -88.72 17.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.635 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' B' ' 9' ' ' ASN . 8.6 m120 -75.56 -32.38 60.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.647 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.513 ' HB2' ' HB2' ' B' ' 13' ' ' ASP . 44.3 m-80 57.69 -157.05 0.3 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.016 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -132.86 -59.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -74.68 -46.07 40.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.419 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' B' ' 10' ' ' ASN . 25.9 t70 38.65 -109.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.257 0.973 . . . . 0.0 111.64 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -169.24 172.42 7.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.05 106.2 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 110.452 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.1 p -61.56 -45.81 92.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.324 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.36 98.63 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.98 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -96.8 -14.63 21.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.739 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.775 ' HB2' ' HD3' ' B' ' 31' ' ' PRO . 8.5 p-10 -79.76 36.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.806 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 101.87 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.76 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' B' ' 29' ' ' VAL . 7.8 pt20 -140.31 133.83 30.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.427 HG23 ' N ' ' B' ' 23' ' ' ASP . 5.1 mt -99.36 154.64 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.335 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 5.8 p-10 -93.66 -170.65 2.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.724 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.59 -36.09 77.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.458 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -69.83 -36.34 75.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.077 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.87 33.2 6.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.668 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' B' ' 28' ' ' GLU . 11.5 t70 -98.62 -96.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' B' ' 27' ' ' ASP . 31.6 mm-40 -167.57 137.79 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 109.551 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 92.4 t -123.66 101.05 8.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.692 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.877 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.0 p -103.16 175.75 2.11 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.474 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.877 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 29.8 Cg_endo -62.96 -10.83 21.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.49 2.127 . . . . 0.0 113.512 -177.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.02 13.91 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.024 0.44 . . . . 0.0 110.786 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -112.92 152.49 29.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -97.0 124.4 40.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.0 159.87 41.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' B' ' 48' ' ' LEU . 53.7 t -129.87 143.07 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.5 mt -110.21 115.67 50.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 CA-C-O 121.804 0.811 . . . . 0.0 110.887 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.96 87.46 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.185 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 79.4 -18.77 6.4 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.38 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 -21.83 0.4 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.575 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.64 142.71 27.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -94.79 134.58 31.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.414 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.4 mp -127.9 128.18 68.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.438 HD22 ' N ' ' B' ' 45' ' ' ARG . 1.9 tt -61.8 137.45 58.25 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.438 ' N ' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.08 0.15 3.91 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -172.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.76 -12.74 30.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.368 0.604 . . . . 0.0 110.032 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -114.38 -7.01 12.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.512 0.672 . . . . 0.0 110.055 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.546 HD11 ' HB ' ' B' ' 36' ' ' VAL . 49.9 tp -57.19 -44.27 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.062 -170.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -59.85 -40.65 89.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.968 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -69.5 -43.28 73.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.161 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -62.73 -36.34 82.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 62.9 mt -70.41 -30.76 67.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 0.0 110.68 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -94.16 -49.5 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.723 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -103.03 -53.0 2.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 tp 72.04 47.99 0.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.303 0.641 . . . . 0.0 112.162 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.474 ' HA3' ' CD2' ' A' ' 58' ' ' PHE . . . 82.24 -31.13 2.92 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.938 -0.648 . . . . 0.0 114.24 169.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.95 122.9 25.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.667 -0.313 . . . . 0.0 111.322 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.633 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 8.1 tp10 -92.26 102.35 14.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -95.54 120.1 35.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.86 -167.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -115.44 178.11 4.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.836 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -169.51 149.66 4.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.72 75.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.02 0.438 . . . . 0.0 110.523 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 61.49 28.61 17.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.246 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp -84.15 15.89 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 0.0 110.166 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.57 -41.37 54.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.508 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t60 64.54 -78.45 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.315 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -166.6 21.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.658 0.742 . . . . 0.0 109.041 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.38 143.48 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -101.51 92.74 5.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.882 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -127.52 -59.89 1.2 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.421 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 76.6 t60 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.64 -178.35 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.771 ' HG3' HG13 ' A' ' 2' ' ' VAL . 38.6 tpp . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.747 0.308 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.771 HG13 ' HG3' ' A' ' 1' ' ' MET . 20.9 m -118.72 141.25 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 67.78 152.02 0.08 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.849 0.718 . . . . 0.0 111.508 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.07 141.94 63.51 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.844 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.91 58.35 6.67 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.09 2.527 . . . . 0.0 113.617 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -67.54 134.29 51.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.67 12.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.746 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.11 -19.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.285 0.565 . . . . 0.0 110.454 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.63 113.16 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 69.35 31.66 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.428 0.632 . . . . 0.0 109.734 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 73.5 -65.73 0.34 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.348 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -143.63 -77.79 0.23 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -154.01 94.19 1.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.523 0.677 . . . . 0.0 109.927 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.513 ' HB3' HD11 ' A' ' 15' ' ' LEU . 73.3 mmtt 71.81 -63.14 0.44 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.017 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 14' ' ' LYS . 6.0 mp -126.35 161.27 28.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.062 0.458 . . . . 0.0 110.727 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -93.15 114.35 26.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -136.6 158.86 43.44 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.867 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 m 74.6 -52.07 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.786 0.835 . . . . 0.0 112.286 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -77.03 84.47 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.437 0.637 . . . . 0.0 110.396 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.47 144.95 30.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.877 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -133.86 139.92 46.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 23' ' ' ASP . 19.3 mt -112.74 152.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -81.24 179.9 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.038 0.447 . . . . 0.0 110.771 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -56.4 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.465 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -70.83 -45.22 64.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.439 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.03 15.77 3.75 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.667 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.83 132.57 44.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.23 124.28 23.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.965 0.412 . . . . 0.0 110.595 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 23' ' ' ASP . 44.8 t -108.58 107.31 22.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.686 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 24.0 p -95.99 167.61 12.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 62.7 Cg_exo -52.74 -16.63 5.98 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.273 2.649 . . . . 0.0 114.32 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.93 2.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.652 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -105.72 150.48 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' HB3' ' HD3' ' A' ' 45' ' ' ARG . 19.2 m-20 -94.82 120.72 35.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 109.863 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.9 p90 -142.59 161.76 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.871 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' B' ' 60' ' ' PHE . 75.7 t -131.94 134.97 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 51.2 mt -95.97 121.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 28.7 t70 -90.2 86.73 6.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 78.4 -40.43 1.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.115 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.84 -28.48 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -81.66 136.05 35.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.456 HG23 ' CD2' ' A' ' 35' ' ' TYR . 92.7 mt -87.66 134.24 28.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.548 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.418 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -138.76 135.17 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 172.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.25 145.18 55.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HG2' HD23 ' A' ' 48' ' ' LEU . 25.5 mtp-105 -65.61 -5.99 9.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.2 -63.2 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.503 . . . . 0.0 109.946 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.04 -14.89 61.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.586 HD23 ' HG2' ' A' ' 45' ' ' ARG . 18.6 tp -51.74 -42.6 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.336 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -60.21 -44.23 95.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -41.43 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.999 0.428 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 84.5 t80 -65.91 -43.76 87.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.39 -23.24 61.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.537 0.208 . . . . 0.0 111.33 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -70.51 -46.81 62.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 110.393 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.48 -35.91 29.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.205 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.48 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 26.3 tp60 -97.59 -67.54 0.84 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.319 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 44.32 41.14 4.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.583 0.706 . . . . 0.0 109.131 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -108.34 -24.1 6.35 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.309 -0.948 . . . . 0.0 114.528 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CG ' ' HA3' ' B' ' 57' ' ' GLY . 1.0 OUTLIER 57.53 -151.81 0.41 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -175.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.536 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 33.0 mt-10 -113.61 101.39 9.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.983 163.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -93.63 103.53 15.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.785 ' HZ3' HD12 ' B' ' 37' ' ' ILE . 93.5 mttt -117.48 105.34 11.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.75 0.786 . . . . 0.0 111.777 -173.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.13 160.16 30.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.191 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.43 -59.66 4.65 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.291 0.369 . . . . 0.0 111.134 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -178.41 14.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.658 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.94 150.09 26.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.886 -174.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.81 6.83 40.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -93.72 93.57 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.9 m170 -80.51 135.57 36.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 110.362 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.19 71.42 10.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.334 0.588 . . . . 0.0 110.222 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -150.56 107.92 3.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.033 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -98.63 -3.82 35.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.808 177.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.444 ' H3 ' ' CD ' ' B' ' 3' ' ' GLU . 27.3 ttt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 t 54.32 39.43 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.207 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.545 ' O ' ' HD3' ' B' ' 5' ' ' PRO . 0.7 OUTLIER -90.27 -177.2 5.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.475 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -84.0 108.39 13.83 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.154 0.502 . . . . 0.0 110.243 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' B' ' 3' ' ' GLU . 92.3 Cg_endo -91.85 20.15 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.99 2.46 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 91.8 mmm 60.34 82.06 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.811 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.87 108.57 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.925 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.12 137.11 24.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.776 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -78.05 80.4 4.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.694 0.759 . . . . 0.0 110.566 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -167.06 137.91 3.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.562 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -88.21 21.81 2.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.333 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -43.51 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.473 1.108 . . . . 0.0 112.788 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -126.78 159.35 34.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.21 112.72 24.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.647 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.18 -76.22 0.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.08 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.9 p 53.84 -176.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.933 0.893 . . . . 0.0 112.418 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -109.74 88.28 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.24 0.543 . . . . 0.0 109.613 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 42.4 m -81.85 -55.47 4.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.804 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 75.76 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.513 0.673 . . . . 0.0 111.339 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.39 128.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.727 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.547 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 26.1 pt20 -107.27 149.79 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.928 0.394 . . . . 0.0 111.031 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 13.3 mt -112.7 140.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.162 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.56 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 13.1 p-10 -77.06 -170.4 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.112 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.88 -26.66 60.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -80.32 -23.17 40.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.709 0.29 . . . . 0.0 110.772 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 89.26 17.29 55.9 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.948 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.89 -8.61 42.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.28 0.562 . . . . 0.0 109.929 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' B' ' 22' ' ' ILE . 43.1 tt0 76.65 139.57 0.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.861 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 14.5 t -112.68 102.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 110.488 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 59.3 p -84.75 159.53 57.71 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.828 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 48.6 Cg_endo -69.21 7.68 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.651 2.234 . . . . 0.0 112.811 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.95 -6.46 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.285 0.564 . . . . 0.0 109.591 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -117.64 160.14 21.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.969 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.86 143.73 29.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.455 ' HB3' HG12 ' B' ' 29' ' ' VAL . 13.1 p90 -145.69 166.07 26.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.354 0.597 . . . . 0.0 110.672 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 59' ' ' GLU . 53.8 t -136.96 144.54 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.785 HD12 ' HZ3' ' A' ' 61' ' ' LYS . 33.7 mt -109.94 116.81 53.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.377 0.608 . . . . 0.0 110.087 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.47 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 2.0 m-20 -97.44 86.67 3.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.891 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 62.63 45.56 95.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.826 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.3 64.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.845 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 3.3 tp10 -95.51 119.43 34.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.432 HG23 ' HA ' ' B' ' 23' ' ' ASP . 97.0 mt -83.89 120.84 35.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.58 ' HB ' HD11 ' B' ' 48' ' ' LEU . 2.7 mp -126.26 128.6 71.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.425 ' H ' ' HB2' ' B' ' 23' ' ' ASP . 28.5 tp -66.58 139.75 57.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.604 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -60.25 -15.99 29.86 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.75 -45.03 82.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.74 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.48 17.66 6.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 111.493 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.58 HD11 ' HB ' ' B' ' 43' ' ' ILE . 48.9 tp -63.21 -31.49 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.389 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.76 -45.83 59.11 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 111.583 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -68.78 -37.11 79.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.416 . . . . 0.0 110.898 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.406 ' CZ ' ' HG2' ' B' ' 41' ' ' GLU . 15.9 t80 -72.77 -32.66 65.78 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 75.1 mt -65.37 -29.33 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.413 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 -64.74 -44.75 89.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.431 . . . . 0.0 110.205 174.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.12 -54.36 9.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.783 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -103.52 -67.08 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.02 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 24.1 tp 78.72 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.855 0.722 . . . . 0.0 111.241 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 79.87 -45.55 2.97 Favored Glycine 0 C--O 1.235 0.205 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.736 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -69.53 139.1 53.77 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.569 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 3.9 tp10 -114.69 102.21 9.81 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 167.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.515 ' HA ' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -83.86 93.76 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.541 -175.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.468 ' HG2' ' HG3' ' B' ' 59' ' ' GLU . 27.9 mmtm -93.49 83.17 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.326 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' B' ' 64' ' ' GLN . 92.9 m-20 -81.83 60.23 4.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.441 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 64' ' ' GLN . . . 68.78 -27.18 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.9 0.88 . . . . 0.0 113.016 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' B' ' 62' ' ' ASN . 96.8 mt-30 67.67 18.32 9.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.332 0.587 . . . . 0.0 110.409 -175.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.44 120.84 36.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 -22.98 14.2 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.4 m170 56.86 49.28 14.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.506 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -66.18 140.78 58.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 67.31 32.6 5.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.436 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -76.61 -51.27 11.91 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -173.3 -74.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.892 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.229 -177.562 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' HE3' HG21 ' A' ' 2' ' ' VAL . 30.9 ttp . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.581 HG21 ' HE3' ' A' ' 1' ' ' MET . 34.5 m -64.35 -19.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.17 15.25 29.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.65 98.86 21.5 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.367 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.92 83.72 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.87 2.38 . . . . 0.0 112.078 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.414 ' HG3' HG21 ' A' ' 7' ' ' VAL . 25.9 ptt? -91.43 -33.42 15.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.249 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.414 HG21 ' HG3' ' A' ' 6' ' ' MET . 21.7 t -98.53 79.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.07 137.97 49.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.648 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -91.14 109.78 21.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -61.98 132.67 53.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -84.59 47.14 1.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.577 0.704 . . . . 0.0 111.347 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -145.19 89.84 1.98 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.161 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.0 -37.85 83.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.371 -171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.01 144.45 35.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.181 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -140.17 75.6 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 p -84.97 132.88 34.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.854 -177.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 72.98 145.03 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.171 0.919 . . . . 0.0 110.083 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 20' ' ' VAL . 5.3 m -103.05 -3.63 25.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.4 0.619 . . . . 0.0 110.169 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.6 25.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.568 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' H ' ' C ' ' A' ' 18' ' ' THR . 5.2 t -81.33 83.7 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.999 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.464 ' NE2' HD11 ' A' ' 42' ' ' ILE . 10.9 pt20 -96.35 166.21 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 22' ' ' ILE . 6.5 mt -125.12 157.57 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.64 -169.86 2.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -72.8 -26.42 61.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.567 0.222 . . . . 0.0 111.022 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -72.87 -40.82 65.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.89 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 17.82 4.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.264 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -104.98 129.88 53.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -59.0 120.0 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.278 0.561 . . . . 0.0 111.603 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 44' ' ' LEU . 41.0 t -95.9 113.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 p -103.74 166.57 11.48 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.19 -6.01 2.56 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.782 2.321 . . . . 0.0 113.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -96.07 -4.38 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.368 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -110.13 166.26 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.406 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.88 119.02 38.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.452 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 29' ' ' VAL . 32.2 p90 -135.97 149.76 49.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 0.0 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.61 133.71 68.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.2 mt -97.5 121.4 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -94.75 84.27 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.876 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.32 -47.59 2.96 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.437 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.29 -29.02 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 129.19 34.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.509 0.671 . . . . 0.0 110.765 174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.464 HD11 ' NE2' ' A' ' 21' ' ' GLN . 57.6 mt -90.59 133.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.981 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.3 mp -136.61 132.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 29' ' ' VAL . 84.4 mt -58.65 151.62 20.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.299 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -12.77 22.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.938 0.399 . . . . 0.0 110.882 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.99 -36.24 72.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.422 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.66 5.19 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 110.617 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.86 -48.58 81.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.068 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.96 -37.18 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 6.8 tpt180 -73.62 -39.81 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.698 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -64.08 -47.83 78.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.19 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.801 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 65.7 mt -61.98 -41.24 97.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 50.5 ttt-85 -46.54 -40.21 12.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.143 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -49.81 8.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.037 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 5.6 tp-100 -88.34 -68.2 0.78 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.801 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 48.0 mt 42.89 30.86 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.368 0.267 . . . . 0.0 111.286 -171.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.798 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -127.64 3.27 7.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.692 -166.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 53.87 -149.63 0.41 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.447 0.623 . . . . 0.0 110.313 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.545 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.9 tp10 -112.16 101.95 10.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.65 117.38 31.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.712 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.92 156.82 24.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.411 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -141.06 160.44 40.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.501 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.56 -22.34 59.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.437 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.62 38.21 18.81 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.176 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tt -78.18 0.06 26.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.941 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 71.35 17.24 5.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.478 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -79.34 99.4 7.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -53.84 115.23 1.89 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.777 0.798 . . . . 0.0 112.164 -170.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.441 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 1.6 p80 -100.77 123.98 45.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.377 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -76.53 88.7 3.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.303 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -95.94 -10.76 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.334 0.588 . . . . 0.0 110.106 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.4 t60 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.604 178.329 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.9 m -88.7 27.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.32 128.26 48.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.154 0.502 . . . . 0.0 111.916 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -142.66 63.44 14.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.867 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.26 34.35 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.767 2.978 . . . . 0.0 113.528 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 43.6 ttm -139.64 26.05 2.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.835 0.826 . . . . 0.0 109.71 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.01 16.51 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.931 0.872 . . . . 0.0 109.573 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.19 127.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.905 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -91.61 -28.41 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.844 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -83.55 118.1 23.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -90.42 145.98 24.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.521 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -131.68 154.43 48.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.083 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -128.36 135.77 50.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -56.65 -65.73 0.56 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.612 0.244 . . . . 0.0 111.389 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -159.49 112.69 2.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.233 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 140.76 32.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 169.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.43 -36.67 76.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 12.2 m 64.76 -86.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.268 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -138.37 7.05 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 109.342 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -77.89 101.05 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.544 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.55 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 12.9 pt20 -101.56 158.49 16.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.586 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' B' ' 28' ' ' GLU . 53.2 mt -140.83 152.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.857 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.79 -173.87 2.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.331 0.586 . . . . 0.0 111.148 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -67.11 -29.18 68.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.153 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -79.78 -14.49 58.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.288 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.86 33.49 26.97 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.287 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.1 -87.2 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.843 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' B' ' 22' ' ' ILE . 41.7 tt0 -179.17 137.5 0.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.86 120.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.037 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 77.0 p -108.09 169.09 6.98 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.29 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_exo -60.36 -2.5 1.91 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.858 2.372 . . . . 0.0 113.022 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.37 -11.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.736 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.15 147.08 26.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.707 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.35 112.18 23.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -133.68 157.8 44.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 0.0 111.221 -172.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.84 145.0 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.423 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 67.7 mt -107.18 110.72 32.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.282 0.563 . . . . 0.0 109.881 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.6 92.25 3.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.203 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.06 36.6 31.24 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.521 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.94 -28.64 7.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.187 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.83 150.22 24.7 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 78.6 mt -108.86 141.48 24.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.564 -174.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mp -134.77 123.0 40.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.504 HD22 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -59.85 140.06 56.89 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.573 HH11 HD21 ' B' ' 48' ' ' LEU . 11.3 mmm180 -55.92 -17.97 7.86 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -77.22 -31.43 55.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.523 . . . . 0.0 110.047 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -102.96 -7.01 21.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.525 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.573 HD21 HH11 ' B' ' 45' ' ' ARG . 45.1 tp -64.45 -28.64 69.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.427 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -54.33 45.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.94 -33.31 70.36 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.732 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.72 -40.36 87.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.335 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 75.8 mt -72.06 -32.55 67.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 53' ' ' ARG . 44.1 mtt180 -64.11 -40.53 96.4 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.491 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -79.85 -65.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.802 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -95.1 -41.83 8.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.825 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 23.1 tp 78.41 17.98 1.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.895 0.747 . . . . 0.0 111.56 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.13 -38.36 3.19 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.069 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -65.88 117.2 7.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.724 -0.28 . . . . 0.0 110.956 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.556 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 37.0 tt0 -92.3 102.19 14.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.638 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -85.42 112.03 20.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.556 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 7.1 mmmm -115.22 88.6 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.241 0.544 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -82.55 154.22 25.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.52 69.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 48.8 81.18 0.05 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.252 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.65 -18.66 60.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.877 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 52.99 51.44 15.83 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -173.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.49 113.97 11.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.219 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -132.45 137.44 47.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.316 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -78.57 -34.95 46.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -158.41 111.71 2.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.118 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -90.17 79.61 6.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.098 -172.374 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.507 0.194 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 m -98.07 146.43 8.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 62.38 97.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.479 0.657 . . . . 0.0 110.57 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.589 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -137.36 88.55 16.93 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.512 0.672 . . . . 0.0 111.484 -173.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.64 5.89 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.941 2.427 . . . . 0.0 112.981 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -100.82 93.28 5.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.779 0.323 . . . . 0.0 111.333 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -102.92 -9.97 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.57 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 8' ' ' ILE . 4.2 mp -86.83 132.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 63.29 77.44 0.33 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.64 112.45 24.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.144 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.38 -45.44 9.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.155 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.0 t60 56.56 51.09 11.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.859 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.04 118.89 15.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.463 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -110.79 19.7 18.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.398 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.49 -21.34 60.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.637 HG21 ' HG3' ' A' ' 17' ' ' GLU . 10.6 m 70.97 -94.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.82 172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.637 ' HG3' HG21 ' A' ' 16' ' ' THR . 43.7 mt-10 -135.67 -179.02 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -172.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 m -103.99 -45.41 4.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.263 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.58 97.24 8.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 109.863 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.67 132.77 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.786 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -123.59 171.18 9.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.567 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.429 HG21 ' HA2' ' A' ' 26' ' ' GLY . 21.8 mt -138.61 155.22 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.619 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 22' ' ' ILE . 5.6 p-10 -82.42 -167.52 1.62 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -69.97 -34.26 73.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.921 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -82.07 -15.46 53.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.429 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 85.25 36.98 10.23 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.728 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.6 t70 -87.93 -85.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.7 tt0 176.15 136.55 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.621 0.576 . . . . 0.0 109.676 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.438 HG23 HD23 ' A' ' 44' ' ' LEU . 73.6 t -123.09 112.65 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.484 . . . . 0.0 110.67 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 32' ' ' VAL . 70.7 p -104.81 162.01 21.06 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.45 7.22 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.946 2.431 . . . . 0.0 113.257 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 t -103.89 -12.09 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.145 0.498 . . . . 0.0 109.884 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -92.87 151.31 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.635 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -97.02 115.44 27.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.403 0.62 . . . . 0.0 109.704 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.59 172.89 12.34 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.571 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.452 ' HB ' HD13 ' A' ' 48' ' ' LEU . 64.2 t -137.03 139.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 14.5 mt -95.65 110.11 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.732 0.777 . . . . 0.0 109.455 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' OD2' ' HG3' ' A' ' 55' ' ' GLN . 9.8 t0 -82.66 85.87 6.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.243 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 59' ' ' GLU . . . 76.43 -35.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.091 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.18 -28.29 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.43 147.17 29.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.815 0.34 . . . . 0.0 110.396 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.5 mt -97.78 129.76 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.286 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mp -136.71 123.88 31.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD23 HG23 ' A' ' 29' ' ' VAL . 85.6 mt -56.19 146.38 23.56 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -68.56 -0.02 4.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.221 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -81.26 -19.18 43.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.94 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -129.09 -7.01 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.245 0.545 . . . . 0.0 110.335 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 HD13 ' HB ' ' A' ' 36' ' ' VAL . 28.7 tp -50.2 -35.58 27.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.3 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -52.29 -42.57 63.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.004 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -69.83 -39.61 76.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.196 0.522 . . . . 0.0 110.351 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -38.09 88.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.194 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 62.2 mt -69.95 -25.04 63.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.036 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -69.08 -38.47 79.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.7 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.8 -67.83 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 8.7 pt20 -102.92 -20.89 14.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 40.3 tp 69.5 23.04 6.14 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 168.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.87 0.64 39.25 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.356 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.13 127.88 55.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.608 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 23.9 tt0 -91.95 102.03 14.59 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.72 122.12 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -111.84 -175.68 2.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.871 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.76 161.49 23.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.87 -8.67 30.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.834 0.349 . . . . 0.0 111.06 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 65.34 31.11 10.73 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.711 0.767 . . . . 0.0 109.598 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.3 tp -110.9 22.07 15.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.089 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.71 ' HG3' ' HA ' ' A' ' 70' ' ' HIS . 55.5 tt0 -74.27 76.41 1.83 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 122.159 0.98 . . . . 0.0 109.681 175.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -128.79 -53.39 1.23 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.644 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -87.04 -52.98 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.235 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -85.69 102.0 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.022 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.71 ' HA ' ' HG3' ' A' ' 66' ' ' GLU . 1.9 m-70 -99.79 137.55 38.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 111.772 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.442 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 65.6 m80 -84.45 -35.1 23.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.873 179.187 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.0 t -80.82 86.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -133.71 139.9 46.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 0.0 112.206 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.38 79.67 3.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.34 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.06 -41.72 76.0 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.082 2.522 . . . . 0.0 112.273 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 91.1 mmm -126.98 112.39 15.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.989 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.42 123.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.084 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 pt -80.07 50.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.654 0.74 . . . . 0.0 111.448 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.54 129.74 27.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -93.98 159.07 15.34 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -91.46 -52.21 4.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -153.57 17.97 0.53 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.15 -24.55 47.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.316 -171.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -74.72 -1.96 24.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.03 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.3 -22.44 64.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -92.26 -9.05 43.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 66.36 -66.62 0.17 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.156 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 61.8 m -152.76 -83.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -160.34 33.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.5 107.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.006 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.498 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 10.5 pt20 -89.03 132.62 34.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 109.974 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.411 HG21 HD13 ' B' ' 22' ' ' ILE . 21.9 mt -116.44 148.94 18.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.796 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -79.88 -174.58 4.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -71.6 -22.84 61.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.363 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . 0.43 ' HB2' ' ND2' ' B' ' 47' ' ' ASN . 13.8 t80 -74.39 -45.25 48.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.44 27.64 2.79 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.059 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -96.0 -124.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -141.05 140.55 34.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.434 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 41.8 t -119.81 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.486 0.66 . . . . 0.0 109.345 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -86.96 167.77 20.59 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.89 -3.6 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.853 2.369 . . . . 0.0 113.496 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.43 8.48 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.226 0.536 . . . . 0.0 110.509 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -106.23 130.87 54.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.02 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.26 120.98 23.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' B' ' 42' ' ' ILE . 34.8 p90 -143.3 164.53 29.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.44 ' HB ' HD11 ' B' ' 48' ' ' LEU . 72.9 t -132.8 145.83 33.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 39' ' ' GLY . 46.9 mt -111.57 127.89 68.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.342 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.415 ' CB ' ' HE2' ' B' ' 51' ' ' TYR . 25.3 t70 -119.29 89.77 3.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.052 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 42.37 9.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.303 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.58 -22.25 11.56 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.934 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -87.56 129.13 35.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.996 0.426 . . . . 0.0 110.151 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.502 HG21 ' CD2' ' B' ' 35' ' ' TYR . 78.3 mt -83.99 141.07 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.0 mp -135.57 125.37 42.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.56 148.03 20.71 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -61.33 -17.36 53.39 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.959 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.52 0.11 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.741 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' B' ' 25' ' ' TYR . 54.0 t30 -124.04 -1.74 8.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 109.167 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.44 HD11 ' HB ' ' B' ' 36' ' ' VAL . 39.6 tp -69.15 -45.41 70.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.07 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.91 -53.08 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.125 0.488 . . . . 0.0 110.596 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.37 -47.48 85.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.956 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.415 ' HE2' ' CB ' ' B' ' 38' ' ' ASP . 92.7 t80 -62.76 -39.95 95.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.481 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.699 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 43.0 mt -67.72 -47.55 69.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.394 -0.191 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -59.39 -19.03 43.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 110.903 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.07 -54.13 4.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.936 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.813 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 6.3 tp60 -91.53 -67.64 0.84 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 19.4 mt 39.57 34.85 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.813 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -120.46 -1.03 12.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.22 -171.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.46 -157.26 0.27 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -115.88 101.88 9.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.687 169.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.92 121.48 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.154 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -136.11 68.07 1.45 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.868 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -71.35 176.68 4.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.043 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -74.55 -5.93 45.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.884 0.373 . . . . 0.0 110.507 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 55.87 43.22 27.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.616 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 87.7 mt -58.11 130.98 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.712 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 97.73 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -119.36 23.19 11.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.896 -173.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -92.07 77.67 5.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.525 0.679 . . . . 0.0 109.57 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -126.84 170.11 12.54 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -74.25 91.4 2.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.224 0.535 . . . . 0.0 110.736 -175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -132.15 146.08 51.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.381 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 22.6 p80 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.172 178.576 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.64 0.733 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.12 86.54 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.965 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.28 -17.26 31.09 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -58.68 118.57 29.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.956 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -16.49 29.12 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.531 2.154 . . . . 0.0 112.426 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.2 ttt 70.83 127.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.029 0.831 . . . . 0.0 110.615 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.25 101.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 pt -127.03 145.99 33.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.792 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -138.8 -7.05 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 72.9 138.37 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.919 0.762 . . . . 0.0 110.702 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -76.03 18.17 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.2 t60 55.43 51.01 13.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.764 0.792 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -81.93 168.04 18.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.328 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -89.09 39.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.806 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 67.15 89.73 0.1 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 109.684 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.16 124.2 17.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.728 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' HB3' ' H ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -68.34 -85.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.299 1.047 . . . . 0.0 109.131 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.449 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 3.7 t -102.55 -137.96 0.34 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.762 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.81 -29.05 32.84 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.202 0.525 . . . . 0.0 109.653 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t 70.82 110.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.175 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.461 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 6.7 pt20 -122.37 158.4 29.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.223 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.43 145.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 1.2 p-10 -77.26 -161.06 0.19 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.037 0.446 . . . . 0.0 110.196 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.5 -23.83 39.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.65 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -104.33 -4.07 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.1 5.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.769 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -114.13 149.06 36.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.07 127.79 34.05 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 110.472 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.492 HG21 HD22 ' A' ' 44' ' ' LEU . 15.7 t -95.69 117.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.766 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 p -115.6 169.04 7.36 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.766 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 47.7 Cg_endo -67.3 20.21 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.987 2.458 . . . . 0.0 114.3 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 30' ' ' THR . 22.4 t -122.19 -26.62 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.118 0.485 . . . . 0.0 110.248 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.69 145.47 29.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.0 110.853 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.546 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 1.8 t70 -87.81 142.87 27.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.01 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' HB3' HG11 ' A' ' 29' ' ' VAL . 26.8 p90 -149.96 164.66 34.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.802 0.334 . . . . 0.0 111.021 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.4 153.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.368 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 73.6 mt -111.16 108.22 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.079 0 CA-C-O 121.819 0.819 . . . . 0.0 111.051 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' HB2' HD11 ' A' ' 43' ' ' ILE . 1.8 m-20 -99.88 90.5 4.45 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.769 -177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 74.58 23.98 73.86 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.03 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.93 -29.98 6.57 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.365 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.1 158.78 15.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.366 0.603 . . . . 0.0 111.095 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.8 mt -103.58 138.87 26.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.142 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 38' ' ' ASP . 3.9 mp -131.56 122.8 51.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -59.23 135.07 57.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 14.3 mmt180 -58.08 -14.23 6.32 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.78 -14.49 56.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.476 . . . . 0.0 110.149 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -115.4 -9.91 12.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.403 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 28.2 tp -68.8 -28.77 67.06 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.138 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 53' ' ' ARG . 3.3 tm-20 -54.43 -66.37 0.41 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.61 -28.66 67.11 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.332 -177.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.38 -40.99 94.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.497 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 39.0 mt -65.42 -33.16 75.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.567 ' HG3' ' HA ' ' A' ' 50' ' ' ARG . 11.1 mtm180 -62.55 -39.31 93.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.065 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 23.5 mm-40 -87.66 -52.79 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.713 0.292 . . . . 0.0 111.317 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -90.24 -51.55 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.138 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.98 44.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.361 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 79.37 -51.72 3.98 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 121.236 -0.507 . . . . 0.0 114.158 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -68.98 122.97 19.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.773 -0.251 . . . . 0.0 110.862 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -92.52 101.78 14.22 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.251 170.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.46 95.23 6.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.917 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HD2' HD13 ' B' ' 37' ' ' ILE . 16.8 mttp -98.41 87.61 3.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.715 0.769 . . . . 0.0 110.632 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -81.42 176.49 9.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.9 4.91 17.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.811 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 66.94 12.17 8.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.681 0.753 . . . . 0.0 110.163 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.496 HD13 ' HD2' ' A' ' 67' ' ' HIS . 1.1 tm? -133.41 88.18 2.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.331 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.75 119.67 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.997 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.496 ' HD2' HD13 ' A' ' 65' ' ' LEU . 41.9 m170 -63.83 -38.36 90.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.869 -172.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -133.54 104.98 6.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.714 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -121.94 -26.12 4.85 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.005 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -81.11 145.4 31.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -91.86 125.31 36.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.912 0.386 . . . . 0.0 111.464 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.807 177.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.135 0.493 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.05 135.57 58.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -80.34 81.32 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.897 0.38 . . . . 0.0 111.452 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.471 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 15.0 p30 -154.0 131.83 6.36 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.204 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 9.2 Cg_endo -91.27 96.15 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.242 2.628 . . . . 0.0 112.487 178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mmt -85.92 -75.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.18 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 33.1 mm 56.9 -99.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.002 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' B' ' 10' ' ' ASN . 3.2 m-20 -130.98 19.75 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' B' ' 9' ' ' ASN . 47.1 m-80 78.67 107.25 0.07 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.203 0.939 . . . . 0.0 109.107 -169.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -85.39 -24.02 27.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.544 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -116.87 129.22 55.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 111.356 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -156.61 -90.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 173.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -154.76 94.52 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.677 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tt -80.71 99.58 8.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 35.2 p -92.78 116.01 28.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.387 0.613 . . . . 0.0 111.568 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -106.35 95.44 5.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p -87.05 -67.01 0.85 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.843 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.4 4.06 22.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.513 0.673 . . . . 0.0 109.403 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.1 90.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.21 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.659 ' OE1' ' HB ' ' B' ' 29' ' ' VAL . 0.9 OUTLIER -106.69 166.19 10.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.401 HG21 HD11 ' B' ' 22' ' ' ILE . 14.6 mt -128.0 151.74 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -71.56 -173.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -67.41 -32.12 72.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -86.1 -45.69 11.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.75 31.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.233 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.78 125.43 53.68 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.78 128.05 34.37 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 111.393 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.659 ' HB ' ' OE1' ' B' ' 21' ' ' GLN . 19.0 t -114.57 119.6 61.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.005 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 36.2 p -110.34 164.56 14.54 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.744 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 51.9 Cg_exo -53.98 -18.73 13.82 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.388 2.725 . . . . 0.0 114.209 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.91 -0.93 10.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.949 0.404 . . . . 0.0 111.175 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -102.51 147.26 26.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.84 128.72 42.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.411 ' OH ' ' HD3' ' A' ' 61' ' ' LYS . 30.1 p90 -148.48 -178.01 6.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.451 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 98.4 t -140.05 139.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.462 HD13 ' HD2' ' A' ' 61' ' ' LYS . 45.1 mt -105.02 117.85 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 110.073 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.92 92.04 3.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.468 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.539 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 84.74 0.57 89.18 Favored Glycine 0 C--N 1.316 -0.534 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.645 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.4 -20.27 4.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.724 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -99.82 151.06 21.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.012 0.434 . . . . 0.0 110.17 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.76 138.86 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.608 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.664 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.2 mp -140.01 126.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' B' ' 48' ' ' LEU . 20.5 mt -55.81 146.67 20.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 172.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -62.4 -11.15 14.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.63 0.252 . . . . 0.0 111.354 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 31.9 tp10 -74.75 -51.36 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -100.5 3.54 42.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.664 HD23 ' HB ' ' B' ' 43' ' ' ILE . 2.8 tm? -65.75 -33.16 75.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.342 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.34 -49.67 76.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.505 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -67.25 -32.66 73.84 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.306 0.574 . . . . 0.0 110.165 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -66.85 -43.89 82.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.733 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 24.5 mt -66.89 -23.75 66.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -69.4 -33.83 73.59 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -84.7 -65.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.533 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' B' ' 57' ' ' GLY . 47.2 tp60 -85.35 -67.2 0.82 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.554 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.733 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 18.6 tp 60.35 -22.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' B' ' 55' ' ' GLN . . . -107.31 35.88 4.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.897 -167.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 50.51 -153.48 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.145 0.473 . . . . 0.0 110.933 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 10.9 tp10 -110.56 102.39 10.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.251 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -91.83 117.73 30.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.75 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -118.63 -173.1 2.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.587 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.514 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 29.9 p-10 -168.72 -175.45 2.43 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.39 15.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.815 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' B' ' 62' ' ' ASN . 67.2 mt-30 57.74 48.79 13.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.34 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp -82.86 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.45 6.16 18.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.84 132.72 51.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 111.884 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -91.33 125.23 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -77.17 42.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 73.1 m80 62.98 -172.66 0.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -163.31 111.54 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.307 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 45.4 m170 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.937 175.184 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.69 0.281 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.49 -79.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -178.07 -54.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -118.55 158.05 48.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.874 0.368 . . . . 0.0 111.464 -174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.95 25.2 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.136 2.557 . . . . 0.0 111.541 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 16.0 tpt -94.63 -24.66 17.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.223 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.71 139.18 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.972 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' HD11 ' A' ' 8' ' ' ILE . 1.7 pp -71.84 127.72 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 111.665 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -78.84 -22.26 46.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -87.63 93.23 9.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.921 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -76.19 106.9 8.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.305 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -84.92 -8.72 58.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.25 135.93 42.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.098 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' HZ3' ' HB3' ' A' ' 14' ' ' LYS . 7.7 mtpm? -104.26 -31.92 9.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt 62.93 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.549 0.531 . . . . 0.0 111.467 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 p -90.8 -77.35 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.64 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.61 129.74 47.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.385 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -153.24 -50.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.681 0.277 . . . . 0.0 111.696 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -84.2 8.66 15.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -97.58 101.24 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.871 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 29' ' ' VAL . 4.9 pt20 -123.06 156.71 34.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' ASP . 22.7 mt -125.21 138.3 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.714 0.292 . . . . 0.0 111.491 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' OD2' ' HA ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -67.36 162.26 23.32 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.435 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -50.2 -35.37 26.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 113.134 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.87 1.08 48.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 39.14 7.95 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -121.4 127.81 51.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.71 125.73 26.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.585 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.643 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 58.0 t -120.33 102.1 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.548 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.762 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 p -78.19 166.58 42.17 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.762 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -59.69 -10.67 12.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.892 2.395 . . . . 0.0 114.472 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.61 7.76 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.659 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -98.65 154.53 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 7.7 m-20 -76.89 111.3 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.656 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.495 ' HB3' HG11 ' A' ' 29' ' ' VAL . 42.9 p90 -147.52 168.17 22.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 111.164 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.9 t -137.75 148.23 25.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 60.1 mt -105.67 118.52 53.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-O 121.306 0.575 . . . . 0.0 110.052 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.506 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 2.1 m-20 -106.39 87.68 2.6 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.615 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.63 80.14 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.102 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.99 -25.82 2.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.012 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -97.39 155.97 16.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.114 0.483 . . . . 0.0 110.78 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.1 mt -96.4 137.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.363 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.488 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 3.7 mp -131.34 120.51 46.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD21 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -57.51 136.66 56.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' N ' HD21 ' A' ' 44' ' ' LEU . 11.9 mmm-85 -55.78 -13.96 2.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.82 -57.39 7.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.293 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.0 7.52 44.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.434 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 46.0 tp -54.68 -28.97 51.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.257 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -42.26 -46.18 4.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.623 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 2.4 mpt_? -73.89 -39.56 63.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.265 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -44.77 83.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.966 0.412 . . . . 0.0 110.665 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.909 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 51.9 mt -68.31 -24.58 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -76.8 -26.76 54.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.916 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -92.41 -70.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.821 0.344 . . . . 0.0 111.731 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.4 -23.21 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.878 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.909 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 42.3 tp 66.14 43.32 2.9 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.316 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.506 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.21 -18.31 41.88 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.811 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 9.3 m-85 -99.46 136.7 39.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.564 -0.374 . . . . 0.0 110.719 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.444 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 34.7 tt0 -93.05 102.02 14.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 167.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.06 92.49 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.934 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE2' ' OE2' ' A' ' 59' ' ' GLU . 14.1 mmtt -97.56 173.83 6.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 111.955 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.6 175.85 9.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.425 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.25 72.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.703 0.287 . . . . 0.0 111.021 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.19 50.87 12.66 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD12 HG13 ' B' ' 32' ' ' VAL . 66.8 tp -70.28 89.2 0.65 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.47 84.65 3.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.0 109.566 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -131.98 105.37 7.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.844 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 78.3 m80 -74.5 150.33 39.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.013 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 88.7 m-70 72.2 108.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.067 0.854 . . . . 0.0 111.181 -176.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -91.82 -24.37 19.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.432 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -151.62 138.56 19.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.362 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--N 1.318 -0.766 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.512 175.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.4 94.19 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.719 0.771 . . . . 0.0 109.991 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.97 -56.29 2.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.556 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.36 111.49 55.22 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.399 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.5 101.67 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.62 2.213 . . . . 0.0 111.442 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.71 78.43 5.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.106 0.479 . . . . 0.0 110.476 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 120.19 41.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.37 99.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.151 0.501 . . . . 0.0 110.552 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.97 25.37 4.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.717 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -59.68 134.37 56.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.469 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . 0.459 ' HD1' ' H ' ' B' ' 11' ' ' TRP . 0.2 OUTLIER -76.82 72.9 3.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.769 0.795 . . . . 0.0 111.962 -173.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.35 101.02 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.262 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.29 44.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.121 -171.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 56.9 -161.13 0.21 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.814 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt 61.79 19.27 10.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.965 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -105.69 178.58 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.813 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.13 119.26 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.872 0.368 . . . . 0.0 110.622 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -55.27 -64.24 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.623 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.06 20.18 1.94 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.963 0.887 . . . . 0.0 109.002 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.37 94.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.083 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.432 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 9.2 pt20 -92.4 131.34 37.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.211 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.491 HG23 ' O ' ' B' ' 23' ' ' ASP . 36.1 mt -104.83 141.73 19.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.491 ' O ' HG23 ' B' ' 22' ' ' ILE . 0.5 OUTLIER -76.75 173.67 11.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.63 -21.82 60.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.304 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.65 3.61 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.0 27.24 14.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.402 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.92 145.27 43.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.606 0.703 . . . . 0.0 109.813 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.43 119.53 13.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.413 . . . . 0.0 111.172 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.432 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 18.6 t -90.28 88.15 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.441 ' C ' ' H ' ' B' ' 32' ' ' VAL . 51.1 p -68.27 157.92 86.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.853 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.1 13.99 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.86 2.374 . . . . 0.0 112.635 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.457 HG13 HD12 ' A' ' 65' ' ' LEU . 33.8 m -121.95 3.1 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.055 176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -114.28 151.98 32.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.988 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.93 136.55 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.46 ' CD2' HG22 ' B' ' 42' ' ' ILE . 21.0 p90 -149.34 166.28 29.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.2 t -136.04 142.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 46.2 mt -104.83 120.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.647 0.261 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.07 91.07 5.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.3 0.572 . . . . 0.0 109.75 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 37' ' ' ILE . . . 81.19 -28.97 2.86 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.154 174.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.48 -27.2 0.15 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.42 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.233 0.54 . . . . 0.0 110.534 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.46 HG22 ' CD2' ' B' ' 35' ' ' TYR . 79.2 mt -82.24 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.468 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.751 ' HB ' HD21 ' B' ' 48' ' ' LEU . 3.7 mp -130.44 123.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.975 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 51.0 mt -55.46 143.91 27.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.693 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 10.7 mmt180 -66.96 0.81 2.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -73.01 -35.23 66.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 0.0 110.803 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -129.05 5.76 5.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.304 0.573 . . . . 0.0 110.265 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.751 HD21 ' HB ' ' B' ' 43' ' ' ILE . 3.0 tm? -51.71 -44.78 63.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.129 -172.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -59.79 -30.29 68.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.851 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 0.6 OUTLIER -76.35 -38.58 55.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.313 . . . . 0.0 110.808 -178.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -66.25 -32.47 73.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 32.9 mt -64.9 -48.24 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.47 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 7.5 ptp180 -69.04 -27.58 65.78 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.448 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -93.98 -34.57 13.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.536 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 54.2 tp60 -103.19 -67.88 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.085 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER 37.32 40.3 0.19 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.827 0.704 . . . . 0.0 110.078 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.536 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -131.21 6.19 5.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.652 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 50.8 -154.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.852 0.326 . . . . 0.0 110.126 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 5.9 tp10 -102.83 101.84 11.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.644 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.83 95.92 10.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 110.345 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -112.89 56.26 0.68 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.439 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.24 74.35 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.14 8.97 3.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.238 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' B' ' 64' ' ' GLN . 7.8 tp60 52.11 40.89 29.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.48 115.21 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.037 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -51.17 -67.54 0.24 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.69 0.619 . . . . 0.0 110.573 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.471 ' CG ' ' H ' ' B' ' 68' ' ' HIS . 20.1 t-80 59.96 -171.57 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.524 0.515 . . . . 0.0 109.915 173.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.471 ' H ' ' CG ' ' B' ' 67' ' ' HIS . 34.1 m80 -139.57 127.81 22.59 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.902 -0.499 . . . . 0.0 110.465 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -79.93 93.4 5.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.85 136.1 57.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.821 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -52.65 129.64 30.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.583 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 3.4 m80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.685 175.701 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tmm? . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 2' ' ' VAL . 18.2 t 75.44 22.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.852 0.834 . . . . 0.0 109.719 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -67.65 121.31 15.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.638 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -155.64 165.29 18.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.1 -29.12 82.04 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.808 2.338 . . . . 0.0 113.835 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 54.2 ttp -93.63 80.93 4.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.38 0.609 . . . . 0.0 110.729 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.94 152.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.21 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 pt -54.06 148.7 2.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.058 0.224 . . . . 0.0 110.718 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -43.44 121.7 2.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.856 0.836 . . . . 0.0 112.959 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 14' ' ' LYS . 24.3 t-20 -73.48 157.89 35.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.977 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -59.37 -35.73 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -82.89 127.72 33.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.839 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 t70 68.16 27.5 6.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.751 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 25.3 pttm -92.67 31.9 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 0.0 110.943 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.93 -25.23 55.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.395 0.617 . . . . 0.0 110.13 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 p -123.44 -168.0 1.7 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.62 144.2 57.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 20' ' ' VAL . 28.6 m -87.11 -42.84 12.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.02 -170.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -76.79 28.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.707 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 18' ' ' THR . 15.1 t -114.87 102.42 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.303 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.2 148.72 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.544 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 23' ' ' ASP . 34.9 mt -123.89 154.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 9.2 p-10 -78.15 -164.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 110.328 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.92 -27.9 43.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.723 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.27 -17.38 34.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.21 5.91 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.163 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 t70 -92.08 -96.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.7 tt0 174.35 118.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.88 95.1 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.259 0.552 . . . . 0.0 110.76 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' VAL . 9.1 p -80.73 161.64 63.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.917 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 46.6 Cg_endo -67.96 13.71 0.18 Allowed 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 122.828 2.352 . . . . 0.0 113.177 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' THR . 27.3 m -115.43 11.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.614 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.74 172.76 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.289 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -103.79 125.22 50.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.862 0.363 . . . . 0.0 110.452 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.01 169.91 16.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.227 0.537 . . . . 0.0 110.877 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' B' ' 60' ' ' PHE . 70.7 t -137.53 139.55 43.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -105.76 120.99 57.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.436 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -108.76 86.98 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.15 42.9 34.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.21 -0.904 . . . . 0.0 113.681 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.04 -17.63 57.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.786 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -109.18 133.48 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.361 0.601 . . . . 0.0 110.923 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -85.77 137.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.585 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 3.0 mp -135.18 128.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.52 143.91 57.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.614 ' HD2' HD22 ' A' ' 48' ' ' LEU . 11.9 mmm-85 -63.55 -11.65 26.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.42 -49.6 73.1 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.113 0.258 . . . . 0.0 111.266 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -129.35 39.15 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.712 . . . . 0.0 110.155 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.614 HD22 ' HD2' ' A' ' 45' ' ' ARG . 11.7 tp -71.63 -35.82 70.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.773 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -55.35 -36.73 66.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.963 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 mtt-85 -78.27 -27.46 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.092 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.26 -33.7 61.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.492 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.729 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 73.5 mt -71.09 -24.54 62.33 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.57 172.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -71.32 -28.2 63.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 51.8 mm-40 -86.04 -54.05 4.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.391 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.515 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 11.0 tt0 -99.23 -67.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.781 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 4.7 tp 49.31 31.32 3.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.35 0.406 . . . . 0.0 110.408 -174.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.515 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -125.3 -6.17 6.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.73 -164.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.02 -154.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.802 0.801 . . . . 0.0 109.312 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.569 ' OE2' HD12 ' B' ' 37' ' ' ILE . 28.0 tt0 -116.44 102.28 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.457 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -83.49 102.68 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 6.0 tptm -97.91 90.29 4.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 -175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -85.16 44.91 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.918 -174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 66.7 -4.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.482 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.583 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER 56.46 23.48 7.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.101 0.477 . . . . 0.0 110.181 -177.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.2 tp -71.16 104.83 3.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.385 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CD ' ' HD1' ' A' ' 68' ' ' HIS . 0.4 OUTLIER -123.93 106.59 10.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -145.66 43.62 1.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.428 ' HD1' ' CD ' ' A' ' 66' ' ' GLU . 43.7 p-80 -58.59 136.17 57.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.881 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -126.03 111.75 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.709 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -101.93 0.08 34.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.555 0.693 . . . . 0.0 109.172 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -141.16 109.46 5.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.581 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.854 177.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.825 0.345 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.78 78.74 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.974 0.416 . . . . 0.0 110.163 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -151.76 90.89 1.59 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -153.3 75.65 6.49 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.057 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.41 -11.92 4.87 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.126 2.551 . . . . 0.0 111.74 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 46.7 ttp -165.58 135.96 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.701 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.68 122.65 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.404 HD11 ' N ' ' B' ' 8' ' ' ILE . 4.1 mp -78.4 104.9 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -156.22 103.8 2.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.93 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -87.96 122.59 31.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.996 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -98.33 86.25 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 68.69 -61.22 0.42 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.948 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.92 85.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.487 0.715 . . . . 0.0 112.352 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.55 133.75 55.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.766 175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.24 144.45 42.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.383 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -36.01 82.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 110.516 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -103.07 128.57 49.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.624 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 29.9 m -129.29 -48.52 1.19 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.072 0.463 . . . . 0.0 110.202 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -131.91 15.39 4.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.134 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 138.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.669 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 14.2 pt20 -132.96 168.55 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 110.821 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.438 HG23 ' N ' ' B' ' 23' ' ' ASP . 34.5 mt -136.28 155.95 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.615 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 6.3 p-10 -79.38 -171.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.189 0.519 . . . . 0.0 110.791 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -70.04 -29.88 67.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.754 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -88.07 -21.52 24.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.1 38.5 4.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.025 -1.083 . . . . 0.0 113.227 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.6 t70 -89.09 -89.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 37.1 tt0 171.97 137.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.669 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 59.5 t -116.83 109.58 28.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.947 0.403 . . . . 0.0 110.707 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -94.17 159.84 33.33 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.56 3.76 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.67 -0.83 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 109.983 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -102.49 142.13 34.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.707 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.501 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 6.7 m-20 -83.85 120.18 25.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.307 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 21.9 p90 -142.58 161.94 36.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.589 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' B' ' 48' ' ' LEU . 84.4 t -124.81 139.48 50.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.569 HD12 ' OE2' ' A' ' 59' ' ' GLU . 53.4 mt -106.47 112.51 39.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 40' ' ' GLY . 1.4 m-20 -85.39 85.02 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.949 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.626 ' HA3' ' HG3' ' B' ' 59' ' ' GLU . . . 74.53 -32.15 1.0 Allowed Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.602 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 38' ' ' ASP . . . 171.52 -21.73 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -171.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -81.44 143.04 32.39 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.2 mt -107.75 119.8 57.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.421 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.413 ' N ' HD12 ' B' ' 43' ' ' ILE . 3.0 mp -126.73 121.72 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.115 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 40.6 mt -57.23 146.4 28.49 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.501 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 66.7 mtp180 -69.07 0.26 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -60.1 -51.82 68.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.004 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -126.45 19.71 7.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' B' ' 36' ' ' VAL . 16.8 tp -53.23 -37.4 62.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.23 -43.82 64.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.575 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.71 -36.26 65.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.296 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -67.49 -35.98 80.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.0 -31.31 70.92 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.585 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -69.87 -24.24 63.39 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.709 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -89.09 -55.92 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.44 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.906 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.8 tp 82.72 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 124.141 0.9 . . . . 0.0 111.801 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.405 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 81.46 -49.4 4.02 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.45 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 33.6 m-85 -70.92 124.45 24.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.626 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 26.7 mt-10 -92.08 101.79 14.33 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.751 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.52 ' HA ' HG22 ' A' ' 36' ' ' VAL . 97.1 m-85 -81.4 87.92 6.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.514 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -107.39 80.53 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.631 0.729 . . . . 0.0 110.923 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -71.9 158.26 36.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.05 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.01 95.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.994 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 55.47 58.77 4.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.307 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.621 HD13 ' H ' ' B' ' 65' ' ' LEU . 4.2 mp -63.66 129.74 41.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.492 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.06 77.98 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.724 0.773 . . . . 0.0 110.818 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -107.7 81.96 1.59 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.79 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -76.96 121.87 24.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -86.81 129.08 35.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -118.07 135.58 54.1 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -119.6 -7.5 10.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.11 0.481 . . . . 0.0 110.402 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 41.1 m170 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.359 174.495 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttm . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.35 138.59 46.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.852 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.38 151.58 21.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.318 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.477 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.0 m-20 67.37 166.94 0.12 Allowed Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 124.065 0.853 . . . . 0.0 111.641 173.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 4' ' ' ASN . 16.6 Cg_endo -59.9 116.88 3.61 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.176 1.917 . . . . 0.0 110.322 169.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 71.4 mtm -51.59 125.72 15.5 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.39 0.614 . . . . 0.0 111.814 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.1 156.65 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.822 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.494 ' O ' HD13 ' A' ' 8' ' ' ILE . 2.3 pp -71.03 147.8 10.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.098 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -129.2 14.47 6.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.445 0.641 . . . . 0.0 109.944 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -96.88 100.66 12.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.139 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -65.59 0.6 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.061 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -148.92 -55.65 0.19 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 63.55 -87.95 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.341 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -142.35 20.01 2.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.394 0.616 . . . . 0.0 109.945 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.1 tp -79.73 137.11 36.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.37 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 p -100.96 -123.57 0.17 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.4 90.75 7.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 112.154 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.6 p -91.77 -48.12 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.701 0.762 . . . . 0.0 109.678 171.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -150.14 17.21 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.14 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 t -93.92 124.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.694 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.479 ' NE2' HD12 ' A' ' 42' ' ' ILE . 9.8 pt20 -123.19 157.58 32.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 13.0 mt -120.03 152.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.0 p-10 -90.6 -167.91 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.306 0.574 . . . . 0.0 110.904 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -69.93 -24.52 63.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -89.38 -34.26 16.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.496 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA2' ' CG2' ' A' ' 22' ' ' ILE . . . 99.74 27.67 7.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.591 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.71 -10.42 48.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 73.08 120.38 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.338 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 23' ' ' ASP . 47.6 t -113.61 113.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.514 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 p -102.97 167.75 9.79 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.4 -11.49 6.43 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.826 2.35 . . . . 0.0 113.404 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.27 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.464 0.65 . . . . 0.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -107.62 146.08 32.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' OD2' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -89.92 130.52 36.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.431 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.6 p90 -153.76 161.58 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.825 0.345 . . . . 0.0 111.023 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 49.4 t -128.18 150.33 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 40.5 mt -115.78 116.88 53.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.157 0 CA-C-O 121.894 0.855 . . . . 0.0 111.187 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.41 89.32 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.731 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' HA2' ' CG2' ' B' ' 37' ' ' ILE . . . 69.17 45.11 63.07 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.247 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.5 -21.9 35.9 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.464 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -91.72 133.53 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.241 0.543 . . . . 0.0 110.578 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.479 HD12 ' NE2' ' A' ' 21' ' ' GLN . 60.3 mt -91.74 132.18 36.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.916 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.814 ' HB ' HD21 ' A' ' 48' ' ' LEU . 3.1 mp -130.99 125.99 58.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 29' ' ' VAL . 18.2 tp -63.61 143.54 57.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.511 ' HG3' ' OD2' ' A' ' 34' ' ' ASP . 12.8 mmm180 -62.48 -6.89 3.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 7.2 mm-40 -71.33 -57.79 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.47 0.34 53.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.814 HD21 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -62.76 -27.29 69.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.461 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.37 -48.33 74.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.694 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -61.6 -41.76 97.9 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.429 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.47 -37.96 89.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.292 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 19.5 mt -71.32 -26.7 62.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -71.3 -45.68 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.432 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.12 -32.38 13.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -102.97 -56.16 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.188 -0.32 . . . . 0.0 110.374 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 26.6 tp 77.65 37.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 111.914 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' CD2' ' B' ' 58' ' ' PHE . . . 89.43 -43.54 3.02 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.137 172.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.421 ' HE2' HD22 ' A' ' 56' ' ' LEU . 3.3 m-85 -70.14 117.97 12.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.526 ' O ' HG11 ' B' ' 36' ' ' VAL . 9.6 tp10 -92.04 101.43 13.97 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.436 ' HA ' HG21 ' B' ' 36' ' ' VAL . 63.8 m-85 -89.75 86.29 6.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.06 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -84.71 174.77 9.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -142.34 177.26 8.38 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 64.3 -84.47 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.369 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD23 HG13 ' B' ' 32' ' ' VAL . 26.9 tp 55.33 30.13 14.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.049 0.452 . . . . 0.0 111.472 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 62.14 12.34 4.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.512 -176.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -120.11 75.1 1.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.398 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -139.12 140.73 38.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.329 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -111.99 143.21 43.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.496 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.08 -68.68 0.32 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -172.92 -62.34 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.548 173.76 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.16 163.47 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.14 117.89 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.503 176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -99.01 143.75 26.94 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.863 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.89 -28.33 23.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.114 2.542 . . . . 0.0 113.295 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 58.4 mtt -78.58 71.57 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.018 0.437 . . . . 0.0 110.251 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.79 3.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.391 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.36 14.77 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -86.41 8.25 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.11 160.73 19.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.589 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -76.3 143.87 40.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.335 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -92.78 -175.26 3.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.4 101.72 2.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.841 0.829 . . . . 0.0 111.304 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -146.23 -41.93 0.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.155 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.54 98.63 2.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -84.63 121.82 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.753 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.55 173.57 10.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.978 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 12.9 m -155.98 -62.92 0.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -174.14 35.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.942 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.83 103.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.988 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.436 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 10.4 pt20 -104.91 158.13 16.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.786 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.429 HG21 ' N ' ' B' ' 23' ' ' ASP . 18.1 mt -130.08 155.76 41.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 6.7 p-10 -83.88 -165.11 1.04 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.273 0.558 . . . . 0.0 110.955 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.77 -31.68 68.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.373 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -41.13 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.576 0.227 . . . . 0.0 110.891 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.3 35.82 3.03 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.671 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 19.0 t70 -88.58 -89.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 41.1 tt0 176.02 130.66 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 48.3 t -114.35 113.12 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.191 0.519 . . . . 0.0 110.819 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 67.1 p -106.15 169.3 7.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.3 Cg_exo -58.68 -4.54 1.96 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.154 2.569 . . . . 0.0 114.151 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.468 HG13 HD23 ' A' ' 65' ' ' LEU . 19.2 m -106.52 0.65 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 110.795 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -96.78 136.94 36.62 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.534 ' HB3' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -80.68 108.54 14.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -126.63 155.44 42.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.106 0.479 . . . . 0.0 111.236 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 59' ' ' GLU . 41.8 t -129.85 145.75 35.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.521 ' CG2' ' HA2' ' A' ' 39' ' ' GLY . 36.1 mt -115.23 126.3 72.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.609 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.74 83.35 3.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.18 3.38 Favored Glycine 0 C--O 1.227 -0.327 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.303 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.76 -30.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -81.39 134.24 35.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.098 0.475 . . . . 0.0 110.315 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.92 138.37 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.386 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.8 mp -137.04 130.72 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.416 HD22 HG21 ' B' ' 29' ' ' VAL . 79.8 mt -60.39 150.06 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.534 ' HG3' ' HB3' ' B' ' 34' ' ' ASP . 20.8 mmt180 -61.37 -11.84 11.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.89 0.376 . . . . 0.0 110.964 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.1 -36.52 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.664 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -111.75 8.12 20.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.914 0.388 . . . . 0.0 110.644 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.523 HD11 ' HB ' ' B' ' 36' ' ' VAL . 63.9 tp -60.64 -47.93 84.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.443 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.71 -47.94 80.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.623 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 7.0 mtp180 -64.3 -45.96 85.69 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.111 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.431 ' CG ' HG12 ' B' ' 43' ' ' ILE . 47.1 t80 -59.07 -39.39 81.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.661 0.267 . . . . 0.0 110.925 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 39.0 mt -72.55 -28.72 63.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.611 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 8.4 ptp180 -86.86 -11.5 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.286 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 70.2 mm-40 -92.67 -54.92 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.185 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.415 ' HG2' ' N ' ' B' ' 57' ' ' GLY . 5.0 tt0 -102.02 -65.96 0.95 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -174.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 2.2 tp 55.0 43.94 29.03 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' B' ' 55' ' ' GLN . . . -100.87 -50.37 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.771 -165.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 48.05 -176.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.271 0.628 . . . . 0.0 110.908 -167.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 30.8 tt0 -103.79 102.49 12.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.609 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.61 100.69 13.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.328 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -91.43 162.06 14.73 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.51 138.4 9.72 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.92 -43.75 64.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 68.59 -3.42 1.38 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.578 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mp -127.26 108.28 10.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -95.36 35.08 1.35 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -110.79 59.39 0.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.254 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -157.86 85.91 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.445 0.641 . . . . 0.0 109.536 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -89.54 122.76 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.745 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -108.63 -66.02 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.189 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -109.64 6.06 23.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 110.958 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.971 178.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.557 0.218 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.16 3.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.269 0.557 . . . . 0.0 110.367 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -86.97 -176.5 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.082 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -109.3 157.98 35.73 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.09 7.6 2.82 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.883 2.389 . . . . 0.0 113.268 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 62.5 mtt -138.24 85.7 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.832 0.349 . . . . 0.0 110.38 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.65 -41.06 91.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.32 94.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.826 0.822 . . . . 0.0 108.898 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -86.82 143.29 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.937 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -130.99 152.16 50.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 7.7 t90 72.25 -43.69 0.57 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.303 1.041 . . . . 0.0 111.862 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -79.63 -4.56 52.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.204 0.526 . . . . 0.0 109.964 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.12 152.17 45.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.949 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.41 -38.2 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.95 57.78 1.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.099 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.17 116.59 29.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.764 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -124.16 95.77 4.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -125.94 -44.31 1.79 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.508 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -101.36 18.98 18.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.831 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.34 121.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.04 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 171.79 7.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 28' ' ' GLU . 21.0 mt -136.39 139.42 45.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 166.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.69 -166.99 1.74 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -70.78 -19.8 62.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.307 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -74.54 -32.43 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.549 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.97 25.55 26.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.143 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -96.42 -85.4 0.34 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HA ' HG12 ' A' ' 22' ' ' ILE . 17.5 tt0 -176.81 150.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 174.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG22 ' HB3' ' A' ' 23' ' ' ASP . 58.6 t -130.92 117.34 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.702 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 p -116.25 168.45 8.6 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.854 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.702 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 41.2 Cg_endo -67.71 9.84 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.726 2.284 . . . . 0.0 113.766 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.1 6.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.517 . . . . 0.0 109.999 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -109.78 147.07 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.995 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.23 124.12 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -147.3 163.95 34.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.771 ' HB ' HD13 ' A' ' 48' ' ' LEU . 61.6 t -136.52 137.72 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -99.64 121.83 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.86 86.48 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' O ' HG21 ' B' ' 37' ' ' ILE . . . 77.55 -36.26 1.59 Allowed Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.768 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.628 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.67 135.24 34.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.108 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -91.17 133.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.988 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.9 mp -136.87 134.5 48.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 60.7 mt -54.39 151.57 7.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.67 -8.04 24.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.67 -45.47 10.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.245 0.545 . . . . 0.0 109.719 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -85.86 -4.95 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.229 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.771 HD13 ' HB ' ' A' ' 36' ' ' VAL . 56.1 tp -54.97 -50.83 67.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.521 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.557 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 mt-10 -52.81 -48.99 66.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.307 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -59.44 -49.36 78.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.76 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.6 -32.92 74.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 40.4 mt -72.25 -24.36 61.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.566 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 94.0 mtt180 -72.13 -38.98 69.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.6 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -68.82 0.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.872 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 11.8 pt20 -103.79 -53.12 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.677 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 18.3 tp 47.78 43.37 16.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -123.5 -3.82 8.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.139 -1.029 . . . . 0.0 114.633 -165.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.22 -160.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 11.0 mm-40 -105.27 101.75 11.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -110.53 104.53 13.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.167 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 71.1 mmtt -101.8 152.46 20.86 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -155.89 149.91 25.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -5.81 27.0 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.084 0.24 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 63.11 42.24 7.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.857 0.837 . . . . 0.0 109.81 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.5 tp -90.2 38.65 0.94 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.409 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -36.98 64.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.569 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 47.27 63.95 1.77 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.843 0.714 . . . . 0.0 110.679 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.69 110.04 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.857 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -74.79 -18.88 60.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.666 0.746 . . . . 0.0 109.082 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -96.7 106.64 18.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.251 170.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -116.42 23.26 12.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.732 175.408 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.06 82.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 121.292 0.567 . . . . 0.0 110.146 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.81 -173.35 2.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.901 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.478 ' HB3' ' SD ' ' B' ' 6' ' ' MET . 97.5 m-20 -88.75 109.27 28.59 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.173 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 7.3 Cg_exo -74.21 -13.05 23.39 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.114 2.542 . . . . 0.0 112.899 -176.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' MET . . . . . 0.478 ' SD ' ' HB3' ' B' ' 4' ' ' ASN . 0.6 OUTLIER -79.62 82.09 5.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.599 0.714 . . . . 0.0 110.809 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.44 100.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.73 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 pp -101.24 163.18 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.596 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 11.8 m120 62.35 93.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.903 0.752 . . . . 0.0 111.382 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -89.79 152.56 21.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -83.19 -29.14 28.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' B' ' 13' ' ' ASP . 57.1 t-80 -124.16 142.02 51.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.235 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 12' ' ' HIS . 12.3 t70 69.84 108.45 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.721 0.638 . . . . 0.0 110.337 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -111.78 66.58 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.14 0.495 . . . . 0.0 110.392 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.619 ' HG ' HG21 ' B' ' 16' ' ' THR . 55.9 tp 71.58 -71.55 0.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.602 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.619 HG21 ' HG ' ' B' ' 15' ' ' LEU . 23.2 p -136.91 153.69 50.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.055 0.455 . . . . 0.0 112.215 -173.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' B' ' 18' ' ' THR . 0.0 OUTLIER -134.33 171.76 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.468 ' H ' ' CD ' ' B' ' 17' ' ' GLU . 16.2 m -58.51 -72.26 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.679 0.275 . . . . 0.0 111.737 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.08 30.33 5.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.254 0.549 . . . . 0.0 109.56 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -121.9 119.52 58.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.587 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.07 173.92 12.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.103 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.425 HG21 ' N ' ' B' ' 23' ' ' ASP . 30.3 mt -130.42 155.98 42.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.425 ' N ' HG21 ' B' ' 22' ' ' ILE . 7.5 p-10 -81.14 -162.19 0.47 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.257 0.551 . . . . 0.0 111.109 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -76.83 -30.2 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.743 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -80.51 -19.76 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.314 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.422 ' HA2' HG22 ' B' ' 22' ' ' ILE . . . 83.92 41.09 8.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.611 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.37 -82.68 0.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 178.02 140.91 0.09 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.464 HG12 ' HB3' ' B' ' 35' ' ' TYR . 21.9 t -126.4 141.72 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.685 ' HG1' ' HB2' ' B' ' 33' ' ' ASP . 71.5 p -124.53 155.83 68.57 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 -15.19 42.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.778 2.318 . . . . 0.0 112.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.53 9.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.636 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . 0.685 ' HB2' ' HG1' ' B' ' 30' ' ' THR . 0.1 OUTLIER -125.17 150.55 46.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -86.32 130.06 34.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.224 0.535 . . . . 0.0 110.743 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.464 ' HB3' HG12 ' B' ' 29' ' ' VAL . 32.9 p90 -144.0 152.22 40.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' B' ' 48' ' ' LEU . 74.9 t -129.78 139.92 50.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 57.6 mt -101.09 116.84 45.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.623 0.725 . . . . 0.0 109.697 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -112.76 91.0 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.304 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.12 -4.37 86.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.44 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.93 4.33 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.87 143.04 27.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 110.308 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.474 HG12 HG12 ' B' ' 37' ' ' ILE . 81.3 mt -97.26 129.12 47.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.237 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.03 129.46 75.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.72 131.23 50.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.532 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 2.3 tmm_? -70.42 0.97 5.58 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -167.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.28 -7.21 57.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.436 0.636 . . . . 0.0 109.85 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -129.15 20.16 5.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.647 HD13 ' HB ' ' B' ' 36' ' ' VAL . 58.9 tp -71.4 -38.37 71.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.992 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.5 -44.61 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.98 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.68 -46.09 87.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.009 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -68.85 -32.88 72.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.04 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.9 mt -72.92 -28.51 62.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.615 0.245 . . . . 0.0 110.925 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.626 HH21 ' HG2' ' B' ' 54' ' ' GLU . 6.7 ttp180 -64.12 -41.53 97.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.234 0.54 . . . . 0.0 110.012 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.626 ' HG2' HH21 ' B' ' 53' ' ' ARG . 49.5 mt-10 -91.0 -51.02 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.876 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.407 HE21 ' HG2' ' B' ' 59' ' ' GLU . 7.2 tp60 -94.5 -54.46 3.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.435 0.16 . . . . 0.0 111.376 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.8 tp 74.82 33.54 0.77 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 -11.04 60.74 Favored Glycine 0 C--O 1.235 0.18 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.602 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -105.47 110.1 22.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.606 0.241 . . . . 0.0 111.3 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.407 ' HG2' HE21 ' B' ' 55' ' ' GLN . 0.0 OUTLIER -92.07 102.12 14.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.56 110.02 21.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.06 -171.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.93 97.39 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 111.264 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -85.38 162.94 18.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.79 10.68 2.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 111.131 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -82.95 76.93 9.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.84 -9.83 19.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.772 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 66.33 11.56 8.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.482 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -80.29 -6.41 57.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -116.13 25.15 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.349 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -66.87 167.97 10.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.407 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -57.65 97.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.76 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.32 2.66 7.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.218 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.483 -179.824 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.5 -24.34 34.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 121.422 0.63 . . . . 0.0 109.938 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.71 142.93 36.84 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -95.25 116.16 66.08 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.66 112.48 1.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.455 2.104 . . . . 0.0 110.803 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.17 92.61 0.56 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -88.52 60.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.765 0.793 . . . . 0.0 108.893 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 pt -129.11 150.04 34.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.07 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -94.28 155.79 16.84 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -67.99 -179.74 1.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.652 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -46.08 121.55 3.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 112.439 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -91.42 68.05 5.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.923 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.1 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -167.35 94.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.789 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -87.14 -78.73 0.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.389 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m 66.73 157.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -79.88 93.35 5.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 m -89.77 -58.29 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.196 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.56 76.52 9.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.058 0.456 . . . . 0.0 111.199 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.14 97.3 5.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.452 ' NE2' HD11 ' A' ' 42' ' ' ILE . 10.6 pt20 -108.21 159.37 16.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.474 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 23' ' ' ASP . 26.7 mt -130.53 156.49 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 22' ' ' ILE . 7.7 p-10 -77.83 -167.7 1.05 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -75.37 -31.76 60.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.443 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.21 -19.19 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.523 -174.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.28 50.12 2.67 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.404 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -99.64 -94.89 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -179.49 123.87 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.85 106.84 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.774 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.8 p -93.24 158.28 37.45 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HB2' HD23 ' B' ' 65' ' ' LEU . 27.9 Cg_exo -62.98 1.29 1.19 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.689 2.259 . . . . 0.0 113.18 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -98.8 -4.44 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.349 0.595 . . . . 0.0 109.928 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.47 ' O ' ' HD1' ' A' ' 35' ' ' TYR . 52.0 m-20 -108.64 120.44 42.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.706 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.11 126.24 27.48 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.949 0.404 . . . . 0.0 110.717 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 33' ' ' ASP . 38.9 p90 -146.35 168.0 22.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 0.0 110.902 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' B' ' 60' ' ' PHE . 75.4 t -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.75 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 24.4 mt -106.16 122.06 59.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 56' ' ' LEU . 10.2 t70 -94.06 86.77 5.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.708 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . 78.52 -42.52 2.22 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.021 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.27 -30.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.47 145.6 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.21 0.529 . . . . 0.0 110.472 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.452 HD11 ' NE2' ' A' ' 21' ' ' GLN . 66.3 mt -102.57 136.85 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.006 -172.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.434 ' HB ' HD12 ' A' ' 48' ' ' LEU . 2.6 mp -138.41 129.53 36.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 175.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.07 150.52 24.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.252 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.05 -5.93 25.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.403 178.005 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -55.73 15.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 110.188 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.64 25.25 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.143 0.973 . . . . 0.0 109.138 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 36.1 tp -56.0 -50.18 71.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.164 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.67 -28.51 69.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.571 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.415 ' NH2' ' HD2' ' A' ' 53' ' ' ARG . 1.1 tpm_? -64.24 -49.27 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 110.265 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 33.4 t80 -75.68 -24.57 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.939 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.742 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 50.6 mt -69.69 -26.64 64.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HD2' ' NH2' ' A' ' 50' ' ' ARG . 18.4 ttm180 -86.02 -19.5 30.24 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 1.1 tp10 -79.16 -54.09 6.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.18 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.613 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 30.2 tt0 -103.14 -67.69 0.87 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.559 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.742 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.1 tt 33.03 47.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.689 0.757 . . . . 0.0 109.716 -168.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.613 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -118.7 -18.09 4.92 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.733 -170.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 10.6 m-85 53.55 -151.54 0.33 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.628 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 21.1 mt-10 -119.64 102.13 8.4 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.919 166.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -84.36 119.87 25.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.628 ' HZ1' ' HB3' ' A' ' 59' ' ' GLU . 46.0 mmtm -117.57 102.58 9.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 111.599 -177.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 64' ' ' GLN . 91.9 m-20 -79.37 160.54 26.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.721 174.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 65' ' ' LEU . . . -73.34 32.56 0.07 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER 70.8 -39.75 0.46 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.592 0.757 . . . . 0.0 110.768 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' A' ' 63' ' ' ALA . 43.2 tp -58.56 102.54 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.903 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.92 74.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 61.99 20.5 11.61 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.732 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -116.96 114.65 24.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.146 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -141.23 126.38 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' HB2' ' H ' ' A' ' 71' ' ' HIS . 11.1 m170 63.54 -88.17 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -166.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.419 ' H ' ' HB2' ' A' ' 70' ' ' HIS . 55.3 m80 -147.58 -72.65 0.21 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 167.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.02 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -83.53 96.24 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.737 0.779 . . . . 0.0 110.184 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.43 72.72 5.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.251 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -136.59 103.64 9.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.37 99.24 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.361 2.04 . . . . 0.0 111.766 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 83.4 mtp -86.17 -78.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.626 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.55 120.28 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.022 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.98 130.66 37.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.169 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.724 ' HB2' ' HE3' ' B' ' 11' ' ' TRP . 9.3 p30 -74.4 141.81 45.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.22 0.533 . . . . 0.0 110.763 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -86.08 -1.6 57.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.464 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . 0.724 ' HE3' ' HB2' ' B' ' 9' ' ' ASN . 32.0 m-90 -80.98 -9.72 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.553 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 37.0 m80 72.82 -68.89 0.21 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.831 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -154.49 -46.75 0.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.435 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -149.17 166.3 29.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.692 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.55 70.04 1.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 171.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 29.5 m -82.84 -29.91 29.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.726 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.97 -67.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.983 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 62.4 p 56.48 147.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 112.856 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.13 -31.89 63.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.72 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t 55.82 76.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.355 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.504 ' OE1' HD13 ' B' ' 42' ' ' ILE . 3.5 pp0? -93.33 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.653 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -126.75 147.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.801 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' B' ' 29' ' ' VAL . 5.3 p-10 -86.18 -164.41 1.04 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.08 0.467 . . . . 0.0 110.761 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -68.28 -28.96 67.64 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.26 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -59.76 -44.24 93.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.675 0.274 . . . . 0.0 111.008 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.22 33.21 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.029 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.3 -84.84 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.715 0.293 . . . . 0.0 110.342 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -169.55 142.2 2.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' B' ' 23' ' ' ASP . 22.0 t -123.65 86.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.676 0.75 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.436 ' C ' ' H ' ' B' ' 32' ' ' VAL . 0.1 OUTLIER -81.29 153.85 71.71 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.093 175.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.06 12.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 123.4 2.734 . . . . 0.0 114.787 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' B' ' 30' ' ' THR . 33.9 m -103.21 -5.55 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.048 0.451 . . . . 0.0 110.282 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.35 155.81 17.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.267 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.618 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 5.3 m-20 -89.81 118.61 29.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.542 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -144.24 160.59 40.72 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.703 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.61 146.87 31.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.601 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mt -103.02 100.02 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.75 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 7.8 m-20 -96.54 90.8 5.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.463 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.597 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 72.49 37.1 58.61 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.516 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.62 -26.27 23.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.595 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.23 142.54 27.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.769 0.319 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.504 HD13 ' OE1' ' B' ' 21' ' ' GLN . 76.7 mt -100.49 128.43 52.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.424 ' N ' HD12 ' B' ' 43' ' ' ILE . 4.3 mp -126.46 126.8 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.302 . . . . 0.0 110.422 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.515 HD23 ' HG2' ' B' ' 46' ' ' GLU . 1.1 tt -69.37 134.69 49.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.618 ' HE ' ' HB3' ' B' ' 34' ' ' ASP . 15.6 mtm180 -69.25 0.53 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.515 ' HG2' HD23 ' B' ' 44' ' ' LEU . 42.6 mm-40 -69.05 -18.05 63.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.893 0.378 . . . . 0.0 110.387 171.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -129.24 3.5 5.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.196 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 61.4 tp -57.74 -33.21 68.22 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.159 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 30.6 mt-10 -57.4 -52.66 64.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.779 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.513 ' HA ' ' HD3' ' B' ' 53' ' ' ARG . 7.4 mpt_? -71.14 -31.56 67.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -65.72 -39.38 91.11 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.337 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -69.38 -29.32 67.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.513 ' HD3' ' HA ' ' B' ' 50' ' ' ARG . 32.4 mtp180 -65.7 -32.71 74.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -94.45 -62.48 1.32 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.77 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -85.5 -42.2 14.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.051 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.6 tp 74.11 13.42 4.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.142 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.75 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 88.28 -29.03 5.82 Favored Glycine 0 CA--C 1.517 0.169 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.487 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -69.85 126.05 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.581 0.229 . . . . 0.0 111.107 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.1 tp10 -92.77 101.88 14.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.51 ' HA ' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.31 86.0 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -84.08 93.64 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 0.0 110.658 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -66.1 126.44 28.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.742 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.58 64.59 8.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 110.541 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -76.52 -56.16 4.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.39 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.572 HD23 ' HB2' ' A' ' 31' ' ' PRO . 24.4 tp 52.52 69.68 0.66 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.141 174.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.9 102.81 4.88 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.967 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.504 ' HB3' ' H ' ' B' ' 68' ' ' HIS . 1.3 m-70 -98.6 -153.07 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.169 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.504 ' H ' ' HB3' ' B' ' 67' ' ' HIS . 85.5 m-70 -83.58 36.17 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.094 0.473 . . . . 0.0 110.886 -173.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -137.55 48.73 2.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.08 0.466 . . . . 0.0 110.503 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -77.61 -35.19 53.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -89.8 130.82 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.273 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 22.5 p80 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.356 174.744 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.922 0.391 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.53 23.2 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -74.79 139.82 43.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.579 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -141.75 156.78 65.86 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.84 102.27 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.5 2.133 . . . . 0.0 111.147 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 68.3 mtm -74.97 108.33 7.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.339 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.15 144.94 22.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.81 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.95 155.93 8.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.352 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -139.76 99.81 3.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -162.85 170.99 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.565 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -90.68 19.84 5.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -171.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -129.78 140.67 51.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.855 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -133.08 92.01 2.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.74 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -133.74 86.52 2.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 tp -80.27 -31.89 38.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 69.89 156.73 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.01 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.848 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 23.6 mt-10 -89.03 103.42 16.04 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.975 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.6 p -64.6 -78.27 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.141 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -88.97 -5.67 57.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.41 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 17' ' ' GLU . 6.1 t -84.29 117.56 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -175.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.0 159.68 41.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.347 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 23' ' ' ASP . 20.8 mt -134.03 153.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.647 0.261 . . . . 0.0 110.377 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.8 p-10 -80.44 -177.77 6.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 110.78 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.62 -28.14 69.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.848 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -86.61 -17.24 34.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 37.43 6.96 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.746 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 t70 -90.84 -88.39 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.9 tt0 174.69 138.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.8 116.93 28.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.033 0.444 . . . . 0.0 110.338 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.765 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 60.5 p -110.05 172.8 3.31 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.999 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.765 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 42.6 Cg_endo -68.48 2.3 2.97 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.313 2.009 . . . . 0.0 112.197 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.34 14.04 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.548 0.69 . . . . 0.0 109.449 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' HB3' HD11 ' A' ' 44' ' ' LEU . 41.9 m-20 -118.69 146.62 44.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.207 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.01 118.26 30.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HB3' HD13 ' A' ' 44' ' ' LEU . 31.0 p90 -144.02 168.01 21.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.486 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.667 ' HB ' HD12 ' A' ' 48' ' ' LEU . 72.0 t -131.51 133.68 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 ' O ' ' HA2' ' B' ' 39' ' ' GLY . 61.1 mt -103.52 121.96 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.323 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -93.13 86.2 5.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.339 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.537 ' C ' ' HG3' ' A' ' 59' ' ' GLU . . . 78.31 -31.56 1.85 Allowed Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.35 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.43 -23.0 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.14 130.56 35.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.3 mt -89.76 129.14 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.567 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.6 mp -133.98 122.73 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 35' ' ' TYR . 13.9 tp -64.8 149.76 48.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -23.42 32.47 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -81.54 -22.92 37.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 110.59 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -112.9 4.25 16.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.298 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.667 HD12 ' HB ' ' A' ' 36' ' ' VAL . 29.3 tp -70.68 -60.68 2.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 35.1 mt-10 -61.93 -16.18 49.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -165.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 53' ' ' ARG . 19.2 tpt180 -80.99 -49.91 10.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.225 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' HD2' HG12 ' A' ' 43' ' ' ILE . 16.1 t80 -63.75 -43.27 96.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 14.9 mt -63.82 -41.36 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 40.0 ttm-85 -52.04 -46.53 65.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.845 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.01 -25.26 23.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 29.0 tt0 -99.47 -68.08 0.82 Allowed 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.423 -0.798 . . . . 0.0 112.048 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 65.5 mt 42.27 43.99 3.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.317 0.58 . . . . 0.0 109.71 -169.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -100.8 -14.33 32.04 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.277 -168.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 57.22 -151.59 0.41 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.537 ' HG3' ' C ' ' A' ' 39' ' ' GLY . 2.3 mt-10 -118.22 102.16 8.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 163.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.37 103.55 12.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.078 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -109.04 37.83 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.305 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -55.71 119.38 5.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.775 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.95 52.71 2.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -61.52 -39.54 91.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.624 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 24.3 tp 69.63 133.78 0.03 OUTLIER 'General case' 0 C--N 1.338 0.078 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.691 171.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.06 11.69 15.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.513 0.673 . . . . 0.0 110.116 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.624 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 33.2 m170 -117.25 96.54 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.885 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -111.8 101.11 9.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.37 110.69 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.964 -174.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -142.91 -174.81 4.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.073 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -75.33 74.89 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.785 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.331 175.543 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.453 ' HB3' ' H ' ' B' ' 2' ' ' VAL . 1.2 mpt? . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.453 ' H ' ' HB3' ' B' ' 1' ' ' MET . 33.8 m -91.24 157.98 2.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.631 . . . . 0.0 112.326 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' B' ' 3' ' ' GLU . 7.9 tp10 -85.99 5.44 33.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.534 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 t30 66.6 88.26 0.11 Allowed Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.674 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.55 98.17 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.122 2.548 . . . . 0.0 112.922 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' MET . . . . . 0.613 ' HG3' HG22 ' B' ' 7' ' ' VAL . 26.3 ptt? -119.42 -25.02 6.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.613 HG22 ' HG3' ' B' ' 6' ' ' MET . 47.1 t -122.89 131.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.338 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 tt -112.4 107.5 23.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.406 0.622 . . . . 0.0 110.346 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -90.72 118.37 30.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.626 0.726 . . . . 0.0 110.756 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.65 5.43 31.15 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -142.65 131.45 22.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.383 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -91.66 120.07 32.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.083 0.468 . . . . 0.0 111.1 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.29 -6.25 56.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.295 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -97.67 17.14 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -78.7 -42.23 28.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.786 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.9 p -124.81 171.83 9.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.736 0.303 . . . . 0.0 111.475 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' B' ' 17' ' ' GLU . 2.1 pm0 -79.13 -176.43 5.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 0.0 111.59 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.0 m -99.56 -126.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.742 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -107.99 70.98 0.79 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.405 0.622 . . . . 0.0 109.528 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.66 131.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.712 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.602 HE21 HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.99 -172.9 4.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.362 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' B' ' 28' ' ' GLU . 41.0 mt -126.7 150.04 32.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.6 OUTLIER -83.11 -170.08 2.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.796 0.332 . . . . 0.0 110.285 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.07 -27.25 62.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.76 0.424 . . . . 0.0 111.021 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . 0.408 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 29.1 t80 -76.61 -30.59 56.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.75 30.08 5.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.188 -1.005 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -111.65 132.33 54.66 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.467 ' HA ' HG12 ' B' ' 22' ' ' ILE . 26.1 tt0 -64.71 124.18 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.334 0.588 . . . . 0.0 110.598 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' B' ' 35' ' ' TYR . 42.9 t -104.47 129.94 56.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.814 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 72.0 p -118.89 175.69 2.03 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.827 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_endo -64.47 5.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.392 2.062 . . . . 0.0 113.207 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' B' ' 30' ' ' THR . 3.6 t -116.1 18.53 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.576 0.703 . . . . 0.0 109.418 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -129.1 125.81 37.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.366 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.38 109.76 2.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.211 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.413 ' HB3' HG13 ' B' ' 29' ' ' VAL . 16.6 p90 -135.88 149.13 48.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.159 0.504 . . . . 0.0 110.197 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.87 142.59 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.21 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.5 mt -102.93 115.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.524 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -94.63 89.06 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.518 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 83.0 -26.65 4.2 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.642 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.32 -26.25 0.35 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.44 129.55 34.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.602 HG21 HE21 ' B' ' 21' ' ' GLN . 64.3 mt -93.1 136.6 24.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.686 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -136.44 133.96 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.419 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -69.05 143.75 54.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.626 ' HD3' HD22 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -57.23 -20.71 28.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -172.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.43 -29.93 62.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.1 0.476 . . . . 0.0 110.708 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -106.92 -12.62 15.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.604 0.716 . . . . 0.0 109.773 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.626 HD22 ' HD3' ' B' ' 45' ' ' ARG . 31.5 tp -60.67 -52.01 66.93 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.959 -175.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.31 -37.31 80.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.323 0.582 . . . . 0.0 110.236 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 23.8 tpt85 -64.58 -53.55 46.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.234 176.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.67 -36.54 76.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.996 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 66.7 mt -63.66 -47.32 81.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.912 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 14.1 ptt85 -63.22 -28.46 70.05 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.242 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.57 -36.84 17.32 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.665 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.2 tp-100 -103.04 -68.19 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 27.1 mt 38.5 40.57 0.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.504 0.502 . . . . 0.0 110.723 -167.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.665 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -107.06 -13.72 20.73 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.306 -167.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 57.75 -154.93 0.34 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.66 102.03 9.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.306 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.55 99.86 11.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -92.43 91.6 7.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.111 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.0 128.56 36.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.828 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.96 -11.02 60.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.365 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 54.51 78.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.814 0.816 . . . . 0.0 110.119 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp -156.42 151.73 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.634 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.59 55.67 1.68 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.219 0.533 . . . . 0.0 110.978 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -80.69 73.65 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.622 0.725 . . . . 0.0 109.761 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -75.8 112.66 12.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.097 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -69.46 -22.45 63.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.192 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -68.52 95.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.684 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -165.87 135.9 3.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.966 0.412 . . . . 0.0 110.977 -172.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 C--O 1.245 0.855 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.777 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.91 75.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.649 0.737 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.19 134.91 33.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.51 66.83 2.36 Favored Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 123.691 0.62 . . . . 0.0 110.157 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.29 -23.33 33.08 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.095 2.53 . . . . 0.0 113.002 -172.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 42.3 tpp -155.82 149.79 25.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.61 156.76 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.871 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -108.19 135.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -154.32 -85.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.859 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.42 HD22 HD21 ' A' ' 15' ' ' LEU . 3.3 p-10 -175.58 147.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -132.83 137.33 46.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.991 0.424 . . . . 0.0 110.782 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -155.84 139.86 16.38 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -51.01 -59.21 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -108.38 105.02 14.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD21 HD22 ' A' ' 10' ' ' ASN . 1.4 tm? -62.02 116.63 5.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.557 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -120.08 -30.93 4.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 0.0 109.316 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.84 98.8 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.422 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 m -92.84 -54.47 3.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.408 0.623 . . . . 0.0 110.425 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.15 70.84 10.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.459 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 89.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.732 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.404 ' NE2' HG22 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -115.94 141.05 48.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.582 -178.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 23' ' ' ASP . 27.8 mt -99.62 161.23 3.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 3.2 p-10 -79.35 -167.12 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -77.38 -31.37 54.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.734 0.302 . . . . 0.0 111.591 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -80.03 -31.96 39.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.66 39.99 1.52 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.635 -1.269 . . . . 0.0 113.067 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.02 -110.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -174.38 124.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.54 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -105.19 165.12 13.74 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.089 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.73 1.65 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.289 2.66 . . . . 0.0 114.304 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.22 17.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -112.99 138.16 50.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.215 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.44 116.07 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -133.56 166.99 21.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.774 ' HB ' HD21 ' A' ' 48' ' ' LEU . 92.3 t -135.63 138.38 48.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.0 mt -106.44 114.05 44.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 52.6 t0 -95.44 87.74 4.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.21 0.529 . . . . 0.0 110.373 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.735 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 81.29 -11.64 42.87 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.264 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -22.4 1.56 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -83.89 130.16 34.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.404 HG22 ' NE2' ' A' ' 21' ' ' GLN . 81.4 mt -89.11 131.04 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.383 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.5 mp -134.8 136.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -74.1 146.12 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.555 ' N ' HD21 ' A' ' 44' ' ' LEU . 2.0 mmt180 -56.47 -21.52 26.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.51 -40.56 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.943 0.401 . . . . 0.0 110.024 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -89.18 -1.35 58.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 110.447 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.774 HD21 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -64.14 -40.6 96.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.02 -55.56 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.666 -174.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -64.53 -35.23 80.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.596 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -46.75 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' A' ' 48' ' ' LEU . 87.7 mt -66.35 -26.43 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -73.79 -33.72 64.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.687 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.68 -51.04 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 12.8 tt0 -90.47 -68.36 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.492 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 38.74 35.56 0.12 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.792 0.682 . . . . 0.0 110.763 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -136.73 10.44 3.98 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.145 -171.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 1.3 m-85 58.34 -158.65 0.29 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.235 0.54 . . . . 0.0 110.882 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.6 tp10 -100.88 102.02 12.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.03 90.48 4.91 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.916 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 73.5 mmtt -86.64 147.12 26.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.521 -175.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -119.22 141.78 48.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -10.69 58.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.768 0.318 . . . . 0.0 111.066 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 61.75 42.66 10.45 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.484 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.47 26.03 9.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.344 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.39 93.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.022 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.66 55.5 1.87 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.832 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -103.54 92.07 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.206 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -123.56 18.33 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -91.51 97.9 11.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.624 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -121.86 -3.97 9.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 167.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.021 174.832 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -86.38 85.16 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.0 -25.31 20.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.555 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.04 152.26 79.43 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.436 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.49 48.85 1.04 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.612 2.875 . . . . 0.0 112.406 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -92.2 -4.65 53.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.184 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 t -82.87 84.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.362 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 34.6 pt -85.38 -11.85 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.623 -176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 66.49 112.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.805 0.691 . . . . 0.0 110.789 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' B' ' 13' ' ' ASP . 65.2 t30 -79.28 125.13 29.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.194 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -81.66 -19.22 42.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.472 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -153.93 106.42 2.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' B' ' 10' ' ' ASN . 32.2 m-20 -77.0 169.74 17.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -82.27 43.12 0.78 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.916 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' B' ' 13' ' ' ASP . 3.5 mm? -71.06 128.17 35.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.158 0.504 . . . . 0.0 110.525 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -76.09 157.58 32.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.642 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 41.97 66.7 0.67 Allowed 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.069 0.855 . . . . 0.0 112.587 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 11.1 m -69.12 -59.3 3.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.284 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -127.25 23.96 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 109.483 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.83 127.0 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.266 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -135.92 172.39 13.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.367 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.439 HG23 HD11 ' B' ' 22' ' ' ILE . 11.9 mt -130.68 146.31 34.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 178.67 7.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -63.81 -26.15 68.5 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.734 0.414 . . . . 0.0 111.79 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.65 -2.06 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.67 17.32 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.736 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.36 128.66 39.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -72.57 99.69 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.0 t -86.61 114.64 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.517 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 78.3 p -102.61 172.85 3.94 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.011 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 77.1 Cg_exo -49.56 -22.47 6.52 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.224 2.616 . . . . 0.0 114.331 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.95 6.81 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -101.77 123.39 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -69.19 121.79 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.256 -179.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 26.0 p90 -144.66 161.14 39.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.909 0.385 . . . . 0.0 110.988 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' B' ' 48' ' ' LEU . 54.4 t -135.09 143.73 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.577 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 48.9 mt -109.32 115.93 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 111.223 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.07 90.11 6.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 109.529 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.735 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 81.97 -34.12 2.6 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.282 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.69 -24.7 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -174.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -82.59 134.57 35.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.074 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 69.1 mt -92.52 129.57 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.827 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.01 122.52 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.51 141.37 47.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.518 ' HG3' ' OD2' ' B' ' 34' ' ' ASP . 30.3 mmm-85 -60.81 -12.07 9.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -67.99 -47.06 69.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.71 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -103.17 -3.66 25.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.973 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' B' ' 36' ' ' VAL . 37.4 tp -47.86 -41.92 25.31 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.662 -173.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -53.98 -44.61 70.97 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.808 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -74.67 -41.29 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -65.16 -45.16 86.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.447 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 35.2 mt -69.84 -24.84 63.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.199 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -68.15 -44.25 76.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.558 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -93.81 -30.33 14.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.554 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp-100 -99.34 -67.55 0.84 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.09 37.89 1.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.439 0.638 . . . . 0.0 109.607 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.554 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -116.62 1.04 20.23 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.819 -165.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.68 -150.91 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.773 0.787 . . . . 0.0 109.377 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -115.04 101.79 9.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.33 96.57 10.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.31 86.16 2.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.512 0.673 . . . . 0.0 111.072 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -67.93 169.49 9.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.839 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.443 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -77.05 13.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 62.47 14.93 7.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.975 0.417 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 93.0 mt -75.73 135.56 40.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.154 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -56.11 -39.68 72.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.037 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -71.37 -42.66 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.312 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' B' ' 71' ' ' HIS . 20.0 m80 67.42 141.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.869 0.731 . . . . 0.0 111.926 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.15 -43.48 52.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -108.6 88.58 2.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' B' ' 68' ' ' HIS . 76.6 t60 -121.83 130.15 53.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.947 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 44.6 m80 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.703 171.554 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.23 69.89 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.978 0.895 . . . . 0.0 109.897 176.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.1 132.15 11.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.983 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.4 p-10 -157.32 164.67 20.8 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.376 -173.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 4' ' ' ASN . 95.1 Cg_endo -85.51 -168.11 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.023 175.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -155.97 -166.51 2.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 p -65.39 99.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.494 0.664 . . . . 0.0 109.706 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.7 mt -84.59 123.77 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -79.89 116.46 20.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.484 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -81.41 -168.96 2.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 59.99 59.28 2.46 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -144.54 115.82 8.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.44 -36.58 63.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.182 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -132.96 152.7 51.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.967 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.94 75.81 8.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.6 p 53.68 -168.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.788 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -101.48 -22.37 14.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.3 m 72.66 -65.96 0.33 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.468 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -88.28 89.22 7.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.24 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t -131.71 137.12 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.476 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.518 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -116.53 116.11 27.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.549 0.69 . . . . 0.0 110.387 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.17 142.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -63.08 -170.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.151 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -73.81 -31.64 63.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.455 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -72.17 -36.69 69.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 109.952 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 24.32 7.55 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.003 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 6.7 t70 -80.5 -81.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 40.3 tt0 163.92 123.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.809 0.693 . . . . 0.0 110.299 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 35' ' ' TYR . 9.4 t -113.35 134.89 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -111.47 153.93 43.99 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.201 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.62 1.73 2.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.0 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.14 -3.8 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.503 0.668 . . . . 0.0 109.46 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.38 179.39 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -111.7 128.98 56.24 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.473 ' HB3' HG12 ' A' ' 29' ' ' VAL . 36.8 p90 -141.46 167.47 22.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.136 0.493 . . . . 0.0 110.691 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.968 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 96.2 t -136.62 138.29 46.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.8 113.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.214 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 40' ' ' GLY . 11.8 t0 -88.22 88.6 7.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.137 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.514 ' O ' HG23 ' B' ' 37' ' ' ILE . . . 73.95 -27.65 0.95 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.423 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 165.43 -22.05 0.13 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -82.49 145.93 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.107 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 21' ' ' GLN . 83.5 mt -98.51 131.21 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.455 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HB ' HD21 ' A' ' 48' ' ' LEU . 1.7 mp -139.69 130.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 45' ' ' ARG . 5.6 tt -63.13 143.22 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.438 ' N ' HD23 ' A' ' 44' ' ' LEU . 10.5 mmm-85 -51.06 -23.28 2.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.83 -29.96 35.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.067 0.46 . . . . 0.0 110.808 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.81 -12.7 18.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.431 0.634 . . . . 0.0 109.911 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.968 ' HG ' ' HB ' ' A' ' 36' ' ' VAL . 2.8 tm? -61.68 -37.12 82.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.845 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -54.76 -52.4 62.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HE ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 ttm180 -76.34 -20.66 57.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -76.43 -30.7 57.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.021 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 56' ' ' LEU . 64.8 mt -67.72 -32.76 73.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.272 0.558 . . . . 0.0 109.667 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -61.38 -35.13 76.65 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -74.99 -64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.182 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -103.27 -59.22 1.75 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.8 tp 89.45 39.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.101 0.96 . . . . 0.0 112.117 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' B' ' 57' ' ' GLY . . . 72.39 57.67 5.44 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.449 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -155.2 120.22 4.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.123 0.461 . . . . 0.0 112.102 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.53 ' CB ' ' HB ' ' B' ' 37' ' ' ILE . 3.1 mm-40 -101.45 101.7 12.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 160.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.75 109.51 19.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.298 -168.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -121.42 174.63 6.63 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -165.12 169.95 15.56 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 65' ' ' LEU . . . -73.07 -2.97 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.192 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 69.89 -46.62 0.6 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.586 0.754 . . . . 0.0 109.44 -171.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 63' ' ' ALA . 60.4 tp -81.12 77.75 7.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.435 171.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -72.07 -1.71 15.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -68.73 -2.49 9.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.011 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -74.01 -5.52 41.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.718 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -89.31 91.19 8.65 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -122.43 109.48 14.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -168.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -84.1 -33.05 24.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 158.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.276 170.621 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.15 169.19 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.746 0.308 . . . . 0.0 110.724 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.76 150.05 26.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.175 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 21.9 p-10 -85.28 128.7 58.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.828 0.347 . . . . 0.0 110.178 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 16.0 Cg_exo -69.08 175.08 8.0 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.962 2.441 . . . . 0.0 112.139 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 46.3 ttm -78.22 108.08 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.14 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.06 114.09 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.11 97.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.535 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 51.9 t30 55.2 74.03 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.32 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -87.98 -52.46 5.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -94.19 130.06 40.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.665 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.12 126.3 34.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 111.089 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -130.74 174.59 9.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -148.53 156.01 41.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 pp -85.73 158.99 19.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.871 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -66.17 132.13 47.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.279 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.82 -63.08 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.993 -171.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.402 ' C ' ' H ' ' B' ' 20' ' ' VAL . 4.9 m -94.04 -17.67 22.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.478 0.656 . . . . 0.0 110.619 -177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.97 37.72 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' B' ' 18' ' ' THR . 17.3 t -88.27 109.08 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.41 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 13.6 pt20 -93.21 132.78 37.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.164 0.507 . . . . 0.0 111.284 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.455 HD13 HG21 ' B' ' 22' ' ' ILE . 24.2 mt -103.25 151.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 0.5 OUTLIER -85.09 -177.91 6.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.62 -25.0 67.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.807 0.443 . . . . 0.0 111.82 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -89.65 -18.02 27.28 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.51 13.59 27.82 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.633 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.72 129.45 36.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.32 99.59 4.14 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.513 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 46.5 t -81.38 101.16 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.44 0.638 . . . . 0.0 111.189 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 21.9 p -86.06 163.12 44.33 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.471 174.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 50.5 Cg_endo -68.82 20.33 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.933 2.422 . . . . 0.0 113.37 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' B' ' 30' ' ' THR . 7.0 t -116.67 1.01 8.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.109 0.481 . . . . 0.0 109.994 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -121.83 170.15 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -92.66 124.89 37.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.576 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.458 ' HB3' HG12 ' B' ' 29' ' ' VAL . 18.5 p90 -136.73 146.22 45.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.97 0.414 . . . . 0.0 110.64 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.67 138.95 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 36.8 mt -99.86 113.62 35.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-O 121.628 0.727 . . . . 0.0 109.83 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -106.87 90.17 3.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.653 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' B' ' 59' ' ' GLU . . . 81.51 12.01 82.4 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.421 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.38 -30.46 4.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -97.51 150.29 21.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.331 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 72.9 mt -89.76 140.79 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.176 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.439 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.3 mp -134.41 129.9 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.506 HD11 HG22 ' B' ' 29' ' ' VAL . 3.9 tt -72.18 137.8 47.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HG2' HD22 ' B' ' 48' ' ' LEU . 12.3 mtm180 -70.85 0.32 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.92 -15.26 56.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.23 3.21 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.278 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.591 ' HG ' ' HG ' ' B' ' 52' ' ' LEU . 28.1 tp -73.24 -34.89 66.13 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -170.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -51.59 -41.49 61.23 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' B' ' 53' ' ' ARG . 7.6 ttm180 -77.55 -33.31 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -71.01 -38.21 72.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.591 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 58.0 mt -67.34 -29.15 68.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.164 0.506 . . . . 0.0 110.072 172.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' B' ' 50' ' ' ARG . 18.6 ttm180 -65.77 -28.19 68.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -70.01 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.647 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' B' ' 56' ' ' LEU . 2.4 pt20 -104.23 -48.63 3.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' B' ' 55' ' ' GLN . 29.0 tp 82.36 42.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.918 0.761 . . . . 0.0 111.224 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 57' ' ' GLY . . . 95.3 -20.57 48.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.763 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -87.58 107.39 18.57 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -174.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.596 ' CG ' ' HA3' ' B' ' 39' ' ' GLY . 3.0 mm-40 -101.63 102.24 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.147 0.498 . . . . 0.0 110.679 171.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -89.62 123.05 33.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.454 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -127.12 79.89 1.91 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 111.013 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -75.12 162.55 28.42 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' B' ' 65' ' ' LEU . . . -58.36 -36.34 73.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.485 0.183 . . . . 0.0 111.35 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.06 -13.45 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' B' ' 63' ' ' ALA . 53.7 tp -86.02 90.8 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.18 44.69 0.88 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.013 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -74.89 -14.16 60.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.81 107.44 9.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 171.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -104.93 -62.67 1.31 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.321 . . . . 0.0 111.498 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -156.03 152.61 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -90.9 108.14 19.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.127 177.391 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.652 0.263 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.85 -30.3 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.954 0.407 . . . . 0.0 110.333 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.529 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 43.7 mt-10 -102.85 135.35 44.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.451 172.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.24 103.38 17.63 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 0.0 110.447 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 3' ' ' GLU . 4.1 Cg_exo -80.84 105.42 1.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.965 2.443 . . . . 0.0 111.393 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.5 ptp -104.12 10.27 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.733 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.4 99.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm 64.75 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.616 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -154.9 -82.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.609 0.719 . . . . 0.0 109.427 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -167.78 -49.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -97.23 162.48 13.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.188 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -125.81 15.88 8.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 14' ' ' LYS . 9.3 t70 -90.26 -161.16 0.76 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.638 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 83.0 tttt -96.18 9.02 42.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.788 0.804 . . . . 0.0 109.073 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 18' ' ' THR . 7.1 tt -73.38 112.03 9.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.614 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 p -89.28 -58.92 2.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.856 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -94.34 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.521 ' HA ' HD23 ' A' ' 15' ' ' LEU . 57.2 m -158.82 -72.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.827 0.346 . . . . 0.0 110.271 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.91 30.55 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.951 0.881 . . . . 0.0 109.145 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.82 102.79 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.51 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt20 -101.39 147.54 26.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.05 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.422 HG23 ' HA2' ' A' ' 26' ' ' GLY . 29.0 mt -123.17 153.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 6.4 p-10 -76.29 -164.89 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -78.78 -29.97 45.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.954 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HD2' HD21 ' A' ' 47' ' ' ASN . 65.5 m-85 -96.1 -7.57 35.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 22' ' ' ILE . . . 84.87 51.18 3.89 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.164 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 18.5 t70 -94.77 -86.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 35.1 tt0 167.89 135.36 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.312 1.045 . . . . 0.0 108.212 170.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.53 104.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 110.68 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.79 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 71.9 p -96.12 174.08 3.71 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.79 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.6 Cg_endo -66.05 4.24 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.15 1.9 . . . . 0.0 112.416 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 30' ' ' THR . 26.4 t -103.39 -18.23 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.133 177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -94.43 119.93 33.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.379 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.23 138.58 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.402 ' CD2' HG23 ' A' ' 42' ' ' ILE . 21.3 p90 -155.93 166.24 34.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.206 0.526 . . . . 0.0 111.136 -173.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.401 HG12 ' O ' ' B' ' 59' ' ' GLU . 69.4 t -135.07 145.79 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 20.1 mt -103.37 120.11 52.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 121.794 0.807 . . . . 0.0 110.82 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.438 ' HB3' HD13 ' A' ' 43' ' ' ILE . 26.2 t0 -105.93 90.28 3.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.607 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 77.9 20.13 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.09 42.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.77 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.71 139.17 34.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.7 mt -88.86 138.88 18.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.51 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -139.53 127.47 26.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.3 tt -62.88 148.62 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.815 HH11 HD22 ' A' ' 48' ' ' LEU . 8.2 mmm180 -61.89 -7.25 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.89 -55.39 3.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 0.0 110.725 175.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.494 HD21 ' HD2' ' A' ' 25' ' ' TYR . 15.0 p-10 -89.62 3.64 51.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.312 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.815 HD22 HH11 ' A' ' 45' ' ' ARG . 36.8 tp -61.16 -32.62 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.986 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -44.43 -54.32 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.301 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.49 ' NH2' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -68.77 -33.09 73.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.87 -172.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.574 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -76.18 -39.3 55.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.712 -176.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.5 mt -67.73 -22.28 65.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.794 0.807 . . . . 0.0 109.364 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.49 HH11 ' NH2' ' A' ' 50' ' ' ARG . 27.9 ttm180 -76.65 -25.17 53.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.264 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -90.16 -69.48 0.72 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.861 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.12 -16.16 15.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 30.3 tp 71.74 28.34 2.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 171.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 98.54 -8.51 62.09 Favored Glycine 0 C--N 1.321 -0.294 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.748 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.4 ' HE1' ' HA3' ' B' ' 57' ' ' GLY . 12.4 m-85 -117.1 129.76 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.078 0.439 . . . . 0.0 111.995 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.674 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 11.8 mt-10 -96.45 102.14 13.88 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 164.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -81.81 106.67 13.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.674 ' HE2' ' HB3' ' A' ' 59' ' ' GLU . 3.8 mptp? -108.68 80.61 1.35 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 109.766 174.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -83.75 146.47 28.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.227 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.95 79.11 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.375 0.607 . . . . 0.0 110.331 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.97 89.38 7.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.454 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mp -61.92 -83.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.017 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 54.05 20.9 2.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.366 0.603 . . . . 0.0 110.768 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -125.63 136.41 53.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.382 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 71.57 -54.67 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.926 0.766 . . . . 0.0 110.774 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -163.52 148.53 11.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -72.65 139.82 47.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -76.77 -60.1 2.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.943 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.951 -174.129 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 m 39.14 62.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 124.289 0.993 . . . . 0.0 112.216 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.63 -60.17 3.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.368 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 2.8 p-10 -176.27 144.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.824 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 4.6 Cg_exo -80.79 158.07 21.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.457 2.105 . . . . 0.0 110.375 170.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 48.9 tpp -81.74 84.32 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.342 0.591 . . . . 0.0 109.408 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.07 114.71 30.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.706 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mt -77.75 96.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -76.2 165.68 24.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -80.85 149.24 29.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -116.2 -33.15 5.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.795 0.331 . . . . 0.0 111.454 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -128.71 119.04 23.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.74 0.305 . . . . 0.0 111.229 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -108.67 -171.51 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -121.36 115.87 23.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.247 0.546 . . . . 0.0 112.178 -177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.74 137.98 35.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.146 170.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.473 HG23 ' O ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -73.52 -4.9 36.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.296 0.569 . . . . 0.0 111.433 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 71.35 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.884 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -157.61 -66.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.9 14.26 25.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.599 0.714 . . . . 0.0 110.241 -175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.473 ' O ' HG23 ' B' ' 16' ' ' THR . 4.8 t -108.79 130.99 60.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.479 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.456 ' OE1' HG23 ' B' ' 42' ' ' ILE . 3.0 pp0? -148.14 163.63 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.48 150.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.671 0.272 . . . . 0.0 110.964 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.37 -168.08 1.06 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -70.56 -29.01 65.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.74 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -86.04 -8.63 57.79 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.58 36.88 25.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.242 168.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 -92.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.423 0.611 . . . . 0.0 110.493 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -173.46 137.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -119.19 121.23 66.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.016 0.436 . . . . 0.0 110.14 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 57.3 p -102.42 168.81 8.38 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.84 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 33.4 Cg_endo -64.97 -4.03 8.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.58 2.186 . . . . 0.0 112.627 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.53 -2.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.304 0.573 . . . . 0.0 110.138 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -107.54 136.8 46.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.47 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -69.1 116.23 9.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.289 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.24 139.41 35.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 110.583 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.55 139.16 45.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 36.2 mt -91.18 96.69 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.822 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 95.2 m-20 -79.17 90.63 4.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.022 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.596 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 78.05 -17.66 5.81 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.971 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.39 -19.34 0.92 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 8.3 tp10 -93.02 144.67 25.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.456 HG23 ' OE1' ' B' ' 21' ' ' GLN . 80.2 mt -99.95 129.7 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.156 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.19 128.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.484 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 82.2 mt -54.52 141.35 31.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 23.8 mtm180 -71.65 0.52 8.52 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.584 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.03 -13.04 59.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -128.35 -0.62 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.153 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 36.2 tp -60.37 -40.35 90.5 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.826 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 27.4 tt0 -53.66 -51.64 62.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.559 0.218 . . . . 0.0 111.056 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.568 ' HD2' ' HD3' ' B' ' 53' ' ' ARG . 9.9 mmm180 -61.71 -36.29 80.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.366 -176.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.416 ' HH ' ' HG2' ' B' ' 41' ' ' GLU . 10.0 t80 -65.36 -43.38 90.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.947 0.403 . . . . 0.0 110.08 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 73.4 mt -71.92 -31.26 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.568 ' HD3' ' HD2' ' B' ' 50' ' ' ARG . 19.5 mtp180 -63.95 -33.4 75.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 25.1 mm-40 -92.18 -61.99 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.259 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -98.19 -29.17 13.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.1 tp 80.42 7.32 1.49 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.461 0.704 . . . . 0.0 111.924 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.822 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 91.74 1.55 70.71 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.414 -0.898 . . . . 0.0 115.149 166.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -98.94 134.91 41.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.78 0.79 . . . . 0.0 109.725 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.697 ' HB3' ' HE2' ' B' ' 61' ' ' LYS . 6.7 mt-10 -92.21 101.65 14.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.401 171.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.36 122.36 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.118 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.697 ' HE2' ' HB3' ' B' ' 59' ' ' GLU . 72.2 mmtt -119.17 157.62 27.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' B' ' 62' ' ' ASN . 3.1 m120 -135.59 137.78 42.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.04 0.447 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.11 -49.66 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.899 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.94 2.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.459 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 99.0 mt -105.62 94.27 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -171.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.63 -35.09 76.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.86 0.838 . . . . 0.0 108.843 169.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -98.44 109.45 22.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.15 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -74.6 -13.45 60.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.557 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -71.5 106.77 4.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -163.23 133.72 4.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.881 0.372 . . . . 0.0 110.666 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.9 7.96 26.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 . . . . . 0 C--O 1.244 0.778 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.971 174.521 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' HB ' ' OE1' ' A' ' 3' ' ' GLU . 77.1 t -97.84 -49.85 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' OE1' ' HB ' ' A' ' 2' ' ' VAL . 2.1 mp0 -85.87 37.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 7.3 t30 71.78 127.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 123.638 0.586 . . . . 0.0 111.751 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.28 122.13 10.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.68 2.254 . . . . 0.0 111.62 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.1 mmt -92.33 93.0 8.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.064 0.459 . . . . 0.0 110.286 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.3 -16.35 8.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.694 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mt -82.81 91.16 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.806 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -99.2 -33.14 10.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.569 . . . . 0.0 109.948 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 11' ' ' TRP . 3.5 t-20 -70.74 -11.66 61.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.142 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 6.3 m0 71.9 113.99 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.338 0.655 . . . . 0.0 111.679 -177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -107.97 -12.78 15.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.46 144.59 39.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.068 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -73.1 132.4 43.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.32 0.581 . . . . 0.0 112.213 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -87.59 51.75 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.126 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 p 57.94 -178.91 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.286 1.035 . . . . 0.0 111.982 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.2 30.69 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 110.26 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 m 69.38 -87.35 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.561 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.77 17.67 0.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.782 0.801 . . . . 0.0 108.87 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.86 102.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.623 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 167.14 15.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mt -116.74 153.93 18.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.997 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.528 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 4.3 p-10 -83.84 -160.08 0.42 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.562 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -80.07 -23.51 41.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -41.13 35.55 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.6 45.32 1.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.825 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.28 -88.71 0.45 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 176.83 129.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.27 138.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 32' ' ' VAL . 63.7 p -123.82 160.5 51.22 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.26 2.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.185 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG21 HD22 ' B' ' 65' ' ' LEU . 12.0 t -97.47 -16.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.4 141.72 45.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.794 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.2 138.85 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.698 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CD2' HG23 ' A' ' 42' ' ' ILE . 33.1 p90 -148.69 175.01 11.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.891 175.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 94.5 t -134.5 139.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.51 HG22 ' HA2' ' B' ' 39' ' ' GLY . 18.3 mt -103.42 119.76 52.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -105.11 89.51 3.16 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.369 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 88.87 -40.09 3.09 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.22 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.35 -23.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.654 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.49 164.91 14.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 111.055 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.444 HG23 ' CD2' ' A' ' 35' ' ' TYR . 71.2 mt -116.82 129.29 73.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.809 -171.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.759 ' HB ' HD21 ' A' ' 48' ' ' LEU . 3.0 mp -130.35 123.72 56.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.197 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 3.9 tt -60.37 141.31 56.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.46 ' N ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.7 -16.95 7.28 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -77.59 -33.42 53.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.419 0.628 . . . . 0.0 110.006 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -104.97 -5.76 20.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.957 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.759 HD21 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -66.79 -25.95 66.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.791 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.95 -30.05 68.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 74.3 ttt180 -82.65 -33.82 27.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.562 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.3 t80 -69.26 -36.3 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 29.6 mt -74.91 -34.64 62.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.996 0.426 . . . . 0.0 110.095 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' HB3' ' HA ' ' A' ' 50' ' ' ARG . 4.6 ttp180 -59.86 -55.4 34.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.182 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -93.0 -39.21 11.23 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.622 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 50.5 tp60 -97.49 -68.39 0.8 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.792 -0.568 . . . . 0.0 111.164 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' HG ' ' HE1' ' B' ' 58' ' ' PHE . 0.7 OUTLIER 39.35 34.97 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.658 0.742 . . . . 0.0 110.225 -175.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.622 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -117.24 -19.81 4.98 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.873 -1.156 . . . . 0.0 114.583 -165.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 58.32 -153.96 0.37 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 7.4 tp10 -109.28 101.78 10.75 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.302 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.38 121.26 30.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.2 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -119.96 148.07 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.55 0.691 . . . . 0.0 111.105 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.42 148.05 47.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.035 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 75.67 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.721 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.29 72.76 10.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.992 -177.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.7 109.46 20.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.795 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -69.45 97.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.362 0.601 . . . . 0.0 111.158 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -99.58 83.74 2.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.481 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -100.08 99.44 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.661 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -128.33 -11.62 5.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -74.45 119.34 18.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.937 0.398 . . . . 0.0 110.624 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -72.87 -26.14 61.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.923 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.6 m80 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.187 174.483 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.85 128.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.083 0.468 . . . . 0.0 111.626 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -172.46 -73.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.817 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' B' ' 5' ' ' PRO . 45.7 t30 -163.42 110.56 0.99 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.893 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' 4' ' ' ASN . 26.3 Cg_endo -62.02 146.53 96.19 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.658 2.239 . . . . 0.0 111.955 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' B' ' 6' ' ' MET . 1.8 mpt? -60.83 -59.27 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.638 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.38 131.84 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.095 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -113.28 123.71 69.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.096 0.474 . . . . 0.0 110.562 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -92.71 96.19 10.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -106.52 110.11 22.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.282 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -86.71 89.57 7.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.605 0.717 . . . . 0.0 110.286 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -160.06 101.05 1.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.707 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -99.82 -15.83 18.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.341 0.591 . . . . 0.0 109.816 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' B' ' 14' ' ' LYS . 46.9 mtmt -137.58 152.26 49.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.519 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.475 ' C ' ' HG1' ' B' ' 16' ' ' THR . 42.3 tp -129.82 -66.38 0.79 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.475 ' HG1' ' C ' ' B' ' 15' ' ' LEU . 21.9 p 46.94 -97.15 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.21 133.0 34.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.088 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -154.11 -58.66 0.12 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.17 90.28 7.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.613 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.14 97.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.027 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.496 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 11.0 pt20 -116.11 151.91 34.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.687 -170.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 15.4 mt -119.65 146.45 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.171 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.9 OUTLIER -70.77 -173.71 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 111.16 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.24 -30.57 71.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.585 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.64 -43.84 11.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.21 29.01 0.3 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.781 -1.2 . . . . 0.0 113.486 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -114.77 137.87 51.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.34 132.28 53.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 111.734 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 16.4 t -111.26 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.233 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 31.5 p -87.02 164.47 36.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.5 Cg_endo -65.38 -3.7 8.06 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.77 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 t -101.27 1.28 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.327 0.584 . . . . 0.0 109.656 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -112.35 141.31 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.154 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 8.6 m-20 -78.06 135.73 37.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.24 162.97 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.962 0.41 . . . . 0.0 110.638 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.53 144.38 38.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 37.0 mt -107.05 100.14 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 0.0 109.265 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.767 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 5.9 m-20 -93.56 90.27 6.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.543 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.51 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . 74.75 25.46 69.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.393 176.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.78 -12.38 59.35 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.82 133.22 37.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -95.62 130.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.523 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.9 mp -138.2 126.13 29.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' B' ' 23' ' ' ASP . 5.2 mp -55.25 143.2 28.77 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.532 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 12.3 mtp180 -70.27 -0.38 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.707 0.289 . . . . 0.0 111.598 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.59 -16.15 43.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.781 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -123.74 -4.36 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.884 0.85 . . . . 0.0 109.309 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 2.6 tm? -65.4 -35.4 80.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.963 -175.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 1.9 tm-20 -57.25 -55.96 27.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -60.68 -36.38 78.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.052 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.26 -33.55 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.676 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 68.6 mt -69.53 -29.16 66.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.474 . . . . 0.0 110.299 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' B' ' 53' ' ' ARG . 46.3 mtp85 -72.07 -24.28 61.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.46 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.44 -66.46 0.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.631 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -98.21 -34.31 10.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.641 -174.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.2 tp 77.05 1.97 3.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.491 0.717 . . . . 0.0 111.276 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.767 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 106.92 -32.91 6.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.097 170.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.541 ' HE1' ' HG ' ' A' ' 56' ' ' LEU . 34.2 m-85 -70.93 123.43 22.01 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.671 -0.311 . . . . 0.0 110.819 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.438 ' OE1' ' HE2' ' B' ' 61' ' ' LYS . 40.5 tt0 -95.57 101.99 13.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.287 170.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -82.88 91.78 7.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.438 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 60.5 mmtt -81.75 75.07 8.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -64.51 158.43 24.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.09 -51.53 24.1 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.665 0.603 . . . . 0.0 110.876 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 62.28 15.45 7.61 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.61 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 32' ' ' VAL . 16.1 tp -85.58 30.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.533 0.683 . . . . 0.0 110.445 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -76.96 11.9 1.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.524 0.678 . . . . 0.0 109.692 174.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' B' ' 65' ' ' LEU . 34.4 m170 -76.21 62.13 1.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.746 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -108.25 24.06 13.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.611 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 54.5 m80 73.11 150.34 0.1 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.559 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -117.94 -179.42 3.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.123 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -75.83 97.03 3.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 173.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.585 -178.576 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.67 0.272 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.08 146.1 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 85.79 6.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.78 114.91 62.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.51 99.47 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.686 2.257 . . . . 0.0 112.513 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 6' ' ' MET . 0.0 OUTLIER -85.49 93.15 8.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.685 0.755 . . . . 0.0 110.646 178.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.77 -27.63 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.894 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -104.6 177.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.225 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -71.9 156.59 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.982 0.42 . . . . 0.0 110.587 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -81.73 -37.7 26.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -86.78 49.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.62 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -94.3 27.08 3.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.75 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.53 5.66 50.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.328 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -83.32 150.67 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.471 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.33 144.76 25.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.52 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -92.2 149.36 21.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.46 -69.3 0.32 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.757 0.313 . . . . 0.0 111.308 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m -127.46 -87.72 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.667 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.23 76.96 1.21 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.598 0.713 . . . . 0.0 109.753 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.2 t -117.91 87.98 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.948 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.416 ' OE1' ' HB ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -120.95 172.59 7.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.21 -176.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 28' ' ' GLU . 45.5 mt -129.8 150.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.9 p-10 -86.36 -170.28 3.02 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.2 -17.73 62.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.407 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 2.0 t80 -76.73 -41.99 42.94 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.74 34.92 3.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.987 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -102.36 -87.24 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.062 0.431 . . . . 0.0 109.992 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.519 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 -175.45 138.96 0.42 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 HD21 ' A' ' 44' ' ' LEU . 7.9 t -125.86 113.52 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 110.75 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 32' ' ' VAL . 24.9 p -114.84 163.93 18.13 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.022 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.71 7.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.499 2.799 . . . . 0.0 114.637 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' A' ' 30' ' ' THR . 22.0 m -100.18 -5.87 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.59 176.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -119.96 160.31 22.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.26 121.35 37.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.926 -173.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.21 159.66 41.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.055 0.455 . . . . 0.0 110.701 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 48' ' ' LEU . 96.0 t -134.08 142.42 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.753 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 42' ' ' ILE . 18.7 mt -102.73 121.74 54.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.623 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -94.48 89.17 5.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 79.58 -51.08 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.616 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -31.14 0.02 OUTLIER Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -174.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.59 142.2 33.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.229 0.537 . . . . 0.0 110.038 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 37' ' ' ILE . 84.0 mt -98.22 135.78 31.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.306 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 2.2 mp -137.78 132.1 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 29' ' ' VAL . 83.4 mt -58.92 152.6 19.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 172.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 48' ' ' LEU . 44.5 mmm-85 -63.65 -16.3 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.92 0.39 . . . . 0.0 110.577 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.22 -38.63 50.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.45 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.5 4.06 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.335 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 36' ' ' VAL . 40.4 tp -60.58 -41.32 94.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.499 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.16 -55.17 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.122 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.7 51.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.87 -45.0 91.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.481 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 58.0 mt -66.51 -48.77 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -61.97 -29.05 69.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.655 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -51.83 8.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.491 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.569 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 7.2 tt0 -103.49 -67.49 0.88 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 20.2 mt 47.72 43.35 16.67 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -168.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.569 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -113.65 1.94 24.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.672 -166.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' CZ ' ' HE1' ' B' ' 58' ' ' PHE . 8.3 m-85 59.33 -154.84 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.484 0.642 . . . . 0.0 109.69 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.5 tp10 -122.12 102.05 7.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 166.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.602 ' HD2' HD22 ' A' ' 62' ' ' ASN . 9.0 m-85 -99.26 110.95 23.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.247 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 74.1 mmtt -112.5 63.89 0.63 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.127 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.602 HD22 ' HD2' ' A' ' 60' ' ' PHE . 50.8 m-80 -74.11 149.87 40.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.46 63.03 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 72.73 -51.08 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.038 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.79 118.96 7.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.59 109.55 20.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.374 0.607 . . . . 0.0 111.353 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -115.59 93.24 4.19 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -131.71 163.59 27.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 0.0 111.717 -172.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -85.76 156.52 20.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 169.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.53 -59.81 4.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -175.55 77.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.432 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.422 -178.732 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.424 ' HG2' HG13 ' B' ' 2' ' ' VAL . 25.9 ttt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.424 HG13 ' HG2' ' B' ' 1' ' ' MET . 27.0 m -137.54 9.12 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.557 0.218 . . . . 0.0 111.511 -178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.533 ' HG2' HD21 ' B' ' 4' ' ' ASN . 0.5 OUTLIER -81.58 -36.11 29.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -174.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.654 ' HB2' ' HD2' ' B' ' 5' ' ' PRO . 9.9 p30 -129.47 166.29 26.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' B' ' 4' ' ' ASN . 43.0 Cg_endo -67.77 61.09 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.14 2.56 . . . . 0.0 113.349 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' B' ' 6' ' ' MET . 45.6 ttm -93.26 11.72 27.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t 70.8 102.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.883 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.3 mt -75.04 118.74 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.66 143.22 26.62 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.35 -81.61 0.34 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -171.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . 0.48 ' HA ' ' HE3' ' B' ' 11' ' ' TRP . 2.2 m95 56.19 88.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.332 0.587 . . . . 0.0 109.717 -168.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -134.5 29.79 3.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.476 -170.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.77 48.17 0.92 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.933 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 61.33 15.13 6.24 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.815 173.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 42.2 tp 63.32 21.94 13.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.588 . . . . 0.0 110.532 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 62.8 p -85.53 157.19 20.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.863 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -82.04 -16.24 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 34.9 m 76.49 -82.36 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.455 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.05 87.24 2.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.925 0.869 . . . . 0.0 111.375 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.6 124.11 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.096 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . 0.484 ' NE2' HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -130.01 166.55 19.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 0.0 111.438 -176.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.479 HG23 ' N ' ' B' ' 23' ' ' ASP . 23.8 mt -119.96 161.21 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.721 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.479 ' N ' HG23 ' B' ' 22' ' ' ILE . 5.0 p-10 -89.69 -159.87 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -73.02 -37.96 66.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.375 -175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -87.09 3.07 47.66 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.352 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 73.07 20.52 80.0 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.607 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.5 t70 -72.34 -87.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.308 173.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 30.2 tt0 175.33 141.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.36 123.04 67.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 0.0 110.3 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 64.0 p -106.86 160.94 24.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.936 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.06 3.36 0.56 Allowed 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.038 2.492 . . . . 0.0 113.558 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.4 12.86 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.599 0.714 . . . . 0.0 109.433 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -113.15 158.39 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.458 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.35 105.71 17.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -128.64 157.16 42.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.169 0.509 . . . . 0.0 110.512 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.4 ' HB ' HD22 ' B' ' 48' ' ' LEU . 92.2 t -135.24 142.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.883 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 34.3 mt -105.96 124.24 61.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.63 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 30.6 t70 -120.6 90.51 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.769 . . . . 0.0 110.696 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.41 28.42 27.47 Favored Glycine 0 C--N 1.315 -0.609 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.261 172.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 -22.72 38.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.295 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.98 136.41 33.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.484 HG21 ' NE2' ' B' ' 21' ' ' GLN . 74.3 mt -101.25 133.34 44.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.4 124.13 39.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.524 HD22 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -68.1 143.61 55.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.524 ' N ' HD22 ' B' ' 44' ' ' LEU . 38.9 mmm-85 -53.72 -22.02 8.29 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.2 -36.78 75.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -106.4 -19.94 13.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.407 ' CD2' ' HD2' ' B' ' 45' ' ' ARG . 24.4 tp -55.75 -42.41 75.38 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -172.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -33.6 68.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -41.02 25.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 0.0 110.258 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -57.92 -44.2 86.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.692 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.63 -38.84 64.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -57.82 -39.01 76.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -83.45 -43.99 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.555 ' HG2' ' H ' ' B' ' 57' ' ' GLY . 46.3 tt0 -99.5 -67.09 0.87 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.48 29.95 1.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.599 0.36 . . . . 0.0 111.689 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.555 ' H ' ' HG2' ' B' ' 55' ' ' GLN . . . -125.44 15.22 7.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.584 -171.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.503 ' HE1' ' CZ ' ' A' ' 58' ' ' PHE . 2.3 m-30 56.8 -153.36 0.37 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.999 0.428 . . . . 0.0 109.98 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' B' ' 59' ' ' GLU . 3.7 tp10 -117.93 102.16 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.313 0.578 . . . . 0.0 110.5 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -83.64 100.92 11.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.817 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -85.19 -175.46 5.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -165.83 168.12 16.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.43 11.31 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 70.21 -81.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.456 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp 48.21 70.7 0.42 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.333 0.587 . . . . 0.0 110.117 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.87 -6.41 16.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.511 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.25 -35.31 49.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.765 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -108.67 15.46 23.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -93.2 49.44 1.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.008 -0.433 . . . . 0.0 111.106 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 70.2 -71.67 0.12 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.39 108.62 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.905 0.384 . . . . 0.0 111.925 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t60 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.613 172.671 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.97 135.02 59.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -123.09 93.9 4.1 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.211 0.529 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -125.84 114.02 24.6 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.437 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 118.0 5.23 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.714 2.276 . . . . 0.0 112.701 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 ttt -81.4 107.41 14.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.54 120.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.438 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.588 ' HB ' ' HB2' ' A' ' 11' ' ' TRP . 24.2 pt -66.77 135.54 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.974 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.61 67.23 6.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 57.5 71.29 0.59 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.996 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 58.8 t-105 -94.44 147.52 23.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.055 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -88.88 176.76 6.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.075 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.84 147.2 23.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 0.0 111.645 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -99.11 -21.05 16.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.939 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.91 85.84 4.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.673 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -149.22 153.89 38.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -68.41 139.04 55.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.957 0.408 . . . . 0.0 110.717 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.0 m -121.08 -6.77 9.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.798 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.62 21.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.58 92.27 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.496 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 26.9 pt20 -88.26 167.08 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.243 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG21 ' HA2' ' A' ' 26' ' ' GLY . 28.4 mt -136.19 149.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.03 -179.99 4.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -57.99 -35.9 71.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.818 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -84.64 -12.96 52.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 87.76 40.78 6.6 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.118 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 28' ' ' GLU . 12.4 t70 -90.27 -97.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.409 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 29.6 tt0 179.38 127.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 22.0 t -123.04 107.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.226 0.536 . . . . 0.0 110.534 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 67.6 p -98.0 168.28 10.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.016 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 50.2 Cg_exo -56.52 -10.54 5.18 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.049 2.499 . . . . 0.0 113.721 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.19 10.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -106.19 145.73 31.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.928 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.571 ' OD1' ' HB2' ' B' ' 62' ' ' ASN . 35.9 m-20 -89.39 124.82 34.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -148.21 164.71 33.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.391 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.66 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 64.3 t -133.43 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 90.7 mt -112.94 108.17 24.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-O 121.685 0.755 . . . . 0.0 110.638 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -83.3 79.62 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.943 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.1 5.84 29.11 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.513 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.7 -24.8 1.97 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.545 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 40.0 mt-10 -81.56 134.28 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.2 mt -96.45 122.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.717 ' HB ' HD21 ' A' ' 48' ' ' LEU . 3.9 mp -129.45 127.55 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.188 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -62.36 143.03 57.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -55.58 -20.88 14.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.63 -47.54 80.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.603 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -96.86 0.44 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.193 0.521 . . . . 0.0 110.114 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' ' 43' ' ' ILE . 2.9 tm? -68.6 -36.71 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.394 -172.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.02 -34.28 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.81 -34.16 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 110.272 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.86 -41.76 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.386 174.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -63.52 -34.21 77.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.748 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -64.8 -41.83 95.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.605 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -66.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -103.33 -25.42 13.31 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.876 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 31.3 tp 64.1 43.46 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 173.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 86.14 -16.55 42.58 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.377 -0.916 . . . . 0.0 114.106 172.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.491 ' HE2' HD21 ' A' ' 56' ' ' LEU . 12.6 m-85 -91.7 133.29 35.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.89 102.01 14.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -78.5 107.02 10.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.716 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 17.5 tptt -93.81 177.09 6.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 8.3 t30 -143.62 151.89 40.7 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' B' ' 31' ' ' PRO . . . -49.89 -31.1 11.39 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 14.0 mm100 68.18 26.59 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 176.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.85 -30.91 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 68.55 -3.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.071 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 18.6 m170 -67.62 136.01 53.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 7.8 m-70 76.99 -26.11 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.123 0.889 . . . . 0.0 111.02 -174.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 45.3 m80 59.83 97.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 50.7 m80 69.99 117.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -165.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -59.3 117.93 5.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.154 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.434 -178.386 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.719 0.295 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.18 22.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -172.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.32 -52.0 5.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.484 ' C ' HD21 ' B' ' 4' ' ' ASN . 0.2 OUTLIER 59.26 89.38 0.11 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.512 -175.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.36 86.71 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.56 2.173 . . . . 0.0 111.693 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 87.0 mtp -76.8 -15.28 59.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 109.917 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 m -110.88 111.29 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.345 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 28.3 pt -81.57 34.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' B' ' 11' ' ' TRP . 94.2 m-20 52.41 74.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.185 0.517 . . . . 0.0 111.039 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.54 34.28 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.392 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . 0.418 ' H ' ' C ' ' B' ' 9' ' ' ASN . 65.6 m95 -83.01 2.85 32.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.336 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -68.44 109.43 3.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.09 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -138.99 104.2 4.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.82 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -104.54 -46.6 4.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.755 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -147.34 76.43 1.41 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.68 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 141.18 48.59 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 168.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -99.89 129.72 46.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.142 0.496 . . . . 0.0 110.857 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -120.36 -62.87 1.42 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.489 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.16 78.92 9.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.444 0.64 . . . . 0.0 110.868 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.86 105.37 18.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -106.59 162.01 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.502 . . . . 0.0 111.678 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.422 HG23 ' N ' ' B' ' 23' ' ' ASP . 35.1 mt -128.54 154.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.474 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.464 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 4.7 p-10 -82.79 -167.29 1.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.488 0.661 . . . . 0.0 111.601 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.1 -35.74 81.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.026 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -83.73 -7.61 59.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.73 65.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.165 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 28.3 t70 -80.53 -84.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 35.1 tt0 174.9 135.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . 0.435 HG22 HD21 ' B' ' 44' ' ' LEU . 40.7 t -121.51 118.34 55.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.211 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.818 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 70.2 p -111.93 172.67 3.36 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.324 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.818 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 46.3 Cg_endo -69.43 19.69 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.824 2.349 . . . . 0.0 113.071 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' B' ' 30' ' ' THR . 10.6 t -121.07 -3.42 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 109.961 177.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -101.76 172.3 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.718 -173.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.513 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 14.8 m-20 -111.39 106.42 15.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.509 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 22.0 p90 -124.84 142.5 51.4 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.987 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.4 138.76 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.194 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' B' ' 41' ' ' GLU . 57.0 mt -100.2 109.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.084 0.468 . . . . 0.0 110.664 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.43 90.1 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.149 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.49 -2.55 46.12 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.457 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.53 -30.47 1.42 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.149 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 31.1 mt-10 -88.13 145.33 25.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' B' ' 35' ' ' TYR . 61.7 mt -95.8 130.29 44.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.072 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.61 122.15 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.268 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 93.7 mt -62.15 144.69 55.07 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' CB ' ' B' ' 48' ' ' LEU . 48.0 mtm180 -69.27 -0.24 5.89 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.238 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.56 -27.23 64.96 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.1 2.54 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.025 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.579 ' CB ' ' HA ' ' B' ' 45' ' ' ARG . 32.5 tp -58.72 -40.75 84.62 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.49 -42.23 74.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.458 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -75.0 -40.02 60.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.587 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.05 -34.1 77.61 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.292 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 20.2 mt -72.19 -29.41 63.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.085 0.469 . . . . 0.0 110.585 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -65.46 -50.44 65.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 110.193 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.42 -48.64 12.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.244 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' GLN . . . . . 0.554 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 4.3 tp-100 -96.02 -67.6 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.515 -174.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 4.9 tp 42.74 40.26 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.743 0.652 . . . . 0.0 109.509 -171.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.554 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -101.41 -24.35 8.91 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.489 -0.862 . . . . 0.0 114.1 -165.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.72 -151.77 0.33 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.7 tp10 -116.44 101.78 8.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -107.33 111.83 24.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.582 -171.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.515 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 73.5 mmtt -124.62 -169.56 2.0 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.728 0.775 . . . . 0.0 110.99 -175.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.571 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 6.4 p30 -169.35 -159.44 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.06 57.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 118.531 0.605 . . . . 0.0 111.417 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 61.19 19.79 10.39 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.074 0.55 . . . . 0.0 111.161 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.02 -25.31 58.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 -176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 46.91 80.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.6 0.714 . . . . 0.0 110.528 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -137.1 72.92 1.43 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.948 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -64.78 132.2 48.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -73.08 -6.74 47.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.375 0.607 . . . . 0.0 110.713 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -131.11 104.73 7.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.69 107.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.412 0.625 . . . . 0.0 112.016 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.894 175.896 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 C--O 1.228 -0.077 0 CA-C-O 121.874 0.845 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.32 121.24 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.478 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.805 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 29.0 pt20 -93.78 142.11 27.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.68 148.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.54 174.94 9.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.53 -35.72 70.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.91 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -82.43 -11.07 58.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.66 40.7 7.6 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.186 -1.006 . . . . 0.0 113.08 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 19.5 t70 -93.62 -95.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 23.9 tt0 177.42 126.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.805 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 39.8 t -109.21 104.63 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.308 0.575 . . . . 0.0 110.323 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.5 p -92.55 167.25 15.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.596 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 31.6 Cg_endo -65.09 -9.2 20.81 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.539 HG22 HD23 ' B' ' 65' ' ' LEU . 3.4 t -112.76 29.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.68 0.752 . . . . 0.0 109.133 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -129.84 139.69 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.862 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -89.27 128.54 35.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' HG23 ' A' ' 42' ' ' ILE . 18.6 p90 -142.4 170.11 16.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.44 135.58 49.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 30.4 mt -96.28 115.33 35.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.813 0.34 . . . . 0.0 110.264 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.47 88.1 6.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.407 0.622 . . . . 0.0 109.561 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 83.07 -33.42 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.229 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.16 -22.81 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.713 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.89 147.56 23.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 0.0 110.226 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.558 HG23 ' CD2' ' A' ' 35' ' ' TYR . 94.5 mt -94.38 128.85 45.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.909 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 ' HA ' ' A' ' 48' ' ' LEU . 3.8 mp -130.03 129.59 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.178 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 45' ' ' ARG . 4.1 tt -67.36 138.7 56.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 48' ' ' LEU . 8.2 mmm-85 -53.55 -22.46 8.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.27 -40.8 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.252 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.58 -4.56 58.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.001 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' HG21 ' A' ' 43' ' ' ILE . 33.8 tp -61.81 -44.2 97.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.54 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.1 -45.3 71.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.912 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -62.46 -48.7 78.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.387 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.5 -36.61 81.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.617 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 70.6 mt -66.8 -39.53 87.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.261 0.553 . . . . 0.0 110.485 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -70.49 -21.53 62.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.153 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.08 -59.5 2.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.734 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 27.3 tt0 -103.12 -67.46 0.88 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.2 tt 42.33 43.32 2.94 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.456 0.646 . . . . 0.0 109.378 -168.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.734 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -126.32 6.4 7.63 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.949 -1.119 . . . . 0.0 113.839 -166.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 54.6 -153.88 0.29 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.0 tp10 -112.89 101.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.037 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -97.77 110.17 22.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.521 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 72.2 mmtt -110.71 163.66 13.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -144.98 -179.14 6.42 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 172.056 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 122.067 0.937 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.67 129.35 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.836 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -140.73 165.49 27.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.23 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.461 HG21 ' HA2' ' B' ' 26' ' ' GLY . 16.8 mt -132.02 156.22 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.436 ' N ' HG22 ' B' ' 22' ' ' ILE . 4.7 p-10 -79.89 -165.85 0.9 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 110.784 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -72.15 -34.74 68.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.557 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.4 -41.02 25.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 118.22 38.12 0.82 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 11.1 t70 -86.2 -93.38 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 32.0 tt0 168.81 121.99 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 35' ' ' TYR . 14.4 t -112.53 127.56 69.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.444 0.64 . . . . 0.0 110.505 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 69.3 p -124.63 169.64 10.47 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.65 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 44.6 Cg_endo -68.58 18.15 0.15 Allowed 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.452 2.101 . . . . 0.0 113.053 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' B' ' 30' ' ' THR . 35.7 t -108.7 -32.44 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.866 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ASP . . . . . 0.419 ' OD2' HG13 ' B' ' 29' ' ' VAL . 6.0 p-10 -104.14 134.87 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.581 0.705 . . . . 0.0 111.086 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.7 135.74 48.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.499 ' CG ' HG11 ' B' ' 29' ' ' VAL . 26.0 p90 -152.1 166.42 31.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.737 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.858 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 75.5 t -135.82 146.97 28.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.9 mt -112.77 118.33 57.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 1.1 m-20 -98.02 88.9 4.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.594 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 70.47 24.08 77.06 Favored Glycine 0 C--N 1.319 -0.4 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.448 172.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.6 -23.99 8.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.549 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.39 138.33 35.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.821 0.343 . . . . 0.0 110.541 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -89.33 136.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.627 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.425 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.8 mp -134.97 131.25 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -52.19 140.3 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -67.36 -5.21 13.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 0.0 109.827 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.74 -26.49 54.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.471 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.87 5.07 9.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.737 0.78 . . . . 0.0 109.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.858 ' HG ' ' HB ' ' B' ' 36' ' ' VAL . 2.7 tm? -66.99 -38.19 85.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.013 -170.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -58.95 -39.61 82.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -63.66 -39.64 94.84 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.229 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.08 -38.66 72.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.641 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.414 ' HG ' HD13 ' B' ' 48' ' ' LEU . 18.8 mt -67.12 -25.06 66.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.955 0.407 . . . . 0.0 110.86 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.13 -41.04 74.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.748 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.51 -41.12 9.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -100.89 -52.71 3.23 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.374 -0.204 . . . . 0.0 111.414 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.6 tp 76.59 37.37 0.32 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.896 0.748 . . . . 0.0 111.491 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 75.97 -11.39 11.44 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 170.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -101.24 120.84 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.359 0.579 . . . . 0.0 112.036 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.467 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 43.7 tt0 -92.28 102.03 14.53 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.58 109.16 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.844 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 9.7 mmmm -116.29 78.72 1.22 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.122 0.487 . . . . 0.0 111.157 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.11 165.7 19.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.99 60.61 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.242 0.339 . . . . 0.0 110.928 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 63.64 19.37 11.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.845 0.831 . . . . 0.0 110.049 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 32' ' ' VAL . 26.5 tp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.743 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.517 -0.301 0 CA-C-O 121.784 0.802 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.24 132.26 67.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.985 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 13.2 pt20 -142.19 159.39 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.163 -175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.6 mt -133.14 149.49 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 4.5 p-10 -78.69 -171.16 2.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.16 0.505 . . . . 0.0 110.589 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -72.03 -27.94 63.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.564 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 47' ' ' ASN . 6.4 m-85 -86.28 -8.13 57.97 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.13 39.69 15.56 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.143 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 17.4 t70 -95.8 -89.81 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.5 tt0 176.54 142.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 68.8 t -122.22 121.38 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.55 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -117.75 162.86 26.92 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.13 -11.14 7.19 Favored 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 122.899 2.399 . . . . 0.0 114.224 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -96.44 2.29 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.004 0.431 . . . . 0.0 110.793 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -99.75 140.55 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.901 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.28 111.02 18.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -138.77 158.48 44.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.005 0.431 . . . . 0.0 110.818 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 48' ' ' LEU . 92.3 t -133.89 140.59 46.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 46.4 mt -101.89 121.24 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.611 0.243 . . . . 0.0 110.435 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.09 88.74 3.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.425 0.631 . . . . 0.0 110.029 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.832 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 87.63 -24.52 10.11 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.271 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.26 -28.11 0.5 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.55 130.33 35.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.095 0.474 . . . . 0.0 109.896 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 37' ' ' ILE . 76.8 mt -87.41 137.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.547 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.8 mp -138.74 125.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.147 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 29' ' ' VAL . 86.6 mt -52.84 148.68 7.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 170.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -62.89 -11.99 22.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.02 -15.33 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.278 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.404 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 88.1 m-20 -117.36 -13.54 10.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 36' ' ' VAL . 22.9 tp -64.74 -38.2 90.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -50.6 -51.57 47.28 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.652 0.595 . . . . 0.0 110.691 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 tpp85 -67.42 -36.23 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.958 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -65.73 -43.9 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.738 0.304 . . . . 0.0 110.432 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 46.7 mt -71.76 -22.51 61.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -78.61 -22.23 47.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.122 0.487 . . . . 0.0 109.738 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 72.7 mm-40 -93.68 -60.12 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.733 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 25.0 tt0 -92.15 -67.68 0.84 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.485 -173.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 14.2 tp 43.73 37.98 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.047 0.451 . . . . 0.0 110.541 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.733 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -127.74 2.02 6.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.991 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.9 OUTLIER 61.33 -153.75 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.34 0.591 . . . . 0.0 110.686 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 11.1 tp10 -106.03 102.18 11.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.496 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.502 ' HA ' HG22 ' B' ' 36' ' ' VAL . 32.6 m-85 -89.54 104.78 17.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.504 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.548 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 55.4 mttm -118.49 94.14 4.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 111.241 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -83.43 70.27 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.311 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.937 178.226 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 121.149 0.5 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.23 135.62 49.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.572 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -136.36 -179.48 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.912 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' B' ' 28' ' ' GLU . 15.2 mt -129.59 141.62 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 2.5 p-10 -88.98 -170.92 3.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.06 0.457 . . . . 0.0 110.517 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.44 -30.12 70.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.412 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.26 -39.88 74.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.118 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.08 2.56 31.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.328 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.7 m-20 -71.83 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 34.5 tt0 172.84 157.82 0.11 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.459 174.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 76.7 t -130.51 105.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.534 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.775 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -104.19 171.26 5.21 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.775 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 25.9 Cg_endo -62.93 -0.57 2.16 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.682 2.254 . . . . 0.0 113.418 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.43 6.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.063 0.459 . . . . 0.0 110.582 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -102.92 138.88 39.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.259 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.7 128.4 33.59 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -156.62 159.59 38.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.394 0.616 . . . . 0.0 111.334 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' B' ' 48' ' ' LEU . 78.1 t -134.4 137.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.245 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 59.4 mt -103.66 110.28 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -81.93 84.54 6.9 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 109.916 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.832 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 74.32 -16.51 2.88 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.712 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.04 -22.73 0.45 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -83.09 121.15 26.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.73 129.08 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.513 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.3 mp -134.32 136.85 52.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB3' ' OE1' ' B' ' 46' ' ' GLU . 39.4 mt -55.73 145.94 22.65 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 170.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -12.45 61.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' B' ' 44' ' ' LEU . 1.5 pm0 -87.75 -10.84 49.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -123.76 0.56 8.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.828 0.823 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' B' ' 36' ' ' VAL . 18.7 tp -67.96 -51.21 50.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.987 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.35 -53.96 12.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.31 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 0.1 OUTLIER -76.82 -33.73 57.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 -175.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.461 ' CD2' HG12 ' B' ' 43' ' ' ILE . 43.7 t80 -69.22 -40.02 78.2 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.761 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.7 mt -62.82 -38.73 91.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' B' ' 53' ' ' ARG . 1.3 tmm_? -55.32 -33.99 63.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.812 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 64.3 mm-40 -87.35 -38.32 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.162 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.585 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.9 tp-100 -99.07 -68.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 112.128 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 63.5 mt 40.75 43.59 1.69 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.117 0.484 . . . . 0.0 109.828 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -105.22 -14.14 23.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.191 -167.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 7.9 m-85 58.7 -158.43 0.3 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -112.81 102.0 10.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 162.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -103.29 106.25 16.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.141 -170.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.86 150.07 25.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 0.0 110.886 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -137.35 140.1 41.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.35 -12.62 61.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.164 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 60.6 26.03 15.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.567 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.252 0.548 . . . . 0.0 110.192 178.717 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 121.145 0.497 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.34 84.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.188 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.715 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 21.9 pt20 -105.29 159.49 15.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 27' ' ' ASP . 14.0 mt -124.83 144.64 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . 1.2 p-10 -88.06 -176.95 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.068 0.461 . . . . 0.0 111.135 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.96 -37.18 71.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.174 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -65.57 -43.05 91.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.19 16.95 5.94 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 9.2 t0 -106.45 158.61 16.77 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.47 132.19 41.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.229 0.537 . . . . 0.0 110.505 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.715 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 55.9 t -107.36 96.22 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.584 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 48.5 p -97.31 172.82 4.56 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 19.6 Cg_endo -62.22 -7.33 9.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.286 1.991 . . . . 0.0 112.523 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.14 -0.08 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 109.978 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -106.4 131.33 53.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.668 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -133.6 164.21 27.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.91 144.39 33.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 55.1 mt -106.43 115.72 48.64 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 122.182 0.991 . . . . 0.0 110.805 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.483 ' HB3' HD11 ' A' ' 43' ' ' ILE . 44.1 t0 -109.95 89.3 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.239 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.483 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.72 41.29 15.65 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.606 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.65 -17.28 15.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.965 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.92 137.84 32.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 35.1 mt -94.26 139.56 18.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.818 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.5 mp -139.03 127.73 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 27' ' ' ASP . 92.5 mt -57.03 145.49 30.38 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 169.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -58.28 -19.54 35.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.466 176.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.46 -44.04 92.33 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.977 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -110.38 7.9 23.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.357 0.599 . . . . 0.0 110.044 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.413 HD23 ' HD2' ' A' ' 45' ' ' ARG . 40.9 tp -65.71 -35.12 79.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.299 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.14 -33.43 67.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.296 0.569 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 8.4 tpm_? -67.01 -53.34 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.505 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.818 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -63.87 -43.29 96.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.44 -29.03 68.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.845 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -71.38 -26.52 62.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.751 0.31 . . . . 0.0 110.362 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 16.9 mm-40 -85.83 -68.96 0.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.974 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -103.88 -21.78 13.6 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.959 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.2 tp 65.45 44.24 3.16 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.441 0.463 . . . . 0.0 112.166 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.56 -11.42 68.36 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.742 171.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -95.89 104.37 16.3 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.718 -0.284 . . . . 0.0 110.467 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 61' ' ' LYS . 45.0 tt0 -93.04 102.84 15.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.017 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' B' ' 36' ' ' VAL . 94.1 m-85 -79.12 109.05 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.877 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 25.5 mmtp -109.65 105.8 15.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.164 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -75.81 168.65 19.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.499 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 0.0 111.389 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.57 94.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' B' ' 29' ' ' VAL . 6.7 pt20 -103.34 157.38 17.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' B' ' 28' ' ' GLU . 18.6 mt -130.78 147.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.661 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.424 ' HB3' HG21 ' B' ' 29' ' ' VAL . 10.0 p-10 -73.72 -166.84 0.4 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.425 0.631 . . . . 0.0 111.062 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.86 -36.11 79.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.61 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -89.97 -34.82 15.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.494 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 110.51 41.35 1.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.802 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.38 -10.34 41.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.016 0.436 . . . . 0.0 109.846 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.649 ' HA ' HG12 ' B' ' 22' ' ' ILE . 30.8 tt0 65.09 97.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.066 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' B' ' 23' ' ' ASP . 40.6 t -95.86 103.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.02 -173.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.724 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 66.4 p -96.44 167.34 12.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.959 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.724 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.0 Cg_endo -64.76 20.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.649 2.899 . . . . 0.0 113.698 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.467 ' H ' ' C ' ' B' ' 30' ' ' THR . 20.9 t -101.76 -21.15 5.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.159 0.504 . . . . 0.0 109.818 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -115.45 169.3 9.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.935 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -103.39 146.36 28.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 110.451 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.39 170.82 18.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.122 0.487 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' HD13 ' B' ' 48' ' ' LEU . 82.0 t -136.84 140.36 43.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mt -102.73 118.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -89.48 86.55 6.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 74.68 -36.27 1.02 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.212 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.79 -25.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -173.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.58 130.95 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.18 124.81 40.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.16 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.26 121.8 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.137 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.7 tt -58.57 138.75 56.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.488 ' N ' HD23 ' B' ' 44' ' ' LEU . 5.5 mmm-85 -56.46 -16.76 6.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' B' ' 44' ' ' LEU . 9.0 mm-40 -74.57 -28.49 60.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -173.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -125.82 24.02 7.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.813 0.816 . . . . 0.0 109.447 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.61 HD13 ' HB ' ' B' ' 36' ' ' VAL . 25.9 tp -68.78 -45.14 72.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.264 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -45.84 67.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.112 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 9.3 tpt180 -68.6 -43.2 76.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.309 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.49 -45.95 77.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.874 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.34 -30.0 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.612 0.244 . . . . 0.0 111.066 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 53' ' ' ARG . 17.8 ttm-85 -63.1 -41.9 99.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -93.75 -25.91 17.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp60 -102.5 -67.74 0.86 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.356 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 40.77 40.31 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.689 0.756 . . . . 0.0 109.693 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.798 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -103.04 -34.01 4.13 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.381 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.9 -165.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.8 tp10 -115.74 102.26 9.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 123.45 45.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.098 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.86 176.81 7.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 0.0 110.347 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -166.33 170.84 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.72 57.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.463 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 58.58 24.17 11.7 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.424 0.63 . . . . 0.0 111.157 -172.891 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.4 103.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.407 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 152.05 23.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.233 0.539 . . . . 0.0 111.451 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 28' ' ' GLU . 53.4 mt -118.88 149.4 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.89 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.34 -163.01 0.73 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -75.95 -25.0 55.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.025 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -69.05 -33.01 72.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.7 33.78 10.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.789 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -103.4 -80.73 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.939 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.503 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 179.28 137.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.34 115.88 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 p -104.71 162.5 19.61 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 28.0 Cg_endo -62.95 -1.62 2.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 113.161 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.77 -2.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.575 0.226 . . . . 0.0 111.101 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.21 -170.95 1.74 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 5.1 t0 -126.87 134.9 50.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.59 -171.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 42' ' ' ILE . 35.5 p90 -156.49 161.05 40.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.048 0.452 . . . . 0.0 111.452 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 48' ' ' LEU . 87.4 t -137.25 144.73 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 19.2 mt -105.6 124.66 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 111.403 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 16.8 t70 -96.99 87.99 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.19 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 80.6 -22.22 4.88 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.502 173.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.58 -31.57 0.37 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 123.61 28.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 37' ' ' ILE . 70.5 mt -82.56 142.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.883 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -136.41 132.7 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -60.17 143.57 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HG3' ' CG ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -58.03 -19.68 33.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.75 -33.78 60.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.63 0.15 16.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 28.7 tp -55.99 -56.08 25.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.979 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -68.63 -23.5 64.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.22 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -73.92 -42.73 60.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.422 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 55.5 t80 -64.63 -36.1 83.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.369 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 77.6 mt -65.74 -33.61 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.291 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -68.63 -28.62 67.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 6.1 mm-40 -80.51 -57.74 3.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.601 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.585 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 43.0 tt0 -102.93 -67.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER 48.19 45.35 19.89 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -169.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -109.31 -33.76 2.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.285 -167.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CD2' ' HA3' ' B' ' 57' ' ' GLY . 1.7 m-85 63.5 -166.71 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.152 0.476 . . . . 0.0 109.748 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.2 tp10 -107.6 101.84 11.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.391 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -106.7 112.04 24.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.985 0.421 . . . . 0.0 110.24 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HG3' ' CZ ' ' B' ' 35' ' ' TYR . 69.9 mmtt -101.69 177.55 4.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -162.42 136.44 6.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.555 0.693 . . . . 0.0 110.396 178.508 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.778 ' HB2' ' HD3' ' B' ' 31' ' ' PRO . 8.5 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.086 0.469 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 101.87 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.76 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' B' ' 29' ' ' VAL . 7.8 pt20 -140.31 133.83 30.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -99.36 154.64 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.335 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.442 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 5.8 p-10 -93.66 -170.65 2.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.724 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.59 -36.09 77.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.458 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -69.83 -36.34 75.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.077 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.87 33.2 6.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.668 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' B' ' 28' ' ' GLU . 11.5 t70 -98.62 -96.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' B' ' 27' ' ' ASP . 31.6 mm-40 -167.57 137.79 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 109.551 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 92.4 t -123.66 101.05 8.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.692 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.0 p -103.16 175.75 2.11 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.474 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 29.8 Cg_endo -62.96 -10.83 21.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.49 2.127 . . . . 0.0 113.512 -177.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.02 13.91 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.024 0.44 . . . . 0.0 110.786 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -112.92 152.49 29.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -97.0 124.4 40.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 61' ' ' LYS . 32.0 p90 -143.0 159.87 41.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' B' ' 48' ' ' LEU . 53.7 t -129.87 143.07 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.5 mt -110.21 115.67 50.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 CA-C-O 121.804 0.811 . . . . 0.0 110.887 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.96 87.46 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.185 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 79.4 -18.77 6.4 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.38 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 -21.83 0.4 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.575 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.64 142.71 27.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -94.79 134.58 31.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.4 mp -127.9 128.18 68.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.446 HD23 ' N ' ' B' ' 45' ' ' ARG . 1.9 tt -61.8 137.45 58.25 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.446 ' N ' HD23 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.08 0.15 3.91 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -172.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.76 -12.74 30.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.368 0.604 . . . . 0.0 110.032 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -114.38 -7.01 12.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.512 0.672 . . . . 0.0 110.055 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' B' ' 36' ' ' VAL . 49.9 tp -57.19 -44.27 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.062 -170.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -59.85 -40.65 89.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.968 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -69.5 -43.28 73.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.161 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -62.73 -36.34 82.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 62.9 mt -70.41 -30.76 67.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 0.0 110.68 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -94.16 -49.5 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.723 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -103.03 -53.0 2.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 tp 72.04 47.99 0.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.303 0.641 . . . . 0.0 112.162 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' CD2' ' A' ' 58' ' ' PHE . . . 82.24 -31.13 2.92 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.938 -0.648 . . . . 0.0 114.24 169.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.95 122.9 25.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.667 -0.313 . . . . 0.0 111.322 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.658 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 8.1 tp10 -92.26 102.35 14.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -95.54 120.1 35.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.86 -167.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -115.44 178.11 4.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.836 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -169.51 149.66 4.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.72 75.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.02 0.438 . . . . 0.0 110.523 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 61.49 28.61 17.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.246 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 0.0 110.166 177.283 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 121.437 0.637 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.47 144.95 30.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.877 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -133.86 139.92 46.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.74 152.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -81.24 179.9 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.038 0.447 . . . . 0.0 110.771 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -56.4 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.465 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -70.83 -45.22 64.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.439 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.03 15.77 3.75 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.667 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.83 132.57 44.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.23 124.28 23.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.965 0.412 . . . . 0.0 110.595 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 23' ' ' ASP . 44.8 t -108.58 107.31 22.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.686 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 24.0 p -95.99 167.61 12.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 62.7 Cg_exo -52.74 -16.63 5.98 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.273 2.649 . . . . 0.0 114.32 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.93 2.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.652 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -105.72 150.48 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 45' ' ' ARG . 19.2 m-20 -94.82 120.72 35.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 109.863 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.9 p90 -142.59 161.76 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.871 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.7 t -131.94 134.97 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 51.2 mt -95.97 121.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 28.7 t70 -90.2 86.73 6.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.554 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 78.4 -40.43 1.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.115 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.84 -28.48 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -81.66 136.05 35.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 35' ' ' TYR . 92.7 mt -87.66 134.24 28.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.548 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.76 135.17 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.25 145.18 55.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.615 ' HG2' HD22 ' A' ' 48' ' ' LEU . 25.5 mtp-105 -65.61 -5.99 9.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.2 -63.2 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.503 . . . . 0.0 109.946 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.04 -14.89 61.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' A' ' 45' ' ' ARG . 18.6 tp -51.74 -42.6 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.336 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -60.21 -44.23 95.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -41.43 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.999 0.428 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.525 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 84.5 t80 -65.91 -43.76 87.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.39 -23.24 61.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.537 0.208 . . . . 0.0 111.33 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -70.51 -46.81 62.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 110.393 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.48 -35.91 29.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.205 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.552 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 26.3 tp60 -97.59 -67.54 0.84 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.319 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 44.32 41.14 4.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.583 0.706 . . . . 0.0 109.131 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.552 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -108.34 -24.1 6.35 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.309 -0.948 . . . . 0.0 114.528 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CG ' ' HA3' ' B' ' 57' ' ' GLY . 1.0 OUTLIER 57.53 -151.81 0.41 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -175.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.575 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 33.0 mt-10 -113.61 101.39 9.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.983 163.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -93.63 103.53 15.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 59' ' ' GLU . 93.5 mttt -117.48 105.34 11.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.75 0.786 . . . . 0.0 111.777 -173.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.13 160.16 30.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.191 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.379 0 O-C-N 123.291 0.369 . . . . 0.0 111.134 177.467 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.513 0.673 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.39 128.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.727 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.573 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 26.1 pt20 -107.27 149.79 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.928 0.394 . . . . 0.0 111.031 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 13.3 mt -112.7 140.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.162 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.564 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 13.1 p-10 -77.06 -170.4 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.112 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.88 -26.66 60.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -80.32 -23.17 40.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.709 0.29 . . . . 0.0 110.772 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 89.26 17.29 55.9 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.948 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.89 -8.61 42.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.28 0.562 . . . . 0.0 109.929 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' B' ' 22' ' ' ILE . 43.1 tt0 76.65 139.57 0.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.861 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 14.5 t -112.68 102.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 110.488 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 59.3 p -84.75 159.53 57.71 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.828 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 48.6 Cg_endo -69.21 7.68 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.651 2.234 . . . . 0.0 112.811 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.95 -6.46 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.285 0.564 . . . . 0.0 109.591 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -117.64 160.14 21.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.969 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.86 143.73 29.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.406 ' CD2' HG23 ' B' ' 42' ' ' ILE . 13.1 p90 -145.69 166.07 26.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.354 0.597 . . . . 0.0 110.672 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 59' ' ' GLU . 53.8 t -136.96 144.54 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 33.7 mt -109.94 116.81 53.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.377 0.608 . . . . 0.0 110.087 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 2.0 m-20 -97.44 86.67 3.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.891 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 62.63 45.56 95.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.826 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.3 64.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.845 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 3.3 tp10 -95.51 119.43 34.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' B' ' 23' ' ' ASP . 97.0 mt -83.89 120.84 35.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.602 ' HB ' HD13 ' B' ' 48' ' ' LEU . 2.7 mp -126.26 128.6 71.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' B' ' 23' ' ' ASP . 28.5 tp -66.58 139.75 57.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.604 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -60.25 -15.99 29.86 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.75 -45.03 82.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.74 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.48 17.66 6.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 111.493 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.602 HD13 ' HB ' ' B' ' 43' ' ' ILE . 48.9 tp -63.21 -31.49 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.389 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.76 -45.83 59.11 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 111.583 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 8.1 tpt180 -68.78 -37.11 79.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.416 . . . . 0.0 110.898 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' B' ' 41' ' ' GLU . 15.9 t80 -72.77 -32.66 65.78 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 75.1 mt -65.37 -29.33 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.413 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 -64.74 -44.75 89.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.431 . . . . 0.0 110.205 174.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.12 -54.36 9.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.783 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -103.52 -67.08 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.02 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 24.1 tp 78.72 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.855 0.722 . . . . 0.0 111.241 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 79.87 -45.55 2.97 Favored Glycine 0 C--O 1.235 0.205 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.736 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -69.53 139.1 53.77 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.602 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 3.9 tp10 -114.69 102.21 9.81 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 167.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -83.86 93.76 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.541 -175.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 59' ' ' GLU . 27.9 mmtm -93.49 83.17 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.326 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' B' ' 64' ' ' GLN . 92.9 m-20 -81.83 60.23 4.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.441 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' B' ' 64' ' ' GLN . . . 68.78 -27.18 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.9 0.88 . . . . 0.0 113.016 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' B' ' 62' ' ' ASN . 96.8 mt-30 67.67 18.32 9.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.332 0.587 . . . . 0.0 110.409 -175.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 179.68 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 121.154 0.502 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -81.33 83.7 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.999 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -96.35 166.21 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.561 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.12 157.57 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.64 -169.86 2.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -72.8 -26.42 61.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.567 0.222 . . . . 0.0 111.022 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -72.87 -40.82 65.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.89 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 17.82 4.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.264 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -104.98 129.88 53.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -59.0 120.0 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.278 0.561 . . . . 0.0 111.603 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.492 HG22 HD21 ' A' ' 44' ' ' LEU . 41.0 t -95.9 113.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 p -103.74 166.57 11.48 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.19 -6.01 2.56 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.782 2.321 . . . . 0.0 113.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -96.07 -4.38 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.368 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -110.13 166.26 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.406 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.88 119.02 38.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.452 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HB3' HG11 ' A' ' 29' ' ' VAL . 32.2 p90 -135.97 149.76 49.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 0.0 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.61 133.71 68.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.2 mt -97.5 121.4 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -94.75 84.27 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.876 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.32 -47.59 2.96 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.437 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.29 -29.02 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 129.19 34.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.509 0.671 . . . . 0.0 110.765 174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.59 133.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.981 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.3 mp -136.61 132.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 29' ' ' VAL . 84.4 mt -58.65 151.62 20.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.299 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -12.77 22.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.938 0.399 . . . . 0.0 110.882 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.99 -36.24 72.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.422 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.66 5.19 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 110.617 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.86 -48.58 81.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.068 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.96 -37.18 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 6.8 tpt180 -73.62 -39.81 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.698 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -64.08 -47.83 78.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.19 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.815 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 65.7 mt -61.98 -41.24 97.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 50.5 ttt-85 -46.54 -40.21 12.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.143 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -49.81 8.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.037 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.849 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 5.6 tp-100 -88.34 -68.2 0.78 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 48.0 mt 42.89 30.86 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.368 0.267 . . . . 0.0 111.286 -171.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.849 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -127.64 3.27 7.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.692 -166.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 53.87 -149.63 0.41 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.447 0.623 . . . . 0.0 110.313 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.9 tp10 -112.16 101.95 10.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.65 117.38 31.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.712 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.92 156.82 24.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.411 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -141.06 160.44 40.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.501 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.437 178.658 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 121.551 0.691 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -77.89 101.05 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.544 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.563 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 12.9 pt20 -101.56 158.49 16.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.586 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' B' ' 28' ' ' GLU . 53.2 mt -140.83 152.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.857 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.79 -173.87 2.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.331 0.586 . . . . 0.0 111.148 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -67.11 -29.18 68.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.153 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -79.78 -14.49 58.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.288 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.86 33.49 26.97 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.287 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.1 -87.2 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.843 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' B' ' 22' ' ' ILE . 41.7 tt0 -179.17 137.5 0.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.86 120.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.037 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 77.0 p -108.09 169.09 6.98 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.29 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_exo -60.36 -2.5 1.91 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.858 2.372 . . . . 0.0 113.022 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.37 -11.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.736 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.15 147.08 26.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.707 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.35 112.18 23.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -133.68 157.8 44.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 0.0 111.221 -172.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.84 145.0 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.423 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 67.7 mt -107.18 110.72 32.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.282 0.563 . . . . 0.0 109.881 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.6 92.25 3.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.203 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.06 36.6 31.24 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.521 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.94 -28.64 7.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.187 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.83 150.22 24.7 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.563 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 78.6 mt -108.86 141.48 24.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.564 -174.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mp -134.77 123.0 40.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -59.85 140.06 56.89 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.585 HH11 HD23 ' B' ' 48' ' ' LEU . 11.3 mmm180 -55.92 -17.97 7.86 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -77.22 -31.43 55.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.523 . . . . 0.0 110.047 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -102.96 -7.01 21.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.525 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.585 HD23 HH11 ' B' ' 45' ' ' ARG . 45.1 tp -64.45 -28.64 69.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.427 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -54.33 45.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.94 -33.31 70.36 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.732 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.72 -40.36 87.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.335 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 75.8 mt -72.06 -32.55 67.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 53' ' ' ARG . 44.1 mtt180 -64.11 -40.53 96.4 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.491 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -79.85 -65.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -95.1 -41.83 8.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.825 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 23.1 tp 78.41 17.98 1.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.895 0.747 . . . . 0.0 111.56 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.13 -38.36 3.19 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.069 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -65.88 117.2 7.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.724 -0.28 . . . . 0.0 110.956 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.567 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 37.0 tt0 -92.3 102.19 14.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.638 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -85.42 112.03 20.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 7.1 mmmm -115.22 88.6 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.241 0.544 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -82.55 154.22 25.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.52 69.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 48.8 81.18 0.05 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.252 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.321 -0.668 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.877 -178.3 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.124 0.488 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.67 132.77 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.786 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -123.59 171.18 9.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.567 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG21 ' HA2' ' A' ' 26' ' ' GLY . 21.8 mt -138.61 155.22 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.619 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 22' ' ' ILE . 5.6 p-10 -82.42 -167.52 1.62 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -69.97 -34.26 73.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.921 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -82.07 -15.46 53.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 85.25 36.98 10.23 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.728 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.6 t70 -87.93 -85.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.7 tt0 176.15 136.55 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.621 0.576 . . . . 0.0 109.676 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 44' ' ' LEU . 73.6 t -123.09 112.65 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.484 . . . . 0.0 110.67 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 32' ' ' VAL . 70.7 p -104.81 162.01 21.06 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.45 7.22 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.946 2.431 . . . . 0.0 113.257 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 t -103.89 -12.09 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.145 0.498 . . . . 0.0 109.884 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -92.87 151.31 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.635 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -97.02 115.44 27.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.403 0.62 . . . . 0.0 109.704 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.59 172.89 12.34 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.571 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 48' ' ' LEU . 64.2 t -137.03 139.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 14.5 mt -95.65 110.11 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.732 0.777 . . . . 0.0 109.455 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD2' ' HG3' ' A' ' 55' ' ' GLN . 9.8 t0 -82.66 85.87 6.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.243 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 59' ' ' GLU . . . 76.43 -35.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.091 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.18 -28.29 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.43 147.17 29.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.815 0.34 . . . . 0.0 110.396 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.5 mt -97.78 129.76 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.286 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 43' ' ' ILE . 2.3 mp -136.71 123.88 31.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.457 HD21 HG22 ' A' ' 29' ' ' VAL . 85.6 mt -56.19 146.38 23.56 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -68.56 -0.02 4.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.221 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -81.26 -19.18 43.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.94 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -129.09 -7.01 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.245 0.545 . . . . 0.0 110.335 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 36' ' ' VAL . 28.7 tp -50.2 -35.58 27.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.3 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -52.29 -42.57 63.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.004 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -69.83 -39.61 76.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.196 0.522 . . . . 0.0 110.351 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -38.09 88.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.194 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 62.2 mt -69.95 -25.04 63.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.036 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -69.08 -38.47 79.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.7 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.8 -67.83 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 8.7 pt20 -102.92 -20.89 14.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 40.3 tp 69.5 23.04 6.14 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 168.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.87 0.64 39.25 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.356 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.13 127.88 55.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.628 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 23.9 tt0 -91.95 102.03 14.59 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.72 122.12 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -111.84 -175.68 2.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.871 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.76 161.49 23.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.834 0.349 . . . . 0.0 111.06 177.741 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.5 107.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.006 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 10.5 pt20 -89.03 132.62 34.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 109.974 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.44 148.94 18.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.796 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.53 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -79.88 -174.58 4.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -71.6 -22.84 61.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.363 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' B' ' 47' ' ' ASN . 13.8 t80 -74.39 -45.25 48.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.44 27.64 2.79 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.059 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -96.0 -124.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -141.05 140.55 34.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 41.8 t -119.81 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.486 0.66 . . . . 0.0 109.345 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -86.96 167.77 20.59 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 35.9 Cg_exo -58.89 -3.6 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.853 2.369 . . . . 0.0 113.496 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.43 8.48 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.226 0.536 . . . . 0.0 110.509 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -106.23 130.87 54.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.02 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.26 120.98 23.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' B' ' 42' ' ' ILE . 34.8 p90 -143.3 164.53 29.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' B' ' 48' ' ' LEU . 72.9 t -132.8 145.83 33.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 39' ' ' GLY . 46.9 mt -111.57 127.89 68.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.342 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' HE2' ' B' ' 51' ' ' TYR . 25.3 t70 -119.29 89.77 3.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.052 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 42.37 9.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.303 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.58 -22.25 11.56 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.934 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -87.56 129.13 35.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.996 0.426 . . . . 0.0 110.151 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.517 HG23 ' CD2' ' B' ' 35' ' ' TYR . 78.3 mt -83.99 141.07 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.0 mp -135.57 125.37 42.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.56 148.03 20.71 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -61.33 -17.36 53.39 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.959 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.52 0.11 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.741 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' B' ' 25' ' ' TYR . 54.0 t30 -124.04 -1.74 8.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 109.167 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' B' ' 36' ' ' VAL . 39.6 tp -69.15 -45.41 70.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.07 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.91 -53.08 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.125 0.488 . . . . 0.0 110.596 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.37 -47.48 85.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.956 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.416 ' HE2' ' CB ' ' B' ' 38' ' ' ASP . 92.7 t80 -62.76 -39.95 95.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.481 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 43.0 mt -67.72 -47.55 69.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.394 -0.191 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -59.39 -19.03 43.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 110.903 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.07 -54.13 4.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.936 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.867 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 6.3 tp60 -91.53 -67.64 0.84 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 19.4 mt 39.57 34.85 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.867 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -120.46 -1.03 12.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.22 -171.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.46 -157.26 0.27 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -115.88 101.88 9.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.687 169.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.92 121.48 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.154 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -136.11 68.07 1.45 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.868 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -71.35 176.68 4.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.043 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -74.55 -5.93 45.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.884 0.373 . . . . 0.0 110.507 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 55.87 43.22 27.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.616 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 87.7 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.712 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.202 0.525 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t 70.82 110.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.175 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 5.5 pt20 -122.37 158.4 29.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.223 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.43 145.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 1.2 p-10 -77.26 -161.06 0.19 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.037 0.446 . . . . 0.0 110.196 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.5 -23.83 39.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.65 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -104.33 -4.07 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.1 5.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.769 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -114.13 149.06 36.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.07 127.79 34.05 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 110.472 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 44' ' ' LEU . 15.7 t -95.69 117.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.797 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 p -115.6 169.04 7.36 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.797 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 47.7 Cg_endo -67.3 20.21 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.987 2.458 . . . . 0.0 114.3 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.19 -26.62 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.118 0.485 . . . . 0.0 110.248 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.69 145.47 29.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.0 110.853 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' B' ' 62' ' ' ASN . 1.8 t70 -87.81 142.87 27.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.01 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 26.8 p90 -149.96 164.66 34.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.802 0.334 . . . . 0.0 111.021 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.4 153.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.368 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 73.6 mt -111.16 108.22 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.079 0 CA-C-O 121.819 0.819 . . . . 0.0 111.051 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 43' ' ' ILE . 1.8 m-20 -99.88 90.5 4.45 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.769 -177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 74.58 23.98 73.86 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.03 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.93 -29.98 6.57 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.365 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.1 158.78 15.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.366 0.603 . . . . 0.0 111.095 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 72.8 mt -103.58 138.87 26.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.142 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 38' ' ' ASP . 3.9 mp -131.56 122.8 51.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -59.23 135.07 57.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 14.3 mmt180 -58.08 -14.23 6.32 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.78 -14.49 56.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.476 . . . . 0.0 110.149 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -115.4 -9.91 12.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.403 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 28.2 tp -68.8 -28.77 67.06 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.138 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 53' ' ' ARG . 3.3 tm-20 -54.43 -66.37 0.41 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.61 -28.66 67.11 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.332 -177.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.38 -40.99 94.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 39.0 mt -65.42 -33.16 75.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 50' ' ' ARG . 11.1 mtm180 -62.55 -39.31 93.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.065 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 23.5 mm-40 -87.66 -52.79 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.713 0.292 . . . . 0.0 111.317 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -90.24 -51.55 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.138 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.98 44.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.361 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 79.37 -51.72 3.98 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 121.236 -0.507 . . . . 0.0 114.158 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -68.98 122.97 19.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.773 -0.251 . . . . 0.0 110.862 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -92.52 101.78 14.22 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.251 170.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.46 95.23 6.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.917 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD2' HD12 ' B' ' 37' ' ' ILE . 16.8 mttp -98.41 87.61 3.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.715 0.769 . . . . 0.0 110.632 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -81.42 176.49 9.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.811 177.392 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.513 0.673 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.1 90.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.21 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.668 ' OE1' ' HB ' ' B' ' 29' ' ' VAL . 0.9 OUTLIER -106.69 166.19 10.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.0 151.74 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -71.56 -173.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -67.41 -32.12 72.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -86.1 -45.69 11.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.75 31.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.233 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.78 125.43 53.68 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.78 128.05 34.37 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 111.393 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.668 ' HB ' ' OE1' ' B' ' 21' ' ' GLN . 19.0 t -114.57 119.6 61.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.005 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 36.2 p -110.34 164.56 14.54 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.744 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 51.9 Cg_exo -53.98 -18.73 13.82 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.388 2.725 . . . . 0.0 114.209 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.91 -0.93 10.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.949 0.404 . . . . 0.0 111.175 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -102.51 147.26 26.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.84 128.72 42.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 61' ' ' LYS . 30.1 p90 -148.48 -178.01 6.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.449 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 98.4 t -140.05 139.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.459 HD12 ' HD2' ' A' ' 61' ' ' LYS . 45.1 mt -105.02 117.85 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 110.073 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.92 92.04 3.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.468 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.584 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 84.74 0.57 89.18 Favored Glycine 0 C--N 1.316 -0.534 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.645 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.4 -20.27 4.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.724 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -99.82 151.06 21.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.012 0.434 . . . . 0.0 110.17 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.76 138.86 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.608 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.663 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.2 mp -140.01 126.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 48' ' ' LEU . 20.5 mt -55.81 146.67 20.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 172.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -62.4 -11.15 14.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.63 0.252 . . . . 0.0 111.354 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 31.9 tp10 -74.75 -51.36 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -100.5 3.54 42.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.663 HD23 ' HB ' ' B' ' 43' ' ' ILE . 2.8 tm? -65.75 -33.16 75.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.342 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.34 -49.67 76.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.505 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -67.25 -32.66 73.84 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.306 0.574 . . . . 0.0 110.165 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -66.85 -43.89 82.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 24.5 mt -66.89 -23.75 66.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -69.4 -33.83 73.59 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -84.7 -65.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.533 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' B' ' 57' ' ' GLY . 47.2 tp60 -85.35 -67.2 0.82 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.554 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 18.6 tp 60.35 -22.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' B' ' 55' ' ' GLN . . . -107.31 35.88 4.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.897 -167.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 50.51 -153.48 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.145 0.473 . . . . 0.0 110.933 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 10.9 tp10 -110.56 102.39 10.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.251 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -91.83 117.73 30.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.75 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -118.63 -173.1 2.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.587 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ASN . . . . . 0.542 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 29.9 p-10 -168.72 -175.45 2.43 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.39 15.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.815 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' B' ' 62' ' ' ASN . 67.2 mt-30 57.74 48.79 13.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.34 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.724 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -97.58 101.24 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.871 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 29' ' ' VAL . 4.9 pt20 -123.06 156.71 34.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 23' ' ' ASP . 22.7 mt -125.21 138.3 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.714 0.292 . . . . 0.0 111.491 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -67.36 162.26 23.32 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.435 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -50.2 -35.37 26.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 113.134 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.87 1.08 48.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 39.14 7.95 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -121.4 127.81 51.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.71 125.73 26.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.585 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.66 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 58.0 t -120.33 102.1 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.548 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.78 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 p -78.19 166.58 42.17 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.78 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -59.69 -10.67 12.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.892 2.395 . . . . 0.0 114.472 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.61 7.76 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.659 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -98.65 154.53 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 7.7 m-20 -76.89 111.3 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.656 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' HB3' HG11 ' A' ' 29' ' ' VAL . 42.9 p90 -147.52 168.17 22.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 111.164 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.9 t -137.75 148.23 25.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 60.1 mt -105.67 118.52 53.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-O 121.306 0.575 . . . . 0.0 110.052 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.515 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 2.1 m-20 -106.39 87.68 2.6 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.615 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.63 80.14 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.102 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.99 -25.82 2.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.012 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -97.39 155.97 16.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.114 0.483 . . . . 0.0 110.78 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.1 mt -96.4 137.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.363 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 3.7 mp -131.34 120.51 46.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -57.51 136.66 56.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 11.9 mmm-85 -55.78 -13.96 2.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.82 -57.39 7.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.293 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.0 7.52 44.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.434 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 46.0 tp -54.68 -28.97 51.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.257 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -42.26 -46.18 4.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.623 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 2.4 mpt_? -73.89 -39.56 63.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.265 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -44.77 83.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.966 0.412 . . . . 0.0 110.665 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 51.9 mt -68.31 -24.58 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -76.8 -26.76 54.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.916 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -92.41 -70.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.821 0.344 . . . . 0.0 111.731 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 2.1 pm0 -102.4 -23.21 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.878 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 42.3 tp 66.14 43.32 2.9 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.316 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.21 -18.31 41.88 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.811 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 9.3 m-85 -99.46 136.7 39.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.564 -0.374 . . . . 0.0 110.719 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 34.7 tt0 -93.05 102.02 14.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 167.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.06 92.49 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.934 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HE2' ' OE2' ' A' ' 59' ' ' GLU . 14.1 mmtt -97.56 173.83 6.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 111.955 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.6 175.85 9.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.425 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 120.703 0.287 . . . . 0.0 111.021 176.409 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.963 0.887 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.37 94.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.083 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.438 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 9.2 pt20 -92.4 131.34 37.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.211 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.502 HG22 ' O ' ' B' ' 23' ' ' ASP . 36.1 mt -104.83 141.73 19.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.502 ' O ' HG22 ' B' ' 22' ' ' ILE . 0.5 OUTLIER -76.75 173.67 11.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.63 -21.82 60.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.304 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.65 3.61 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.0 27.24 14.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.402 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.92 145.27 43.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.606 0.703 . . . . 0.0 109.813 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.43 119.53 13.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.413 . . . . 0.0 111.172 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 18.6 t -90.28 88.15 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 51.1 p -68.27 157.92 86.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.853 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.1 13.99 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.86 2.374 . . . . 0.0 112.635 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -121.95 3.1 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.055 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -114.28 151.98 32.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.988 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.93 136.55 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' B' ' 42' ' ' ILE . 21.0 p90 -149.34 166.28 29.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.2 t -136.04 142.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 46.2 mt -104.83 120.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.647 0.261 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.07 91.07 5.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.3 0.572 . . . . 0.0 109.75 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 81.19 -28.97 2.86 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.154 174.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.48 -27.2 0.15 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.42 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.233 0.54 . . . . 0.0 110.534 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' B' ' 35' ' ' TYR . 79.2 mt -82.24 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.468 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.749 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.7 mp -130.44 123.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.975 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 51.0 mt -55.46 143.91 27.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.693 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 10.7 mmt180 -66.96 0.81 2.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -73.01 -35.23 66.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 0.0 110.803 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -129.05 5.76 5.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.304 0.573 . . . . 0.0 110.265 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.749 HD23 ' HB ' ' B' ' 43' ' ' ILE . 3.0 tm? -51.71 -44.78 63.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.129 -172.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -59.79 -30.29 68.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.851 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 0.6 OUTLIER -76.35 -38.58 55.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.313 . . . . 0.0 110.808 -178.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -66.25 -32.47 73.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 32.9 mt -64.9 -48.24 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.47 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 7.5 ptp180 -69.04 -27.58 65.78 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.448 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -93.98 -34.57 13.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.596 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 54.2 tp60 -103.19 -67.88 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.085 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER 37.32 40.3 0.19 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.827 0.704 . . . . 0.0 110.078 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.596 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -131.21 6.19 5.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.652 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 50.8 -154.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.852 0.326 . . . . 0.0 110.126 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 5.9 tp10 -102.83 101.84 11.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.644 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.83 95.92 10.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 110.345 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 12.7 mmtp -112.89 56.26 0.68 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.439 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.24 74.35 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.14 8.97 3.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.238 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' B' ' 64' ' ' GLN . 7.8 tp60 52.11 40.89 29.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.037 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.1 t -114.87 102.42 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.303 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.2 148.72 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.544 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 mt -123.89 154.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 9.2 p-10 -78.15 -164.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 110.328 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.92 -27.9 43.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.723 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.27 -17.38 34.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.21 5.91 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.163 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 t70 -92.08 -96.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.7 tt0 174.35 118.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.88 95.1 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.259 0.552 . . . . 0.0 110.76 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 9.1 p -80.73 161.64 63.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.917 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 46.6 Cg_endo -67.96 13.71 0.18 Allowed 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 122.828 2.352 . . . . 0.0 113.177 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 30' ' ' THR . 27.3 m -115.43 11.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.614 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.74 172.76 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.289 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -103.79 125.22 50.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.862 0.363 . . . . 0.0 110.452 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.01 169.91 16.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.227 0.537 . . . . 0.0 110.877 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' B' ' 60' ' ' PHE . 70.7 t -137.53 139.55 43.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -105.76 120.99 57.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.436 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -108.76 86.98 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.15 42.9 34.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.21 -0.904 . . . . 0.0 113.681 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.04 -17.63 57.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.786 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -109.18 133.48 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.361 0.601 . . . . 0.0 110.923 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -85.77 137.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.585 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 3.0 mp -135.18 128.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.52 143.91 57.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HD2' HD22 ' A' ' 48' ' ' LEU . 11.9 mmm-85 -63.55 -11.65 26.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.42 -49.6 73.1 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.113 0.258 . . . . 0.0 111.266 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -129.35 39.15 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.712 . . . . 0.0 110.155 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 45' ' ' ARG . 11.7 tp -71.63 -35.82 70.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.773 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -55.35 -36.73 66.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.963 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 mtt-85 -78.27 -27.46 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.092 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.26 -33.7 61.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.492 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.738 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 73.5 mt -71.09 -24.54 62.33 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.57 172.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 53' ' ' ARG . 22.7 ttm-85 -71.32 -28.2 63.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 51.8 mm-40 -86.04 -54.05 4.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.391 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 11.0 tt0 -99.23 -67.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.781 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 4.7 tp 49.31 31.32 3.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.35 0.406 . . . . 0.0 110.408 -174.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -125.3 -6.17 6.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.73 -164.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.02 -154.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.802 0.801 . . . . 0.0 109.312 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' OE2' HD12 ' B' ' 37' ' ' ILE . 28.0 tt0 -116.44 102.28 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.457 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -83.49 102.68 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 6.0 tptm -97.91 90.29 4.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 -175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -85.16 44.91 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.918 -174.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.482 179.472 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.2 p30 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.816 0.341 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 138.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.679 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 14.2 pt20 -132.96 168.55 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 110.821 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 23' ' ' ASP . 34.5 mt -136.28 155.95 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.639 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 6.3 p-10 -79.38 -171.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.189 0.519 . . . . 0.0 110.791 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -70.04 -29.88 67.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.754 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -88.07 -21.52 24.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.1 38.5 4.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.025 -1.083 . . . . 0.0 113.227 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.6 t70 -89.09 -89.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 37.1 tt0 171.97 137.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.679 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 59.5 t -116.83 109.58 28.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.947 0.403 . . . . 0.0 110.707 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -94.17 159.84 33.33 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.56 3.76 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.67 -0.83 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 109.983 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -102.49 142.13 34.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.707 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 6.7 m-20 -83.85 120.18 25.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.307 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 21.9 p90 -142.58 161.94 36.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.589 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' B' ' 48' ' ' LEU . 84.4 t -124.81 139.48 50.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.582 HD12 ' OE2' ' A' ' 59' ' ' GLU . 53.4 mt -106.47 112.51 39.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.39 85.02 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.949 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' HG3' ' B' ' 59' ' ' GLU . . . 74.53 -32.15 1.0 Allowed Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.602 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.52 -21.73 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -81.44 143.04 32.39 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.401 HG21 HE21 ' B' ' 21' ' ' GLN . 75.2 mt -107.75 119.8 57.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.421 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.42 ' N ' HD12 ' B' ' 43' ' ' ILE . 3.0 mp -126.73 121.72 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.115 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 40.6 mt -57.23 146.4 28.49 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.558 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 66.7 mtp180 -69.07 0.26 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -60.1 -51.82 68.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.004 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -126.45 19.71 7.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.457 HD22 ' HG2' ' B' ' 45' ' ' ARG . 16.8 tp -53.23 -37.4 62.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.23 -43.82 64.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.575 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.71 -36.26 65.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.296 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -67.49 -35.98 80.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.0 -31.31 70.92 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.585 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -69.87 -24.24 63.39 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.709 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -89.09 -55.92 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -98.44 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.906 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.8 tp 82.72 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 124.141 0.9 . . . . 0.0 111.801 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 81.46 -49.4 4.02 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.45 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 33.6 m-85 -70.92 124.45 24.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.613 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 26.7 mt-10 -92.08 101.79 14.33 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.751 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 36' ' ' VAL . 97.1 m-85 -81.4 87.92 6.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.514 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -107.39 80.53 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.631 0.729 . . . . 0.0 110.923 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -71.9 158.26 36.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.05 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.01 95.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.994 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 55.47 58.77 4.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.307 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.713 ' H ' HD12 ' B' ' 65' ' ' LEU . 4.2 mp . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.492 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.554 0.693 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 t -93.92 124.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.694 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -123.19 157.58 32.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.503 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 13.0 mt -120.03 152.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.0 p-10 -90.6 -167.91 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.306 0.574 . . . . 0.0 110.904 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -69.93 -24.52 63.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -89.38 -34.26 16.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.496 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.503 ' HA2' ' CG2' ' A' ' 22' ' ' ILE . . . 99.74 27.67 7.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.591 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.71 -10.42 48.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 73.08 120.38 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.338 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 23' ' ' ASP . 47.6 t -113.61 113.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.514 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 p -102.97 167.75 9.79 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 51.2 Cg_exo -56.4 -11.49 6.43 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.826 2.35 . . . . 0.0 113.404 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.27 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.464 0.65 . . . . 0.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -107.62 146.08 32.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD2' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -89.92 130.52 36.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.6 p90 -153.76 161.58 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.825 0.345 . . . . 0.0 111.023 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.507 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 49.4 t -128.18 150.33 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 40.5 mt -115.78 116.88 53.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.157 0 CA-C-O 121.894 0.855 . . . . 0.0 111.187 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.41 89.32 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.731 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' B' ' 37' ' ' ILE . . . 69.17 45.11 63.07 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.247 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.5 -21.9 35.9 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.464 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -91.72 133.53 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.241 0.543 . . . . 0.0 110.578 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' A' ' 35' ' ' TYR . 60.3 mt -91.74 132.18 36.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.916 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.82 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.1 mp -130.99 125.99 58.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 29' ' ' VAL . 18.2 tp -63.61 143.54 57.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.549 HH11 HD12 ' A' ' 48' ' ' LEU . 12.8 mmm180 -62.48 -6.89 3.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 7.2 mm-40 -71.33 -57.79 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.47 0.34 53.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.82 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -62.76 -27.29 69.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.461 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.37 -48.33 74.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.694 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -61.6 -41.76 97.9 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.429 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.47 -37.96 89.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.292 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.524 ' HG ' HD13 ' A' ' 48' ' ' LEU . 19.5 mt -71.32 -26.7 62.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -71.3 -45.68 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.432 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.12 -32.38 13.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -102.97 -56.16 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.188 -0.32 . . . . 0.0 110.374 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 26.6 tp 77.65 37.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 111.914 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' B' ' 58' ' ' PHE . . . 89.43 -43.54 3.02 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.137 172.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.428 ' HE2' HD23 ' A' ' 56' ' ' LEU . 3.3 m-85 -70.14 117.97 12.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG13 ' B' ' 36' ' ' VAL . 9.6 tp10 -92.04 101.43 13.97 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' HA ' HG22 ' B' ' 36' ' ' VAL . 63.8 m-85 -89.75 86.29 6.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.06 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -84.71 174.77 9.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -142.34 177.26 8.38 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 174.842 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.83 103.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.988 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.45 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 10.4 pt20 -104.91 158.13 16.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.786 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.423 HG22 ' N ' ' B' ' 23' ' ' ASP . 18.1 mt -130.08 155.76 41.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 6.7 p-10 -83.88 -165.11 1.04 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.273 0.558 . . . . 0.0 110.955 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.77 -31.68 68.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.373 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -41.13 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.576 0.227 . . . . 0.0 110.891 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.3 35.82 3.03 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.671 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 19.0 t70 -88.58 -89.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 41.1 tt0 176.02 130.66 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.46 HG22 HD21 ' B' ' 44' ' ' LEU . 48.3 t -114.35 113.12 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.191 0.519 . . . . 0.0 110.819 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 67.1 p -106.15 169.3 7.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.3 Cg_exo -58.68 -4.54 1.96 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.154 2.569 . . . . 0.0 114.151 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.461 HG22 ' OG1' ' B' ' 30' ' ' THR . 19.2 m -106.52 0.65 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 110.795 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -96.78 136.94 36.62 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.538 ' HB3' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -80.68 108.54 14.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.142 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -126.63 155.44 42.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.106 0.479 . . . . 0.0 111.236 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 59' ' ' GLU . 41.8 t -129.85 145.75 35.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.536 ' CG2' ' HA2' ' A' ' 39' ' ' GLY . 36.1 mt -115.23 126.3 72.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.609 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.74 83.35 3.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.18 3.38 Favored Glycine 0 C--O 1.227 -0.327 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.303 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.76 -30.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -81.39 134.24 35.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.098 0.475 . . . . 0.0 110.315 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.92 138.37 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.386 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.509 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.8 mp -137.04 130.72 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.46 HD21 HG22 ' B' ' 29' ' ' VAL . 79.8 mt -60.39 150.06 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' B' ' 34' ' ' ASP . 20.8 mmt180 -61.37 -11.84 11.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.89 0.376 . . . . 0.0 110.964 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.1 -36.52 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.664 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -111.75 8.12 20.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.914 0.388 . . . . 0.0 110.644 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.528 HD13 ' HB ' ' B' ' 36' ' ' VAL . 63.9 tp -60.64 -47.93 84.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.443 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.71 -47.94 80.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 7.0 mtp180 -64.3 -45.96 85.69 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.111 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.44 ' CG ' HG12 ' B' ' 43' ' ' ILE . 47.1 t80 -59.07 -39.39 81.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.661 0.267 . . . . 0.0 110.925 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 39.0 mt -72.55 -28.72 63.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.618 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 8.4 ptp180 -86.86 -11.5 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.286 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 70.2 mm-40 -92.67 -54.92 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.185 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' B' ' 57' ' ' GLY . 37.6 tt0 -102.02 -65.96 0.95 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -174.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 2.2 tp 55.0 43.94 29.03 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' B' ' 55' ' ' GLN . . . -100.87 -50.37 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.771 -165.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.424 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 48.05 -176.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.271 0.628 . . . . 0.0 110.908 -167.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 30.8 tt0 -103.79 102.49 12.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.609 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.61 100.69 13.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.328 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -91.43 162.06 14.73 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.51 138.4 9.72 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.92 -43.75 64.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 68.59 -3.42 1.38 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.578 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -179.244 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 122.051 0.929 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.34 121.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.04 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 171.79 7.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 28' ' ' GLU . 21.0 mt -136.39 139.42 45.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 166.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.69 -166.99 1.74 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -70.78 -19.8 62.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.307 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.439 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 31.1 t80 -74.54 -32.43 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.549 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.97 25.55 26.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.143 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -96.42 -85.4 0.34 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HA ' HG12 ' A' ' 22' ' ' ILE . 17.5 tt0 -176.81 150.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 174.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 23' ' ' ASP . 58.6 t -130.92 117.34 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.729 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 p -116.25 168.45 8.6 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.854 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 41.2 Cg_endo -67.71 9.84 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.726 2.284 . . . . 0.0 113.766 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.1 6.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.517 . . . . 0.0 109.999 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -109.78 147.07 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.995 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.23 124.12 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -147.3 163.95 34.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 48' ' ' LEU . 61.6 t -136.52 137.72 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -99.64 121.83 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.86 86.48 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.47 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 77.55 -36.26 1.59 Allowed Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.768 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.628 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.67 135.24 34.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.108 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -91.17 133.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.988 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.9 mp -136.87 134.5 48.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 60.7 mt -54.39 151.57 7.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG2' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.67 -8.04 24.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.67 -45.47 10.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.245 0.545 . . . . 0.0 109.719 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -85.86 -4.95 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.229 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 36' ' ' VAL . 56.1 tp -54.97 -50.83 67.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.521 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 mt-10 -52.81 -48.99 66.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.307 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -59.44 -49.36 78.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.76 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.6 -32.92 74.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 40.4 mt -72.25 -24.36 61.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.566 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 94.0 mtt180 -72.13 -38.98 69.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.6 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -68.82 0.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.872 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 11.8 pt20 -103.79 -53.12 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.677 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 18.3 tp 47.78 43.37 16.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.493 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -123.5 -3.82 8.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.139 -1.029 . . . . 0.0 114.633 -165.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.22 -160.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 11.0 mm-40 -105.27 101.75 11.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -110.53 104.53 13.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.167 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.8 152.46 20.86 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -155.89 149.91 25.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.43 0 O-C-N 123.084 0.24 . . . . 0.0 111.317 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -121.9 119.52 58.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.587 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.4 HE21 HD13 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.07 173.92 12.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.103 176.002 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.423 HG21 ' HA2' ' B' ' 26' ' ' GLY . 30.3 mt -130.42 155.98 42.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.423 ' N ' HG22 ' B' ' 22' ' ' ILE . 7.5 p-10 -81.14 -162.19 0.47 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.257 0.551 . . . . 0.0 111.109 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -76.83 -30.2 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.743 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -80.51 -19.76 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.314 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 83.92 41.09 8.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.611 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.37 -82.68 0.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 178.02 140.91 0.09 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' B' ' 35' ' ' TYR . 21.9 t -126.4 141.72 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -124.53 155.83 68.57 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 -15.19 42.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.778 2.318 . . . . 0.0 112.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.53 9.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.636 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.17 150.55 46.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -86.32 130.06 34.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.224 0.535 . . . . 0.0 110.743 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.485 ' HB3' HG11 ' B' ' 29' ' ' VAL . 32.9 p90 -144.0 152.22 40.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.646 ' HB ' HD13 ' B' ' 48' ' ' LEU . 74.9 t -129.78 139.92 50.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 57.6 mt -101.09 116.84 45.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.623 0.725 . . . . 0.0 109.697 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -112.76 91.0 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.304 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.12 -4.37 86.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.44 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.93 4.33 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.87 143.04 27.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 110.308 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.495 HG12 HG12 ' B' ' 37' ' ' ILE . 81.3 mt -97.26 129.12 47.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.237 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.03 129.46 75.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.72 131.23 50.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 2.3 tmm_? -70.42 0.97 5.58 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -167.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.28 -7.21 57.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.436 0.636 . . . . 0.0 109.85 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -129.15 20.16 5.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' B' ' 36' ' ' VAL . 58.9 tp -71.4 -38.37 71.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.992 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.5 -44.61 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.98 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.68 -46.09 87.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.009 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -68.85 -32.88 72.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.04 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.9 mt -72.92 -28.51 62.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.615 0.245 . . . . 0.0 110.925 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.66 HH21 ' HG2' ' B' ' 54' ' ' GLU . 6.7 ttp180 -64.12 -41.53 97.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.234 0.54 . . . . 0.0 110.012 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.66 ' HG2' HH21 ' B' ' 53' ' ' ARG . 49.5 mt-10 -91.0 -51.02 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.876 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.457 HE21 ' HG2' ' B' ' 59' ' ' GLU . 7.2 tp60 -94.5 -54.46 3.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.435 0.16 . . . . 0.0 111.376 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.8 tp 74.82 33.54 0.77 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 -11.04 60.74 Favored Glycine 0 C--O 1.235 0.18 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.602 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -105.47 110.1 22.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.606 0.241 . . . . 0.0 111.3 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.457 ' HG2' HE21 ' B' ' 55' ' ' GLN . 0.0 OUTLIER -92.07 102.12 14.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.56 110.02 21.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.06 -171.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.93 97.39 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 111.264 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -85.38 162.94 18.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.79 10.68 2.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 111.131 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -82.95 76.93 9.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.772 176.684 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.14 97.3 5.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.46 ' NE2' HD13 ' A' ' 42' ' ' ILE . 10.6 pt20 -108.21 159.37 16.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.474 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 23' ' ' ASP . 26.7 mt -130.53 156.49 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 7.7 p-10 -77.83 -167.7 1.05 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -75.37 -31.76 60.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.443 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.21 -19.19 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.523 -174.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.28 50.12 2.67 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.404 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -99.64 -94.89 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -179.49 123.87 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.85 106.84 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.774 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.8 p -93.24 158.28 37.45 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HB2' HD22 ' B' ' 65' ' ' LEU . 27.9 Cg_exo -62.98 1.29 1.19 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.689 2.259 . . . . 0.0 113.18 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -98.8 -4.44 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.349 0.595 . . . . 0.0 109.928 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.47 ' O ' ' HD1' ' A' ' 35' ' ' TYR . 52.0 m-20 -108.64 120.44 42.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.706 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.11 126.24 27.48 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.949 0.404 . . . . 0.0 110.717 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 33' ' ' ASP . 38.9 p90 -146.35 168.0 22.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 0.0 110.902 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.4 t -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.75 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 24.4 mt -106.16 122.06 59.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 56' ' ' LEU . 10.2 t70 -94.06 86.77 5.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . 78.52 -42.52 2.22 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.021 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.27 -30.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.47 145.6 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.21 0.529 . . . . 0.0 110.472 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.46 HD13 ' NE2' ' A' ' 21' ' ' GLN . 66.3 mt -102.57 136.85 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.006 -172.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 51' ' ' TYR . 2.6 mp -138.41 129.53 36.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 175.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.07 150.52 24.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.252 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.05 -5.93 25.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.403 178.005 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -55.73 15.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 110.188 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.64 25.25 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.143 0.973 . . . . 0.0 109.138 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 36.1 tp -56.0 -50.18 71.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.164 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.67 -28.51 69.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.571 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.421 HH22 ' HD2' ' A' ' 53' ' ' ARG . 1.1 tpm_? -64.24 -49.27 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 110.265 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 33.4 t80 -75.68 -24.57 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.939 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 50.6 mt -69.69 -26.64 64.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.421 ' HD2' HH22 ' A' ' 50' ' ' ARG . 18.4 ttm180 -86.02 -19.5 30.24 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 1.1 tp10 -79.16 -54.09 6.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.18 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 30.2 tt0 -103.14 -67.69 0.87 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.559 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.1 tt 33.03 47.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.689 0.757 . . . . 0.0 109.716 -168.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.664 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -118.7 -18.09 4.92 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.733 -170.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.731 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 10.6 m-85 53.55 -151.54 0.33 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 21.1 mt-10 -119.64 102.13 8.4 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.919 166.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -84.36 119.87 25.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 59' ' ' GLU . 46.0 mmtm -117.57 102.58 9.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 111.599 -177.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -79.37 160.54 26.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.721 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.978 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.66 0.267 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t 55.82 76.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.355 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.511 ' OE1' HD13 ' B' ' 42' ' ' ILE . 3.5 pp0? -93.33 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.653 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -126.75 147.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.801 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.493 ' HB3' HG21 ' B' ' 29' ' ' VAL . 5.3 p-10 -86.18 -164.41 1.04 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.08 0.467 . . . . 0.0 110.761 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -68.28 -28.96 67.64 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.26 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -59.76 -44.24 93.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.675 0.274 . . . . 0.0 111.008 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.22 33.21 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.029 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.3 -84.84 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.715 0.293 . . . . 0.0 110.342 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -169.55 142.2 2.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' B' ' 23' ' ' ASP . 22.0 t -123.65 86.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.676 0.75 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.469 HG23 HG22 ' B' ' 32' ' ' VAL . 0.1 OUTLIER -81.29 153.85 71.71 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.093 175.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.06 12.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 123.4 2.734 . . . . 0.0 114.787 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 30' ' ' THR . 33.9 m -103.21 -5.55 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.048 0.451 . . . . 0.0 110.282 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.35 155.81 17.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.267 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.649 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 5.3 m-20 -89.81 118.61 29.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.542 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -144.24 160.59 40.72 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.703 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.61 146.87 31.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.601 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mt -103.02 100.02 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.748 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 7.8 m-20 -96.54 90.8 5.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.463 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.655 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 72.49 37.1 58.61 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.516 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.62 -26.27 23.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.595 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.23 142.54 27.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.769 0.319 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.511 HD13 ' OE1' ' B' ' 21' ' ' GLN . 76.7 mt -100.49 128.43 52.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' HD12 ' B' ' 43' ' ' ILE . 4.3 mp -126.46 126.8 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.302 . . . . 0.0 110.422 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.1 tt -69.37 134.69 49.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.649 ' HE ' ' HB3' ' B' ' 34' ' ' ASP . 15.6 mtm180 -69.25 0.53 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLU . . . . . 0.541 ' HG2' HD22 ' B' ' 44' ' ' LEU . 42.6 mm-40 -69.05 -18.05 63.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.893 0.378 . . . . 0.0 110.387 171.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -129.24 3.5 5.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.196 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 61.4 tp -57.74 -33.21 68.22 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.159 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 30.6 mt-10 -57.4 -52.66 64.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.779 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' B' ' 53' ' ' ARG . 7.4 mpt_? -71.14 -31.56 67.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -65.72 -39.38 91.11 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.337 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -69.38 -29.32 67.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' B' ' 50' ' ' ARG . 32.4 mtp180 -65.7 -32.71 74.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -94.45 -62.48 1.32 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.77 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -85.5 -42.2 14.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.051 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.6 tp 74.11 13.42 4.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.142 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 88.28 -29.03 5.82 Favored Glycine 0 CA--C 1.517 0.169 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.487 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -69.85 126.05 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.581 0.229 . . . . 0.0 111.107 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.1 tp10 -92.77 101.88 14.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.539 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.31 86.0 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -84.08 93.64 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 0.0 110.658 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -66.1 126.44 28.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.742 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.58 64.59 8.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 110.541 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -76.52 -56.16 4.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.39 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 31' ' ' PRO . 24.4 tp . . . . . 0 C--O 1.234 0.277 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.141 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.06 0.457 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 t -84.29 117.56 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.0 159.68 41.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.347 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.8 mt -134.03 153.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.647 0.261 . . . . 0.0 110.377 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.8 p-10 -80.44 -177.77 6.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 110.78 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.62 -28.14 69.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.848 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -86.61 -17.24 34.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 37.43 6.96 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.746 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 t70 -90.84 -88.39 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.9 tt0 174.69 138.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.8 116.93 28.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.033 0.444 . . . . 0.0 110.338 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.784 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 60.5 p -110.05 172.8 3.31 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.999 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.784 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 42.6 Cg_endo -68.48 2.3 2.97 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.313 2.009 . . . . 0.0 112.197 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.34 14.04 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.548 0.69 . . . . 0.0 109.449 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 44' ' ' LEU . 41.9 m-20 -118.69 146.62 44.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.207 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -92.01 118.26 30.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 174.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HB3' HD12 ' A' ' 44' ' ' LEU . 31.0 p90 -144.02 168.01 21.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.486 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.672 ' HB ' HD13 ' A' ' 48' ' ' LEU . 72.0 t -131.51 133.68 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 35' ' ' TYR . 61.1 mt -103.52 121.96 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.323 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -93.13 86.2 5.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.339 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.582 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.31 -31.56 1.85 Allowed Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.35 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.43 -23.0 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.14 130.56 35.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.3 mt -89.76 129.14 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.56 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.6 mp -133.98 122.73 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 35' ' ' TYR . 13.9 tp -64.8 149.76 48.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -55.99 -23.42 32.47 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -81.54 -22.92 37.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 110.59 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -112.9 4.25 16.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.298 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.672 HD13 ' HB ' ' A' ' 36' ' ' VAL . 29.3 tp -70.68 -60.68 2.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 35.1 mt-10 -61.93 -16.18 49.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -165.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 53' ' ' ARG . 19.2 tpt180 -80.99 -49.91 10.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.225 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD2' HG12 ' A' ' 43' ' ' ILE . 16.1 t80 -63.75 -43.27 96.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 14.9 mt -63.82 -41.36 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 40.0 ttm-85 -52.04 -46.53 65.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.845 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.01 -25.26 23.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.675 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 29.0 tt0 -99.47 -68.08 0.82 Allowed 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.423 -0.798 . . . . 0.0 112.048 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 65.5 mt 42.27 43.99 3.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.317 0.58 . . . . 0.0 109.71 -169.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.675 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -100.8 -14.33 32.04 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.277 -168.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 57.22 -151.59 0.41 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' C ' ' A' ' 39' ' ' GLY . 2.3 mt-10 -118.22 102.16 8.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 163.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.37 103.55 12.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.078 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -109.04 37.83 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.305 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -55.71 119.38 5.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.775 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' B' ' 34' ' ' ASP . . . . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.405 0.622 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.66 131.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.712 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.666 HE21 HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.99 -172.9 4.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.362 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 28' ' ' GLU . 41.0 mt -126.7 150.04 32.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.6 OUTLIER -83.11 -170.08 2.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.796 0.332 . . . . 0.0 110.285 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.07 -27.25 62.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.76 0.424 . . . . 0.0 111.021 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' TYR . . . . . 0.446 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 29.1 t80 -76.61 -30.59 56.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.75 30.08 5.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.188 -1.005 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.414 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.9 t70 -111.65 132.33 54.66 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 171.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.485 ' HA ' HG12 ' B' ' 22' ' ' ILE . 26.1 tt0 -64.71 124.18 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.334 0.588 . . . . 0.0 110.598 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' B' ' 35' ' ' TYR . 42.9 t -104.47 129.94 56.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.814 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.859 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 72.0 p -118.89 175.69 2.03 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.859 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_endo -64.47 5.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.392 2.062 . . . . 0.0 113.207 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.1 18.53 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.576 0.703 . . . . 0.0 109.418 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -129.1 125.81 37.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.366 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.433 ' HA ' ' H ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -65.38 109.76 2.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.211 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.407 ' HB3' HG11 ' B' ' 29' ' ' VAL . 16.6 p90 -135.88 149.13 48.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.159 0.504 . . . . 0.0 110.197 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.87 142.59 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.21 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.5 mt -102.93 115.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.524 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -94.63 89.06 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.582 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 83.0 -26.65 4.2 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.642 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.32 -26.25 0.35 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.44 129.55 34.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.666 HG21 HE21 ' B' ' 21' ' ' GLN . 64.3 mt -93.1 136.6 24.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.686 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -136.44 133.96 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.419 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -69.05 143.75 54.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.653 ' HD3' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -57.23 -20.71 28.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -172.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.43 -29.93 62.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.1 0.476 . . . . 0.0 110.708 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -106.92 -12.62 15.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.604 0.716 . . . . 0.0 109.773 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.653 HD23 ' HD3' ' B' ' 45' ' ' ARG . 31.5 tp -60.67 -52.01 66.93 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.959 -175.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.31 -37.31 80.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.323 0.582 . . . . 0.0 110.236 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 23.8 tpt85 -64.58 -53.55 46.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.234 176.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.67 -36.54 76.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.996 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 66.7 mt -63.66 -47.32 81.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.912 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 14.1 ptt85 -63.22 -28.46 70.05 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.242 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.57 -36.84 17.32 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.728 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.2 tp-100 -103.04 -68.19 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 27.1 mt 38.5 40.57 0.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.504 0.502 . . . . 0.0 110.723 -167.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.728 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -107.06 -13.72 20.73 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.306 -167.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 57.75 -154.93 0.34 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.66 102.03 9.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.306 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' A' ' 36' ' ' VAL . 25.1 m-85 -84.55 99.86 11.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -92.43 91.6 7.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.111 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.0 128.56 36.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.828 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.96 -11.02 60.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.365 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 54.51 78.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.814 0.816 . . . . 0.0 110.119 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.634 -174.439 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 89.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.732 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -115.94 141.05 48.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.582 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 23' ' ' ASP . 27.8 mt -99.62 161.23 3.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 3.2 p-10 -79.35 -167.12 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -77.38 -31.37 54.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.734 0.302 . . . . 0.0 111.591 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -80.03 -31.96 39.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.66 39.99 1.52 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.635 -1.269 . . . . 0.0 113.067 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.02 -110.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -174.38 124.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.54 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.3 p -105.19 165.12 13.74 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.089 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.7 Cg_exo -58.73 1.65 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.289 2.66 . . . . 0.0 114.304 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.22 17.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -112.99 138.16 50.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.215 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.44 116.07 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -133.56 166.99 21.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.817 ' HB ' HD21 ' A' ' 48' ' ' LEU . 92.3 t -135.63 138.38 48.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 54.0 mt -106.44 114.05 44.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 52.6 t0 -95.44 87.74 4.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.21 0.529 . . . . 0.0 110.373 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.786 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 81.29 -11.64 42.87 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.264 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -22.4 1.56 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -83.89 130.16 34.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.4 mt -89.11 131.04 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.383 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.543 ' HB ' HD22 ' A' ' 48' ' ' LEU . 3.5 mp -134.8 136.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -74.1 146.12 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.562 ' N ' HD23 ' A' ' 44' ' ' LEU . 2.0 mmt180 -56.47 -21.52 26.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.51 -40.56 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.943 0.401 . . . . 0.0 110.024 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -89.18 -1.35 58.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 110.447 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -64.14 -40.6 96.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.02 -55.56 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.666 -174.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -64.53 -35.23 80.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.596 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -46.75 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 48' ' ' LEU . 87.7 mt -66.35 -26.43 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -73.79 -33.72 64.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.687 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.68 -51.04 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 12.8 tt0 -90.47 -68.36 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.492 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 38.74 35.56 0.12 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.792 0.682 . . . . 0.0 110.763 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -136.73 10.44 3.98 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.145 -171.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 1.3 m-85 58.34 -158.65 0.29 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.235 0.54 . . . . 0.0 110.882 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.6 tp10 -100.88 102.02 12.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.03 90.48 4.91 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.916 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 73.5 mmtt -86.64 147.12 26.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.521 -175.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -119.22 141.78 48.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.768 0.318 . . . . 0.0 111.066 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.415 0.626 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.83 127.0 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.266 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -135.92 172.39 13.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.367 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.68 146.31 34.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.1 OUTLIER -77.69 178.67 7.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.699 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -63.81 -26.15 68.5 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.734 0.414 . . . . 0.0 111.79 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' TYR . . . . . 0.424 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 94.9 m-85 -98.65 -2.06 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.67 17.32 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.736 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.36 128.66 39.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -72.57 99.69 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.0 t -86.61 114.64 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.517 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 78.3 p -102.61 172.85 3.94 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.011 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 77.1 Cg_exo -49.56 -22.47 6.52 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.224 2.616 . . . . 0.0 114.331 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.95 6.81 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -101.77 123.39 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -69.19 121.79 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.256 -179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 26.0 p90 -144.66 161.14 39.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.909 0.385 . . . . 0.0 110.988 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.564 HG23 ' HD3' ' B' ' 45' ' ' ARG . 54.4 t -135.09 143.73 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.577 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 48.9 mt -109.32 115.93 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 111.223 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.07 90.11 6.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 109.529 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.786 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 81.97 -34.12 2.6 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.282 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.69 -24.7 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -174.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -82.59 134.57 35.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.074 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.41 HG12 HG12 ' B' ' 37' ' ' ILE . 69.1 mt -92.52 129.57 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.827 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.01 122.52 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.51 141.37 47.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' HG23 ' B' ' 36' ' ' VAL . 30.3 mmm-85 -60.81 -12.07 9.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -67.99 -47.06 69.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.71 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -103.17 -3.66 25.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.973 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' B' ' 36' ' ' VAL . 37.4 tp -47.86 -41.92 25.31 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.662 -173.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -53.98 -44.61 70.97 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.808 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -74.67 -41.29 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -65.16 -45.16 86.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.447 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 52' ' ' LEU . 35.2 mt -69.84 -24.84 63.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.199 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -68.15 -44.25 76.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.558 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -93.81 -30.33 14.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.617 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp-100 -99.34 -67.55 0.84 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.09 37.89 1.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.439 0.638 . . . . 0.0 109.607 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.617 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -116.62 1.04 20.23 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.819 -165.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.68 -150.91 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.773 0.787 . . . . 0.0 109.377 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 3.3 mm-40 -115.04 101.79 9.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.33 96.57 10.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.31 86.16 2.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.512 0.673 . . . . 0.0 111.072 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -67.93 169.49 9.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.839 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.05 13.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 62.47 14.93 7.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.975 0.417 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.154 179.837 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.247 0.546 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t -131.71 137.12 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.476 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.578 ' HB2' HD13 ' A' ' 42' ' ' ILE . 1.1 pp0? -116.53 116.11 27.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.549 0.69 . . . . 0.0 110.387 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.17 142.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -63.08 -170.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.151 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -73.81 -31.64 63.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.455 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -72.17 -36.69 69.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 109.952 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 24.32 7.55 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.003 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 6.7 t70 -80.5 -81.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.58 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 40.3 tt0 163.92 123.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.809 0.693 . . . . 0.0 110.299 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 35' ' ' TYR . 9.4 t -113.35 134.89 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -111.47 153.93 43.99 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.201 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.62 1.73 2.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.0 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.14 -3.8 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.503 0.668 . . . . 0.0 109.46 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.38 179.39 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -111.7 128.98 56.24 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HB3' HG11 ' A' ' 29' ' ' VAL . 36.8 p90 -141.46 167.47 22.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.136 0.493 . . . . 0.0 110.691 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 96.2 t -136.62 138.29 46.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 47.6 mt -93.8 113.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.214 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 11.8 t0 -88.22 88.6 7.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.137 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 73.95 -27.65 0.95 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.423 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.43 -22.05 0.13 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -82.49 145.93 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.107 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 21' ' ' GLN . 83.5 mt -98.51 131.21 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.455 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 48' ' ' LEU . 1.7 mp -139.69 130.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 45' ' ' ARG . 5.6 tt -63.13 143.22 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 44' ' ' LEU . 10.5 mmm-85 -51.06 -23.28 2.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.83 -29.96 35.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.067 0.46 . . . . 0.0 110.808 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.81 -12.7 18.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.431 0.634 . . . . 0.0 109.911 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.962 ' HG ' ' HB ' ' A' ' 36' ' ' VAL . 2.8 tm? -61.68 -37.12 82.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.845 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -54.76 -52.4 62.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 ttm180 -76.34 -20.66 57.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -76.43 -30.7 57.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.021 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 56' ' ' LEU . 64.8 mt -67.72 -32.76 73.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.272 0.558 . . . . 0.0 109.667 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -61.38 -35.13 76.65 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -74.99 -64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.182 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -103.27 -59.22 1.75 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.8 tp 89.45 39.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.101 0.96 . . . . 0.0 112.117 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 72.39 57.67 5.44 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.449 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -155.2 120.22 4.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.123 0.461 . . . . 0.0 112.102 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.539 ' CB ' ' HB ' ' B' ' 37' ' ' ILE . 3.1 mm-40 -101.45 101.7 12.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 160.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.75 109.51 19.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.298 -168.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -121.42 174.63 6.63 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -165.12 169.95 15.56 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.192 178.348 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.27 109.08 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 13.6 pt20 -93.21 132.78 37.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.164 0.507 . . . . 0.0 111.284 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.25 151.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.523 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 0.5 OUTLIER -85.09 -177.91 6.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.62 -25.0 67.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.807 0.443 . . . . 0.0 111.82 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' TYR . . . . . 0.41 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 47.2 t80 -89.65 -18.02 27.28 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.51 13.59 27.82 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.633 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.72 129.45 36.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.32 99.59 4.14 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 46.5 t -81.38 101.16 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.44 0.638 . . . . 0.0 111.189 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 21.9 p -86.06 163.12 44.33 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.471 174.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 50.5 Cg_endo -68.82 20.33 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.933 2.422 . . . . 0.0 113.37 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' B' ' 30' ' ' THR . 7.0 t -116.67 1.01 8.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.109 0.481 . . . . 0.0 109.994 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -121.83 170.15 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -92.66 124.89 37.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.576 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.489 ' HB3' HG11 ' B' ' 29' ' ' VAL . 18.5 p90 -136.73 146.22 45.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.97 0.414 . . . . 0.0 110.64 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.67 138.95 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 36.8 mt -99.86 113.62 35.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-O 121.628 0.727 . . . . 0.0 109.83 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -106.87 90.17 3.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.653 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' B' ' 59' ' ' GLU . . . 81.51 12.01 82.4 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.421 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.38 -30.46 4.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -97.51 150.29 21.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.331 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 72.9 mt -89.76 140.79 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.176 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.405 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.3 mp -134.41 129.9 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.516 HD12 HG22 ' B' ' 29' ' ' VAL . 3.9 tt -72.18 137.8 47.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 12.3 mtm180 -70.85 0.32 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.92 -15.26 56.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.23 3.21 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.278 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 28.1 tp -73.24 -34.89 66.13 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -170.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -51.59 -41.49 61.23 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 53' ' ' ARG . 7.6 ttm180 -77.55 -33.31 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -71.01 -38.21 72.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.582 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 58.0 mt -67.34 -29.15 68.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.164 0.506 . . . . 0.0 110.072 172.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' B' ' 50' ' ' ARG . 18.6 ttm180 -65.77 -28.19 68.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -70.01 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.647 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' B' ' 56' ' ' LEU . 2.4 pt20 -104.23 -48.63 3.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' B' ' 55' ' ' GLN . 29.0 tp 82.36 42.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.918 0.761 . . . . 0.0 111.224 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 57' ' ' GLY . . . 95.3 -20.57 48.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.763 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -87.58 107.39 18.57 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -174.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.613 ' CG ' ' HA3' ' B' ' 39' ' ' GLY . 3.0 mm-40 -101.63 102.24 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.147 0.498 . . . . 0.0 110.679 171.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -89.62 123.05 33.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.454 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -127.12 79.89 1.91 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 111.013 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -75.12 162.55 28.42 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 65' ' ' LEU . . . -58.36 -36.34 73.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.485 0.183 . . . . 0.0 111.35 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.06 -13.45 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' B' ' 63' ' ' ALA . 53.7 tp . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 121.951 0.881 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.82 102.79 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.51 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt20 -101.39 147.54 26.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.05 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.421 HG21 ' HA2' ' A' ' 26' ' ' GLY . 29.0 mt -123.17 153.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 6.4 p-10 -76.29 -164.89 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -78.78 -29.97 45.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.954 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.542 ' HD2' HD22 ' A' ' 47' ' ' ASN . 65.5 m-85 -96.1 -7.57 35.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 84.87 51.18 3.89 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.164 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 18.5 t70 -94.77 -86.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 35.1 tt0 167.89 135.36 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.312 1.045 . . . . 0.0 108.212 170.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.53 104.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 110.68 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.801 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 71.9 p -96.12 174.08 3.71 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.801 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.6 Cg_endo -66.05 4.24 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.15 1.9 . . . . 0.0 112.416 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.39 -18.23 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.133 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -94.43 119.93 33.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.379 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.23 138.58 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -155.93 166.24 34.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.206 0.526 . . . . 0.0 111.136 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 59' ' ' GLU . 69.4 t -135.07 145.79 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 20.1 mt -103.37 120.11 52.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 121.794 0.807 . . . . 0.0 110.82 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 43' ' ' ILE . 26.2 t0 -105.93 90.28 3.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.607 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.645 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 77.9 20.13 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.09 42.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.77 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.71 139.17 34.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.7 mt -88.86 138.88 18.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.51 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -139.53 127.47 26.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.3 tt -62.88 148.62 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.842 HH11 HD23 ' A' ' 48' ' ' LEU . 8.2 mmm180 -61.89 -7.25 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.89 -55.39 3.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 0.0 110.725 175.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.542 HD22 ' HD2' ' A' ' 25' ' ' TYR . 15.0 p-10 -89.62 3.64 51.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.312 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.842 HD23 HH11 ' A' ' 45' ' ' ARG . 36.8 tp -61.16 -32.62 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.986 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -44.43 -54.32 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.301 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NH2' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -68.77 -33.09 73.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.87 -172.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.574 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -76.18 -39.3 55.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.712 -176.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.5 mt -67.73 -22.28 65.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.794 0.807 . . . . 0.0 109.364 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.504 HH11 ' NH2' ' A' ' 50' ' ' ARG . 27.9 ttm180 -76.65 -25.17 53.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.264 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -90.16 -69.48 0.72 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.861 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.12 -16.16 15.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 30.3 tp 71.74 28.34 2.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 171.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 98.54 -8.51 62.09 Favored Glycine 0 C--N 1.321 -0.294 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.748 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.402 ' HE1' ' HA3' ' B' ' 57' ' ' GLY . 12.4 m-85 -117.1 129.76 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.078 0.439 . . . . 0.0 111.995 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.683 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 11.8 mt-10 -96.45 102.14 13.88 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 164.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -81.81 106.67 13.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.683 ' HE2' ' HB3' ' A' ' 59' ' ' GLU . 3.8 mptp? -108.68 80.61 1.35 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 109.766 174.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -83.75 146.47 28.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.227 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 121.375 0.607 . . . . 0.0 110.331 179.452 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 121.599 0.714 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.79 130.99 60.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.479 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.454 ' OE1' HG21 ' B' ' 42' ' ' ILE . 3.0 pp0? -148.14 163.63 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.48 150.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.671 0.272 . . . . 0.0 110.964 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.37 -168.08 1.06 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -70.56 -29.01 65.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.74 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -86.04 -8.63 57.79 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.58 36.88 25.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.242 168.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 -92.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.423 0.611 . . . . 0.0 110.493 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -173.46 137.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -119.19 121.23 66.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.016 0.436 . . . . 0.0 110.14 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 57.3 p -102.42 168.81 8.38 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.84 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.706 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 33.4 Cg_endo -64.97 -4.03 8.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.58 2.186 . . . . 0.0 112.627 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.53 -2.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.304 0.573 . . . . 0.0 110.138 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -107.54 136.8 46.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.47 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -69.1 116.23 9.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.289 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.24 139.41 35.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 110.583 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.55 139.16 45.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 36.2 mt -91.18 96.69 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 95.2 m-20 -79.17 90.63 4.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.022 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 78.05 -17.66 5.81 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.971 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.39 -19.34 0.92 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 8.3 tp10 -93.02 144.67 25.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.454 HG21 ' OE1' ' B' ' 21' ' ' GLN . 80.2 mt -99.95 129.7 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.156 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.19 128.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.484 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 82.2 mt -54.52 141.35 31.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 23.8 mtm180 -71.65 0.52 8.52 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.584 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.03 -13.04 59.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -128.35 -0.62 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.153 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 36.2 tp -60.37 -40.35 90.5 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.826 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 27.4 tt0 -53.66 -51.64 62.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.559 0.218 . . . . 0.0 111.056 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.595 ' HD2' ' HD3' ' B' ' 53' ' ' ARG . 9.9 mmm180 -61.71 -36.29 80.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.366 -176.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -65.36 -43.38 90.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.947 0.403 . . . . 0.0 110.08 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 73.4 mt -71.92 -31.26 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.595 ' HD3' ' HD2' ' B' ' 50' ' ' ARG . 19.5 mtp180 -63.95 -33.4 75.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 25.1 mm-40 -92.18 -61.99 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.259 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -98.19 -29.17 13.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.1 tp 80.42 7.32 1.49 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.461 0.704 . . . . 0.0 111.924 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 91.74 1.55 70.71 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.414 -0.898 . . . . 0.0 115.149 166.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -98.94 134.91 41.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.78 0.79 . . . . 0.0 109.725 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.72 ' HB3' ' HE2' ' B' ' 61' ' ' LYS . 6.7 mt-10 -92.21 101.65 14.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.401 171.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.36 122.36 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.118 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.72 ' HE2' ' HB3' ' B' ' 59' ' ' GLU . 72.2 mmtt -119.17 157.62 27.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -135.59 137.78 42.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.04 0.447 . . . . 0.0 110.637 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.11 -49.66 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.899 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.94 2.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.459 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -171.972 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.521 -0.139 0 CA-C-O 121.782 0.801 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.86 102.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.623 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 167.14 15.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mt -116.74 153.93 18.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.997 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.545 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 4.3 p-10 -83.84 -160.08 0.42 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.562 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -80.07 -23.51 41.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -41.13 35.55 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.6 45.32 1.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.825 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.28 -88.71 0.45 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 176.83 129.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.27 138.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.7 p -123.82 160.5 51.22 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.26 2.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.185 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 HD22 ' B' ' 65' ' ' LEU . 12.0 t -97.47 -16.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.4 141.72 45.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.794 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.2 138.85 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.698 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.455 ' CD2' HG23 ' A' ' 42' ' ' ILE . 33.1 p90 -148.69 175.01 11.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.891 175.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 94.5 t -134.5 139.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.526 HG22 ' HA2' ' B' ' 39' ' ' GLY . 18.3 mt -103.42 119.76 52.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -105.11 89.51 3.16 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.369 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 88.87 -40.09 3.09 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.22 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.35 -23.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.654 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.49 164.91 14.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 111.055 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.455 HG23 ' CD2' ' A' ' 35' ' ' TYR . 71.2 mt -116.82 129.29 73.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.809 -171.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.0 mp -130.35 123.72 56.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.197 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.545 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 3.9 tt -60.37 141.31 56.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.7 -16.95 7.28 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -77.59 -33.42 53.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.419 0.628 . . . . 0.0 110.006 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -104.97 -5.76 20.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.957 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -66.79 -25.95 66.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.791 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.95 -30.05 68.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 74.3 ttt180 -82.65 -33.82 27.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.562 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.3 t80 -69.26 -36.3 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 29.6 mt -74.91 -34.64 62.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.996 0.426 . . . . 0.0 110.095 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 50' ' ' ARG . 4.6 ttp180 -59.86 -55.4 34.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.182 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 53' ' ' ARG . 53.6 mt-10 -93.0 -39.21 11.23 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.684 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 50.5 tp60 -97.49 -68.39 0.8 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.792 -0.568 . . . . 0.0 111.164 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HG ' ' HE1' ' B' ' 58' ' ' PHE . 0.7 OUTLIER 39.35 34.97 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.658 0.742 . . . . 0.0 110.225 -175.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.684 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -117.24 -19.81 4.98 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.873 -1.156 . . . . 0.0 114.583 -165.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 58.32 -153.96 0.37 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 7.4 tp10 -109.28 101.78 10.75 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.302 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.38 121.26 30.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.2 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -119.96 148.07 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.55 0.691 . . . . 0.0 111.105 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.42 148.05 47.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.035 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.122 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.14 97.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.027 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.508 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 11.0 pt20 -116.11 151.91 34.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.687 -170.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 15.4 mt -119.65 146.45 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.171 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.9 OUTLIER -70.77 -173.71 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 111.16 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.24 -30.57 71.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.585 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.64 -43.84 11.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.21 29.01 0.3 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.781 -1.2 . . . . 0.0 113.486 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -114.77 137.87 51.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.34 132.28 53.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 111.734 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.508 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 16.4 t -111.26 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.233 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.646 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 31.5 p -87.02 164.47 36.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.5 Cg_endo -65.38 -3.7 8.06 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.77 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 t -101.27 1.28 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.327 0.584 . . . . 0.0 109.656 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -112.35 141.31 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.154 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 8.6 m-20 -78.06 135.73 37.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.24 162.97 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.962 0.41 . . . . 0.0 110.638 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.423 HG23 ' HG2' ' B' ' 45' ' ' ARG . 95.3 t -128.53 144.38 38.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 37.0 mt -107.05 100.14 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 0.0 109.265 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.784 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 5.9 m-20 -93.56 90.27 6.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.543 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . 74.75 25.46 69.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.393 176.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.78 -12.38 59.35 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.82 133.22 37.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -95.62 130.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.523 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.555 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.9 mp -138.2 126.13 29.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' B' ' 23' ' ' ASP . 5.2 mp -55.25 143.2 28.77 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 12.3 mtp180 -70.27 -0.38 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.707 0.289 . . . . 0.0 111.598 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.59 -16.15 43.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.781 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.74 -4.36 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.884 0.85 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 2.6 tm? -65.4 -35.4 80.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.963 -175.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 1.9 tm-20 -57.25 -55.96 27.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -60.68 -36.38 78.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.052 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.26 -33.55 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.676 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 68.6 mt -69.53 -29.16 66.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.474 . . . . 0.0 110.299 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 53' ' ' ARG . 46.3 mtp85 -72.07 -24.28 61.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.46 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.44 -66.46 0.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.631 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -98.21 -34.31 10.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.641 -174.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.2 tp 77.05 1.97 3.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.491 0.717 . . . . 0.0 111.276 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.784 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 106.92 -32.91 6.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.097 170.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.535 ' HE1' ' HG ' ' A' ' 56' ' ' LEU . 34.2 m-85 -70.93 123.43 22.01 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.671 -0.311 . . . . 0.0 110.819 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.459 ' OE1' ' HE2' ' B' ' 61' ' ' LYS . 40.5 tt0 -95.57 101.99 13.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.287 170.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -82.88 91.78 7.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.459 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 60.5 mmtt -81.75 75.07 8.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -64.51 158.43 24.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.09 -51.53 24.1 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.665 0.603 . . . . 0.0 110.876 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 62.28 15.45 7.61 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.61 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 32' ' ' VAL . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.533 0.683 . . . . 0.0 110.445 -178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.598 0.713 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.2 t -117.91 87.98 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.948 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.426 ' OE1' ' HB ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -120.95 172.59 7.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.21 -176.237 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 28' ' ' GLU . 45.5 mt -129.8 150.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.9 p-10 -86.36 -170.28 3.02 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.2 -17.73 62.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.407 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 2.0 t80 -76.73 -41.99 42.94 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.74 34.92 3.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.987 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -102.36 -87.24 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.062 0.431 . . . . 0.0 109.992 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 -175.45 138.96 0.42 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG22 HD21 ' A' ' 44' ' ' LEU . 7.9 t -125.86 113.52 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 110.75 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 32' ' ' VAL . 24.9 p -114.84 163.93 18.13 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.022 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.71 7.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.499 2.799 . . . . 0.0 114.637 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 30' ' ' THR . 22.0 m -100.18 -5.87 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.59 176.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD2' HD22 ' A' ' 44' ' ' LEU . 5.0 t70 -119.96 160.31 22.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -96.26 121.35 37.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.926 -173.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.21 159.66 41.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.055 0.455 . . . . 0.0 110.701 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HB ' HD13 ' A' ' 48' ' ' LEU . 96.0 t -134.08 142.42 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.753 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 42' ' ' ILE . 18.7 mt -102.73 121.74 54.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.623 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -94.48 89.17 5.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 79.58 -51.08 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.616 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -31.14 0.02 OUTLIER Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -174.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.59 142.2 33.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.229 0.537 . . . . 0.0 110.038 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 37' ' ' ILE . 84.0 mt -98.22 135.78 31.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.306 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 2.2 mp -137.78 132.1 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD21 HG22 ' A' ' 29' ' ' VAL . 83.4 mt -58.92 152.6 19.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 172.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HD2' HD22 ' A' ' 48' ' ' LEU . 44.5 mmm-85 -63.65 -16.3 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.92 0.39 . . . . 0.0 110.577 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.22 -38.63 50.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.45 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.5 4.06 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.335 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 36' ' ' VAL . 40.4 tp -60.58 -41.32 94.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.499 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.16 -55.17 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.122 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.7 51.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.87 -45.0 91.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.481 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 58.0 mt -66.51 -48.77 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -61.97 -29.05 69.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.655 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -51.83 8.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.491 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 46.5 tt0 -103.49 -67.49 0.88 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 20.2 mt 47.72 43.35 16.67 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -168.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -113.65 1.94 24.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.672 -166.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' CZ ' ' HE1' ' B' ' 58' ' ' PHE . 8.3 m-85 59.33 -154.84 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.484 0.642 . . . . 0.0 109.69 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.5 tp10 -122.12 102.05 7.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 166.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.26 110.95 23.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.247 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 74.1 mmtt -112.5 63.89 0.63 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.127 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -74.11 149.87 40.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.093 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.925 0.869 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.6 124.11 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.096 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLN . . . . . 0.431 HE22 ' CG1' ' B' ' 29' ' ' VAL . 2.7 pp0? -130.01 166.55 19.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 0.0 111.438 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.472 HG22 ' N ' ' B' ' 23' ' ' ASP . 23.8 mt -119.96 161.21 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.721 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' B' ' 44' ' ' LEU . 5.0 p-10 -89.69 -159.87 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -73.02 -37.96 66.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.375 -175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -87.09 3.07 47.66 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.352 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 73.07 20.52 80.0 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.607 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.5 t70 -72.34 -87.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.308 173.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 30.2 tt0 175.33 141.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.431 ' CG1' HE22 ' B' ' 21' ' ' GLN . 44.4 t -122.36 123.04 67.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 0.0 110.3 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 64.0 p -106.86 160.94 24.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.936 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.06 3.36 0.56 Allowed 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.038 2.492 . . . . 0.0 113.558 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.4 12.86 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.599 0.714 . . . . 0.0 109.433 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -113.15 158.39 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.458 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.35 105.71 17.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -128.64 157.16 42.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.169 0.509 . . . . 0.0 110.512 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.24 142.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.883 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 34.3 mt -105.96 124.24 61.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.636 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 30.6 t70 -120.6 90.51 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.769 . . . . 0.0 110.696 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' GLY . . . 86.41 28.42 27.47 Favored Glycine 0 C--N 1.315 -0.609 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.261 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 -22.72 38.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.295 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.98 136.41 33.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.453 HG12 HG12 ' B' ' 37' ' ' ILE . 74.3 mt -101.25 133.34 44.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.4 124.13 39.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.528 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -68.1 143.61 55.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.528 ' N ' HD23 ' B' ' 44' ' ' LEU . 38.9 mmm-85 -53.72 -22.02 8.29 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.2 -36.78 75.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -106.4 -19.94 13.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.425 ' CD2' ' HD2' ' B' ' 45' ' ' ARG . 24.4 tp -55.75 -42.41 75.38 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -172.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -33.6 68.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -80.36 -41.02 25.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 0.0 110.258 178.166 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -57.92 -44.2 86.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.692 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.63 -38.84 64.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -57.82 -39.01 76.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -83.45 -43.99 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' H ' ' B' ' 57' ' ' GLY . 46.3 tt0 -99.5 -67.09 0.87 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.48 29.95 1.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.599 0.36 . . . . 0.0 111.689 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG2' ' B' ' 55' ' ' GLN . . . -125.44 15.22 7.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.584 -171.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.504 ' HE1' ' CZ ' ' A' ' 58' ' ' PHE . 2.3 m-30 56.8 -153.36 0.37 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.999 0.428 . . . . 0.0 109.98 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' B' ' 59' ' ' GLU . 3.7 tp10 -117.93 102.16 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.313 0.578 . . . . 0.0 110.5 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -83.64 100.92 11.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.817 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -85.19 -175.46 5.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -165.83 168.12 16.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.43 11.31 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 70.21 -81.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.456 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.333 0.587 . . . . 0.0 110.117 -171.392 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.58 92.27 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.523 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 26.9 pt20 -88.26 167.08 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.243 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 26' ' ' GLY . 28.4 mt -136.19 149.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.03 -179.99 4.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -57.99 -35.9 71.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.818 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -84.64 -12.96 52.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 87.76 40.78 6.6 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.118 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 28' ' ' GLU . 12.4 t70 -90.27 -97.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 29.6 tt0 179.38 127.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.523 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 22.0 t -123.04 107.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.226 0.536 . . . . 0.0 110.534 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 67.6 p -98.0 168.28 10.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.016 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 50.2 Cg_exo -56.52 -10.54 5.18 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.049 2.499 . . . . 0.0 113.721 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.19 10.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -106.19 145.73 31.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.928 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.584 ' OD1' ' HB2' ' B' ' 62' ' ' ASN . 35.9 m-20 -89.39 124.82 34.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -148.21 164.71 33.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.391 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 64.3 t -133.43 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 90.7 mt -112.94 108.17 24.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-O 121.685 0.755 . . . . 0.0 110.638 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -83.3 79.62 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.943 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.1 5.84 29.11 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.513 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.7 -24.8 1.97 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.545 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 40.0 mt-10 -81.56 134.28 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.2 mt -96.45 122.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.729 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.9 mp -129.45 127.55 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.188 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -62.36 143.03 57.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -55.58 -20.88 14.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.63 -47.54 80.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.603 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -96.86 0.44 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.193 0.521 . . . . 0.0 110.114 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.9 tm? -68.6 -36.71 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.394 -172.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.02 -34.28 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.81 -34.16 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 110.272 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.86 -41.76 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.386 174.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -63.52 -34.21 77.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.748 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -64.8 -41.83 95.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.605 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -66.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -103.33 -25.42 13.31 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 31.3 tp 64.1 43.46 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 173.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 86.14 -16.55 42.58 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.377 -0.916 . . . . 0.0 114.106 172.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HE2' HD23 ' A' ' 56' ' ' LEU . 12.6 m-85 -91.7 133.29 35.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.89 102.01 14.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -78.5 107.02 10.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.716 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 17.5 tptt -93.81 177.09 6.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -143.62 151.89 40.7 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.444 0.64 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.86 105.37 18.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -106.59 162.01 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.502 . . . . 0.0 111.678 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 23' ' ' ASP . 35.1 mt -128.54 154.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.474 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 4.7 p-10 -82.79 -167.29 1.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.488 0.661 . . . . 0.0 111.601 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.1 -35.74 81.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.026 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -83.73 -7.61 59.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.73 65.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.165 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 28.3 t70 -80.53 -84.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 35.1 tt0 174.9 135.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' VAL . . . . . 0.456 HG22 HD21 ' B' ' 44' ' ' LEU . 40.7 t -121.51 118.34 55.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.211 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.836 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 70.2 p -111.93 172.67 3.36 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.324 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.836 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 46.3 Cg_endo -69.43 19.69 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.824 2.349 . . . . 0.0 113.071 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' B' ' 30' ' ' THR . 10.6 t -121.07 -3.42 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 109.961 177.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -101.76 172.3 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.718 -173.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.583 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 14.8 m-20 -111.39 106.42 15.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 22.0 p90 -124.84 142.5 51.4 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.987 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.4 138.76 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.194 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' GLU . 57.0 mt -100.2 109.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.084 0.468 . . . . 0.0 110.664 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.43 90.1 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.149 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.49 -2.55 46.12 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.457 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.53 -30.47 1.42 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.149 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 31.1 mt-10 -88.13 145.33 25.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.463 HG23 ' CD2' ' B' ' 35' ' ' TYR . 61.7 mt -95.8 130.29 44.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.072 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.61 122.15 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.268 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 93.7 mt -62.15 144.69 55.07 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' CB ' ' B' ' 48' ' ' LEU . 48.0 mtm180 -69.27 -0.24 5.89 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.238 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.56 -27.23 64.96 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.1 2.54 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.025 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.587 ' CB ' ' HA ' ' B' ' 45' ' ' ARG . 32.5 tp -58.72 -40.75 84.62 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.49 -42.23 74.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.458 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -75.0 -40.02 60.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.587 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.05 -34.1 77.61 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.292 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 20.2 mt -72.19 -29.41 63.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.085 0.469 . . . . 0.0 110.585 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -65.46 -50.44 65.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 110.193 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.42 -48.64 12.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.244 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 4.3 tp-100 -96.02 -67.6 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.515 -174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 4.9 tp 42.74 40.26 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.743 0.652 . . . . 0.0 109.509 -171.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -101.41 -24.35 8.91 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.489 -0.862 . . . . 0.0 114.1 -165.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.72 -151.77 0.33 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.7 tp10 -116.44 101.78 8.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -107.33 111.83 24.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.582 -171.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.512 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 73.5 mmtt -124.62 -169.56 2.0 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.728 0.775 . . . . 0.0 110.99 -175.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ASN . . . . . 0.584 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 6.4 p30 -169.35 -159.44 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.06 57.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 118.531 0.605 . . . . 0.0 111.417 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 61.19 19.79 10.39 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.074 0.55 . . . . 0.0 111.161 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 -176.26 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.935 0.398 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.23 172.77 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.92 159.65 30.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.16 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.471 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -150.94 109.17 3.06 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.516 178.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 4' ' ' ASN . 11.1 Cg_endo -55.57 -33.93 88.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.069 2.513 . . . . 0.0 111.707 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.527 ' HG3' HG23 ' A' ' 8' ' ' ILE . 26.8 ptm -140.81 157.84 44.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 t -78.28 92.86 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.067 0.461 . . . . 0.0 110.195 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.527 HG23 ' HG3' ' A' ' 6' ' ' MET . 26.8 pt -93.83 155.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.545 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -88.62 103.56 16.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -90.54 174.06 7.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.784 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.02 -41.94 88.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.024 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 17.8 t-80 65.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.086 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 12' ' ' HIS . 27.5 m-20 -144.39 132.22 21.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -146.72 140.77 26.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.8 0.334 . . . . 0.0 110.99 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.6 pt? -129.72 164.31 24.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.913 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.94 141.27 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.983 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 1.6 mp0 -68.83 123.46 21.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 m -62.65 -67.8 0.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 110.442 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -143.47 23.17 1.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.874 0.845 . . . . 0.0 109.271 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.32 121.24 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.478 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.805 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 29.0 pt20 -93.78 142.11 27.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.68 148.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.54 174.94 9.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.53 -35.72 70.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.91 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -82.43 -11.07 58.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.66 40.7 7.6 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.186 -1.006 . . . . 0.0 113.08 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 19.5 t70 -93.62 -95.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 23.9 tt0 177.42 126.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.805 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 39.8 t -109.21 104.63 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.308 0.575 . . . . 0.0 110.323 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.5 p -92.55 167.25 15.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.596 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 31.6 Cg_endo -65.09 -9.2 20.81 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.539 HG22 HD23 ' B' ' 65' ' ' LEU . 3.4 t -112.76 29.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.68 0.752 . . . . 0.0 109.133 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -129.84 139.69 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.862 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -89.27 128.54 35.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' HG23 ' A' ' 42' ' ' ILE . 18.6 p90 -142.4 170.11 16.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.44 135.58 49.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 30.4 mt -96.28 115.33 35.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.813 0.34 . . . . 0.0 110.264 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.47 88.1 6.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.407 0.622 . . . . 0.0 109.561 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 83.07 -33.42 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.229 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.16 -22.81 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.713 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.89 147.56 23.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 0.0 110.226 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.558 HG23 ' CD2' ' A' ' 35' ' ' TYR . 94.5 mt -94.38 128.85 45.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.909 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 ' HA ' ' A' ' 48' ' ' LEU . 3.8 mp -130.03 129.59 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.178 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 45' ' ' ARG . 4.1 tt -67.36 138.7 56.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 48' ' ' LEU . 8.2 mmm-85 -53.55 -22.46 8.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.27 -40.8 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.252 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.58 -4.56 58.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.001 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' HG21 ' A' ' 43' ' ' ILE . 33.8 tp -61.81 -44.2 97.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.54 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.1 -45.3 71.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.912 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -62.46 -48.7 78.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.387 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.5 -36.61 81.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.617 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 70.6 mt -66.8 -39.53 87.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.261 0.553 . . . . 0.0 110.485 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -70.49 -21.53 62.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.153 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.08 -59.5 2.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.734 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 27.3 tt0 -103.12 -67.46 0.88 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.2 tt 42.33 43.32 2.94 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.456 0.646 . . . . 0.0 109.378 -168.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.734 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -126.32 6.4 7.63 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.949 -1.119 . . . . 0.0 113.839 -166.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 54.6 -153.88 0.29 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.0 tp10 -112.89 101.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.037 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -97.77 110.17 22.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.521 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 72.2 mmtt -110.71 163.66 13.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -144.98 -179.14 6.42 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 65' ' ' LEU . . . -60.49 -32.29 71.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 172.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 71.86 -43.47 0.56 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.508 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 63' ' ' ALA . 1.7 tm? -57.5 -44.19 84.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.02 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 56.88 73.92 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.042 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -65.52 122.2 16.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -75.85 71.14 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.4 m80 40.7 -95.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.423 1.089 . . . . 0.0 112.808 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -150.94 -28.47 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.6 t60 77.16 -49.77 0.54 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.022 0.929 . . . . 0.0 111.722 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 C--O 1.244 0.8 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.979 176.08 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.773 0.321 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.406 HG23 ' HG3' ' B' ' 3' ' ' GLU . 35.4 m -93.46 179.59 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.406 ' HG3' HG23 ' B' ' 2' ' ' VAL . 39.6 mt-10 75.21 -47.85 0.62 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.912 0.885 . . . . 0.0 112.182 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 62.5 t30 -79.85 116.69 62.9 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 23.2 Cg_exo -63.71 92.91 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.219 2.612 . . . . 0.0 113.322 -174.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 63.8 mtt -111.15 -9.88 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.26 140.55 42.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 pt -127.64 160.47 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.079 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.25 143.06 26.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.674 0.273 . . . . 0.0 110.319 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -142.75 170.0 16.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.989 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -89.62 -178.11 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.035 0.445 . . . . 0.0 111.205 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -89.58 76.92 7.29 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.52 -52.54 65.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.424 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.96 86.22 3.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.089 0.471 . . . . 0.0 110.95 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.8 -38.08 3.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.606 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -71.1 153.97 42.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.52 122.63 16.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -84.42 -80.09 0.2 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.953 0.406 . . . . 0.0 111.592 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -121.06 12.53 11.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.939 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.67 129.35 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.836 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -140.73 165.49 27.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.23 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.461 HG21 ' HA2' ' B' ' 26' ' ' GLY . 16.8 mt -132.02 156.22 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.436 ' N ' HG22 ' B' ' 22' ' ' ILE . 4.7 p-10 -79.89 -165.85 0.9 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 110.784 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -72.15 -34.74 68.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.557 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.4 -41.02 25.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 118.22 38.12 0.82 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 11.1 t70 -86.2 -93.38 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 32.0 tt0 168.81 121.99 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 35' ' ' TYR . 14.4 t -112.53 127.56 69.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.444 0.64 . . . . 0.0 110.505 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 69.3 p -124.63 169.64 10.47 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.65 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 44.6 Cg_endo -68.58 18.15 0.15 Allowed 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.452 2.101 . . . . 0.0 113.053 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' B' ' 30' ' ' THR . 35.7 t -108.7 -32.44 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.866 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ASP . . . . . 0.419 ' OD2' HG13 ' B' ' 29' ' ' VAL . 6.0 p-10 -104.14 134.87 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.581 0.705 . . . . 0.0 111.086 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.7 135.74 48.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.499 ' CG ' HG11 ' B' ' 29' ' ' VAL . 26.0 p90 -152.1 166.42 31.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.737 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.858 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 75.5 t -135.82 146.97 28.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.9 mt -112.77 118.33 57.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 1.1 m-20 -98.02 88.9 4.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.594 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 70.47 24.08 77.06 Favored Glycine 0 C--N 1.319 -0.4 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.448 172.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.6 -23.99 8.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.549 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.39 138.33 35.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.821 0.343 . . . . 0.0 110.541 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -89.33 136.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.627 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.425 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.8 mp -134.97 131.25 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -52.19 140.3 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -67.36 -5.21 13.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 0.0 109.827 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.74 -26.49 54.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.471 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.87 5.07 9.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.737 0.78 . . . . 0.0 109.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.858 ' HG ' ' HB ' ' B' ' 36' ' ' VAL . 2.7 tm? -66.99 -38.19 85.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.013 -170.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -58.95 -39.61 82.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -63.66 -39.64 94.84 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.229 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.08 -38.66 72.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.641 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.414 ' HG ' HD13 ' B' ' 48' ' ' LEU . 18.8 mt -67.12 -25.06 66.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.955 0.407 . . . . 0.0 110.86 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.13 -41.04 74.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.748 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.51 -41.12 9.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -100.89 -52.71 3.23 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.374 -0.204 . . . . 0.0 111.414 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.6 tp 76.59 37.37 0.32 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.896 0.748 . . . . 0.0 111.491 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 75.97 -11.39 11.44 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 170.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -101.24 120.84 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.359 0.579 . . . . 0.0 112.036 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.467 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 43.7 tt0 -92.28 102.03 14.53 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.58 109.16 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.844 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 9.7 mmmm -116.29 78.72 1.22 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.122 0.487 . . . . 0.0 111.157 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.11 165.7 19.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.99 60.61 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.242 0.339 . . . . 0.0 110.928 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 63.64 19.37 11.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.845 0.831 . . . . 0.0 110.049 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 32' ' ' VAL . 26.5 tp -121.91 29.17 7.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.743 -176.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -71.57 74.8 0.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.424 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.74 95.96 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -67.84 137.55 55.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.151 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -62.34 109.22 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -151.4 118.99 6.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -72.38 -38.77 68.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.392 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.558 -0.734 . . . . 0.0 109.595 176.226 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.505 0.193 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.34 76.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.203 1.001 . . . . 0.0 111.368 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.62 -67.35 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.804 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -157.31 101.12 1.89 Allowed Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.832 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.91 103.86 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.518 2.145 . . . . 0.0 111.436 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.3 ptm -74.66 72.76 1.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.662 0.744 . . . . 0.0 110.864 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.57 -16.25 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.223 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.1 tt -123.5 94.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.582 0.706 . . . . 0.0 111.342 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -114.99 83.49 1.92 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -107.17 150.12 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -72.61 131.93 43.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.309 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -134.68 -14.5 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.86 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 14' ' ' LYS . 23.4 t70 -177.88 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.3 pttm -163.66 -178.06 5.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.733 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.3 pt? -120.06 168.82 10.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.72 -173.42 4.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.115 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 64.79 94.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.8 m -115.57 -52.66 2.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -133.12 67.04 1.54 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.784 0.802 . . . . 0.0 109.658 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.24 132.26 67.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.985 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 13.2 pt20 -142.19 159.39 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.163 -175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.6 mt -133.14 149.49 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 4.5 p-10 -78.69 -171.16 2.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.16 0.505 . . . . 0.0 110.589 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -72.03 -27.94 63.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.564 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 47' ' ' ASN . 6.4 m-85 -86.28 -8.13 57.97 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.13 39.69 15.56 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.143 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 17.4 t70 -95.8 -89.81 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.5 tt0 176.54 142.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 68.8 t -122.22 121.38 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.55 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -117.75 162.86 26.92 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.13 -11.14 7.19 Favored 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 122.899 2.399 . . . . 0.0 114.224 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -96.44 2.29 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.004 0.431 . . . . 0.0 110.793 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -99.75 140.55 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.901 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.28 111.02 18.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -138.77 158.48 44.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.005 0.431 . . . . 0.0 110.818 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 48' ' ' LEU . 92.3 t -133.89 140.59 46.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 46.4 mt -101.89 121.24 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.611 0.243 . . . . 0.0 110.435 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.09 88.74 3.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.425 0.631 . . . . 0.0 110.029 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.832 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 87.63 -24.52 10.11 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.271 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.26 -28.11 0.5 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.55 130.33 35.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.095 0.474 . . . . 0.0 109.896 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 37' ' ' ILE . 76.8 mt -87.41 137.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.547 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.8 mp -138.74 125.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.147 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 29' ' ' VAL . 86.6 mt -52.84 148.68 7.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 170.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -62.89 -11.99 22.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.02 -15.33 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.278 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.404 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 88.1 m-20 -117.36 -13.54 10.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 36' ' ' VAL . 22.9 tp -64.74 -38.2 90.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -50.6 -51.57 47.28 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.652 0.595 . . . . 0.0 110.691 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 tpp85 -67.42 -36.23 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.958 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -65.73 -43.9 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.738 0.304 . . . . 0.0 110.432 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 46.7 mt -71.76 -22.51 61.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -78.61 -22.23 47.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.122 0.487 . . . . 0.0 109.738 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 72.7 mm-40 -93.68 -60.12 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.733 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 25.0 tt0 -92.15 -67.68 0.84 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.485 -173.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 14.2 tp 43.73 37.98 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.047 0.451 . . . . 0.0 110.541 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.733 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -127.74 2.02 6.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.991 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.9 OUTLIER 61.33 -153.75 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.34 0.591 . . . . 0.0 110.686 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 11.1 tp10 -106.03 102.18 11.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.496 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.502 ' HA ' HG22 ' B' ' 36' ' ' VAL . 32.6 m-85 -89.54 104.78 17.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.504 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.548 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 55.4 mttm -118.49 94.14 4.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 111.241 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 65' ' ' LEU . 48.6 m-80 -83.43 70.27 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.311 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.45 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.937 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -151.94 17.57 0.67 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.183 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 62' ' ' ASN . 94.9 mt -69.62 114.82 8.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.537 -175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.04 89.76 5.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.405 0.621 . . . . 0.0 110.081 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -141.63 42.35 1.73 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.477 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -69.21 121.43 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.537 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.5 m80 72.47 143.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.996 0.81 . . . . 0.0 110.857 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -86.58 -179.9 6.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -67.96 -34.52 76.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.272 176.881 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' B' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.128 0.49 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.1 3.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.31 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -122.31 171.61 8.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.672 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -97.5 154.51 37.95 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.83 113.53 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.288 2.659 . . . . 0.0 112.667 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -70.92 171.96 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.204 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.37 118.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.6 0.714 . . . . 0.0 111.464 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.1 tp -124.93 0.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.788 0.804 . . . . 0.0 109.529 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -72.37 168.05 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.021 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -103.64 176.01 5.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.855 0.36 . . . . 0.0 110.63 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -92.75 158.55 15.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.303 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -92.64 169.33 10.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.372 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.19 -47.66 34.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.252 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -154.42 151.16 28.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.641 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.33 -39.2 5.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.24 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 60.8 p 54.34 -162.57 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.787 0.835 . . . . 0.0 111.629 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.68 -14.94 59.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 109.83 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 8.7 m 70.56 -80.55 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.089 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.84 89.24 4.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.0 110.289 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.23 135.62 49.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.572 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -136.36 -179.48 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.912 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' B' ' 28' ' ' GLU . 15.2 mt -129.59 141.62 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 2.5 p-10 -88.98 -170.92 3.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.06 0.457 . . . . 0.0 110.517 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.44 -30.12 70.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.412 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.26 -39.88 74.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.118 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.08 2.56 31.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.328 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.7 m-20 -71.83 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 34.5 tt0 172.84 157.82 0.11 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.459 174.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 76.7 t -130.51 105.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.534 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.775 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -104.19 171.26 5.21 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.775 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 25.9 Cg_endo -62.93 -0.57 2.16 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.682 2.254 . . . . 0.0 113.418 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.43 6.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.063 0.459 . . . . 0.0 110.582 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -102.92 138.88 39.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.259 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.7 128.4 33.59 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -156.62 159.59 38.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.394 0.616 . . . . 0.0 111.334 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' B' ' 48' ' ' LEU . 78.1 t -134.4 137.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.245 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 59.4 mt -103.66 110.28 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -81.93 84.54 6.9 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 109.916 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.832 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 74.32 -16.51 2.88 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.712 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.04 -22.73 0.45 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -83.09 121.15 26.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.73 129.08 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.513 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.3 mp -134.32 136.85 52.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB3' ' OE1' ' B' ' 46' ' ' GLU . 39.4 mt -55.73 145.94 22.65 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 170.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -12.45 61.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' B' ' 44' ' ' LEU . 1.5 pm0 -87.75 -10.84 49.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -123.76 0.56 8.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.828 0.823 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' B' ' 36' ' ' VAL . 18.7 tp -67.96 -51.21 50.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.987 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.35 -53.96 12.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.31 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 0.1 OUTLIER -76.82 -33.73 57.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 -175.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.461 ' CD2' HG12 ' B' ' 43' ' ' ILE . 43.7 t80 -69.22 -40.02 78.2 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.761 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.7 mt -62.82 -38.73 91.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' B' ' 53' ' ' ARG . 1.3 tmm_? -55.32 -33.99 63.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.812 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 64.3 mm-40 -87.35 -38.32 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.162 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.585 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.9 tp-100 -99.07 -68.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 112.128 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 63.5 mt 40.75 43.59 1.69 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.117 0.484 . . . . 0.0 109.828 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -105.22 -14.14 23.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.191 -167.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 7.9 m-85 58.7 -158.43 0.3 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -112.81 102.0 10.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 162.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -103.29 106.25 16.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.141 -170.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.86 150.07 25.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 0.0 110.886 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -137.35 140.1 41.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.35 -12.62 61.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.164 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 60.6 26.03 15.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.567 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.14 80.11 2.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.252 0.548 . . . . 0.0 110.192 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' B' ' 68' ' ' HIS . 12.8 pt-20 -73.75 -19.77 60.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.779 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 p80 49.52 20.63 0.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.045 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.544 ' H ' ' HG3' ' B' ' 66' ' ' GLU . 30.7 t-80 -83.56 137.55 33.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.256 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.17 111.16 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.24 49.43 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.478 -171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.64 171.37 15.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.675 0.274 . . . . 0.0 110.445 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.633 -0.698 . . . . 0.0 110.268 177.967 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.749 0.309 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.62 0.67 9.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.85 -71.64 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.42 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 61.85 98.87 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 112.145 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.57 101.1 1.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.533 2.155 . . . . 0.0 112.258 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -70.7 119.14 14.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 p -82.13 -20.04 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -124.39 139.77 49.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.337 . . . . 0.0 110.797 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -122.28 147.68 45.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.348 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.39 108.04 19.24 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.47 98.99 10.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.169 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -104.12 138.55 40.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.83 89.0 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.695 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt 177.06 141.26 0.08 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.668 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -97.12 -57.61 2.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.983 0.42 . . . . 0.0 110.101 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -95.8 149.92 20.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -99.78 103.7 15.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.95 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.4 p 49.01 -92.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 113.705 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -127.27 8.94 6.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.145 0.497 . . . . 0.0 110.316 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.34 84.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.188 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.715 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 21.9 pt20 -105.29 159.49 15.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 27' ' ' ASP . 14.0 mt -124.83 144.64 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . 1.2 p-10 -88.06 -176.95 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.068 0.461 . . . . 0.0 111.135 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.96 -37.18 71.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.174 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -65.57 -43.05 91.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.19 16.95 5.94 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 9.2 t0 -106.45 158.61 16.77 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.47 132.19 41.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.229 0.537 . . . . 0.0 110.505 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.715 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 55.9 t -107.36 96.22 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.584 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 48.5 p -97.31 172.82 4.56 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 19.6 Cg_endo -62.22 -7.33 9.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.286 1.991 . . . . 0.0 112.523 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.14 -0.08 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 109.978 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -106.4 131.33 53.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.668 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -133.6 164.21 27.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.91 144.39 33.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 55.1 mt -106.43 115.72 48.64 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 122.182 0.991 . . . . 0.0 110.805 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' HB3' HD11 ' A' ' 43' ' ' ILE . 44.1 t0 -109.95 89.3 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.239 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.483 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.72 41.29 15.65 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.606 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.65 -17.28 15.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.965 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.92 137.84 32.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 35.1 mt -94.26 139.56 18.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.818 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.5 mp -139.03 127.73 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 27' ' ' ASP . 92.5 mt -57.03 145.49 30.38 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 169.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -58.28 -19.54 35.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.466 176.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.46 -44.04 92.33 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.977 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -110.38 7.9 23.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.357 0.599 . . . . 0.0 110.044 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.413 HD23 ' HD2' ' A' ' 45' ' ' ARG . 40.9 tp -65.71 -35.12 79.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.299 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.14 -33.43 67.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.296 0.569 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 8.4 tpm_? -67.01 -53.34 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.505 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.818 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -63.87 -43.29 96.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.44 -29.03 68.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.845 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -71.38 -26.52 62.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.751 0.31 . . . . 0.0 110.362 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 16.9 mm-40 -85.83 -68.96 0.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.974 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -103.88 -21.78 13.6 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.959 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.2 tp 65.45 44.24 3.16 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.441 0.463 . . . . 0.0 112.166 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.56 -11.42 68.36 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.742 171.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -95.89 104.37 16.3 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.718 -0.284 . . . . 0.0 110.467 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 61' ' ' LYS . 45.0 tt0 -93.04 102.84 15.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.017 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' B' ' 36' ' ' VAL . 94.1 m-85 -79.12 109.05 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.877 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 25.5 mmtp -109.65 105.8 15.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.164 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 64' ' ' GLN . 2.7 m120 -75.81 168.65 19.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.499 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB3' HD22 ' A' ' 65' ' ' LEU . . . -70.22 32.51 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 0.0 111.389 175.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 62' ' ' ASN . 50.7 mt-30 60.1 16.04 5.64 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 111.078 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 65' ' ' LEU . 2.1 pt? -90.25 93.61 9.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.925 0.869 . . . . 0.0 111.535 -173.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -82.17 -68.11 0.73 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 58.88 25.22 13.37 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.146 162.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -97.45 135.41 39.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.876 0.369 . . . . 0.0 110.035 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -70.11 111.18 5.58 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -75.31 82.41 2.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.597 0.713 . . . . 0.0 111.161 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 176.62 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.721 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.01 -173.454 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.799 0.333 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -139.72 28.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.964 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -80.52 74.17 7.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.004 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -172.13 95.05 0.39 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.61 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.35 112.47 1.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.635 2.223 . . . . 0.0 111.609 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.5 mtt -87.79 -16.33 34.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.751 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.5 -25.69 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.057 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -88.56 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.349 0.595 . . . . 0.0 110.483 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.94 -1.19 57.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.186 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -125.11 15.99 8.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.84 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -80.47 113.54 18.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.831 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -147.63 133.82 19.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.152 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -170.4 -149.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.548 ' HB2' HD12 ' B' ' 15' ' ' LEU . 26.7 mttt 76.39 -68.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 174.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' B' ' 14' ' ' LYS . 5.8 mp -91.05 20.47 4.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.996 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -61.04 -45.11 96.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.399 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -88.76 120.78 30.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -90.3 -82.23 0.28 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.58 30.03 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.57 94.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' B' ' 29' ' ' VAL . 6.7 pt20 -103.34 157.38 17.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' B' ' 28' ' ' GLU . 18.6 mt -130.78 147.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.661 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.424 ' HB3' HG21 ' B' ' 29' ' ' VAL . 10.0 p-10 -73.72 -166.84 0.4 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.425 0.631 . . . . 0.0 111.062 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.86 -36.11 79.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.61 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -89.97 -34.82 15.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.494 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 110.51 41.35 1.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.802 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.38 -10.34 41.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.016 0.436 . . . . 0.0 109.846 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.649 ' HA ' HG12 ' B' ' 22' ' ' ILE . 30.8 tt0 65.09 97.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.066 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' B' ' 23' ' ' ASP . 40.6 t -95.86 103.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.02 -173.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.724 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 66.4 p -96.44 167.34 12.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.959 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.724 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.0 Cg_endo -64.76 20.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.649 2.899 . . . . 0.0 113.698 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.467 ' H ' ' C ' ' B' ' 30' ' ' THR . 20.9 t -101.76 -21.15 5.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.159 0.504 . . . . 0.0 109.818 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -115.45 169.3 9.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.935 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -103.39 146.36 28.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 110.451 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.39 170.82 18.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.122 0.487 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' HD13 ' B' ' 48' ' ' LEU . 82.0 t -136.84 140.36 43.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mt -102.73 118.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -89.48 86.55 6.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 74.68 -36.27 1.02 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.212 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.79 -25.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -173.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.58 130.95 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.18 124.81 40.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.16 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.26 121.8 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.137 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.7 tt -58.57 138.75 56.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.488 ' N ' HD23 ' B' ' 44' ' ' LEU . 5.5 mmm-85 -56.46 -16.76 6.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' B' ' 44' ' ' LEU . 9.0 mm-40 -74.57 -28.49 60.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -173.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -125.82 24.02 7.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.813 0.816 . . . . 0.0 109.447 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.61 HD13 ' HB ' ' B' ' 36' ' ' VAL . 25.9 tp -68.78 -45.14 72.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.264 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -45.84 67.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.112 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 9.3 tpt180 -68.6 -43.2 76.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.309 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.49 -45.95 77.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.874 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.34 -30.0 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.612 0.244 . . . . 0.0 111.066 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 53' ' ' ARG . 17.8 ttm-85 -63.1 -41.9 99.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -93.75 -25.91 17.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp60 -102.5 -67.74 0.86 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.356 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 40.77 40.31 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.689 0.756 . . . . 0.0 109.693 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.798 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -103.04 -34.01 4.13 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.381 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.9 -165.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.8 tp10 -115.74 102.26 9.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 123.45 45.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.098 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.86 176.81 7.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 0.0 110.347 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -166.33 170.84 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.72 57.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.463 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 58.58 24.17 11.7 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.26 65.73 8.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.424 0.63 . . . . 0.0 111.157 -172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.75 4.38 42.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.537 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -73.52 157.02 37.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.06 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -75.91 -73.63 0.26 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.4 t60 46.77 43.69 13.31 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.764 0.665 . . . . 0.0 111.721 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -77.58 159.3 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.327 0.584 . . . . 0.0 112.057 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -127.9 144.49 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.884 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.377 -178.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 163.19 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.77 100.88 12.83 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -118.76 122.96 29.4 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.353 0.597 . . . . 0.0 110.959 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -95.75 13.19 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 69.2 mtm -89.21 76.71 7.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.674 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.35 -3.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 168.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.75 123.66 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 60.13 77.93 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.704 0.628 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -93.62 139.35 30.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.449 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 68.52 164.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.843 0.714 . . . . 0.0 111.826 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.2 -55.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.787 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -117.12 11.95 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.203 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -113.19 23.6 13.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.052 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tt -136.76 127.45 27.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.759 0.314 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -129.92 -172.56 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.16 139.26 24.47 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 m 76.12 -39.85 0.38 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -80.27 14.51 1.91 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.4 103.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.407 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 152.05 23.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.233 0.539 . . . . 0.0 111.451 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 28' ' ' GLU . 53.4 mt -118.88 149.4 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.89 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.34 -163.01 0.73 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -75.95 -25.0 55.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.025 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -69.05 -33.01 72.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.7 33.78 10.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.789 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -103.4 -80.73 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.939 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.503 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 179.28 137.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.34 115.88 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 p -104.71 162.5 19.61 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 28.0 Cg_endo -62.95 -1.62 2.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 113.161 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.77 -2.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.575 0.226 . . . . 0.0 111.101 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.21 -170.95 1.74 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 5.1 t0 -126.87 134.9 50.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.59 -171.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 42' ' ' ILE . 35.5 p90 -156.49 161.05 40.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.048 0.452 . . . . 0.0 111.452 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 48' ' ' LEU . 87.4 t -137.25 144.73 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 19.2 mt -105.6 124.66 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 111.403 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 16.8 t70 -96.99 87.99 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.19 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 80.6 -22.22 4.88 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.502 173.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.58 -31.57 0.37 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 123.61 28.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 37' ' ' ILE . 70.5 mt -82.56 142.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.883 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -136.41 132.7 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -60.17 143.57 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HG3' ' CG ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -58.03 -19.68 33.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.75 -33.78 60.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.63 0.15 16.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 28.7 tp -55.99 -56.08 25.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.979 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -68.63 -23.5 64.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.22 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -73.92 -42.73 60.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.422 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 55.5 t80 -64.63 -36.1 83.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.369 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 77.6 mt -65.74 -33.61 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.291 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -68.63 -28.62 67.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 6.1 mm-40 -80.51 -57.74 3.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.601 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.585 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 43.0 tt0 -102.93 -67.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER 48.19 45.35 19.89 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -169.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -109.31 -33.76 2.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.285 -167.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CD2' ' HA3' ' B' ' 57' ' ' GLY . 1.7 m-85 63.5 -166.71 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.152 0.476 . . . . 0.0 109.748 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.2 tp10 -107.6 101.84 11.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.391 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -106.7 112.04 24.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.985 0.421 . . . . 0.0 110.24 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HG3' ' CZ ' ' B' ' 35' ' ' TYR . 69.9 mmtt -101.69 177.55 4.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -162.42 136.44 6.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.97 62.85 1.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.555 0.693 . . . . 0.0 110.396 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -86.92 43.19 1.07 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.764 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 tp -81.4 90.53 6.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.662 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.0 103.89 16.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.622 0.725 . . . . 0.0 110.39 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -78.93 129.78 34.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.67 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -80.93 90.7 5.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.228 0.537 . . . . 0.0 111.766 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -115.5 125.53 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -109.87 149.81 29.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.802 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -121.45 132.43 54.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.54 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.193 177.937 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.773 0.321 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.16 99.96 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.506 0.67 . . . . 0.0 110.373 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.8 23.64 12.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.218 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -109.03 98.29 29.5 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.289 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.88 146.05 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.743 2.295 . . . . 0.0 112.654 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 47.1 ttm -132.93 95.66 3.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.875 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t 64.22 87.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.648 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 pt -88.72 17.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.635 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -75.56 -32.38 60.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.647 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' B' ' 13' ' ' ASP . 44.3 m-80 57.69 -157.05 0.3 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.016 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -132.86 -59.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -74.68 -46.07 40.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.419 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' B' ' 10' ' ' ASN . 25.9 t70 38.65 -109.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.257 0.973 . . . . 0.0 111.64 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -169.24 172.42 7.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.05 106.2 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 110.452 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.1 p -61.56 -45.81 92.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.324 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.36 98.63 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.98 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -96.8 -14.63 21.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.739 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.778 ' HB2' ' HD3' ' B' ' 31' ' ' PRO . 8.5 p-10 -79.76 36.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.806 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 101.87 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.76 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' B' ' 29' ' ' VAL . 7.8 pt20 -140.31 133.83 30.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -99.36 154.64 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.335 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.442 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 5.8 p-10 -93.66 -170.65 2.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.724 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.59 -36.09 77.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.458 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -69.83 -36.34 75.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.077 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.87 33.2 6.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.668 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' B' ' 28' ' ' GLU . 11.5 t70 -98.62 -96.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' B' ' 27' ' ' ASP . 31.6 mm-40 -167.57 137.79 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 109.551 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 92.4 t -123.66 101.05 8.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.692 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.0 p -103.16 175.75 2.11 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.474 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 29.8 Cg_endo -62.96 -10.83 21.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.49 2.127 . . . . 0.0 113.512 -177.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.02 13.91 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.024 0.44 . . . . 0.0 110.786 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -112.92 152.49 29.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -97.0 124.4 40.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 61' ' ' LYS . 32.0 p90 -143.0 159.87 41.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' B' ' 48' ' ' LEU . 53.7 t -129.87 143.07 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.5 mt -110.21 115.67 50.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 CA-C-O 121.804 0.811 . . . . 0.0 110.887 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.96 87.46 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.185 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 79.4 -18.77 6.4 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.38 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 -21.83 0.4 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.575 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.64 142.71 27.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -94.79 134.58 31.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.4 mp -127.9 128.18 68.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.446 HD23 ' N ' ' B' ' 45' ' ' ARG . 1.9 tt -61.8 137.45 58.25 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.446 ' N ' HD23 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.08 0.15 3.91 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -172.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.76 -12.74 30.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.368 0.604 . . . . 0.0 110.032 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -114.38 -7.01 12.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.512 0.672 . . . . 0.0 110.055 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' B' ' 36' ' ' VAL . 49.9 tp -57.19 -44.27 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.062 -170.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -59.85 -40.65 89.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.968 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -69.5 -43.28 73.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.161 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -62.73 -36.34 82.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 62.9 mt -70.41 -30.76 67.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 0.0 110.68 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -94.16 -49.5 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.723 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -103.03 -53.0 2.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 tp 72.04 47.99 0.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.303 0.641 . . . . 0.0 112.162 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' CD2' ' A' ' 58' ' ' PHE . . . 82.24 -31.13 2.92 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.938 -0.648 . . . . 0.0 114.24 169.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.95 122.9 25.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.667 -0.313 . . . . 0.0 111.322 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.658 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 8.1 tp10 -92.26 102.35 14.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -95.54 120.1 35.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.86 -167.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -115.44 178.11 4.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.836 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -169.51 149.66 4.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.72 75.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.02 0.438 . . . . 0.0 110.523 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 61.49 28.61 17.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.246 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp -84.15 15.89 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 0.0 110.166 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.57 -41.37 54.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.508 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 64.54 -78.45 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.315 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -166.6 21.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.658 0.742 . . . . 0.0 109.041 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.38 143.48 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -101.51 92.74 5.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.882 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -127.52 -59.89 1.2 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.421 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 76.6 t60 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.64 -178.35 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.802 ' HG3' HG13 ' A' ' 2' ' ' VAL . 38.6 tpp . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.747 0.308 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.802 HG13 ' HG3' ' A' ' 1' ' ' MET . 20.9 m -118.72 141.25 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 67.78 152.02 0.08 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.849 0.718 . . . . 0.0 111.508 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.07 141.94 63.51 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.844 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.91 58.35 6.67 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.09 2.527 . . . . 0.0 113.617 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -67.54 134.29 51.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.67 12.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.746 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.11 -19.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.285 0.565 . . . . 0.0 110.454 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.63 113.16 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 69.35 31.66 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.428 0.632 . . . . 0.0 109.734 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 73.5 -65.73 0.34 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.348 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -143.63 -77.79 0.23 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -154.01 94.19 1.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.523 0.677 . . . . 0.0 109.927 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.543 ' HB3' HD12 ' A' ' 15' ' ' LEU . 73.3 mmtt 71.81 -63.14 0.44 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.017 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 14' ' ' LYS . 6.0 mp -126.35 161.27 28.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.062 0.458 . . . . 0.0 110.727 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -93.15 114.35 26.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -136.6 158.86 43.44 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.867 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 m 74.6 -52.07 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.786 0.835 . . . . 0.0 112.286 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -77.03 84.47 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.437 0.637 . . . . 0.0 110.396 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.47 144.95 30.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.877 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -133.86 139.92 46.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.74 152.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -81.24 179.9 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.038 0.447 . . . . 0.0 110.771 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -56.4 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.465 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -70.83 -45.22 64.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.439 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.03 15.77 3.75 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.667 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.83 132.57 44.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.23 124.28 23.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.965 0.412 . . . . 0.0 110.595 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 23' ' ' ASP . 44.8 t -108.58 107.31 22.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.686 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 24.0 p -95.99 167.61 12.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 62.7 Cg_exo -52.74 -16.63 5.98 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.273 2.649 . . . . 0.0 114.32 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.93 2.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.652 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -105.72 150.48 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 45' ' ' ARG . 19.2 m-20 -94.82 120.72 35.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 109.863 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.9 p90 -142.59 161.76 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.871 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.7 t -131.94 134.97 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 51.2 mt -95.97 121.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 28.7 t70 -90.2 86.73 6.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.554 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 78.4 -40.43 1.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.115 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.84 -28.48 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -81.66 136.05 35.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 35' ' ' TYR . 92.7 mt -87.66 134.24 28.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.548 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.76 135.17 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.25 145.18 55.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.615 ' HG2' HD22 ' A' ' 48' ' ' LEU . 25.5 mtp-105 -65.61 -5.99 9.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.2 -63.2 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.503 . . . . 0.0 109.946 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.04 -14.89 61.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' A' ' 45' ' ' ARG . 18.6 tp -51.74 -42.6 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.336 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -60.21 -44.23 95.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -41.43 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.999 0.428 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.525 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 84.5 t80 -65.91 -43.76 87.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.39 -23.24 61.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.537 0.208 . . . . 0.0 111.33 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -70.51 -46.81 62.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 110.393 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.48 -35.91 29.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.205 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.552 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 26.3 tp60 -97.59 -67.54 0.84 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.319 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 44.32 41.14 4.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.583 0.706 . . . . 0.0 109.131 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.552 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -108.34 -24.1 6.35 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.309 -0.948 . . . . 0.0 114.528 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CG ' ' HA3' ' B' ' 57' ' ' GLY . 1.0 OUTLIER 57.53 -151.81 0.41 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -175.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.575 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 33.0 mt-10 -113.61 101.39 9.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.983 163.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -93.63 103.53 15.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 59' ' ' GLU . 93.5 mttt -117.48 105.34 11.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.75 0.786 . . . . 0.0 111.777 -173.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.13 160.16 30.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.191 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.43 -59.66 4.65 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.291 0.369 . . . . 0.0 111.134 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -178.41 14.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.658 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.94 150.09 26.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.886 -174.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.81 6.83 40.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -93.72 93.57 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.9 m170 -80.51 135.57 36.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 110.362 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.19 71.42 10.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.334 0.588 . . . . 0.0 110.222 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -150.56 107.92 3.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.033 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -98.63 -3.82 35.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.808 177.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' B' ' 1' ' ' MET . 27.3 ttt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 t 54.32 39.43 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.207 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.545 ' O ' ' HD3' ' B' ' 5' ' ' PRO . 0.7 OUTLIER -90.27 -177.2 5.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.475 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -84.0 108.39 13.83 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.154 0.502 . . . . 0.0 110.243 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' B' ' 3' ' ' GLU . 92.3 Cg_endo -91.85 20.15 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.99 2.46 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 91.8 mmm 60.34 82.06 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.811 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.87 108.57 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.925 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.12 137.11 24.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.776 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -78.05 80.4 4.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.694 0.759 . . . . 0.0 110.566 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -167.06 137.91 3.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.562 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -88.21 21.81 2.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.333 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -43.51 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.473 1.108 . . . . 0.0 112.788 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -126.78 159.35 34.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.21 112.72 24.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.647 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.18 -76.22 0.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.08 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.9 p 53.84 -176.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.933 0.893 . . . . 0.0 112.418 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -109.74 88.28 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.24 0.543 . . . . 0.0 109.613 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 42.4 m -81.85 -55.47 4.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.804 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 75.76 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.513 0.673 . . . . 0.0 111.339 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.39 128.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.727 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.573 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 26.1 pt20 -107.27 149.79 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.928 0.394 . . . . 0.0 111.031 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 13.3 mt -112.7 140.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.162 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.564 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 13.1 p-10 -77.06 -170.4 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.112 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.88 -26.66 60.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -80.32 -23.17 40.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.709 0.29 . . . . 0.0 110.772 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 89.26 17.29 55.9 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.948 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.89 -8.61 42.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.28 0.562 . . . . 0.0 109.929 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' B' ' 22' ' ' ILE . 43.1 tt0 76.65 139.57 0.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.861 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 14.5 t -112.68 102.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 110.488 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 59.3 p -84.75 159.53 57.71 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.828 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 48.6 Cg_endo -69.21 7.68 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.651 2.234 . . . . 0.0 112.811 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.95 -6.46 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.285 0.564 . . . . 0.0 109.591 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -117.64 160.14 21.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.969 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.86 143.73 29.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.406 ' CD2' HG23 ' B' ' 42' ' ' ILE . 13.1 p90 -145.69 166.07 26.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.354 0.597 . . . . 0.0 110.672 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 59' ' ' GLU . 53.8 t -136.96 144.54 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 33.7 mt -109.94 116.81 53.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.377 0.608 . . . . 0.0 110.087 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 2.0 m-20 -97.44 86.67 3.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.891 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 62.63 45.56 95.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.826 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.3 64.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.845 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 3.3 tp10 -95.51 119.43 34.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' B' ' 23' ' ' ASP . 97.0 mt -83.89 120.84 35.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.602 ' HB ' HD13 ' B' ' 48' ' ' LEU . 2.7 mp -126.26 128.6 71.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' B' ' 23' ' ' ASP . 28.5 tp -66.58 139.75 57.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.604 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -60.25 -15.99 29.86 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.75 -45.03 82.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.74 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.48 17.66 6.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 111.493 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.602 HD13 ' HB ' ' B' ' 43' ' ' ILE . 48.9 tp -63.21 -31.49 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.389 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.76 -45.83 59.11 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 111.583 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 8.1 tpt180 -68.78 -37.11 79.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.416 . . . . 0.0 110.898 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' B' ' 41' ' ' GLU . 15.9 t80 -72.77 -32.66 65.78 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 75.1 mt -65.37 -29.33 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.413 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 -64.74 -44.75 89.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.431 . . . . 0.0 110.205 174.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.12 -54.36 9.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.783 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -103.52 -67.08 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.02 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 24.1 tp 78.72 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.855 0.722 . . . . 0.0 111.241 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 79.87 -45.55 2.97 Favored Glycine 0 C--O 1.235 0.205 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.736 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -69.53 139.1 53.77 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.602 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 3.9 tp10 -114.69 102.21 9.81 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 167.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -83.86 93.76 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.541 -175.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 59' ' ' GLU . 27.9 mmtm -93.49 83.17 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.326 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' B' ' 64' ' ' GLN . 92.9 m-20 -81.83 60.23 4.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.441 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' B' ' 64' ' ' GLN . . . 68.78 -27.18 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.9 0.88 . . . . 0.0 113.016 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' B' ' 62' ' ' ASN . 96.8 mt-30 67.67 18.32 9.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.332 0.587 . . . . 0.0 110.409 -175.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.44 120.84 36.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 -22.98 14.2 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.4 m170 56.86 49.28 14.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.506 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -66.18 140.78 58.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 67.31 32.6 5.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.436 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -76.61 -51.27 11.91 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -173.3 -74.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.892 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.229 -177.562 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 30.9 ttp . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' H ' ' HG2' ' A' ' 1' ' ' MET . 34.5 m -64.35 -19.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.17 15.25 29.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.65 98.86 21.5 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.367 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.92 83.72 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.87 2.38 . . . . 0.0 112.078 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.437 ' HG3' HG23 ' A' ' 7' ' ' VAL . 25.9 ptt? -91.43 -33.42 15.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.249 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG23 ' HG3' ' A' ' 6' ' ' MET . 21.7 t -98.53 79.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.07 137.97 49.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.648 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -91.14 109.78 21.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -61.98 132.67 53.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -84.59 47.14 1.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.577 0.704 . . . . 0.0 111.347 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -145.19 89.84 1.98 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.161 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.0 -37.85 83.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.371 -171.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.01 144.45 35.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.181 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -140.17 75.6 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 p -84.97 132.88 34.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.854 -177.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 19' ' ' ASP . 3.6 tp10 72.98 145.03 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.171 0.919 . . . . 0.0 110.083 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -103.05 -3.63 25.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.4 0.619 . . . . 0.0 110.169 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.402 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 5.2 m-20 -80.6 25.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.568 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -81.33 83.7 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.999 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -96.35 166.21 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.561 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.12 157.57 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.64 -169.86 2.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -72.8 -26.42 61.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.567 0.222 . . . . 0.0 111.022 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -72.87 -40.82 65.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.89 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 17.82 4.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.264 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -104.98 129.88 53.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -59.0 120.0 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.278 0.561 . . . . 0.0 111.603 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.492 HG22 HD21 ' A' ' 44' ' ' LEU . 41.0 t -95.9 113.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 p -103.74 166.57 11.48 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.19 -6.01 2.56 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.782 2.321 . . . . 0.0 113.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -96.07 -4.38 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.368 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -110.13 166.26 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.406 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.88 119.02 38.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.452 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HB3' HG11 ' A' ' 29' ' ' VAL . 32.2 p90 -135.97 149.76 49.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 0.0 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.61 133.71 68.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.2 mt -97.5 121.4 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -94.75 84.27 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.876 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.32 -47.59 2.96 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.437 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.29 -29.02 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 129.19 34.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.509 0.671 . . . . 0.0 110.765 174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.59 133.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.981 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.3 mp -136.61 132.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 29' ' ' VAL . 84.4 mt -58.65 151.62 20.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.299 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -12.77 22.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.938 0.399 . . . . 0.0 110.882 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.99 -36.24 72.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.422 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.66 5.19 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 110.617 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.86 -48.58 81.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.068 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.96 -37.18 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 6.8 tpt180 -73.62 -39.81 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.698 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -64.08 -47.83 78.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.19 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.815 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 65.7 mt -61.98 -41.24 97.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 50.5 ttt-85 -46.54 -40.21 12.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.143 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -49.81 8.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.037 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.849 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 5.6 tp-100 -88.34 -68.2 0.78 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 48.0 mt 42.89 30.86 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.368 0.267 . . . . 0.0 111.286 -171.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.849 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -127.64 3.27 7.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.692 -166.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 53.87 -149.63 0.41 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.447 0.623 . . . . 0.0 110.313 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.9 tp10 -112.16 101.95 10.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.65 117.38 31.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.712 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.92 156.82 24.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.411 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -141.06 160.44 40.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.501 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.56 -22.34 59.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.437 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.62 38.21 18.81 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.176 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tt -78.18 0.06 26.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.941 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 71.35 17.24 5.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.478 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -79.34 99.4 7.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -53.84 115.23 1.89 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.777 0.798 . . . . 0.0 112.164 -170.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -100.77 123.98 45.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.377 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -76.53 88.7 3.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.303 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -95.94 -10.76 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.334 0.588 . . . . 0.0 110.106 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.4 t60 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.604 178.329 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.9 m -88.7 27.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.32 128.26 48.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.154 0.502 . . . . 0.0 111.916 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -142.66 63.44 14.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.867 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.26 34.35 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.767 2.978 . . . . 0.0 113.528 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 43.6 ttm -139.64 26.05 2.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.835 0.826 . . . . 0.0 109.71 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.01 16.51 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.931 0.872 . . . . 0.0 109.573 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.19 127.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.905 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -91.61 -28.41 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.844 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -83.55 118.1 23.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -90.42 145.98 24.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.521 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -131.68 154.43 48.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.083 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -128.36 135.77 50.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -56.65 -65.73 0.56 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.612 0.244 . . . . 0.0 111.389 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -159.49 112.69 2.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.233 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 140.76 32.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 169.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.43 -36.67 76.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 12.2 m 64.76 -86.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.268 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -138.37 7.05 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 109.342 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -77.89 101.05 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.544 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.563 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 12.9 pt20 -101.56 158.49 16.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.586 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' B' ' 28' ' ' GLU . 53.2 mt -140.83 152.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.857 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.79 -173.87 2.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.331 0.586 . . . . 0.0 111.148 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -67.11 -29.18 68.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.153 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -79.78 -14.49 58.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.288 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.86 33.49 26.97 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.287 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.1 -87.2 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.843 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' B' ' 22' ' ' ILE . 41.7 tt0 -179.17 137.5 0.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.86 120.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.037 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 77.0 p -108.09 169.09 6.98 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.29 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_exo -60.36 -2.5 1.91 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.858 2.372 . . . . 0.0 113.022 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.37 -11.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.736 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.15 147.08 26.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.707 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.35 112.18 23.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -133.68 157.8 44.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 0.0 111.221 -172.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.84 145.0 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.423 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 67.7 mt -107.18 110.72 32.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.282 0.563 . . . . 0.0 109.881 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.6 92.25 3.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.203 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.06 36.6 31.24 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.521 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.94 -28.64 7.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.187 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.83 150.22 24.7 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.563 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 78.6 mt -108.86 141.48 24.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.564 -174.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mp -134.77 123.0 40.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -59.85 140.06 56.89 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.585 HH11 HD23 ' B' ' 48' ' ' LEU . 11.3 mmm180 -55.92 -17.97 7.86 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -77.22 -31.43 55.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.523 . . . . 0.0 110.047 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -102.96 -7.01 21.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.525 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.585 HD23 HH11 ' B' ' 45' ' ' ARG . 45.1 tp -64.45 -28.64 69.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.427 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -54.33 45.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.94 -33.31 70.36 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.732 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.72 -40.36 87.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.335 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 75.8 mt -72.06 -32.55 67.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 53' ' ' ARG . 44.1 mtt180 -64.11 -40.53 96.4 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.491 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -79.85 -65.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -95.1 -41.83 8.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.825 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 23.1 tp 78.41 17.98 1.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.895 0.747 . . . . 0.0 111.56 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.13 -38.36 3.19 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.069 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -65.88 117.2 7.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.724 -0.28 . . . . 0.0 110.956 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.567 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 37.0 tt0 -92.3 102.19 14.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.638 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -85.42 112.03 20.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 7.1 mmmm -115.22 88.6 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.241 0.544 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -82.55 154.22 25.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.52 69.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 48.8 81.18 0.05 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.252 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.65 -18.66 60.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.877 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 52.99 51.44 15.83 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -173.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.49 113.97 11.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.219 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -132.45 137.44 47.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.316 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -78.57 -34.95 46.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -158.41 111.71 2.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.118 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -90.17 79.61 6.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.098 -172.374 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.507 0.194 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 m -98.07 146.43 8.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 62.38 97.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.479 0.657 . . . . 0.0 110.57 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -137.36 88.55 16.93 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.512 0.672 . . . . 0.0 111.484 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.64 5.89 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.941 2.427 . . . . 0.0 112.981 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -100.82 93.28 5.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.779 0.323 . . . . 0.0 111.333 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -102.92 -9.97 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.57 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 8' ' ' ILE . 4.2 mp -86.83 132.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 63.29 77.44 0.33 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.64 112.45 24.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.144 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.38 -45.44 9.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.155 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.0 t60 56.56 51.09 11.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.859 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.04 118.89 15.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.463 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -110.79 19.7 18.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.398 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.49 -21.34 60.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 17' ' ' GLU . 10.6 m 70.97 -94.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.82 172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.653 ' HG3' HG22 ' A' ' 16' ' ' THR . 43.7 mt-10 -135.67 -179.02 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -172.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 m -103.99 -45.41 4.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.263 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.58 97.24 8.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 109.863 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.67 132.77 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.786 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -123.59 171.18 9.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.567 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG21 ' HA2' ' A' ' 26' ' ' GLY . 21.8 mt -138.61 155.22 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.619 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 22' ' ' ILE . 5.6 p-10 -82.42 -167.52 1.62 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -69.97 -34.26 73.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.921 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -82.07 -15.46 53.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 85.25 36.98 10.23 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.728 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.6 t70 -87.93 -85.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.7 tt0 176.15 136.55 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.621 0.576 . . . . 0.0 109.676 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 44' ' ' LEU . 73.6 t -123.09 112.65 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.484 . . . . 0.0 110.67 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 32' ' ' VAL . 70.7 p -104.81 162.01 21.06 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.45 7.22 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.946 2.431 . . . . 0.0 113.257 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 t -103.89 -12.09 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.145 0.498 . . . . 0.0 109.884 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -92.87 151.31 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.635 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -97.02 115.44 27.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.403 0.62 . . . . 0.0 109.704 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.59 172.89 12.34 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.571 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 48' ' ' LEU . 64.2 t -137.03 139.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 14.5 mt -95.65 110.11 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.732 0.777 . . . . 0.0 109.455 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD2' ' HG3' ' A' ' 55' ' ' GLN . 9.8 t0 -82.66 85.87 6.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.243 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 59' ' ' GLU . . . 76.43 -35.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.091 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.18 -28.29 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.43 147.17 29.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.815 0.34 . . . . 0.0 110.396 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.5 mt -97.78 129.76 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.286 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 43' ' ' ILE . 2.3 mp -136.71 123.88 31.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.457 HD21 HG22 ' A' ' 29' ' ' VAL . 85.6 mt -56.19 146.38 23.56 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -68.56 -0.02 4.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.221 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -81.26 -19.18 43.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.94 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -129.09 -7.01 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.245 0.545 . . . . 0.0 110.335 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 36' ' ' VAL . 28.7 tp -50.2 -35.58 27.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.3 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -52.29 -42.57 63.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.004 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -69.83 -39.61 76.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.196 0.522 . . . . 0.0 110.351 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -38.09 88.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.194 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 62.2 mt -69.95 -25.04 63.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.036 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -69.08 -38.47 79.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.7 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.8 -67.83 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 8.7 pt20 -102.92 -20.89 14.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 40.3 tp 69.5 23.04 6.14 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 168.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.87 0.64 39.25 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.356 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.13 127.88 55.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.628 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 23.9 tt0 -91.95 102.03 14.59 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.72 122.12 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -111.84 -175.68 2.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.871 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.76 161.49 23.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.87 -8.67 30.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.834 0.349 . . . . 0.0 111.06 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 65.34 31.11 10.73 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.711 0.767 . . . . 0.0 109.598 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 65' ' ' LEU . 24.3 tp -110.9 22.07 15.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.089 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.747 ' HG3' ' HA ' ' A' ' 70' ' ' HIS . 55.5 tt0 -74.27 76.41 1.83 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 122.159 0.98 . . . . 0.0 109.681 175.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -128.79 -53.39 1.23 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.644 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -87.04 -52.98 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.235 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -85.69 102.0 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.022 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.747 ' HA ' ' HG3' ' A' ' 66' ' ' GLU . 1.9 m-70 -99.79 137.55 38.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 111.772 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.472 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 65.6 m80 -84.45 -35.1 23.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.873 179.187 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.0 t -80.82 86.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -133.71 139.9 46.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 0.0 112.206 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.38 79.67 3.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.34 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.06 -41.72 76.0 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.082 2.522 . . . . 0.0 112.273 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 91.1 mmm -126.98 112.39 15.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.989 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.42 123.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.084 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 pt -80.07 50.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.654 0.74 . . . . 0.0 111.448 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.54 129.74 27.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -93.98 159.07 15.34 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -91.46 -52.21 4.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -153.57 17.97 0.53 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.15 -24.55 47.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.316 -171.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -74.72 -1.96 24.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.03 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.3 -22.44 64.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -92.26 -9.05 43.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 66.36 -66.62 0.17 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.156 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 61.8 m -152.76 -83.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -160.34 33.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.5 107.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.006 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 10.5 pt20 -89.03 132.62 34.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 109.974 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.44 148.94 18.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.796 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.53 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -79.88 -174.58 4.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -71.6 -22.84 61.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.363 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' B' ' 47' ' ' ASN . 13.8 t80 -74.39 -45.25 48.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.44 27.64 2.79 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.059 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -96.0 -124.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -141.05 140.55 34.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 41.8 t -119.81 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.486 0.66 . . . . 0.0 109.345 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -86.96 167.77 20.59 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 35.9 Cg_exo -58.89 -3.6 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.853 2.369 . . . . 0.0 113.496 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.43 8.48 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.226 0.536 . . . . 0.0 110.509 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -106.23 130.87 54.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.02 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.26 120.98 23.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' B' ' 42' ' ' ILE . 34.8 p90 -143.3 164.53 29.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' B' ' 48' ' ' LEU . 72.9 t -132.8 145.83 33.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 39' ' ' GLY . 46.9 mt -111.57 127.89 68.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.342 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' HE2' ' B' ' 51' ' ' TYR . 25.3 t70 -119.29 89.77 3.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.052 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 42.37 9.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.303 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.58 -22.25 11.56 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.934 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -87.56 129.13 35.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.996 0.426 . . . . 0.0 110.151 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.517 HG23 ' CD2' ' B' ' 35' ' ' TYR . 78.3 mt -83.99 141.07 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.0 mp -135.57 125.37 42.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.56 148.03 20.71 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -61.33 -17.36 53.39 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.959 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.52 0.11 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.741 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' B' ' 25' ' ' TYR . 54.0 t30 -124.04 -1.74 8.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 109.167 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' B' ' 36' ' ' VAL . 39.6 tp -69.15 -45.41 70.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.07 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.91 -53.08 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.125 0.488 . . . . 0.0 110.596 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.37 -47.48 85.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.956 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.416 ' HE2' ' CB ' ' B' ' 38' ' ' ASP . 92.7 t80 -62.76 -39.95 95.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.481 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 43.0 mt -67.72 -47.55 69.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.394 -0.191 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -59.39 -19.03 43.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 110.903 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.07 -54.13 4.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.936 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.867 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 6.3 tp60 -91.53 -67.64 0.84 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 19.4 mt 39.57 34.85 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.867 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -120.46 -1.03 12.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.22 -171.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.46 -157.26 0.27 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -115.88 101.88 9.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.687 169.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.92 121.48 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.154 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -136.11 68.07 1.45 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.868 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -71.35 176.68 4.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.043 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -74.55 -5.93 45.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.884 0.373 . . . . 0.0 110.507 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 55.87 43.22 27.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.616 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 87.7 mt -58.11 130.98 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.712 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 97.73 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -119.36 23.19 11.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.896 -173.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -92.07 77.67 5.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.525 0.679 . . . . 0.0 109.57 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -126.84 170.11 12.54 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -74.25 91.4 2.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.224 0.535 . . . . 0.0 110.736 -175.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -132.15 146.08 51.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.381 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 22.6 p80 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.172 178.576 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.64 0.733 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.12 86.54 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.965 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.28 -17.26 31.09 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -58.68 118.57 29.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.956 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -16.49 29.12 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.531 2.154 . . . . 0.0 112.426 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.2 ttt 70.83 127.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.029 0.831 . . . . 0.0 110.615 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.25 101.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 pt -127.03 145.99 33.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.792 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -138.8 -7.05 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 72.9 138.37 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.919 0.762 . . . . 0.0 110.702 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -76.03 18.17 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.2 t60 55.43 51.01 13.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.764 0.792 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -81.93 168.04 18.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.328 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -89.09 39.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.806 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 67.15 89.73 0.1 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 109.684 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.16 124.2 17.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.728 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' HB3' ' H ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -68.34 -85.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.299 1.047 . . . . 0.0 109.131 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.539 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 3.7 t -102.55 -137.96 0.34 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.762 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.81 -29.05 32.84 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.202 0.525 . . . . 0.0 109.653 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 18' ' ' THR . 46.2 t 70.82 110.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.175 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 5.5 pt20 -122.37 158.4 29.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.223 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.43 145.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 1.2 p-10 -77.26 -161.06 0.19 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.037 0.446 . . . . 0.0 110.196 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.5 -23.83 39.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.65 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -104.33 -4.07 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.1 5.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.769 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -114.13 149.06 36.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.07 127.79 34.05 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 110.472 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 44' ' ' LEU . 15.7 t -95.69 117.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.797 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 p -115.6 169.04 7.36 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.797 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 47.7 Cg_endo -67.3 20.21 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.987 2.458 . . . . 0.0 114.3 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.19 -26.62 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.118 0.485 . . . . 0.0 110.248 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.69 145.47 29.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.0 110.853 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' B' ' 62' ' ' ASN . 1.8 t70 -87.81 142.87 27.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.01 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 26.8 p90 -149.96 164.66 34.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.802 0.334 . . . . 0.0 111.021 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.4 153.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.368 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 73.6 mt -111.16 108.22 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.079 0 CA-C-O 121.819 0.819 . . . . 0.0 111.051 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 43' ' ' ILE . 1.8 m-20 -99.88 90.5 4.45 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.769 -177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 74.58 23.98 73.86 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.03 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.93 -29.98 6.57 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.365 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.1 158.78 15.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.366 0.603 . . . . 0.0 111.095 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 72.8 mt -103.58 138.87 26.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.142 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 38' ' ' ASP . 3.9 mp -131.56 122.8 51.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -59.23 135.07 57.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 14.3 mmt180 -58.08 -14.23 6.32 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.78 -14.49 56.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.476 . . . . 0.0 110.149 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -115.4 -9.91 12.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.403 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 28.2 tp -68.8 -28.77 67.06 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.138 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 53' ' ' ARG . 3.3 tm-20 -54.43 -66.37 0.41 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.61 -28.66 67.11 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.332 -177.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.38 -40.99 94.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 39.0 mt -65.42 -33.16 75.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 50' ' ' ARG . 11.1 mtm180 -62.55 -39.31 93.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.065 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 23.5 mm-40 -87.66 -52.79 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.713 0.292 . . . . 0.0 111.317 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -90.24 -51.55 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.138 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.98 44.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.361 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 79.37 -51.72 3.98 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 121.236 -0.507 . . . . 0.0 114.158 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -68.98 122.97 19.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.773 -0.251 . . . . 0.0 110.862 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -92.52 101.78 14.22 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.251 170.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.46 95.23 6.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.917 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD2' HD12 ' B' ' 37' ' ' ILE . 16.8 mttp -98.41 87.61 3.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.715 0.769 . . . . 0.0 110.632 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -81.42 176.49 9.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.9 4.91 17.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.811 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 66.94 12.17 8.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.681 0.753 . . . . 0.0 110.163 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.41 88.18 2.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.331 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.75 119.67 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.997 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -63.83 -38.36 90.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.869 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -133.54 104.98 6.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.714 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -121.94 -26.12 4.85 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.005 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -81.11 145.4 31.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -91.86 125.31 36.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.912 0.386 . . . . 0.0 111.464 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.807 177.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.135 0.493 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.05 135.57 58.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -80.34 81.32 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.897 0.38 . . . . 0.0 111.452 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 15.0 p30 -154.0 131.83 6.36 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.204 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 9.2 Cg_endo -91.27 96.15 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.242 2.628 . . . . 0.0 112.487 178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mmt -85.92 -75.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.18 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 33.1 mm 56.9 -99.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.002 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' B' ' 10' ' ' ASN . 3.2 m-20 -130.98 19.75 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' B' ' 9' ' ' ASN . 47.1 m-80 78.67 107.25 0.07 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.203 0.939 . . . . 0.0 109.107 -169.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -85.39 -24.02 27.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.544 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -116.87 129.22 55.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 111.356 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -156.61 -90.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 173.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -154.76 94.52 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.677 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tt -80.71 99.58 8.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 35.2 p -92.78 116.01 28.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.387 0.613 . . . . 0.0 111.568 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -106.35 95.44 5.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p -87.05 -67.01 0.85 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.843 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.4 4.06 22.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.513 0.673 . . . . 0.0 109.403 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.1 90.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.21 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.668 ' OE1' ' HB ' ' B' ' 29' ' ' VAL . 0.9 OUTLIER -106.69 166.19 10.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.0 151.74 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -71.56 -173.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -67.41 -32.12 72.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -86.1 -45.69 11.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.75 31.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.233 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.78 125.43 53.68 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.78 128.05 34.37 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 111.393 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.668 ' HB ' ' OE1' ' B' ' 21' ' ' GLN . 19.0 t -114.57 119.6 61.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.005 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 36.2 p -110.34 164.56 14.54 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.744 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 51.9 Cg_exo -53.98 -18.73 13.82 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.388 2.725 . . . . 0.0 114.209 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.91 -0.93 10.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.949 0.404 . . . . 0.0 111.175 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -102.51 147.26 26.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.84 128.72 42.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 61' ' ' LYS . 30.1 p90 -148.48 -178.01 6.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.449 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 98.4 t -140.05 139.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.459 HD12 ' HD2' ' A' ' 61' ' ' LYS . 45.1 mt -105.02 117.85 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 110.073 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.92 92.04 3.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.468 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.584 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 84.74 0.57 89.18 Favored Glycine 0 C--N 1.316 -0.534 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.645 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.4 -20.27 4.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.724 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -99.82 151.06 21.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.012 0.434 . . . . 0.0 110.17 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.76 138.86 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.608 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.663 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.2 mp -140.01 126.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 48' ' ' LEU . 20.5 mt -55.81 146.67 20.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 172.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -62.4 -11.15 14.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.63 0.252 . . . . 0.0 111.354 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 31.9 tp10 -74.75 -51.36 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -100.5 3.54 42.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.663 HD23 ' HB ' ' B' ' 43' ' ' ILE . 2.8 tm? -65.75 -33.16 75.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.342 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.34 -49.67 76.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.505 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -67.25 -32.66 73.84 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.306 0.574 . . . . 0.0 110.165 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -66.85 -43.89 82.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 24.5 mt -66.89 -23.75 66.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -69.4 -33.83 73.59 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -84.7 -65.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.533 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' B' ' 57' ' ' GLY . 47.2 tp60 -85.35 -67.2 0.82 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.554 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 18.6 tp 60.35 -22.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' B' ' 55' ' ' GLN . . . -107.31 35.88 4.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.897 -167.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 50.51 -153.48 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.145 0.473 . . . . 0.0 110.933 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 10.9 tp10 -110.56 102.39 10.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.251 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -91.83 117.73 30.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.75 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -118.63 -173.1 2.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.587 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.542 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 29.9 p-10 -168.72 -175.45 2.43 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.39 15.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.815 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' B' ' 62' ' ' ASN . 67.2 mt-30 57.74 48.79 13.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.34 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp -82.86 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.45 6.16 18.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.84 132.72 51.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 111.884 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -91.33 125.23 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -77.17 42.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 73.1 m80 62.98 -172.66 0.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -163.31 111.54 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.307 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 45.4 m170 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.937 175.184 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.69 0.281 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.49 -79.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -178.07 -54.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -118.55 158.05 48.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.874 0.368 . . . . 0.0 111.464 -174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.95 25.2 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.136 2.557 . . . . 0.0 111.541 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 16.0 tpt -94.63 -24.66 17.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.223 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.71 139.18 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.972 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 8' ' ' ILE . 1.7 pp -71.84 127.72 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 111.665 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -78.84 -22.26 46.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -87.63 93.23 9.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.921 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -76.19 106.9 8.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.305 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -84.92 -8.72 58.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.25 135.93 42.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.098 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -104.26 -31.92 9.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt 62.93 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.549 0.531 . . . . 0.0 111.467 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 p -90.8 -77.35 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.64 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.61 129.74 47.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.385 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -153.24 -50.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.681 0.277 . . . . 0.0 111.696 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -84.2 8.66 15.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -97.58 101.24 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.871 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 29' ' ' VAL . 4.9 pt20 -123.06 156.71 34.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 23' ' ' ASP . 22.7 mt -125.21 138.3 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.714 0.292 . . . . 0.0 111.491 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -67.36 162.26 23.32 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.435 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -50.2 -35.37 26.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 113.134 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.87 1.08 48.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 39.14 7.95 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -121.4 127.81 51.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.71 125.73 26.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.585 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.66 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 58.0 t -120.33 102.1 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.548 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.78 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 p -78.19 166.58 42.17 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.78 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -59.69 -10.67 12.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.892 2.395 . . . . 0.0 114.472 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.61 7.76 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.659 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -98.65 154.53 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 7.7 m-20 -76.89 111.3 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.656 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' HB3' HG11 ' A' ' 29' ' ' VAL . 42.9 p90 -147.52 168.17 22.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 111.164 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.9 t -137.75 148.23 25.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 60.1 mt -105.67 118.52 53.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-O 121.306 0.575 . . . . 0.0 110.052 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.515 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 2.1 m-20 -106.39 87.68 2.6 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.615 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.63 80.14 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.102 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.99 -25.82 2.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.012 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -97.39 155.97 16.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.114 0.483 . . . . 0.0 110.78 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.1 mt -96.4 137.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.363 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 3.7 mp -131.34 120.51 46.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -57.51 136.66 56.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 11.9 mmm-85 -55.78 -13.96 2.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.82 -57.39 7.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.293 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.0 7.52 44.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.434 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 46.0 tp -54.68 -28.97 51.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.257 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -42.26 -46.18 4.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.623 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 2.4 mpt_? -73.89 -39.56 63.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.265 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -44.77 83.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.966 0.412 . . . . 0.0 110.665 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 51.9 mt -68.31 -24.58 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -76.8 -26.76 54.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.916 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -92.41 -70.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.821 0.344 . . . . 0.0 111.731 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 2.1 pm0 -102.4 -23.21 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.878 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 42.3 tp 66.14 43.32 2.9 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.316 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.21 -18.31 41.88 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.811 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 9.3 m-85 -99.46 136.7 39.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.564 -0.374 . . . . 0.0 110.719 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 34.7 tt0 -93.05 102.02 14.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 167.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.06 92.49 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.934 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HE2' ' OE2' ' A' ' 59' ' ' GLU . 14.1 mmtt -97.56 173.83 6.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 111.955 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.6 175.85 9.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.425 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.25 72.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.703 0.287 . . . . 0.0 111.021 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.19 50.87 12.66 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD13 HG12 ' B' ' 32' ' ' VAL . 66.8 tp -70.28 89.2 0.65 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.47 84.65 3.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.0 109.566 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -131.98 105.37 7.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.844 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 78.3 m80 -74.5 150.33 39.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.013 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 88.7 m-70 72.2 108.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.067 0.854 . . . . 0.0 111.181 -176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -91.82 -24.37 19.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.432 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -151.62 138.56 19.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.362 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--N 1.318 -0.766 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.512 175.937 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.4 94.19 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.719 0.771 . . . . 0.0 109.991 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.97 -56.29 2.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.556 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.36 111.49 55.22 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.399 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.5 101.67 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.62 2.213 . . . . 0.0 111.442 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.71 78.43 5.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.106 0.479 . . . . 0.0 110.476 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 120.19 41.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.37 99.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.151 0.501 . . . . 0.0 110.552 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.97 25.37 4.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.717 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -59.68 134.37 56.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.469 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' TRP . . . . . 0.503 ' HD1' ' H ' ' B' ' 11' ' ' TRP . 0.2 OUTLIER -76.82 72.9 3.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.769 0.795 . . . . 0.0 111.962 -173.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.35 101.02 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.262 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.29 44.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.121 -171.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 56.9 -161.13 0.21 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.814 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt 61.79 19.27 10.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.965 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -105.69 178.58 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.813 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.13 119.26 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.872 0.368 . . . . 0.0 110.622 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -55.27 -64.24 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.623 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.06 20.18 1.94 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.963 0.887 . . . . 0.0 109.002 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.37 94.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.083 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.438 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 9.2 pt20 -92.4 131.34 37.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.211 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.502 HG22 ' O ' ' B' ' 23' ' ' ASP . 36.1 mt -104.83 141.73 19.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.502 ' O ' HG22 ' B' ' 22' ' ' ILE . 0.5 OUTLIER -76.75 173.67 11.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.63 -21.82 60.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.304 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.65 3.61 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.0 27.24 14.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.402 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.92 145.27 43.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.606 0.703 . . . . 0.0 109.813 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.43 119.53 13.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.413 . . . . 0.0 111.172 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 18.6 t -90.28 88.15 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 51.1 p -68.27 157.92 86.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.853 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.1 13.99 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.86 2.374 . . . . 0.0 112.635 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 65' ' ' LEU . 33.8 m -121.95 3.1 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.055 176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -114.28 151.98 32.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.988 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.93 136.55 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' B' ' 42' ' ' ILE . 21.0 p90 -149.34 166.28 29.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.2 t -136.04 142.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 46.2 mt -104.83 120.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.647 0.261 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.07 91.07 5.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.3 0.572 . . . . 0.0 109.75 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 81.19 -28.97 2.86 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.154 174.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.48 -27.2 0.15 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.42 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.233 0.54 . . . . 0.0 110.534 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' B' ' 35' ' ' TYR . 79.2 mt -82.24 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.468 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.749 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.7 mp -130.44 123.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.975 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 51.0 mt -55.46 143.91 27.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.693 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 10.7 mmt180 -66.96 0.81 2.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -73.01 -35.23 66.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 0.0 110.803 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -129.05 5.76 5.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.304 0.573 . . . . 0.0 110.265 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.749 HD23 ' HB ' ' B' ' 43' ' ' ILE . 3.0 tm? -51.71 -44.78 63.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.129 -172.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -59.79 -30.29 68.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.851 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 0.6 OUTLIER -76.35 -38.58 55.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.313 . . . . 0.0 110.808 -178.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -66.25 -32.47 73.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 32.9 mt -64.9 -48.24 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.47 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 7.5 ptp180 -69.04 -27.58 65.78 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.448 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -93.98 -34.57 13.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.596 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 54.2 tp60 -103.19 -67.88 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.085 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER 37.32 40.3 0.19 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.827 0.704 . . . . 0.0 110.078 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.596 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -131.21 6.19 5.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.652 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 50.8 -154.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.852 0.326 . . . . 0.0 110.126 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 5.9 tp10 -102.83 101.84 11.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.644 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.83 95.92 10.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 110.345 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 12.7 mmtp -112.89 56.26 0.68 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.439 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.24 74.35 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.14 8.97 3.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.238 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' B' ' 64' ' ' GLN . 7.8 tp60 52.11 40.89 29.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.48 115.21 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.037 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -51.17 -67.54 0.24 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.69 0.619 . . . . 0.0 110.573 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' B' ' 68' ' ' HIS . 20.1 t-80 59.96 -171.57 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.524 0.515 . . . . 0.0 109.915 173.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' B' ' 67' ' ' HIS . 34.1 m80 -139.57 127.81 22.59 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.902 -0.499 . . . . 0.0 110.465 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -79.93 93.4 5.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.85 136.1 57.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.821 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -52.65 129.64 30.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.583 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 3.4 m80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.685 175.701 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tmm? . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 2' ' ' VAL . 18.2 t 75.44 22.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.852 0.834 . . . . 0.0 109.719 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -67.65 121.31 15.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.638 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -155.64 165.29 18.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.1 -29.12 82.04 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.808 2.338 . . . . 0.0 113.835 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 54.2 ttp -93.63 80.93 4.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.38 0.609 . . . . 0.0 110.729 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.94 152.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.21 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 pt -54.06 148.7 2.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.058 0.224 . . . . 0.0 110.718 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.44 121.7 2.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.856 0.836 . . . . 0.0 112.959 -173.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 14' ' ' LYS . 24.3 t-20 -73.48 157.89 35.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.977 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -59.37 -35.73 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -82.89 127.72 33.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.839 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 t70 68.16 27.5 6.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.751 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 25.3 pttm -92.67 31.9 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 0.0 110.943 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.93 -25.23 55.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.395 0.617 . . . . 0.0 110.13 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 p -123.44 -168.0 1.7 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.62 144.2 57.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 20' ' ' VAL . 28.6 m -87.11 -42.84 12.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.02 -170.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -76.79 28.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.707 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 18' ' ' THR . 15.1 t -114.87 102.42 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.303 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.2 148.72 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.544 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 mt -123.89 154.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 9.2 p-10 -78.15 -164.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 110.328 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.92 -27.9 43.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.723 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.27 -17.38 34.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.21 5.91 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.163 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 t70 -92.08 -96.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.7 tt0 174.35 118.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.88 95.1 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.259 0.552 . . . . 0.0 110.76 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 9.1 p -80.73 161.64 63.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.917 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 46.6 Cg_endo -67.96 13.71 0.18 Allowed 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 122.828 2.352 . . . . 0.0 113.177 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 30' ' ' THR . 27.3 m -115.43 11.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.614 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.74 172.76 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.289 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -103.79 125.22 50.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.862 0.363 . . . . 0.0 110.452 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.01 169.91 16.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.227 0.537 . . . . 0.0 110.877 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' B' ' 60' ' ' PHE . 70.7 t -137.53 139.55 43.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -105.76 120.99 57.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.436 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -108.76 86.98 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.15 42.9 34.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.21 -0.904 . . . . 0.0 113.681 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.04 -17.63 57.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.786 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -109.18 133.48 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.361 0.601 . . . . 0.0 110.923 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -85.77 137.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.585 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 3.0 mp -135.18 128.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.52 143.91 57.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HD2' HD22 ' A' ' 48' ' ' LEU . 11.9 mmm-85 -63.55 -11.65 26.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.42 -49.6 73.1 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.113 0.258 . . . . 0.0 111.266 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -129.35 39.15 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.712 . . . . 0.0 110.155 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 45' ' ' ARG . 11.7 tp -71.63 -35.82 70.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.773 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -55.35 -36.73 66.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.963 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 mtt-85 -78.27 -27.46 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.092 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.26 -33.7 61.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.492 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.738 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 73.5 mt -71.09 -24.54 62.33 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.57 172.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 53' ' ' ARG . 22.7 ttm-85 -71.32 -28.2 63.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 51.8 mm-40 -86.04 -54.05 4.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.391 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 11.0 tt0 -99.23 -67.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.781 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 4.7 tp 49.31 31.32 3.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.35 0.406 . . . . 0.0 110.408 -174.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -125.3 -6.17 6.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.73 -164.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.02 -154.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.802 0.801 . . . . 0.0 109.312 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' OE2' HD12 ' B' ' 37' ' ' ILE . 28.0 tt0 -116.44 102.28 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.457 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -83.49 102.68 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 6.0 tptm -97.91 90.29 4.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 -175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -85.16 44.91 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.918 -174.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 66.7 -4.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.482 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 56.46 23.48 7.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.101 0.477 . . . . 0.0 110.181 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.2 tp -71.16 104.83 3.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.385 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.93 106.59 10.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -145.66 43.62 1.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -58.59 136.17 57.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.881 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -126.03 111.75 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.709 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -101.93 0.08 34.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.555 0.693 . . . . 0.0 109.172 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -141.16 109.46 5.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.581 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.854 177.972 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.825 0.345 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.78 78.74 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.974 0.416 . . . . 0.0 110.163 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -151.76 90.89 1.59 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -153.3 75.65 6.49 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.057 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.41 -11.92 4.87 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.126 2.551 . . . . 0.0 111.74 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 46.7 ttp -165.58 135.96 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.701 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.68 122.65 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.41 HD12 ' N ' ' B' ' 8' ' ' ILE . 4.1 mp -78.4 104.9 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -156.22 103.8 2.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.93 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -87.96 122.59 31.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.996 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -98.33 86.25 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 68.69 -61.22 0.42 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.948 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.92 85.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.487 0.715 . . . . 0.0 112.352 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.55 133.75 55.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.766 175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.24 144.45 42.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.383 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -36.01 82.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 110.516 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -103.07 128.57 49.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.624 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 29.9 m -129.29 -48.52 1.19 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.072 0.463 . . . . 0.0 110.202 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -131.91 15.39 4.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.134 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 138.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.679 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 14.2 pt20 -132.96 168.55 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 110.821 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 23' ' ' ASP . 34.5 mt -136.28 155.95 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.639 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 6.3 p-10 -79.38 -171.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.189 0.519 . . . . 0.0 110.791 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -70.04 -29.88 67.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.754 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -88.07 -21.52 24.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.1 38.5 4.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.025 -1.083 . . . . 0.0 113.227 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.6 t70 -89.09 -89.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 37.1 tt0 171.97 137.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.679 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 59.5 t -116.83 109.58 28.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.947 0.403 . . . . 0.0 110.707 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -94.17 159.84 33.33 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.56 3.76 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.67 -0.83 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 109.983 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -102.49 142.13 34.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.707 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 6.7 m-20 -83.85 120.18 25.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.307 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 21.9 p90 -142.58 161.94 36.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.589 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' B' ' 48' ' ' LEU . 84.4 t -124.81 139.48 50.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.582 HD12 ' OE2' ' A' ' 59' ' ' GLU . 53.4 mt -106.47 112.51 39.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.39 85.02 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.949 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' HG3' ' B' ' 59' ' ' GLU . . . 74.53 -32.15 1.0 Allowed Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.602 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.52 -21.73 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -81.44 143.04 32.39 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.401 HG21 HE21 ' B' ' 21' ' ' GLN . 75.2 mt -107.75 119.8 57.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.421 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.42 ' N ' HD12 ' B' ' 43' ' ' ILE . 3.0 mp -126.73 121.72 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.115 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 40.6 mt -57.23 146.4 28.49 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.558 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 66.7 mtp180 -69.07 0.26 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -60.1 -51.82 68.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.004 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -126.45 19.71 7.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.457 HD22 ' HG2' ' B' ' 45' ' ' ARG . 16.8 tp -53.23 -37.4 62.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.23 -43.82 64.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.575 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.71 -36.26 65.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.296 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -67.49 -35.98 80.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.0 -31.31 70.92 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.585 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -69.87 -24.24 63.39 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.709 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -89.09 -55.92 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -98.44 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.906 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.8 tp 82.72 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 124.141 0.9 . . . . 0.0 111.801 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 81.46 -49.4 4.02 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.45 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 33.6 m-85 -70.92 124.45 24.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.613 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 26.7 mt-10 -92.08 101.79 14.33 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.751 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 36' ' ' VAL . 97.1 m-85 -81.4 87.92 6.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.514 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -107.39 80.53 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.631 0.729 . . . . 0.0 110.923 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -71.9 158.26 36.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.05 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.01 95.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.994 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 55.47 58.77 4.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.307 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.713 ' H ' HD12 ' B' ' 65' ' ' LEU . 4.2 mp -63.66 129.74 41.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.492 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.06 77.98 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.724 0.773 . . . . 0.0 110.818 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -107.7 81.96 1.59 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.79 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -76.96 121.87 24.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -86.81 129.08 35.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -118.07 135.58 54.1 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -119.6 -7.5 10.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.11 0.481 . . . . 0.0 110.402 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 41.1 m170 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.359 174.495 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttm . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.35 138.59 46.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.852 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.38 151.58 21.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.318 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.0 m-20 67.37 166.94 0.12 Allowed Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 124.065 0.853 . . . . 0.0 111.641 173.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 4' ' ' ASN . 16.6 Cg_endo -59.9 116.88 3.61 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.176 1.917 . . . . 0.0 110.322 169.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 71.4 mtm -51.59 125.72 15.5 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.39 0.614 . . . . 0.0 111.814 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.1 156.65 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.822 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.496 ' O ' HD12 ' A' ' 8' ' ' ILE . 2.3 pp -71.03 147.8 10.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.098 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -129.2 14.47 6.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.445 0.641 . . . . 0.0 109.944 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -96.88 100.66 12.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.139 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -65.59 0.6 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.061 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -148.92 -55.65 0.19 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 63.55 -87.95 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.341 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -142.35 20.01 2.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.394 0.616 . . . . 0.0 109.945 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.1 tp -79.73 137.11 36.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.37 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 p -100.96 -123.57 0.17 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.4 90.75 7.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 112.154 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.6 p -91.77 -48.12 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.701 0.762 . . . . 0.0 109.678 171.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -150.14 17.21 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.14 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 t -93.92 124.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.694 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -123.19 157.58 32.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 13.0 mt -120.03 152.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.0 p-10 -90.6 -167.91 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.306 0.574 . . . . 0.0 110.904 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -69.93 -24.52 63.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -89.38 -34.26 16.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.496 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.503 ' HA2' ' CG2' ' A' ' 22' ' ' ILE . . . 99.74 27.67 7.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.591 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.71 -10.42 48.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 73.08 120.38 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.338 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 23' ' ' ASP . 47.6 t -113.61 113.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.514 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 p -102.97 167.75 9.79 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 51.2 Cg_exo -56.4 -11.49 6.43 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.826 2.35 . . . . 0.0 113.404 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.27 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.464 0.65 . . . . 0.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -107.62 146.08 32.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD2' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -89.92 130.52 36.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.6 p90 -153.76 161.58 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.825 0.345 . . . . 0.0 111.023 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.507 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 49.4 t -128.18 150.33 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 40.5 mt -115.78 116.88 53.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.157 0 CA-C-O 121.894 0.855 . . . . 0.0 111.187 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.41 89.32 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.731 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' B' ' 37' ' ' ILE . . . 69.17 45.11 63.07 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.247 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.5 -21.9 35.9 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.464 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -91.72 133.53 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.241 0.543 . . . . 0.0 110.578 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' A' ' 35' ' ' TYR . 60.3 mt -91.74 132.18 36.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.916 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.82 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.1 mp -130.99 125.99 58.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 29' ' ' VAL . 18.2 tp -63.61 143.54 57.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.549 HH11 HD12 ' A' ' 48' ' ' LEU . 12.8 mmm180 -62.48 -6.89 3.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 7.2 mm-40 -71.33 -57.79 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.47 0.34 53.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.82 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -62.76 -27.29 69.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.461 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.37 -48.33 74.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.694 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -61.6 -41.76 97.9 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.429 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.47 -37.96 89.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.292 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.524 ' HG ' HD13 ' A' ' 48' ' ' LEU . 19.5 mt -71.32 -26.7 62.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -71.3 -45.68 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.432 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.12 -32.38 13.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -102.97 -56.16 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.188 -0.32 . . . . 0.0 110.374 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 26.6 tp 77.65 37.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 111.914 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' B' ' 58' ' ' PHE . . . 89.43 -43.54 3.02 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.137 172.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.428 ' HE2' HD23 ' A' ' 56' ' ' LEU . 3.3 m-85 -70.14 117.97 12.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG13 ' B' ' 36' ' ' VAL . 9.6 tp10 -92.04 101.43 13.97 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' HA ' HG22 ' B' ' 36' ' ' VAL . 63.8 m-85 -89.75 86.29 6.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.06 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -84.71 174.77 9.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -142.34 177.26 8.38 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 64.3 -84.47 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.369 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.492 HD22 HG12 ' B' ' 32' ' ' VAL . 26.9 tp 55.33 30.13 14.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.049 0.452 . . . . 0.0 111.472 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 62.14 12.34 4.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.512 -176.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -120.11 75.1 1.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.398 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -139.12 140.73 38.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.329 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -111.99 143.21 43.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.496 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.08 -68.68 0.32 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -172.92 -62.34 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.548 173.76 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.16 163.47 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' B' ' 3' ' ' GLU . 1.8 mp0 -56.14 117.89 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.503 176.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -99.01 143.75 26.94 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.863 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.89 -28.33 23.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.114 2.542 . . . . 0.0 113.295 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 58.4 mtt -78.58 71.57 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.018 0.437 . . . . 0.0 110.251 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.79 3.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.391 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.36 14.77 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -86.41 8.25 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.11 160.73 19.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.589 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -76.3 143.87 40.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.335 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -92.78 -175.26 3.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.4 101.72 2.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.841 0.829 . . . . 0.0 111.304 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -146.23 -41.93 0.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.155 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.54 98.63 2.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -84.63 121.82 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.753 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.55 173.57 10.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.978 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 12.9 m -155.98 -62.92 0.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -174.14 35.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.942 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.83 103.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.988 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.45 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 10.4 pt20 -104.91 158.13 16.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.786 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.423 HG22 ' N ' ' B' ' 23' ' ' ASP . 18.1 mt -130.08 155.76 41.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 6.7 p-10 -83.88 -165.11 1.04 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.273 0.558 . . . . 0.0 110.955 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.77 -31.68 68.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.373 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -41.13 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.576 0.227 . . . . 0.0 110.891 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.3 35.82 3.03 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.671 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 19.0 t70 -88.58 -89.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 41.1 tt0 176.02 130.66 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.46 HG22 HD21 ' B' ' 44' ' ' LEU . 48.3 t -114.35 113.12 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.191 0.519 . . . . 0.0 110.819 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 67.1 p -106.15 169.3 7.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.3 Cg_exo -58.68 -4.54 1.96 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.154 2.569 . . . . 0.0 114.151 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.492 HG12 HD22 ' A' ' 65' ' ' LEU . 19.2 m -106.52 0.65 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 110.795 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -96.78 136.94 36.62 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.538 ' HB3' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -80.68 108.54 14.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.142 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -126.63 155.44 42.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.106 0.479 . . . . 0.0 111.236 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 59' ' ' GLU . 41.8 t -129.85 145.75 35.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.536 ' CG2' ' HA2' ' A' ' 39' ' ' GLY . 36.1 mt -115.23 126.3 72.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.609 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.74 83.35 3.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.18 3.38 Favored Glycine 0 C--O 1.227 -0.327 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.303 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.76 -30.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -81.39 134.24 35.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.098 0.475 . . . . 0.0 110.315 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.92 138.37 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.386 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.509 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.8 mp -137.04 130.72 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.46 HD21 HG22 ' B' ' 29' ' ' VAL . 79.8 mt -60.39 150.06 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' B' ' 34' ' ' ASP . 20.8 mmt180 -61.37 -11.84 11.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.89 0.376 . . . . 0.0 110.964 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.1 -36.52 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.664 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -111.75 8.12 20.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.914 0.388 . . . . 0.0 110.644 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.528 HD13 ' HB ' ' B' ' 36' ' ' VAL . 63.9 tp -60.64 -47.93 84.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.443 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.71 -47.94 80.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 7.0 mtp180 -64.3 -45.96 85.69 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.111 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.44 ' CG ' HG12 ' B' ' 43' ' ' ILE . 47.1 t80 -59.07 -39.39 81.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.661 0.267 . . . . 0.0 110.925 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 39.0 mt -72.55 -28.72 63.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.618 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 8.4 ptp180 -86.86 -11.5 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.286 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 70.2 mm-40 -92.67 -54.92 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.185 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' B' ' 57' ' ' GLY . 37.6 tt0 -102.02 -65.96 0.95 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -174.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 2.2 tp 55.0 43.94 29.03 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' B' ' 55' ' ' GLN . . . -100.87 -50.37 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.771 -165.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.424 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 48.05 -176.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.271 0.628 . . . . 0.0 110.908 -167.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 30.8 tt0 -103.79 102.49 12.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.609 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.61 100.69 13.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.328 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -91.43 162.06 14.73 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.51 138.4 9.72 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.92 -43.75 64.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 68.59 -3.42 1.38 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.578 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mp -127.26 108.28 10.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -95.36 35.08 1.35 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -110.79 59.39 0.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.254 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -157.86 85.91 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.445 0.641 . . . . 0.0 109.536 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -89.54 122.76 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.745 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -108.63 -66.02 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.189 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -109.64 6.06 23.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 110.958 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.971 178.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.557 0.218 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.16 3.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.269 0.557 . . . . 0.0 110.367 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -86.97 -176.5 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.082 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -109.3 157.98 35.73 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.09 7.6 2.82 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.883 2.389 . . . . 0.0 113.268 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 62.5 mtt -138.24 85.7 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.832 0.349 . . . . 0.0 110.38 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.65 -41.06 91.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.32 94.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.826 0.822 . . . . 0.0 108.898 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -86.82 143.29 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.937 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -130.99 152.16 50.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 7.7 t90 72.25 -43.69 0.57 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.303 1.041 . . . . 0.0 111.862 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -79.63 -4.56 52.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.204 0.526 . . . . 0.0 109.964 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.12 152.17 45.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.949 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.41 -38.2 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.95 57.78 1.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.099 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.17 116.59 29.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.764 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -124.16 95.77 4.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -125.94 -44.31 1.79 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.508 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -101.36 18.98 18.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.831 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.34 121.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.04 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 171.79 7.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 28' ' ' GLU . 21.0 mt -136.39 139.42 45.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 166.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.69 -166.99 1.74 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -70.78 -19.8 62.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.307 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 31.1 t80 -74.54 -32.43 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.549 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.97 25.55 26.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.143 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -96.42 -85.4 0.34 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HA ' HG12 ' A' ' 22' ' ' ILE . 17.5 tt0 -176.81 150.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 174.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 23' ' ' ASP . 58.6 t -130.92 117.34 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.729 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 p -116.25 168.45 8.6 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.854 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 41.2 Cg_endo -67.71 9.84 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.726 2.284 . . . . 0.0 113.766 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.1 6.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.517 . . . . 0.0 109.999 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -109.78 147.07 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.995 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.23 124.12 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -147.3 163.95 34.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 48' ' ' LEU . 61.6 t -136.52 137.72 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -99.64 121.83 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.86 86.48 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.47 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 77.55 -36.26 1.59 Allowed Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.768 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.628 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.67 135.24 34.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.108 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -91.17 133.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.988 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.9 mp -136.87 134.5 48.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 60.7 mt -54.39 151.57 7.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG2' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.67 -8.04 24.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.67 -45.47 10.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.245 0.545 . . . . 0.0 109.719 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -85.86 -4.95 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.229 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 36' ' ' VAL . 56.1 tp -54.97 -50.83 67.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.521 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 mt-10 -52.81 -48.99 66.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.307 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -59.44 -49.36 78.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.76 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.6 -32.92 74.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 40.4 mt -72.25 -24.36 61.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.566 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 94.0 mtt180 -72.13 -38.98 69.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.6 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -68.82 0.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.872 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 11.8 pt20 -103.79 -53.12 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.677 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 18.3 tp 47.78 43.37 16.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.493 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -123.5 -3.82 8.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.139 -1.029 . . . . 0.0 114.633 -165.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.22 -160.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 11.0 mm-40 -105.27 101.75 11.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -110.53 104.53 13.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.167 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.8 152.46 20.86 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -155.89 149.91 25.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -5.81 27.0 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.084 0.24 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 63.11 42.24 7.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.857 0.837 . . . . 0.0 109.81 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.5 tp -90.2 38.65 0.94 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.409 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -73.88 -36.98 64.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.569 178.382 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 47.27 63.95 1.77 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.843 0.714 . . . . 0.0 110.679 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.69 110.04 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.857 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -74.79 -18.88 60.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.666 0.746 . . . . 0.0 109.082 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -96.7 106.64 18.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.251 170.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -116.42 23.26 12.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.732 175.408 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.06 82.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 121.292 0.567 . . . . 0.0 110.146 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.81 -173.35 2.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.901 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.472 ' HB3' ' SD ' ' B' ' 6' ' ' MET . 97.5 m-20 -88.75 109.27 28.59 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.173 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 7.3 Cg_exo -74.21 -13.05 23.39 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.114 2.542 . . . . 0.0 112.899 -176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' B' ' 4' ' ' ASN . 0.6 OUTLIER -79.62 82.09 5.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.599 0.714 . . . . 0.0 110.809 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.44 100.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.73 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 pp -101.24 163.18 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.596 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 62.35 93.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.903 0.752 . . . . 0.0 111.382 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -89.79 152.56 21.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -83.19 -29.14 28.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' B' ' 13' ' ' ASP . 57.1 t-80 -124.16 142.02 51.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.235 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' B' ' 12' ' ' HIS . 12.3 t70 69.84 108.45 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.721 0.638 . . . . 0.0 110.337 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -111.78 66.58 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.14 0.495 . . . . 0.0 110.392 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.644 ' HG ' HG23 ' B' ' 16' ' ' THR . 55.9 tp 71.58 -71.55 0.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.602 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.644 HG23 ' HG ' ' B' ' 15' ' ' LEU . 23.2 p -136.91 153.69 50.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.055 0.455 . . . . 0.0 112.215 -173.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' B' ' 18' ' ' THR . 0.0 OUTLIER -134.33 171.76 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.132 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.454 ' H ' ' CD ' ' B' ' 17' ' ' GLU . 16.2 m -58.51 -72.26 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.679 0.275 . . . . 0.0 111.737 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.08 30.33 5.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.254 0.549 . . . . 0.0 109.56 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -121.9 119.52 58.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.587 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.4 HE21 HD13 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.07 173.92 12.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.103 176.002 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.423 HG21 ' HA2' ' B' ' 26' ' ' GLY . 30.3 mt -130.42 155.98 42.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.423 ' N ' HG22 ' B' ' 22' ' ' ILE . 7.5 p-10 -81.14 -162.19 0.47 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.257 0.551 . . . . 0.0 111.109 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -76.83 -30.2 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.743 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -80.51 -19.76 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.314 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 83.92 41.09 8.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.611 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.37 -82.68 0.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 178.02 140.91 0.09 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' B' ' 35' ' ' TYR . 21.9 t -126.4 141.72 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -124.53 155.83 68.57 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 -15.19 42.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.778 2.318 . . . . 0.0 112.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.53 9.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.636 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.17 150.55 46.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -86.32 130.06 34.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.224 0.535 . . . . 0.0 110.743 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.485 ' HB3' HG11 ' B' ' 29' ' ' VAL . 32.9 p90 -144.0 152.22 40.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.646 ' HB ' HD13 ' B' ' 48' ' ' LEU . 74.9 t -129.78 139.92 50.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 57.6 mt -101.09 116.84 45.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.623 0.725 . . . . 0.0 109.697 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -112.76 91.0 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.304 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.12 -4.37 86.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.44 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.93 4.33 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.87 143.04 27.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 110.308 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.495 HG12 HG12 ' B' ' 37' ' ' ILE . 81.3 mt -97.26 129.12 47.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.237 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.03 129.46 75.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.72 131.23 50.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 2.3 tmm_? -70.42 0.97 5.58 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -167.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.28 -7.21 57.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.436 0.636 . . . . 0.0 109.85 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -129.15 20.16 5.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' B' ' 36' ' ' VAL . 58.9 tp -71.4 -38.37 71.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.992 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.5 -44.61 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.98 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.68 -46.09 87.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.009 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -68.85 -32.88 72.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.04 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.9 mt -72.92 -28.51 62.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.615 0.245 . . . . 0.0 110.925 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.66 HH21 ' HG2' ' B' ' 54' ' ' GLU . 6.7 ttp180 -64.12 -41.53 97.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.234 0.54 . . . . 0.0 110.012 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.66 ' HG2' HH21 ' B' ' 53' ' ' ARG . 49.5 mt-10 -91.0 -51.02 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.876 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.457 HE21 ' HG2' ' B' ' 59' ' ' GLU . 7.2 tp60 -94.5 -54.46 3.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.435 0.16 . . . . 0.0 111.376 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.8 tp 74.82 33.54 0.77 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 -11.04 60.74 Favored Glycine 0 C--O 1.235 0.18 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.602 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -105.47 110.1 22.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.606 0.241 . . . . 0.0 111.3 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.457 ' HG2' HE21 ' B' ' 55' ' ' GLN . 0.0 OUTLIER -92.07 102.12 14.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.56 110.02 21.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.06 -171.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.93 97.39 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 111.264 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -85.38 162.94 18.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.79 10.68 2.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 111.131 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -82.95 76.93 9.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.84 -9.83 19.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.772 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 66.33 11.56 8.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.482 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -80.29 -6.41 57.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -116.13 25.15 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.349 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -66.87 167.97 10.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.407 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -57.65 97.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.76 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.32 2.66 7.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.218 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.483 -179.824 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.5 -24.34 34.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 121.422 0.63 . . . . 0.0 109.938 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.71 142.93 36.84 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -95.25 116.16 66.08 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.66 112.48 1.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.455 2.104 . . . . 0.0 110.803 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.17 92.61 0.56 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -88.52 60.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.765 0.793 . . . . 0.0 108.893 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 pt -129.11 150.04 34.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.07 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -94.28 155.79 16.84 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -67.99 -179.74 1.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.652 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -46.08 121.55 3.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 112.439 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -91.42 68.05 5.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.923 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.1 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -167.35 94.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.789 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -87.14 -78.73 0.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.389 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m 66.73 157.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -79.88 93.35 5.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 m -89.77 -58.29 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.196 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.56 76.52 9.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.058 0.456 . . . . 0.0 111.199 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.14 97.3 5.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.46 ' NE2' HD13 ' A' ' 42' ' ' ILE . 10.6 pt20 -108.21 159.37 16.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.474 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 23' ' ' ASP . 26.7 mt -130.53 156.49 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 7.7 p-10 -77.83 -167.7 1.05 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -75.37 -31.76 60.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.443 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.21 -19.19 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.523 -174.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.28 50.12 2.67 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.404 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -99.64 -94.89 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -179.49 123.87 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.85 106.84 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.774 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.8 p -93.24 158.28 37.45 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HB2' HD22 ' B' ' 65' ' ' LEU . 27.9 Cg_exo -62.98 1.29 1.19 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.689 2.259 . . . . 0.0 113.18 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -98.8 -4.44 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.349 0.595 . . . . 0.0 109.928 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.47 ' O ' ' HD1' ' A' ' 35' ' ' TYR . 52.0 m-20 -108.64 120.44 42.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.706 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.11 126.24 27.48 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.949 0.404 . . . . 0.0 110.717 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 33' ' ' ASP . 38.9 p90 -146.35 168.0 22.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 0.0 110.902 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.4 t -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.75 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 24.4 mt -106.16 122.06 59.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 56' ' ' LEU . 10.2 t70 -94.06 86.77 5.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . 78.52 -42.52 2.22 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.021 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.27 -30.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.47 145.6 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.21 0.529 . . . . 0.0 110.472 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.46 HD13 ' NE2' ' A' ' 21' ' ' GLN . 66.3 mt -102.57 136.85 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.006 -172.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 51' ' ' TYR . 2.6 mp -138.41 129.53 36.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 175.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.07 150.52 24.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.252 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.05 -5.93 25.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.403 178.005 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -55.73 15.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 110.188 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.64 25.25 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.143 0.973 . . . . 0.0 109.138 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 36.1 tp -56.0 -50.18 71.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.164 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.67 -28.51 69.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.571 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.421 HH22 ' HD2' ' A' ' 53' ' ' ARG . 1.1 tpm_? -64.24 -49.27 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 110.265 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 33.4 t80 -75.68 -24.57 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.939 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 50.6 mt -69.69 -26.64 64.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.421 ' HD2' HH22 ' A' ' 50' ' ' ARG . 18.4 ttm180 -86.02 -19.5 30.24 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 1.1 tp10 -79.16 -54.09 6.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.18 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 30.2 tt0 -103.14 -67.69 0.87 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.559 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.1 tt 33.03 47.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.689 0.757 . . . . 0.0 109.716 -168.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.664 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -118.7 -18.09 4.92 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.733 -170.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.731 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 10.6 m-85 53.55 -151.54 0.33 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 21.1 mt-10 -119.64 102.13 8.4 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.919 166.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -84.36 119.87 25.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 59' ' ' GLU . 46.0 mmtm -117.57 102.58 9.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 111.599 -177.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -79.37 160.54 26.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.721 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 65' ' ' LEU . . . -73.34 32.56 0.07 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -39.75 0.46 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.592 0.757 . . . . 0.0 110.768 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 63' ' ' ALA . 43.2 tp -58.56 102.54 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.903 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.92 74.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 61.99 20.5 11.61 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.732 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -116.96 114.65 24.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.146 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -141.23 126.38 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.5 ' HB2' ' H ' ' A' ' 71' ' ' HIS . 11.1 m170 63.54 -88.17 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -166.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.5 ' H ' ' HB2' ' A' ' 70' ' ' HIS . 55.3 m80 -147.58 -72.65 0.21 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 167.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.02 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -83.53 96.24 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.737 0.779 . . . . 0.0 110.184 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.43 72.72 5.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.251 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -136.59 103.64 9.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.37 99.24 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.361 2.04 . . . . 0.0 111.766 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 83.4 mtp -86.17 -78.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.626 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.55 120.28 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.022 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.98 130.66 37.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.169 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.734 ' HB2' ' HE3' ' B' ' 11' ' ' TRP . 9.3 p30 -74.4 141.81 45.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.22 0.533 . . . . 0.0 110.763 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -86.08 -1.6 57.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.464 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' TRP . . . . . 0.734 ' HE3' ' HB2' ' B' ' 9' ' ' ASN . 32.0 m-90 -80.98 -9.72 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.553 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 37.0 m80 72.82 -68.89 0.21 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.831 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -154.49 -46.75 0.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.435 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -149.17 166.3 29.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.692 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.55 70.04 1.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 171.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 29.5 m -82.84 -29.91 29.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.726 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.97 -67.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.983 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 62.4 p 56.48 147.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 112.856 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.13 -31.89 63.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.72 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t 55.82 76.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.355 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.511 ' OE1' HD13 ' B' ' 42' ' ' ILE . 3.5 pp0? -93.33 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.653 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -126.75 147.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.801 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.493 ' HB3' HG21 ' B' ' 29' ' ' VAL . 5.3 p-10 -86.18 -164.41 1.04 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.08 0.467 . . . . 0.0 110.761 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -68.28 -28.96 67.64 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.26 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -59.76 -44.24 93.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.675 0.274 . . . . 0.0 111.008 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.22 33.21 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.029 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.3 -84.84 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.715 0.293 . . . . 0.0 110.342 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -169.55 142.2 2.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' B' ' 23' ' ' ASP . 22.0 t -123.65 86.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.676 0.75 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.469 HG23 HG22 ' B' ' 32' ' ' VAL . 0.1 OUTLIER -81.29 153.85 71.71 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.093 175.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.06 12.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 123.4 2.734 . . . . 0.0 114.787 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 30' ' ' THR . 33.9 m -103.21 -5.55 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.048 0.451 . . . . 0.0 110.282 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.35 155.81 17.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.267 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.649 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 5.3 m-20 -89.81 118.61 29.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.542 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -144.24 160.59 40.72 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.703 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.61 146.87 31.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.601 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mt -103.02 100.02 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.748 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 7.8 m-20 -96.54 90.8 5.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.463 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.655 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 72.49 37.1 58.61 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.516 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.62 -26.27 23.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.595 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.23 142.54 27.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.769 0.319 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.511 HD13 ' OE1' ' B' ' 21' ' ' GLN . 76.7 mt -100.49 128.43 52.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' HD12 ' B' ' 43' ' ' ILE . 4.3 mp -126.46 126.8 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.302 . . . . 0.0 110.422 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.1 tt -69.37 134.69 49.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.649 ' HE ' ' HB3' ' B' ' 34' ' ' ASP . 15.6 mtm180 -69.25 0.53 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.541 ' HG2' HD22 ' B' ' 44' ' ' LEU . 42.6 mm-40 -69.05 -18.05 63.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.893 0.378 . . . . 0.0 110.387 171.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -129.24 3.5 5.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.196 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 61.4 tp -57.74 -33.21 68.22 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.159 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 30.6 mt-10 -57.4 -52.66 64.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.779 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' B' ' 53' ' ' ARG . 7.4 mpt_? -71.14 -31.56 67.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -65.72 -39.38 91.11 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.337 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -69.38 -29.32 67.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' B' ' 50' ' ' ARG . 32.4 mtp180 -65.7 -32.71 74.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -94.45 -62.48 1.32 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.77 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -85.5 -42.2 14.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.051 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.6 tp 74.11 13.42 4.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.142 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 88.28 -29.03 5.82 Favored Glycine 0 CA--C 1.517 0.169 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.487 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -69.85 126.05 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.581 0.229 . . . . 0.0 111.107 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.1 tp10 -92.77 101.88 14.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.539 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.31 86.0 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -84.08 93.64 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 0.0 110.658 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -66.1 126.44 28.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.742 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.58 64.59 8.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 110.541 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -76.52 -56.16 4.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.39 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 31' ' ' PRO . 24.4 tp 52.52 69.68 0.66 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.141 174.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.9 102.81 4.88 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.967 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.423 ' HB3' ' H ' ' B' ' 68' ' ' HIS . 1.4 m80 -98.6 -153.07 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.169 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.423 ' H ' ' HB3' ' B' ' 67' ' ' HIS . 85.5 m-70 -83.58 36.17 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.094 0.473 . . . . 0.0 110.886 -173.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -137.55 48.73 2.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.08 0.466 . . . . 0.0 110.503 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -77.61 -35.19 53.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -89.8 130.82 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.273 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 22.5 p80 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.356 174.744 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.922 0.391 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.53 23.2 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -74.79 139.82 43.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.579 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -141.75 156.78 65.86 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.84 102.27 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.5 2.133 . . . . 0.0 111.147 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 68.3 mtm -74.97 108.33 7.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.339 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.15 144.94 22.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.81 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.95 155.93 8.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.352 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -139.76 99.81 3.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -162.85 170.99 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.565 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -90.68 19.84 5.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -171.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -129.78 140.67 51.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.855 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -133.08 92.01 2.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.74 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -133.74 86.52 2.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 tp -80.27 -31.89 38.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 69.89 156.73 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.01 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.863 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 23.6 mt-10 -89.03 103.42 16.04 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.975 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.6 p -64.6 -78.27 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.141 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -88.97 -5.67 57.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.41 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.863 ' HB ' ' HB3' ' A' ' 17' ' ' GLU . 6.1 t -84.29 117.56 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -175.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.0 159.68 41.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.347 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.8 mt -134.03 153.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.647 0.261 . . . . 0.0 110.377 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.8 p-10 -80.44 -177.77 6.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 110.78 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.62 -28.14 69.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.848 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -86.61 -17.24 34.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 37.43 6.96 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.746 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 t70 -90.84 -88.39 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.9 tt0 174.69 138.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.8 116.93 28.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.033 0.444 . . . . 0.0 110.338 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.784 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 60.5 p -110.05 172.8 3.31 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.999 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.784 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 42.6 Cg_endo -68.48 2.3 2.97 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.313 2.009 . . . . 0.0 112.197 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.34 14.04 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.548 0.69 . . . . 0.0 109.449 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 44' ' ' LEU . 41.9 m-20 -118.69 146.62 44.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.207 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -92.01 118.26 30.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 174.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HB3' HD12 ' A' ' 44' ' ' LEU . 31.0 p90 -144.02 168.01 21.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.486 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.672 ' HB ' HD13 ' A' ' 48' ' ' LEU . 72.0 t -131.51 133.68 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 35' ' ' TYR . 61.1 mt -103.52 121.96 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.323 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -93.13 86.2 5.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.339 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.582 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.31 -31.56 1.85 Allowed Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.35 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.43 -23.0 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.14 130.56 35.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.3 mt -89.76 129.14 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.56 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.6 mp -133.98 122.73 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 35' ' ' TYR . 13.9 tp -64.8 149.76 48.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -55.99 -23.42 32.47 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -81.54 -22.92 37.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 110.59 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -112.9 4.25 16.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.298 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.672 HD13 ' HB ' ' A' ' 36' ' ' VAL . 29.3 tp -70.68 -60.68 2.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 35.1 mt-10 -61.93 -16.18 49.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -165.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 53' ' ' ARG . 19.2 tpt180 -80.99 -49.91 10.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.225 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD2' HG12 ' A' ' 43' ' ' ILE . 16.1 t80 -63.75 -43.27 96.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 14.9 mt -63.82 -41.36 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 40.0 ttm-85 -52.04 -46.53 65.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.845 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.01 -25.26 23.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.675 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 29.0 tt0 -99.47 -68.08 0.82 Allowed 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.423 -0.798 . . . . 0.0 112.048 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 65.5 mt 42.27 43.99 3.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.317 0.58 . . . . 0.0 109.71 -169.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.675 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -100.8 -14.33 32.04 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.277 -168.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 57.22 -151.59 0.41 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' C ' ' A' ' 39' ' ' GLY . 2.3 mt-10 -118.22 102.16 8.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 163.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.37 103.55 12.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.078 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -109.04 37.83 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.305 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -55.71 119.38 5.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.775 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' B' ' 34' ' ' ASP . . . -88.95 52.71 2.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 -175.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -61.52 -39.54 91.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.707 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 24.3 tp 69.63 133.78 0.03 OUTLIER 'General case' 0 C--N 1.338 0.078 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.691 171.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.06 11.69 15.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.513 0.673 . . . . 0.0 110.116 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.707 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 33.2 m170 -117.25 96.54 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.885 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -111.8 101.11 9.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.37 110.69 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.964 -174.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -142.91 -174.81 4.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.073 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -75.33 74.89 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.785 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.331 175.543 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.405 ' HB3' ' H ' ' B' ' 2' ' ' VAL . 1.2 mpt? . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' B' ' 1' ' ' MET . 33.8 m -91.24 157.98 2.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.631 . . . . 0.0 112.326 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' B' ' 3' ' ' GLU . 7.9 tp10 -85.99 5.44 33.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.534 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 t30 66.6 88.26 0.11 Allowed Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.674 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.55 98.17 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.122 2.548 . . . . 0.0 112.922 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' MET . . . . . 0.64 ' HG3' HG23 ' B' ' 7' ' ' VAL . 26.3 ptt? -119.42 -25.02 6.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.64 HG23 ' HG3' ' B' ' 6' ' ' MET . 47.1 t -122.89 131.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.338 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 tt -112.4 107.5 23.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.406 0.622 . . . . 0.0 110.346 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -90.72 118.37 30.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.626 0.726 . . . . 0.0 110.756 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.65 5.43 31.15 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -142.65 131.45 22.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.383 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -91.66 120.07 32.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.083 0.468 . . . . 0.0 111.1 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.29 -6.25 56.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.295 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -97.67 17.14 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -78.7 -42.23 28.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.786 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.9 p -124.81 171.83 9.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.736 0.303 . . . . 0.0 111.475 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 17' ' ' GLU . 2.1 pm0 -79.13 -176.43 5.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 0.0 111.59 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.0 m -99.56 -126.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.742 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -107.99 70.98 0.79 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.405 0.622 . . . . 0.0 109.528 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.66 131.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.712 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.666 HE21 HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.99 -172.9 4.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.362 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 28' ' ' GLU . 41.0 mt -126.7 150.04 32.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.6 OUTLIER -83.11 -170.08 2.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.796 0.332 . . . . 0.0 110.285 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.07 -27.25 62.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.76 0.424 . . . . 0.0 111.021 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' TYR . . . . . 0.446 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 29.1 t80 -76.61 -30.59 56.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.75 30.08 5.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.188 -1.005 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.414 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.9 t70 -111.65 132.33 54.66 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 171.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.485 ' HA ' HG12 ' B' ' 22' ' ' ILE . 26.1 tt0 -64.71 124.18 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.334 0.588 . . . . 0.0 110.598 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' B' ' 35' ' ' TYR . 42.9 t -104.47 129.94 56.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.814 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.859 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 72.0 p -118.89 175.69 2.03 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.859 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_endo -64.47 5.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.392 2.062 . . . . 0.0 113.207 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.1 18.53 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.576 0.703 . . . . 0.0 109.418 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -129.1 125.81 37.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.366 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.433 ' HA ' ' H ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -65.38 109.76 2.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.211 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.407 ' HB3' HG11 ' B' ' 29' ' ' VAL . 16.6 p90 -135.88 149.13 48.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.159 0.504 . . . . 0.0 110.197 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.87 142.59 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.21 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.5 mt -102.93 115.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.524 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -94.63 89.06 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.582 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 83.0 -26.65 4.2 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.642 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.32 -26.25 0.35 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.44 129.55 34.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.666 HG21 HE21 ' B' ' 21' ' ' GLN . 64.3 mt -93.1 136.6 24.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.686 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -136.44 133.96 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.419 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -69.05 143.75 54.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.653 ' HD3' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -57.23 -20.71 28.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -172.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.43 -29.93 62.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.1 0.476 . . . . 0.0 110.708 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -106.92 -12.62 15.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.604 0.716 . . . . 0.0 109.773 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.653 HD23 ' HD3' ' B' ' 45' ' ' ARG . 31.5 tp -60.67 -52.01 66.93 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.959 -175.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.31 -37.31 80.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.323 0.582 . . . . 0.0 110.236 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 23.8 tpt85 -64.58 -53.55 46.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.234 176.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.67 -36.54 76.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.996 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 66.7 mt -63.66 -47.32 81.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.912 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 14.1 ptt85 -63.22 -28.46 70.05 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.242 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.57 -36.84 17.32 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.728 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.2 tp-100 -103.04 -68.19 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 27.1 mt 38.5 40.57 0.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.504 0.502 . . . . 0.0 110.723 -167.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.728 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -107.06 -13.72 20.73 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.306 -167.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 57.75 -154.93 0.34 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.66 102.03 9.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.306 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' A' ' 36' ' ' VAL . 25.1 m-85 -84.55 99.86 11.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -92.43 91.6 7.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.111 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.0 128.56 36.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.828 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.96 -11.02 60.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.365 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 54.51 78.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.814 0.816 . . . . 0.0 110.119 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp -156.42 151.73 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.634 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.59 55.67 1.68 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.219 0.533 . . . . 0.0 110.978 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -80.69 73.65 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.622 0.725 . . . . 0.0 109.761 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -75.8 112.66 12.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.097 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -69.46 -22.45 63.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.192 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -68.52 95.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.684 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -165.87 135.9 3.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.966 0.412 . . . . 0.0 110.977 -172.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 C--O 1.245 0.855 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.777 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.91 75.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.649 0.737 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.19 134.91 33.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 58.51 66.83 2.36 Favored Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 123.691 0.62 . . . . 0.0 110.157 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.29 -23.33 33.08 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.095 2.53 . . . . 0.0 113.002 -172.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 42.3 tpp -155.82 149.79 25.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.61 156.76 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.871 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -108.19 135.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -154.32 -85.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.859 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -175.58 147.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -132.83 137.33 46.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.991 0.424 . . . . 0.0 110.782 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -155.84 139.86 16.38 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -51.01 -59.21 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -108.38 105.02 14.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.02 116.63 5.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.557 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -120.08 -30.93 4.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 0.0 109.316 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.84 98.8 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.422 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 m -92.84 -54.47 3.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.408 0.623 . . . . 0.0 110.425 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.15 70.84 10.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.459 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 89.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.732 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -115.94 141.05 48.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.582 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 23' ' ' ASP . 27.8 mt -99.62 161.23 3.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 3.2 p-10 -79.35 -167.12 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -77.38 -31.37 54.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.734 0.302 . . . . 0.0 111.591 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -80.03 -31.96 39.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.66 39.99 1.52 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.635 -1.269 . . . . 0.0 113.067 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.02 -110.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -174.38 124.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.54 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.3 p -105.19 165.12 13.74 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.089 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.7 Cg_exo -58.73 1.65 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.289 2.66 . . . . 0.0 114.304 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.22 17.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -112.99 138.16 50.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.215 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.44 116.07 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -133.56 166.99 21.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.817 ' HB ' HD21 ' A' ' 48' ' ' LEU . 92.3 t -135.63 138.38 48.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 54.0 mt -106.44 114.05 44.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 52.6 t0 -95.44 87.74 4.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.21 0.529 . . . . 0.0 110.373 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.786 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 81.29 -11.64 42.87 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.264 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -22.4 1.56 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -83.89 130.16 34.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.4 mt -89.11 131.04 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.383 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.543 ' HB ' HD22 ' A' ' 48' ' ' LEU . 3.5 mp -134.8 136.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -74.1 146.12 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.562 ' N ' HD23 ' A' ' 44' ' ' LEU . 2.0 mmt180 -56.47 -21.52 26.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.51 -40.56 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.943 0.401 . . . . 0.0 110.024 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -89.18 -1.35 58.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 110.447 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -64.14 -40.6 96.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.02 -55.56 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.666 -174.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -64.53 -35.23 80.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.596 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -46.75 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 48' ' ' LEU . 87.7 mt -66.35 -26.43 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -73.79 -33.72 64.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.687 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.68 -51.04 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 12.8 tt0 -90.47 -68.36 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.492 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 38.74 35.56 0.12 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.792 0.682 . . . . 0.0 110.763 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -136.73 10.44 3.98 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.145 -171.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 1.3 m-85 58.34 -158.65 0.29 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.235 0.54 . . . . 0.0 110.882 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.6 tp10 -100.88 102.02 12.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.03 90.48 4.91 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.916 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 73.5 mmtt -86.64 147.12 26.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.521 -175.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -119.22 141.78 48.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -10.69 58.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.768 0.318 . . . . 0.0 111.066 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 61.75 42.66 10.45 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.484 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.47 26.03 9.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.344 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.39 93.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.022 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.66 55.5 1.87 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.832 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -103.54 92.07 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.206 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -123.56 18.33 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -91.51 97.9 11.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.624 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -121.86 -3.97 9.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 167.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.021 174.832 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -86.38 85.16 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.0 -25.31 20.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.555 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 18.3 m120 -78.04 152.26 79.43 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.436 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 12.2 Cg_exo -71.49 48.85 1.04 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.612 2.875 . . . . 0.0 112.406 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -92.2 -4.65 53.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.184 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 t -82.87 84.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.362 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 34.6 pt -85.38 -11.85 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.623 -176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 66.49 112.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.805 0.691 . . . . 0.0 110.789 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' B' ' 13' ' ' ASP . 65.2 t30 -79.28 125.13 29.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.194 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -81.66 -19.22 42.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.472 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -153.93 106.42 2.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.526 ' HA ' ' ND2' ' B' ' 10' ' ' ASN . 32.2 m-20 -77.0 169.74 17.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -82.27 43.12 0.78 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.916 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' B' ' 13' ' ' ASP . 3.5 mm? -71.06 128.17 35.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.158 0.504 . . . . 0.0 110.525 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -76.09 157.58 32.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.642 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 41.97 66.7 0.67 Allowed 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.069 0.855 . . . . 0.0 112.587 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 11.1 m -69.12 -59.3 3.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.284 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -127.25 23.96 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 109.483 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.83 127.0 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.266 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -135.92 172.39 13.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.367 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.68 146.31 34.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.1 OUTLIER -77.69 178.67 7.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -63.81 -26.15 68.5 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.734 0.414 . . . . 0.0 111.79 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' TYR . . . . . 0.424 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 94.9 m-85 -98.65 -2.06 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.67 17.32 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.736 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.36 128.66 39.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -72.57 99.69 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.0 t -86.61 114.64 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.517 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 78.3 p -102.61 172.85 3.94 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.011 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 77.1 Cg_exo -49.56 -22.47 6.52 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.224 2.616 . . . . 0.0 114.331 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.95 6.81 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -101.77 123.39 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -69.19 121.79 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.256 -179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 26.0 p90 -144.66 161.14 39.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.909 0.385 . . . . 0.0 110.988 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.564 HG23 ' HD3' ' B' ' 45' ' ' ARG . 54.4 t -135.09 143.73 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.577 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 48.9 mt -109.32 115.93 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 111.223 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.07 90.11 6.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 109.529 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.786 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 81.97 -34.12 2.6 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.282 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.69 -24.7 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -174.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -82.59 134.57 35.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.074 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.41 HG12 HG12 ' B' ' 37' ' ' ILE . 69.1 mt -92.52 129.57 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.827 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.01 122.52 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.51 141.37 47.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' HG23 ' B' ' 36' ' ' VAL . 30.3 mmm-85 -60.81 -12.07 9.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -67.99 -47.06 69.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.71 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -103.17 -3.66 25.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.973 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' B' ' 36' ' ' VAL . 37.4 tp -47.86 -41.92 25.31 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.662 -173.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -53.98 -44.61 70.97 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.808 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -74.67 -41.29 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -65.16 -45.16 86.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.447 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 52' ' ' LEU . 35.2 mt -69.84 -24.84 63.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.199 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -68.15 -44.25 76.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.558 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -93.81 -30.33 14.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.617 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp-100 -99.34 -67.55 0.84 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.09 37.89 1.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.439 0.638 . . . . 0.0 109.607 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.617 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -116.62 1.04 20.23 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.819 -165.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.68 -150.91 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.773 0.787 . . . . 0.0 109.377 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 3.3 mm-40 -115.04 101.79 9.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.33 96.57 10.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.31 86.16 2.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.512 0.673 . . . . 0.0 111.072 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -67.93 169.49 9.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.839 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.05 13.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 62.47 14.93 7.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.975 0.417 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.73 135.56 40.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.154 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -56.11 -39.68 72.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.037 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -71.37 -42.66 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.312 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 71' ' ' HIS . 20.0 m80 67.42 141.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.869 0.731 . . . . 0.0 111.926 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.15 -43.48 52.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -108.6 88.58 2.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 68' ' ' HIS . 76.6 t60 -121.83 130.15 53.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.947 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 44.6 m80 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.703 171.554 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.23 69.89 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.978 0.895 . . . . 0.0 109.897 176.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.1 132.15 11.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.983 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.4 p-10 -157.32 164.67 20.8 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.376 -173.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 4' ' ' ASN . 95.1 Cg_endo -85.51 -168.11 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.023 175.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -155.97 -166.51 2.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 p -65.39 99.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.494 0.664 . . . . 0.0 109.706 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.7 mt -84.59 123.77 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -79.89 116.46 20.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.484 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -81.41 -168.96 2.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 59.99 59.28 2.46 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -144.54 115.82 8.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.44 -36.58 63.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.182 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -132.96 152.7 51.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.967 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.94 75.81 8.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.6 p 53.68 -168.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.788 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -101.48 -22.37 14.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.3 m 72.66 -65.96 0.33 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.468 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -88.28 89.22 7.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.24 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t -131.71 137.12 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.476 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.578 ' HB2' HD13 ' A' ' 42' ' ' ILE . 1.1 pp0? -116.53 116.11 27.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.549 0.69 . . . . 0.0 110.387 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.17 142.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -63.08 -170.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.151 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -73.81 -31.64 63.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.455 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -72.17 -36.69 69.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 109.952 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 24.32 7.55 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.003 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 6.7 t70 -80.5 -81.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.58 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 40.3 tt0 163.92 123.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.809 0.693 . . . . 0.0 110.299 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 35' ' ' TYR . 9.4 t -113.35 134.89 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -111.47 153.93 43.99 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.201 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.62 1.73 2.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.0 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.14 -3.8 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.503 0.668 . . . . 0.0 109.46 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.38 179.39 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -111.7 128.98 56.24 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HB3' HG11 ' A' ' 29' ' ' VAL . 36.8 p90 -141.46 167.47 22.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.136 0.493 . . . . 0.0 110.691 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 96.2 t -136.62 138.29 46.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 47.6 mt -93.8 113.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.214 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 11.8 t0 -88.22 88.6 7.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.137 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 73.95 -27.65 0.95 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.423 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.43 -22.05 0.13 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -82.49 145.93 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.107 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 21' ' ' GLN . 83.5 mt -98.51 131.21 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.455 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 48' ' ' LEU . 1.7 mp -139.69 130.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 45' ' ' ARG . 5.6 tt -63.13 143.22 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 44' ' ' LEU . 10.5 mmm-85 -51.06 -23.28 2.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.83 -29.96 35.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.067 0.46 . . . . 0.0 110.808 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.81 -12.7 18.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.431 0.634 . . . . 0.0 109.911 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.962 ' HG ' ' HB ' ' A' ' 36' ' ' VAL . 2.8 tm? -61.68 -37.12 82.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.845 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -54.76 -52.4 62.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 ttm180 -76.34 -20.66 57.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -76.43 -30.7 57.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.021 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 56' ' ' LEU . 64.8 mt -67.72 -32.76 73.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.272 0.558 . . . . 0.0 109.667 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -61.38 -35.13 76.65 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -74.99 -64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.182 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -103.27 -59.22 1.75 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.8 tp 89.45 39.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.101 0.96 . . . . 0.0 112.117 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 72.39 57.67 5.44 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.449 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -155.2 120.22 4.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.123 0.461 . . . . 0.0 112.102 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.539 ' CB ' ' HB ' ' B' ' 37' ' ' ILE . 3.1 mm-40 -101.45 101.7 12.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 160.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.75 109.51 19.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.298 -168.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -121.42 174.63 6.63 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -165.12 169.95 15.56 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.07 -2.97 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.192 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 69.89 -46.62 0.6 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.586 0.754 . . . . 0.0 109.44 -171.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.12 77.75 7.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.435 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -72.07 -1.71 15.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -68.73 -2.49 9.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.011 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.412 ' HE2' ' CG ' ' B' ' 34' ' ' ASP . 7.5 p80 -74.01 -5.52 41.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.718 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -89.31 91.19 8.65 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -122.43 109.48 14.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -168.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -84.1 -33.05 24.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 158.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.276 170.621 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.15 169.19 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.746 0.308 . . . . 0.0 110.724 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.76 150.05 26.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.175 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 21.9 p-10 -85.28 128.7 58.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.828 0.347 . . . . 0.0 110.178 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 16.0 Cg_exo -69.08 175.08 8.0 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.962 2.441 . . . . 0.0 112.139 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 46.3 ttm -78.22 108.08 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.14 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.06 114.09 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.11 97.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.535 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 51.9 t30 55.2 74.03 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.32 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -87.98 -52.46 5.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -94.19 130.06 40.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.665 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.12 126.3 34.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 111.089 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -130.74 174.59 9.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -148.53 156.01 41.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' B' ' 15' ' ' LEU . 3.9 pp -85.73 158.99 19.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.871 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -66.17 132.13 47.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.279 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.82 -63.08 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.993 -171.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -94.04 -17.67 22.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.478 0.656 . . . . 0.0 110.619 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.97 37.72 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.27 109.08 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 13.6 pt20 -93.21 132.78 37.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.164 0.507 . . . . 0.0 111.284 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.25 151.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.523 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 0.5 OUTLIER -85.09 -177.91 6.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.62 -25.0 67.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.807 0.443 . . . . 0.0 111.82 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' TYR . . . . . 0.41 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 47.2 t80 -89.65 -18.02 27.28 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.51 13.59 27.82 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.633 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.72 129.45 36.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.32 99.59 4.14 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 46.5 t -81.38 101.16 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.44 0.638 . . . . 0.0 111.189 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 21.9 p -86.06 163.12 44.33 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.471 174.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 50.5 Cg_endo -68.82 20.33 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.933 2.422 . . . . 0.0 113.37 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' B' ' 30' ' ' THR . 7.0 t -116.67 1.01 8.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.109 0.481 . . . . 0.0 109.994 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -121.83 170.15 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.412 ' CG ' ' HE2' ' A' ' 68' ' ' HIS . 6.2 m-20 -92.66 124.89 37.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.576 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.489 ' HB3' HG11 ' B' ' 29' ' ' VAL . 18.5 p90 -136.73 146.22 45.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.97 0.414 . . . . 0.0 110.64 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.67 138.95 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 36.8 mt -99.86 113.62 35.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-O 121.628 0.727 . . . . 0.0 109.83 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -106.87 90.17 3.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.653 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' B' ' 59' ' ' GLU . . . 81.51 12.01 82.4 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.421 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.38 -30.46 4.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -97.51 150.29 21.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.331 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 72.9 mt -89.76 140.79 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.176 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.405 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.3 mp -134.41 129.9 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.516 HD12 HG22 ' B' ' 29' ' ' VAL . 3.9 tt -72.18 137.8 47.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 12.3 mtm180 -70.85 0.32 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.92 -15.26 56.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.23 3.21 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.278 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 28.1 tp -73.24 -34.89 66.13 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -170.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -51.59 -41.49 61.23 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 53' ' ' ARG . 7.6 ttm180 -77.55 -33.31 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -71.01 -38.21 72.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.582 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 58.0 mt -67.34 -29.15 68.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.164 0.506 . . . . 0.0 110.072 172.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' B' ' 50' ' ' ARG . 18.6 ttm180 -65.77 -28.19 68.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -70.01 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.647 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' B' ' 56' ' ' LEU . 2.4 pt20 -104.23 -48.63 3.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' B' ' 55' ' ' GLN . 29.0 tp 82.36 42.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.918 0.761 . . . . 0.0 111.224 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 57' ' ' GLY . . . 95.3 -20.57 48.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.763 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -87.58 107.39 18.57 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -174.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.613 ' CG ' ' HA3' ' B' ' 39' ' ' GLY . 3.0 mm-40 -101.63 102.24 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.147 0.498 . . . . 0.0 110.679 171.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -89.62 123.05 33.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.454 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -127.12 79.89 1.91 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 111.013 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -75.12 162.55 28.42 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 65' ' ' LEU . . . -58.36 -36.34 73.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.485 0.183 . . . . 0.0 111.35 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.06 -13.45 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' B' ' 63' ' ' ALA . 53.7 tp -86.02 90.8 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.18 44.69 0.88 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.013 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -74.89 -14.16 60.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.81 107.44 9.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 171.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -104.93 -62.67 1.31 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.321 . . . . 0.0 111.498 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -156.03 152.61 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -90.9 108.14 19.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.127 177.391 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.652 0.263 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.85 -30.3 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.954 0.407 . . . . 0.0 110.333 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.523 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 43.7 mt-10 -102.85 135.35 44.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.451 172.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.24 103.38 17.63 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 0.0 110.447 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 3' ' ' GLU . 4.1 Cg_exo -80.84 105.42 1.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.965 2.443 . . . . 0.0 111.393 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.5 ptp -104.12 10.27 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.733 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.4 99.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm 64.75 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.616 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -154.9 -82.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.609 0.719 . . . . 0.0 109.427 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -167.78 -49.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -97.23 162.48 13.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.188 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -125.81 15.88 8.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 14' ' ' LYS . 9.3 t70 -90.26 -161.16 0.76 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.638 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 83.0 tttt -96.18 9.02 42.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.788 0.804 . . . . 0.0 109.073 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 18' ' ' THR . 7.1 tt -73.38 112.03 9.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.614 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 p -89.28 -58.92 2.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.856 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -94.34 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.531 ' HA ' HD21 ' A' ' 15' ' ' LEU . 57.2 m -158.82 -72.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.827 0.346 . . . . 0.0 110.271 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.91 30.55 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.951 0.881 . . . . 0.0 109.145 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.82 102.79 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.51 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt20 -101.39 147.54 26.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.05 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG21 ' HA2' ' A' ' 26' ' ' GLY . 29.0 mt -123.17 153.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 6.4 p-10 -76.29 -164.89 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -78.78 -29.97 45.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.954 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.542 ' HD2' HD22 ' A' ' 47' ' ' ASN . 65.5 m-85 -96.1 -7.57 35.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 84.87 51.18 3.89 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.164 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 18.5 t70 -94.77 -86.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 35.1 tt0 167.89 135.36 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.312 1.045 . . . . 0.0 108.212 170.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.53 104.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 110.68 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.801 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 71.9 p -96.12 174.08 3.71 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.801 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.6 Cg_endo -66.05 4.24 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.15 1.9 . . . . 0.0 112.416 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.39 -18.23 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.133 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -94.43 119.93 33.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.379 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.23 138.58 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -155.93 166.24 34.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.206 0.526 . . . . 0.0 111.136 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 59' ' ' GLU . 69.4 t -135.07 145.79 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 20.1 mt -103.37 120.11 52.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 121.794 0.807 . . . . 0.0 110.82 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 43' ' ' ILE . 26.2 t0 -105.93 90.28 3.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.607 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.645 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 77.9 20.13 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.09 42.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.77 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.71 139.17 34.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.7 mt -88.86 138.88 18.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.51 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -139.53 127.47 26.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.3 tt -62.88 148.62 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.842 HH11 HD23 ' A' ' 48' ' ' LEU . 8.2 mmm180 -61.89 -7.25 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.89 -55.39 3.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 0.0 110.725 175.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.542 HD22 ' HD2' ' A' ' 25' ' ' TYR . 15.0 p-10 -89.62 3.64 51.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.312 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.842 HD23 HH11 ' A' ' 45' ' ' ARG . 36.8 tp -61.16 -32.62 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.986 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -44.43 -54.32 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.301 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NH2' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -68.77 -33.09 73.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.87 -172.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.574 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -76.18 -39.3 55.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.712 -176.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.5 mt -67.73 -22.28 65.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.794 0.807 . . . . 0.0 109.364 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.504 HH11 ' NH2' ' A' ' 50' ' ' ARG . 27.9 ttm180 -76.65 -25.17 53.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.264 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -90.16 -69.48 0.72 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.861 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.12 -16.16 15.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 30.3 tp 71.74 28.34 2.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 171.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 98.54 -8.51 62.09 Favored Glycine 0 C--N 1.321 -0.294 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.748 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.402 ' HE1' ' HA3' ' B' ' 57' ' ' GLY . 12.4 m-85 -117.1 129.76 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.078 0.439 . . . . 0.0 111.995 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.683 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 11.8 mt-10 -96.45 102.14 13.88 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 164.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -81.81 106.67 13.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.683 ' HE2' ' HB3' ' A' ' 59' ' ' GLU . 3.8 mptp? -108.68 80.61 1.35 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 109.766 174.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -83.75 146.47 28.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.227 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.95 79.11 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.375 0.607 . . . . 0.0 110.331 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -83.97 89.38 7.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.454 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mp -61.92 -83.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.017 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 54.05 20.9 2.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.366 0.603 . . . . 0.0 110.768 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -125.63 136.41 53.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.382 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 71.57 -54.67 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.926 0.766 . . . . 0.0 110.774 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -163.52 148.53 11.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -72.65 139.82 47.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -76.77 -60.1 2.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.943 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.951 -174.129 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 m 39.14 62.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 124.289 0.993 . . . . 0.0 112.216 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.63 -60.17 3.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.368 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 2.8 p-10 -176.27 144.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.824 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 4.6 Cg_exo -80.79 158.07 21.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.457 2.105 . . . . 0.0 110.375 170.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 48.9 tpp -81.74 84.32 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.342 0.591 . . . . 0.0 109.408 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.07 114.71 30.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.706 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mt -77.75 96.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -76.2 165.68 24.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -80.85 149.24 29.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -116.2 -33.15 5.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.795 0.331 . . . . 0.0 111.454 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -128.71 119.04 23.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.74 0.305 . . . . 0.0 111.229 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -108.67 -171.51 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -121.36 115.87 23.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.247 0.546 . . . . 0.0 112.178 -177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.74 137.98 35.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.146 170.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.482 HG22 ' O ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -73.52 -4.9 36.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.296 0.569 . . . . 0.0 111.433 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 71.35 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.884 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -157.61 -66.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.9 14.26 25.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.599 0.714 . . . . 0.0 110.241 -175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.482 ' O ' HG22 ' B' ' 16' ' ' THR . 4.8 t -108.79 130.99 60.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.479 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.454 ' OE1' HG21 ' B' ' 42' ' ' ILE . 3.0 pp0? -148.14 163.63 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.48 150.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.671 0.272 . . . . 0.0 110.964 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.37 -168.08 1.06 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -70.56 -29.01 65.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.74 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -86.04 -8.63 57.79 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.58 36.88 25.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.242 168.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 -92.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.423 0.611 . . . . 0.0 110.493 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -173.46 137.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -119.19 121.23 66.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.016 0.436 . . . . 0.0 110.14 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 57.3 p -102.42 168.81 8.38 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.84 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.706 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 33.4 Cg_endo -64.97 -4.03 8.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.58 2.186 . . . . 0.0 112.627 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.53 -2.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.304 0.573 . . . . 0.0 110.138 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -107.54 136.8 46.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.47 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -69.1 116.23 9.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.289 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.24 139.41 35.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 110.583 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.55 139.16 45.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 36.2 mt -91.18 96.69 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 95.2 m-20 -79.17 90.63 4.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.022 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 78.05 -17.66 5.81 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.971 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.39 -19.34 0.92 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 8.3 tp10 -93.02 144.67 25.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.454 HG21 ' OE1' ' B' ' 21' ' ' GLN . 80.2 mt -99.95 129.7 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.156 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.19 128.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.484 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 82.2 mt -54.52 141.35 31.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 23.8 mtm180 -71.65 0.52 8.52 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.584 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.03 -13.04 59.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -128.35 -0.62 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.153 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 36.2 tp -60.37 -40.35 90.5 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.826 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 27.4 tt0 -53.66 -51.64 62.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.559 0.218 . . . . 0.0 111.056 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.595 ' HD2' ' HD3' ' B' ' 53' ' ' ARG . 9.9 mmm180 -61.71 -36.29 80.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.366 -176.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -65.36 -43.38 90.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.947 0.403 . . . . 0.0 110.08 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 73.4 mt -71.92 -31.26 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.595 ' HD3' ' HD2' ' B' ' 50' ' ' ARG . 19.5 mtp180 -63.95 -33.4 75.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 25.1 mm-40 -92.18 -61.99 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.259 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -98.19 -29.17 13.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.1 tp 80.42 7.32 1.49 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.461 0.704 . . . . 0.0 111.924 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 91.74 1.55 70.71 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.414 -0.898 . . . . 0.0 115.149 166.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -98.94 134.91 41.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.78 0.79 . . . . 0.0 109.725 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.72 ' HB3' ' HE2' ' B' ' 61' ' ' LYS . 6.7 mt-10 -92.21 101.65 14.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.401 171.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.36 122.36 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.118 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.72 ' HE2' ' HB3' ' B' ' 59' ' ' GLU . 72.2 mmtt -119.17 157.62 27.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' B' ' 62' ' ' ASN . 3.1 m120 -135.59 137.78 42.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.04 0.447 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.11 -49.66 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.899 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.94 2.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.459 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 99.0 mt -105.62 94.27 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -171.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.63 -35.09 76.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.86 0.838 . . . . 0.0 108.843 169.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -98.44 109.45 22.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.15 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -74.6 -13.45 60.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.557 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -71.5 106.77 4.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -163.23 133.72 4.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.881 0.372 . . . . 0.0 110.666 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.9 7.96 26.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 . . . . . 0 C--O 1.244 0.778 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.971 174.521 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HB ' ' OE1' ' A' ' 3' ' ' GLU . 77.1 t -97.84 -49.85 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' OE1' ' HB ' ' A' ' 2' ' ' VAL . 2.1 mp0 -85.87 37.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 7.3 t30 71.78 127.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 123.638 0.586 . . . . 0.0 111.751 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.28 122.13 10.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.68 2.254 . . . . 0.0 111.62 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.1 mmt -92.33 93.0 8.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.064 0.459 . . . . 0.0 110.286 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.3 -16.35 8.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.694 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mt -82.81 91.16 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.806 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -99.2 -33.14 10.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.569 . . . . 0.0 109.948 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' TRP . 63.2 t30 -70.74 -11.66 61.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.142 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 6.3 m0 71.9 113.99 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.338 0.655 . . . . 0.0 111.679 -177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -107.97 -12.78 15.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.46 144.59 39.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.068 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -73.1 132.4 43.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.32 0.581 . . . . 0.0 112.213 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -87.59 51.75 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.126 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 p 57.94 -178.91 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.286 1.035 . . . . 0.0 111.982 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.2 30.69 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 110.26 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 m 69.38 -87.35 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.561 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.77 17.67 0.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.782 0.801 . . . . 0.0 108.87 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.86 102.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.623 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 167.14 15.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mt -116.74 153.93 18.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.997 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.545 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 4.3 p-10 -83.84 -160.08 0.42 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.562 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -80.07 -23.51 41.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -41.13 35.55 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.6 45.32 1.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.825 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.28 -88.71 0.45 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 176.83 129.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.27 138.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.7 p -123.82 160.5 51.22 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.26 2.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.185 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 HD22 ' B' ' 65' ' ' LEU . 12.0 t -97.47 -16.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.4 141.72 45.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.794 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.2 138.85 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.698 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.455 ' CD2' HG23 ' A' ' 42' ' ' ILE . 33.1 p90 -148.69 175.01 11.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.891 175.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 94.5 t -134.5 139.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.526 HG22 ' HA2' ' B' ' 39' ' ' GLY . 18.3 mt -103.42 119.76 52.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -105.11 89.51 3.16 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.369 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 88.87 -40.09 3.09 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.22 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.35 -23.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.654 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.49 164.91 14.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 111.055 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.455 HG23 ' CD2' ' A' ' 35' ' ' TYR . 71.2 mt -116.82 129.29 73.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.809 -171.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.0 mp -130.35 123.72 56.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.197 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.545 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 3.9 tt -60.37 141.31 56.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.7 -16.95 7.28 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -77.59 -33.42 53.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.419 0.628 . . . . 0.0 110.006 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -104.97 -5.76 20.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.957 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -66.79 -25.95 66.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.791 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.95 -30.05 68.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 74.3 ttt180 -82.65 -33.82 27.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.562 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.3 t80 -69.26 -36.3 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 29.6 mt -74.91 -34.64 62.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.996 0.426 . . . . 0.0 110.095 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 50' ' ' ARG . 4.6 ttp180 -59.86 -55.4 34.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.182 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 53' ' ' ARG . 53.6 mt-10 -93.0 -39.21 11.23 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.684 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 50.5 tp60 -97.49 -68.39 0.8 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.792 -0.568 . . . . 0.0 111.164 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HG ' ' HE1' ' B' ' 58' ' ' PHE . 0.7 OUTLIER 39.35 34.97 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.658 0.742 . . . . 0.0 110.225 -175.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.684 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -117.24 -19.81 4.98 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.873 -1.156 . . . . 0.0 114.583 -165.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 58.32 -153.96 0.37 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 7.4 tp10 -109.28 101.78 10.75 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.302 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.38 121.26 30.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.2 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -119.96 148.07 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.55 0.691 . . . . 0.0 111.105 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.42 148.05 47.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.035 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 75.67 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -83.29 72.76 10.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.992 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.7 109.46 20.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.795 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -69.45 97.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.362 0.601 . . . . 0.0 111.158 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -99.58 83.74 2.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.481 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -100.08 99.44 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.661 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -128.33 -11.62 5.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -74.45 119.34 18.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.937 0.398 . . . . 0.0 110.624 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -72.87 -26.14 61.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.923 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.6 m80 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.187 174.483 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.85 128.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.083 0.468 . . . . 0.0 111.626 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -172.46 -73.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.817 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' B' ' 5' ' ' PRO . 45.7 t30 -163.42 110.56 0.99 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.893 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' B' ' 4' ' ' ASN . 26.3 Cg_endo -62.02 146.53 96.19 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.658 2.239 . . . . 0.0 111.955 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -60.83 -59.27 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.638 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.38 131.84 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.095 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -113.28 123.71 69.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.096 0.474 . . . . 0.0 110.562 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -92.71 96.19 10.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -106.52 110.11 22.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.282 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -86.71 89.57 7.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.605 0.717 . . . . 0.0 110.286 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -160.06 101.05 1.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.707 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -99.82 -15.83 18.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.341 0.591 . . . . 0.0 109.816 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' B' ' 14' ' ' LYS . 46.9 mtmt -137.58 152.26 49.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.519 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -129.82 -66.38 0.79 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p 46.94 -97.15 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.21 133.0 34.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.088 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -154.11 -58.66 0.12 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.17 90.28 7.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.613 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.14 97.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.027 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.508 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 11.0 pt20 -116.11 151.91 34.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.687 -170.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 15.4 mt -119.65 146.45 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.171 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.9 OUTLIER -70.77 -173.71 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 111.16 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.24 -30.57 71.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.585 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.64 -43.84 11.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.21 29.01 0.3 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.781 -1.2 . . . . 0.0 113.486 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -114.77 137.87 51.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.34 132.28 53.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 111.734 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.508 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 16.4 t -111.26 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.233 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.646 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 31.5 p -87.02 164.47 36.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.5 Cg_endo -65.38 -3.7 8.06 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.77 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 t -101.27 1.28 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.327 0.584 . . . . 0.0 109.656 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -112.35 141.31 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.154 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 8.6 m-20 -78.06 135.73 37.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.24 162.97 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.962 0.41 . . . . 0.0 110.638 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.423 HG23 ' HG2' ' B' ' 45' ' ' ARG . 95.3 t -128.53 144.38 38.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 37.0 mt -107.05 100.14 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 0.0 109.265 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.784 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 5.9 m-20 -93.56 90.27 6.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.543 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . 74.75 25.46 69.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.393 176.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.78 -12.38 59.35 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.82 133.22 37.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -95.62 130.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.523 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.555 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.9 mp -138.2 126.13 29.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' B' ' 23' ' ' ASP . 5.2 mp -55.25 143.2 28.77 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 12.3 mtp180 -70.27 -0.38 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.707 0.289 . . . . 0.0 111.598 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.59 -16.15 43.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.781 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.74 -4.36 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.884 0.85 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 2.6 tm? -65.4 -35.4 80.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.963 -175.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 1.9 tm-20 -57.25 -55.96 27.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -60.68 -36.38 78.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.052 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.26 -33.55 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.676 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 68.6 mt -69.53 -29.16 66.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.474 . . . . 0.0 110.299 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 53' ' ' ARG . 46.3 mtp85 -72.07 -24.28 61.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.46 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.44 -66.46 0.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.631 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -98.21 -34.31 10.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.641 -174.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.2 tp 77.05 1.97 3.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.491 0.717 . . . . 0.0 111.276 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.784 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 106.92 -32.91 6.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.097 170.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.535 ' HE1' ' HG ' ' A' ' 56' ' ' LEU . 34.2 m-85 -70.93 123.43 22.01 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.671 -0.311 . . . . 0.0 110.819 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.459 ' OE1' ' HE2' ' B' ' 61' ' ' LYS . 40.5 tt0 -95.57 101.99 13.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.287 170.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -82.88 91.78 7.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.459 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 60.5 mmtt -81.75 75.07 8.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -64.51 158.43 24.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.09 -51.53 24.1 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.665 0.603 . . . . 0.0 110.876 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 62.28 15.45 7.61 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.61 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 32' ' ' VAL . 16.1 tp -85.58 30.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.533 0.683 . . . . 0.0 110.445 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -76.96 11.9 1.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.524 0.678 . . . . 0.0 109.692 174.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' B' ' 65' ' ' LEU . 34.4 m170 -76.21 62.13 1.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.746 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -108.25 24.06 13.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.611 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 54.5 m80 73.11 150.34 0.1 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.559 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -117.94 -179.42 3.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.123 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -75.83 97.03 3.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 173.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.585 -178.576 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.67 0.272 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.08 146.1 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 85.79 6.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.78 114.91 62.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.51 99.47 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.686 2.257 . . . . 0.0 112.513 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 6' ' ' MET . 0.0 OUTLIER -85.49 93.15 8.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.685 0.755 . . . . 0.0 110.646 178.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.77 -27.63 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.894 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -104.6 177.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.225 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -71.9 156.59 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.982 0.42 . . . . 0.0 110.587 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -81.73 -37.7 26.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -86.78 49.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.62 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -94.3 27.08 3.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.75 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.53 5.66 50.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.328 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -83.32 150.67 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.471 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.33 144.76 25.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.52 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -92.2 149.36 21.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.46 -69.3 0.32 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.757 0.313 . . . . 0.0 111.308 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m -127.46 -87.72 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.667 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.23 76.96 1.21 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.598 0.713 . . . . 0.0 109.753 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.2 t -117.91 87.98 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.948 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.426 ' OE1' ' HB ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -120.95 172.59 7.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.21 -176.237 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 28' ' ' GLU . 45.5 mt -129.8 150.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.9 p-10 -86.36 -170.28 3.02 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.2 -17.73 62.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.407 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 2.0 t80 -76.73 -41.99 42.94 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.74 34.92 3.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.987 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -102.36 -87.24 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.062 0.431 . . . . 0.0 109.992 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 -175.45 138.96 0.42 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG22 HD21 ' A' ' 44' ' ' LEU . 7.9 t -125.86 113.52 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 110.75 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 32' ' ' VAL . 24.9 p -114.84 163.93 18.13 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.022 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.71 7.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.499 2.799 . . . . 0.0 114.637 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 30' ' ' THR . 22.0 m -100.18 -5.87 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.59 176.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD2' HD22 ' A' ' 44' ' ' LEU . 5.0 t70 -119.96 160.31 22.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -96.26 121.35 37.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.926 -173.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.21 159.66 41.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.055 0.455 . . . . 0.0 110.701 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HB ' HD13 ' A' ' 48' ' ' LEU . 96.0 t -134.08 142.42 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.753 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 42' ' ' ILE . 18.7 mt -102.73 121.74 54.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.623 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -94.48 89.17 5.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 79.58 -51.08 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.616 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -31.14 0.02 OUTLIER Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -174.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.59 142.2 33.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.229 0.537 . . . . 0.0 110.038 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 37' ' ' ILE . 84.0 mt -98.22 135.78 31.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.306 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 2.2 mp -137.78 132.1 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD21 HG22 ' A' ' 29' ' ' VAL . 83.4 mt -58.92 152.6 19.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 172.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HD2' HD22 ' A' ' 48' ' ' LEU . 44.5 mmm-85 -63.65 -16.3 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.92 0.39 . . . . 0.0 110.577 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.22 -38.63 50.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.45 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.5 4.06 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.335 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 36' ' ' VAL . 40.4 tp -60.58 -41.32 94.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.499 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.16 -55.17 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.122 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.7 51.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.87 -45.0 91.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.481 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 58.0 mt -66.51 -48.77 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -61.97 -29.05 69.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.655 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -51.83 8.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.491 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 46.5 tt0 -103.49 -67.49 0.88 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 20.2 mt 47.72 43.35 16.67 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -168.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -113.65 1.94 24.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.672 -166.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' CZ ' ' HE1' ' B' ' 58' ' ' PHE . 8.3 m-85 59.33 -154.84 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.484 0.642 . . . . 0.0 109.69 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.5 tp10 -122.12 102.05 7.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 166.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.26 110.95 23.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.247 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 74.1 mmtt -112.5 63.89 0.63 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.127 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -74.11 149.87 40.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.46 63.03 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 72.73 -51.08 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.038 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.79 118.96 7.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.59 109.55 20.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.374 0.607 . . . . 0.0 111.353 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -115.59 93.24 4.19 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -131.71 163.59 27.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 0.0 111.717 -172.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -85.76 156.52 20.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 169.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.53 -59.81 4.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -175.55 77.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.432 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.422 -178.732 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.449 ' HG2' HG13 ' B' ' 2' ' ' VAL . 25.9 ttt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' B' ' 1' ' ' MET . 27.0 m -137.54 9.12 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.557 0.218 . . . . 0.0 111.511 -178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.591 ' HG2' HD22 ' B' ' 4' ' ' ASN . 0.5 OUTLIER -81.58 -36.11 29.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -174.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.669 ' HB2' ' HD2' ' B' ' 5' ' ' PRO . 9.9 p30 -129.47 166.29 26.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' B' ' 4' ' ' ASN . 43.0 Cg_endo -67.77 61.09 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.14 2.56 . . . . 0.0 113.349 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' B' ' 6' ' ' MET . 45.6 ttm -93.26 11.72 27.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t 70.8 102.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.883 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.3 mt -75.04 118.74 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.66 143.22 26.62 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -92.35 -81.61 0.34 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -171.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' TRP . . . . . 0.51 ' HA ' ' HE3' ' B' ' 11' ' ' TRP . 2.2 m95 56.19 88.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.332 0.587 . . . . 0.0 109.717 -168.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -134.5 29.79 3.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.476 -170.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.77 48.17 0.92 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.933 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 61.33 15.13 6.24 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.815 173.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 42.2 tp 63.32 21.94 13.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.588 . . . . 0.0 110.532 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 62.8 p -85.53 157.19 20.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.863 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -82.04 -16.24 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 34.9 m 76.49 -82.36 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.455 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.05 87.24 2.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.925 0.869 . . . . 0.0 111.375 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.6 124.11 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.096 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLN . . . . . 0.431 HE22 ' CG1' ' B' ' 29' ' ' VAL . 2.7 pp0? -130.01 166.55 19.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 0.0 111.438 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.472 HG22 ' N ' ' B' ' 23' ' ' ASP . 23.8 mt -119.96 161.21 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.721 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' B' ' 44' ' ' LEU . 5.0 p-10 -89.69 -159.87 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -73.02 -37.96 66.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.375 -175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -87.09 3.07 47.66 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.352 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 73.07 20.52 80.0 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.607 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.5 t70 -72.34 -87.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.308 173.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 30.2 tt0 175.33 141.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.431 ' CG1' HE22 ' B' ' 21' ' ' GLN . 44.4 t -122.36 123.04 67.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 0.0 110.3 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 64.0 p -106.86 160.94 24.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.936 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.06 3.36 0.56 Allowed 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.038 2.492 . . . . 0.0 113.558 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.4 12.86 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.599 0.714 . . . . 0.0 109.433 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -113.15 158.39 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.458 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.35 105.71 17.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -128.64 157.16 42.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.169 0.509 . . . . 0.0 110.512 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.24 142.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.883 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 34.3 mt -105.96 124.24 61.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.636 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 30.6 t70 -120.6 90.51 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.769 . . . . 0.0 110.696 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' GLY . . . 86.41 28.42 27.47 Favored Glycine 0 C--N 1.315 -0.609 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.261 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 -22.72 38.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.295 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.98 136.41 33.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.453 HG12 HG12 ' B' ' 37' ' ' ILE . 74.3 mt -101.25 133.34 44.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.4 124.13 39.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.528 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -68.1 143.61 55.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.528 ' N ' HD23 ' B' ' 44' ' ' LEU . 38.9 mmm-85 -53.72 -22.02 8.29 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.2 -36.78 75.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -106.4 -19.94 13.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.425 ' CD2' ' HD2' ' B' ' 45' ' ' ARG . 24.4 tp -55.75 -42.41 75.38 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -172.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -33.6 68.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -80.36 -41.02 25.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 0.0 110.258 178.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -57.92 -44.2 86.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.692 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.63 -38.84 64.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -57.82 -39.01 76.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -83.45 -43.99 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' H ' ' B' ' 57' ' ' GLY . 46.3 tt0 -99.5 -67.09 0.87 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.48 29.95 1.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.599 0.36 . . . . 0.0 111.689 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG2' ' B' ' 55' ' ' GLN . . . -125.44 15.22 7.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.584 -171.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.504 ' HE1' ' CZ ' ' A' ' 58' ' ' PHE . 2.3 m-30 56.8 -153.36 0.37 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.999 0.428 . . . . 0.0 109.98 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' B' ' 59' ' ' GLU . 3.7 tp10 -117.93 102.16 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.313 0.578 . . . . 0.0 110.5 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -83.64 100.92 11.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.817 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -85.19 -175.46 5.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -165.83 168.12 16.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.43 11.31 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 70.21 -81.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.456 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp 48.21 70.7 0.42 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.333 0.587 . . . . 0.0 110.117 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.87 -6.41 16.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.511 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.25 -35.31 49.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.765 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -108.67 15.46 23.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -93.2 49.44 1.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.008 -0.433 . . . . 0.0 111.106 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 70.2 -71.67 0.12 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.39 108.62 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.905 0.384 . . . . 0.0 111.925 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t60 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.613 172.671 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.97 135.02 59.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -123.09 93.9 4.1 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.211 0.529 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -125.84 114.02 24.6 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.437 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 118.0 5.23 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.714 2.276 . . . . 0.0 112.701 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 ttt -81.4 107.41 14.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.54 120.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.438 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 11' ' ' TRP . 24.2 pt -66.77 135.54 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.974 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.61 67.23 6.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 57.5 71.29 0.59 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.996 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.621 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 58.8 t-105 -94.44 147.52 23.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.055 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -88.88 176.76 6.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.075 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.84 147.2 23.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 0.0 111.645 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -99.11 -21.05 16.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.939 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.91 85.84 4.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.673 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -149.22 153.89 38.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -68.41 139.04 55.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.957 0.408 . . . . 0.0 110.717 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.0 m -121.08 -6.77 9.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.798 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.62 21.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.58 92.27 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.523 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 26.9 pt20 -88.26 167.08 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.243 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 26' ' ' GLY . 28.4 mt -136.19 149.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.03 -179.99 4.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -57.99 -35.9 71.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.818 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -84.64 -12.96 52.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 87.76 40.78 6.6 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.118 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 28' ' ' GLU . 12.4 t70 -90.27 -97.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 29.6 tt0 179.38 127.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.523 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 22.0 t -123.04 107.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.226 0.536 . . . . 0.0 110.534 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 67.6 p -98.0 168.28 10.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.016 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 50.2 Cg_exo -56.52 -10.54 5.18 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.049 2.499 . . . . 0.0 113.721 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.19 10.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -106.19 145.73 31.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.928 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.584 ' OD1' ' HB2' ' B' ' 62' ' ' ASN . 35.9 m-20 -89.39 124.82 34.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -148.21 164.71 33.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.391 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 64.3 t -133.43 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 90.7 mt -112.94 108.17 24.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-O 121.685 0.755 . . . . 0.0 110.638 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -83.3 79.62 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.943 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.1 5.84 29.11 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.513 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.7 -24.8 1.97 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.545 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 40.0 mt-10 -81.56 134.28 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.2 mt -96.45 122.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.729 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.9 mp -129.45 127.55 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.188 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -62.36 143.03 57.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -55.58 -20.88 14.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.63 -47.54 80.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.603 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -96.86 0.44 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.193 0.521 . . . . 0.0 110.114 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.9 tm? -68.6 -36.71 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.394 -172.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.02 -34.28 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.81 -34.16 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 110.272 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.86 -41.76 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.386 174.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -63.52 -34.21 77.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.748 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -64.8 -41.83 95.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.605 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -66.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -103.33 -25.42 13.31 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 31.3 tp 64.1 43.46 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 173.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 86.14 -16.55 42.58 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.377 -0.916 . . . . 0.0 114.106 172.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HE2' HD23 ' A' ' 56' ' ' LEU . 12.6 m-85 -91.7 133.29 35.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.89 102.01 14.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -78.5 107.02 10.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.716 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 17.5 tptt -93.81 177.09 6.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 20.6 t-20 -143.62 151.89 40.7 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' B' ' 31' ' ' PRO . . . -49.89 -31.1 11.39 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 25.4 mm-40 68.18 26.59 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 176.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.85 -30.91 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 68.55 -3.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.071 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 18.6 m170 -67.62 136.01 53.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 7.8 m-70 76.99 -26.11 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.123 0.889 . . . . 0.0 111.02 -174.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 45.3 m80 59.83 97.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 50.7 m80 69.99 117.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -165.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -59.3 117.93 5.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.154 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.434 -178.386 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.719 0.295 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.18 22.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -172.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.32 -52.0 5.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 59.26 89.38 0.11 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.512 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.36 86.71 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.56 2.173 . . . . 0.0 111.693 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 87.0 mtp -76.8 -15.28 59.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 109.917 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 m -110.88 111.29 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.345 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 28.3 pt -81.57 34.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 52.41 74.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.185 0.517 . . . . 0.0 111.039 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.54 34.28 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.392 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -83.01 2.85 32.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.336 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -68.44 109.43 3.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.09 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -138.99 104.2 4.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.82 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -104.54 -46.6 4.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.755 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -147.34 76.43 1.41 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.68 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 141.18 48.59 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 168.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -99.89 129.72 46.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.142 0.496 . . . . 0.0 110.857 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -120.36 -62.87 1.42 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.489 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.16 78.92 9.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.444 0.64 . . . . 0.0 110.868 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.86 105.37 18.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -106.59 162.01 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.502 . . . . 0.0 111.678 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 23' ' ' ASP . 35.1 mt -128.54 154.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.474 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 4.7 p-10 -82.79 -167.29 1.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.488 0.661 . . . . 0.0 111.601 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.1 -35.74 81.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.026 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -83.73 -7.61 59.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.73 65.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.165 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 28.3 t70 -80.53 -84.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 35.1 tt0 174.9 135.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' VAL . . . . . 0.456 HG22 HD21 ' B' ' 44' ' ' LEU . 40.7 t -121.51 118.34 55.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.211 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.836 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 70.2 p -111.93 172.67 3.36 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.324 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.836 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 46.3 Cg_endo -69.43 19.69 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.824 2.349 . . . . 0.0 113.071 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' B' ' 30' ' ' THR . 10.6 t -121.07 -3.42 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 109.961 177.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -101.76 172.3 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.718 -173.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.583 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 14.8 m-20 -111.39 106.42 15.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 22.0 p90 -124.84 142.5 51.4 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.987 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.4 138.76 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.194 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' GLU . 57.0 mt -100.2 109.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.084 0.468 . . . . 0.0 110.664 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.43 90.1 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.149 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.49 -2.55 46.12 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.457 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.53 -30.47 1.42 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.149 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 31.1 mt-10 -88.13 145.33 25.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.463 HG23 ' CD2' ' B' ' 35' ' ' TYR . 61.7 mt -95.8 130.29 44.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.072 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.61 122.15 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.268 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 93.7 mt -62.15 144.69 55.07 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' CB ' ' B' ' 48' ' ' LEU . 48.0 mtm180 -69.27 -0.24 5.89 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.238 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.56 -27.23 64.96 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.1 2.54 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.025 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.587 ' CB ' ' HA ' ' B' ' 45' ' ' ARG . 32.5 tp -58.72 -40.75 84.62 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.49 -42.23 74.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.458 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -75.0 -40.02 60.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.587 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.05 -34.1 77.61 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.292 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 20.2 mt -72.19 -29.41 63.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.085 0.469 . . . . 0.0 110.585 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -65.46 -50.44 65.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 110.193 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.42 -48.64 12.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.244 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 4.3 tp-100 -96.02 -67.6 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.515 -174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 4.9 tp 42.74 40.26 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.743 0.652 . . . . 0.0 109.509 -171.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -101.41 -24.35 8.91 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.489 -0.862 . . . . 0.0 114.1 -165.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.72 -151.77 0.33 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.7 tp10 -116.44 101.78 8.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -107.33 111.83 24.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.582 -171.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.512 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 73.5 mmtt -124.62 -169.56 2.0 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.728 0.775 . . . . 0.0 110.99 -175.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.584 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 6.4 p30 -169.35 -159.44 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.06 57.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 118.531 0.605 . . . . 0.0 111.417 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 61.19 19.79 10.39 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.074 0.55 . . . . 0.0 111.161 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.02 -25.31 58.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 -176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 46.91 80.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.6 0.714 . . . . 0.0 110.528 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -137.1 72.92 1.43 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.948 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -64.78 132.2 48.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -73.08 -6.74 47.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.375 0.607 . . . . 0.0 110.713 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -131.11 104.73 7.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.69 107.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.412 0.625 . . . . 0.0 112.016 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.894 175.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 C--O 1.228 -0.077 0 CA-C-O 121.874 0.845 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.32 121.24 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.478 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.805 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 29.0 pt20 -93.78 142.11 27.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.68 148.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.54 174.94 9.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.53 -35.72 70.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.91 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -82.43 -11.07 58.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.66 40.7 7.6 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.186 -1.006 . . . . 0.0 113.08 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 19.5 t70 -93.62 -95.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 23.9 tt0 177.42 126.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.805 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 39.8 t -109.21 104.63 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.308 0.575 . . . . 0.0 110.323 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.5 p -92.55 167.25 15.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.596 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 31.6 Cg_endo -65.09 -9.2 20.81 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.539 HG22 HD23 ' B' ' 65' ' ' LEU . 3.4 t -112.76 29.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.68 0.752 . . . . 0.0 109.133 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -129.84 139.69 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.862 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -89.27 128.54 35.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' HG23 ' A' ' 42' ' ' ILE . 18.6 p90 -142.4 170.11 16.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.44 135.58 49.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 30.4 mt -96.28 115.33 35.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.813 0.34 . . . . 0.0 110.264 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.47 88.1 6.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.407 0.622 . . . . 0.0 109.561 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 83.07 -33.42 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.229 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.16 -22.81 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.713 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.89 147.56 23.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 0.0 110.226 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.558 HG23 ' CD2' ' A' ' 35' ' ' TYR . 94.5 mt -94.38 128.85 45.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.909 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 ' HA ' ' A' ' 48' ' ' LEU . 3.8 mp -130.03 129.59 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.178 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 45' ' ' ARG . 4.1 tt -67.36 138.7 56.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 48' ' ' LEU . 8.2 mmm-85 -53.55 -22.46 8.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.27 -40.8 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.252 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.58 -4.56 58.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.001 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' HG21 ' A' ' 43' ' ' ILE . 33.8 tp -61.81 -44.2 97.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.54 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.1 -45.3 71.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.912 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -62.46 -48.7 78.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.387 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.5 -36.61 81.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.617 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 70.6 mt -66.8 -39.53 87.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.261 0.553 . . . . 0.0 110.485 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -70.49 -21.53 62.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.153 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.08 -59.5 2.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.734 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 27.3 tt0 -103.12 -67.46 0.88 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.2 tt 42.33 43.32 2.94 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.456 0.646 . . . . 0.0 109.378 -168.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.734 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -126.32 6.4 7.63 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.949 -1.119 . . . . 0.0 113.839 -166.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 54.6 -153.88 0.29 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.0 tp10 -112.89 101.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.037 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -97.77 110.17 22.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.521 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 72.2 mmtt -110.71 163.66 13.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -144.98 -179.14 6.42 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 172.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 122.067 0.937 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.67 129.35 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.836 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -140.73 165.49 27.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.23 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.461 HG21 ' HA2' ' B' ' 26' ' ' GLY . 16.8 mt -132.02 156.22 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.436 ' N ' HG22 ' B' ' 22' ' ' ILE . 4.7 p-10 -79.89 -165.85 0.9 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 110.784 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -72.15 -34.74 68.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.557 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.4 -41.02 25.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 118.22 38.12 0.82 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 11.1 t70 -86.2 -93.38 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 32.0 tt0 168.81 121.99 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 35' ' ' TYR . 14.4 t -112.53 127.56 69.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.444 0.64 . . . . 0.0 110.505 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 69.3 p -124.63 169.64 10.47 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.65 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 44.6 Cg_endo -68.58 18.15 0.15 Allowed 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.452 2.101 . . . . 0.0 113.053 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' B' ' 30' ' ' THR . 35.7 t -108.7 -32.44 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.866 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . 0.419 ' OD2' HG13 ' B' ' 29' ' ' VAL . 6.0 p-10 -104.14 134.87 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.581 0.705 . . . . 0.0 111.086 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.7 135.74 48.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.499 ' CG ' HG11 ' B' ' 29' ' ' VAL . 26.0 p90 -152.1 166.42 31.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.737 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.858 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 75.5 t -135.82 146.97 28.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.9 mt -112.77 118.33 57.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 1.1 m-20 -98.02 88.9 4.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.594 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 70.47 24.08 77.06 Favored Glycine 0 C--N 1.319 -0.4 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.448 172.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.6 -23.99 8.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.549 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.39 138.33 35.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.821 0.343 . . . . 0.0 110.541 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -89.33 136.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.627 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.425 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.8 mp -134.97 131.25 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -52.19 140.3 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -67.36 -5.21 13.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 0.0 109.827 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.74 -26.49 54.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.471 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.87 5.07 9.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.737 0.78 . . . . 0.0 109.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.858 ' HG ' ' HB ' ' B' ' 36' ' ' VAL . 2.7 tm? -66.99 -38.19 85.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.013 -170.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -58.95 -39.61 82.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -63.66 -39.64 94.84 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.229 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.08 -38.66 72.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.641 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.414 ' HG ' HD13 ' B' ' 48' ' ' LEU . 18.8 mt -67.12 -25.06 66.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.955 0.407 . . . . 0.0 110.86 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.13 -41.04 74.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.748 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.51 -41.12 9.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.707 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -100.89 -52.71 3.23 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.374 -0.204 . . . . 0.0 111.414 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.6 tp 76.59 37.37 0.32 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.896 0.748 . . . . 0.0 111.491 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 75.97 -11.39 11.44 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 170.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -101.24 120.84 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.359 0.579 . . . . 0.0 112.036 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.467 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 43.7 tt0 -92.28 102.03 14.53 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.58 109.16 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.844 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 9.7 mmmm -116.29 78.72 1.22 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.122 0.487 . . . . 0.0 111.157 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.11 165.7 19.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.99 60.61 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.242 0.339 . . . . 0.0 110.928 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 63.64 19.37 11.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.845 0.831 . . . . 0.0 110.049 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 32' ' ' VAL . 26.5 tp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.743 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.517 -0.301 0 CA-C-O 121.784 0.802 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.24 132.26 67.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.985 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 13.2 pt20 -142.19 159.39 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.163 -175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.6 mt -133.14 149.49 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 4.5 p-10 -78.69 -171.16 2.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.16 0.505 . . . . 0.0 110.589 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -72.03 -27.94 63.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.564 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 47' ' ' ASN . 6.4 m-85 -86.28 -8.13 57.97 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.13 39.69 15.56 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.143 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 17.4 t70 -95.8 -89.81 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.5 tt0 176.54 142.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 68.8 t -122.22 121.38 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.55 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -117.75 162.86 26.92 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.13 -11.14 7.19 Favored 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 122.899 2.399 . . . . 0.0 114.224 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -96.44 2.29 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.004 0.431 . . . . 0.0 110.793 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -99.75 140.55 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.901 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.28 111.02 18.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -138.77 158.48 44.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.005 0.431 . . . . 0.0 110.818 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 48' ' ' LEU . 92.3 t -133.89 140.59 46.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 46.4 mt -101.89 121.24 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.611 0.243 . . . . 0.0 110.435 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.09 88.74 3.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.425 0.631 . . . . 0.0 110.029 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.832 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 87.63 -24.52 10.11 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.271 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.26 -28.11 0.5 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.55 130.33 35.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.095 0.474 . . . . 0.0 109.896 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 37' ' ' ILE . 76.8 mt -87.41 137.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.547 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.8 mp -138.74 125.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.147 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 29' ' ' VAL . 86.6 mt -52.84 148.68 7.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 170.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -62.89 -11.99 22.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.02 -15.33 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.278 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.404 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 88.1 m-20 -117.36 -13.54 10.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 36' ' ' VAL . 22.9 tp -64.74 -38.2 90.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -50.6 -51.57 47.28 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.652 0.595 . . . . 0.0 110.691 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 tpp85 -67.42 -36.23 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.958 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -65.73 -43.9 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.738 0.304 . . . . 0.0 110.432 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 46.7 mt -71.76 -22.51 61.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -78.61 -22.23 47.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.122 0.487 . . . . 0.0 109.738 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 72.7 mm-40 -93.68 -60.12 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.733 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 25.0 tt0 -92.15 -67.68 0.84 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.485 -173.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 14.2 tp 43.73 37.98 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.047 0.451 . . . . 0.0 110.541 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.733 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -127.74 2.02 6.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.991 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.9 OUTLIER 61.33 -153.75 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.34 0.591 . . . . 0.0 110.686 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 11.1 tp10 -106.03 102.18 11.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.496 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.502 ' HA ' HG22 ' B' ' 36' ' ' VAL . 32.6 m-85 -89.54 104.78 17.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.504 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.548 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 55.4 mttm -118.49 94.14 4.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 111.241 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -83.43 70.27 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.311 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.937 178.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 121.149 0.5 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.23 135.62 49.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.572 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.475 HE21 ' HB2' ' B' ' 21' ' ' GLN . 6.7 mt-30 -136.36 -179.48 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.912 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' B' ' 28' ' ' GLU . 15.2 mt -129.59 141.62 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 2.5 p-10 -88.98 -170.92 3.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.06 0.457 . . . . 0.0 110.517 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.44 -30.12 70.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.412 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.26 -39.88 74.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.118 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.08 2.56 31.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.328 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.7 m-20 -71.83 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 34.5 tt0 172.84 157.82 0.11 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.459 174.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 76.7 t -130.51 105.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.534 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.775 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -104.19 171.26 5.21 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.775 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 25.9 Cg_endo -62.93 -0.57 2.16 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.682 2.254 . . . . 0.0 113.418 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.43 6.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.063 0.459 . . . . 0.0 110.582 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -102.92 138.88 39.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.259 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.7 128.4 33.59 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -156.62 159.59 38.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.394 0.616 . . . . 0.0 111.334 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' B' ' 48' ' ' LEU . 78.1 t -134.4 137.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.245 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 59.4 mt -103.66 110.28 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -81.93 84.54 6.9 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 109.916 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.832 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 74.32 -16.51 2.88 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.712 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.04 -22.73 0.45 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -83.09 121.15 26.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.73 129.08 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.513 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.3 mp -134.32 136.85 52.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB3' ' OE1' ' B' ' 46' ' ' GLU . 39.4 mt -55.73 145.94 22.65 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 170.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -12.45 61.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' B' ' 44' ' ' LEU . 1.5 pm0 -87.75 -10.84 49.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -123.76 0.56 8.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.828 0.823 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' B' ' 36' ' ' VAL . 18.7 tp -67.96 -51.21 50.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.987 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.35 -53.96 12.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.31 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 0.1 OUTLIER -76.82 -33.73 57.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 -175.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.461 ' CD2' HG12 ' B' ' 43' ' ' ILE . 43.7 t80 -69.22 -40.02 78.2 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.761 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.7 mt -62.82 -38.73 91.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' B' ' 53' ' ' ARG . 1.3 tmm_? -55.32 -33.99 63.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.812 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 64.3 mm-40 -87.35 -38.32 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.162 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.585 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.9 tp-100 -99.07 -68.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 112.128 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 63.5 mt 40.75 43.59 1.69 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.117 0.484 . . . . 0.0 109.828 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -105.22 -14.14 23.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.191 -167.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 7.9 m-85 58.7 -158.43 0.3 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -112.81 102.0 10.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 162.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -103.29 106.25 16.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.141 -170.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.86 150.07 25.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 0.0 110.886 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -137.35 140.1 41.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.35 -12.62 61.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.164 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 60.6 26.03 15.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.567 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.252 0.548 . . . . 0.0 110.192 178.717 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 . . . . . 0 CA--C 1.52 -0.173 0 CA-C-O 121.145 0.497 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.34 84.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.188 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.715 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 21.9 pt20 -105.29 159.49 15.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 27' ' ' ASP . 14.0 mt -124.83 144.64 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . 1.2 p-10 -88.06 -176.95 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.068 0.461 . . . . 0.0 111.135 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.96 -37.18 71.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.174 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -65.57 -43.05 91.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.19 16.95 5.94 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 9.2 t0 -106.45 158.61 16.77 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.47 132.19 41.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.229 0.537 . . . . 0.0 110.505 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.715 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 55.9 t -107.36 96.22 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.584 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 48.5 p -97.31 172.82 4.56 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 19.6 Cg_endo -62.22 -7.33 9.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.286 1.991 . . . . 0.0 112.523 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.14 -0.08 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 109.978 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -106.4 131.33 53.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.668 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -133.6 164.21 27.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.91 144.39 33.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 55.1 mt -106.43 115.72 48.64 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 122.182 0.991 . . . . 0.0 110.805 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.483 ' HB3' HD11 ' A' ' 43' ' ' ILE . 44.1 t0 -109.95 89.3 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.239 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.483 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.72 41.29 15.65 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.606 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.65 -17.28 15.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.965 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.92 137.84 32.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 35.1 mt -94.26 139.56 18.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.818 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.5 mp -139.03 127.73 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 27' ' ' ASP . 92.5 mt -57.03 145.49 30.38 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 169.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -58.28 -19.54 35.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.466 176.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.46 -44.04 92.33 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.977 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -110.38 7.9 23.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.357 0.599 . . . . 0.0 110.044 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.413 HD23 ' HD2' ' A' ' 45' ' ' ARG . 40.9 tp -65.71 -35.12 79.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.299 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.14 -33.43 67.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.296 0.569 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 8.4 tpm_? -67.01 -53.34 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.505 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.818 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -63.87 -43.29 96.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.44 -29.03 68.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.845 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -71.38 -26.52 62.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.751 0.31 . . . . 0.0 110.362 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 16.9 mm-40 -85.83 -68.96 0.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.974 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -103.88 -21.78 13.6 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.959 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.2 tp 65.45 44.24 3.16 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.441 0.463 . . . . 0.0 112.166 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.56 -11.42 68.36 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.742 171.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -95.89 104.37 16.3 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.718 -0.284 . . . . 0.0 110.467 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 61' ' ' LYS . 45.0 tt0 -93.04 102.84 15.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.017 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' B' ' 36' ' ' VAL . 94.1 m-85 -79.12 109.05 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.877 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 25.5 mmtp -109.65 105.8 15.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.164 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -75.81 168.65 19.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.499 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 0.0 111.389 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.57 94.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' B' ' 29' ' ' VAL . 6.7 pt20 -103.34 157.38 17.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' B' ' 28' ' ' GLU . 18.6 mt -130.78 147.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.661 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.424 ' HB3' HG21 ' B' ' 29' ' ' VAL . 10.0 p-10 -73.72 -166.84 0.4 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.425 0.631 . . . . 0.0 111.062 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.86 -36.11 79.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.61 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -89.97 -34.82 15.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.494 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 110.51 41.35 1.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.802 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.38 -10.34 41.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.016 0.436 . . . . 0.0 109.846 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.649 ' HA ' HG12 ' B' ' 22' ' ' ILE . 30.8 tt0 65.09 97.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.066 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' B' ' 23' ' ' ASP . 40.6 t -95.86 103.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.02 -173.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.724 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 66.4 p -96.44 167.34 12.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.959 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.724 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.0 Cg_endo -64.76 20.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.649 2.899 . . . . 0.0 113.698 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.467 ' H ' ' C ' ' B' ' 30' ' ' THR . 20.9 t -101.76 -21.15 5.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.159 0.504 . . . . 0.0 109.818 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -115.45 169.3 9.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.935 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -103.39 146.36 28.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 110.451 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.39 170.82 18.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.122 0.487 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' HD13 ' B' ' 48' ' ' LEU . 82.0 t -136.84 140.36 43.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mt -102.73 118.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -89.48 86.55 6.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 74.68 -36.27 1.02 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.212 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.79 -25.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -173.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.58 130.95 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.18 124.81 40.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.16 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.26 121.8 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.137 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.7 tt -58.57 138.75 56.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.488 ' N ' HD23 ' B' ' 44' ' ' LEU . 5.5 mmm-85 -56.46 -16.76 6.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' B' ' 44' ' ' LEU . 9.0 mm-40 -74.57 -28.49 60.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -173.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -125.82 24.02 7.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.813 0.816 . . . . 0.0 109.447 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.61 HD13 ' HB ' ' B' ' 36' ' ' VAL . 25.9 tp -68.78 -45.14 72.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.264 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -45.84 67.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.112 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 9.3 tpt180 -68.6 -43.2 76.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.309 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.49 -45.95 77.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.874 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.34 -30.0 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.612 0.244 . . . . 0.0 111.066 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 53' ' ' ARG . 17.8 ttm-85 -63.1 -41.9 99.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -93.75 -25.91 17.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp60 -102.5 -67.74 0.86 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.356 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 40.77 40.31 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.689 0.756 . . . . 0.0 109.693 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.798 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -103.04 -34.01 4.13 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.381 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.9 -165.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.8 tp10 -115.74 102.26 9.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 123.45 45.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.098 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.86 176.81 7.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 0.0 110.347 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -166.33 170.84 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.72 57.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.463 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 58.58 24.17 11.7 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.424 0.63 . . . . 0.0 111.157 -172.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.4 103.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.407 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 152.05 23.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.233 0.539 . . . . 0.0 111.451 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 28' ' ' GLU . 53.4 mt -118.88 149.4 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.89 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.34 -163.01 0.73 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -75.95 -25.0 55.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.025 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -69.05 -33.01 72.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.7 33.78 10.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.789 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -103.4 -80.73 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.939 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.503 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 179.28 137.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.34 115.88 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 p -104.71 162.5 19.61 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 28.0 Cg_endo -62.95 -1.62 2.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 113.161 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.77 -2.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.575 0.226 . . . . 0.0 111.101 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.21 -170.95 1.74 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 5.1 t0 -126.87 134.9 50.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.59 -171.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 42' ' ' ILE . 35.5 p90 -156.49 161.05 40.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.048 0.452 . . . . 0.0 111.452 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 48' ' ' LEU . 87.4 t -137.25 144.73 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 19.2 mt -105.6 124.66 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 111.403 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 16.8 t70 -96.99 87.99 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.19 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 80.6 -22.22 4.88 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.502 173.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.58 -31.57 0.37 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 123.61 28.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 37' ' ' ILE . 70.5 mt -82.56 142.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.883 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -136.41 132.7 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -60.17 143.57 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HG3' ' CG ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -58.03 -19.68 33.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.75 -33.78 60.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.63 0.15 16.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 28.7 tp -55.99 -56.08 25.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.979 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -68.63 -23.5 64.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.22 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -73.92 -42.73 60.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.422 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 55.5 t80 -64.63 -36.1 83.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.369 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 77.6 mt -65.74 -33.61 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.291 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -68.63 -28.62 67.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 6.1 mm-40 -80.51 -57.74 3.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.601 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.585 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 6.0 tt0 -102.93 -67.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER 48.19 45.35 19.89 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -169.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -109.31 -33.76 2.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.285 -167.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CD2' ' HA3' ' B' ' 57' ' ' GLY . 1.7 m-85 63.5 -166.71 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.152 0.476 . . . . 0.0 109.748 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.2 tp10 -107.6 101.84 11.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.391 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -106.7 112.04 24.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.985 0.421 . . . . 0.0 110.24 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HG3' ' CZ ' ' B' ' 35' ' ' TYR . 69.9 mmtt -101.69 177.55 4.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -162.42 136.44 6.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.555 0.693 . . . . 0.0 110.396 178.508 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.778 ' HB2' ' HD3' ' B' ' 31' ' ' PRO . 8.5 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.086 0.469 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 101.87 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.76 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' B' ' 29' ' ' VAL . 7.8 pt20 -140.31 133.83 30.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -99.36 154.64 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.335 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.442 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 5.8 p-10 -93.66 -170.65 2.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.724 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.59 -36.09 77.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.458 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -69.83 -36.34 75.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.077 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.87 33.2 6.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.668 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' B' ' 28' ' ' GLU . 11.5 t70 -98.62 -96.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' B' ' 27' ' ' ASP . 31.6 mm-40 -167.57 137.79 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 109.551 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 92.4 t -123.66 101.05 8.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.692 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.0 p -103.16 175.75 2.11 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.474 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 29.8 Cg_endo -62.96 -10.83 21.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.49 2.127 . . . . 0.0 113.512 -177.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.02 13.91 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.024 0.44 . . . . 0.0 110.786 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -112.92 152.49 29.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -97.0 124.4 40.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 61' ' ' LYS . 32.0 p90 -143.0 159.87 41.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' B' ' 48' ' ' LEU . 53.7 t -129.87 143.07 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.5 mt -110.21 115.67 50.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 CA-C-O 121.804 0.811 . . . . 0.0 110.887 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.96 87.46 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.185 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 79.4 -18.77 6.4 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.38 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 -21.83 0.4 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.575 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.64 142.71 27.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -94.79 134.58 31.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.4 mp -127.9 128.18 68.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.446 HD23 ' N ' ' B' ' 45' ' ' ARG . 1.9 tt -61.8 137.45 58.25 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.446 ' N ' HD23 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.08 0.15 3.91 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -172.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.76 -12.74 30.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.368 0.604 . . . . 0.0 110.032 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -114.38 -7.01 12.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.512 0.672 . . . . 0.0 110.055 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' B' ' 36' ' ' VAL . 49.9 tp -57.19 -44.27 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.062 -170.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -59.85 -40.65 89.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.968 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -69.5 -43.28 73.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.161 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -62.73 -36.34 82.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 62.9 mt -70.41 -30.76 67.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 0.0 110.68 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -94.16 -49.5 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.723 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -103.03 -53.0 2.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 tp 72.04 47.99 0.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.303 0.641 . . . . 0.0 112.162 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' CD2' ' A' ' 58' ' ' PHE . . . 82.24 -31.13 2.92 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.938 -0.648 . . . . 0.0 114.24 169.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.95 122.9 25.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.667 -0.313 . . . . 0.0 111.322 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.658 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 8.1 tp10 -92.26 102.35 14.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -95.54 120.1 35.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.86 -167.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -115.44 178.11 4.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.836 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -169.51 149.66 4.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.72 75.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.02 0.438 . . . . 0.0 110.523 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 61.49 28.61 17.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.246 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 0.0 110.166 177.283 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 121.437 0.637 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.47 144.95 30.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.877 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -133.86 139.92 46.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.74 152.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -81.24 179.9 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.038 0.447 . . . . 0.0 110.771 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -56.4 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.465 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -70.83 -45.22 64.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.439 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.03 15.77 3.75 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.667 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.83 132.57 44.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.23 124.28 23.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.965 0.412 . . . . 0.0 110.595 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 23' ' ' ASP . 44.8 t -108.58 107.31 22.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.686 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 24.0 p -95.99 167.61 12.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 62.7 Cg_exo -52.74 -16.63 5.98 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.273 2.649 . . . . 0.0 114.32 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.93 2.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.652 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -105.72 150.48 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 45' ' ' ARG . 19.2 m-20 -94.82 120.72 35.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 109.863 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.9 p90 -142.59 161.76 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.871 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.7 t -131.94 134.97 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 51.2 mt -95.97 121.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 28.7 t70 -90.2 86.73 6.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.554 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 78.4 -40.43 1.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.115 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.84 -28.48 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -81.66 136.05 35.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 35' ' ' TYR . 92.7 mt -87.66 134.24 28.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.548 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.76 135.17 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.25 145.18 55.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.615 ' HG2' HD22 ' A' ' 48' ' ' LEU . 25.5 mtp-105 -65.61 -5.99 9.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.2 -63.2 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.503 . . . . 0.0 109.946 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.04 -14.89 61.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' A' ' 45' ' ' ARG . 18.6 tp -51.74 -42.6 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.336 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -60.21 -44.23 95.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -41.43 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.999 0.428 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.525 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 84.5 t80 -65.91 -43.76 87.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.39 -23.24 61.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.537 0.208 . . . . 0.0 111.33 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -70.51 -46.81 62.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 110.393 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.48 -35.91 29.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.205 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.552 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 26.3 tp60 -97.59 -67.54 0.84 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.319 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 44.32 41.14 4.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.583 0.706 . . . . 0.0 109.131 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.552 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -108.34 -24.1 6.35 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.309 -0.948 . . . . 0.0 114.528 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CG ' ' HA3' ' B' ' 57' ' ' GLY . 1.0 OUTLIER 57.53 -151.81 0.41 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -175.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.575 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 33.0 mt-10 -113.61 101.39 9.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.983 163.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -93.63 103.53 15.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 59' ' ' GLU . 93.5 mttt -117.48 105.34 11.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.75 0.786 . . . . 0.0 111.777 -173.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.13 160.16 30.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.191 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.379 0 O-C-N 123.291 0.369 . . . . 0.0 111.134 177.467 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.513 0.673 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.39 128.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.727 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.573 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 26.1 pt20 -107.27 149.79 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.928 0.394 . . . . 0.0 111.031 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 13.3 mt -112.7 140.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.162 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.564 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 13.1 p-10 -77.06 -170.4 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.112 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.88 -26.66 60.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -80.32 -23.17 40.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.709 0.29 . . . . 0.0 110.772 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 89.26 17.29 55.9 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.948 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.89 -8.61 42.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.28 0.562 . . . . 0.0 109.929 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' B' ' 22' ' ' ILE . 43.1 tt0 76.65 139.57 0.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.861 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 14.5 t -112.68 102.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 110.488 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 59.3 p -84.75 159.53 57.71 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.828 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 48.6 Cg_endo -69.21 7.68 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.651 2.234 . . . . 0.0 112.811 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.95 -6.46 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.285 0.564 . . . . 0.0 109.591 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -117.64 160.14 21.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.969 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.86 143.73 29.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.406 ' CD2' HG23 ' B' ' 42' ' ' ILE . 13.1 p90 -145.69 166.07 26.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.354 0.597 . . . . 0.0 110.672 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 59' ' ' GLU . 53.8 t -136.96 144.54 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 33.7 mt -109.94 116.81 53.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.377 0.608 . . . . 0.0 110.087 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 2.0 m-20 -97.44 86.67 3.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.891 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 62.63 45.56 95.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.826 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.3 64.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.845 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 3.3 tp10 -95.51 119.43 34.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' B' ' 23' ' ' ASP . 97.0 mt -83.89 120.84 35.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.602 ' HB ' HD13 ' B' ' 48' ' ' LEU . 2.7 mp -126.26 128.6 71.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' B' ' 23' ' ' ASP . 28.5 tp -66.58 139.75 57.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.604 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -60.25 -15.99 29.86 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.75 -45.03 82.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.74 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.48 17.66 6.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 111.493 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.602 HD13 ' HB ' ' B' ' 43' ' ' ILE . 48.9 tp -63.21 -31.49 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.389 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.76 -45.83 59.11 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 111.583 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 8.1 tpt180 -68.78 -37.11 79.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.416 . . . . 0.0 110.898 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' B' ' 41' ' ' GLU . 15.9 t80 -72.77 -32.66 65.78 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 75.1 mt -65.37 -29.33 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.413 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 -64.74 -44.75 89.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.431 . . . . 0.0 110.205 174.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.12 -54.36 9.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.783 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -103.52 -67.08 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.02 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 24.1 tp 78.72 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.855 0.722 . . . . 0.0 111.241 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 79.87 -45.55 2.97 Favored Glycine 0 C--O 1.235 0.205 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.736 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -69.53 139.1 53.77 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.602 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 3.9 tp10 -114.69 102.21 9.81 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 167.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -83.86 93.76 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.541 -175.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 59' ' ' GLU . 27.9 mmtm -93.49 83.17 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.326 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' B' ' 64' ' ' GLN . 92.9 m-20 -81.83 60.23 4.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.441 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' B' ' 64' ' ' GLN . . . 68.78 -27.18 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.9 0.88 . . . . 0.0 113.016 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' B' ' 62' ' ' ASN . 96.8 mt-30 67.67 18.32 9.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.332 0.587 . . . . 0.0 110.409 -175.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 179.68 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 121.154 0.502 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -81.33 83.7 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.999 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.457 ' NE2' HD13 ' A' ' 42' ' ' ILE . 10.9 pt20 -96.35 166.21 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.12 157.57 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.64 -169.86 2.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -72.8 -26.42 61.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.567 0.222 . . . . 0.0 111.022 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -72.87 -40.82 65.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.89 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 17.82 4.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.264 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -104.98 129.88 53.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -59.0 120.0 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.278 0.561 . . . . 0.0 111.603 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.492 HG22 HD21 ' A' ' 44' ' ' LEU . 41.0 t -95.9 113.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 p -103.74 166.57 11.48 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.19 -6.01 2.56 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.782 2.321 . . . . 0.0 113.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -96.07 -4.38 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.368 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -110.13 166.26 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.406 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.88 119.02 38.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.452 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HB3' HG11 ' A' ' 29' ' ' VAL . 32.2 p90 -135.97 149.76 49.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 0.0 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.61 133.71 68.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.2 mt -97.5 121.4 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -94.75 84.27 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.876 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.32 -47.59 2.96 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.437 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.29 -29.02 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 129.19 34.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.509 0.671 . . . . 0.0 110.765 174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.457 HD13 ' NE2' ' A' ' 21' ' ' GLN . 57.6 mt -90.59 133.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.981 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.3 mp -136.61 132.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 29' ' ' VAL . 84.4 mt -58.65 151.62 20.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.299 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -12.77 22.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.938 0.399 . . . . 0.0 110.882 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.99 -36.24 72.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.422 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.66 5.19 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 110.617 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.86 -48.58 81.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.068 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.96 -37.18 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 6.8 tpt180 -73.62 -39.81 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.698 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -64.08 -47.83 78.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.19 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.815 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 65.7 mt -61.98 -41.24 97.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 50.5 ttt-85 -46.54 -40.21 12.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.143 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -49.81 8.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.037 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.849 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 5.6 tp-100 -88.34 -68.2 0.78 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 48.0 mt 42.89 30.86 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.368 0.267 . . . . 0.0 111.286 -171.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.849 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -127.64 3.27 7.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.692 -166.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 53.87 -149.63 0.41 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.447 0.623 . . . . 0.0 110.313 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.9 tp10 -112.16 101.95 10.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.65 117.38 31.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.712 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.92 156.82 24.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.411 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -141.06 160.44 40.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.501 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.437 178.658 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 121.551 0.691 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -77.89 101.05 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.544 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.563 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 12.9 pt20 -101.56 158.49 16.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.586 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' B' ' 28' ' ' GLU . 53.2 mt -140.83 152.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.857 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.79 -173.87 2.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.331 0.586 . . . . 0.0 111.148 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -67.11 -29.18 68.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.153 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -79.78 -14.49 58.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.288 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.86 33.49 26.97 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.287 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.1 -87.2 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.843 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' B' ' 22' ' ' ILE . 41.7 tt0 -179.17 137.5 0.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.86 120.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.037 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 77.0 p -108.09 169.09 6.98 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.29 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_exo -60.36 -2.5 1.91 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.858 2.372 . . . . 0.0 113.022 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.37 -11.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.736 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.15 147.08 26.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.707 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.35 112.18 23.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -133.68 157.8 44.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 0.0 111.221 -172.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.84 145.0 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.423 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 67.7 mt -107.18 110.72 32.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.282 0.563 . . . . 0.0 109.881 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.6 92.25 3.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.203 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.06 36.6 31.24 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.521 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.94 -28.64 7.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.187 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.83 150.22 24.7 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.563 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 78.6 mt -108.86 141.48 24.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.564 -174.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mp -134.77 123.0 40.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -59.85 140.06 56.89 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.585 HH11 HD23 ' B' ' 48' ' ' LEU . 11.3 mmm180 -55.92 -17.97 7.86 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -77.22 -31.43 55.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.523 . . . . 0.0 110.047 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -102.96 -7.01 21.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.525 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.585 HD23 HH11 ' B' ' 45' ' ' ARG . 45.1 tp -64.45 -28.64 69.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.427 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -54.33 45.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.94 -33.31 70.36 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.732 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.72 -40.36 87.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.335 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 75.8 mt -72.06 -32.55 67.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 53' ' ' ARG . 44.1 mtt180 -64.11 -40.53 96.4 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.491 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -79.85 -65.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.82 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -95.1 -41.83 8.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.825 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 23.1 tp 78.41 17.98 1.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.895 0.747 . . . . 0.0 111.56 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.13 -38.36 3.19 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.069 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -65.88 117.2 7.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.724 -0.28 . . . . 0.0 110.956 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.567 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 37.0 tt0 -92.3 102.19 14.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.638 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -85.42 112.03 20.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 7.1 mmmm -115.22 88.6 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.241 0.544 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -82.55 154.22 25.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.52 69.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 48.8 81.18 0.05 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.252 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--N 1.321 -0.668 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.877 -178.3 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.124 0.488 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.67 132.77 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.786 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -123.59 171.18 9.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.567 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG21 ' HA2' ' A' ' 26' ' ' GLY . 21.8 mt -138.61 155.22 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.619 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 22' ' ' ILE . 5.6 p-10 -82.42 -167.52 1.62 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -69.97 -34.26 73.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.921 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -82.07 -15.46 53.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 85.25 36.98 10.23 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.728 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.6 t70 -87.93 -85.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.7 tt0 176.15 136.55 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.621 0.576 . . . . 0.0 109.676 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 44' ' ' LEU . 73.6 t -123.09 112.65 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.484 . . . . 0.0 110.67 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 32' ' ' VAL . 70.7 p -104.81 162.01 21.06 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.45 7.22 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.946 2.431 . . . . 0.0 113.257 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 t -103.89 -12.09 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.145 0.498 . . . . 0.0 109.884 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -92.87 151.31 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.635 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -97.02 115.44 27.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.403 0.62 . . . . 0.0 109.704 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.59 172.89 12.34 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.571 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 48' ' ' LEU . 64.2 t -137.03 139.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 14.5 mt -95.65 110.11 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.732 0.777 . . . . 0.0 109.455 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD2' ' HG3' ' A' ' 55' ' ' GLN . 9.8 t0 -82.66 85.87 6.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.243 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 59' ' ' GLU . . . 76.43 -35.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.091 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.18 -28.29 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.43 147.17 29.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.815 0.34 . . . . 0.0 110.396 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.5 mt -97.78 129.76 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.286 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 43' ' ' ILE . 2.3 mp -136.71 123.88 31.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.457 HD21 HG22 ' A' ' 29' ' ' VAL . 85.6 mt -56.19 146.38 23.56 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -68.56 -0.02 4.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.221 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -81.26 -19.18 43.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.94 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -129.09 -7.01 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.245 0.545 . . . . 0.0 110.335 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 36' ' ' VAL . 28.7 tp -50.2 -35.58 27.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.3 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -52.29 -42.57 63.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.004 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -69.83 -39.61 76.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.196 0.522 . . . . 0.0 110.351 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -38.09 88.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.194 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 62.2 mt -69.95 -25.04 63.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.036 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -69.08 -38.47 79.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.7 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.8 -67.83 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 8.7 pt20 -102.92 -20.89 14.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 40.3 tp 69.5 23.04 6.14 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 168.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.87 0.64 39.25 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.356 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.13 127.88 55.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.628 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 23.9 tt0 -91.95 102.03 14.59 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.72 122.12 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -111.84 -175.68 2.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.871 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.76 161.49 23.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.834 0.349 . . . . 0.0 111.06 177.741 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.5 107.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.006 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 10.5 pt20 -89.03 132.62 34.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 109.974 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.44 148.94 18.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.796 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.53 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -79.88 -174.58 4.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -71.6 -22.84 61.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.363 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' B' ' 47' ' ' ASN . 13.8 t80 -74.39 -45.25 48.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.44 27.64 2.79 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.059 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -96.0 -124.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -141.05 140.55 34.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 41.8 t -119.81 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.486 0.66 . . . . 0.0 109.345 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -86.96 167.77 20.59 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 35.9 Cg_exo -58.89 -3.6 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.853 2.369 . . . . 0.0 113.496 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.43 8.48 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.226 0.536 . . . . 0.0 110.509 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -106.23 130.87 54.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.02 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.26 120.98 23.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' B' ' 42' ' ' ILE . 34.8 p90 -143.3 164.53 29.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' B' ' 48' ' ' LEU . 72.9 t -132.8 145.83 33.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 39' ' ' GLY . 46.9 mt -111.57 127.89 68.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.342 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' HE2' ' B' ' 51' ' ' TYR . 25.3 t70 -119.29 89.77 3.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.052 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 42.37 9.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.303 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.58 -22.25 11.56 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.934 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -87.56 129.13 35.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.996 0.426 . . . . 0.0 110.151 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.517 HG23 ' CD2' ' B' ' 35' ' ' TYR . 78.3 mt -83.99 141.07 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.0 mp -135.57 125.37 42.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.56 148.03 20.71 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -61.33 -17.36 53.39 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.959 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.52 0.11 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.741 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' B' ' 25' ' ' TYR . 54.0 t30 -124.04 -1.74 8.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 109.167 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' B' ' 36' ' ' VAL . 39.6 tp -69.15 -45.41 70.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.07 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.91 -53.08 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.125 0.488 . . . . 0.0 110.596 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.37 -47.48 85.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.956 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.416 ' HE2' ' CB ' ' B' ' 38' ' ' ASP . 92.7 t80 -62.76 -39.95 95.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.481 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 43.0 mt -67.72 -47.55 69.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.394 -0.191 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -59.39 -19.03 43.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 110.903 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.07 -54.13 4.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.936 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.867 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 6.3 tp60 -91.53 -67.64 0.84 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 19.4 mt 39.57 34.85 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.867 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -120.46 -1.03 12.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.22 -171.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.46 -157.26 0.27 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -115.88 101.88 9.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.687 169.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.92 121.48 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.154 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -136.11 68.07 1.45 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.868 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -71.35 176.68 4.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.043 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -74.55 -5.93 45.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.884 0.373 . . . . 0.0 110.507 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 55.87 43.22 27.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.616 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 87.7 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.712 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.202 0.525 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t 70.82 110.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.175 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 6.7 pt20 -122.37 158.4 29.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.223 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.43 145.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 1.2 p-10 -77.26 -161.06 0.19 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.037 0.446 . . . . 0.0 110.196 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.5 -23.83 39.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.65 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -104.33 -4.07 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.1 5.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.769 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -114.13 149.06 36.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.07 127.79 34.05 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 110.472 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 44' ' ' LEU . 15.7 t -95.69 117.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.797 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 p -115.6 169.04 7.36 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.797 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 47.7 Cg_endo -67.3 20.21 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.987 2.458 . . . . 0.0 114.3 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.19 -26.62 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.118 0.485 . . . . 0.0 110.248 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.69 145.47 29.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.0 110.853 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' B' ' 62' ' ' ASN . 1.8 t70 -87.81 142.87 27.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.01 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 26.8 p90 -149.96 164.66 34.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.802 0.334 . . . . 0.0 111.021 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.4 153.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.368 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 73.6 mt -111.16 108.22 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.079 0 CA-C-O 121.819 0.819 . . . . 0.0 111.051 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 43' ' ' ILE . 1.8 m-20 -99.88 90.5 4.45 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.769 -177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 74.58 23.98 73.86 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.03 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.93 -29.98 6.57 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.365 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.1 158.78 15.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.366 0.603 . . . . 0.0 111.095 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 72.8 mt -103.58 138.87 26.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.142 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 38' ' ' ASP . 3.9 mp -131.56 122.8 51.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -59.23 135.07 57.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 14.3 mmt180 -58.08 -14.23 6.32 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.78 -14.49 56.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.476 . . . . 0.0 110.149 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -115.4 -9.91 12.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.403 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 28.2 tp -68.8 -28.77 67.06 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.138 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 53' ' ' ARG . 3.3 tm-20 -54.43 -66.37 0.41 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.61 -28.66 67.11 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.332 -177.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.38 -40.99 94.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 39.0 mt -65.42 -33.16 75.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 50' ' ' ARG . 11.1 mtm180 -62.55 -39.31 93.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.065 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 23.5 mm-40 -87.66 -52.79 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.713 0.292 . . . . 0.0 111.317 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -90.24 -51.55 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.138 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.98 44.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.361 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 79.37 -51.72 3.98 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 121.236 -0.507 . . . . 0.0 114.158 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -68.98 122.97 19.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.773 -0.251 . . . . 0.0 110.862 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -92.52 101.78 14.22 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.251 170.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.46 95.23 6.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.917 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD2' HD12 ' B' ' 37' ' ' ILE . 16.8 mttp -98.41 87.61 3.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.715 0.769 . . . . 0.0 110.632 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -81.42 176.49 9.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.811 177.392 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.513 0.673 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.1 90.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.21 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.668 ' OE1' ' HB ' ' B' ' 29' ' ' VAL . 0.9 OUTLIER -106.69 166.19 10.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.0 151.74 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -71.56 -173.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -67.41 -32.12 72.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -86.1 -45.69 11.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.75 31.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.233 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.78 125.43 53.68 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.78 128.05 34.37 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 111.393 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.668 ' HB ' ' OE1' ' B' ' 21' ' ' GLN . 19.0 t -114.57 119.6 61.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.005 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 36.2 p -110.34 164.56 14.54 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.744 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 51.9 Cg_exo -53.98 -18.73 13.82 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.388 2.725 . . . . 0.0 114.209 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.91 -0.93 10.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.949 0.404 . . . . 0.0 111.175 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -102.51 147.26 26.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.84 128.72 42.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 61' ' ' LYS . 30.1 p90 -148.48 -178.01 6.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.449 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 98.4 t -140.05 139.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.459 HD12 ' HD2' ' A' ' 61' ' ' LYS . 45.1 mt -105.02 117.85 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 110.073 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.92 92.04 3.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.468 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.584 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 84.74 0.57 89.18 Favored Glycine 0 C--N 1.316 -0.534 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.645 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.4 -20.27 4.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.724 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -99.82 151.06 21.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.012 0.434 . . . . 0.0 110.17 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.76 138.86 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.608 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.663 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.2 mp -140.01 126.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 48' ' ' LEU . 20.5 mt -55.81 146.67 20.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 172.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -62.4 -11.15 14.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.63 0.252 . . . . 0.0 111.354 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 31.9 tp10 -74.75 -51.36 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -100.5 3.54 42.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.663 HD23 ' HB ' ' B' ' 43' ' ' ILE . 2.8 tm? -65.75 -33.16 75.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.342 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.34 -49.67 76.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.505 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -67.25 -32.66 73.84 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.306 0.574 . . . . 0.0 110.165 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -66.85 -43.89 82.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 24.5 mt -66.89 -23.75 66.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -69.4 -33.83 73.59 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -84.7 -65.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.533 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' B' ' 57' ' ' GLY . 47.2 tp60 -85.35 -67.2 0.82 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.554 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 18.6 tp 60.35 -22.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' B' ' 55' ' ' GLN . . . -107.31 35.88 4.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.897 -167.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 50.51 -153.48 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.145 0.473 . . . . 0.0 110.933 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 10.9 tp10 -110.56 102.39 10.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.251 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -91.83 117.73 30.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.75 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -118.63 -173.1 2.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.587 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . 0.542 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 29.9 p-10 -168.72 -175.45 2.43 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.39 15.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.815 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' B' ' 62' ' ' ASN . 67.2 mt-30 57.74 48.79 13.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.34 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.724 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -97.58 101.24 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.871 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 29' ' ' VAL . 4.9 pt20 -123.06 156.71 34.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 23' ' ' ASP . 22.7 mt -125.21 138.3 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.714 0.292 . . . . 0.0 111.491 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -67.36 162.26 23.32 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.435 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -50.2 -35.37 26.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 113.134 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.87 1.08 48.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 39.14 7.95 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -121.4 127.81 51.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.71 125.73 26.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.585 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.66 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 58.0 t -120.33 102.1 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.548 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.78 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 p -78.19 166.58 42.17 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.78 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -59.69 -10.67 12.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.892 2.395 . . . . 0.0 114.472 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.61 7.76 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.659 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -98.65 154.53 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 7.7 m-20 -76.89 111.3 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.656 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' HB3' HG11 ' A' ' 29' ' ' VAL . 42.9 p90 -147.52 168.17 22.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 111.164 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.9 t -137.75 148.23 25.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 60.1 mt -105.67 118.52 53.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-O 121.306 0.575 . . . . 0.0 110.052 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.515 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 2.1 m-20 -106.39 87.68 2.6 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.615 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.63 80.14 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.102 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.99 -25.82 2.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.012 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -97.39 155.97 16.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.114 0.483 . . . . 0.0 110.78 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.1 mt -96.4 137.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.363 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 3.7 mp -131.34 120.51 46.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -57.51 136.66 56.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 11.9 mmm-85 -55.78 -13.96 2.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.82 -57.39 7.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.293 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.0 7.52 44.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.434 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 46.0 tp -54.68 -28.97 51.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.257 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -42.26 -46.18 4.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.623 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 2.4 mpt_? -73.89 -39.56 63.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.265 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -44.77 83.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.966 0.412 . . . . 0.0 110.665 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 51.9 mt -68.31 -24.58 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -76.8 -26.76 54.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.916 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -92.41 -70.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.821 0.344 . . . . 0.0 111.731 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.4 -23.21 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.878 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 42.3 tp 66.14 43.32 2.9 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.316 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.21 -18.31 41.88 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.811 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 9.3 m-85 -99.46 136.7 39.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.564 -0.374 . . . . 0.0 110.719 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 34.7 tt0 -93.05 102.02 14.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 167.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.06 92.49 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.934 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HE2' ' OE2' ' A' ' 59' ' ' GLU . 14.1 mmtt -97.56 173.83 6.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 111.955 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.6 175.85 9.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.425 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 120.703 0.287 . . . . 0.0 111.021 176.409 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.963 0.887 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.37 94.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.083 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.438 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 9.2 pt20 -92.4 131.34 37.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.211 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.502 HG22 ' O ' ' B' ' 23' ' ' ASP . 36.1 mt -104.83 141.73 19.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.502 ' O ' HG22 ' B' ' 22' ' ' ILE . 0.5 OUTLIER -76.75 173.67 11.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.63 -21.82 60.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.304 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.65 3.61 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.0 27.24 14.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.402 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.92 145.27 43.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.606 0.703 . . . . 0.0 109.813 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.43 119.53 13.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.413 . . . . 0.0 111.172 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 18.6 t -90.28 88.15 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 51.1 p -68.27 157.92 86.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.853 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.1 13.99 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.86 2.374 . . . . 0.0 112.635 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -121.95 3.1 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.055 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -114.28 151.98 32.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.988 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.93 136.55 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' B' ' 42' ' ' ILE . 21.0 p90 -149.34 166.28 29.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.2 t -136.04 142.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 46.2 mt -104.83 120.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.647 0.261 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.07 91.07 5.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.3 0.572 . . . . 0.0 109.75 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 81.19 -28.97 2.86 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.154 174.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.48 -27.2 0.15 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.42 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.233 0.54 . . . . 0.0 110.534 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' B' ' 35' ' ' TYR . 79.2 mt -82.24 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.468 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.749 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.7 mp -130.44 123.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.975 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 51.0 mt -55.46 143.91 27.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.693 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 10.7 mmt180 -66.96 0.81 2.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -73.01 -35.23 66.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 0.0 110.803 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -129.05 5.76 5.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.304 0.573 . . . . 0.0 110.265 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.749 HD23 ' HB ' ' B' ' 43' ' ' ILE . 3.0 tm? -51.71 -44.78 63.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.129 -172.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -59.79 -30.29 68.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.851 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 0.6 OUTLIER -76.35 -38.58 55.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.313 . . . . 0.0 110.808 -178.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -66.25 -32.47 73.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 32.9 mt -64.9 -48.24 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.47 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 7.5 ptp180 -69.04 -27.58 65.78 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.448 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -93.98 -34.57 13.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.596 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 54.2 tp60 -103.19 -67.88 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.085 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER 37.32 40.3 0.19 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.827 0.704 . . . . 0.0 110.078 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.596 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -131.21 6.19 5.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.652 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 50.8 -154.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.852 0.326 . . . . 0.0 110.126 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 5.9 tp10 -102.83 101.84 11.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.644 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.83 95.92 10.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 110.345 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 12.7 mmtp -112.89 56.26 0.68 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.439 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.24 74.35 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.14 8.97 3.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.238 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' B' ' 64' ' ' GLN . 7.8 tp60 52.11 40.89 29.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.037 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.1 t -114.87 102.42 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.303 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.2 148.72 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.544 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 mt -123.89 154.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 9.2 p-10 -78.15 -164.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 110.328 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.92 -27.9 43.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.723 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.27 -17.38 34.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.21 5.91 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.163 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 t70 -92.08 -96.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.7 tt0 174.35 118.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.88 95.1 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.259 0.552 . . . . 0.0 110.76 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 9.1 p -80.73 161.64 63.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.917 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 46.6 Cg_endo -67.96 13.71 0.18 Allowed 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 122.828 2.352 . . . . 0.0 113.177 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 30' ' ' THR . 27.3 m -115.43 11.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.614 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.74 172.76 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.289 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -103.79 125.22 50.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.862 0.363 . . . . 0.0 110.452 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.01 169.91 16.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.227 0.537 . . . . 0.0 110.877 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' B' ' 60' ' ' PHE . 70.7 t -137.53 139.55 43.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -105.76 120.99 57.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.436 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -108.76 86.98 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.15 42.9 34.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.21 -0.904 . . . . 0.0 113.681 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.04 -17.63 57.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.786 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -109.18 133.48 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.361 0.601 . . . . 0.0 110.923 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -85.77 137.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.585 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 3.0 mp -135.18 128.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.52 143.91 57.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HD2' HD22 ' A' ' 48' ' ' LEU . 11.9 mmm-85 -63.55 -11.65 26.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.42 -49.6 73.1 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.113 0.258 . . . . 0.0 111.266 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -129.35 39.15 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.712 . . . . 0.0 110.155 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 45' ' ' ARG . 11.7 tp -71.63 -35.82 70.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.773 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -55.35 -36.73 66.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.963 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 mtt-85 -78.27 -27.46 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.092 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.26 -33.7 61.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.492 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.738 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 73.5 mt -71.09 -24.54 62.33 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.57 172.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 53' ' ' ARG . 22.7 ttm-85 -71.32 -28.2 63.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 51.8 mm-40 -86.04 -54.05 4.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.391 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 11.0 tt0 -99.23 -67.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.781 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 4.7 tp 49.31 31.32 3.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.35 0.406 . . . . 0.0 110.408 -174.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -125.3 -6.17 6.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.73 -164.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.02 -154.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.802 0.801 . . . . 0.0 109.312 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' OE2' HD12 ' B' ' 37' ' ' ILE . 28.0 tt0 -116.44 102.28 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.457 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -83.49 102.68 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 6.0 tptm -97.91 90.29 4.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 -175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -85.16 44.91 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.918 -174.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.482 179.472 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.2 p30 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.816 0.341 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 138.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.679 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 14.2 pt20 -132.96 168.55 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 110.821 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 23' ' ' ASP . 34.5 mt -136.28 155.95 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.639 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 6.3 p-10 -79.38 -171.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.189 0.519 . . . . 0.0 110.791 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -70.04 -29.88 67.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.754 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -88.07 -21.52 24.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.1 38.5 4.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.025 -1.083 . . . . 0.0 113.227 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.6 t70 -89.09 -89.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 37.1 tt0 171.97 137.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.679 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 59.5 t -116.83 109.58 28.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.947 0.403 . . . . 0.0 110.707 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -94.17 159.84 33.33 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.56 3.76 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.67 -0.83 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 109.983 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -102.49 142.13 34.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.707 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 6.7 m-20 -83.85 120.18 25.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.307 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 21.9 p90 -142.58 161.94 36.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.589 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' B' ' 48' ' ' LEU . 84.4 t -124.81 139.48 50.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.582 HD12 ' OE2' ' A' ' 59' ' ' GLU . 53.4 mt -106.47 112.51 39.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.39 85.02 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.949 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' HG3' ' B' ' 59' ' ' GLU . . . 74.53 -32.15 1.0 Allowed Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.602 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.52 -21.73 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -81.44 143.04 32.39 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.401 HG21 HE21 ' B' ' 21' ' ' GLN . 75.2 mt -107.75 119.8 57.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.421 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.42 ' N ' HD12 ' B' ' 43' ' ' ILE . 3.0 mp -126.73 121.72 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.115 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 40.6 mt -57.23 146.4 28.49 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.558 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 66.7 mtp180 -69.07 0.26 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -60.1 -51.82 68.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.004 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -126.45 19.71 7.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.457 HD22 ' HG2' ' B' ' 45' ' ' ARG . 16.8 tp -53.23 -37.4 62.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.23 -43.82 64.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.575 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.71 -36.26 65.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.296 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -67.49 -35.98 80.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.0 -31.31 70.92 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.585 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -69.87 -24.24 63.39 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.709 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -89.09 -55.92 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.44 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.906 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.8 tp 82.72 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 124.141 0.9 . . . . 0.0 111.801 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 81.46 -49.4 4.02 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.45 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 33.6 m-85 -70.92 124.45 24.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.613 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 26.7 mt-10 -92.08 101.79 14.33 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.751 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 36' ' ' VAL . 97.1 m-85 -81.4 87.92 6.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.514 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -107.39 80.53 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.631 0.729 . . . . 0.0 110.923 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -71.9 158.26 36.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.05 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.01 95.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.994 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 55.47 58.77 4.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.307 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.713 ' H ' HD12 ' B' ' 65' ' ' LEU . 4.2 mp . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.492 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.554 0.693 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 t -93.92 124.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.694 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.488 ' NE2' HD13 ' A' ' 42' ' ' ILE . 9.8 pt20 -123.19 157.58 32.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.503 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 13.0 mt -120.03 152.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.0 p-10 -90.6 -167.91 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.306 0.574 . . . . 0.0 110.904 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -69.93 -24.52 63.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -89.38 -34.26 16.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.496 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.503 ' HA2' ' CG2' ' A' ' 22' ' ' ILE . . . 99.74 27.67 7.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.591 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.71 -10.42 48.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 73.08 120.38 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.338 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 23' ' ' ASP . 47.6 t -113.61 113.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.514 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 p -102.97 167.75 9.79 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 51.2 Cg_exo -56.4 -11.49 6.43 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.826 2.35 . . . . 0.0 113.404 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.27 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.464 0.65 . . . . 0.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -107.62 146.08 32.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD2' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -89.92 130.52 36.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.6 p90 -153.76 161.58 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.825 0.345 . . . . 0.0 111.023 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.507 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 49.4 t -128.18 150.33 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 40.5 mt -115.78 116.88 53.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.157 0 CA-C-O 121.894 0.855 . . . . 0.0 111.187 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.41 89.32 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.731 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' B' ' 37' ' ' ILE . . . 69.17 45.11 63.07 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.247 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.5 -21.9 35.9 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.464 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -91.72 133.53 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.241 0.543 . . . . 0.0 110.578 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.488 HD13 ' NE2' ' A' ' 21' ' ' GLN . 60.3 mt -91.74 132.18 36.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.916 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.82 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.1 mp -130.99 125.99 58.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 29' ' ' VAL . 18.2 tp -63.61 143.54 57.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.549 HH11 HD12 ' A' ' 48' ' ' LEU . 12.8 mmm180 -62.48 -6.89 3.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 7.2 mm-40 -71.33 -57.79 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.47 0.34 53.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.82 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -62.76 -27.29 69.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.461 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.37 -48.33 74.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.694 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -61.6 -41.76 97.9 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.429 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.47 -37.96 89.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.292 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.524 ' HG ' HD13 ' A' ' 48' ' ' LEU . 19.5 mt -71.32 -26.7 62.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -71.3 -45.68 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.432 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.12 -32.38 13.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -102.97 -56.16 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.188 -0.32 . . . . 0.0 110.374 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 26.6 tp 77.65 37.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 111.914 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' B' ' 58' ' ' PHE . . . 89.43 -43.54 3.02 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.137 172.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.428 ' HE2' HD23 ' A' ' 56' ' ' LEU . 3.3 m-85 -70.14 117.97 12.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG13 ' B' ' 36' ' ' VAL . 9.6 tp10 -92.04 101.43 13.97 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' HA ' HG22 ' B' ' 36' ' ' VAL . 63.8 m-85 -89.75 86.29 6.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.06 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -84.71 174.77 9.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -142.34 177.26 8.38 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 174.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.83 103.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.988 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.45 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 10.4 pt20 -104.91 158.13 16.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.786 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.423 HG22 ' N ' ' B' ' 23' ' ' ASP . 18.1 mt -130.08 155.76 41.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 6.7 p-10 -83.88 -165.11 1.04 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.273 0.558 . . . . 0.0 110.955 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.77 -31.68 68.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.373 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -41.13 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.576 0.227 . . . . 0.0 110.891 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.3 35.82 3.03 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.671 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 19.0 t70 -88.58 -89.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 41.1 tt0 176.02 130.66 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.46 HG22 HD21 ' B' ' 44' ' ' LEU . 48.3 t -114.35 113.12 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.191 0.519 . . . . 0.0 110.819 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 67.1 p -106.15 169.3 7.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.3 Cg_exo -58.68 -4.54 1.96 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.154 2.569 . . . . 0.0 114.151 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.461 HG22 ' OG1' ' B' ' 30' ' ' THR . 19.2 m -106.52 0.65 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 110.795 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -96.78 136.94 36.62 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.538 ' HB3' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -80.68 108.54 14.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -126.63 155.44 42.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.106 0.479 . . . . 0.0 111.236 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 59' ' ' GLU . 41.8 t -129.85 145.75 35.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.536 ' CG2' ' HA2' ' A' ' 39' ' ' GLY . 36.1 mt -115.23 126.3 72.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.609 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.74 83.35 3.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.18 3.38 Favored Glycine 0 C--O 1.227 -0.327 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.303 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.76 -30.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -81.39 134.24 35.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.098 0.475 . . . . 0.0 110.315 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.92 138.37 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.386 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.509 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.8 mp -137.04 130.72 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.46 HD21 HG22 ' B' ' 29' ' ' VAL . 79.8 mt -60.39 150.06 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' B' ' 34' ' ' ASP . 20.8 mmt180 -61.37 -11.84 11.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.89 0.376 . . . . 0.0 110.964 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.1 -36.52 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.664 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -111.75 8.12 20.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.914 0.388 . . . . 0.0 110.644 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.528 HD13 ' HB ' ' B' ' 36' ' ' VAL . 63.9 tp -60.64 -47.93 84.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.443 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.71 -47.94 80.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 7.0 mtp180 -64.3 -45.96 85.69 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.111 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.44 ' CG ' HG12 ' B' ' 43' ' ' ILE . 47.1 t80 -59.07 -39.39 81.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.661 0.267 . . . . 0.0 110.925 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 39.0 mt -72.55 -28.72 63.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.618 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 8.4 ptp180 -86.86 -11.5 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.286 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 70.2 mm-40 -92.67 -54.92 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.185 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' B' ' 57' ' ' GLY . 5.0 tt0 -102.02 -65.96 0.95 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -174.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 2.2 tp 55.0 43.94 29.03 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' B' ' 55' ' ' GLN . . . -100.87 -50.37 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.771 -165.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.424 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 48.05 -176.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.271 0.628 . . . . 0.0 110.908 -167.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 30.8 tt0 -103.79 102.49 12.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.609 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.61 100.69 13.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.328 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -91.43 162.06 14.73 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.51 138.4 9.72 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.92 -43.75 64.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 68.59 -3.42 1.38 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.578 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -179.244 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 122.051 0.929 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.34 121.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.04 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 171.79 7.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 28' ' ' GLU . 21.0 mt -136.39 139.42 45.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 166.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.69 -166.99 1.74 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' HD2' HD21 ' A' ' 47' ' ' ASN . 72.9 t80 -70.78 -19.8 62.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.307 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.439 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 31.1 t80 -74.54 -32.43 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.549 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.97 25.55 26.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.143 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -96.42 -85.4 0.34 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HA ' HG12 ' A' ' 22' ' ' ILE . 17.5 tt0 -176.81 150.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 174.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 23' ' ' ASP . 58.6 t -130.92 117.34 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.729 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 p -116.25 168.45 8.6 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.854 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 41.2 Cg_endo -67.71 9.84 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.726 2.284 . . . . 0.0 113.766 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.1 6.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.517 . . . . 0.0 109.999 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -109.78 147.07 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.995 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.23 124.12 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -147.3 163.95 34.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 48' ' ' LEU . 61.6 t -136.52 137.72 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -99.64 121.83 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.86 86.48 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.47 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 77.55 -36.26 1.59 Allowed Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.768 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.628 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.67 135.24 34.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.108 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -91.17 133.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.988 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.9 mp -136.87 134.5 48.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 60.7 mt -54.39 151.57 7.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG2' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.67 -8.04 24.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.67 -45.47 10.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.245 0.545 . . . . 0.0 109.719 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.414 HD21 ' HD2' ' A' ' 24' ' ' PHE . 62.4 t30 -85.86 -4.95 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.229 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 36' ' ' VAL . 56.1 tp -54.97 -50.83 67.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.521 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 mt-10 -52.81 -48.99 66.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.307 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -59.44 -49.36 78.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.76 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.6 -32.92 74.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 40.4 mt -72.25 -24.36 61.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.566 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 94.0 mtt180 -72.13 -38.98 69.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.6 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -68.82 0.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.872 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 11.8 pt20 -103.79 -53.12 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.677 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 18.3 tp 47.78 43.37 16.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.493 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -123.5 -3.82 8.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.139 -1.029 . . . . 0.0 114.633 -165.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.22 -160.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 11.0 mm-40 -105.27 101.75 11.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -110.53 104.53 13.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.167 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.8 152.46 20.86 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -155.89 149.91 25.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.43 0 O-C-N 123.084 0.24 . . . . 0.0 111.317 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -121.9 119.52 58.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.587 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.4 HE21 HD13 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.07 173.92 12.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.103 176.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.423 HG21 ' HA2' ' B' ' 26' ' ' GLY . 30.3 mt -130.42 155.98 42.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.423 ' N ' HG22 ' B' ' 22' ' ' ILE . 7.5 p-10 -81.14 -162.19 0.47 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.257 0.551 . . . . 0.0 111.109 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -76.83 -30.2 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.743 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -80.51 -19.76 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.314 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 83.92 41.09 8.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.611 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.37 -82.68 0.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 178.02 140.91 0.09 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' B' ' 35' ' ' TYR . 21.9 t -126.4 141.72 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -124.53 155.83 68.57 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 -15.19 42.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.778 2.318 . . . . 0.0 112.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.53 9.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.636 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.17 150.55 46.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -86.32 130.06 34.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.224 0.535 . . . . 0.0 110.743 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.485 ' HB3' HG11 ' B' ' 29' ' ' VAL . 32.9 p90 -144.0 152.22 40.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.646 ' HB ' HD13 ' B' ' 48' ' ' LEU . 74.9 t -129.78 139.92 50.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 57.6 mt -101.09 116.84 45.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.623 0.725 . . . . 0.0 109.697 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -112.76 91.0 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.304 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.12 -4.37 86.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.44 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.93 4.33 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.87 143.04 27.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 110.308 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.495 HG12 HG12 ' B' ' 37' ' ' ILE . 81.3 mt -97.26 129.12 47.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.237 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.03 129.46 75.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.72 131.23 50.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 2.3 tmm_? -70.42 0.97 5.58 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -167.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.28 -7.21 57.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.436 0.636 . . . . 0.0 109.85 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -129.15 20.16 5.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' B' ' 36' ' ' VAL . 58.9 tp -71.4 -38.37 71.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.992 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.5 -44.61 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.98 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.68 -46.09 87.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.009 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -68.85 -32.88 72.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.04 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.9 mt -72.92 -28.51 62.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.615 0.245 . . . . 0.0 110.925 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.66 HH21 ' HG2' ' B' ' 54' ' ' GLU . 6.7 ttp180 -64.12 -41.53 97.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.234 0.54 . . . . 0.0 110.012 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.66 ' HG2' HH21 ' B' ' 53' ' ' ARG . 49.5 mt-10 -91.0 -51.02 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.876 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.457 HE21 ' HG2' ' B' ' 59' ' ' GLU . 7.2 tp60 -94.5 -54.46 3.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.435 0.16 . . . . 0.0 111.376 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.8 tp 74.82 33.54 0.77 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 -11.04 60.74 Favored Glycine 0 C--O 1.235 0.18 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.602 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -105.47 110.1 22.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.606 0.241 . . . . 0.0 111.3 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.457 ' HG2' HE21 ' B' ' 55' ' ' GLN . 0.0 OUTLIER -92.07 102.12 14.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.56 110.02 21.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.06 -171.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.93 97.39 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 111.264 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -85.38 162.94 18.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.79 10.68 2.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 111.131 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -82.95 76.93 9.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.772 176.684 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.14 97.3 5.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.46 ' NE2' HD13 ' A' ' 42' ' ' ILE . 10.6 pt20 -108.21 159.37 16.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.474 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 23' ' ' ASP . 26.7 mt -130.53 156.49 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 7.7 p-10 -77.83 -167.7 1.05 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -75.37 -31.76 60.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.443 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.21 -19.19 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.523 -174.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.28 50.12 2.67 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.404 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -99.64 -94.89 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -179.49 123.87 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.85 106.84 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.774 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.8 p -93.24 158.28 37.45 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HB2' HD22 ' B' ' 65' ' ' LEU . 27.9 Cg_exo -62.98 1.29 1.19 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.689 2.259 . . . . 0.0 113.18 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -98.8 -4.44 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.349 0.595 . . . . 0.0 109.928 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.47 ' O ' ' HD1' ' A' ' 35' ' ' TYR . 52.0 m-20 -108.64 120.44 42.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.706 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.11 126.24 27.48 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.949 0.404 . . . . 0.0 110.717 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 33' ' ' ASP . 38.9 p90 -146.35 168.0 22.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 0.0 110.902 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.4 t -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.75 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 24.4 mt -106.16 122.06 59.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 56' ' ' LEU . 10.2 t70 -94.06 86.77 5.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . 78.52 -42.52 2.22 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.021 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.27 -30.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.47 145.6 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.21 0.529 . . . . 0.0 110.472 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.46 HD13 ' NE2' ' A' ' 21' ' ' GLN . 66.3 mt -102.57 136.85 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.006 -172.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 51' ' ' TYR . 2.6 mp -138.41 129.53 36.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 175.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.07 150.52 24.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.252 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.05 -5.93 25.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.403 178.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -55.73 15.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 110.188 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.64 25.25 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.143 0.973 . . . . 0.0 109.138 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 36.1 tp -56.0 -50.18 71.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.164 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.67 -28.51 69.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.571 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.421 HH22 ' HD2' ' A' ' 53' ' ' ARG . 1.1 tpm_? -64.24 -49.27 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 110.265 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 33.4 t80 -75.68 -24.57 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.939 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 50.6 mt -69.69 -26.64 64.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.421 ' HD2' HH22 ' A' ' 50' ' ' ARG . 18.4 ttm180 -86.02 -19.5 30.24 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 1.1 tp10 -79.16 -54.09 6.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.18 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 30.2 tt0 -103.14 -67.69 0.87 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.559 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.1 tt 33.03 47.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.689 0.757 . . . . 0.0 109.716 -168.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.664 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -118.7 -18.09 4.92 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.733 -170.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.731 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 10.6 m-85 53.55 -151.54 0.33 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 21.1 mt-10 -119.64 102.13 8.4 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.919 166.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -84.36 119.87 25.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 59' ' ' GLU . 46.0 mmtm -117.57 102.58 9.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 111.599 -177.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -79.37 160.54 26.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.721 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.66 0.267 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t 55.82 76.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.355 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.511 ' OE1' HD13 ' B' ' 42' ' ' ILE . 3.5 pp0? -93.33 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.653 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -126.75 147.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.801 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.493 ' HB3' HG21 ' B' ' 29' ' ' VAL . 5.3 p-10 -86.18 -164.41 1.04 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.08 0.467 . . . . 0.0 110.761 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -68.28 -28.96 67.64 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.26 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -59.76 -44.24 93.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.675 0.274 . . . . 0.0 111.008 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.22 33.21 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.029 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.3 -84.84 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.715 0.293 . . . . 0.0 110.342 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -169.55 142.2 2.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' B' ' 23' ' ' ASP . 22.0 t -123.65 86.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.676 0.75 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.469 HG23 HG22 ' B' ' 32' ' ' VAL . 0.1 OUTLIER -81.29 153.85 71.71 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.093 175.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.06 12.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 123.4 2.734 . . . . 0.0 114.787 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 30' ' ' THR . 33.9 m -103.21 -5.55 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.048 0.451 . . . . 0.0 110.282 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.35 155.81 17.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.267 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.649 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 5.3 m-20 -89.81 118.61 29.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.542 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -144.24 160.59 40.72 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.703 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.61 146.87 31.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.601 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mt -103.02 100.02 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.748 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 7.8 m-20 -96.54 90.8 5.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.463 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.655 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 72.49 37.1 58.61 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.516 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.62 -26.27 23.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.595 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.23 142.54 27.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.769 0.319 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.511 HD13 ' OE1' ' B' ' 21' ' ' GLN . 76.7 mt -100.49 128.43 52.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' HD12 ' B' ' 43' ' ' ILE . 4.3 mp -126.46 126.8 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.302 . . . . 0.0 110.422 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.1 tt -69.37 134.69 49.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.649 ' HE ' ' HB3' ' B' ' 34' ' ' ASP . 15.6 mtm180 -69.25 0.53 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . 0.541 ' HG2' HD22 ' B' ' 44' ' ' LEU . 42.6 mm-40 -69.05 -18.05 63.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.893 0.378 . . . . 0.0 110.387 171.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -129.24 3.5 5.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.196 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 61.4 tp -57.74 -33.21 68.22 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.159 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 30.6 mt-10 -57.4 -52.66 64.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.779 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' B' ' 53' ' ' ARG . 7.4 mpt_? -71.14 -31.56 67.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -65.72 -39.38 91.11 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.337 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -69.38 -29.32 67.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' B' ' 50' ' ' ARG . 32.4 mtp180 -65.7 -32.71 74.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -94.45 -62.48 1.32 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.77 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -85.5 -42.2 14.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.051 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.6 tp 74.11 13.42 4.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.142 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 88.28 -29.03 5.82 Favored Glycine 0 CA--C 1.517 0.169 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.487 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -69.85 126.05 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.581 0.229 . . . . 0.0 111.107 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.1 tp10 -92.77 101.88 14.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.539 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.31 86.0 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -84.08 93.64 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 0.0 110.658 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -66.1 126.44 28.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.742 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.58 64.59 8.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 110.541 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -76.52 -56.16 4.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.39 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 31' ' ' PRO . 24.4 tp . . . . . 0 C--O 1.234 0.277 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.141 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.06 0.457 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 t -84.29 117.56 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.0 159.68 41.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.347 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.8 mt -134.03 153.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.647 0.261 . . . . 0.0 110.377 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.8 p-10 -80.44 -177.77 6.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 110.78 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.62 -28.14 69.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.848 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -86.61 -17.24 34.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 37.43 6.96 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.746 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 t70 -90.84 -88.39 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.9 tt0 174.69 138.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.8 116.93 28.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.033 0.444 . . . . 0.0 110.338 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.784 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 60.5 p -110.05 172.8 3.31 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.999 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.784 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 42.6 Cg_endo -68.48 2.3 2.97 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.313 2.009 . . . . 0.0 112.197 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.34 14.04 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.548 0.69 . . . . 0.0 109.449 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 44' ' ' LEU . 41.9 m-20 -118.69 146.62 44.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.207 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -92.01 118.26 30.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 174.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HB3' HD12 ' A' ' 44' ' ' LEU . 31.0 p90 -144.02 168.01 21.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.486 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.672 ' HB ' HD13 ' A' ' 48' ' ' LEU . 72.0 t -131.51 133.68 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 35' ' ' TYR . 61.1 mt -103.52 121.96 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.323 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -93.13 86.2 5.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.339 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.582 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.31 -31.56 1.85 Allowed Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.35 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.43 -23.0 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.14 130.56 35.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.3 mt -89.76 129.14 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.56 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.6 mp -133.98 122.73 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 35' ' ' TYR . 13.9 tp -64.8 149.76 48.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -55.99 -23.42 32.47 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -81.54 -22.92 37.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 110.59 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -112.9 4.25 16.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.298 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.672 HD13 ' HB ' ' A' ' 36' ' ' VAL . 29.3 tp -70.68 -60.68 2.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 35.1 mt-10 -61.93 -16.18 49.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -165.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 53' ' ' ARG . 19.2 tpt180 -80.99 -49.91 10.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.225 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD2' HG12 ' A' ' 43' ' ' ILE . 16.1 t80 -63.75 -43.27 96.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 14.9 mt -63.82 -41.36 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 40.0 ttm-85 -52.04 -46.53 65.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.845 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.01 -25.26 23.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.675 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 29.0 tt0 -99.47 -68.08 0.82 Allowed 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.423 -0.798 . . . . 0.0 112.048 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 65.5 mt 42.27 43.99 3.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.317 0.58 . . . . 0.0 109.71 -169.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.675 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -100.8 -14.33 32.04 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.277 -168.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 57.22 -151.59 0.41 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' C ' ' A' ' 39' ' ' GLY . 2.3 mt-10 -118.22 102.16 8.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 163.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.37 103.55 12.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.078 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -109.04 37.83 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.305 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -55.71 119.38 5.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.775 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' B' ' 34' ' ' ASP . . . . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.405 0.622 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.66 131.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.712 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.666 HE21 HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.99 -172.9 4.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.362 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 28' ' ' GLU . 41.0 mt -126.7 150.04 32.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.6 OUTLIER -83.11 -170.08 2.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.796 0.332 . . . . 0.0 110.285 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.07 -27.25 62.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.76 0.424 . . . . 0.0 111.021 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . 0.446 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 29.1 t80 -76.61 -30.59 56.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.75 30.08 5.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.188 -1.005 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.414 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.9 t70 -111.65 132.33 54.66 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 171.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.485 ' HA ' HG12 ' B' ' 22' ' ' ILE . 26.1 tt0 -64.71 124.18 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.334 0.588 . . . . 0.0 110.598 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' B' ' 35' ' ' TYR . 42.9 t -104.47 129.94 56.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.814 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.859 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 72.0 p -118.89 175.69 2.03 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.859 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_endo -64.47 5.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.392 2.062 . . . . 0.0 113.207 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.1 18.53 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.576 0.703 . . . . 0.0 109.418 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -129.1 125.81 37.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.366 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.433 ' HA ' ' H ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -65.38 109.76 2.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.211 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.407 ' HB3' HG11 ' B' ' 29' ' ' VAL . 16.6 p90 -135.88 149.13 48.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.159 0.504 . . . . 0.0 110.197 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.87 142.59 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.21 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.5 mt -102.93 115.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.524 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -94.63 89.06 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.582 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 83.0 -26.65 4.2 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.642 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.32 -26.25 0.35 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.44 129.55 34.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.666 HG21 HE21 ' B' ' 21' ' ' GLN . 64.3 mt -93.1 136.6 24.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.686 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -136.44 133.96 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.419 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -69.05 143.75 54.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.653 ' HD3' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -57.23 -20.71 28.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -172.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.43 -29.93 62.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.1 0.476 . . . . 0.0 110.708 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -106.92 -12.62 15.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.604 0.716 . . . . 0.0 109.773 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.653 HD23 ' HD3' ' B' ' 45' ' ' ARG . 31.5 tp -60.67 -52.01 66.93 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.959 -175.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.31 -37.31 80.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.323 0.582 . . . . 0.0 110.236 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 23.8 tpt85 -64.58 -53.55 46.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.234 176.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.67 -36.54 76.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.996 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 66.7 mt -63.66 -47.32 81.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.912 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 14.1 ptt85 -63.22 -28.46 70.05 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.242 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.57 -36.84 17.32 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.728 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.2 tp-100 -103.04 -68.19 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 27.1 mt 38.5 40.57 0.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.504 0.502 . . . . 0.0 110.723 -167.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.728 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -107.06 -13.72 20.73 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.306 -167.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 57.75 -154.93 0.34 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.66 102.03 9.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.306 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' A' ' 36' ' ' VAL . 25.1 m-85 -84.55 99.86 11.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -92.43 91.6 7.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.111 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.0 128.56 36.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.828 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.96 -11.02 60.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.365 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 54.51 78.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.814 0.816 . . . . 0.0 110.119 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.634 -174.439 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 89.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.732 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.417 ' NE2' HG21 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -115.94 141.05 48.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.582 -178.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 23' ' ' ASP . 27.8 mt -99.62 161.23 3.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 3.2 p-10 -79.35 -167.12 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -77.38 -31.37 54.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.734 0.302 . . . . 0.0 111.591 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -80.03 -31.96 39.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.66 39.99 1.52 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.635 -1.269 . . . . 0.0 113.067 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.02 -110.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -174.38 124.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.54 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.3 p -105.19 165.12 13.74 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.089 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.7 Cg_exo -58.73 1.65 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.289 2.66 . . . . 0.0 114.304 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.22 17.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -112.99 138.16 50.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.215 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.44 116.07 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -133.56 166.99 21.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.817 ' HB ' HD21 ' A' ' 48' ' ' LEU . 92.3 t -135.63 138.38 48.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 54.0 mt -106.44 114.05 44.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 52.6 t0 -95.44 87.74 4.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.21 0.529 . . . . 0.0 110.373 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.786 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 81.29 -11.64 42.87 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.264 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -22.4 1.56 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -83.89 130.16 34.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.417 HG21 ' NE2' ' A' ' 21' ' ' GLN . 81.4 mt -89.11 131.04 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.383 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.543 ' HB ' HD22 ' A' ' 48' ' ' LEU . 3.5 mp -134.8 136.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -74.1 146.12 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.562 ' N ' HD23 ' A' ' 44' ' ' LEU . 2.0 mmt180 -56.47 -21.52 26.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.51 -40.56 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.943 0.401 . . . . 0.0 110.024 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -89.18 -1.35 58.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 110.447 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -64.14 -40.6 96.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.02 -55.56 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.666 -174.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -64.53 -35.23 80.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.596 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -46.75 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 48' ' ' LEU . 87.7 mt -66.35 -26.43 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -73.79 -33.72 64.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.687 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.68 -51.04 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 12.8 tt0 -90.47 -68.36 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.492 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 38.74 35.56 0.12 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.792 0.682 . . . . 0.0 110.763 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -136.73 10.44 3.98 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.145 -171.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 1.3 m-85 58.34 -158.65 0.29 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.235 0.54 . . . . 0.0 110.882 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.6 tp10 -100.88 102.02 12.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.03 90.48 4.91 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.916 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 73.5 mmtt -86.64 147.12 26.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.521 -175.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -119.22 141.78 48.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.768 0.318 . . . . 0.0 111.066 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.415 0.626 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.83 127.0 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.266 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -135.92 172.39 13.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.367 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.68 146.31 34.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.1 OUTLIER -77.69 178.67 7.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -63.81 -26.15 68.5 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.734 0.414 . . . . 0.0 111.79 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . 0.424 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 94.9 m-85 -98.65 -2.06 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.67 17.32 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.736 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.36 128.66 39.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -72.57 99.69 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.0 t -86.61 114.64 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.517 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 78.3 p -102.61 172.85 3.94 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.011 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 77.1 Cg_exo -49.56 -22.47 6.52 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.224 2.616 . . . . 0.0 114.331 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.95 6.81 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -101.77 123.39 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -69.19 121.79 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.256 -179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 26.0 p90 -144.66 161.14 39.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.909 0.385 . . . . 0.0 110.988 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.564 HG23 ' HD3' ' B' ' 45' ' ' ARG . 54.4 t -135.09 143.73 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.577 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 48.9 mt -109.32 115.93 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 111.223 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.07 90.11 6.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 109.529 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.786 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 81.97 -34.12 2.6 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.282 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.69 -24.7 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -174.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -82.59 134.57 35.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.074 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.41 HG12 HG12 ' B' ' 37' ' ' ILE . 69.1 mt -92.52 129.57 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.827 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.01 122.52 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.51 141.37 47.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' HG23 ' B' ' 36' ' ' VAL . 30.3 mmm-85 -60.81 -12.07 9.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -67.99 -47.06 69.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.71 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -103.17 -3.66 25.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.973 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' B' ' 36' ' ' VAL . 37.4 tp -47.86 -41.92 25.31 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.662 -173.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -53.98 -44.61 70.97 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.808 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -74.67 -41.29 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -65.16 -45.16 86.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.447 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 52' ' ' LEU . 35.2 mt -69.84 -24.84 63.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.199 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -68.15 -44.25 76.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.558 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -93.81 -30.33 14.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.617 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp-100 -99.34 -67.55 0.84 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.09 37.89 1.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.439 0.638 . . . . 0.0 109.607 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.617 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -116.62 1.04 20.23 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.819 -165.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.68 -150.91 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.773 0.787 . . . . 0.0 109.377 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 3.3 mm-40 -115.04 101.79 9.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.33 96.57 10.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.31 86.16 2.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.512 0.673 . . . . 0.0 111.072 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -67.93 169.49 9.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.839 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.05 13.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 62.47 14.93 7.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.975 0.417 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.154 179.837 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.247 0.546 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t -131.71 137.12 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.476 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.578 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -116.53 116.11 27.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.549 0.69 . . . . 0.0 110.387 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.17 142.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -63.08 -170.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.151 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -73.81 -31.64 63.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.455 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -72.17 -36.69 69.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 109.952 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 24.32 7.55 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.003 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 6.7 t70 -80.5 -81.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.58 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 40.3 tt0 163.92 123.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.809 0.693 . . . . 0.0 110.299 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 35' ' ' TYR . 9.4 t -113.35 134.89 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -111.47 153.93 43.99 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.201 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.62 1.73 2.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.0 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.14 -3.8 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.503 0.668 . . . . 0.0 109.46 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.38 179.39 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -111.7 128.98 56.24 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HB3' HG11 ' A' ' 29' ' ' VAL . 36.8 p90 -141.46 167.47 22.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.136 0.493 . . . . 0.0 110.691 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 96.2 t -136.62 138.29 46.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 47.6 mt -93.8 113.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.214 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 11.8 t0 -88.22 88.6 7.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.137 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 73.95 -27.65 0.95 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.423 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.43 -22.05 0.13 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -82.49 145.93 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.107 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 21' ' ' GLN . 83.5 mt -98.51 131.21 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.455 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 48' ' ' LEU . 1.7 mp -139.69 130.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 45' ' ' ARG . 5.6 tt -63.13 143.22 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 44' ' ' LEU . 10.5 mmm-85 -51.06 -23.28 2.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.83 -29.96 35.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.067 0.46 . . . . 0.0 110.808 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.81 -12.7 18.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.431 0.634 . . . . 0.0 109.911 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.962 ' HG ' ' HB ' ' A' ' 36' ' ' VAL . 2.8 tm? -61.68 -37.12 82.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.845 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -54.76 -52.4 62.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 ttm180 -76.34 -20.66 57.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -76.43 -30.7 57.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.021 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 56' ' ' LEU . 64.8 mt -67.72 -32.76 73.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.272 0.558 . . . . 0.0 109.667 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -61.38 -35.13 76.65 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -74.99 -64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.182 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -103.27 -59.22 1.75 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.8 tp 89.45 39.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.101 0.96 . . . . 0.0 112.117 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 72.39 57.67 5.44 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.449 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -155.2 120.22 4.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.123 0.461 . . . . 0.0 112.102 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.539 ' CB ' ' HB ' ' B' ' 37' ' ' ILE . 3.1 mm-40 -101.45 101.7 12.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 160.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.75 109.51 19.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.298 -168.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -121.42 174.63 6.63 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -165.12 169.95 15.56 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.192 178.348 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.27 109.08 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 13.6 pt20 -93.21 132.78 37.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.164 0.507 . . . . 0.0 111.284 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.25 151.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.523 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 0.5 OUTLIER -85.09 -177.91 6.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.62 -25.0 67.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.807 0.443 . . . . 0.0 111.82 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . 0.41 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 47.2 t80 -89.65 -18.02 27.28 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.51 13.59 27.82 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.633 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.72 129.45 36.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.32 99.59 4.14 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 46.5 t -81.38 101.16 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.44 0.638 . . . . 0.0 111.189 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 21.9 p -86.06 163.12 44.33 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.471 174.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 50.5 Cg_endo -68.82 20.33 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.933 2.422 . . . . 0.0 113.37 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' B' ' 30' ' ' THR . 7.0 t -116.67 1.01 8.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.109 0.481 . . . . 0.0 109.994 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -121.83 170.15 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -92.66 124.89 37.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.576 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.489 ' HB3' HG11 ' B' ' 29' ' ' VAL . 18.5 p90 -136.73 146.22 45.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.97 0.414 . . . . 0.0 110.64 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.67 138.95 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 36.8 mt -99.86 113.62 35.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-O 121.628 0.727 . . . . 0.0 109.83 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -106.87 90.17 3.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.653 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' B' ' 59' ' ' GLU . . . 81.51 12.01 82.4 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.421 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.38 -30.46 4.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -97.51 150.29 21.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.331 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 72.9 mt -89.76 140.79 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.176 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.405 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.3 mp -134.41 129.9 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.516 HD12 HG22 ' B' ' 29' ' ' VAL . 3.9 tt -72.18 137.8 47.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 12.3 mtm180 -70.85 0.32 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.92 -15.26 56.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.23 3.21 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.278 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 28.1 tp -73.24 -34.89 66.13 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -170.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -51.59 -41.49 61.23 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 53' ' ' ARG . 7.6 ttm180 -77.55 -33.31 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -71.01 -38.21 72.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.582 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 58.0 mt -67.34 -29.15 68.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.164 0.506 . . . . 0.0 110.072 172.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' B' ' 50' ' ' ARG . 18.6 ttm180 -65.77 -28.19 68.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -70.01 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.647 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' B' ' 56' ' ' LEU . 2.4 pt20 -104.23 -48.63 3.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' B' ' 55' ' ' GLN . 29.0 tp 82.36 42.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.918 0.761 . . . . 0.0 111.224 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 57' ' ' GLY . . . 95.3 -20.57 48.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.763 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -87.58 107.39 18.57 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -174.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.613 ' CG ' ' HA3' ' B' ' 39' ' ' GLY . 3.0 mm-40 -101.63 102.24 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.147 0.498 . . . . 0.0 110.679 171.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -89.62 123.05 33.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.454 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -127.12 79.89 1.91 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 111.013 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -75.12 162.55 28.42 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 65' ' ' LEU . . . -58.36 -36.34 73.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.485 0.183 . . . . 0.0 111.35 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.06 -13.45 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' B' ' 63' ' ' ALA . 53.7 tp . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 121.951 0.881 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.82 102.79 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.51 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt20 -101.39 147.54 26.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.05 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.421 HG21 ' HA2' ' A' ' 26' ' ' GLY . 29.0 mt -123.17 153.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 6.4 p-10 -76.29 -164.89 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -78.78 -29.97 45.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.954 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.542 ' HD2' HD22 ' A' ' 47' ' ' ASN . 65.5 m-85 -96.1 -7.57 35.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 84.87 51.18 3.89 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.164 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 18.5 t70 -94.77 -86.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 35.1 tt0 167.89 135.36 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.312 1.045 . . . . 0.0 108.212 170.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.53 104.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 110.68 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.801 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 71.9 p -96.12 174.08 3.71 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.801 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.6 Cg_endo -66.05 4.24 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.15 1.9 . . . . 0.0 112.416 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.39 -18.23 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.133 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -94.43 119.93 33.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.379 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.23 138.58 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -155.93 166.24 34.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.206 0.526 . . . . 0.0 111.136 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 59' ' ' GLU . 69.4 t -135.07 145.79 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 20.1 mt -103.37 120.11 52.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 121.794 0.807 . . . . 0.0 110.82 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 43' ' ' ILE . 26.2 t0 -105.93 90.28 3.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.607 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.645 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 77.9 20.13 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.09 42.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.77 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.71 139.17 34.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.7 mt -88.86 138.88 18.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.51 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -139.53 127.47 26.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.3 tt -62.88 148.62 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.842 HH11 HD23 ' A' ' 48' ' ' LEU . 8.2 mmm180 -61.89 -7.25 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.89 -55.39 3.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 0.0 110.725 175.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.542 HD22 ' HD2' ' A' ' 25' ' ' TYR . 15.0 p-10 -89.62 3.64 51.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.312 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.842 HD23 HH11 ' A' ' 45' ' ' ARG . 36.8 tp -61.16 -32.62 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.986 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -44.43 -54.32 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.301 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NH2' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -68.77 -33.09 73.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.87 -172.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.574 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -76.18 -39.3 55.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.712 -176.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.5 mt -67.73 -22.28 65.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.794 0.807 . . . . 0.0 109.364 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.504 HH11 ' NH2' ' A' ' 50' ' ' ARG . 27.9 ttm180 -76.65 -25.17 53.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.264 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -90.16 -69.48 0.72 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.861 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.12 -16.16 15.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 30.3 tp 71.74 28.34 2.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 171.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 98.54 -8.51 62.09 Favored Glycine 0 C--N 1.321 -0.294 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.748 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.402 ' HE1' ' HA3' ' B' ' 57' ' ' GLY . 12.4 m-85 -117.1 129.76 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.078 0.439 . . . . 0.0 111.995 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.683 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 11.8 mt-10 -96.45 102.14 13.88 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 164.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -81.81 106.67 13.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.683 ' HE2' ' HB3' ' A' ' 59' ' ' GLU . 3.8 mptp? -108.68 80.61 1.35 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 109.766 174.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -83.75 146.47 28.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.227 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 121.375 0.607 . . . . 0.0 110.331 179.452 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 121.599 0.714 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.79 130.99 60.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.479 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.454 ' OE1' HG21 ' B' ' 42' ' ' ILE . 3.0 pp0? -148.14 163.63 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.48 150.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.671 0.272 . . . . 0.0 110.964 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.37 -168.08 1.06 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -70.56 -29.01 65.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.74 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -86.04 -8.63 57.79 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.58 36.88 25.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.242 168.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 -92.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.423 0.611 . . . . 0.0 110.493 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -173.46 137.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -119.19 121.23 66.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.016 0.436 . . . . 0.0 110.14 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 57.3 p -102.42 168.81 8.38 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.84 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.706 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 33.4 Cg_endo -64.97 -4.03 8.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.58 2.186 . . . . 0.0 112.627 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.53 -2.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.304 0.573 . . . . 0.0 110.138 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -107.54 136.8 46.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.47 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -69.1 116.23 9.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.289 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.24 139.41 35.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 110.583 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.55 139.16 45.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 36.2 mt -91.18 96.69 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 95.2 m-20 -79.17 90.63 4.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.022 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 78.05 -17.66 5.81 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.971 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.39 -19.34 0.92 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 8.3 tp10 -93.02 144.67 25.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.454 HG21 ' OE1' ' B' ' 21' ' ' GLN . 80.2 mt -99.95 129.7 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.156 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.19 128.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.484 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 82.2 mt -54.52 141.35 31.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 23.8 mtm180 -71.65 0.52 8.52 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.584 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.03 -13.04 59.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -128.35 -0.62 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.153 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 36.2 tp -60.37 -40.35 90.5 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.826 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 27.4 tt0 -53.66 -51.64 62.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.559 0.218 . . . . 0.0 111.056 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.595 ' HD2' ' HD3' ' B' ' 53' ' ' ARG . 9.9 mmm180 -61.71 -36.29 80.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.366 -176.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -65.36 -43.38 90.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.947 0.403 . . . . 0.0 110.08 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 73.4 mt -71.92 -31.26 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.595 ' HD3' ' HD2' ' B' ' 50' ' ' ARG . 19.5 mtp180 -63.95 -33.4 75.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 25.1 mm-40 -92.18 -61.99 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.259 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -98.19 -29.17 13.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.1 tp 80.42 7.32 1.49 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.461 0.704 . . . . 0.0 111.924 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 91.74 1.55 70.71 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.414 -0.898 . . . . 0.0 115.149 166.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -98.94 134.91 41.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.78 0.79 . . . . 0.0 109.725 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.72 ' HB3' ' HE2' ' B' ' 61' ' ' LYS . 6.7 mt-10 -92.21 101.65 14.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.401 171.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.36 122.36 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.118 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.72 ' HE2' ' HB3' ' B' ' 59' ' ' GLU . 72.2 mmtt -119.17 157.62 27.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' B' ' 62' ' ' ASN . 3.1 m120 -135.59 137.78 42.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.04 0.447 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.11 -49.66 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.899 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.94 2.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.459 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 99.0 mt . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -171.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.521 -0.139 0 CA-C-O 121.782 0.801 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.86 102.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.623 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 167.14 15.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mt -116.74 153.93 18.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.997 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.545 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 4.3 p-10 -83.84 -160.08 0.42 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.562 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -80.07 -23.51 41.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -41.13 35.55 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.6 45.32 1.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.825 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.28 -88.71 0.45 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 176.83 129.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.27 138.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.7 p -123.82 160.5 51.22 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.26 2.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.185 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 HD22 ' B' ' 65' ' ' LEU . 12.0 t -97.47 -16.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.4 141.72 45.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.794 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.2 138.85 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.698 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.455 ' CD2' HG23 ' A' ' 42' ' ' ILE . 33.1 p90 -148.69 175.01 11.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.891 175.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 94.5 t -134.5 139.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.526 HG22 ' HA2' ' B' ' 39' ' ' GLY . 18.3 mt -103.42 119.76 52.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -105.11 89.51 3.16 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.369 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 88.87 -40.09 3.09 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.22 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.35 -23.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.654 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.49 164.91 14.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 111.055 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.455 HG23 ' CD2' ' A' ' 35' ' ' TYR . 71.2 mt -116.82 129.29 73.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.809 -171.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.0 mp -130.35 123.72 56.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.197 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.545 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 3.9 tt -60.37 141.31 56.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.7 -16.95 7.28 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -77.59 -33.42 53.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.419 0.628 . . . . 0.0 110.006 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -104.97 -5.76 20.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.957 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -66.79 -25.95 66.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.791 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.95 -30.05 68.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 74.3 ttt180 -82.65 -33.82 27.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.562 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.3 t80 -69.26 -36.3 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 29.6 mt -74.91 -34.64 62.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.996 0.426 . . . . 0.0 110.095 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 50' ' ' ARG . 4.6 ttp180 -59.86 -55.4 34.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.182 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 53' ' ' ARG . 53.6 mt-10 -93.0 -39.21 11.23 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.684 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 50.5 tp60 -97.49 -68.39 0.8 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.792 -0.568 . . . . 0.0 111.164 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HG ' ' HE1' ' B' ' 58' ' ' PHE . 0.7 OUTLIER 39.35 34.97 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.658 0.742 . . . . 0.0 110.225 -175.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.684 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -117.24 -19.81 4.98 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.873 -1.156 . . . . 0.0 114.583 -165.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 58.32 -153.96 0.37 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 7.4 tp10 -109.28 101.78 10.75 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.302 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.38 121.26 30.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.2 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -119.96 148.07 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.55 0.691 . . . . 0.0 111.105 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.42 148.05 47.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.035 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.122 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.222 0.534 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.14 97.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.027 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.508 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 11.0 pt20 -116.11 151.91 34.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.687 -170.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 15.4 mt -119.65 146.45 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.171 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.9 OUTLIER -70.77 -173.71 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 111.16 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.24 -30.57 71.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.585 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.64 -43.84 11.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.21 29.01 0.3 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.781 -1.2 . . . . 0.0 113.486 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -114.77 137.87 51.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.34 132.28 53.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 111.734 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.508 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 16.4 t -111.26 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.233 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.646 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 31.5 p -87.02 164.47 36.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.5 Cg_endo -65.38 -3.7 8.06 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.77 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 t -101.27 1.28 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.327 0.584 . . . . 0.0 109.656 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -112.35 141.31 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.154 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 8.6 m-20 -78.06 135.73 37.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.24 162.97 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.962 0.41 . . . . 0.0 110.638 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.423 HG23 ' HG2' ' B' ' 45' ' ' ARG . 95.3 t -128.53 144.38 38.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 37.0 mt -107.05 100.14 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 0.0 109.265 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.784 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 5.9 m-20 -93.56 90.27 6.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.543 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . 74.75 25.46 69.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.393 176.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.78 -12.38 59.35 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.82 133.22 37.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -95.62 130.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.523 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.555 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.9 mp -138.2 126.13 29.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' B' ' 23' ' ' ASP . 5.2 mp -55.25 143.2 28.77 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 12.3 mtp180 -70.27 -0.38 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.707 0.289 . . . . 0.0 111.598 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.59 -16.15 43.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.781 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -123.74 -4.36 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.884 0.85 . . . . 0.0 109.309 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 2.6 tm? -65.4 -35.4 80.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.963 -175.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 1.9 tm-20 -57.25 -55.96 27.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -60.68 -36.38 78.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.052 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.26 -33.55 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.676 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 68.6 mt -69.53 -29.16 66.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.474 . . . . 0.0 110.299 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 53' ' ' ARG . 46.3 mtp85 -72.07 -24.28 61.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.46 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.44 -66.46 0.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.631 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -98.21 -34.31 10.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.641 -174.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.2 tp 77.05 1.97 3.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.491 0.717 . . . . 0.0 111.276 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.784 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 106.92 -32.91 6.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.097 170.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.535 ' HE1' ' HG ' ' A' ' 56' ' ' LEU . 34.2 m-85 -70.93 123.43 22.01 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.671 -0.311 . . . . 0.0 110.819 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.459 ' OE1' ' HE2' ' B' ' 61' ' ' LYS . 40.5 tt0 -95.57 101.99 13.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.287 170.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -82.88 91.78 7.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.459 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 60.5 mmtt -81.75 75.07 8.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -64.51 158.43 24.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.09 -51.53 24.1 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.665 0.603 . . . . 0.0 110.876 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 62.28 15.45 7.61 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.61 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 32' ' ' VAL . 16.1 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.533 0.683 . . . . 0.0 110.445 -178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.598 0.713 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.2 t -117.91 87.98 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.948 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.426 ' OE1' ' HB ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -120.95 172.59 7.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.21 -176.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 28' ' ' GLU . 45.5 mt -129.8 150.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.9 p-10 -86.36 -170.28 3.02 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.2 -17.73 62.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.407 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 2.0 t80 -76.73 -41.99 42.94 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.74 34.92 3.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.987 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -102.36 -87.24 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.062 0.431 . . . . 0.0 109.992 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 -175.45 138.96 0.42 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG22 HD21 ' A' ' 44' ' ' LEU . 7.9 t -125.86 113.52 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 110.75 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 32' ' ' VAL . 24.9 p -114.84 163.93 18.13 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.022 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.71 7.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.499 2.799 . . . . 0.0 114.637 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 30' ' ' THR . 22.0 m -100.18 -5.87 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.59 176.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD2' HD22 ' A' ' 44' ' ' LEU . 5.0 t70 -119.96 160.31 22.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -96.26 121.35 37.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.926 -173.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.21 159.66 41.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.055 0.455 . . . . 0.0 110.701 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HB ' HD13 ' A' ' 48' ' ' LEU . 96.0 t -134.08 142.42 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.753 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 42' ' ' ILE . 18.7 mt -102.73 121.74 54.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.623 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -94.48 89.17 5.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 79.58 -51.08 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.616 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -31.14 0.02 OUTLIER Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -174.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.59 142.2 33.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.229 0.537 . . . . 0.0 110.038 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 37' ' ' ILE . 84.0 mt -98.22 135.78 31.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.306 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 2.2 mp -137.78 132.1 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD21 HG22 ' A' ' 29' ' ' VAL . 83.4 mt -58.92 152.6 19.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 172.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HD2' HD22 ' A' ' 48' ' ' LEU . 44.5 mmm-85 -63.65 -16.3 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.92 0.39 . . . . 0.0 110.577 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.22 -38.63 50.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.45 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.5 4.06 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.335 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 36' ' ' VAL . 40.4 tp -60.58 -41.32 94.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.499 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.16 -55.17 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.122 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.7 51.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.87 -45.0 91.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.481 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 58.0 mt -66.51 -48.77 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -61.97 -29.05 69.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.655 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -51.83 8.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.491 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 7.2 tt0 -103.49 -67.49 0.88 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 20.2 mt 47.72 43.35 16.67 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -168.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -113.65 1.94 24.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.672 -166.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.504 ' CZ ' ' HE1' ' B' ' 58' ' ' PHE . 8.3 m-85 59.33 -154.84 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.484 0.642 . . . . 0.0 109.69 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.5 tp10 -122.12 102.05 7.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 166.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.648 ' HD2' HD21 ' A' ' 62' ' ' ASN . 9.0 m-85 -99.26 110.95 23.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.247 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 74.1 mmtt -112.5 63.89 0.63 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.127 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.648 HD21 ' HD2' ' A' ' 60' ' ' PHE . 50.8 m-80 -74.11 149.87 40.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.093 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.925 0.869 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.6 124.11 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.096 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . 0.494 ' NE2' HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -130.01 166.55 19.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 0.0 111.438 -176.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.472 HG22 ' N ' ' B' ' 23' ' ' ASP . 23.8 mt -119.96 161.21 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.721 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' B' ' 44' ' ' LEU . 5.0 p-10 -89.69 -159.87 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -73.02 -37.96 66.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.375 -175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -87.09 3.07 47.66 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.352 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 73.07 20.52 80.0 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.607 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.5 t70 -72.34 -87.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.308 173.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 30.2 tt0 175.33 141.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.36 123.04 67.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 0.0 110.3 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 64.0 p -106.86 160.94 24.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.936 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.06 3.36 0.56 Allowed 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.038 2.492 . . . . 0.0 113.558 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.4 12.86 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.599 0.714 . . . . 0.0 109.433 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -113.15 158.39 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.458 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.35 105.71 17.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -128.64 157.16 42.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.169 0.509 . . . . 0.0 110.512 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.24 142.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.883 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 34.3 mt -105.96 124.24 61.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.636 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 30.6 t70 -120.6 90.51 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.769 . . . . 0.0 110.696 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' GLY . . . 86.41 28.42 27.47 Favored Glycine 0 C--N 1.315 -0.609 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.261 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 -22.72 38.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.295 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.98 136.41 33.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.494 HG21 ' NE2' ' B' ' 21' ' ' GLN . 74.3 mt -101.25 133.34 44.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.4 124.13 39.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.528 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -68.1 143.61 55.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.528 ' N ' HD23 ' B' ' 44' ' ' LEU . 38.9 mmm-85 -53.72 -22.02 8.29 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.2 -36.78 75.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -106.4 -19.94 13.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.425 ' CD2' ' HD2' ' B' ' 45' ' ' ARG . 24.4 tp -55.75 -42.41 75.38 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -172.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -33.6 68.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -80.36 -41.02 25.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 0.0 110.258 178.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -57.92 -44.2 86.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.692 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.63 -38.84 64.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -57.82 -39.01 76.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -83.45 -43.99 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' H ' ' B' ' 57' ' ' GLY . 46.3 tt0 -99.5 -67.09 0.87 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.48 29.95 1.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.599 0.36 . . . . 0.0 111.689 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG2' ' B' ' 55' ' ' GLN . . . -125.44 15.22 7.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.584 -171.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.504 ' HE1' ' CZ ' ' A' ' 58' ' ' PHE . 2.3 m-30 56.8 -153.36 0.37 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.999 0.428 . . . . 0.0 109.98 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' B' ' 59' ' ' GLU . 3.7 tp10 -117.93 102.16 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.313 0.578 . . . . 0.0 110.5 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -83.64 100.92 11.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.817 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -85.19 -175.46 5.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -165.83 168.12 16.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.43 11.31 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 70.21 -81.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.456 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--O 1.235 0.302 0 CA-C-O 121.333 0.587 . . . . 0.0 110.117 -171.392 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.58 92.27 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.523 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 26.9 pt20 -88.26 167.08 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.243 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 26' ' ' GLY . 28.4 mt -136.19 149.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.03 -179.99 4.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -57.99 -35.9 71.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.818 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -84.64 -12.96 52.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 87.76 40.78 6.6 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.118 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 28' ' ' GLU . 12.4 t70 -90.27 -97.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 29.6 tt0 179.38 127.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.523 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 22.0 t -123.04 107.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.226 0.536 . . . . 0.0 110.534 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 67.6 p -98.0 168.28 10.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.016 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 50.2 Cg_exo -56.52 -10.54 5.18 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.049 2.499 . . . . 0.0 113.721 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.19 10.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -106.19 145.73 31.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.928 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.584 ' OD1' ' HB2' ' B' ' 62' ' ' ASN . 35.9 m-20 -89.39 124.82 34.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -148.21 164.71 33.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.391 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 64.3 t -133.43 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 90.7 mt -112.94 108.17 24.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-O 121.685 0.755 . . . . 0.0 110.638 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -83.3 79.62 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.943 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.1 5.84 29.11 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.513 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.7 -24.8 1.97 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.545 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 40.0 mt-10 -81.56 134.28 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.2 mt -96.45 122.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.729 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.9 mp -129.45 127.55 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.188 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -62.36 143.03 57.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -55.58 -20.88 14.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.63 -47.54 80.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.603 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -96.86 0.44 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.193 0.521 . . . . 0.0 110.114 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.9 tm? -68.6 -36.71 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.394 -172.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.02 -34.28 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.81 -34.16 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 110.272 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.86 -41.76 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.386 174.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -63.52 -34.21 77.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.748 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -64.8 -41.83 95.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.605 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -66.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -103.33 -25.42 13.31 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 31.3 tp 64.1 43.46 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 173.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 86.14 -16.55 42.58 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.377 -0.916 . . . . 0.0 114.106 172.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HE2' HD23 ' A' ' 56' ' ' LEU . 12.6 m-85 -91.7 133.29 35.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.89 102.01 14.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -78.5 107.02 10.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.716 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 17.5 tptt -93.81 177.09 6.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -143.62 151.89 40.7 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.444 0.64 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.86 105.37 18.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -106.59 162.01 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.502 . . . . 0.0 111.678 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 23' ' ' ASP . 35.1 mt -128.54 154.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.474 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 4.7 p-10 -82.79 -167.29 1.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.488 0.661 . . . . 0.0 111.601 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.1 -35.74 81.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.026 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -83.73 -7.61 59.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.73 65.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.165 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 28.3 t70 -80.53 -84.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 35.1 tt0 174.9 135.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . 0.456 HG22 HD21 ' B' ' 44' ' ' LEU . 40.7 t -121.51 118.34 55.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.211 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.836 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 70.2 p -111.93 172.67 3.36 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.324 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.836 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 46.3 Cg_endo -69.43 19.69 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.824 2.349 . . . . 0.0 113.071 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' B' ' 30' ' ' THR . 10.6 t -121.07 -3.42 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 109.961 177.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -101.76 172.3 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.718 -173.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.583 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 14.8 m-20 -111.39 106.42 15.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 22.0 p90 -124.84 142.5 51.4 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.987 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.4 138.76 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.194 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' GLU . 57.0 mt -100.2 109.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.084 0.468 . . . . 0.0 110.664 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.43 90.1 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.149 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.49 -2.55 46.12 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.457 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.53 -30.47 1.42 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.149 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 31.1 mt-10 -88.13 145.33 25.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.463 HG23 ' CD2' ' B' ' 35' ' ' TYR . 61.7 mt -95.8 130.29 44.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.072 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.61 122.15 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.268 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 93.7 mt -62.15 144.69 55.07 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' CB ' ' B' ' 48' ' ' LEU . 48.0 mtm180 -69.27 -0.24 5.89 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.238 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.56 -27.23 64.96 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.1 2.54 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.025 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.587 ' CB ' ' HA ' ' B' ' 45' ' ' ARG . 32.5 tp -58.72 -40.75 84.62 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.49 -42.23 74.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.458 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -75.0 -40.02 60.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.587 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.05 -34.1 77.61 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.292 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 20.2 mt -72.19 -29.41 63.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.085 0.469 . . . . 0.0 110.585 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -65.46 -50.44 65.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 110.193 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.42 -48.64 12.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.244 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 4.3 tp-100 -96.02 -67.6 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.515 -174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 4.9 tp 42.74 40.26 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.743 0.652 . . . . 0.0 109.509 -171.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -101.41 -24.35 8.91 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.489 -0.862 . . . . 0.0 114.1 -165.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.72 -151.77 0.33 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.7 tp10 -116.44 101.78 8.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -107.33 111.83 24.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.582 -171.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.512 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 73.5 mmtt -124.62 -169.56 2.0 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.728 0.775 . . . . 0.0 110.99 -175.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . 0.584 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 6.4 p30 -169.35 -159.44 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.06 57.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 118.531 0.605 . . . . 0.0 111.417 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 61.19 19.79 10.39 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.074 0.55 . . . . 0.0 111.161 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 -176.26 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.935 0.398 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.23 172.77 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.92 159.65 30.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.16 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.471 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 4.8 p30 -150.94 109.17 3.06 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.516 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 4' ' ' ASN . 11.1 Cg_endo -55.57 -33.93 88.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.069 2.513 . . . . 0.0 111.707 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.527 ' HG3' HG23 ' A' ' 8' ' ' ILE . 26.8 ptm -140.81 157.84 44.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 t -78.28 92.86 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.067 0.461 . . . . 0.0 110.195 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.527 HG23 ' HG3' ' A' ' 6' ' ' MET . 26.8 pt -93.83 155.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.545 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -88.62 103.56 16.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -90.54 174.06 7.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.784 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.02 -41.94 88.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.024 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 17.8 t-80 65.9 -87.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.086 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 12' ' ' HIS . 27.5 m-20 -144.39 132.22 21.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -146.72 140.77 26.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.8 0.334 . . . . 0.0 110.99 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.6 pt? -129.72 164.31 24.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.913 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.94 141.27 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.983 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 1.6 mp0 -68.83 123.46 21.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 m -62.65 -67.8 0.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 110.442 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -143.47 23.17 1.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.874 0.845 . . . . 0.0 109.271 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.32 121.24 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.478 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.805 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 29.0 pt20 -93.78 142.11 27.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -114.68 148.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.54 174.94 9.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.53 -35.72 70.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.91 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -82.43 -11.07 58.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.66 40.7 7.6 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.186 -1.006 . . . . 0.0 113.08 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 19.5 t70 -93.62 -95.99 0.15 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 23.9 tt0 177.42 126.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.805 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 39.8 t -109.21 104.63 17.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.308 0.575 . . . . 0.0 110.323 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.5 p -92.55 167.25 15.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.596 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 31.6 Cg_endo -65.09 -9.2 20.81 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.469 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.539 HG22 HD23 ' B' ' 65' ' ' LEU . 3.4 t -112.76 29.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.68 0.752 . . . . 0.0 109.133 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -129.84 139.69 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.862 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -89.27 128.54 35.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' HG23 ' A' ' 42' ' ' ILE . 18.6 p90 -142.4 170.11 16.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.44 135.58 49.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 30.4 mt -96.28 115.33 35.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.813 0.34 . . . . 0.0 110.264 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.47 88.1 6.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.407 0.622 . . . . 0.0 109.561 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 83.07 -33.42 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.229 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.16 -22.81 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.713 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.89 147.56 23.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 0.0 110.226 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.558 HG23 ' CD2' ' A' ' 35' ' ' TYR . 94.5 mt -94.38 128.85 45.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.909 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 HG21 ' HA ' ' A' ' 48' ' ' LEU . 3.8 mp -130.03 129.59 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.178 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 45' ' ' ARG . 4.1 tt -67.36 138.7 56.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HD2' HD22 ' A' ' 48' ' ' LEU . 8.2 mmm-85 -53.55 -22.46 8.37 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.27 -40.8 26.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.252 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.58 -4.56 58.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.001 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HA ' HG21 ' A' ' 43' ' ' ILE . 33.8 tp -61.81 -44.2 97.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.54 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.1 -45.3 71.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.912 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -62.46 -48.7 78.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.387 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -67.5 -36.61 81.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.617 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.703 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 70.6 mt -66.8 -39.53 87.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.261 0.553 . . . . 0.0 110.485 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -70.49 -21.53 62.75 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.153 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.08 -59.5 2.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.594 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.734 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 27.3 tt0 -103.12 -67.46 0.88 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.2 tt 42.33 43.32 2.94 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.456 0.646 . . . . 0.0 109.378 -168.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.734 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -126.32 6.4 7.63 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.949 -1.119 . . . . 0.0 113.839 -166.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 54.6 -153.88 0.29 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.0 tp10 -112.89 101.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.549 -0.861 . . . . 0.0 110.037 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -97.77 110.17 22.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.521 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 72.2 mmtt -110.71 163.66 13.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -144.98 -179.14 6.42 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 65' ' ' LEU . . . -60.49 -32.29 71.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 172.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 71.86 -43.47 0.56 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.508 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 63' ' ' ALA . 1.7 tm? -57.5 -44.19 84.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.02 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 56.88 73.92 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.042 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -65.52 122.2 16.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -75.85 71.14 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 77.4 m80 40.7 -95.98 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.423 1.089 . . . . 0.0 112.808 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -150.94 -28.47 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.6 t60 77.16 -49.77 0.54 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.022 0.929 . . . . 0.0 111.722 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 C--O 1.244 0.8 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.979 176.08 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.773 0.321 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.406 HG23 ' HG3' ' B' ' 3' ' ' GLU . 35.4 m -93.46 179.59 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.406 ' HG3' HG23 ' B' ' 2' ' ' VAL . 39.6 mt-10 75.21 -47.85 0.62 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.912 0.885 . . . . 0.0 112.182 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 62.5 t30 -79.85 116.69 62.9 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 23.2 Cg_exo -63.71 92.91 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.219 2.612 . . . . 0.0 113.322 -174.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 63.8 mtt -111.15 -9.88 14.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.313 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.26 140.55 42.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.814 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.2 pt -127.64 160.47 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.079 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.25 143.06 26.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.674 0.273 . . . . 0.0 110.319 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -142.75 170.0 16.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.989 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -89.62 -178.11 5.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.035 0.445 . . . . 0.0 111.205 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -89.58 76.92 7.29 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.52 -52.54 65.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.424 -173.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.96 86.22 3.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.089 0.471 . . . . 0.0 110.95 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 tp -118.8 -38.08 3.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.606 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -71.1 153.97 42.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.092 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.52 122.63 16.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.347 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -84.42 -80.09 0.2 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.953 0.406 . . . . 0.0 111.592 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -121.06 12.53 11.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.067 0.937 . . . . 0.0 108.939 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -94.67 129.35 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.836 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -140.73 165.49 27.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.23 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.461 HG21 ' HA2' ' B' ' 26' ' ' GLY . 16.8 mt -132.02 156.22 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.436 ' N ' HG22 ' B' ' 22' ' ' ILE . 4.7 p-10 -79.89 -165.85 0.9 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 110.784 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -72.15 -34.74 68.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.557 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.4 -41.02 25.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 118.22 38.12 0.82 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 11.1 t70 -86.2 -93.38 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 32.0 tt0 168.81 121.99 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 35' ' ' TYR . 14.4 t -112.53 127.56 69.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.444 0.64 . . . . 0.0 110.505 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 69.3 p -124.63 169.64 10.47 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.65 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 44.6 Cg_endo -68.58 18.15 0.15 Allowed 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.452 2.101 . . . . 0.0 113.053 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' B' ' 30' ' ' THR . 35.7 t -108.7 -32.44 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.866 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . 0.419 ' OD2' HG13 ' B' ' 29' ' ' VAL . 6.0 p-10 -104.14 134.87 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.581 0.705 . . . . 0.0 111.086 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.7 135.74 48.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.807 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.499 ' CG ' HG11 ' B' ' 29' ' ' VAL . 26.0 p90 -152.1 166.42 31.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.737 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.858 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 75.5 t -135.82 146.97 28.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.9 mt -112.77 118.33 57.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.101 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 1.1 m-20 -98.02 88.9 4.36 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.594 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 70.47 24.08 77.06 Favored Glycine 0 C--N 1.319 -0.4 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.448 172.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.6 -23.99 8.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.549 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.39 138.33 35.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.821 0.343 . . . . 0.0 110.541 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -89.33 136.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.627 -176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.425 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.8 mp -134.97 131.25 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -52.19 140.3 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -67.36 -5.21 13.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 0.0 109.827 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.74 -26.49 54.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.471 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.87 5.07 9.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.737 0.78 . . . . 0.0 109.782 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.858 ' HG ' ' HB ' ' B' ' 36' ' ' VAL . 2.7 tm? -66.99 -38.19 85.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.013 -170.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -58.95 -39.61 82.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -63.66 -39.64 94.84 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.229 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.08 -38.66 72.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.641 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.414 ' HG ' HD13 ' B' ' 48' ' ' LEU . 18.8 mt -67.12 -25.06 66.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.955 0.407 . . . . 0.0 110.86 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.13 -41.04 74.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.748 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.51 -41.12 9.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.707 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -100.89 -52.71 3.23 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.374 -0.204 . . . . 0.0 111.414 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.6 tp 76.59 37.37 0.32 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.896 0.748 . . . . 0.0 111.491 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 75.97 -11.39 11.44 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 170.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -101.24 120.84 40.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.359 0.579 . . . . 0.0 112.036 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.467 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 43.7 tt0 -92.28 102.03 14.53 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 166.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -76.58 109.16 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.844 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 9.7 mmmm -116.29 78.72 1.22 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.122 0.487 . . . . 0.0 111.157 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.11 165.7 19.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.99 60.61 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.242 0.339 . . . . 0.0 110.928 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 63.64 19.37 11.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.845 0.831 . . . . 0.0 110.049 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 32' ' ' VAL . 26.5 tp -121.91 29.17 7.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.743 -176.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -71.57 74.8 0.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.424 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.74 95.96 10.17 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -67.84 137.55 55.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.151 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -62.34 109.22 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.147 0.498 . . . . 0.0 110.812 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -151.4 118.99 6.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -72.38 -38.77 68.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.392 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 C--O 1.245 0.824 0 CA-C-O 118.558 -0.734 . . . . 0.0 109.595 176.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.505 0.193 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.34 76.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 122.203 1.001 . . . . 0.0 111.368 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.62 -67.35 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.804 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -157.31 101.12 1.89 Allowed Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.957 . . . . 0.0 108.832 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.91 103.86 0.3 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.518 2.145 . . . . 0.0 111.436 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.3 ptm -74.66 72.76 1.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.662 0.744 . . . . 0.0 110.864 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.57 -16.25 10.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.223 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.1 tt -123.5 94.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.582 0.706 . . . . 0.0 111.342 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -114.99 83.49 1.92 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -107.17 150.12 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -72.61 131.93 43.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.309 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -134.68 -14.5 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.86 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 14' ' ' LYS . 23.4 t70 -177.88 -55.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.3 pttm -163.66 -178.06 5.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.733 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.3 pt? -120.06 168.82 10.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.72 -173.42 4.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.115 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 64.79 94.87 0.05 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.8 m -115.57 -52.66 2.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -133.12 67.04 1.54 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.784 0.802 . . . . 0.0 109.658 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.24 132.26 67.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.985 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 13.2 pt20 -142.19 159.39 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.163 -175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.6 mt -133.14 149.49 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 4.5 p-10 -78.69 -171.16 2.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.16 0.505 . . . . 0.0 110.589 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -72.03 -27.94 63.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.564 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 47' ' ' ASN . 6.4 m-85 -86.28 -8.13 57.97 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.13 39.69 15.56 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.143 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 17.4 t70 -95.8 -89.81 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.5 tt0 176.54 142.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 68.8 t -122.22 121.38 63.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.55 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.7 p -117.75 162.86 26.92 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.13 -11.14 7.19 Favored 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 122.899 2.399 . . . . 0.0 114.224 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -96.44 2.29 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.004 0.431 . . . . 0.0 110.793 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -99.75 140.55 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.901 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.28 111.02 18.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -138.77 158.48 44.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.005 0.431 . . . . 0.0 110.818 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 48' ' ' LEU . 92.3 t -133.89 140.59 46.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 46.4 mt -101.89 121.24 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.611 0.243 . . . . 0.0 110.435 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.09 88.74 3.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.425 0.631 . . . . 0.0 110.029 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.832 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 87.63 -24.52 10.11 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.271 174.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.26 -28.11 0.5 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.55 130.33 35.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.095 0.474 . . . . 0.0 109.896 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 37' ' ' ILE . 76.8 mt -87.41 137.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.547 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.8 mp -138.74 125.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.147 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 29' ' ' VAL . 86.6 mt -52.84 148.68 7.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 170.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -62.89 -11.99 22.06 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.02 -15.33 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.278 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.404 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 88.1 m-20 -117.36 -13.54 10.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.518 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' HB ' ' A' ' 36' ' ' VAL . 22.9 tp -64.74 -38.2 90.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -50.6 -51.57 47.28 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.652 0.595 . . . . 0.0 110.691 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 tpp85 -67.42 -36.23 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.958 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -65.73 -43.9 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.738 0.304 . . . . 0.0 110.432 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 46.7 mt -71.76 -22.51 61.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -78.61 -22.23 47.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.122 0.487 . . . . 0.0 109.738 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 72.7 mm-40 -93.68 -60.12 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.733 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 25.0 tt0 -92.15 -67.68 0.84 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.485 -173.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 14.2 tp 43.73 37.98 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.047 0.451 . . . . 0.0 110.541 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.733 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -127.74 2.02 6.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.991 -169.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.9 OUTLIER 61.33 -153.75 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.34 0.591 . . . . 0.0 110.686 177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 11.1 tp10 -106.03 102.18 11.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.496 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.502 ' HA ' HG22 ' B' ' 36' ' ' VAL . 32.6 m-85 -89.54 104.78 17.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.504 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.548 ' HG3' ' HG3' ' A' ' 59' ' ' GLU . 55.4 mttm -118.49 94.14 4.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.501 0.667 . . . . 0.0 111.241 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 65' ' ' LEU . 48.6 m-80 -83.43 70.27 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.311 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.45 -88.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.937 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -151.94 17.57 0.67 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.183 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 62' ' ' ASN . 94.9 mt -69.62 114.82 8.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.537 -175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -81.04 89.76 5.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.405 0.621 . . . . 0.0 110.081 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -141.63 42.35 1.73 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.477 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -69.21 121.43 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.537 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 46.5 m80 72.47 143.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.996 0.81 . . . . 0.0 110.857 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -86.58 -179.9 6.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -67.96 -34.52 76.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.272 176.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' B' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.128 0.49 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.1 3.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.31 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -122.31 171.61 8.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.672 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.402 ' N ' HD22 ' B' ' 4' ' ' ASN . 0.9 OUTLIER -97.5 154.51 37.95 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.83 113.53 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.288 2.659 . . . . 0.0 112.667 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -70.92 171.96 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.204 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.37 118.21 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.6 0.714 . . . . 0.0 111.464 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.1 tp -124.93 0.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.788 0.804 . . . . 0.0 109.529 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -72.37 168.05 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.021 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -103.64 176.01 5.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.855 0.36 . . . . 0.0 110.63 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -92.75 158.55 15.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.303 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -92.64 169.33 10.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.372 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.19 -47.66 34.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.252 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -154.42 151.16 28.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.641 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.33 -39.2 5.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.24 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 60.8 p 54.34 -162.57 0.13 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.787 0.835 . . . . 0.0 111.629 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.68 -14.94 59.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 109.83 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 8.7 m 70.56 -80.55 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.089 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.84 89.24 4.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.0 110.289 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.23 135.62 49.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.572 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.475 HE21 ' HB2' ' B' ' 21' ' ' GLN . 6.7 mt-30 -136.36 -179.48 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.912 -177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' B' ' 28' ' ' GLU . 15.2 mt -129.59 141.62 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 165.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 2.5 p-10 -88.98 -170.92 3.08 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.06 0.457 . . . . 0.0 110.517 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.44 -30.12 70.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.412 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.26 -39.88 74.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.118 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.08 2.56 31.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.328 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.7 m-20 -71.83 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 34.5 tt0 172.84 157.82 0.11 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.459 174.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 76.7 t -130.51 105.72 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.534 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.775 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -104.19 171.26 5.21 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.775 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 25.9 Cg_endo -62.93 -0.57 2.16 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.682 2.254 . . . . 0.0 113.418 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.43 6.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.063 0.459 . . . . 0.0 110.582 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -102.92 138.88 39.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.259 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.7 128.4 33.59 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -156.62 159.59 38.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.394 0.616 . . . . 0.0 111.334 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' B' ' 48' ' ' LEU . 78.1 t -134.4 137.91 50.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.245 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 59.4 mt -103.66 110.28 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -81.93 84.54 6.9 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.356 0.598 . . . . 0.0 109.916 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.832 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 74.32 -16.51 2.88 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.712 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.04 -22.73 0.45 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -83.09 121.15 26.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.73 129.08 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.513 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.3 mp -134.32 136.85 52.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.551 ' HB3' ' OE1' ' B' ' 46' ' ' GLU . 39.4 mt -55.73 145.94 22.65 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 170.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -12.45 61.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' B' ' 44' ' ' LEU . 1.5 pm0 -87.75 -10.84 49.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -123.76 0.56 8.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.828 0.823 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' B' ' 36' ' ' VAL . 18.7 tp -67.96 -51.21 50.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.987 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.35 -53.96 12.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.31 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 0.1 OUTLIER -76.82 -33.73 57.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 -175.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.461 ' CD2' HG12 ' B' ' 43' ' ' ILE . 43.7 t80 -69.22 -40.02 78.2 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.761 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.729 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.7 mt -62.82 -38.73 91.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 174.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' B' ' 53' ' ' ARG . 1.3 tmm_? -55.32 -33.99 63.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.812 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 64.3 mm-40 -87.35 -38.32 16.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.162 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.585 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.9 tp-100 -99.07 -68.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 112.128 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.729 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 63.5 mt 40.75 43.59 1.69 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.117 0.484 . . . . 0.0 109.828 -168.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -105.22 -14.14 23.1 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.191 -167.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.572 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 7.9 m-85 58.7 -158.43 0.3 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -112.81 102.0 10.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 162.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -103.29 106.25 16.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.141 -170.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -104.86 150.07 25.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 0.0 110.886 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -137.35 140.1 41.23 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.35 -12.62 61.52 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.164 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 60.6 26.03 15.73 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.567 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.14 80.11 2.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.252 0.548 . . . . 0.0 110.192 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' B' ' 68' ' ' HIS . 12.8 pt-20 -73.75 -19.77 60.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.779 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 p80 49.52 20.63 0.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.045 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.544 ' H ' ' HG3' ' B' ' 66' ' ' GLU . 30.7 t-80 -83.56 137.55 33.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.256 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.17 111.16 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.023 0.439 . . . . 0.0 110.155 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.24 49.43 1.21 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.478 -171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.64 171.37 15.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.675 0.274 . . . . 0.0 110.445 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.633 -0.698 . . . . 0.0 110.268 177.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.749 0.309 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.62 0.67 9.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.748 0.309 . . . . 0.0 111.161 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.85 -71.64 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.42 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 61.85 98.87 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 112.145 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.57 101.1 1.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.533 2.155 . . . . 0.0 112.258 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -70.7 119.14 14.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 p -82.13 -20.04 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.5 tt -124.39 139.77 49.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.337 . . . . 0.0 110.797 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -122.28 147.68 45.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.348 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.39 108.04 19.24 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.47 98.99 10.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.169 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -104.12 138.55 40.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.83 89.0 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.695 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt 177.06 141.26 0.08 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.668 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -97.12 -57.61 2.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.983 0.42 . . . . 0.0 110.101 177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -95.8 149.92 20.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -99.78 103.7 15.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.95 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.4 p 49.01 -92.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 113.705 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -127.27 8.94 6.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.145 0.497 . . . . 0.0 110.316 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.8 t -82.34 84.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.188 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.715 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 21.9 pt20 -105.29 159.49 15.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 27' ' ' ASP . 14.0 mt -124.83 144.64 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . 1.2 p-10 -88.06 -176.95 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.068 0.461 . . . . 0.0 111.135 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.96 -37.18 71.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.174 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -65.57 -43.05 91.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.19 16.95 5.94 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 9.2 t0 -106.45 158.61 16.77 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.47 132.19 41.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.229 0.537 . . . . 0.0 110.505 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.715 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 55.9 t -107.36 96.22 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.584 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 48.5 p -97.31 172.82 4.56 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 19.6 Cg_endo -62.22 -7.33 9.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.286 1.991 . . . . 0.0 112.523 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.14 -0.08 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 109.978 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -106.4 131.33 53.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.038 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.74 108.78 15.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.668 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -133.6 164.21 27.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.99 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.91 144.39 33.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 55.1 mt -106.43 115.72 48.64 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 122.182 0.991 . . . . 0.0 110.805 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' HB3' HD11 ' A' ' 43' ' ' ILE . 44.1 t0 -109.95 89.3 2.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 113.207 -1.815 . . . . 0.0 109.239 -176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.483 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.72 41.29 15.65 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.606 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.65 -17.28 15.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.965 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.92 137.84 32.0 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 35.1 mt -94.26 139.56 18.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.818 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.5 mp -139.03 127.73 28.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 27' ' ' ASP . 92.5 mt -57.03 145.49 30.38 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 169.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -58.28 -19.54 35.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.466 176.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.46 -44.04 92.33 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.977 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -110.38 7.9 23.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.357 0.599 . . . . 0.0 110.044 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.413 HD23 ' HD2' ' A' ' 45' ' ' ARG . 40.9 tp -65.71 -35.12 79.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.299 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.14 -33.43 67.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.296 0.569 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 8.4 tpm_? -67.01 -53.34 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.505 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.818 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -63.87 -43.29 96.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.44 -29.03 68.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.845 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -71.38 -26.52 62.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.751 0.31 . . . . 0.0 110.362 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 16.9 mm-40 -85.83 -68.96 0.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.974 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -103.88 -21.78 13.6 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.959 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.2 tp 65.45 44.24 3.16 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.441 0.463 . . . . 0.0 112.166 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.56 -11.42 68.36 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.742 171.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -95.89 104.37 16.3 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.718 -0.284 . . . . 0.0 110.467 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 61' ' ' LYS . 45.0 tt0 -93.04 102.84 15.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.017 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' B' ' 36' ' ' VAL . 94.1 m-85 -79.12 109.05 13.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.877 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 59' ' ' GLU . 25.5 mmtp -109.65 105.8 15.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.164 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 64' ' ' GLN . 2.7 m120 -75.81 168.65 19.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.499 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB3' HD22 ' A' ' 65' ' ' LEU . . . -70.22 32.51 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 0.0 111.389 175.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 62' ' ' ASN . 45.5 mt-30 60.1 16.04 5.64 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.562 0.745 . . . . 0.0 111.078 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 65' ' ' LEU . 2.1 pt? -90.25 93.61 9.42 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.925 0.869 . . . . 0.0 111.535 -173.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -82.17 -68.11 0.73 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 58.88 25.22 13.37 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.146 162.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -97.45 135.41 39.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.876 0.369 . . . . 0.0 110.035 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -70.11 111.18 5.58 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -75.31 82.41 2.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.597 0.713 . . . . 0.0 111.161 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 176.62 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.721 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 . . . . . 0 C--O 1.254 1.291 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.01 -173.454 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.799 0.333 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -139.72 28.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.964 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -80.52 74.17 7.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.004 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -172.13 95.05 0.39 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.61 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.35 112.47 1.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.635 2.223 . . . . 0.0 111.609 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.5 mtt -87.79 -16.33 34.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.751 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.5 -25.69 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.057 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -88.56 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.349 0.595 . . . . 0.0 110.483 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.94 -1.19 57.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.186 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -125.11 15.99 8.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.84 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -80.47 113.54 18.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.831 -173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -147.63 133.82 19.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.152 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -170.4 -149.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.548 ' HB2' HD12 ' B' ' 15' ' ' LEU . 26.7 mttt 76.39 -68.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 174.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' B' ' 14' ' ' LYS . 5.8 mp -91.05 20.47 4.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.996 -174.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -61.04 -45.11 96.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.399 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -88.76 120.78 30.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -90.3 -82.23 0.28 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.58 30.03 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.57 94.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' B' ' 29' ' ' VAL . 6.7 pt20 -103.34 157.38 17.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' B' ' 28' ' ' GLU . 18.6 mt -130.78 147.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.661 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.424 ' HB3' HG21 ' B' ' 29' ' ' VAL . 10.0 p-10 -73.72 -166.84 0.4 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.425 0.631 . . . . 0.0 111.062 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.86 -36.11 79.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.61 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -89.97 -34.82 15.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.494 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 110.51 41.35 1.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.802 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.38 -10.34 41.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.016 0.436 . . . . 0.0 109.846 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.649 ' HA ' HG12 ' B' ' 22' ' ' ILE . 30.8 tt0 65.09 97.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.066 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' B' ' 23' ' ' ASP . 40.6 t -95.86 103.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.02 -173.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.724 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 66.4 p -96.44 167.34 12.45 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.959 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.724 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.0 Cg_endo -64.76 20.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.477 0.532 0 C-N-CA 123.649 2.899 . . . . 0.0 113.698 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.467 ' H ' ' C ' ' B' ' 30' ' ' THR . 20.9 t -101.76 -21.15 5.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.159 0.504 . . . . 0.0 109.818 175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -115.45 169.3 9.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.935 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -103.39 146.36 28.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 110.451 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.39 170.82 18.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.122 0.487 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.61 ' HB ' HD13 ' B' ' 48' ' ' LEU . 82.0 t -136.84 140.36 43.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mt -102.73 118.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -89.48 86.55 6.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 74.68 -36.27 1.02 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.212 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.79 -25.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -173.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.58 130.95 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.18 124.81 40.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.16 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.26 121.8 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.137 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.7 tt -58.57 138.75 56.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.488 ' N ' HD23 ' B' ' 44' ' ' LEU . 5.5 mmm-85 -56.46 -16.76 6.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' B' ' 44' ' ' LEU . 9.0 mm-40 -74.57 -28.49 60.95 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -173.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -125.82 24.02 7.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.813 0.816 . . . . 0.0 109.447 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.61 HD13 ' HB ' ' B' ' 36' ' ' VAL . 25.9 tp -68.78 -45.14 72.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.264 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -45.84 67.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.112 -177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 9.3 tpt180 -68.6 -43.2 76.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.309 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.49 -45.95 77.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.874 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 29.4 mt -67.34 -30.0 69.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.612 0.244 . . . . 0.0 111.066 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 53' ' ' ARG . 17.8 ttm-85 -63.1 -41.9 99.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -93.75 -25.91 17.22 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp60 -102.5 -67.74 0.86 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.356 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 40.77 40.31 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.689 0.756 . . . . 0.0 109.693 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.798 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -103.04 -34.01 4.13 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.526 -0.761 . . . . 0.0 114.381 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.9 -165.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.8 tp10 -115.74 102.26 9.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 123.45 45.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.098 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.86 176.81 7.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 0.0 110.347 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -166.33 170.84 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -15.72 57.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.463 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 58.58 24.17 11.7 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.516 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.26 65.73 8.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.424 0.63 . . . . 0.0 111.157 -172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.75 4.38 42.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.537 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -73.52 157.02 37.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.06 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -75.91 -73.63 0.26 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.4 t60 46.77 43.69 13.31 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.764 0.665 . . . . 0.0 111.721 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -77.58 159.3 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.327 0.584 . . . . 0.0 112.057 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -127.9 144.49 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.884 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.377 -178.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 163.19 30.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.77 100.88 12.83 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -118.76 122.96 29.4 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.353 0.597 . . . . 0.0 110.959 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -95.75 13.19 1.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 69.2 mtm -89.21 76.71 7.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.674 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.35 -3.58 8.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 168.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.75 123.66 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.018 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.6 m120 60.13 77.93 0.3 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.704 0.628 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' A' ' 10' ' ' ASN . 10.6 m120 -93.62 139.35 30.89 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.449 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 68.52 164.81 0.24 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.843 0.714 . . . . 0.0 111.826 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.2 -55.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.787 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -117.12 11.95 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.0 111.203 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -113.19 23.6 13.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.052 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tt -136.76 127.45 27.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.759 0.314 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.4 t -129.92 -172.56 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -147.16 139.26 24.47 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 m 76.12 -39.85 0.38 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -80.27 14.51 1.91 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.4 103.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.407 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 152.05 23.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.233 0.539 . . . . 0.0 111.451 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 28' ' ' GLU . 53.4 mt -118.88 149.4 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.89 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -84.34 -163.01 0.73 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -75.95 -25.0 55.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.025 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -69.05 -33.01 72.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.7 33.78 10.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.789 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -103.4 -80.73 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.681 -0.408 . . . . 0.0 109.939 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.503 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 179.28 137.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.34 115.88 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 7.0 p -104.71 162.5 19.61 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 28.0 Cg_endo -62.95 -1.62 2.94 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 113.161 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.77 -2.74 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.575 0.226 . . . . 0.0 111.101 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -111.21 -170.95 1.74 Allowed 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 5.1 t0 -126.87 134.9 50.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.59 -171.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 42' ' ' ILE . 35.5 p90 -156.49 161.05 40.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.048 0.452 . . . . 0.0 111.452 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.43 ' HB ' HD13 ' A' ' 48' ' ' LEU . 87.4 t -137.25 144.73 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 19.2 mt -105.6 124.66 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 111.403 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 16.8 t70 -96.99 87.99 4.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.19 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 80.6 -22.22 4.88 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.502 173.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.58 -31.57 0.37 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 123.61 28.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 HG12 ' A' ' 37' ' ' ILE . 70.5 mt -82.56 142.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.883 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -136.41 132.7 49.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -60.17 143.57 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HG3' ' CG ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -58.03 -19.68 33.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -75.75 -33.78 60.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.63 0.15 16.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 28.7 tp -55.99 -56.08 25.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.979 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -68.63 -23.5 64.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.22 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -73.92 -42.73 60.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.422 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 55.5 t80 -64.63 -36.1 83.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.369 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 77.6 mt -65.74 -33.61 76.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.291 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -68.63 -28.62 67.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 6.1 mm-40 -80.51 -57.74 3.44 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.601 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.585 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 6.0 tt0 -102.93 -67.91 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER 48.19 45.35 19.89 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -169.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -109.31 -33.76 2.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.285 -167.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CD2' ' HA3' ' B' ' 57' ' ' GLY . 1.7 m-85 63.5 -166.71 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.152 0.476 . . . . 0.0 109.748 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 9.2 tp10 -107.6 101.84 11.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.391 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -106.7 112.04 24.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.985 0.421 . . . . 0.0 110.24 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HG3' ' CZ ' ' B' ' 35' ' ' TYR . 69.9 mmtt -101.69 177.55 4.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.635 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -162.42 136.44 6.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.97 62.85 1.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.555 0.693 . . . . 0.0 110.396 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -86.92 43.19 1.07 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.764 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.8 tp -81.4 90.53 6.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.662 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.0 103.89 16.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.622 0.725 . . . . 0.0 110.39 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -78.93 129.78 34.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.67 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -80.93 90.7 5.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.228 0.537 . . . . 0.0 111.766 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -115.5 125.53 53.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -109.87 149.81 29.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.802 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -121.45 132.43 54.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.54 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.855 -0.593 . . . . 0.0 110.193 177.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.773 0.321 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 m -105.16 99.96 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.506 0.67 . . . . 0.0 110.373 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.8 23.64 12.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.218 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -109.03 98.29 29.5 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.289 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.88 146.05 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.743 2.295 . . . . 0.0 112.654 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 47.1 ttm -132.93 95.66 3.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.875 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 43.7 t 64.22 87.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.648 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 pt -88.72 17.6 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.635 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' B' ' 9' ' ' ASN . 8.6 m120 -75.56 -32.38 60.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.647 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' B' ' 13' ' ' ASP . 44.3 m-80 57.69 -157.05 0.3 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.016 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -132.86 -59.67 0.89 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -74.68 -46.07 40.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.419 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' B' ' 10' ' ' ASN . 25.9 t70 38.65 -109.58 0.08 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.257 0.973 . . . . 0.0 111.64 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -169.24 172.42 7.33 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.05 106.2 18.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 110.452 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.1 p -61.56 -45.81 92.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.324 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.36 98.63 0.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.98 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -96.8 -14.63 21.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.739 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.778 ' HB2' ' HD3' ' B' ' 31' ' ' PRO . 8.5 p-10 -79.76 36.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.806 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 101.87 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.76 -173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' B' ' 29' ' ' VAL . 7.8 pt20 -140.31 133.83 30.1 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -99.36 154.64 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.335 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.442 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 5.8 p-10 -93.66 -170.65 2.4 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.724 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.59 -36.09 77.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.458 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -69.83 -36.34 75.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.077 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.87 33.2 6.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.668 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' B' ' 28' ' ' GLU . 11.5 t70 -98.62 -96.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' B' ' 27' ' ' ASP . 31.6 mm-40 -167.57 137.79 2.83 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.355 0.662 . . . . 0.0 109.551 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 92.4 t -123.66 101.05 8.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.692 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.0 p -103.16 175.75 2.11 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.474 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 29.8 Cg_endo -62.96 -10.83 21.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.49 2.127 . . . . 0.0 113.512 -177.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.02 13.91 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.024 0.44 . . . . 0.0 110.786 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -112.92 152.49 29.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.804 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -97.0 124.4 40.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 61' ' ' LYS . 32.0 p90 -143.0 159.87 41.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' B' ' 48' ' ' LEU . 53.7 t -129.87 143.07 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 36.5 mt -110.21 115.67 50.32 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 CA-C-O 121.804 0.811 . . . . 0.0 110.887 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.96 87.46 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.185 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 79.4 -18.77 6.4 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.38 175.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 -21.83 0.4 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.575 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.64 142.71 27.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -94.79 134.58 31.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.4 mp -127.9 128.18 68.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.446 HD23 ' N ' ' B' ' 45' ' ' ARG . 1.9 tt -61.8 137.45 58.25 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.446 ' N ' HD23 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.08 0.15 3.91 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -172.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.76 -12.74 30.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.368 0.604 . . . . 0.0 110.032 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -114.38 -7.01 12.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.512 0.672 . . . . 0.0 110.055 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' B' ' 36' ' ' VAL . 49.9 tp -57.19 -44.27 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.062 -170.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -59.85 -40.65 89.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.968 -173.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -69.5 -43.28 73.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.161 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -62.73 -36.34 82.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 62.9 mt -70.41 -30.76 67.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 0.0 110.68 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -94.16 -49.5 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.723 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -103.03 -53.0 2.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 tp 72.04 47.99 0.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.303 0.641 . . . . 0.0 112.162 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.484 ' HA3' ' CD2' ' A' ' 58' ' ' PHE . . . 82.24 -31.13 2.92 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.938 -0.648 . . . . 0.0 114.24 169.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.95 122.9 25.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.667 -0.313 . . . . 0.0 111.322 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.658 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 8.1 tp10 -92.26 102.35 14.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -95.54 120.1 35.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.86 -167.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -115.44 178.11 4.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.836 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -169.51 149.66 4.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.43 -37.72 75.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.02 0.438 . . . . 0.0 110.523 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 61.49 28.61 17.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.246 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.3 mp -84.15 15.89 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 0.0 110.166 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -50.57 -41.37 54.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.508 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t60 64.54 -78.45 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.315 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -166.6 21.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.658 0.742 . . . . 0.0 109.041 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -90.38 143.48 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -101.51 92.74 5.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.882 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -127.52 -59.89 1.2 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.421 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 76.6 t60 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.64 -178.35 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.802 ' HG3' HG13 ' A' ' 2' ' ' VAL . 38.6 tpp . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.747 0.308 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.802 HG13 ' HG3' ' A' ' 1' ' ' MET . 20.9 m -118.72 141.25 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 67.78 152.02 0.08 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.849 0.718 . . . . 0.0 111.508 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.07 141.94 63.51 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.844 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.91 58.35 6.67 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.09 2.527 . . . . 0.0 113.617 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -67.54 134.29 51.0 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.67 12.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.746 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.11 -19.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.285 0.565 . . . . 0.0 110.454 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -61.63 113.16 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 69.35 31.66 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.428 0.632 . . . . 0.0 109.734 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 73.5 -65.73 0.34 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.348 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -143.63 -77.79 0.23 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -154.01 94.19 1.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.523 0.677 . . . . 0.0 109.927 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.543 ' HB3' HD12 ' A' ' 15' ' ' LEU . 73.3 mmtt 71.81 -63.14 0.44 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.017 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD12 ' HB3' ' A' ' 14' ' ' LYS . 6.0 mp -126.35 161.27 28.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.062 0.458 . . . . 0.0 110.727 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -93.15 114.35 26.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 171.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -136.6 158.86 43.44 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.867 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 m 74.6 -52.07 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.786 0.835 . . . . 0.0 112.286 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -77.03 84.47 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.437 0.637 . . . . 0.0 110.396 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.47 144.95 30.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.877 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -133.86 139.92 46.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.74 152.04 14.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -81.24 179.9 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.038 0.447 . . . . 0.0 110.771 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -56.4 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.465 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -70.83 -45.22 64.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.439 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.03 15.77 3.75 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.667 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -98.83 132.57 44.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -68.23 124.28 23.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.965 0.412 . . . . 0.0 110.595 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 23' ' ' ASP . 44.8 t -108.58 107.31 22.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.686 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 24.0 p -95.99 167.61 12.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 62.7 Cg_exo -52.74 -16.63 5.98 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.273 2.649 . . . . 0.0 114.32 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.93 2.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.652 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -105.72 150.48 25.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 45' ' ' ARG . 19.2 m-20 -94.82 120.72 35.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.155 0.502 . . . . 0.0 109.863 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.9 p90 -142.59 161.76 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.871 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.7 t -131.94 134.97 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 51.2 mt -95.97 121.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.265 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' CB ' ' HE2' ' A' ' 51' ' ' TYR . 28.7 t70 -90.2 86.73 6.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.554 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 78.4 -40.43 1.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.115 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.84 -28.48 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -81.66 136.05 35.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 35' ' ' TYR . 92.7 mt -87.66 134.24 28.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.548 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.76 135.17 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 tp -67.25 145.18 55.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.615 ' HG2' HD22 ' A' ' 48' ' ' LEU . 25.5 mtp-105 -65.61 -5.99 9.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.2 -63.2 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.503 . . . . 0.0 109.946 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -73.04 -14.89 61.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' A' ' 45' ' ' ARG . 18.6 tp -51.74 -42.6 62.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.336 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -60.21 -44.23 95.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -41.43 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.999 0.428 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.525 ' HE2' ' CB ' ' A' ' 38' ' ' ASP . 84.5 t80 -65.91 -43.76 87.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.39 -23.24 61.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.537 0.208 . . . . 0.0 111.33 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -70.51 -46.81 62.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 110.393 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.48 -35.91 29.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.205 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.552 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 26.3 tp60 -97.59 -67.54 0.84 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.319 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 44.32 41.14 4.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.583 0.706 . . . . 0.0 109.131 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.552 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -108.34 -24.1 6.35 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.309 -0.948 . . . . 0.0 114.528 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CG ' ' HA3' ' B' ' 57' ' ' GLY . 1.0 OUTLIER 57.53 -151.81 0.41 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -175.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.575 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 33.0 mt-10 -113.61 101.39 9.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.983 163.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -93.63 103.53 15.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' A' ' 59' ' ' GLU . 93.5 mttt -117.48 105.34 11.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.75 0.786 . . . . 0.0 111.777 -173.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.13 160.16 30.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.191 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.43 -59.66 4.65 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.291 0.369 . . . . 0.0 111.134 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -178.41 14.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.658 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.94 150.09 26.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.886 -174.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.81 6.83 40.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -93.72 93.57 8.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.9 m170 -80.51 135.57 36.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.004 0.43 . . . . 0.0 110.362 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -86.19 71.42 10.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.334 0.588 . . . . 0.0 110.222 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -150.56 107.92 3.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.033 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -98.63 -3.82 35.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 C--O 1.243 0.752 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.808 177.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' B' ' 1' ' ' MET . 27.3 ttt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 121.222 0.534 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 t 54.32 39.43 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.898 0.856 . . . . 0.0 110.207 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.545 ' O ' ' HD3' ' B' ' 5' ' ' PRO . 0.7 OUTLIER -90.27 -177.2 5.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.475 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -84.0 108.39 13.83 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.154 0.502 . . . . 0.0 110.243 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' B' ' 3' ' ' GLU . 92.3 Cg_endo -91.85 20.15 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.99 2.46 . . . . 0.0 111.226 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 91.8 mmm 60.34 82.06 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.811 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 m -103.87 108.57 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.925 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 56.3 mt -72.12 137.11 24.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.776 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -78.05 80.4 4.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.694 0.759 . . . . 0.0 110.566 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -167.06 137.91 3.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.562 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -88.21 21.81 2.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.333 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -43.51 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.473 1.108 . . . . 0.0 112.788 -173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -126.78 159.35 34.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.21 112.72 24.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.647 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.18 -76.22 0.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.08 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 71.9 p 53.84 -176.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.933 0.893 . . . . 0.0 112.418 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -109.74 88.28 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.24 0.543 . . . . 0.0 109.613 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 42.4 m -81.85 -55.47 4.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.804 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 75.76 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.513 0.673 . . . . 0.0 111.339 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.39 128.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.727 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.573 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 26.1 pt20 -107.27 149.79 27.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.928 0.394 . . . . 0.0 111.031 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 13.3 mt -112.7 140.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.162 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.564 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 13.1 p-10 -77.06 -170.4 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.112 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.88 -26.66 60.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.217 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -80.32 -23.17 40.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.709 0.29 . . . . 0.0 110.772 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' B' ' 22' ' ' ILE . . . 89.26 17.29 55.9 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.948 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -92.89 -8.61 42.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.28 0.562 . . . . 0.0 109.929 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' B' ' 22' ' ' ILE . 43.1 tt0 76.65 139.57 0.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.861 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 14.5 t -112.68 102.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 110.488 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 59.3 p -84.75 159.53 57.71 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.828 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 48.6 Cg_endo -69.21 7.68 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.651 2.234 . . . . 0.0 112.811 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.95 -6.46 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.285 0.564 . . . . 0.0 109.591 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -117.64 160.14 21.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.969 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -99.86 143.73 29.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.406 ' CD2' HG23 ' B' ' 42' ' ' ILE . 13.1 p90 -145.69 166.07 26.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.354 0.597 . . . . 0.0 110.672 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 59' ' ' GLU . 53.8 t -136.96 144.54 31.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 33.7 mt -109.94 116.81 53.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 CA-C-O 121.377 0.608 . . . . 0.0 110.087 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' B' ' 57' ' ' GLY . 2.0 m-20 -97.44 86.67 3.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.891 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' B' ' 59' ' ' GLU . . . 62.63 45.56 95.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.826 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.3 64.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.845 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 3.3 tp10 -95.51 119.43 34.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' B' ' 23' ' ' ASP . 97.0 mt -83.89 120.84 35.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.602 ' HB ' HD13 ' B' ' 48' ' ' LEU . 2.7 mp -126.26 128.6 71.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.088 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' B' ' 23' ' ' ASP . 28.5 tp -66.58 139.75 57.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.604 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -60.25 -15.99 29.86 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.75 -45.03 82.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.74 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.48 17.66 6.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 111.493 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.602 HD13 ' HB ' ' B' ' 43' ' ' ILE . 48.9 tp -63.21 -31.49 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.389 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.76 -45.83 59.11 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 111.583 -174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' B' ' 50' ' ' ARG . 8.1 tpt180 -68.78 -37.11 79.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.416 . . . . 0.0 110.898 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' B' ' 41' ' ' GLU . 15.9 t80 -72.77 -32.66 65.78 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 75.1 mt -65.37 -29.33 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.856 0.36 . . . . 0.0 110.413 174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 -64.74 -44.75 89.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.431 . . . . 0.0 110.205 174.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.12 -54.36 9.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.783 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -103.52 -67.08 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.02 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 24.1 tp 78.72 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.855 0.722 . . . . 0.0 111.241 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 79.87 -45.55 2.97 Favored Glycine 0 C--O 1.235 0.205 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.736 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -69.53 139.1 53.77 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.602 ' HB2' ' HA3' ' B' ' 39' ' ' GLY . 3.9 tp10 -114.69 102.21 9.81 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 167.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -83.86 93.76 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.541 -175.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.498 ' HG2' ' HG3' ' B' ' 59' ' ' GLU . 27.9 mmtm -93.49 83.17 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.326 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' B' ' 64' ' ' GLN . 92.9 m-20 -81.83 60.23 4.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.441 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' B' ' 64' ' ' GLN . . . 68.78 -27.18 0.15 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.9 0.88 . . . . 0.0 113.016 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' B' ' 62' ' ' ASN . 96.8 mt-30 67.67 18.32 9.85 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.332 0.587 . . . . 0.0 110.409 -175.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.44 120.84 36.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 -22.98 14.2 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.4 m170 56.86 49.28 14.42 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.506 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -66.18 140.78 58.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.53 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 67.31 32.6 5.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.436 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -76.61 -51.27 11.91 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -173.3 -74.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.892 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.229 -177.562 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 30.9 ttp . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' H ' ' HG2' ' A' ' 1' ' ' MET . 34.5 m -64.35 -19.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.17 15.25 29.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 110.775 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.65 98.86 21.5 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.367 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.92 83.72 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.87 2.38 . . . . 0.0 112.078 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.437 ' HG3' HG23 ' A' ' 7' ' ' VAL . 25.9 ptt? -91.43 -33.42 15.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.249 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG23 ' HG3' ' A' ' 6' ' ' MET . 21.7 t -98.53 79.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.07 137.97 49.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.648 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -91.14 109.78 21.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -61.98 132.67 53.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -84.59 47.14 1.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.577 0.704 . . . . 0.0 111.347 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -145.19 89.84 1.98 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.161 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.0 -37.85 83.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.371 -171.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.01 144.45 35.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.043 0.449 . . . . 0.0 111.181 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -140.17 75.6 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 p -84.97 132.88 34.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.854 -177.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 19' ' ' ASP . 3.6 tp10 72.98 145.03 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.171 0.919 . . . . 0.0 110.083 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -103.05 -3.63 25.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.4 0.619 . . . . 0.0 110.169 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.402 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 5.2 m-20 -80.6 25.33 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.568 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 t -81.33 83.7 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.999 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.457 ' NE2' HD13 ' A' ' 42' ' ' ILE . 10.9 pt20 -96.35 166.21 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.561 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -125.12 157.57 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.64 -169.86 2.71 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -72.8 -26.42 61.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.567 0.222 . . . . 0.0 111.022 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -72.87 -40.82 65.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.89 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 17.82 4.7 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.264 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -104.98 129.88 53.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -59.0 120.0 8.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.278 0.561 . . . . 0.0 111.603 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.492 HG22 HD21 ' A' ' 44' ' ' LEU . 41.0 t -95.9 113.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.899 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 p -103.74 166.57 11.48 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.19 -6.01 2.56 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.782 2.321 . . . . 0.0 113.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -96.07 -4.38 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.368 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -110.13 166.26 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.406 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.88 119.02 38.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.452 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HB3' HG11 ' A' ' 29' ' ' VAL . 32.2 p90 -135.97 149.76 49.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.343 0.592 . . . . 0.0 110.726 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.61 133.71 68.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.2 mt -97.5 121.4 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -94.75 84.27 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.876 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.32 -47.59 2.96 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.437 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.29 -29.02 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 129.19 34.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.509 0.671 . . . . 0.0 110.765 174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.457 HD13 ' NE2' ' A' ' 21' ' ' GLN . 57.6 mt -90.59 133.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.981 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.3 mp -136.61 132.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 29' ' ' VAL . 84.4 mt -58.65 151.62 20.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.299 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -12.77 22.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.938 0.399 . . . . 0.0 110.882 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.99 -36.24 72.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.422 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.66 5.19 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.128 0.489 . . . . 0.0 110.617 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.86 -48.58 81.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.068 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.96 -37.18 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 6.8 tpt180 -73.62 -39.81 64.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.698 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -64.08 -47.83 78.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.19 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.815 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 65.7 mt -61.98 -41.24 97.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.021 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 50.5 ttt-85 -46.54 -40.21 12.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.143 176.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -49.81 8.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.037 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.849 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 5.6 tp-100 -88.34 -68.2 0.78 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 48.0 mt 42.89 30.86 0.27 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.368 0.267 . . . . 0.0 111.286 -171.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.849 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -127.64 3.27 7.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.692 -166.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 53.87 -149.63 0.41 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.447 0.623 . . . . 0.0 110.313 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.9 tp10 -112.16 101.95 10.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.65 117.38 31.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.712 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -114.92 156.82 24.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.411 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -141.06 160.44 40.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.501 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.56 -22.34 59.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.437 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.62 38.21 18.81 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.176 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tt -78.18 0.06 26.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.941 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 71.35 17.24 5.9 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.478 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -79.34 99.4 7.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 171.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -53.84 115.23 1.89 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.777 0.798 . . . . 0.0 112.164 -170.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.522 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 1.6 p80 -100.77 123.98 45.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.377 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -76.53 88.7 3.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.303 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -95.94 -10.76 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.334 0.588 . . . . 0.0 110.106 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.4 t60 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.604 178.329 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.9 m -88.7 27.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.32 128.26 48.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.154 0.502 . . . . 0.0 111.916 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -142.66 63.44 14.12 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.867 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.26 34.35 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.767 2.978 . . . . 0.0 113.528 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 43.6 ttm -139.64 26.05 2.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.835 0.826 . . . . 0.0 109.71 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.01 16.51 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.931 0.872 . . . . 0.0 109.573 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -66.19 127.76 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.905 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -91.61 -28.41 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.844 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -83.55 118.1 23.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -90.42 145.98 24.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.521 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -131.68 154.43 48.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.083 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -128.36 135.77 50.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -56.65 -65.73 0.56 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.612 0.244 . . . . 0.0 111.389 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 59.9 tp -159.49 112.69 2.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.233 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.27 140.76 32.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 169.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -69.43 -36.67 76.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 12.2 m 64.76 -86.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.268 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -138.37 7.05 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 109.342 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -77.89 101.05 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.544 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.563 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 12.9 pt20 -101.56 158.49 16.04 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.586 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' B' ' 28' ' ' GLU . 53.2 mt -140.83 152.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.857 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.79 -173.87 2.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.331 0.586 . . . . 0.0 111.148 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -67.11 -29.18 68.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.153 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -79.78 -14.49 58.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.288 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.86 33.49 26.97 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.287 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.1 -87.2 0.2 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.843 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' B' ' 22' ' ' ILE . 41.7 tt0 -179.17 137.5 0.14 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.86 120.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.037 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 77.0 p -108.09 169.09 6.98 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.29 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_exo -60.36 -2.5 1.91 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.858 2.372 . . . . 0.0 113.022 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.37 -11.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.736 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -101.15 147.08 26.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.707 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.35 112.18 23.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -133.68 157.8 44.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 0.0 111.221 -172.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.84 145.0 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.423 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 67.7 mt -107.18 110.72 32.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.282 0.563 . . . . 0.0 109.881 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.6 92.25 3.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.203 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.06 36.6 31.24 Favored Glycine 0 C--N 1.318 -0.465 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.521 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.94 -28.64 7.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.187 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -85.83 150.22 24.7 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.563 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 78.6 mt -108.86 141.48 24.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.564 -174.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mp -134.77 123.0 40.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -59.85 140.06 56.89 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.585 HH11 HD23 ' B' ' 48' ' ' LEU . 11.3 mmm180 -55.92 -17.97 7.86 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -77.22 -31.43 55.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.199 0.523 . . . . 0.0 110.047 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -102.96 -7.01 21.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.525 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.585 HD23 HH11 ' B' ' 45' ' ' ARG . 45.1 tp -64.45 -28.64 69.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.427 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -55.6 -54.33 45.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.94 -33.31 70.36 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.732 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -59.72 -40.36 87.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.335 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 75.8 mt -72.06 -32.55 67.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.952 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 53' ' ' ARG . 44.1 mtt180 -64.11 -40.53 96.4 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.491 175.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -79.85 -65.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.82 HE21 ' HA ' ' B' ' 55' ' ' GLN . 0.0 OUTLIER -95.1 -41.83 8.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.825 -173.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 23.1 tp 78.41 17.98 1.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.895 0.747 . . . . 0.0 111.56 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.13 -38.36 3.19 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.069 169.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -65.88 117.2 7.92 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.724 -0.28 . . . . 0.0 110.956 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.567 ' HG2' ' HD3' ' B' ' 61' ' ' LYS . 37.0 tt0 -92.3 102.19 14.68 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.638 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -85.42 112.03 20.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.605 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' B' ' 59' ' ' GLU . 7.1 mmmm -115.22 88.6 2.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.241 0.544 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -82.55 154.22 25.13 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.52 69.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 48.8 81.18 0.05 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.252 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.65 -18.66 60.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.877 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 52.99 51.44 15.83 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -173.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.49 113.97 11.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.219 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -132.45 137.44 47.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.316 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -78.57 -34.95 46.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -158.41 111.71 2.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.118 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -90.17 79.61 6.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.098 -172.374 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.507 0.194 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 m -98.07 146.43 8.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 62.38 97.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.479 0.657 . . . . 0.0 110.57 -174.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.603 HD22 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -137.36 88.55 16.93 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.512 0.672 . . . . 0.0 111.484 -173.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.64 5.89 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.941 2.427 . . . . 0.0 112.981 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 66.4 mtt -100.82 93.28 5.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.779 0.323 . . . . 0.0 111.333 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -102.92 -9.97 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.57 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 8' ' ' ILE . 4.2 mp -86.83 132.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 63.29 77.44 0.33 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -99.64 112.45 24.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.144 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.38 -45.44 9.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.155 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.0 t60 56.56 51.09 11.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.859 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -72.04 118.89 15.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.463 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -110.79 19.7 18.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.398 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.49 -21.34 60.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 17' ' ' GLU . 10.6 m 70.97 -94.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.82 172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.653 ' HG3' HG22 ' A' ' 16' ' ' THR . 43.7 mt-10 -135.67 -179.02 5.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.397 -172.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 m -103.99 -45.41 4.75 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.263 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.58 97.24 8.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 109.863 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.5 t -115.67 132.77 64.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.786 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -123.59 171.18 9.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.567 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG21 ' HA2' ' A' ' 26' ' ' GLY . 21.8 mt -138.61 155.22 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.619 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 22' ' ' ILE . 5.6 p-10 -82.42 -167.52 1.62 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.117 0.484 . . . . 0.0 111.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -69.97 -34.26 73.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.921 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -82.07 -15.46 53.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 85.25 36.98 10.23 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.728 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.6 t70 -87.93 -85.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 27.7 tt0 176.15 136.55 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.621 0.576 . . . . 0.0 109.676 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 44' ' ' LEU . 73.6 t -123.09 112.65 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.484 . . . . 0.0 110.67 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 32' ' ' VAL . 70.7 p -104.81 162.01 21.06 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.45 7.22 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.946 2.431 . . . . 0.0 113.257 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 t -103.89 -12.09 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.145 0.498 . . . . 0.0 109.884 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -92.87 151.31 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.635 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -97.02 115.44 27.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.403 0.62 . . . . 0.0 109.704 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.59 172.89 12.34 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.571 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 48' ' ' LEU . 64.2 t -137.03 139.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 14.5 mt -95.65 110.11 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.732 0.777 . . . . 0.0 109.455 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD2' ' HG3' ' A' ' 55' ' ' GLN . 9.8 t0 -82.66 85.87 6.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.243 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 59' ' ' GLU . . . 76.43 -35.8 1.35 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.091 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.18 -28.29 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.43 147.17 29.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.815 0.34 . . . . 0.0 110.396 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.5 mt -97.78 129.76 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.286 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 43' ' ' ILE . 2.3 mp -136.71 123.88 31.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.457 HD21 HG22 ' A' ' 29' ' ' VAL . 85.6 mt -56.19 146.38 23.56 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -68.56 -0.02 4.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.221 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -81.26 -19.18 43.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.94 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -129.09 -7.01 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.245 0.545 . . . . 0.0 110.335 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 36' ' ' VAL . 28.7 tp -50.2 -35.58 27.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.3 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -52.29 -42.57 63.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.004 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -69.83 -39.61 76.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.196 0.522 . . . . 0.0 110.351 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -38.09 88.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.194 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 62.2 mt -69.95 -25.04 63.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.036 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -69.08 -38.47 79.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.7 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.8 -67.83 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' HG3' ' OD2' ' A' ' 38' ' ' ASP . 8.7 pt20 -102.92 -20.89 14.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 40.3 tp 69.5 23.04 6.14 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 168.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.87 0.64 39.25 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.356 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -116.13 127.88 55.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.628 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 23.9 tt0 -91.95 102.03 14.59 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.72 122.12 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.801 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -111.84 -175.68 2.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.871 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.76 161.49 23.38 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.87 -8.67 30.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.834 0.349 . . . . 0.0 111.06 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 65.34 31.11 10.73 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.711 0.767 . . . . 0.0 109.598 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 65' ' ' LEU . 24.3 tp -110.9 22.07 15.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.089 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.747 ' HG3' ' HA ' ' A' ' 70' ' ' HIS . 55.5 tt0 -74.27 76.41 1.83 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 122.159 0.98 . . . . 0.0 109.681 175.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -128.79 -53.39 1.23 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.644 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -87.04 -52.98 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.235 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -85.69 102.0 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.022 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.747 ' HA ' ' HG3' ' A' ' 66' ' ' GLU . 1.9 m-70 -99.79 137.55 38.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 111.772 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.472 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 65.6 m80 -84.45 -35.1 23.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.873 179.187 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.0 t -80.82 86.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -133.71 139.9 46.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.441 0.639 . . . . 0.0 112.206 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -156.38 79.67 3.91 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.34 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.06 -41.72 76.0 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.082 2.522 . . . . 0.0 112.273 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 91.1 mmm -126.98 112.39 15.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.989 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.42 123.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.084 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 pt -80.07 50.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.654 0.74 . . . . 0.0 111.448 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.54 129.74 27.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -93.98 159.07 15.34 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -91.46 -52.21 4.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.116 0.484 . . . . 0.0 110.495 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -153.57 17.97 0.53 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.15 -24.55 47.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.316 -171.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -74.72 -1.96 24.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.03 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.3 -22.44 64.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.902 0.382 . . . . 0.0 111.26 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -92.26 -9.05 43.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 66.36 -66.62 0.17 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.156 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 61.8 m -152.76 -83.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -160.34 33.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -73.5 107.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.006 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 10.5 pt20 -89.03 132.62 34.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.989 0.423 . . . . 0.0 109.974 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.44 148.94 18.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.796 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.53 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -79.88 -174.58 4.47 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.115 0.483 . . . . 0.0 110.877 -179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -71.6 -22.84 61.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.363 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' B' ' 47' ' ' ASN . 13.8 t80 -74.39 -45.25 48.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.44 27.64 2.79 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.059 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -96.0 -124.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -141.05 140.55 34.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 41.8 t -119.81 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.486 0.66 . . . . 0.0 109.345 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 68.7 p -86.96 167.77 20.59 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 35.9 Cg_exo -58.89 -3.6 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.853 2.369 . . . . 0.0 113.496 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.43 8.48 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.226 0.536 . . . . 0.0 110.509 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -106.23 130.87 54.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.02 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.26 120.98 23.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' B' ' 42' ' ' ILE . 34.8 p90 -143.3 164.53 29.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' B' ' 48' ' ' LEU . 72.9 t -132.8 145.83 33.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 39' ' ' GLY . 46.9 mt -111.57 127.89 68.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.342 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' HE2' ' B' ' 51' ' ' TYR . 25.3 t70 -119.29 89.77 3.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.052 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 42.37 9.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.303 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.58 -22.25 11.56 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.934 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -87.56 129.13 35.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.996 0.426 . . . . 0.0 110.151 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.517 HG23 ' CD2' ' B' ' 35' ' ' TYR . 78.3 mt -83.99 141.07 15.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 4.0 mp -135.57 125.37 42.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.56 148.03 20.71 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -61.33 -17.36 53.39 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.959 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -93.52 0.11 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.741 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' B' ' 25' ' ' TYR . 54.0 t30 -124.04 -1.74 8.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 109.167 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' B' ' 36' ' ' VAL . 39.6 tp -69.15 -45.41 70.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.07 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.91 -53.08 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.125 0.488 . . . . 0.0 110.596 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.37 -47.48 85.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.956 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.416 ' HE2' ' CB ' ' B' ' 38' ' ' ASP . 92.7 t80 -62.76 -39.95 95.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.481 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 43.0 mt -67.72 -47.55 69.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.394 -0.191 . . . . 0.0 110.548 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -59.39 -19.03 43.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 110.903 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.07 -54.13 4.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.936 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.867 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 6.3 tp60 -91.53 -67.64 0.84 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 19.4 mt 39.57 34.85 0.16 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.867 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -120.46 -1.03 12.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.22 -171.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.46 -157.26 0.27 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.8 tp10 -115.88 101.88 9.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.687 169.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.92 121.48 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.154 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -136.11 68.07 1.45 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.868 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -71.35 176.68 4.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.043 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB3' ' HG ' ' B' ' 65' ' ' LEU . . . -74.55 -5.93 45.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.884 0.373 . . . . 0.0 110.507 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 55.87 43.22 27.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.616 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' B' ' 63' ' ' ALA . 87.7 mt -58.11 130.98 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.712 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 97.73 0.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -119.36 23.19 11.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.896 -173.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -92.07 77.67 5.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.525 0.679 . . . . 0.0 109.57 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -126.84 170.11 12.54 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -74.25 91.4 2.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.224 0.535 . . . . 0.0 110.736 -175.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -132.15 146.08 51.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.381 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 22.6 p80 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.172 178.576 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.64 0.733 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.12 86.54 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.965 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.28 -17.26 31.09 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -58.68 118.57 29.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.956 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.96 -16.49 29.12 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.531 2.154 . . . . 0.0 112.426 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 28.2 ttt 70.83 127.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.029 0.831 . . . . 0.0 110.615 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.25 101.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.993 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 pt -127.03 145.99 33.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.792 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -138.8 -7.05 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t30 72.9 138.37 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.919 0.762 . . . . 0.0 110.702 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -76.03 18.17 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.2 t60 55.43 51.01 13.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.764 0.792 . . . . 0.0 109.823 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -81.93 168.04 18.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.328 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -89.09 39.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.806 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 67.15 89.73 0.1 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 109.684 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -57.16 124.2 17.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.728 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' HB3' ' H ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -68.34 -85.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.299 1.047 . . . . 0.0 109.131 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.539 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 3.7 t -102.55 -137.96 0.34 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.762 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.81 -29.05 32.84 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.202 0.525 . . . . 0.0 109.653 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 18' ' ' THR . 46.2 t 70.82 110.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.175 177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 6.7 pt20 -122.37 158.4 29.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.223 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.43 145.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 1.2 p-10 -77.26 -161.06 0.19 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.037 0.446 . . . . 0.0 110.196 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.5 -23.83 39.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.65 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -104.33 -4.07 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.99 29.1 5.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.769 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -114.13 149.06 36.2 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.07 127.79 34.05 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 110.472 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 HD23 ' A' ' 44' ' ' LEU . 15.7 t -95.69 117.95 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.797 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 p -115.6 169.04 7.36 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.568 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.797 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 47.7 Cg_endo -67.3 20.21 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.987 2.458 . . . . 0.0 114.3 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.19 -26.62 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.118 0.485 . . . . 0.0 110.248 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.69 145.47 29.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.397 0.618 . . . . 0.0 110.853 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' B' ' 62' ' ' ASN . 1.8 t70 -87.81 142.87 27.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.01 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 29' ' ' VAL . 26.8 p90 -149.96 164.66 34.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.802 0.334 . . . . 0.0 111.021 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.4 153.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.368 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 73.6 mt -111.16 108.22 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.079 0 CA-C-O 121.819 0.819 . . . . 0.0 111.051 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 43' ' ' ILE . 1.8 m-20 -99.88 90.5 4.45 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.769 -177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 74.58 23.98 73.86 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.03 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.93 -29.98 6.57 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.365 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.1 158.78 15.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.366 0.603 . . . . 0.0 111.095 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 72.8 mt -103.58 138.87 26.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.142 -175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 38' ' ' ASP . 3.9 mp -131.56 122.8 51.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD23 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -59.23 135.07 57.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 14.3 mmt180 -58.08 -14.23 6.32 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.78 -14.49 56.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.476 . . . . 0.0 110.149 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -115.4 -9.91 12.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.403 175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 28.2 tp -68.8 -28.77 67.06 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.138 -175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 53' ' ' ARG . 3.3 tm-20 -54.43 -66.37 0.41 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.61 -28.66 67.11 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.332 -177.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.38 -40.99 94.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 39.0 mt -65.42 -33.16 75.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.866 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 50' ' ' ARG . 11.1 mtm180 -62.55 -39.31 93.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.065 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 23.5 mm-40 -87.66 -52.79 5.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.713 0.292 . . . . 0.0 111.317 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -90.24 -51.55 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.138 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.98 44.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.361 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 79.37 -51.72 3.98 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 121.236 -0.507 . . . . 0.0 114.158 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -68.98 122.97 19.77 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.773 -0.251 . . . . 0.0 110.862 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -92.52 101.78 14.22 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.251 170.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.46 95.23 6.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.917 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD2' HD12 ' B' ' 37' ' ' ILE . 16.8 mttp -98.41 87.61 3.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.715 0.769 . . . . 0.0 110.632 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -81.42 176.49 9.66 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.9 4.91 17.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.811 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 66.94 12.17 8.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.681 0.753 . . . . 0.0 110.163 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' A' ' 67' ' ' HIS . 1.1 tm? -133.41 88.18 2.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.331 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.75 119.67 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.997 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.506 ' HD2' HD13 ' A' ' 65' ' ' LEU . 41.9 m170 -63.83 -38.36 90.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.869 -172.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -133.54 104.98 6.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.714 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -121.94 -26.12 4.85 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.005 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -81.11 145.4 31.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -91.86 125.31 36.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.912 0.386 . . . . 0.0 111.464 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.807 177.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.135 0.493 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 37.1 t -132.05 135.57 58.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -80.34 81.32 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.897 0.38 . . . . 0.0 111.452 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 15.0 p30 -154.0 131.83 6.36 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.204 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 9.2 Cg_endo -91.27 96.15 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.242 2.628 . . . . 0.0 112.487 178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 26.6 mmt -85.92 -75.41 0.38 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 49.7 t -120.18 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 33.1 mm 56.9 -99.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.002 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' B' ' 10' ' ' ASN . 3.2 m-20 -130.98 19.75 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' B' ' 9' ' ' ASN . 47.1 m-80 78.67 107.25 0.07 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.203 0.939 . . . . 0.0 109.107 -169.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -85.39 -24.02 27.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.544 -169.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -116.87 129.22 55.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.013 0.435 . . . . 0.0 111.356 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -156.61 -90.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 173.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -154.76 94.52 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.677 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tt -80.71 99.58 8.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 35.2 p -92.78 116.01 28.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.387 0.613 . . . . 0.0 111.568 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -106.35 95.44 5.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p -87.05 -67.01 0.85 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.843 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.4 4.06 22.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.513 0.673 . . . . 0.0 109.403 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.1 90.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.21 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.668 ' OE1' ' HB ' ' B' ' 29' ' ' VAL . 0.9 OUTLIER -106.69 166.19 10.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.0 151.74 35.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.6 OUTLIER -71.56 -173.0 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -67.41 -32.12 72.79 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -86.1 -45.69 11.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.75 31.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.233 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -114.78 125.43 53.68 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.78 128.05 34.37 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 111.393 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.668 ' HB ' ' OE1' ' B' ' 21' ' ' GLN . 19.0 t -114.57 119.6 61.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.005 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 36.2 p -110.34 164.56 14.54 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.744 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 51.9 Cg_exo -53.98 -18.73 13.82 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.388 2.725 . . . . 0.0 114.209 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.91 -0.93 10.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.949 0.404 . . . . 0.0 111.175 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -102.51 147.26 26.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.84 128.72 42.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.42 ' OH ' ' HD3' ' A' ' 61' ' ' LYS . 30.1 p90 -148.48 -178.01 6.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.799 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.449 ' HB ' ' HG ' ' B' ' 48' ' ' LEU . 98.4 t -140.05 139.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.459 HD12 ' HD2' ' A' ' 61' ' ' LYS . 45.1 mt -105.02 117.85 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 110.073 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -106.92 92.04 3.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.468 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.584 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 84.74 0.57 89.18 Favored Glycine 0 C--N 1.316 -0.534 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.645 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.4 -20.27 4.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.724 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -99.82 151.06 21.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.012 0.434 . . . . 0.0 110.17 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.76 138.86 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.608 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.663 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.2 mp -140.01 126.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' B' ' 48' ' ' LEU . 20.5 mt -55.81 146.67 20.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 172.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -62.4 -11.15 14.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.63 0.252 . . . . 0.0 111.354 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 31.9 tp10 -74.75 -51.36 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 0.0 110.712 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -100.5 3.54 42.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 0.0 111.073 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.663 HD23 ' HB ' ' B' ' 43' ' ' ILE . 2.8 tm? -65.75 -33.16 75.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.342 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.34 -49.67 76.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.505 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -67.25 -32.66 73.84 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.306 0.574 . . . . 0.0 110.165 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -66.85 -43.89 82.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.825 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 24.5 mt -66.89 -23.75 66.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.242 0.544 . . . . 0.0 110.545 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -69.4 -33.83 73.59 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -84.7 -65.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.533 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' B' ' 57' ' ' GLY . 47.2 tp60 -85.35 -67.2 0.82 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.554 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 18.6 tp 60.35 -22.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' B' ' 55' ' ' GLN . . . -107.31 35.88 4.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.897 -167.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 50.51 -153.48 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.145 0.473 . . . . 0.0 110.933 170.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 10.9 tp10 -110.56 102.39 10.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.251 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -91.83 117.73 30.05 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.75 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -118.63 -173.1 2.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.587 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.542 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 29.9 p-10 -168.72 -175.45 2.43 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.39 15.13 0.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.815 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' B' ' 62' ' ' ASN . 67.2 mt-30 57.74 48.79 13.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.34 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 mp -82.86 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.45 6.16 18.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.84 132.72 51.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 111.884 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -91.33 125.23 36.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -77.17 42.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 73.1 m80 62.98 -172.66 0.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -163.31 111.54 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.307 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 45.4 m170 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.506 -0.759 . . . . 0.0 109.937 175.184 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.69 0.281 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.49 -79.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -178.07 -54.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -118.55 158.05 48.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.874 0.368 . . . . 0.0 111.464 -174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.95 25.2 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.136 2.557 . . . . 0.0 111.541 172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 16.0 tpt -94.63 -24.66 17.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.223 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.71 139.18 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.972 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 8' ' ' ILE . 1.7 pp -71.84 127.72 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.57 . . . . 0.0 111.665 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -78.84 -22.26 46.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -87.63 93.23 9.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.921 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -76.19 106.9 8.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.305 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -84.92 -8.72 58.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.25 135.93 42.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.098 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -104.26 -31.92 9.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt 62.93 102.11 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.549 0.531 . . . . 0.0 111.467 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 p -90.8 -77.35 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.64 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.61 129.74 47.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.385 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -153.24 -50.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.681 0.277 . . . . 0.0 111.696 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -84.2 8.66 15.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -97.58 101.24 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.871 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.66 ' HG3' ' O ' ' A' ' 29' ' ' VAL . 4.9 pt20 -123.06 156.71 34.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 23' ' ' ASP . 22.7 mt -125.21 138.3 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.714 0.292 . . . . 0.0 111.491 -174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -67.36 162.26 23.32 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.435 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -50.2 -35.37 26.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 113.134 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -84.87 1.08 48.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 39.14 7.95 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.757 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -121.4 127.81 51.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.71 125.73 26.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.585 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.66 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 58.0 t -120.33 102.1 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.548 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.78 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 p -78.19 166.58 42.17 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.78 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -59.69 -10.67 12.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.892 2.395 . . . . 0.0 114.472 -174.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.61 7.76 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.659 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -98.65 154.53 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 7.7 m-20 -76.89 111.3 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.656 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' HB3' HG11 ' A' ' 29' ' ' VAL . 42.9 p90 -147.52 168.17 22.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 111.164 177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.9 t -137.75 148.23 25.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 60.1 mt -105.67 118.52 53.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-O 121.306 0.575 . . . . 0.0 110.052 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.515 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 2.1 m-20 -106.39 87.68 2.6 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.615 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.46 -7.63 80.14 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.102 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.99 -25.82 2.22 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.012 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -97.39 155.97 16.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.114 0.483 . . . . 0.0 110.78 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.1 mt -96.4 137.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.363 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 3.7 mp -131.34 120.51 46.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -57.51 136.66 56.73 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 11.9 mmm-85 -55.78 -13.96 2.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -66.82 -57.39 7.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.293 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -100.0 7.52 44.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.434 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 52' ' ' LEU . 46.0 tp -54.68 -28.97 51.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.257 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -42.26 -46.18 4.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.623 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 2.4 mpt_? -73.89 -39.56 63.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.265 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -44.77 83.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.966 0.412 . . . . 0.0 110.665 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 51.9 mt -68.31 -24.58 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -76.8 -26.76 54.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.916 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -92.41 -70.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.821 0.344 . . . . 0.0 111.731 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.4 -23.21 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.878 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 42.3 tp 66.14 43.32 2.9 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.316 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 88.21 -18.31 41.88 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.811 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 9.3 m-85 -99.46 136.7 39.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.564 -0.374 . . . . 0.0 110.719 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 34.7 tt0 -93.05 102.02 14.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 167.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.06 92.49 3.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.934 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HE2' ' OE2' ' A' ' 59' ' ' GLU . 14.1 mmtt -97.56 173.83 6.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.95 0.881 . . . . 0.0 111.955 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -137.6 175.85 9.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.425 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.81 -38.25 72.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.703 0.287 . . . . 0.0 111.021 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.19 50.87 12.66 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD13 HG12 ' B' ' 32' ' ' VAL . 66.8 tp -70.28 89.2 0.65 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.47 84.65 3.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.428 0.632 . . . . 0.0 109.566 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -131.98 105.37 7.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.844 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 78.3 m80 -74.5 150.33 39.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.013 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 88.7 m-70 72.2 108.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.067 0.854 . . . . 0.0 111.181 -176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -91.82 -24.37 19.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.432 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -151.62 138.56 19.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.362 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 . . . . . 0 C--N 1.318 -0.766 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.512 175.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.4 94.19 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.719 0.771 . . . . 0.0 109.991 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -95.97 -56.29 2.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.556 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.36 111.49 55.22 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.399 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.5 101.67 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.62 2.213 . . . . 0.0 111.442 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.71 78.43 5.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.106 0.479 . . . . 0.0 110.476 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 120.19 41.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.37 99.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.151 0.501 . . . . 0.0 110.552 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.97 25.37 4.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.717 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -59.68 134.37 56.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.469 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . 0.503 ' HD1' ' H ' ' B' ' 11' ' ' TRP . 0.2 OUTLIER -76.82 72.9 3.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.769 0.795 . . . . 0.0 111.962 -173.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.35 101.02 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.262 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.29 44.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.121 -171.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 56.9 -161.13 0.21 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.814 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt 61.79 19.27 10.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.965 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -105.69 178.58 4.52 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.813 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.13 119.26 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.872 0.368 . . . . 0.0 110.622 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -55.27 -64.24 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.623 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.06 20.18 1.94 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.963 0.887 . . . . 0.0 109.002 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.37 94.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.083 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.438 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 9.2 pt20 -92.4 131.34 37.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.211 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.502 HG22 ' O ' ' B' ' 23' ' ' ASP . 36.1 mt -104.83 141.73 19.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.502 ' O ' HG22 ' B' ' 22' ' ' ILE . 0.5 OUTLIER -76.75 173.67 11.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.63 -21.82 60.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.304 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.65 3.61 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.0 27.24 14.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.402 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -116.92 145.27 43.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.606 0.703 . . . . 0.0 109.813 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.43 119.53 13.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.968 0.413 . . . . 0.0 111.172 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 18.6 t -90.28 88.15 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 51.1 p -68.27 157.92 86.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.853 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.1 13.99 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.86 2.374 . . . . 0.0 112.635 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 65' ' ' LEU . 33.8 m -121.95 3.1 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.055 176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -114.28 151.98 32.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.988 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.93 136.55 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 -174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.471 ' CD2' HG23 ' B' ' 42' ' ' ILE . 21.0 p90 -149.34 166.28 29.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.941 0.4 . . . . 0.0 111.061 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 74.2 t -136.04 142.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 46.2 mt -104.83 120.02 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.647 0.261 . . . . 0.0 111.205 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.07 91.07 5.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.3 0.572 . . . . 0.0 109.75 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 37' ' ' ILE . . . 81.19 -28.97 2.86 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.154 174.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.48 -27.2 0.15 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.42 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.233 0.54 . . . . 0.0 110.534 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' B' ' 35' ' ' TYR . 79.2 mt -82.24 133.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.468 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.749 ' HB ' HD23 ' B' ' 48' ' ' LEU . 3.7 mp -130.44 123.06 54.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.975 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 51.0 mt -55.46 143.91 27.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.693 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 10.7 mmt180 -66.96 0.81 2.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.445 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -73.01 -35.23 66.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 0.0 110.803 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -129.05 5.76 5.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.304 0.573 . . . . 0.0 110.265 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.749 HD23 ' HB ' ' B' ' 43' ' ' ILE . 3.0 tm? -51.71 -44.78 63.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.129 -172.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -59.79 -30.29 68.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.851 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 0.6 OUTLIER -76.35 -38.58 55.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.756 0.313 . . . . 0.0 110.808 -178.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -66.25 -32.47 73.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 32.9 mt -64.9 -48.24 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.47 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 7.5 ptp180 -69.04 -27.58 65.78 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.448 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -93.98 -34.57 13.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.596 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 54.2 tp60 -103.19 -67.88 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.085 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER 37.32 40.3 0.19 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.827 0.704 . . . . 0.0 110.078 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.596 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -131.21 6.19 5.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.652 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 50.8 -154.16 0.15 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.852 0.326 . . . . 0.0 110.126 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 5.9 tp10 -102.83 101.84 11.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.644 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.83 95.92 10.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 110.345 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . 12.7 mmtp -112.89 56.26 0.68 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.439 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -76.24 74.35 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.14 8.97 3.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.238 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' B' ' 64' ' ' GLN . 7.8 tp60 52.11 40.89 29.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.48 115.21 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.037 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -51.17 -67.54 0.24 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.69 0.619 . . . . 0.0 110.573 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' B' ' 68' ' ' HIS . 20.1 t-80 59.96 -171.57 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.524 0.515 . . . . 0.0 109.915 173.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' B' ' 67' ' ' HIS . 34.1 m80 -139.57 127.81 22.59 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.902 -0.499 . . . . 0.0 110.465 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -79.93 93.4 5.68 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.85 136.1 57.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.821 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -52.65 129.64 30.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.583 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 3.4 m80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.685 175.701 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tmm? . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 2' ' ' VAL . 18.2 t 75.44 22.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.852 0.834 . . . . 0.0 109.719 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -67.65 121.31 15.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.638 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -155.64 165.29 18.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.1 -29.12 82.04 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.808 2.338 . . . . 0.0 113.835 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 54.2 ttp -93.63 80.93 4.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.38 0.609 . . . . 0.0 110.729 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.94 152.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.21 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 pt -54.06 148.7 2.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.058 0.224 . . . . 0.0 110.718 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -43.44 121.7 2.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.856 0.836 . . . . 0.0 112.959 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 14' ' ' LYS . 24.3 t-20 -73.48 157.89 35.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.977 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -59.37 -35.73 74.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -82.89 127.72 33.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.839 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 t70 68.16 27.5 6.79 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.751 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 25.3 pttm -92.67 31.9 1.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 0.0 110.943 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.93 -25.23 55.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.395 0.617 . . . . 0.0 110.13 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 p -123.44 -168.0 1.7 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.416 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.62 144.2 57.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 171.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 20' ' ' VAL . 28.6 m -87.11 -42.84 12.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.02 -170.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -76.79 28.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.707 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 18' ' ' THR . 15.1 t -114.87 102.42 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.303 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.2 148.72 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.544 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 mt -123.89 154.33 30.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 9.2 p-10 -78.15 -164.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.119 0.485 . . . . 0.0 110.328 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.92 -27.9 43.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.723 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.27 -17.38 34.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.54 37.21 5.91 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.163 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 t70 -92.08 -96.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.7 tt0 174.35 118.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.88 95.1 3.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.259 0.552 . . . . 0.0 110.76 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 9.1 p -80.73 161.64 63.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.917 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 46.6 Cg_endo -67.96 13.71 0.18 Allowed 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 122.828 2.352 . . . . 0.0 113.177 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 30' ' ' THR . 27.3 m -115.43 11.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 110.614 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.74 172.76 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.289 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -103.79 125.22 50.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.862 0.363 . . . . 0.0 110.452 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.01 169.91 16.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.227 0.537 . . . . 0.0 110.877 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' B' ' 60' ' ' PHE . 70.7 t -137.53 139.55 43.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -105.76 120.99 57.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.436 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -108.76 86.98 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.15 42.9 34.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.21 -0.904 . . . . 0.0 113.681 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.04 -17.63 57.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.786 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -109.18 133.48 52.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.361 0.601 . . . . 0.0 110.923 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -85.77 137.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.585 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 3.0 mp -135.18 128.59 49.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.52 143.91 57.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HD2' HD22 ' A' ' 48' ' ' LEU . 11.9 mmm-85 -63.55 -11.65 26.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.42 -49.6 73.1 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.113 0.258 . . . . 0.0 111.266 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -129.35 39.15 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.712 . . . . 0.0 110.155 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 45' ' ' ARG . 11.7 tp -71.63 -35.82 70.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.773 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -55.35 -36.73 66.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.963 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.2 mtt-85 -78.27 -27.46 47.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.092 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.26 -33.7 61.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.492 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.738 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 73.5 mt -71.09 -24.54 62.33 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.57 172.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 53' ' ' ARG . 22.7 ttm-85 -71.32 -28.2 63.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 51.8 mm-40 -86.04 -54.05 4.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.391 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 11.0 tt0 -99.23 -67.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.781 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 4.7 tp 49.31 31.32 3.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.35 0.406 . . . . 0.0 110.408 -174.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -125.3 -6.17 6.35 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.825 -1.179 . . . . 0.0 114.73 -164.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.45 ' HE1' ' CZ ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.02 -154.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.802 0.801 . . . . 0.0 109.312 -179.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' OE2' HD12 ' B' ' 37' ' ' ILE . 28.0 tt0 -116.44 102.28 9.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.457 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -83.49 102.68 12.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 6.0 tptm -97.91 90.29 4.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 -175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -85.16 44.91 1.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.918 -174.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 66.7 -4.05 0.81 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.482 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.613 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER 56.46 23.48 7.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.101 0.477 . . . . 0.0 110.181 -177.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.2 tp -71.16 104.83 3.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.385 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.93 106.59 10.55 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -145.66 43.62 1.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -58.59 136.17 57.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.881 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -126.03 111.75 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.709 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -101.93 0.08 34.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.555 0.693 . . . . 0.0 109.172 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -141.16 109.46 5.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.581 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.854 177.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.825 0.345 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.78 78.74 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.974 0.416 . . . . 0.0 110.163 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -151.76 90.89 1.59 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -153.3 75.65 6.49 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.057 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.41 -11.92 4.87 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.126 2.551 . . . . 0.0 111.74 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 46.7 ttp -165.58 135.96 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.701 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.68 122.65 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.98 0.419 . . . . 0.0 110.467 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.41 HD12 ' N ' ' B' ' 8' ' ' ILE . 4.1 mp -78.4 104.9 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -156.22 103.8 2.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.93 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -87.96 122.59 31.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.996 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -98.33 86.25 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 68.69 -61.22 0.42 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.948 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 53.92 85.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.487 0.715 . . . . 0.0 112.352 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.55 133.75 55.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.766 175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.24 144.45 42.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.383 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -36.01 82.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 110.516 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -103.07 128.57 49.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.624 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 29.9 m -129.29 -48.52 1.19 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.072 0.463 . . . . 0.0 110.202 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -131.91 15.39 4.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.134 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.35 138.36 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.679 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 14.2 pt20 -132.96 168.55 18.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 110.821 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 23' ' ' ASP . 34.5 mt -136.28 155.95 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.639 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 6.3 p-10 -79.38 -171.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.189 0.519 . . . . 0.0 110.791 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -70.04 -29.88 67.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.754 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -88.07 -21.52 24.69 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.1 38.5 4.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.025 -1.083 . . . . 0.0 113.227 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.6 t70 -89.09 -89.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 37.1 tt0 171.97 137.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.679 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 59.5 t -116.83 109.58 28.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.947 0.403 . . . . 0.0 110.707 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -94.17 159.84 33.33 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.56 3.76 0.6 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.102 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.67 -0.83 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 109.983 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -102.49 142.13 34.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.707 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 6.7 m-20 -83.85 120.18 25.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.19 0.519 . . . . 0.0 110.307 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 21.9 p90 -142.58 161.94 36.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.589 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' B' ' 48' ' ' LEU . 84.4 t -124.81 139.48 50.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.582 HD12 ' OE2' ' A' ' 59' ' ' GLU . 53.4 mt -106.47 112.51 39.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.39 85.02 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.949 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' HG3' ' B' ' 59' ' ' GLU . . . 74.53 -32.15 1.0 Allowed Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.602 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.52 -21.73 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -81.44 143.04 32.39 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.401 HG21 HE21 ' B' ' 21' ' ' GLN . 75.2 mt -107.75 119.8 57.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.421 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.42 ' N ' HD12 ' B' ' 43' ' ' ILE . 3.0 mp -126.73 121.72 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.115 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 40.6 mt -57.23 146.4 28.49 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 169.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.558 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 66.7 mtp180 -69.07 0.26 4.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.959 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -60.1 -51.82 68.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.004 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -126.45 19.71 7.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.457 HD22 ' HG2' ' B' ' 45' ' ' ARG . 16.8 tp -53.23 -37.4 62.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -52.23 -43.82 64.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.575 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.71 -36.26 65.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.296 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -67.49 -35.98 80.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.0 -31.31 70.92 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.883 0.373 . . . . 0.0 110.585 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -69.87 -24.24 63.39 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.709 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -89.09 -55.92 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.44 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.906 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 18.8 tp 82.72 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 124.141 0.9 . . . . 0.0 111.801 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 58' ' ' PHE . . . 81.46 -49.4 4.02 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.45 ' CZ ' ' HE1' ' A' ' 58' ' ' PHE . 33.6 m-85 -70.92 124.45 24.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.613 ' HG3' ' HA3' ' B' ' 39' ' ' GLY . 26.7 mt-10 -92.08 101.79 14.33 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.751 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 36' ' ' VAL . 97.1 m-85 -81.4 87.92 6.15 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.514 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -107.39 80.53 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.631 0.729 . . . . 0.0 110.923 -175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -71.9 158.26 36.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.05 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.01 95.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.994 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 55.47 58.77 4.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.307 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.713 ' H ' HD12 ' B' ' 65' ' ' LEU . 4.2 mp -63.66 129.74 41.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.492 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.06 77.98 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.724 0.773 . . . . 0.0 110.818 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -107.7 81.96 1.59 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.79 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -76.96 121.87 24.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -86.81 129.08 35.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.818 0.342 . . . . 0.0 111.1 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -118.07 135.58 54.1 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -119.6 -7.5 10.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.11 0.481 . . . . 0.0 110.402 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 41.1 m170 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.247 -0.883 . . . . 0.0 109.359 174.495 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttm . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 m -116.35 138.59 46.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.852 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.38 151.58 21.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.318 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.0 m-20 67.37 166.94 0.12 Allowed Pre-proline 0 N--CA 1.468 0.432 0 O-C-N 124.065 0.853 . . . . 0.0 111.641 173.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 4' ' ' ASN . 16.6 Cg_endo -59.9 116.88 3.61 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.176 1.917 . . . . 0.0 110.322 169.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 71.4 mtm -51.59 125.72 15.5 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.39 0.614 . . . . 0.0 111.814 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.1 156.65 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.822 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.496 ' O ' HD12 ' A' ' 8' ' ' ILE . 2.3 pp -71.03 147.8 10.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.098 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -129.2 14.47 6.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.445 0.641 . . . . 0.0 109.944 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -96.88 100.66 12.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.139 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -65.59 0.6 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.061 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -148.92 -55.65 0.19 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 63.55 -87.95 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.341 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -142.35 20.01 2.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.394 0.616 . . . . 0.0 109.945 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.1 tp -79.73 137.11 36.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.37 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 p -100.96 -123.57 0.17 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.4 90.75 7.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.051 0.453 . . . . 0.0 112.154 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.6 p -91.77 -48.12 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.701 0.762 . . . . 0.0 109.678 171.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -150.14 17.21 0.85 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.14 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 t -93.92 124.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.694 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.488 ' NE2' HD13 ' A' ' 42' ' ' ILE . 9.8 pt20 -123.19 157.58 32.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 13.0 mt -120.03 152.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.0 p-10 -90.6 -167.91 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.306 0.574 . . . . 0.0 110.904 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -69.93 -24.52 63.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -89.38 -34.26 16.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.496 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.503 ' HA2' ' CG2' ' A' ' 22' ' ' ILE . . . 99.74 27.67 7.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.591 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.71 -10.42 48.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 73.08 120.38 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.338 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 23' ' ' ASP . 47.6 t -113.61 113.29 43.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.514 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 p -102.97 167.75 9.79 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 51.2 Cg_exo -56.4 -11.49 6.43 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.826 2.35 . . . . 0.0 113.404 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.27 1.33 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.464 0.65 . . . . 0.0 110.353 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -107.62 146.08 32.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' OD2' ' HG3' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -89.92 130.52 36.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 42' ' ' ILE . 27.6 p90 -153.76 161.58 41.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.825 0.345 . . . . 0.0 111.023 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.507 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 49.4 t -128.18 150.33 33.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 40.5 mt -115.78 116.88 53.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.157 0 CA-C-O 121.894 0.855 . . . . 0.0 111.187 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.41 89.32 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.731 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' B' ' 37' ' ' ILE . . . 69.17 45.11 63.07 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.247 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.5 -21.9 35.9 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.464 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -91.72 133.53 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.241 0.543 . . . . 0.0 110.578 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.488 HD13 ' NE2' ' A' ' 21' ' ' GLN . 60.3 mt -91.74 132.18 36.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.916 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.82 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.1 mp -130.99 125.99 58.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 29' ' ' VAL . 18.2 tp -63.61 143.54 57.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.549 HH11 HD12 ' A' ' 48' ' ' LEU . 12.8 mmm180 -62.48 -6.89 3.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 7.2 mm-40 -71.33 -57.79 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.47 0.34 53.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.82 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -62.76 -27.29 69.18 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.461 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.37 -48.33 74.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.694 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -61.6 -41.76 97.9 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.429 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.47 -37.96 89.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.292 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.524 ' HG ' HD13 ' A' ' 48' ' ' LEU . 19.5 mt -71.32 -26.7 62.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -71.3 -45.68 62.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.432 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.12 -32.38 13.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -102.97 -56.16 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.188 -0.32 . . . . 0.0 110.374 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 26.6 tp 77.65 37.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 111.914 176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' B' ' 58' ' ' PHE . . . 89.43 -43.54 3.02 Favored Glycine 0 CA--C 1.512 -0.113 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.137 172.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.428 ' HE2' HD23 ' A' ' 56' ' ' LEU . 3.3 m-85 -70.14 117.97 12.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG13 ' B' ' 36' ' ' VAL . 9.6 tp10 -92.04 101.43 13.97 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' HA ' HG22 ' B' ' 36' ' ' VAL . 63.8 m-85 -89.75 86.29 6.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.06 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -84.71 174.77 9.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -142.34 177.26 8.38 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.8 98.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 174.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 64.3 -84.47 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.369 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.492 HD22 HG12 ' B' ' 32' ' ' VAL . 26.9 tp 55.33 30.13 14.24 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.049 0.452 . . . . 0.0 111.472 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 62.14 12.34 4.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.512 -176.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -120.11 75.1 1.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.398 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -139.12 140.73 38.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.329 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -111.99 143.21 43.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.496 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -63.08 -68.68 0.32 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -172.92 -62.34 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.548 173.76 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.16 163.47 16.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' B' ' 3' ' ' GLU . 1.8 mp0 -56.14 117.89 4.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.503 176.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -99.01 143.75 26.94 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.863 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.89 -28.33 23.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.114 2.542 . . . . 0.0 113.295 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 58.4 mtt -78.58 71.57 5.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.018 0.437 . . . . 0.0 110.251 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.79 3.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.391 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.36 14.77 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -86.41 8.25 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -85.11 160.73 19.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.589 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -76.3 143.87 40.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.335 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -92.78 -175.26 3.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.904 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.4 101.72 2.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.841 0.829 . . . . 0.0 111.304 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -146.23 -41.93 0.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.155 174.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.54 98.63 2.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -84.63 121.82 28.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.753 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.55 173.57 10.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.978 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 12.9 m -155.98 -62.92 0.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -174.14 35.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.643 -1.162 . . . . 0.0 107.942 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 56.7 t -64.83 103.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.988 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.45 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 10.4 pt20 -104.91 158.13 16.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.786 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.423 HG22 ' N ' ' B' ' 23' ' ' ASP . 18.1 mt -130.08 155.76 41.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 6.7 p-10 -83.88 -165.11 1.04 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.273 0.558 . . . . 0.0 110.955 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.77 -31.68 68.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.373 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -41.13 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.576 0.227 . . . . 0.0 110.891 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.3 35.82 3.03 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.671 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 19.0 t70 -88.58 -89.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 41.1 tt0 176.02 130.66 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.46 HG22 HD21 ' B' ' 44' ' ' LEU . 48.3 t -114.35 113.12 42.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.191 0.519 . . . . 0.0 110.819 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 67.1 p -106.15 169.3 7.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.3 Cg_exo -58.68 -4.54 1.96 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.154 2.569 . . . . 0.0 114.151 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.492 HG12 HD22 ' A' ' 65' ' ' LEU . 19.2 m -106.52 0.65 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.971 0.415 . . . . 0.0 110.795 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -96.78 136.94 36.62 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.538 ' HB3' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -80.68 108.54 14.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -126.63 155.44 42.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.106 0.479 . . . . 0.0 111.236 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 59' ' ' GLU . 41.8 t -129.85 145.75 35.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.536 ' CG2' ' HA2' ' A' ' 39' ' ' GLY . 36.1 mt -115.23 126.3 72.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.609 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.74 83.35 3.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.18 3.38 Favored Glycine 0 C--O 1.227 -0.327 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.303 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.76 -30.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -81.39 134.24 35.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.098 0.475 . . . . 0.0 110.315 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.92 138.37 19.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.386 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.509 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 2.8 mp -137.04 130.72 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.46 HD21 HG22 ' B' ' 29' ' ' VAL . 79.8 mt -60.39 150.06 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' B' ' 34' ' ' ASP . 20.8 mmt180 -61.37 -11.84 11.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.89 0.376 . . . . 0.0 110.964 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.1 -36.52 61.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.664 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -111.75 8.12 20.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.914 0.388 . . . . 0.0 110.644 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.528 HD13 ' HB ' ' B' ' 36' ' ' VAL . 63.9 tp -60.64 -47.93 84.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.443 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.71 -47.94 80.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' B' ' 54' ' ' GLU . 7.0 mtp180 -64.3 -45.96 85.69 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.111 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.44 ' CG ' HG12 ' B' ' 43' ' ' ILE . 47.1 t80 -59.07 -39.39 81.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.661 0.267 . . . . 0.0 110.925 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 39.0 mt -72.55 -28.72 63.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.618 ' HG2' ' HA ' ' B' ' 50' ' ' ARG . 8.4 ptp180 -86.86 -11.5 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.286 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 70.2 mm-40 -92.67 -54.92 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.185 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' B' ' 57' ' ' GLY . 5.0 tt0 -102.02 -65.96 0.95 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.471 -174.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 2.2 tp 55.0 43.94 29.03 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' B' ' 55' ' ' GLN . . . -100.87 -50.37 1.27 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.771 -165.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.424 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 48.05 -176.86 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.271 0.628 . . . . 0.0 110.908 -167.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 30.8 tt0 -103.79 102.49 12.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.609 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.61 100.69 13.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.328 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -91.43 162.06 14.73 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.51 138.4 9.72 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.92 -43.75 64.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 68.59 -3.42 1.38 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.578 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mp -127.26 108.28 10.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -95.36 35.08 1.35 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -110.79 59.39 0.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.254 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -157.86 85.91 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.445 0.641 . . . . 0.0 109.536 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -89.54 122.76 33.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.745 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -108.63 -66.02 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.189 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -109.64 6.06 23.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 110.958 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.971 178.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.557 0.218 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.16 3.65 10.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.269 0.557 . . . . 0.0 110.367 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -86.97 -176.5 5.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.082 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -109.3 157.98 35.73 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.09 7.6 2.82 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.883 2.389 . . . . 0.0 113.268 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 62.5 mtt -138.24 85.7 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.832 0.349 . . . . 0.0 110.38 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.65 -41.06 91.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.32 94.11 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.826 0.822 . . . . 0.0 108.898 171.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -86.82 143.29 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.937 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -130.99 152.16 50.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 7.7 t90 72.25 -43.69 0.57 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.303 1.041 . . . . 0.0 111.862 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -79.63 -4.56 52.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.204 0.526 . . . . 0.0 109.964 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.12 152.17 45.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.949 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.41 -38.2 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.95 57.78 1.27 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.099 -176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.17 116.59 29.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.764 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -124.16 95.77 4.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 110.931 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -125.94 -44.31 1.79 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.508 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -101.36 18.98 18.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.831 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.34 121.63 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.04 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 171.79 7.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.469 HG12 ' HA ' ' A' ' 28' ' ' GLU . 21.0 mt -136.39 139.42 45.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 166.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.4 p-10 -88.69 -166.99 1.74 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' HD2' HD21 ' A' ' 47' ' ' ASN . 72.9 t80 -70.78 -19.8 62.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.307 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 31.1 t80 -74.54 -32.43 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.549 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.97 25.55 26.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.143 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -96.42 -85.4 0.34 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HA ' HG12 ' A' ' 22' ' ' ILE . 17.5 tt0 -176.81 150.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 174.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 23' ' ' ASP . 58.6 t -130.92 117.34 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.729 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 45.0 p -116.25 168.45 8.6 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.854 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 41.2 Cg_endo -67.71 9.84 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.726 2.284 . . . . 0.0 113.766 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.1 6.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.517 . . . . 0.0 109.999 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -109.78 147.07 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.995 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.23 124.12 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -147.3 163.95 34.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 48' ' ' LEU . 61.6 t -136.52 137.72 47.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -99.64 121.83 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -91.86 86.48 5.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.47 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 77.55 -36.26 1.59 Allowed Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.768 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.628 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.67 135.24 34.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.108 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -91.17 133.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.988 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 1.9 mp -136.87 134.5 48.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 60.7 mt -54.39 151.57 7.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG2' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.67 -8.04 24.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.363 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.67 -45.47 10.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.245 0.545 . . . . 0.0 109.719 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.414 HD21 ' HD2' ' A' ' 24' ' ' PHE . 62.4 t30 -85.86 -4.95 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.229 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' A' ' 36' ' ' VAL . 56.1 tp -54.97 -50.83 67.95 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.521 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 mt-10 -52.81 -48.99 66.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.307 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -59.44 -49.36 78.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.76 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.6 -32.92 74.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 40.4 mt -72.25 -24.36 61.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.566 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 94.0 mtt180 -72.13 -38.98 69.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.6 175.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -68.82 0.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.872 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 11.8 pt20 -103.79 -53.12 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.677 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 18.3 tp 47.78 43.37 16.96 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.493 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -123.5 -3.82 8.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.139 -1.029 . . . . 0.0 114.633 -165.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.22 -160.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 11.0 mm-40 -105.27 101.75 11.27 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -110.53 104.53 13.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.167 -171.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.8 152.46 20.86 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -155.89 149.91 25.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -5.81 27.0 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.084 0.24 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 63.11 42.24 7.42 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.857 0.837 . . . . 0.0 109.81 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.5 tp -90.2 38.65 0.94 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.409 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -73.88 -36.98 64.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.569 178.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 47.27 63.95 1.77 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.843 0.714 . . . . 0.0 110.679 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.69 110.04 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.857 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -74.79 -18.88 60.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.666 0.746 . . . . 0.0 109.082 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.6 t60 -96.7 106.64 18.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.251 170.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -116.42 23.26 12.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.732 175.408 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.06 82.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 121.292 0.567 . . . . 0.0 110.146 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.81 -173.35 2.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.901 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.472 ' HB3' ' SD ' ' B' ' 6' ' ' MET . 97.5 m-20 -88.75 109.27 28.59 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.173 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 7.3 Cg_exo -74.21 -13.05 23.39 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.114 2.542 . . . . 0.0 112.899 -176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' B' ' 4' ' ' ASN . 0.6 OUTLIER -79.62 82.09 5.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.599 0.714 . . . . 0.0 110.809 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.44 100.74 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.73 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 pp -101.24 163.18 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.596 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' B' ' 9' ' ' ASN . 11.8 m120 62.35 93.03 0.05 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.903 0.752 . . . . 0.0 111.382 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -89.79 152.56 21.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -83.19 -29.14 28.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.455 0.645 . . . . 0.0 109.788 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' B' ' 13' ' ' ASP . 57.1 t-80 -124.16 142.02 51.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.235 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' B' ' 12' ' ' HIS . 12.3 t70 69.84 108.45 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.721 0.638 . . . . 0.0 110.337 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -111.78 66.58 0.64 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.14 0.495 . . . . 0.0 110.392 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.644 ' HG ' HG23 ' B' ' 16' ' ' THR . 55.9 tp 71.58 -71.55 0.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.602 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.644 HG23 ' HG ' ' B' ' 15' ' ' LEU . 23.2 p -136.91 153.69 50.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.055 0.455 . . . . 0.0 112.215 -173.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' B' ' 18' ' ' THR . 0.0 OUTLIER -134.33 171.76 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.454 ' H ' ' CD ' ' B' ' 17' ' ' GLU . 16.2 m -58.51 -72.26 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.679 0.275 . . . . 0.0 111.737 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.08 30.33 5.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.254 0.549 . . . . 0.0 109.56 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -121.9 119.52 58.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.587 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.4 HE21 HD13 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.07 173.92 12.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.103 176.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.423 HG21 ' HA2' ' B' ' 26' ' ' GLY . 30.3 mt -130.42 155.98 42.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.423 ' N ' HG22 ' B' ' 22' ' ' ILE . 7.5 p-10 -81.14 -162.19 0.47 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.257 0.551 . . . . 0.0 111.109 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -76.83 -30.2 56.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.743 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -80.51 -19.76 45.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.731 0.301 . . . . 0.0 111.314 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 83.92 41.09 8.32 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.611 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.37 -82.68 0.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 178.02 140.91 0.09 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' B' ' 35' ' ' TYR . 21.9 t -126.4 141.72 45.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -124.53 155.83 68.57 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 -15.19 42.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.778 2.318 . . . . 0.0 112.669 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.53 9.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.636 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.17 150.55 46.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -86.32 130.06 34.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.224 0.535 . . . . 0.0 110.743 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.485 ' HB3' HG11 ' B' ' 29' ' ' VAL . 32.9 p90 -144.0 152.22 40.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.646 ' HB ' HD13 ' B' ' 48' ' ' LEU . 74.9 t -129.78 139.92 50.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 57.6 mt -101.09 116.84 45.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-O 121.623 0.725 . . . . 0.0 109.697 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -112.76 91.0 3.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.304 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.12 -4.37 86.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.44 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.93 4.33 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.87 143.04 27.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.023 0.44 . . . . 0.0 110.308 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.495 HG12 HG12 ' B' ' 37' ' ' ILE . 81.3 mt -97.26 129.12 47.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.237 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.03 129.46 75.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.72 131.23 50.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 2.3 tmm_? -70.42 0.97 5.58 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -167.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.28 -7.21 57.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.436 0.636 . . . . 0.0 109.85 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -129.15 20.16 5.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' B' ' 36' ' ' VAL . 58.9 tp -71.4 -38.37 71.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.992 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.5 -44.61 72.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.98 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.68 -46.09 87.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.009 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -68.85 -32.88 72.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.04 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 42.9 mt -72.92 -28.51 62.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.615 0.245 . . . . 0.0 110.925 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.66 HH21 ' HG2' ' B' ' 54' ' ' GLU . 6.7 ttp180 -64.12 -41.53 97.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.234 0.54 . . . . 0.0 110.012 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.66 ' HG2' HH21 ' B' ' 53' ' ' ARG . 49.5 mt-10 -91.0 -51.02 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.876 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.457 HE21 ' HG2' ' B' ' 59' ' ' GLU . 7.2 tp60 -94.5 -54.46 3.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.435 0.16 . . . . 0.0 111.376 -175.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 56' ' ' LEU . 27.8 tp 74.82 33.54 0.77 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 -11.04 60.74 Favored Glycine 0 C--O 1.235 0.18 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.602 173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -105.47 110.1 22.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.606 0.241 . . . . 0.0 111.3 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.457 ' HG2' HE21 ' B' ' 55' ' ' GLN . 0.0 OUTLIER -92.07 102.12 14.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.56 110.02 21.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.06 -171.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -115.93 97.39 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 111.264 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -85.38 162.94 18.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.79 10.68 2.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.126 0.489 . . . . 0.0 111.131 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -82.95 76.93 9.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.84 -9.83 19.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.772 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 66.33 11.56 8.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.482 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -80.29 -6.41 57.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.801 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -116.13 25.15 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.349 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -66.87 167.97 10.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.407 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -57.65 97.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.76 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.32 2.66 7.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.218 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.483 -179.824 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -65.5 -24.34 34.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 121.422 0.63 . . . . 0.0 109.938 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.71 142.93 36.84 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -95.25 116.16 66.08 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.66 112.48 1.48 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.455 2.104 . . . . 0.0 110.803 175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.17 92.61 0.56 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -88.52 60.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.765 0.793 . . . . 0.0 108.893 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.2 pt -129.11 150.04 34.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.07 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -94.28 155.79 16.84 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -67.99 -179.74 1.29 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.652 -173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -46.08 121.55 3.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 112.439 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -91.42 68.05 5.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.923 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.1 -66.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.834 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -167.35 94.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.789 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -87.14 -78.73 0.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.389 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m 66.73 157.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -79.88 93.35 5.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 m -89.77 -58.29 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.196 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.56 76.52 9.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.058 0.456 . . . . 0.0 111.199 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.14 97.3 5.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.46 ' NE2' HD13 ' A' ' 42' ' ' ILE . 10.6 pt20 -108.21 159.37 16.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.474 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 23' ' ' ASP . 26.7 mt -130.53 156.49 42.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 7.7 p-10 -77.83 -167.7 1.05 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -75.37 -31.76 60.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.443 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.21 -19.19 34.41 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.523 -174.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.28 50.12 2.67 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.404 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -99.64 -94.89 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -179.49 123.87 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.85 106.84 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.774 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.8 p -93.24 158.28 37.45 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HB2' HD22 ' B' ' 65' ' ' LEU . 27.9 Cg_exo -62.98 1.29 1.19 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.689 2.259 . . . . 0.0 113.18 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 t -98.8 -4.44 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.349 0.595 . . . . 0.0 109.928 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.47 ' O ' ' HD1' ' A' ' 35' ' ' TYR . 52.0 m-20 -108.64 120.44 42.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.706 -177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.11 126.24 27.48 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.949 0.404 . . . . 0.0 110.717 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 33' ' ' ASP . 38.9 p90 -146.35 168.0 22.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 0.0 110.902 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' B' ' 60' ' ' PHE . 75.4 t -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.75 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 24.4 mt -106.16 122.06 59.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 56' ' ' LEU . 10.2 t70 -94.06 86.77 5.1 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . 78.52 -42.52 2.22 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.021 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.27 -30.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.47 145.6 30.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.21 0.529 . . . . 0.0 110.472 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.46 HD13 ' NE2' ' A' ' 21' ' ' GLN . 66.3 mt -102.57 136.85 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.006 -172.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 51' ' ' TYR . 2.6 mp -138.41 129.53 36.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 175.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.07 150.52 24.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.252 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.05 -5.93 25.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.403 178.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -55.73 15.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 110.188 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.64 25.25 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.143 0.973 . . . . 0.0 109.138 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 36.1 tp -56.0 -50.18 71.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.164 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.67 -28.51 69.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.571 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.421 HH22 ' HD2' ' A' ' 53' ' ' ARG . 1.1 tpm_? -64.24 -49.27 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 110.265 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . 33.4 t80 -75.68 -24.57 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.939 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.745 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 50.6 mt -69.69 -26.64 64.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 110.285 174.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.421 ' HD2' HH22 ' A' ' 50' ' ' ARG . 18.4 ttm180 -86.02 -19.5 30.24 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 51' ' ' TYR . 1.1 tp10 -79.16 -54.09 6.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.18 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 30.2 tt0 -103.14 -67.69 0.87 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.559 -175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.745 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.1 tt 33.03 47.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.689 0.757 . . . . 0.0 109.716 -168.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.664 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -118.7 -18.09 4.92 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.733 -170.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.731 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 10.6 m-85 53.55 -151.54 0.33 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' B' ' 37' ' ' ILE . 21.1 mt-10 -119.64 102.13 8.4 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.919 166.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -84.36 119.87 25.61 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HZ3' ' HB3' ' A' ' 59' ' ' GLU . 46.0 mmtm -117.57 102.58 9.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.263 0.554 . . . . 0.0 111.599 -177.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -79.37 160.54 26.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.721 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 65' ' ' LEU . . . -73.34 32.56 0.07 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -39.75 0.46 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.592 0.757 . . . . 0.0 110.768 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 63' ' ' ALA . 43.2 tp -58.56 102.54 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.903 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.92 74.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 61.99 20.5 11.61 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.732 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -116.96 114.65 24.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.146 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -141.23 126.38 18.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.5 ' HB2' ' H ' ' A' ' 71' ' ' HIS . 11.1 m170 63.54 -88.17 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -166.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.5 ' H ' ' HB2' ' A' ' 70' ' ' HIS . 55.3 m80 -147.58 -72.65 0.21 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 167.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.02 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -83.53 96.24 4.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.737 0.779 . . . . 0.0 110.184 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.43 72.72 5.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.251 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -136.59 103.64 9.32 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.37 99.24 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.361 2.04 . . . . 0.0 111.766 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 83.4 mtp -86.17 -78.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.626 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.55 120.28 57.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.022 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.98 130.66 37.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.169 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.734 ' HB2' ' HE3' ' B' ' 11' ' ' TRP . 9.3 p30 -74.4 141.81 45.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.22 0.533 . . . . 0.0 110.763 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -86.08 -1.6 57.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.464 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . 0.734 ' HE3' ' HB2' ' B' ' 9' ' ' ASN . 32.0 m-90 -80.98 -9.72 59.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.553 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 37.0 m80 72.82 -68.89 0.21 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.831 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -154.49 -46.75 0.09 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.435 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -149.17 166.3 29.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.692 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.55 70.04 1.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 171.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 29.5 m -82.84 -29.91 29.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.726 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.97 -67.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.983 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 62.4 p 56.48 147.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.737 1.215 . . . . 0.0 112.856 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.13 -31.89 63.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.72 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 39.7 t 55.82 76.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.355 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.511 ' OE1' HD13 ' B' ' 42' ' ' ILE . 3.5 pp0? -93.33 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.653 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -126.75 147.95 31.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.801 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.493 ' HB3' HG21 ' B' ' 29' ' ' VAL . 5.3 p-10 -86.18 -164.41 1.04 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.08 0.467 . . . . 0.0 110.761 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -68.28 -28.96 67.64 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.26 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -59.76 -44.24 93.95 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.675 0.274 . . . . 0.0 111.008 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.22 33.21 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.029 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.3 -84.84 0.27 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.715 0.293 . . . . 0.0 110.342 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -169.55 142.2 2.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' B' ' 23' ' ' ASP . 22.0 t -123.65 86.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.676 0.75 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.469 HG23 HG22 ' B' ' 32' ' ' VAL . 0.1 OUTLIER -81.29 153.85 71.71 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.093 175.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.06 12.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 123.4 2.734 . . . . 0.0 114.787 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 30' ' ' THR . 33.9 m -103.21 -5.55 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.048 0.451 . . . . 0.0 110.282 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.35 155.81 17.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.267 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.649 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 5.3 m-20 -89.81 118.61 29.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.542 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -144.24 160.59 40.72 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.703 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.61 146.87 31.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.601 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mt -103.02 100.02 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.748 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 7.8 m-20 -96.54 90.8 5.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.463 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.655 ' H ' ' HA2' ' A' ' 39' ' ' GLY . . . 72.49 37.1 58.61 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.516 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.62 -26.27 23.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.595 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.23 142.54 27.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.769 0.319 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.511 HD13 ' OE1' ' B' ' 21' ' ' GLN . 76.7 mt -100.49 128.43 52.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' HD12 ' B' ' 43' ' ' ILE . 4.3 mp -126.46 126.8 69.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.735 0.302 . . . . 0.0 110.422 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' B' ' 46' ' ' GLU . 1.1 tt -69.37 134.69 49.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.649 ' HE ' ' HB3' ' B' ' 34' ' ' ASP . 15.6 mtm180 -69.25 0.53 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.541 ' HG2' HD22 ' B' ' 44' ' ' LEU . 42.6 mm-40 -69.05 -18.05 63.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.893 0.378 . . . . 0.0 110.387 171.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -129.24 3.5 5.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.196 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 61.4 tp -57.74 -33.21 68.22 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.159 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 30.6 mt-10 -57.4 -52.66 64.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.779 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' B' ' 53' ' ' ARG . 7.4 mpt_? -71.14 -31.56 67.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -65.72 -39.38 91.11 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.337 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -69.38 -29.32 67.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.993 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' B' ' 50' ' ' ARG . 32.4 mtp180 -65.7 -32.71 74.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -94.45 -62.48 1.32 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.77 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -85.5 -42.2 14.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.051 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.6 tp 74.11 13.42 4.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.142 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.748 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 88.28 -29.03 5.82 Favored Glycine 0 CA--C 1.517 0.169 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.487 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -69.85 126.05 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.581 0.229 . . . . 0.0 111.107 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.1 tp10 -92.77 101.88 14.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 168.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.539 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.31 86.0 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -84.08 93.64 8.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 0.0 110.658 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -66.1 126.44 28.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.742 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.58 64.59 8.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 110.541 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -76.52 -56.16 4.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.39 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 31' ' ' PRO . 24.4 tp 52.52 69.68 0.66 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.141 174.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.9 102.81 4.88 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.967 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.423 ' HB3' ' H ' ' B' ' 68' ' ' HIS . 1.3 m-70 -98.6 -153.07 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.169 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.423 ' H ' ' HB3' ' B' ' 67' ' ' HIS . 85.5 m-70 -83.58 36.17 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.094 0.473 . . . . 0.0 110.886 -173.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -137.55 48.73 2.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.08 0.466 . . . . 0.0 110.503 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -77.61 -35.19 53.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -89.8 130.82 35.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.273 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 22.5 p80 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.356 174.744 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.922 0.391 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.53 23.2 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -74.79 139.82 43.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.579 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -141.75 156.78 65.86 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.84 102.27 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.5 2.133 . . . . 0.0 111.147 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 68.3 mtm -74.97 108.33 7.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.339 -172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.15 144.94 22.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.81 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.95 155.93 8.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.352 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -139.76 99.81 3.79 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -162.85 170.99 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.565 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -90.68 19.84 5.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -171.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -129.78 140.67 51.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.855 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -133.08 92.01 2.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.74 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -133.74 86.52 2.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 tp -80.27 -31.89 38.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 69.89 156.73 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.01 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.863 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 23.6 mt-10 -89.03 103.42 16.04 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.975 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.6 p -64.6 -78.27 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.141 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -88.97 -5.67 57.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.41 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.863 ' HB ' ' HB3' ' A' ' 17' ' ' GLU . 6.1 t -84.29 117.56 29.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -175.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -139.0 159.68 41.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.347 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.8 mt -134.03 153.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.647 0.261 . . . . 0.0 110.377 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 5.8 p-10 -80.44 -177.77 6.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 110.78 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.62 -28.14 69.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.848 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -86.61 -17.24 34.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 37.43 6.96 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.746 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 t70 -90.84 -88.39 0.18 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 29.9 tt0 174.69 138.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.8 116.93 28.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.033 0.444 . . . . 0.0 110.338 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.784 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 60.5 p -110.05 172.8 3.31 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.999 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.784 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 42.6 Cg_endo -68.48 2.3 2.97 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.313 2.009 . . . . 0.0 112.197 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.34 14.04 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.548 0.69 . . . . 0.0 109.449 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.446 ' HB3' HD11 ' A' ' 44' ' ' LEU . 41.9 m-20 -118.69 146.62 44.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.207 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -92.01 118.26 30.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 174.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' HB3' HD12 ' A' ' 44' ' ' LEU . 31.0 p90 -144.02 168.01 21.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.486 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.672 ' HB ' HD13 ' A' ' 48' ' ' LEU . 72.0 t -131.51 133.68 61.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 35' ' ' TYR . 61.1 mt -103.52 121.96 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.323 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -93.13 86.2 5.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.339 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.582 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 78.31 -31.56 1.85 Allowed Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.35 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.43 -23.0 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.14 130.56 35.12 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.3 mt -89.76 129.14 41.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.56 HG12 ' HD2' ' A' ' 51' ' ' TYR . 2.6 mp -133.98 122.73 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 35' ' ' TYR . 13.9 tp -64.8 149.76 48.76 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -55.99 -23.42 32.47 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -81.54 -22.92 37.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.952 0.406 . . . . 0.0 110.59 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -112.9 4.25 16.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.298 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.672 HD13 ' HB ' ' A' ' 36' ' ' VAL . 29.3 tp -70.68 -60.68 2.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -165.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 35.1 mt-10 -61.93 -16.18 49.02 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -165.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 53' ' ' ARG . 19.2 tpt180 -80.99 -49.91 10.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.225 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD2' HG12 ' A' ' 43' ' ' ILE . 16.1 t80 -63.75 -43.27 96.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 14.9 mt -63.82 -41.36 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 40.0 ttm-85 -52.04 -46.53 65.08 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.845 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.01 -25.26 23.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.675 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 29.0 tt0 -99.47 -68.08 0.82 Allowed 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.423 -0.798 . . . . 0.0 112.048 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 65.5 mt 42.27 43.99 3.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.317 0.58 . . . . 0.0 109.71 -169.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.675 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -100.8 -14.33 32.04 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.277 -168.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 57.22 -151.59 0.41 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' C ' ' A' ' 39' ' ' GLY . 2.3 mt-10 -118.22 102.16 8.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 163.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.37 103.55 12.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.078 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -109.04 37.83 2.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.305 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -55.71 119.38 5.65 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.775 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' B' ' 34' ' ' ASP . . . -88.95 52.71 2.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 -175.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -61.52 -39.54 91.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.707 ' HG ' ' H ' ' A' ' 67' ' ' HIS . 24.3 tp 69.63 133.78 0.03 OUTLIER 'General case' 0 C--N 1.338 0.078 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.691 171.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.06 11.69 15.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.513 0.673 . . . . 0.0 110.116 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.707 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 33.2 m170 -117.25 96.54 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.885 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -111.8 101.11 9.48 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.37 110.69 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.964 -174.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -142.91 -174.81 4.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.073 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -75.33 74.89 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.785 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.331 175.543 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.405 ' HB3' ' H ' ' B' ' 2' ' ' VAL . 1.2 mpt? . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' B' ' 1' ' ' MET . 33.8 m -91.24 157.98 2.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.631 . . . . 0.0 112.326 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' B' ' 3' ' ' GLU . 7.9 tp10 -85.99 5.44 33.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.534 175.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 t30 66.6 88.26 0.11 Allowed Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.674 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.55 98.17 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.122 2.548 . . . . 0.0 112.922 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . 0.64 ' HG3' HG23 ' B' ' 7' ' ' VAL . 26.3 ptt? -119.42 -25.02 6.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.64 HG23 ' HG3' ' B' ' 6' ' ' MET . 47.1 t -122.89 131.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.338 175.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 tt -112.4 107.5 23.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.406 0.622 . . . . 0.0 110.346 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -90.72 118.37 30.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.626 0.726 . . . . 0.0 110.756 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.65 5.43 31.15 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -142.65 131.45 22.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.383 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -91.66 120.07 32.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.083 0.468 . . . . 0.0 111.1 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.29 -6.25 56.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.295 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -97.67 17.14 18.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -78.7 -42.23 28.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.786 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 20.9 p -124.81 171.83 9.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.736 0.303 . . . . 0.0 111.475 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 17' ' ' GLU . 2.1 pm0 -79.13 -176.43 5.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.619 0.723 . . . . 0.0 111.59 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 3.0 m -99.56 -126.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.742 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -107.99 70.98 0.79 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.405 0.622 . . . . 0.0 109.528 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.66 131.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.712 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.666 HE21 HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -147.99 -172.9 4.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.362 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 28' ' ' GLU . 41.0 mt -126.7 150.04 32.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.6 OUTLIER -83.11 -170.08 2.86 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.796 0.332 . . . . 0.0 110.285 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.07 -27.25 62.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.76 0.424 . . . . 0.0 111.021 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . 0.446 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 29.1 t80 -76.61 -30.59 56.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.75 30.08 5.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.188 -1.005 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.414 ' O ' HG23 ' B' ' 22' ' ' ILE . 19.9 t70 -111.65 132.33 54.66 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 171.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.485 ' HA ' HG12 ' B' ' 22' ' ' ILE . 26.1 tt0 -64.71 124.18 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.334 0.588 . . . . 0.0 110.598 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' B' ' 35' ' ' TYR . 42.9 t -104.47 129.94 56.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.814 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.859 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 72.0 p -118.89 175.69 2.03 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.859 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 31.3 Cg_endo -64.47 5.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.392 2.062 . . . . 0.0 113.207 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.1 18.53 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.576 0.703 . . . . 0.0 109.418 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -129.1 125.81 37.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.366 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.433 ' HA ' ' H ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -65.38 109.76 2.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.211 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.407 ' HB3' HG11 ' B' ' 29' ' ' VAL . 16.6 p90 -135.88 149.13 48.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.159 0.504 . . . . 0.0 110.197 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.87 142.59 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.21 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 31.5 mt -102.93 115.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.524 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -94.63 89.06 5.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.582 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 83.0 -26.65 4.2 Favored Glycine 0 C--O 1.227 -0.285 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.642 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.32 -26.25 0.35 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -81.44 129.55 34.69 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.666 HG21 HE21 ' B' ' 21' ' ' GLN . 64.3 mt -93.1 136.6 24.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.686 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -136.44 133.96 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.419 177.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -69.05 143.75 54.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.653 ' HD3' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -57.23 -20.71 28.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -172.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.43 -29.93 62.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.1 0.476 . . . . 0.0 110.708 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -106.92 -12.62 15.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.604 0.716 . . . . 0.0 109.773 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.653 HD23 ' HD3' ' B' ' 45' ' ' ARG . 31.5 tp -60.67 -52.01 66.93 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.959 -175.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -60.31 -37.31 80.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.323 0.582 . . . . 0.0 110.236 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 53' ' ' ARG . 23.8 tpt85 -64.58 -53.55 46.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.234 176.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -59.67 -36.54 76.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.996 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 66.7 mt -63.66 -47.32 81.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.912 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 14.1 ptt85 -63.22 -28.46 70.05 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.242 -177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.57 -36.84 17.32 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.728 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.2 tp-100 -103.04 -68.19 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 52' ' ' LEU . 27.1 mt 38.5 40.57 0.39 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.504 0.502 . . . . 0.0 110.723 -167.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.728 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -107.06 -13.72 20.73 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.306 -167.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 57.75 -154.93 0.34 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.66 102.03 9.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.306 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' A' ' 36' ' ' VAL . 25.1 m-85 -84.55 99.86 11.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -92.43 91.6 7.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.111 -173.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -91.0 128.56 36.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.828 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.96 -11.02 60.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.365 -175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 54.51 78.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.814 0.816 . . . . 0.0 110.119 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp -156.42 151.73 26.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.634 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.59 55.67 1.68 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.219 0.533 . . . . 0.0 110.978 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -80.69 73.65 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.622 0.725 . . . . 0.0 109.761 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -75.8 112.66 12.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.097 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -69.46 -22.45 63.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.192 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -68.52 95.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.684 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -165.87 135.9 3.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.966 0.412 . . . . 0.0 110.977 -172.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 C--O 1.245 0.855 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.777 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.91 75.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.649 0.737 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.19 134.91 33.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.51 66.83 2.36 Favored Pre-proline 0 N--CA 1.465 0.284 0 O-C-N 123.691 0.62 . . . . 0.0 110.157 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.29 -23.33 33.08 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.095 2.53 . . . . 0.0 113.002 -172.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 42.3 tpp -155.82 149.79 25.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -67.61 156.76 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.871 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -108.19 135.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -154.32 -85.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.859 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.467 HD21 HD21 ' A' ' 15' ' ' LEU . 3.3 p-10 -175.58 147.53 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -132.83 137.33 46.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.991 0.424 . . . . 0.0 110.782 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -155.84 139.86 16.38 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -51.01 -59.21 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.927 0.394 . . . . 0.0 111.144 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -108.38 105.02 14.51 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.467 HD21 HD21 ' A' ' 10' ' ' ASN . 1.4 tm? -62.02 116.63 5.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.557 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -120.08 -30.93 4.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 0.0 109.316 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.84 98.8 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.422 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 m -92.84 -54.47 3.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.408 0.623 . . . . 0.0 110.425 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.15 70.84 10.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.459 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 89.32 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.732 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' NE2' HG21 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -115.94 141.05 48.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.582 -178.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 23' ' ' ASP . 27.8 mt -99.62 161.23 3.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 3.2 p-10 -79.35 -167.12 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -77.38 -31.37 54.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.734 0.302 . . . . 0.0 111.591 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -80.03 -31.96 39.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.66 39.99 1.52 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.635 -1.269 . . . . 0.0 113.067 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -88.02 -110.72 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -174.38 124.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.54 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.086 0.47 . . . . 0.0 110.058 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 70.3 p -105.19 165.12 13.74 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.089 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.7 Cg_exo -58.73 1.65 0.27 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.289 2.66 . . . . 0.0 114.304 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.22 17.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -112.99 138.16 50.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.215 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.44 116.07 20.3 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -133.56 166.99 21.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.817 ' HB ' HD21 ' A' ' 48' ' ' LEU . 92.3 t -135.63 138.38 48.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 54.0 mt -106.44 114.05 44.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 58' ' ' PHE . 52.6 t0 -95.44 87.74 4.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.21 0.529 . . . . 0.0 110.373 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.786 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 81.29 -11.64 42.87 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.264 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.24 -22.4 1.56 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -83.89 130.16 34.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.417 HG21 ' NE2' ' A' ' 21' ' ' GLN . 81.4 mt -89.11 131.04 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.383 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.543 ' HB ' HD22 ' A' ' 48' ' ' LEU . 3.5 mp -134.8 136.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.1 tt -74.1 146.12 43.83 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.562 ' N ' HD23 ' A' ' 44' ' ' LEU . 2.0 mmt180 -56.47 -21.52 26.2 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.51 -40.56 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.943 0.401 . . . . 0.0 110.024 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -89.18 -1.35 58.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 110.447 -177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -64.14 -40.6 96.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.685 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.02 -55.56 19.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.666 -174.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -64.53 -35.23 80.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.596 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -46.75 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.152 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HG ' HD12 ' A' ' 48' ' ' LEU . 87.7 mt -66.35 -26.43 67.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -73.79 -33.72 64.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.687 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.68 -51.04 5.58 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 12.8 tt0 -90.47 -68.36 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.492 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 38.74 35.56 0.12 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.792 0.682 . . . . 0.0 110.763 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . -136.73 10.44 3.98 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.145 -171.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 1.3 m-85 58.34 -158.65 0.29 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.235 0.54 . . . . 0.0 110.882 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.6 tp10 -100.88 102.02 12.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.03 90.48 4.91 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.916 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 35' ' ' TYR . 73.5 mmtt -86.64 147.12 26.04 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.521 -175.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -119.22 141.78 48.59 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -10.69 58.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.768 0.318 . . . . 0.0 111.066 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 61.75 42.66 10.45 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.484 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -104.47 26.03 9.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.344 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.39 93.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.022 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.66 55.5 1.87 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.832 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -103.54 92.07 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.206 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -123.56 18.33 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -91.51 97.9 11.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.624 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -121.86 -3.97 9.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 167.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.021 174.832 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -86.38 85.16 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.0 -25.31 20.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.555 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 18.3 m120 -78.04 152.26 79.43 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.436 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 12.2 Cg_exo -71.49 48.85 1.04 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.612 2.875 . . . . 0.0 112.406 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 66.3 mtt -92.2 -4.65 53.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.184 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 32.5 t -82.87 84.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.362 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 34.6 pt -85.38 -11.85 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.623 -176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 66.49 112.01 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.805 0.691 . . . . 0.0 110.789 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' B' ' 13' ' ' ASP . 65.2 t30 -79.28 125.13 29.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.194 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -81.66 -19.22 42.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.472 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -153.93 106.42 2.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.526 ' HA ' ' ND2' ' B' ' 10' ' ' ASN . 32.2 m-20 -77.0 169.74 17.79 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -82.27 43.12 0.78 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.916 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' B' ' 13' ' ' ASP . 3.5 mm? -71.06 128.17 35.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.158 0.504 . . . . 0.0 110.525 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -76.09 157.58 32.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.642 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 41.97 66.7 0.67 Allowed 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.069 0.855 . . . . 0.0 112.587 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 11.1 m -69.12 -59.3 3.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.284 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -127.25 23.96 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.415 0.626 . . . . 0.0 109.483 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.83 127.0 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.266 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -135.92 172.39 13.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.367 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.68 146.31 34.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' B' ' 25' ' ' TYR . 0.1 OUTLIER -77.69 178.67 7.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -63.81 -26.15 68.5 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 122.734 0.414 . . . . 0.0 111.79 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . 0.424 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 94.9 m-85 -98.65 -2.06 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.21 20.67 17.32 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.736 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.36 128.66 39.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -72.57 99.69 2.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.177 0.513 . . . . 0.0 110.256 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.0 t -86.61 114.64 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.517 -175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 78.3 p -102.61 172.85 3.94 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.011 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.683 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 77.1 Cg_exo -49.56 -22.47 6.52 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.224 2.616 . . . . 0.0 114.331 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.95 6.81 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -101.77 123.39 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.755 0.312 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' B' ' 45' ' ' ARG . 0.3 OUTLIER -69.19 121.79 17.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.256 -179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 26.0 p90 -144.66 161.14 39.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.909 0.385 . . . . 0.0 110.988 -174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.564 HG23 ' HD3' ' B' ' 45' ' ' ARG . 54.4 t -135.09 143.73 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.577 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 48.9 mt -109.32 115.93 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.836 0.351 . . . . 0.0 111.223 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.07 90.11 6.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 109.529 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.786 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 81.97 -34.12 2.6 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.282 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.69 -24.7 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -174.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -82.59 134.57 35.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.074 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.41 HG12 HG12 ' B' ' 37' ' ' ILE . 69.1 mt -92.52 129.57 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.827 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.01 122.52 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.51 141.37 47.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' HG23 ' B' ' 36' ' ' VAL . 30.3 mmm-85 -60.81 -12.07 9.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -67.99 -47.06 69.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.71 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -103.17 -3.66 25.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.973 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' B' ' 36' ' ' VAL . 37.4 tp -47.86 -41.92 25.31 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.662 -173.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -53.98 -44.61 70.97 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.808 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -74.67 -41.29 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -65.16 -45.16 86.08 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.447 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 52' ' ' LEU . 35.2 mt -69.84 -24.84 63.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.199 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -68.15 -44.25 76.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.558 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -93.81 -30.33 14.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.617 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 5.0 tp-100 -99.34 -67.55 0.84 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.973 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.09 37.89 1.33 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.439 0.638 . . . . 0.0 109.607 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.617 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -116.62 1.04 20.23 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.819 -165.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.68 -150.91 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 117.773 0.787 . . . . 0.0 109.377 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 3.3 mm-40 -115.04 101.79 9.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.33 96.57 10.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.31 86.16 2.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.512 0.673 . . . . 0.0 111.072 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -67.93 169.49 9.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.839 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.05 13.13 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 62.47 14.93 7.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.975 0.417 . . . . 0.0 111.182 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.73 135.56 40.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.154 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -56.11 -39.68 72.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.037 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -71.37 -42.66 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.312 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 71' ' ' HIS . 20.0 m80 67.42 141.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.869 0.731 . . . . 0.0 111.926 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.15 -43.48 52.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 0.0 110.031 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -108.6 88.58 2.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 68' ' ' HIS . 76.6 t60 -121.83 130.15 53.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.947 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 44.6 m80 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.703 171.554 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.23 69.89 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.978 0.895 . . . . 0.0 109.897 176.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.1 132.15 11.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.983 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.4 p-10 -157.32 164.67 20.8 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.376 -173.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 4' ' ' ASN . 95.1 Cg_endo -85.51 -168.11 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.672 2.248 . . . . 0.0 112.023 175.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -155.97 -166.51 2.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 p -65.39 99.49 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.494 0.664 . . . . 0.0 109.706 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.7 mt -84.59 123.77 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.126 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -79.89 116.46 20.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.484 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -81.41 -168.96 2.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 59.99 59.28 2.46 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -144.54 115.82 8.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.384 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.44 -36.58 63.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.182 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -132.96 152.7 51.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.967 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.94 75.81 8.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.6 p 53.68 -168.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.788 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -101.48 -22.37 14.55 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.3 m 72.66 -65.96 0.33 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.468 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -88.28 89.22 7.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.24 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t -131.71 137.12 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.476 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.578 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -116.53 116.11 27.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.549 0.69 . . . . 0.0 110.387 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mt -93.17 142.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -63.08 -170.94 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.151 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -73.81 -31.64 63.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.455 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -72.17 -36.69 69.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.063 0.459 . . . . 0.0 109.952 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.39 24.32 7.55 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.003 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 6.7 t70 -80.5 -81.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.58 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 40.3 tt0 163.92 123.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.809 0.693 . . . . 0.0 110.299 176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 35' ' ' TYR . 9.4 t -113.35 134.89 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.3 p -111.47 153.93 43.99 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.201 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.62 1.73 2.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.801 2.334 . . . . 0.0 113.0 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 t -100.14 -3.8 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.503 0.668 . . . . 0.0 109.46 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.38 179.39 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -111.7 128.98 56.24 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' HB3' HG11 ' A' ' 29' ' ' VAL . 36.8 p90 -141.46 167.47 22.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.136 0.493 . . . . 0.0 110.691 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.962 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 96.2 t -136.62 138.29 46.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 47.6 mt -93.8 113.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.214 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 11.8 t0 -88.22 88.6 7.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.137 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' O ' HG22 ' B' ' 37' ' ' ILE . . . 73.95 -27.65 0.95 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.423 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.43 -22.05 0.13 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -82.49 145.93 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.107 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' HB2' ' A' ' 21' ' ' GLN . 83.5 mt -98.51 131.21 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.455 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 48' ' ' LEU . 1.7 mp -139.69 130.34 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 45' ' ' ARG . 5.6 tt -63.13 143.22 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 44' ' ' LEU . 10.5 mmm-85 -51.06 -23.28 2.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.83 -29.96 35.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.067 0.46 . . . . 0.0 110.808 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -100.81 -12.7 18.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.431 0.634 . . . . 0.0 109.911 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.962 ' HG ' ' HB ' ' A' ' 36' ' ' VAL . 2.8 tm? -61.68 -37.12 82.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.845 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -54.76 -52.4 62.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' HE ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 ttm180 -76.34 -20.66 57.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -76.43 -30.7 57.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.021 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 56' ' ' LEU . 64.8 mt -67.72 -32.76 73.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.272 0.558 . . . . 0.0 109.667 171.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -61.38 -35.13 76.65 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -74.99 -64.28 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.182 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -103.27 -59.22 1.75 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.906 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 29.8 tp 89.45 39.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.101 0.96 . . . . 0.0 112.117 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 72.39 57.67 5.44 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.449 171.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -155.2 120.22 4.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.123 0.461 . . . . 0.0 112.102 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.539 ' CB ' ' HB ' ' B' ' 37' ' ' ILE . 3.1 mm-40 -101.45 101.7 12.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 160.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.75 109.51 19.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.298 -168.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -121.42 174.63 6.63 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -165.12 169.95 15.56 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.07 -2.97 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.192 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 69.89 -46.62 0.6 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.586 0.754 . . . . 0.0 109.44 -171.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.12 77.75 7.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.435 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -72.07 -1.71 15.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.198 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -68.73 -2.49 9.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.011 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.412 ' HE2' ' CG ' ' B' ' 34' ' ' ASP . 7.5 p80 -74.01 -5.52 41.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.718 173.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -89.31 91.19 8.65 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 164.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -122.43 109.48 14.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -168.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -84.1 -33.05 24.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 158.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 113.718 -1.583 . . . . 0.0 108.276 170.621 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.15 169.19 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.746 0.308 . . . . 0.0 110.724 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.76 150.05 26.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.175 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.495 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 21.9 p-10 -85.28 128.7 58.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.828 0.347 . . . . 0.0 110.178 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 16.0 Cg_exo -69.08 175.08 8.0 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.962 2.441 . . . . 0.0 112.139 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 46.3 ttm -78.22 108.08 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.14 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.06 114.09 19.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.11 97.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.535 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 51.9 t30 55.2 74.03 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.32 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -87.98 -52.46 5.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -94.19 130.06 40.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.665 173.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.12 126.3 34.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 111.089 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -130.74 174.59 9.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -148.53 156.01 41.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' B' ' 15' ' ' LEU . 3.9 pp -85.73 158.99 19.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.871 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -66.17 132.13 47.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.279 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.82 -63.08 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.993 -171.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -94.04 -17.67 22.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.478 0.656 . . . . 0.0 110.619 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.97 37.72 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.27 109.08 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.06 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' B' ' 42' ' ' ILE . 13.6 pt20 -93.21 132.78 37.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.164 0.507 . . . . 0.0 111.284 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.25 151.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.523 ' HB3' ' CG2' ' B' ' 29' ' ' VAL . 0.5 OUTLIER -85.09 -177.91 6.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.62 -25.0 67.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.807 0.443 . . . . 0.0 111.82 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . 0.41 ' H ' ' CG ' ' B' ' 23' ' ' ASP . 47.2 t80 -89.65 -18.02 27.28 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.51 13.59 27.82 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.633 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.72 129.45 36.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.32 99.59 4.14 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.523 ' CG2' ' HB3' ' B' ' 23' ' ' ASP . 46.5 t -81.38 101.16 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.44 0.638 . . . . 0.0 111.189 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 21.9 p -86.06 163.12 44.33 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.471 174.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 50.5 Cg_endo -68.82 20.33 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.933 2.422 . . . . 0.0 113.37 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' B' ' 30' ' ' THR . 7.0 t -116.67 1.01 8.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.109 0.481 . . . . 0.0 109.994 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -121.83 170.15 10.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.412 ' CG ' ' HE2' ' A' ' 68' ' ' HIS . 6.2 m-20 -92.66 124.89 37.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.576 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.489 ' HB3' HG11 ' B' ' 29' ' ' VAL . 18.5 p90 -136.73 146.22 45.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.97 0.414 . . . . 0.0 110.64 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 53.1 t -127.67 138.95 53.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.539 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 36.8 mt -99.86 113.62 35.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-O 121.628 0.727 . . . . 0.0 109.83 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -106.87 90.17 3.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.653 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' B' ' 59' ' ' GLU . . . 81.51 12.01 82.4 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.421 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.38 -30.46 4.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -97.51 150.29 21.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.331 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' B' ' 21' ' ' GLN . 72.9 mt -89.76 140.79 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.176 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.405 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.3 mp -134.41 129.9 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.516 HD12 HG22 ' B' ' 29' ' ' VAL . 3.9 tt -72.18 137.8 47.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 12.3 mtm180 -70.85 0.32 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.92 -15.26 56.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.23 3.21 7.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.278 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 28.1 tp -73.24 -34.89 66.13 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -170.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -51.59 -41.49 61.23 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 53' ' ' ARG . 7.6 ttm180 -77.55 -33.31 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -71.01 -38.21 72.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.582 ' HG ' ' HG ' ' B' ' 48' ' ' LEU . 58.0 mt -67.34 -29.15 68.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.164 0.506 . . . . 0.0 110.072 172.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' B' ' 50' ' ' ARG . 18.6 ttm180 -65.77 -28.19 68.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -70.01 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.647 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' B' ' 56' ' ' LEU . 2.4 pt20 -104.23 -48.63 3.8 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' B' ' 55' ' ' GLN . 29.0 tp 82.36 42.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.918 0.761 . . . . 0.0 111.224 -177.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 57' ' ' GLY . . . 95.3 -20.57 48.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.763 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -87.58 107.39 18.57 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -174.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.613 ' CG ' ' HA3' ' B' ' 39' ' ' GLY . 3.0 mm-40 -101.63 102.24 12.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.147 0.498 . . . . 0.0 110.679 171.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -89.62 123.05 33.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.454 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -127.12 79.89 1.91 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 111.013 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -75.12 162.55 28.42 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 65' ' ' LEU . . . -58.36 -36.34 73.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.485 0.183 . . . . 0.0 111.35 -176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.06 -13.45 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.509 0.724 . . . . 0.0 111.988 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' B' ' 63' ' ' ALA . 53.7 tp -86.02 90.8 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.18 44.69 0.88 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.013 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -74.89 -14.16 60.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.81 107.44 9.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 171.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -104.93 -62.67 1.31 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.321 . . . . 0.0 111.498 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -156.03 152.61 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -90.9 108.14 19.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.127 177.391 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.652 0.263 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 m -74.85 -30.3 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.954 0.407 . . . . 0.0 110.333 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.523 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 43.7 mt-10 -102.85 135.35 44.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.451 172.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.24 103.38 17.63 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.641 0.258 . . . . 0.0 110.447 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 3' ' ' GLU . 4.1 Cg_exo -80.84 105.42 1.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.965 2.443 . . . . 0.0 111.393 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 21.5 ptp -104.12 10.27 35.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.733 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.9 t -66.4 99.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.5 mm 64.75 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.616 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -154.9 -82.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.609 0.719 . . . . 0.0 109.427 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -167.78 -49.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -97.23 162.48 13.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.188 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -125.81 15.88 8.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 14' ' ' LYS . 9.3 t70 -90.26 -161.16 0.76 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.638 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 83.0 tttt -96.18 9.02 42.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.788 0.804 . . . . 0.0 109.073 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 18' ' ' THR . 7.1 tt -73.38 112.03 9.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.614 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 p -89.28 -58.92 2.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.856 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -94.34 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.531 ' HA ' HD21 ' A' ' 15' ' ' LEU . 57.2 m -158.82 -72.16 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.827 0.346 . . . . 0.0 110.271 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.91 30.55 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.951 0.881 . . . . 0.0 109.145 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.82 102.79 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.51 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt20 -101.39 147.54 26.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.05 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG21 ' HA2' ' A' ' 26' ' ' GLY . 29.0 mt -123.17 153.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 6.4 p-10 -76.29 -164.89 0.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -78.78 -29.97 45.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.954 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.542 ' HD2' HD22 ' A' ' 47' ' ' ASN . 65.5 m-85 -96.1 -7.57 35.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 84.87 51.18 3.89 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.164 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 18.5 t70 -94.77 -86.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 35.1 tt0 167.89 135.36 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.312 1.045 . . . . 0.0 108.212 170.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.53 104.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 110.68 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.801 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 71.9 p -96.12 174.08 3.71 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.801 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 33.6 Cg_endo -66.05 4.24 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.15 1.9 . . . . 0.0 112.416 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.39 -18.23 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.133 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -94.43 119.93 33.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.379 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -74.23 138.58 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -155.93 166.24 34.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.206 0.526 . . . . 0.0 111.136 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 59' ' ' GLU . 69.4 t -135.07 145.79 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' B' ' 59' ' ' GLU . 20.1 mt -103.37 120.11 52.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 CA-C-O 121.794 0.807 . . . . 0.0 110.82 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 43' ' ' ILE . 26.2 t0 -105.93 90.28 3.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.607 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.645 ' H ' ' HA2' ' B' ' 39' ' ' GLY . . . 77.9 20.13 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 171.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.09 42.46 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.77 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.71 139.17 34.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 87.7 mt -88.86 138.88 18.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.51 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -139.53 127.47 26.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 45' ' ' ARG . 3.3 tt -62.88 148.62 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.842 HH11 HD23 ' A' ' 48' ' ' LEU . 8.2 mmm180 -61.89 -7.25 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.89 -55.39 3.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 0.0 110.725 175.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.542 HD22 ' HD2' ' A' ' 25' ' ' TYR . 15.0 p-10 -89.62 3.64 51.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.312 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.842 HD23 HH11 ' A' ' 45' ' ' ARG . 36.8 tp -61.16 -32.62 72.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.986 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -44.43 -54.32 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.301 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NH2' HH11 ' A' ' 53' ' ' ARG . 0.1 OUTLIER -68.77 -33.09 73.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.87 -172.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.574 ' HD2' HG12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -76.18 -39.3 55.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.712 -176.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.5 mt -67.73 -22.28 65.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.794 0.807 . . . . 0.0 109.364 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.504 HH11 ' NH2' ' A' ' 50' ' ' ARG . 27.9 ttm180 -76.65 -25.17 53.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.264 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -90.16 -69.48 0.72 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.861 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -103.12 -16.16 15.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 30.3 tp 71.74 28.34 2.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 171.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 98.54 -8.51 62.09 Favored Glycine 0 C--N 1.321 -0.294 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.748 174.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.402 ' HE1' ' HA3' ' B' ' 57' ' ' GLY . 12.4 m-85 -117.1 129.76 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.078 0.439 . . . . 0.0 111.995 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.683 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 11.8 mt-10 -96.45 102.14 13.88 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 164.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -81.81 106.67 13.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.683 ' HE2' ' HB3' ' A' ' 59' ' ' GLU . 3.8 mptp? -108.68 80.61 1.35 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 109.766 174.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -83.75 146.47 28.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.227 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.95 79.11 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.375 0.607 . . . . 0.0 110.331 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.97 89.38 7.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.454 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mp -61.92 -83.07 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.017 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 54.05 20.9 2.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.366 0.603 . . . . 0.0 110.768 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -125.63 136.41 53.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.382 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 71.57 -54.67 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.926 0.766 . . . . 0.0 110.774 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -163.52 148.53 11.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -72.65 139.82 47.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -76.77 -60.1 2.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.943 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.951 -174.129 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 m 39.14 62.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 O-C-N 124.289 0.993 . . . . 0.0 112.216 -177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.63 -60.17 3.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.368 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' B' ' 5' ' ' PRO . 2.8 p-10 -176.27 144.15 0.66 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.824 176.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' B' ' 4' ' ' ASN . 4.6 Cg_exo -80.79 158.07 21.33 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.457 2.105 . . . . 0.0 110.375 170.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 48.9 tpp -81.74 84.32 6.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.342 0.591 . . . . 0.0 109.408 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.07 114.71 30.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.706 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mt -77.75 96.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -76.2 165.68 24.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -80.85 149.24 29.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -116.2 -33.15 5.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.795 0.331 . . . . 0.0 111.454 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -128.71 119.04 23.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.74 0.305 . . . . 0.0 111.229 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -108.67 -171.51 1.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -121.36 115.87 23.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.247 0.546 . . . . 0.0 112.178 -177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.74 137.98 35.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.146 170.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.482 HG22 ' O ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -73.52 -4.9 36.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.296 0.569 . . . . 0.0 111.433 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 71.35 -94.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.884 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -157.61 -66.47 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -96.9 14.26 25.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.599 0.714 . . . . 0.0 110.241 -175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.482 ' O ' HG22 ' B' ' 16' ' ' THR . 4.8 t -108.79 130.99 60.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.479 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.454 ' OE1' HG21 ' B' ' 42' ' ' ILE . 3.0 pp0? -148.14 163.63 36.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.48 150.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.671 0.272 . . . . 0.0 110.964 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.37 -168.08 1.06 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -70.56 -29.01 65.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.74 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -86.04 -8.63 57.79 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.58 36.88 25.09 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.242 168.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.96 -92.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.423 0.611 . . . . 0.0 110.493 172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -173.46 137.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 32.4 t -119.19 121.23 66.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.016 0.436 . . . . 0.0 110.14 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 57.3 p -102.42 168.81 8.38 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.84 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.706 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 33.4 Cg_endo -64.97 -4.03 8.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.58 2.186 . . . . 0.0 112.627 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.53 -2.65 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.304 0.573 . . . . 0.0 110.138 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -107.54 136.8 46.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.47 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -69.1 116.23 9.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.289 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -140.24 139.41 35.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 110.583 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.55 139.16 45.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 59' ' ' GLU . 36.2 mt -91.18 96.69 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.834 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 95.2 m-20 -79.17 90.63 4.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.022 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 39' ' ' GLY . . . 78.05 -17.66 5.81 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.971 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.39 -19.34 0.92 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 8.3 tp10 -93.02 144.67 25.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.454 HG21 ' OE1' ' B' ' 21' ' ' GLN . 80.2 mt -99.95 129.7 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.156 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.19 128.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.484 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 82.2 mt -54.52 141.35 31.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' HB2' ' B' ' 48' ' ' LEU . 23.8 mtm180 -71.65 0.52 8.52 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.584 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.03 -13.04 59.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -128.35 -0.62 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.153 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 36.2 tp -60.37 -40.35 90.5 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.826 -173.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 27.4 tt0 -53.66 -51.64 62.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.559 0.218 . . . . 0.0 111.056 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.595 ' HD2' ' HD3' ' B' ' 53' ' ' ARG . 9.9 mmm180 -61.71 -36.29 80.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.366 -176.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -65.36 -43.38 90.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.947 0.403 . . . . 0.0 110.08 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 73.4 mt -71.92 -31.26 66.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.654 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.595 ' HD3' ' HD2' ' B' ' 50' ' ' ARG . 19.5 mtp180 -63.95 -33.4 75.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' B' ' 50' ' ' ARG . 25.1 mm-40 -92.18 -61.99 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.259 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -98.19 -29.17 13.36 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.1 tp 80.42 7.32 1.49 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.461 0.704 . . . . 0.0 111.924 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.834 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 91.74 1.55 70.71 Favored Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.414 -0.898 . . . . 0.0 115.149 166.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -98.94 134.91 41.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.78 0.79 . . . . 0.0 109.725 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.72 ' HB3' ' HE2' ' B' ' 61' ' ' LYS . 6.7 mt-10 -92.21 101.65 14.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.401 171.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.36 122.36 31.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.118 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.72 ' HE2' ' HB3' ' B' ' 59' ' ' GLU . 72.2 mmtt -119.17 157.62 27.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' B' ' 62' ' ' ASN . 3.1 m120 -135.59 137.78 42.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.04 0.447 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.11 -49.66 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.899 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -163.94 2.75 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.459 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 99.0 mt -105.62 94.27 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -171.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.63 -35.09 76.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.86 0.838 . . . . 0.0 108.843 169.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -98.44 109.45 22.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.15 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -74.6 -13.45 60.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.557 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -71.5 106.77 4.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -163.23 133.72 4.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.881 0.372 . . . . 0.0 110.666 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.9 7.96 26.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 . . . . . 0 C--O 1.244 0.778 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.971 174.521 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HB ' ' OE1' ' A' ' 3' ' ' GLU . 77.1 t -97.84 -49.85 11.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' OE1' ' HB ' ' A' ' 2' ' ' VAL . 2.1 mp0 -85.87 37.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 7.3 t30 71.78 127.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 123.638 0.586 . . . . 0.0 111.751 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.28 122.13 10.21 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.68 2.254 . . . . 0.0 111.62 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.1 mmt -92.33 93.0 8.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.064 0.459 . . . . 0.0 110.286 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.3 -16.35 8.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.694 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mt -82.81 91.16 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.806 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -99.2 -33.14 10.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.569 . . . . 0.0 109.948 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' TRP . 3.5 t-20 -70.74 -11.66 61.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.142 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 6.3 m0 71.9 113.99 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.338 0.655 . . . . 0.0 111.679 -177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -107.97 -12.78 15.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.46 144.59 39.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.068 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -73.1 132.4 43.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.32 0.581 . . . . 0.0 112.213 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -87.59 51.75 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.126 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 p 57.94 -178.91 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.286 1.035 . . . . 0.0 111.982 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.2 30.69 0.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 110.26 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 m 69.38 -87.35 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.561 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.77 17.67 0.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.782 0.801 . . . . 0.0 108.87 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.86 102.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.623 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 167.14 15.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mt -116.74 153.93 18.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.997 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.545 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 4.3 p-10 -83.84 -160.08 0.42 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.562 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -80.07 -23.51 41.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -41.13 35.55 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.6 45.32 1.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.825 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -106.28 -88.71 0.45 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 176.83 129.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.27 138.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.7 p -123.82 160.5 51.22 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.26 2.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.185 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 HD22 ' B' ' 65' ' ' LEU . 12.0 t -97.47 -16.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.4 141.72 45.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.794 -176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.2 138.85 36.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.698 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.455 ' CD2' HG23 ' A' ' 42' ' ' ILE . 33.1 p90 -148.69 175.01 11.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.891 175.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 94.5 t -134.5 139.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.526 HG22 ' HA2' ' B' ' 39' ' ' GLY . 18.3 mt -103.42 119.76 52.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.207 0.527 . . . . 0.0 110.369 176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -105.11 89.51 3.16 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.369 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' B' ' 39' ' ' GLY . . . 88.87 -40.09 3.09 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.22 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.35 -23.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.654 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -89.49 164.91 14.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 111.055 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.455 HG23 ' CD2' ' A' ' 35' ' ' TYR . 71.2 mt -116.82 129.29 73.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.809 -171.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.0 mp -130.35 123.72 56.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.197 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.545 ' H ' ' HB2' ' A' ' 23' ' ' ASP . 3.9 tt -60.37 141.31 56.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.7 -16.95 7.28 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -77.59 -33.42 53.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.419 0.628 . . . . 0.0 110.006 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -104.97 -5.76 20.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.957 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.6 tm? -66.79 -25.95 66.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.791 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.95 -30.05 68.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 74.3 ttt180 -82.65 -33.82 27.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.562 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 1.3 t80 -69.26 -36.3 76.97 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 29.6 mt -74.91 -34.64 62.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.996 0.426 . . . . 0.0 110.095 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 50' ' ' ARG . 4.6 ttp180 -59.86 -55.4 34.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.182 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 53' ' ' ARG . 53.6 mt-10 -93.0 -39.21 11.23 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -174.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.684 ' HG3' ' H ' ' A' ' 57' ' ' GLY . 50.5 tp60 -97.49 -68.39 0.8 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.792 -0.568 . . . . 0.0 111.164 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HG ' ' HE1' ' B' ' 58' ' ' PHE . 0.7 OUTLIER 39.35 34.97 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.658 0.742 . . . . 0.0 110.225 -175.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.684 ' H ' ' HG3' ' A' ' 55' ' ' GLN . . . -117.24 -19.81 4.98 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.873 -1.156 . . . . 0.0 114.583 -165.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 58.32 -153.96 0.37 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 7.4 tp10 -109.28 101.78 10.75 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.302 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.38 121.26 30.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.2 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -119.96 148.07 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.55 0.691 . . . . 0.0 111.105 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.42 148.05 47.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.035 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 75.67 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.765 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.29 72.76 10.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.992 -177.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.7 109.46 20.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.795 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -69.45 97.44 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.362 0.601 . . . . 0.0 111.158 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -99.58 83.74 2.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.481 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -100.08 99.44 10.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.661 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -128.33 -11.62 5.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.202 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -74.45 119.34 18.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.937 0.398 . . . . 0.0 110.624 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -72.87 -26.14 61.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.923 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.6 m80 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.394 -0.813 . . . . 0.0 110.187 174.483 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.85 128.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.083 0.468 . . . . 0.0 111.626 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -172.46 -73.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.817 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' B' ' 5' ' ' PRO . 45.7 t30 -163.42 110.56 0.99 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.893 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' B' ' 4' ' ' ASN . 26.3 Cg_endo -62.02 146.53 96.19 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.658 2.239 . . . . 0.0 111.955 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -60.83 -59.27 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.638 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.38 131.84 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.095 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -113.28 123.71 69.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.096 0.474 . . . . 0.0 110.562 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -92.71 96.19 10.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.1 0.476 . . . . 0.0 109.819 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -106.52 110.11 22.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.282 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -86.71 89.57 7.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.605 0.717 . . . . 0.0 110.286 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -160.06 101.05 1.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.707 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -99.82 -15.83 18.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.341 0.591 . . . . 0.0 109.816 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' B' ' 14' ' ' LYS . 46.9 mtmt -137.58 152.26 49.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.519 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.3 tp -129.82 -66.38 0.79 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p 46.94 -97.15 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.21 133.0 34.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.088 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -154.11 -58.66 0.12 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.17 90.28 7.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.613 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.14 97.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.027 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.508 ' HG3' ' HB ' ' B' ' 29' ' ' VAL . 11.0 pt20 -116.11 151.91 34.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.687 -170.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 15.4 mt -119.65 146.45 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.171 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' B' ' 43' ' ' ILE . 0.9 OUTLIER -70.77 -173.71 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 111.16 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.24 -30.57 71.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.585 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.64 -43.84 11.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.21 29.01 0.3 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.781 -1.2 . . . . 0.0 113.486 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -114.77 137.87 51.42 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.34 132.28 53.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 111.734 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.508 ' HB ' ' HG3' ' B' ' 21' ' ' GLN . 16.4 t -111.26 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.233 174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.646 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 31.5 p -87.02 164.47 36.23 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 34.5 Cg_endo -65.38 -3.7 8.06 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.77 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 t -101.27 1.28 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.327 0.584 . . . . 0.0 109.656 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -112.35 141.31 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.154 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' B' ' 45' ' ' ARG . 8.6 m-20 -78.06 135.73 37.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.24 162.97 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.962 0.41 . . . . 0.0 110.638 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.423 HG23 ' HG2' ' B' ' 45' ' ' ARG . 95.3 t -128.53 144.38 38.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 37.0 mt -107.05 100.14 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.566 0.698 . . . . 0.0 109.265 176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.784 ' HB3' ' HA2' ' B' ' 57' ' ' GLY . 5.9 m-20 -93.56 90.27 6.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.543 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . 74.75 25.46 69.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.393 176.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.78 -12.38 59.35 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.82 133.22 37.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -95.62 130.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.523 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.555 ' HA ' ' HB2' ' B' ' 23' ' ' ASP . 3.9 mp -138.2 126.13 29.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' B' ' 23' ' ' ASP . 5.2 mp -55.25 143.2 28.77 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' B' ' 34' ' ' ASP . 12.3 mtp180 -70.27 -0.38 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.707 0.289 . . . . 0.0 111.598 -177.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.59 -16.15 43.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.781 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -123.74 -4.36 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.884 0.85 . . . . 0.0 109.309 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' B' ' 45' ' ' ARG . 2.6 tm? -65.4 -35.4 80.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.963 -175.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 53' ' ' ARG . 1.9 tm-20 -57.25 -55.96 27.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -60.68 -36.38 78.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.052 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.26 -33.55 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.676 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 56' ' ' LEU . 68.6 mt -69.53 -29.16 66.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.474 . . . . 0.0 110.299 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 53' ' ' ARG . 46.3 mtp85 -72.07 -24.28 61.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.46 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.44 -66.46 0.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.631 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -98.21 -34.31 10.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.641 -174.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' B' ' 52' ' ' LEU . 21.2 tp 77.05 1.97 3.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.491 0.717 . . . . 0.0 111.276 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.784 ' HA2' ' HB3' ' B' ' 38' ' ' ASP . . . 106.92 -32.91 6.81 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.097 170.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.535 ' HE1' ' HG ' ' A' ' 56' ' ' LEU . 34.2 m-85 -70.93 123.43 22.01 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 122.671 -0.311 . . . . 0.0 110.819 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.459 ' OE1' ' HE2' ' B' ' 61' ' ' LYS . 40.5 tt0 -95.57 101.99 13.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.287 170.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -82.88 91.78 7.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.459 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 60.5 mmtt -81.75 75.07 8.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -64.51 158.43 24.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.09 -51.53 24.1 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.665 0.603 . . . . 0.0 110.876 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 62.28 15.45 7.61 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.61 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 32' ' ' VAL . 16.1 tp -85.58 30.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.533 0.683 . . . . 0.0 110.445 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -76.96 11.9 1.59 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.524 0.678 . . . . 0.0 109.692 174.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' B' ' 65' ' ' LEU . 34.4 m170 -76.21 62.13 1.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.746 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -108.25 24.06 13.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.611 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 54.5 m80 73.11 150.34 0.1 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.559 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -117.94 -179.42 3.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.123 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -75.83 97.03 3.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.053 0.454 . . . . 0.0 110.186 173.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.585 -178.576 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.67 0.272 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.08 146.1 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 85.79 6.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.78 114.91 62.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.51 99.47 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.686 2.257 . . . . 0.0 112.513 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 6' ' ' MET . 0.0 OUTLIER -85.49 93.15 8.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.685 0.755 . . . . 0.0 110.646 178.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.77 -27.63 25.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.894 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -104.6 177.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.225 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -71.9 156.59 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.982 0.42 . . . . 0.0 110.587 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -81.73 -37.7 26.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -86.78 49.86 1.89 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.62 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -94.3 27.08 3.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.75 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.53 5.66 50.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.328 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -83.32 150.67 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.471 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.33 144.76 25.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.52 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -92.2 149.36 21.52 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.46 -69.3 0.32 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.757 0.313 . . . . 0.0 111.308 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m -127.46 -87.72 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.667 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -120.23 76.96 1.21 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.598 0.713 . . . . 0.0 109.753 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.2 t -117.91 87.98 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.948 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.426 ' OE1' ' HB ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -120.95 172.59 7.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.21 -176.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 28' ' ' GLU . 45.5 mt -129.8 150.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.9 p-10 -86.36 -170.28 3.02 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -71.2 -17.73 62.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.407 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 2.0 t80 -76.73 -41.99 42.94 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.74 34.92 3.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.987 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -102.36 -87.24 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.062 0.431 . . . . 0.0 109.992 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HA ' HG12 ' A' ' 22' ' ' ILE . 25.4 tt0 -175.45 138.96 0.42 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG22 HD21 ' A' ' 44' ' ' LEU . 7.9 t -125.86 113.52 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 110.75 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 32' ' ' VAL . 24.9 p -114.84 163.93 18.13 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.022 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.71 7.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.499 2.799 . . . . 0.0 114.637 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 30' ' ' THR . 22.0 m -100.18 -5.87 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.59 176.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD2' HD22 ' A' ' 44' ' ' LEU . 5.0 t70 -119.96 160.31 22.98 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -96.26 121.35 37.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.926 -173.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.21 159.66 41.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.055 0.455 . . . . 0.0 110.701 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HB ' HD13 ' A' ' 48' ' ' LEU . 96.0 t -134.08 142.42 41.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.753 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 42' ' ' ILE . 18.7 mt -102.73 121.74 54.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.623 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -94.48 89.17 5.73 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' B' ' 38' ' ' ASP . . . 79.58 -51.08 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.616 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -31.14 0.02 OUTLIER Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -174.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.59 142.2 33.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.229 0.537 . . . . 0.0 110.038 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 37' ' ' ILE . 84.0 mt -98.22 135.78 31.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.306 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 23' ' ' ASP . 2.2 mp -137.78 132.1 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD21 HG22 ' A' ' 29' ' ' VAL . 83.4 mt -58.92 152.6 19.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 172.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HD2' HD22 ' A' ' 48' ' ' LEU . 44.5 mmm-85 -63.65 -16.3 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.92 0.39 . . . . 0.0 110.577 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.22 -38.63 50.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.45 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.5 4.06 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.623 0.725 . . . . 0.0 110.335 -175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 36' ' ' VAL . 40.4 tp -60.58 -41.32 94.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.499 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -57.16 -55.17 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.122 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -53.7 51.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -58.87 -45.0 91.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.481 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 58.0 mt -66.51 -48.77 68.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -61.97 -29.05 69.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.655 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -51.83 8.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.491 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 57' ' ' GLY . 7.2 tt0 -103.49 -67.49 0.88 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 52' ' ' LEU . 20.2 mt 47.72 43.35 16.67 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -168.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 55' ' ' GLN . . . -113.65 1.94 24.72 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.363 -0.922 . . . . 0.0 114.672 -166.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.504 ' CZ ' ' HE1' ' B' ' 58' ' ' PHE . 8.3 m-85 59.33 -154.84 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.484 0.642 . . . . 0.0 109.69 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HB3' ' HB ' ' B' ' 37' ' ' ILE . 8.5 tp10 -122.12 102.05 7.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 166.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.648 ' HD2' HD21 ' A' ' 62' ' ' ASN . 9.0 m-85 -99.26 110.95 23.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.247 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 59' ' ' GLU . 74.1 mmtt -112.5 63.89 0.63 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.127 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.648 HD21 ' HD2' ' A' ' 60' ' ' PHE . 50.8 m-80 -74.11 149.87 40.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.01 -29.46 63.03 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 72.73 -51.08 0.71 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.038 174.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.79 118.96 7.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.59 109.55 20.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.374 0.607 . . . . 0.0 111.353 -177.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -115.59 93.24 4.19 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -131.71 163.59 27.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 0.0 111.717 -172.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -85.76 156.52 20.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 169.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.53 -59.81 4.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -175.55 77.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.432 174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.422 -178.732 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.449 ' HG2' HG13 ' B' ' 2' ' ' VAL . 25.9 ttt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' B' ' 1' ' ' MET . 27.0 m -137.54 9.12 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.557 0.218 . . . . 0.0 111.511 -178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.591 ' HG2' HD22 ' B' ' 4' ' ' ASN . 0.5 OUTLIER -81.58 -36.11 29.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -174.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.669 ' HB2' ' HD2' ' B' ' 5' ' ' PRO . 9.9 p30 -129.47 166.29 26.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' B' ' 4' ' ' ASN . 43.0 Cg_endo -67.77 61.09 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.14 2.56 . . . . 0.0 113.349 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' B' ' 6' ' ' MET . 45.6 ttm -93.26 11.72 27.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 65.4 t 70.8 102.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.883 -174.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.3 mt -75.04 118.74 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.66 143.22 26.62 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.408 HD22 ' N ' ' B' ' 10' ' ' ASN . 0.9 OUTLIER -92.35 -81.61 0.34 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -171.418 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . 0.51 ' HA ' ' HE3' ' B' ' 11' ' ' TRP . 2.2 m95 56.19 88.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.332 0.587 . . . . 0.0 109.717 -168.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -134.5 29.79 3.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.476 -170.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.77 48.17 0.92 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.933 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 61.33 15.13 6.24 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.815 173.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 42.2 tp 63.32 21.94 13.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.588 . . . . 0.0 110.532 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 62.8 p -85.53 157.19 20.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.863 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -82.04 -16.24 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 34.9 m 76.49 -82.36 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.455 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.05 87.24 2.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.925 0.869 . . . . 0.0 111.375 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.6 124.11 49.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.096 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . 0.494 ' NE2' HG21 ' B' ' 42' ' ' ILE . 0.0 OUTLIER -130.01 166.55 19.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 0.0 111.438 -176.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.472 HG22 ' N ' ' B' ' 23' ' ' ASP . 23.8 mt -119.96 161.21 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.721 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' B' ' 44' ' ' LEU . 5.0 p-10 -89.69 -159.87 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -73.02 -37.96 66.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.375 -175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -87.09 3.07 47.66 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.352 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' B' ' 22' ' ' ILE . . . 73.07 20.52 80.0 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.607 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 27.5 t70 -72.34 -87.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.308 173.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 30.2 tt0 175.33 141.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.36 123.04 67.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 0.0 110.3 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 64.0 p -106.86 160.94 24.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.936 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.06 3.36 0.56 Allowed 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.038 2.492 . . . . 0.0 113.558 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.4 12.86 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.599 0.714 . . . . 0.0 109.433 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -113.15 158.39 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.458 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.35 105.71 17.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -128.64 157.16 42.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.169 0.509 . . . . 0.0 110.512 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -135.24 142.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.883 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 34.3 mt -105.96 124.24 61.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.636 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 30.6 t70 -120.6 90.51 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.769 . . . . 0.0 110.696 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' GLY . . . 86.41 28.42 27.47 Favored Glycine 0 C--N 1.315 -0.609 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.261 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.68 -22.72 38.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.295 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.98 136.41 33.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.494 HG21 ' NE2' ' B' ' 21' ' ' GLN . 74.3 mt -101.25 133.34 44.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.4 124.13 39.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.528 HD23 ' N ' ' B' ' 45' ' ' ARG . 3.1 tt -68.1 143.61 55.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.528 ' N ' HD23 ' B' ' 44' ' ' LEU . 38.9 mmm-85 -53.72 -22.02 8.29 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.2 -36.78 75.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -106.4 -19.94 13.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.425 ' CD2' ' HD2' ' B' ' 45' ' ' ARG . 24.4 tp -55.75 -42.41 75.38 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -172.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -33.6 68.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 50' ' ' ARG . 0.0 OUTLIER -80.36 -41.02 25.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.267 0.556 . . . . 0.0 110.258 178.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -57.92 -44.2 86.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.692 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.63 -38.84 64.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.163 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -57.82 -39.01 76.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -83.45 -43.99 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' H ' ' B' ' 57' ' ' GLY . 46.3 tt0 -99.5 -67.09 0.87 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 47.48 29.95 1.5 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.599 0.36 . . . . 0.0 111.689 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG2' ' B' ' 55' ' ' GLN . . . -125.44 15.22 7.22 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.584 -171.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.504 ' HE1' ' CZ ' ' A' ' 58' ' ' PHE . 2.3 m-30 56.8 -153.36 0.37 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.999 0.428 . . . . 0.0 109.98 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' B' ' 59' ' ' GLU . 3.7 tp10 -117.93 102.16 8.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.313 0.578 . . . . 0.0 110.5 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -83.64 100.92 11.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.817 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -85.19 -175.46 5.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -165.83 168.12 16.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.43 11.31 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 70.21 -81.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.456 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp 48.21 70.7 0.42 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.333 0.587 . . . . 0.0 110.117 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.87 -6.41 16.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.511 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.25 -35.31 49.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.765 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -108.67 15.46 23.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -93.2 49.44 1.41 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.008 -0.433 . . . . 0.0 111.106 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 70.2 -71.67 0.12 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.39 108.62 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.905 0.384 . . . . 0.0 111.925 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 65.5 t60 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.613 172.671 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.97 135.02 59.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -123.09 93.9 4.1 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.211 0.529 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -125.84 114.02 24.6 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.437 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 118.0 5.23 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.714 2.276 . . . . 0.0 112.701 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.6 ttt -81.4 107.41 14.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.54 120.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.438 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 11' ' ' TRP . 24.2 pt -66.77 135.54 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.974 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -80.61 67.23 6.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 57.5 71.29 0.59 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.996 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.621 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 58.8 t-105 -94.44 147.52 23.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.055 -176.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -88.88 176.76 6.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.075 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.84 147.2 23.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 0.0 111.645 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -99.11 -21.05 16.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.939 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.91 85.84 4.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.673 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -149.22 153.89 38.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -68.41 139.04 55.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.957 0.408 . . . . 0.0 110.717 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.0 m -121.08 -6.77 9.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.798 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.62 21.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.58 92.27 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.827 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.523 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 26.9 pt20 -88.26 167.08 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.243 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 26' ' ' GLY . 28.4 mt -136.19 149.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.03 -179.99 4.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -57.99 -35.9 71.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.818 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -84.64 -12.96 52.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 22' ' ' ILE . . . 87.76 40.78 6.6 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.118 175.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 28' ' ' GLU . 12.4 t70 -90.27 -97.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 29.6 tt0 179.38 127.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.523 ' HB ' ' HG3' ' A' ' 21' ' ' GLN . 22.0 t -123.04 107.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.226 0.536 . . . . 0.0 110.534 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 31' ' ' PRO . 67.6 p -98.0 168.28 10.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.016 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 50.2 Cg_exo -56.52 -10.54 5.18 Favored 'Trans proline' 0 N--CA 1.477 0.514 0 C-N-CA 123.049 2.499 . . . . 0.0 113.721 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.19 10.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -106.19 145.73 31.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.928 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.584 ' OD1' ' HB2' ' B' ' 62' ' ' ASN . 35.9 m-20 -89.39 124.82 34.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -148.21 164.71 33.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.391 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HB ' ' HG ' ' A' ' 48' ' ' LEU . 64.3 t -133.43 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 59' ' ' GLU . 90.7 mt -112.94 108.17 24.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 CA-C-O 121.685 0.755 . . . . 0.0 110.638 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CG ' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -83.3 79.62 9.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.943 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.1 5.84 29.11 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.513 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.7 -24.8 1.97 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.545 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 40.0 mt-10 -81.56 134.28 35.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.2 mt -96.45 122.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.729 ' HB ' HD23 ' A' ' 48' ' ' LEU . 3.9 mp -129.45 127.55 65.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.188 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -62.36 143.03 57.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -55.58 -20.88 14.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.63 -47.54 80.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.603 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -96.86 0.44 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.193 0.521 . . . . 0.0 110.114 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.729 HD23 ' HB ' ' A' ' 43' ' ' ILE . 2.9 tm? -68.6 -36.71 79.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.394 -172.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.02 -34.28 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.81 -34.16 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 110.272 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.86 -41.76 96.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.386 174.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -63.52 -34.21 77.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.748 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -64.8 -41.83 95.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.0 110.605 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -66.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -103.33 -25.42 13.31 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 52' ' ' LEU . 31.3 tp 64.1 43.46 5.04 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 173.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA2' ' CG ' ' A' ' 38' ' ' ASP . . . 86.14 -16.55 42.58 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.377 -0.916 . . . . 0.0 114.106 172.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HE2' HD23 ' A' ' 56' ' ' LEU . 12.6 m-85 -91.7 133.29 35.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.89 102.01 14.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -78.5 107.02 10.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.716 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' B' ' 35' ' ' TYR . 17.5 tptt -93.81 177.09 6.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.604 ' ND2' ' H ' ' A' ' 64' ' ' GLN . 8.3 t30 -143.62 151.89 40.7 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' B' ' 31' ' ' PRO . . . -49.89 -31.1 11.39 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.604 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 14.0 mm100 68.18 26.59 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 176.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.85 -30.91 71.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 68.55 -3.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.071 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 18.6 m170 -67.62 136.01 53.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 7.8 m-70 76.99 -26.11 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.123 0.889 . . . . 0.0 111.02 -174.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 45.3 m80 59.83 97.98 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 50.7 m80 69.99 117.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -165.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -59.3 117.93 5.37 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.154 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.434 -178.386 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.719 0.295 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -87.18 22.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -172.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.32 -52.0 5.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.503 HD22 ' C ' ' B' ' 4' ' ' ASN . 0.2 OUTLIER 59.26 89.38 0.11 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.512 -175.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.36 86.71 0.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.56 2.173 . . . . 0.0 111.693 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 87.0 mtp -76.8 -15.28 59.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.292 0.568 . . . . 0.0 109.917 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 m -110.88 111.29 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.345 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 28.3 pt -81.57 34.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 52.41 74.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.185 0.517 . . . . 0.0 111.039 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.54 34.28 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.392 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -83.01 2.85 32.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.336 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -68.44 109.43 3.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.09 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -138.99 104.2 4.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.82 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -104.54 -46.6 4.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.755 174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -147.34 76.43 1.41 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.68 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.09 141.18 48.59 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 168.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -99.89 129.72 46.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.142 0.496 . . . . 0.0 110.857 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -120.36 -62.87 1.42 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.489 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.16 78.92 9.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.444 0.64 . . . . 0.0 110.868 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.86 105.37 18.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -106.59 162.01 14.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.153 0.502 . . . . 0.0 111.678 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 23' ' ' ASP . 35.1 mt -128.54 154.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.474 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' B' ' 44' ' ' LEU . 4.7 p-10 -82.79 -167.29 1.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.488 0.661 . . . . 0.0 111.601 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.1 -35.74 81.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.026 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -83.73 -7.61 59.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.73 65.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.165 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 28' ' ' GLU . 28.3 t70 -80.53 -84.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 27' ' ' ASP . 35.1 tt0 174.9 135.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . 0.456 HG22 HD21 ' B' ' 44' ' ' LEU . 40.7 t -121.51 118.34 55.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.018 0.437 . . . . 0.0 110.211 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.836 ' HB ' ' HD2' ' B' ' 31' ' ' PRO . 70.2 p -111.93 172.67 3.36 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.324 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.836 ' HD2' ' HB ' ' B' ' 30' ' ' THR . 46.3 Cg_endo -69.43 19.69 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.824 2.349 . . . . 0.0 113.071 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' B' ' 30' ' ' THR . 10.6 t -121.07 -3.42 8.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.347 0.594 . . . . 0.0 109.961 177.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -101.76 172.3 7.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.718 -173.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.583 ' HB3' ' HE ' ' B' ' 45' ' ' ARG . 14.8 m-20 -111.39 106.42 15.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.525 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 61' ' ' LYS . 22.0 p90 -124.84 142.5 51.4 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.987 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -120.4 138.76 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.194 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' GLU . 57.0 mt -100.2 109.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.084 0.468 . . . . 0.0 110.664 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.43 90.1 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.149 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.49 -2.55 46.12 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.457 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.53 -30.47 1.42 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.149 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 31.1 mt-10 -88.13 145.33 25.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.207 0.527 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.463 HG23 ' CD2' ' B' ' 35' ' ' TYR . 61.7 mt -95.8 130.29 44.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.072 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.61 122.15 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.268 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 23' ' ' ASP . 93.7 mt -62.15 144.69 55.07 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' CB ' ' B' ' 48' ' ' LEU . 48.0 mtm180 -69.27 -0.24 5.89 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.238 178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.56 -27.23 64.96 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.1 2.54 5.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.025 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.587 ' CB ' ' HA ' ' B' ' 45' ' ' ARG . 32.5 tp -58.72 -40.75 84.62 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 -175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.49 -42.23 74.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.458 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -75.0 -40.02 60.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.587 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.05 -34.1 77.61 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.292 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' B' ' 56' ' ' LEU . 20.2 mt -72.19 -29.41 63.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.085 0.469 . . . . 0.0 110.585 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -65.46 -50.44 65.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 110.193 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.42 -48.64 12.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.244 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' GLN . . . . . 0.629 ' HG3' ' H ' ' B' ' 57' ' ' GLY . 4.3 tp-100 -96.02 -67.6 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.515 -174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' B' ' 52' ' ' LEU . 4.9 tp 42.74 40.26 1.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.743 0.652 . . . . 0.0 109.509 -171.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.629 ' H ' ' HG3' ' B' ' 55' ' ' GLN . . . -101.41 -24.35 8.91 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.489 -0.862 . . . . 0.0 114.1 -165.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' B' ' 58' ' ' PHE . 0.0 OUTLIER 53.72 -151.77 0.33 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -175.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.7 tp10 -116.44 101.78 8.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -107.33 111.83 24.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.582 -171.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.512 ' HE2' ' OE1' ' B' ' 59' ' ' GLU . 73.5 mmtt -124.62 -169.56 2.0 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.728 0.775 . . . . 0.0 110.99 -175.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.584 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 6.4 p30 -169.35 -159.44 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.06 57.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 118.531 0.605 . . . . 0.0 111.417 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 61.19 19.79 10.39 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.074 0.55 . . . . 0.0 111.161 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.02 -25.31 58.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 -176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 46.91 80.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.6 0.714 . . . . 0.0 110.528 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -137.1 72.92 1.43 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.948 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -64.78 132.2 48.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -73.08 -6.74 47.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.375 0.607 . . . . 0.0 110.713 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -131.11 104.73 7.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -62.69 107.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.412 0.625 . . . . 0.0 112.016 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.894 175.896 . . . . . . . . 0 0 . 1 stop_ save_